Selected Publications
1. Ackermann, U., et al. (2023). “18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2.” Nuclear Medicine and Biology 116: 108308.
2. Aguado, L., et al. (2023). “Therapeutic effect of α 7 nicotinic receptor activation after ischemic stroke in rats.” Journal of Cerebral Blood Flow & Metabolism: 0271678X231161207.
3. Ahenkorah, S., et al. (2023). “Direct comparison of [18F] AlF-NOTA-JR11 and [18F] AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist.” Nuclear Medicine and Biology 118: 108338.
4. Altomonte, S., et al. (2023). “Discovery of a High-Affinity Fluoromethyl Analog of [11C] 5-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl) phenyl) furan-2-carboxamide ([11C] CPPC) and Their Comparison in Mouse and Monkey as Colony-Stimulating Factor 1 Receptor Positron Emission Tomography Radioligands.” ACS Pharmacology & Translational Science 6(4): 614-632.
5. Alves, R. C., et al. (2023). “Folic acid-conjugated curcumin-loaded bioMOF-101 for breast cancer therapy.” Journal of Drug Delivery Science and Technology: 104702.
6. Andersen, K. B., et al. (2023). “Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C] UCB‐J and [18F] FDG PET Study.” Movement Disorders.
7. Arteaga, A., et al. (2023). “A Model Study to Evaluate Osseointegration and Fracture Healing Following Open Reduction and Internal Fixation (ORIF) in Diabetic Lewis Rats.” The Journal of Foot and Ankle Surgery.
8. Ballweg, A., et al. (2023). “[18F] F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data.” Journal of Neuroinflammation 20(1): 68.
9. Bartos, L. M., et al. (2023). “Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution.” bioRxiv: 2023.2001. 2026.522174.
10. Beall, M., et al. (2023). “Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Predicting Venous Thromboembolism in Children With Lymphoma.” Circulation: Cardiovascular Imaging 16(4): e014992.
11. Bhaidana, H. and D. Paikaray (2023). PET Imaging for Alzheimer’s Neuroanatomical Disease Diagnosis. 2023 International Conference on Artificial Intelligence and Smart Communication (AISC), IEEE.
12. Bilbao‐Asensio, M., et al. (2023). “Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt (IV)‐Prodrug Chemoimmunotherapy Approach.” Advanced Therapeutics 6(2): 2200179.
13. Bonaventura, J., et al. (2023). “Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging.” Science Translational Medicine 15(706): eadd1014.
14. Bouter, C., et al. (2023). “Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice.” Journal of Neural Transmission: 1-15.
15. Brosch-Lenz, J., et al. (2023). “Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy.” Journal of Nuclear Medicine 64(5): 767-774.
16. Brown, K. G., et al. (2023). “Assessment of Transarterial Chemoembolization Using Super-resolution Ultrasound Imaging and a Rat Model of Hepatocellular Carcinoma.” Ultrasound in medicine & biology 49(5): 1318-1326.
17. Brumberg, J., et al. (2023). “Quantification of the purinergic P2X7 receptor with [11C] SMW139 improves through correction for brain-penetrating radiometabolites.” Journal of Cerebral Blood Flow & Metabolism 43(2): 258-268.
18. Buechel, R. R., et al. (2023). “Long-term impact of myocardial inflammation on quantitative myocardial perfusion—a descriptive PET/MR myocarditis study.” European Journal of Nuclear Medicine and Molecular Imaging: 1-10.
19. Cai, L., et al. (2023). “Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (11C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors.” EJNMMI research 13(1): 1-11.
20. Campión, R., et al. (2023). “Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin.” International Journal of Pharmaceutics: 123216.
21. Ceyzériat, K., et al. (2023). “Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum.” Molecular Brain 16(1): 1-11.
22. Chang, K.-W., et al. (2023). “The Titrated Mannitol Improved Central [99mTc] Tc TRODAT-1 Uptake in an Animal Model—A Clinically Feasible Application.” International Journal of Molecular Sciences 24(4): 3773.
23. Chapeau, D., et al. (2023). “[212Pb] Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors.” Pharmaceuticals 16(7): 985.
24. Chen, C.-W., et al. (2023). “Amygdala substructure volumes and serotonin transporter in first-episode, drug-naïve major depressive disorder: A pilot study.” Journal of Psychiatric Research 160: 210-216.
25. Chen, R., et al. (2023). “First total-body kinetic modeling and parametric imaging of dynamic 68Ga-FAPI-04 PET in pancreatic and gastric cancer.” Journal of Nuclear Medicine 64(6): 960-967.
26. Chen, Y., et al. (2023). “18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging.” Frontiers in Oncology 13: 1047080.
27. Chen, Y.-H., et al. (2023). “Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma.” Annals of Nuclear Medicine 37(2): 139-150.
28. Chen, Y.-H., et al. (2023). “The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease.” Nuclear Medicine Communications 44(1): 100-107.
29. Chen, Y.-H., et al. (2023). “Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer.” International Journal of Molecular Sciences 24(4): 3988.
30. Chen, Y.-J., et al. (2023). Assessment of Brown and Beige Adipose Tissue Activation in Mice Using PET/CT Imaging. Thermogenic Fat: Methods and Protocols, Springer: 135-145.
31. Chen, Z., et al. (2023). “Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography.” Movement Disorders.
32. Cheung, P., et al. (2023). “[18F] MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44.” Pharmaceutics 15(2): 499.
33. Choen, S., et al. (2023). “Kinetic Evaluation of the Hypoxia Radiotracers [18F] FMISO and [18F] FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging.” Nuclear Medicine and Molecular Imaging 57(1): 16-25.
34. Choi, K.-M., et al. (2023). “Regulation of beige adipocyte thermogenesis by the cold-repressed ER protein NNAT.” Molecular Metabolism 69: 101679.
35. Chotiwan, N., et al. (2023). “Type I interferon shapes brain distribution and tropism of tick-borne flavivirus.” Nature Communications 14(1): 2007.
36. Chou, T.-H., et al. (2023). “Vessel-by-vessel analysis of lower extremity 18F-NaF PET/CT imaging quantifies diabetes-and chronic kidney disease-induced active microcalcification in patients with peripheral arterial disease.” EJNMMI research 13(1): 1-10.
37. Coelho, M., et al. (2023). “Adjustierung der Rechts-Links-Shunt Normwerte für die Lungenperfusionsszintigraphie unter Berücksichtigung von nicht-gebundenem 99mTc.” Nuklearmedizin-NuclearMedicine 62(02): 167-168.
38. Colon-Mesa, I., et al. (2023). “p27 Kip1 Deficiency Impairs Brown Adipose Tissue Function Favouring Fat Accumulation in Mice.” International Journal of Molecular Sciences 24(3): 2664.
39. Cools, R., et al. (2023). “Radiosynthesis and preclinical evaluation of [11C] SNX-ab as an Hsp90α, β isoform-selective PET probe for in vivo brain and tumour imaging.” EJNMMI Radiopharmacy and Chemistry 8(1): 2.
40. Cosialls, R., et al. (2023). “Ammonium trifluoroborate-modified poly (β-aminoesters): A case study for PET-guided in vivo pharmacokinetic studies of a non-viral gene delivery system.” Journal of Controlled Release 358: 739-751.
41. Costa, P. F., et al. (2023). “18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men.” Journal of Nuclear Medicine 64(4): 598-604.
42. Cui, Y., et al. (2022). “FDG PET Imaging of the Pain Matrix in Neuropathic Pain Model Rats.” Biomedicines 11(1): 63.
43. Czoty, P. W., et al. (2023). “Association of dopamine D2-like and D3 receptor function with initial sensitivity to cocaine reinforcement in male rhesus monkeys.” Brain Research 1807: 148323.
44. da Cunha-Bang, S., et al. (2023). “The association between brain serotonin transporter binding and impulsivity and aggression in healthy individuals.” Journal of Psychiatric Research 165: 1-6.
45. Dehghankelishadi, P., et al. (2023). “Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects.” Journal of Nanobiotechnology 21(1): 102.
46. Destro, G., et al. (2023). “A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy.” Nuclear Medicine and Biology 116: 108312.
47. Dias, A. H., et al. (2023). “Multiparametric dynamic whole-body PSMA PET/CT using [68Ga] Ga-PSMA-11 and [18F] PSMA-1007.” EJNMMI research 13(1): 1-13.
48. Diep, Y. N., et al. (2023). “Astrocytic scar restricting glioblastoma via glutamate–MAO-B activity in glioblastoma-microglia assembloid.” Biomaterials Research 27(1): 71.
49. Díez-Villares, S., et al. (2023). “Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions.” Journal of Controlled Release 356: 702-713.
50. Ding, W., et al. (2023). “A Shortened Model for Logan Reference Plot Implemented via the Self-Supervised Neural Network for Parametric PET Imaging.” IEEE Transactions on Medical Imaging.
51. Ding, W., et al. (2023). “Foramen lacerum impingement of trigeminal nerve root as a rodent model for trigeminal neuralgia.” JCI insight 8(11).
52. Dongxiang, W., et al. (2023). “Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [18F] FDG PET/CT parameters.” European Radiology 33(4): 2840-2849.
53. Doppler, M., et al. (2023). “Predictive Value of [99mTc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [90Y]-TARE: A Single-Center Experience.” Diagnostics 13(14): 2432.
54. dos Santos, S. N., et al. (2023). “Development of glycan-targeted nanoparticles as a novel therapeutic opportunity for gastric cancer treatment.” Cancer Nanotechnology 14(1): 1-21.
55. Drescher, R., et al. (2023). “PET/CT of the Spleen with Gallium-Oxine-Labeled, Heat-Damaged Red Blood Cells: Clinical Experience and Technical Aspects.” Diagnostics 13(3): 566.
56. Du, Y., et al. (2023). “[18F] FNDP PET neuroimaging test–retest repeatability and whole-body dosimetry in humans.” European Journal of Nuclear Medicine and Molecular Imaging: 1-7.
57. Du, Y., et al. (2023). “First-in-human imaging using [11C] MDTC: a radiotracer targeting the cannabinoid receptor type 2.” European Journal of Nuclear Medicine and Molecular Imaging: 1-8.
58. Dumont, L., et al. (2023). “Inhibition of the beta-1 adrenergic receptor does not potentiate mirabegron-stimulated human brown adipose tissue thermogenesis.” medRxiv: 2023.2003. 2022.23287600.
59. Eiro, T., et al. (2023). “Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy.” Cell Reports Medicine 4(5).
60. Engel, B. J., et al. (2023). “Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging.” Cancers 15(15): 3787.
61. Etter, D., et al. (2023). “Towards universal comparability of pericoronary adipose tissue attenuation: a coronary computed tomography angiography phantom study.” European Radiology 33(4): 2324-2330.
62. Facchin, C., et al. (2023). “Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino-and 6, 6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model.” Cells 12(6): 914.
63. Farn, S.-S., et al. (2023). “Automated Synthesis of [18F] Flumazenil Application in GABAA Receptor Neuroimaging Availability for Rat Model of Anxiety.” Pharmaceuticals 16(3): 417.
64. Fayard, A., et al. (2023). “Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.” Neurobiology of Disease 180: 106086.
65. Finze, A., et al. (2023). “Individual regional associations between Aβ-, tau-and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies.” Molecular Psychiatry: 1-13.
66. Fozzato, A., et al. (2023). “Manipulating mitochondrial dynamics in the NTS prevents diet-induced deficits in brown fat morphology and glucose uptake.” Life Sciences: 121922.
67. Fozzato, A., et al. (2023). “Manipulating mitochondrial dynamics in the NTS prevents diet-induced deficits in brown fat morphology and glucose uptake.” bioRxiv: 2023.2001. 2004.522581.
68. Fuglø, D., et al. (2023). “Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls—a Quantitative [18F] Fluoride PET Study.” Molecular Imaging and Biology: 1-9.
69. Galineau, L., et al. (2023). “Glutamatergic synapse in autism: a complex story for a complex disorder.” Molecular Psychiatry 28(2): 801-809.
70. García-García, L., et al. (2023). “The vasodilator naftidrofuryl attenuates short-term brain glucose hypometabolism in the lithium-pilocarpine rat model of status epilepticus without providing neuroprotection.” European Journal of Pharmacology 939: 175453.
71. Gnörich, J., et al. (2023). “Depletion and activation of microglia impact metabolic connectivity of the mouse brain.” Journal of Neuroinflammation 20(1): 47.
72. Guttman, Z., et al. (2023). “Decomposing risky decision-making in methamphetamine use disorder: Behavioral updating and D2 dopamine receptors.” Drug and alcohol dependence 246: 109860.
73. Ha, L. J., et al. (2023). “Hypothalamic neuronal activation in primates drives naturalistic goal-directed eating behavior.” bioRxiv: 2023.2006. 2011.544288.
74. Hata, S., et al. (2023). “Brain p3‐Alcβ peptide restores neuronal viability impaired by Alzheimer’s amyloid β‐peptide.” EMBO Molecular Medicine: e17052.
75. Haustein, R., et al. (2023). “C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation.” Cells 12(3): 443.
76. Hilbrig, C., et al. (2023). “Evaluation of the EPR Effect in the CAM-Model by Molecular Imaging with MRI and PET Using 89Zr-Labeled HSA.” Cancers 15(4): 1126.
77. Hirata, K., et al. (2023). “Altered brain energy metabolism related to astrocytes in Alzheimer′ s disease.” medRxiv: 2023.2003. 2009.23286881.
78. Hiroyama, S., et al. (2023). “Evaluation of an Integrin αvβ3 Radiotracer,[18F] F-FPP-RGD2, for Monitoring Pharmacological Effects of Integrin αv siRNA in the NASH Liver.” Nuclear Medicine and Molecular Imaging: 1-8.
79. Hori, Y., et al. (2023). “Reduced serotonergic transmission alters sensitivity to cost and reward via 5-HT1A and 5-HT1B receptors in monkeys.” bioRxiv: 2023.2002. 2023.529630.
80. Hori, Y., et al. (2023). “Multimodal imaging for validation and optimization of ion channel-based chemogenetics in nonhuman primates.” bioRxiv: 2023.2007. 2006.547946.
81. Horie, S., et al. (2023). “Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2.” Cancer Science.
82. Iker Etchegaray, J., et al. (2023). “Phagocytosis in the retina promotes local insulin production in the eye.” Nature Metabolism 5(2): 207-218.
83. Imai, S., et al. (2023). “Estimation of Microvascular Dysfunction by Using 13N-Ammonia Positron Emission Tomography with Quantitative Myocardial Blood Flow Analysis in Chronic Coronary Syndrome.” Journal of Nippon Medical School 90(2): 228-236.
84. Ishii, H., et al. (2023). “Evaluation and improvement of CuI‐mediated 11C‐cyanation.” Journal of Labelled Compounds and Radiopharmaceuticals 66(3): 95-107.
85. Janovska, P., et al. (2023). “Impairment of adrenergically-regulated thermogenesis in brown fat of obesity-resistant mice is compensated by non-shivering thermogenesis in skeletal muscle.” Molecular Metabolism 69: 101683.
86. Jansen, T. J., et al. (2023). “Monitoring beta cell survival after intrahepatic islet transplantation using dynamic exendin PET imaging: a proof-of-concept study in individuals with type 1 diabetes.” Diabetes: db220884.
87. Janssen, B., et al. (2023). “Identification of a Putative α-synuclein Radioligand Using an in silico Similarity Search.” Molecular Imaging and Biology: 1-16.
88. Janssen, L., et al. (2023). “Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia.” American Journal of Physiology-Endocrinology and Metabolism 324(3): E209-E216.
89. Jiang, X., et al. (2023). “Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts.” Alzheimer’s & Dementia.
90. Jiao, J., et al. (2023). “NiftyPAD-Novel Python package for quantitative analysis of dynamic PET data.” Neuroinformatics 21(2): 457-468.
91. Jiao, R., et al. (2023). “A Theranostic Approach to Imaging and Treating Melanoma with 203Pb/212Pb-Labeled Antibody Targeting Melanin.” Cancers 15(15): 3856.
92. Johnson, B. N., et al. (2023). “PET imaging of kappa opioid receptors and receptor expression quantified in neuron-derived extracellular vesicles in socially housed female and male cynomolgus macaques.” Neuropsychopharmacology 48(2): 410-417.
93. Jonker, I., et al. (2023). “Antiviral treatment in schizophrenia: a randomized pilot PET study on the effects of valaciclovir on neuroinflammation.” Psychological Medicine: 1-9.
94. Kagitani-Shimono, K., et al. (2023). “Extension of microglial activation is associated with epilepsy and cognitive dysfunction in Tuberous sclerosis complex: A TSPO-PET study.” NeuroImage: Clinical 37: 103288.
95. Kapadia, A., et al. (2023). “Hypoperfusion Precedes Tau Deposition in the Entorhinal Cortex: A Retrospective Evaluation of ADNI-2 Data.” Journal of Clinical Neurology (Seoul, Korea) 19(2): 131.
96. Kasahara, S., et al. (2023). “Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole.” Frontiers in Pain Research 4: 1159134.
97. Kato, Y., et al. (2023). “Lower availability of mitochondrial complex I in anterior cingulate cortex in autism: a positron emission tomography study.” American Journal of Psychiatry 180(4): 277-284.
98. Katzdobler, S., et al. (2023). “Additive value of [18F] PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome.” European Journal of Nuclear Medicine and Molecular Imaging 50(2): 423-434.
99. Kersting, D., et al. (2023). “Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy.” Journal of Nuclear Medicine 64(2): 329-336.
100. Kesarwani, P., et al. (2023). “Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR/PPARγ signaling axis.” Nature Communications 14(1): 1459.
101. Kesić, M., et al. (2023). “Constitutive Serotonin Tone as a Modulator of Brown Adipose Tissue Thermogenesis: A Rat Study.” Life 13(7): 1436.
102. Kim, H., et al. (2023). “Magnetothermal-based non-invasive focused magnetic stimulation for functional recovery in chronic stroke treatment.” Scientific Reports 13(1): 4988.
103. Kim, J.-H., et al. (2023). “The Relationship between Character Traits and In Vivo Cerebral Serotonin Transporter Availability in Healthy Subjects: A High-Resolution PET Study with C-11 DASB.” Pharmaceuticals 16(5): 759.
104. Kim, M. S., et al. (2023). “Dual‐phase 18F‐FP‐CIT positron emission tomography and cardiac 123I‐MIBG scintigraphy of Parkinson’s disease patients with GBA mutations: evidence of the body‐first type?” European Journal of Neurology 30(2): 344-352.
105. Kim, S. B., et al. (2023). “Theranostic Surrogacy of [123I] NaI for Differentiated Thyroid Cancer Radionuclide Therapy.” Molecular Pharmaceutics.
106. Kim, S. J. W., et al. (2023). “A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([18F] GE-180) PET/MRI.” Frontiers in Medicine 10: 1091463.
107. Kitamura, S., et al. (2023). “Serotonergic neurotransmission in limbic regions may reflect therapeutic response of depressive patients: A PET study with 11C-WAY-100635 and 18F-MPPF.” International Journal of Neuropsychopharmacology: pyad026.
108. Ko, K.-Y., et al. (2023). “Myocardial Flow Assessment After Heart Transplantation Using Dynamic Cadmium-Zinc-Telluride Single-Photon Emission Computed Tomography With 201Tl and 99mTc Tracers and Validated by 13N-NH3 Positron Emission Tomography.” Circulation: Cardiovascular Imaging 16(6): e015034.
109. Kobayashi, R., et al. (2023). “In vivo [18F] THK-5351 imaging detected reactive astrogliosis in argyrophilic grain disease with comorbid pathology: A clinicopathological study.” Journal of Neuropathology & Experimental Neurology 82(5): 427-437.
110. Kroll, S. L., et al. (2023). “Plasma endocannabinoids in cocaine dependence and their interaction with cocaine craving and metabotropic glutamate receptor 5 density in the human brain.” bioRxiv: 2023.2004. 2018.537293.
111. Kubota, M., et al. (2023). “Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.” Schizophrenia Bulletin 49(3): 688-696.
112. Kumagai, S., et al. (2023). “Early distribution of18 F‐labeled AAV9 vectors in the cerebrospinal fluid after intracerebroventricular or intracisternal magna infusion in non‐human primates.” The Journal of Gene Medicine 25(1): e3457.
113. Kunert, J.-P., et al. (2023). “Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer.” EJNMMI research 13(1): 2.
114. Kunze, L. H., et al. (2023). “Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice.” International Journal of Molecular Sciences 24(12): 10106.
115. Laiglesia, L. M., et al. (2023). “Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice.” Molecular Metabolism: 101749.
116. Lang, M., et al. (2023). “Static and dynamic 68Ga-FAPI PET/CT for the detection of malignant transformation of intraductal papillary mucinous neoplasia of the pancreas.” Journal of Nuclear Medicine 64(2): 244-251.
117. Lapo Pais, M., et al. (2023). “Textural properties of microglial activation in Alzheimer’s disease as measured by (R)-[11C] PK11195 PET.” Brain Communications 5(3): fcad148.
118. Lerchner, W., et al. (2023). “Current Research in Neurobiology.” Current Research in Neurobiology 4: 100091.
119. Lerchner, W., et al. (2023). “Efficient viral expression of a chemogenetic receptor in the old-world monkey amygdala.” Current Research in Neurobiology: 100091.
120. Levinstein, M. R., et al. (2023). “6-O-(2-[18F] Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F] FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo.” Molecular Imaging and Biology 25(2): 384-390.
121. Li, L., et al. (2023). “Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga] Ga-nanobody: from bench to bedside.” European Journal of Nuclear Medicine and Molecular Imaging: 1-15.
122. Li, L., et al. (2023). “Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography.” Quantitative Imaging in Medicine and Surgery 13(8): 5183.
123. Li, L.-F., et al. (2023). “Attenuation of Ventilation-Enhanced Epithelial–Mesenchymal Transition through the Phosphoinositide 3-Kinase-γ in a Murine Bleomycin-Induced Acute Lung Injury Model.” International Journal of Molecular Sciences 24(6): 5538.
124. Li, X., et al. (2023). “In situ-formed micro silk fibroin composite sutures for pain management and anti-infection.” Composites Part B: Engineering 260: 110729.
125. Li, Y., et al. (2023). “Fluorine-18-Labeled Diaryl-azines as Improved β-Amyloid Imaging Tracers: From Bench to First-in-Human Studies.” Journal of Medicinal Chemistry 66(7): 4603-4616.
126. Li, Z., et al. (2023). “Combination of pre-treatment dynamic [18F] FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma.” European Journal of Nuclear Medicine and Molecular Imaging 50(2): 535-545.
127. Liang, C., et al. (2023). “Abnormal [18F] NIFENE binding in transgenic 5xFAD mouse model of Alzheimer’s disease: In vivo PET/CT imaging studies of α4β2* nicotinic acetylcholinergic receptors and in vitro correlations with Aβ plaques.” Synapse 77(3): e22265.
128. Lin, H.-C., et al. (2023). “Visual reading for [18F] Florzolotau ([18F] APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease.” Frontiers in Neuroscience 17: 1148054.
129. Lin, Y.-S., et al. (2023). “Repeated Caffeine Intake Suppresses Cerebral Grey Matter Responses to Chronic Sleep Restriction in an A1 Adenosine Receptor-Dependent Manner.” bioRxiv: 2023.2007. 2023.550201.
130. Lindemann, M., et al. (2023). “Glioblastoma PET/MRI: kinetic investigation of [18F] rhPSMA-7.3,[18F] FET and [18F] fluciclovine in an orthotopic mouse model of cancer.” European Journal of Nuclear Medicine and Molecular Imaging 50(4): 1183-1194.
131. Lindheimer, F., et al. (2023). “Non-invasive in vivo imaging of porcine islet xenografts in a preclinical model with [68Ga] Ga-exendin-4.” Frontiers in Nuclear Medicine 3: 1157480.
132. Liu, G., et al. (2023). “Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors.” European Journal of Medicinal Chemistry 254: 115327.
133. Liu, T., et al. (2023). “Synthesis and Preclinical Evaluation of 2-(4-[18F] Fluorophenyl) imidazo [1, 2-h][1, 7] naphthyridine ([18F] FPND-4): An Aza-Fused Tricyclic Derivative as Positron Emission Tomography Tracer for Neurofibrillary Tangle Imaging.” Journal of Medicinal Chemistry.
134. Longo, M., et al. (2023). “Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria.” International Journal of Molecular Sciences 24(15): 11938.
135. Lu, J., et al. (2023). “YY1 (Yin‐Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression.” Psychiatry and Clinical Neurosciences 77(3): 149-159.
136. Lu, J., et al. (2023). “Blood tau‐PT217 contributes to the anesthesia/surgery‐induced delirium‐like behavior in aged mice.” Alzheimer’s & Dementia.
137. Lu, X., et al. (2023). “68Ga-labeled WVP peptide as a novel PET probe for molecular biological diagnosis of unstable thoracic aortic aneurysm and early dissection: an animal study.” Frontiers in Cardiovascular Medicine 10: 1048927.
138. Ma, Y., et al. (2023). “Effects of Dl-3-n-butylphthalide on cognitive functions and blood–brain barrier in chronic cerebral hypoperfusion rats.” Naunyn-Schmiedeberg’s archives of pharmacology: 1-14.
139. Mannheim, J. G., et al. (2023). “Characterization of the partial volume effect along the axial field-of-view of the Biograph Vision Quadra total-body PET/CT system for multiple isotopes.” EJNMMI physics 10(1): 1-16.
140. Maric, I., et al. (2023). “Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma.” Journal of Nuclear Medicine 64(6): 885-891.
141. Martín-Saladich, Q., et al. (2023). “Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes: A Coronary Artery Analysis.” International Journal of Molecular Sciences 24(4): 3250.
142. Matsumoto, Y., et al. (2023). “Rapidly progressive cerebral atrophy following a posterior cranial fossa stroke: Assessment with semiautomatic CT volumetry.” Acta Neurochirurgica: 1-10.
143. Matsunaga, K., et al. (2023). “Effect of scan-time shortening on the 11C-PHNO binding potential to dopamine D3 receptor in humans and test–retest reliability.” Annals of Nuclear Medicine 37(4): 227-237.
144. Matsuoka, K., et al. (2023). “Association of Glutamate and N-Acetylaspartate Levels with Abnormal Protein Deposition in Alzheimer’s Disease: Insights from Magnetic Resonance Spectroscopic Imaging.” medRxiv: 2023.2004. 2023.23288989.
145. Matthews, D. C., et al. (2022). “Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.” Alzheimer’s & Dementia: Translational Research & Clinical Interventions 8(1): e12325.
146. McClain, S. P., et al. (2023). “In vivo photopharmacology with light-activated opioid drugs.” bioRxiv: 2023.2002. 2002.526901.
147. Michiels, L., et al. (2023). “Longitudinal Synaptic Density PET with 11C‐UCB‐J 6 Months After Ischemic Stroke.” Annals of Neurology 93(5): 911-921.
148. Michiels, L., et al. (2023). “In Vivo Detection of Neurofibrillary Tangles by 18F-MK-6240 PET/MR in Patients With Ischemic Stroke.” Neurology 100(1): e62-e71.
149. Mills, K. A., et al. (2023). “Microglial CSF1R radioligand [11C] CPPC as a marker of disease severity in early Parkinson′ s disease: a pilot study.” medRxiv: 2023.2005. 2028.23290647.
150. Mingels, C., et al. (2023). “Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT.” Annals of Nuclear Medicine 37(5): 310-315.
151. Miranda, A., et al. (2023). “Isoflurane and ketamine-xylazine modify pharmacokinetics of [18F] SynVesT-1 in the mouse brain.” Journal of Cerebral Blood Flow & Metabolism: 0271678X231173185.
152. Miwa, K., et al. (2023). “Impact of γ factor in the penalty function of Bayesian penalized likelihood reconstruction (Q. Clear) to achieve high-resolution PET images.” EJNMMI physics 10(1): 4.
153. Miyakawa, N., et al. (2023). “Chemogenetic attenuation of cortical seizures in nonhuman primates.” Nature Communications 14(1): 971.
154. Miyamoto, M., et al. (2023). “Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.” Annals of Nuclear Medicine 37(5): 300-309.
155. Moallemian, S., et al. (2023). “Multimodal imaging of microstructural cerebral changes and loss of synaptic density in Alzheimer’s disease.” medRxiv: 2023.2004. 2014.23288516.
156. Mohri, K., et al. (2023). “Lasso peptide microcin J25 variant containing RGD motif as a PET probe for integrin av ß 3 in tumor imaging.” European Journal of Pharmaceutical Sciences 180: 106339.
157. Morley, V., et al. (2023). “In vivo18F-DOPA PET imaging identifies a dopaminergic deficit in a rat model with a G51D α-synuclein mutation.” Frontiers in Neuroscience 17: 1095761.
158. Müller, L., et al. (2023). “Excitability and glymphatic function in an animal model of Alzheimer’s disease.” Alzheimer’s & Dementia 19: e059591.
159. Müller, L., et al. (2023). “[18F] GE-180-PET and Post Mortem Marker Characteristics of Long-Term High-Fat-Diet-Induced Chronic Neuroinflammation in Mice.” Biomolecules 13(5): 769.
160. Munk, D. E., et al. (2023). “Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders.” JoVE (Journal of Visualized Experiments)(194): e65109.
161. Murce, E., et al. (2023). “Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.” Pharmaceuticals 16(6): 882.
162. Murgaš, M., et al. (2023). “Effects of bilateral sequential theta-burst stimulation on 5-HT1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial.” Translational Psychiatry 13(1): 33.
163. Nagai, Y. and T. Minamimoto (2023). Methods to Verify Expression and Function of DREADDs Using PET. Vectorology for Optogenetics and Chemogenetics, Springer: 263-273.
164. Nguyen, D., et al. (2023). “Development of a rat model of lymphedema and the implantation of a collagen-based medical device for therapeutic intervention.” Frontiers in Cardiovascular Medicine 10.
165. Nguyen, T. D. T., et al. (2023). “Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.” Cancer Research 83(6): 939-955.
166. Ni, R., et al. (2023). “Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion.” Photoacoustics 32: 100532.
167. Niwa, T., et al. (2023). “Synthesis of 11C-Radiolabeled Eribulin as a Companion Diagnostics PET Tracer for Brain Glioblastoma.” Bulletin of the Chemical Society of Japan 96(3): 283-290.
168. Oh, S. J., et al. (2023). “Effects of Escitalopram on the Functional Neural Circuits in an Animal Model of Adolescent Depression.” Molecular Imaging and Biology: 1-9.
169. Oh, S. J., et al. (2023). “Effect of developmental stress on the in vivo neuronal circuits related to excitation–inhibition balance and mood in adulthood.” Frontiers in Psychiatry 14: 1086370.
170. Ohnishi, A., et al. (2023). “Dosimetry and efficacy of a tau PET tracer [18F] MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease.” Annals of Nuclear Medicine 37(2): 108-120.
171. O’Neill, E., et al. (2023). “Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome.” Theranostics 13(4): 1302.
172. Ote, K., et al. (2023). “List-mode PET image reconstruction using deep image prior.” IEEE Transactions on Medical Imaging.
173. Ou, G., et al. (2023). “Methylene blue targets PHD3 expression in murine microglia to mitigate lipopolysaccharide-induced neuroinflammation and neurocognitive impairments.” International Immunopharmacology 120: 110349.
174. Oya, M., et al. (2023). “Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism.” Scientific Reports 13(1): 11655.
175. Pantel, A. R., et al. (2023). “[18F] FluorThanatrace ([18F] FTT) PET imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer, a pilot study.” Clinical Cancer Research 29(8): 1515-1527.
176. Park, D. G., et al. (2023). “Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.” Journal of Neurology: 1-10.
177. Park, H. S., et al. (2023). “A robust multi-domain network for short-scanning amyloid PET reconstruction.” arXiv preprint arXiv:2305.09986.
178. Park, J., et al. (2023). “Combined Effects of Focused Ultrasound and Photodynamic Treatment for Malignant Brain Tumors Using C6 Glioma Rat Model.” Yonsei Medical Journal 64(4): 233.
179. Passannante, R., et al. (2023). “Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders.” Biomedicines 11(2): 253.
180. Pauwels, E., et al. (2023). “[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients.” European Journal of Nuclear Medicine and Molecular Imaging 50(4): 1134-1145.
181. Peñalva, R., et al. (2023). “Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect.” Food Hydrocolloids 136: 108213.
182. Peyronneau, M., et al. (2023). “[18F] DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function.” European Journal of Nuclear Medicine and Molecular Imaging: 1-14.
183. Pistone, D., et al. (2023). “18F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter-and intra-patient variability.” Physics in Medicine & Biology 68(8): 085015.
184. Poply, K., et al. (2023). “ID: 213463 Dynamic Brain Imaging Response to SCS Differential Frequencies:(DIFY SCS-PET), A Pilot Double-Blind Clinical Trial.” Neuromodulation 26(4): S133.
185. Poxleitner, M., et al. (2023). “Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis.” bioRxiv: 2023.2002. 2015.528645.
186. Puri, T., et al. (2023). “Input function and modeling for determining bone metabolic flux using [18F] sodium fluoride PET imaging: A step‐by‐step guide.” Medical Physics 50(4): 2071-2088.
187. Puuvuori, E., et al. (2023). “PET imaging of neutrophil elastase with 11C-GW457427 in Acute Respiratory Distress Syndrome in pigs.” Journal of Nuclear Medicine 64(3): 423-429.
188. Qiao, N., et al. (2023). “Kinsenoside alleviates oxidative stress-induced blood-brain barrier dysfunction via promoting Nrf2/HO-1 pathway in ischemic stroke.” European Journal of Pharmacology 949: 175717.
189. Qiu, L., et al. (2023). “Discovery of a Promising Fluorine-18 Positron Emission Tomography Radiotracer for Imaging Sphingosine-1-Phosphate Receptor 1 in the Brain.” Journal of Medicinal Chemistry 66(7): 4671-4688.
190. Rainio, O., et al. (2023). “Carimas: an extensive medical imaging data processing tool for research.” Journal of Digital Imaging: 1-9.
191. Rauber, S., et al. (2023). “Molecular Imaging with Fibroblast Activation Protein Tracers Depicts Inflammatory Joint Damage and Its Transition to Resolution of Inflammation.” bioRxiv: 2023.2001. 2017.524425.
192. Read, A. D., et al. (2023). “Electron Leak From the Mitochondrial Electron Transport Chain Complex I at Site IQ Is Crucial for Oxygen Sensing in Rabbit and Human Ductus Arteriosus.” Journal of the American Heart Association: e029131.
193. Reed, M. B., et al. (2023). “Comparison of cardiac image-derived input functions for quantitative whole body [18F] FDG imaging with arterial blood sampling.” Frontiers in Physiology 14: 1074052.
194. Resch, S., et al. (2023). “Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition.” EJNMMI physics 10(1): 11.
195. Rimmerman, E. T., et al. (2023). “Vessel-by-Vessel Computed Tomography Calcium Scoring of the Foot in Peripheral Artery Disease: Association with Patient-Level Factors.” Advances in Wound Care.
196. Ríos, C., et al. (2023). “Characterization of the anticonvulsant effect of dapsone on metabolic activity assessed by [18F] FDG-PET after kainic acid-induced status epilepticus in rats.” Brain Research 1803: 148227.
197. Robert, S. M., et al. (2023). “The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus.” Cell 186(4): 764-785. e721.
198. Robertson, N., et al. (2023). “Omniparticle Contrast Agent for Multimodal Imaging: Synthesis and Characterization in an Animal Model.” Molecular Imaging and Biology 25(2): 401-412.
199. Rua, M., et al. (2023). “Infection-specific PET imaging with 18F-fluorodeoxysorbitol and 2-[18F] F-ρ-aminobenzoic acid: An extended diagnostic tool for bacterial and fungal diseases.” Frontiers in Microbiology 14: 1094929.
200. Rubin, L. H., et al. (2023). “Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.” AIDS: 10.1097.
201. Sachpekidis, C., et al. (2023). “Application of the long axial field-of-view PET/CT with low-dose [18F] FDG in melanoma.” European Journal of Nuclear Medicine and Molecular Imaging 50(4): 1158-1167.
202. Sari, H., et al. (2023). “Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [18F]-FDG datasets from a long axial FOV PET scanner.” European Journal of Nuclear Medicine and Molecular Imaging 50(2): 257-265.
203. Sarrhini, O., et al. (2023). “Enhanced Extraction of Blood and Tissue Time-Activity Curves in Cardiac Mouse FDG PET Imaging by Means of Constrained Nonnegative Matrix Factorization.” International Journal of Biomedical Imaging 2023.
204. Sasaki, K., et al. (2023). “Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys.” Journal of Controlled Release 359: 384-399.
205. Schadt, F., et al. (2023). “Analysis of cerebral glucose metabolism following experimental subarachnoid hemorrhage over 7 days.” Scientific Reports 13(1): 427.
206. Schindler, L., et al. (2022). “Neurotensin analogs by fluoroglycosylation at N ω-carbamoylated arginines for PET imaging of NTS1-positive tumors.” Scientific Reports 12(1): 15028.
207. Schollhammer, R., et al. (2023). “Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study.” Journal of Nuclear Medicine 64(3): 379-385.
208. Seibyl, J. P., et al. (2023). “A visual interpretation algorithm for assessing brain tauopathy with 18F-MK-6240 PET.” Journal of Nuclear Medicine 64(3): 444-451.
209. Seifert, P., et al. (2023). “Optimization of Thyroid Volume Determination by Stitched 3D-Ultrasound Data Sets in Patients with Structural Thyroid Disease.” Biomedicines 11(2): 381.
210. Seo, Y., et al. (2023). “Endogenous Neural Stem Cell Activation after Low-Intensity Focused Ultrasound-Induced Blood–Brain Barrier Modulation.” International Journal of Molecular Sciences 24(6): 5712.
211. Settelmeier, S., et al. (2023). “Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo.” Pharmaceuticals 16(6): 824.
212. Shao, D., et al. (2023). “Brain glucose metabolism and dopamine transporter changes in rats with morphine‐induced conditioned place preference.” Addiction Biology 28(5): e13277.
213. Shao, X., et al. (2023). “Dynamic evolution and mechanism of myocardial glucose metabolism in different functional phenotypes of diabetic cardiomyopathy—a study based on 18 F-FDG microPET myocardial metabolic imaging.” Diabetology & Metabolic Syndrome 15(1): 64.
214. Sharma, G., et al. (2023). “Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma.” Cancers 15(12): 3131.
215. Shimohama, S., et al. (2023). “Impact of amyloid and tau PET on changes in diagnosis and patient management.” Neurology 100(3): e264-e274.
216. Shin, H., et al. (2023). “Vision Transformer Approach for Classification of Alzheimer’s Disease Using 18F-Florbetaben Brain Images.” Applied Sciences 13(6): 3453.
217. Simo, C., et al. (2023). “Positron Emission Tomography Studies of the Biodistribution, Translocation, and Fate of Poly Allyl Amine‐Based Carriers for Sirna Delivery by Systemic and Intratumoral Administration.” Small: 2304326.
218. Simón, J. A., et al. (2023). “Radiolabeled risperidone microSPECT/CT imaging for intranasal implant studies development.” Pharmaceutics 15(3): 843.
219. Simon, K. S., et al. (2023). “Innovative Pre-Clinical Data Using Peptides to Intervene in the Evolution of Pulmonary Fibrosis.” International Journal of Molecular Sciences 24(13): 11049.
220. Simpson, S. R., et al. (2023). “Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET.” Journal of Nuclear Medicine 64(5): 809-815.
221. Slowing, K., et al. (2023). “PET imaging and neurohistochemistry reveal that curcumin attenuates brain hypometabolism and hippocampal damage induced by status epilepticus in rats.” Planta Medica 89(04): 364-376.
222. Smucny, J., et al. (2023). “Increased Striatal Presynaptic Dopamine in a Nonhuman Primate Model of Maternal Immune Activation: A Longitudinal Neurodevelopmental Positron Emission Tomography Study With Implications for Schizophrenia.” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 8(5): 505-513.
223. Solingapuram Sai, K. K., et al. (2023). “Effect of Electronic Cigarette Liquid pH on Retention of 11C-Nicotine in a Respiratory Tract Model.” Nicotine and Tobacco Research 25(7): 1406-1410.
224. Son, S. H., et al. (2023). “Brain FDG PET for visualizing the relation between impaired lung function and cognitive decline in lung cancer: a preliminary study.” Nuclear Medicine Communications 44(6): 488-494.
225. Song, A. K., et al. (2023). “Parasagittal dural space hypertrophy and amyloid-β deposition in Alzheimer’s disease.” Brain Communications 5(3): fcad128.
226. Soyer, A., et al. (2023). “Validation of a pharmacological imaging challenge using 11C-buprenorphine and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain.” Frontiers in Neuroscience 17: 1181786.
227. Spies, M., et al. (2023). “Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo.” Translational Psychiatry 13(1): 208.
228. Staanum, P. F. (2023). “Tumor dosimetry using 177Lu: influence of background activity, measurement method and reconstruction algorithm.” EJNMMI physics 10(1): 1-22.
229. Straat, M. E., et al. (2023). “Stimulation of the beta-2-adrenergic receptor with salbutamol activates human brown adipose tissue.” Cell Reports Medicine 4(2).
230. Suchacki, K. J., et al. (2023). “The serotonin transporter sustains human brown adipose tissue thermogenesis.” Nature Metabolism: 1-18.
231. Tada, T., et al. (2023). “Comparative examination of the pons and corpus callosum as reference regions for quantitative evaluation in positron emission tomography imaging for Alzheimer’s disease using 11C-Pittsburgh Compound-B.” Annals of Nuclear Medicine: 1-9.
232. Takakuwa, N., et al. (2023). “Protocol for making an animal model of “blindsight” in macaque monkeys.” STAR protocols 4(1): 101960.
233. Takita, H., et al. (2023). “Correlation between Phase-difference-enhanced MR Imaging and Amyloid Positron Emission Tomography: A Study on Alzheimer’s Disease Patients and Normal Controls.” Magnetic Resonance in Medical Sciences 22(1): 67-78.
234. Tanada, T., et al. (2023). “Quantification of myocardial blood flow and myocardial flow reserve by 13N-NH3 PET/CT is not significantly affected by pixel size.” The International Journal of Cardiovascular Imaging 39(1): 195-199.
235. Tang, J. M., et al. (2023). “A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F] FEPPA PET.” International Journal of Molecular Sciences 24(8): 7522.
236. Thanapornsangsuth, P., et al. (2023). “Prospective evaluation of plasma phosphorylated tau in a real‐life memory clinic in Thailand.” Alzheimer’s & Dementia.
237. Tichelman, N. L., et al. (2023). “A genetic variation in the adenosine A2A receptor gene contributes to variability in oscillatory alpha power in wake and sleep EEG and A1 adenosine receptor availability in the human brain.” bioRxiv: 2023.2003. 2001.530170.
238. Trang, N. N., et al. (2023). “Ketogenic diet modulates cardiac metabolic dysregulation in streptozocin-induced diabetic rats.” The Journal of Nutritional Biochemistry 111: 109161.
239. Tsai, Y. T., et al. (2023). “Social cognitive deficit is associated with visuomotor coordination impairment and dopamine transporter availability in euthymic bipolar disorder.” Journal of Psychiatric Research.
240. Tsuchihashi, S., et al. (2023). “Development of Novel 111In/225Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics.” Journal of Medicinal Chemistry.
241. Ueberham, L., et al. (2023). “Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [18F] LUZ5-d 8.” Journal of Medicinal Chemistry 66(7): 5242-5260.
242. Unda, S. R., et al. (2023). “Bidirectional Regulation of Motor Circuits Using Magnetogenetic Gene Therapy.” bioRxiv: 2023.2007. 2013.548699.
243. Urano, E., et al. (2023). “An engineered ACE2 decoy broadly neutralizes omicron subvariants and shows therapeutic effect in SARS-CoV-2-infected cynomolgus macaques.” bioRxiv: 2022.2012. 2029.522275.
244. van Der Hoek, S., et al. (2023). “Feasibility Study to Assess Canagliflozin Distribution and Sodium‐Glucose Co‐Transporter 2 Occupancy Using [18F] Canagliflozin in Patients with Type 2 Diabetes.” Clinical Pharmacology & Therapeutics 113(6): 1295-1303.
245. van Dijk, B., et al. (2023). “Evaluating the Targeting of a Staphylococcus-aureus-Infected Implant with a Radiolabeled Antibody In Vivo.” International Journal of Molecular Sciences 24(5): 4374.
246. Vivian, G. K., et al. (2023). “The interaction between aging and protein malnutrition modulates peritoneal macrophage function: An experimental study in male mice.” Experimental Gerontology 171: 112025.
247. Voci, S., et al. (2023). “Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations.” International Journal of Biological Macromolecules: 126111.
248. Vogler, L., et al. (2023). “Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F] UCB-H PET imaging.” NeuroImage: Clinical: 103484.
249. Völter, F., et al. (2023). “Assessment of perfusion deficit with early phases of [18F] PI-2620 tau-PET versus [18F] flutemetamol-amyloid-PET recordings.” European Journal of Nuclear Medicine and Molecular Imaging 50(5): 1384-1394.
250. Wagatsuma, K., et al. (2023). “Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study.” Annals of Nuclear Medicine: 1-10.
251. Wang, H., et al. (2023). “A new 68Ga-labeled ornithine derivative for PET imaging of ornithine metabolism in tumors.” Amino Acids: 1-12.
252. Wang, L., et al. (2023). “Identifying sex-specific risk architectures for predicting amyloid deposition using neural networks.” NeuroImage 275: 120147.
253. Wang, X., et al. (2023). “A novel decellularized matrix of Wnt signaling-activated osteocytes accelerates the repair of critical-sized parietal bone defects with osteoclastogenesis, angiogenesis, and neurogenesis.” Bioactive Materials 21: 110-128.
254. Wang, Z., et al. (2023). “Deconvolution of Plasma Pharmacokinetics from Dynamic Heart Imaging Data Obtained by Single Positron Emission Computed Tomography/Computed Tomography Imaging.” Journal of Pharmacology and Experimental Therapeutics 386(1): 102-110.
255. Warashina, S., et al. (2023). “Two-Chain Mature Hepatocyte Growth Factor-Specific Positron Emission Tomography Imaging in Tumors Using 64Cu-Labeled HiP-8, a Nonstandard Macrocyclic Peptide Probe.” Molecular Pharmaceutics 20(4): 2029-2038.
256. Werner, A., et al. (2023). “Liver PET Reloaded: Automated Synthesis of [68Ga] Ga-BP-IDA for Positron Imaging of the Hepatobiliary Function and First Clinical Experience.” Diagnostics 13(6): 1144.
257. Wetherill, R. R., et al. (2023). “Molecular Imaging of Pulmonary Inflammation in Users of Electronic and Combustible Cigarettes: A Pilot Study.” Journal of Nuclear Medicine 64(5): 797-802.
258. White, J. M., et al. (2023). “Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer.” Theranostics 13(7): 2057.
259. Wichmann, C. W., et al. (2023). “Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.” Nuclear Medicine and Biology: 108366.
260. Willuweit, A., et al. (2023). “Evaluation of the 18F-labeled analog of the therapeutic all-D-enantiomeric peptide RD2 for amyloid β imaging.” European Journal of Pharmaceutical Sciences 184: 106421.
261. Wollring, M. M., et al. (2023). “Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.” Neuro-oncology 25(5): 984-994.
262. Xin, M., et al. (2023). “Pilot study on 11C-CFT dynamic imaging using total-body PET/CT: biodistribution and radiation dosimetry in Parkinson’s disease.” Frontiers in Neurology 14: 1153779.
263. Xiong, M., et al. (2023). “Synaptic density in aging mice measured by [18F] SynVesT-1 PET.” NeuroImage: 120230.
264. Yamasaki, T., et al. (2023). “Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein γ-8 (TARP γ-8) in the brain.” Journal of Cerebral Blood Flow & Metabolism 43(6): 893-904.
265. Yan, X., et al. (2023). “In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain.” European Journal of Nuclear Medicine and Molecular Imaging: 1-9.
266. Yang, X., et al. (2023). “Brain glucose metabolism on [18F]-FDG PET/CT: a dynamic biomarker predicting depression and anxiety in cancer patients.” Frontiers in Oncology 13: 1098943.
267. Yang, Z., et al. (2023). “Associations of striatal dopamine transporter binding with motor and non‐motor symptoms in early Parkinson’s disease.” Clinical and Translational Science.
268. Yasuno, F., et al. (2023). “Involvement of inflammation in the medial temporal region in the development of agitation in Alzheimer’s disease: an in vivo positron emission tomography study.” Psychogeriatrics 23(1): 126-135.
269. Ye, P., et al. (2023). “Activated Microglia in the Early Stage of a Rat Model of Parkinson’s Disease: Revealed by PET-MRI Imaging by [18F] DPA-714 Targeting TSPO.” ACS Chemical Neuroscience 14(11): 2183-2192.
270. Yin, H., et al. (2023). “Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of 68 Ga-DOTATATE in Normal Organs.” Contrast Media & Molecular Imaging 2023.
271. Yoganathan, T., et al. (2023). “Acute stress induces long-term metabolic, functional, and structural remodeling of the heart.” Nature Communications 14(1): 3835.
272. Yoo, C.-H., et al. (2023). “Evaluation of [18F] PF-06455943 as a Potential LRRK2 PET Imaging Agent in the Brain of Nonhuman Primates.” ACS Chemical Neuroscience 14(3): 370-377.
273. Yoshizawa, T., et al. (2023). “Working memory-based and-free reward prediction in a dual dopamine system in the basal ganglia.” bioRxiv: 2023.2003. 2006.531239.
274. Yu, A.-L., et al. (2023). “Tafamidis Treatment Decreases 99mTc-Pyrophosphate Uptake in Patients With Hereditary Ala97Ser Transthyretin Amyloid Cardiomyopathy.” Cardiovascular Imaging 16(6): 866-867.
275. Yu, X., et al. (2023). “Improved accuracy of the biodistribution and internal radiation dosimetry of 13N‐ammonia using a total‐body PET/CT scanner.” Medical Physics.
276. Yuan, G., et al. (2023). “PET imaging studies to investigate functional expression of mGluR2 using [11C] mG2P001.” Journal of Cerebral Blood Flow & Metabolism 43(2): 296-308.
277. Yuki, Y., et al. (2023). “Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.” Vaccine 41(34): 4941-4949.
278. Zablocki-Thomas, P. B., et al. (2023). “Neural correlates and effect of jealousy on cognitive flexibility in the female titi monkey (Plecturocebus cupreus).” Hormones and Behavior 152: 105352.
279. Zatcepin, A., et al. (2023). “Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients.” Zeitschrift für Medizinische Physik.
280. Zerweck, L., et al. (2023). “Evaluation of the cerebrovascular reactivity in patients with Moyamoya Angiopathy by use of breath-hold fMRI: investigation of voxel-wise hemodynamic delay correction in comparison to [15O] water PET.” Neuroradiology 65(3): 539-550.
281. Zhang, Y., et al. (2023). “Development and characterization of nanobody-derived CD47 theranostic pairs in solid tumors.” Research 6: 0077.
282. Zheng, W., et al. (2023). “Synthesis and In Vitro and In Vivo Evaluation of 18F-Labeled Positron Emission Tomography Tracers for Imaging Aβ Plaques.” ACS Chemical Neuroscience 14(5): 988-1003.
283. Zhou, D., et al. (2023). “Long-term dietary folic acid supplementation attenuated aging-induced hippocampus atrophy and promoted glucose uptake in 25-month-old rats with cognitive decline.” The Journal of Nutritional Biochemistry 117: 109328.
284. Zhou, W., et al. (2023). “Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for treatment of Nectin-4-expressing Cancers.” Molecular Cancer Therapeutics: MCT-22-0743.
285. Zhu, W., et al. (2023). “Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.” European Journal of Nuclear Medicine and Molecular Imaging: 1-10.
286. Zounek, A. J., et al. (2023). “Feasibility of radiomic feature harmonization for pooling of [18F] FET or [18F] GE-180 PET images of gliomas.” Zeitschrift für Medizinische Physik 33(1): 91-102.
1. Accrombessi, G., et al. (2022). “An ecological animal model of subthreshold depression in adolescence: behavioral and resting state 18F-FDG PET imaging characterization.” Translational Psychiatry 12(1): 356.
2. Aghakhanyan, G., et al. (2022). “Interplay of tau and functional network connectivity in progressive supranuclear palsy: A [18F] PI-2620 PET/MRI study.” European Journal of Nuclear Medicine and Molecular Imaging 50(1): 103-114.
3. Ahenkorah, S., et al. (2022). “3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals.” Theranostics 12(13): 5971.
4. Akkermans, J., et al. (2022). “Identification of pre-synaptic density networks using [11C] UCB-J PET imaging and ICA in mice.” NeuroImage 264: 119771.
5. Alberts, T., et al. (2022). “Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease.” Toxins 14(2): 94.
6. Alexander, K. A., et al. (2022). “Lymphocytes Are Not Required for Neurogenic Heterotopic Ossification Development after Spinal Cord Injury.” Neurotrauma Reports 3(1): 87-96.
7. Aljohani, F. S., et al. (2022). “Novel 1, 2, 3-triazole-sulphadiazine-ZnO hybrids as potent antimicrobial agents against carbapenem resistant bacteria.” Antibiotics 11(7): 916.
8. Alluri, S., et al. (2022). “Preclinical evaluation of new C-11 labeled benzo-1, 4-dioxane PET radiotracers for brain α2C adrenergic receptors.” European Journal of Medicinal Chemistry 243: 114764.
9. Almeida, S. F., et al. (2022). “Osteosarcoma‐Derived Exosomes as Potential PET Imaging Nanocarriers for Lung Metastasis.” Small 18(49): 2203999.
10. Amboni, M., et al. (2022). “Machine learning can predict mild cognitive impairment in Parkinson’s disease.” Frontiers in Neurology 13: 1010147.
11. Ambur Sankaranarayanan, R., et al. (2022). “PARP targeted Auger emitter therapy with [125I] PARPi-01 for triple-negative breast cancer.” EJNMMI research 12(1): 1-12.
12. Andersen, K. B., et al. (2022). “Healthy brain aging assessed with [18F] FDG and [11C] UCB-J PET.” Nuclear Medicine and Biology 112: 52-58.
13. Antons, M., et al. (2022). “Longitudinal [18] UCB-H/[18F] FDG imaging depicts complex patterns of structural and functional neuroplasticity following bilateral vestibular loss in the rat.” Scientific Reports 12(1): 1-12.
14. Antunes, G. L., et al. (2022). “Airway inflammation induces anxiety-like behavior through neuroinflammatory, neurochemical, and neurometabolic changes in an allergic asthma model.” Metabolic Brain Disease 37(4): 911-926.
15. Archer, S. L., et al. (2022). “SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia.” Redox Biology 58: 102508.
16. Ardanaz, C. G., et al. (2022). “GLUT1 ablation in astrocytes paradoxically improves central and peripheral glucose metabolism via enhanced insulin-stimulated ATP release.” bioRxiv: 2022.2010. 2006.511112.
17. Ardipradja, K. S., et al. (2022). “18F Site-Specific Labelling of a Single-Chain Antibody against Activated Platelets for the Detection of Acute Thrombosis in Positron Emission Tomography.” International Journal of Molecular Sciences 23(13): 6886.
18. Arisawa, T., et al. (2022). “Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors.” Nuclear Medicine and Biology 110: 47-58.
19. Astley, C., et al. (2022). “In‐depth cardiovascular and pulmonary assessments in children with multisystem inflammatory syndrome after SARS‐CoV‐2 infection: A case series study.” Physiological Reports 10(5): e15201.
20. Avendaño‐Estrada, A., et al. (2022). “Comparative analysis of striatal [18F] FDOPA uptake in a partial lesion model of Parkinson’s disease in rats: ratio method versus graphical model.” Synapse 76(5-6): e22231.
21. Bachmann, D., et al. (2022). “Lifestyle affects amyloid burden and cognition differently in men and women.” Annals of Neurology.
22. Backhaus, P., et al. (2022). “Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga] Ga-OncoFAP-DOTAGA.” European Journal of Nuclear Medicine and Molecular Imaging 49(6): 1822-1832.
23. Bai, P., et al. (2022). “Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging.” Bioorganic Chemistry 123: 105779.
24. Bai, P., et al. (2022). “Development of a potential PET probe for HDAC6 imaging in Alzheimer’s disease.” Acta Pharmaceutica Sinica B.
25. Bai, P., et al. (2022). “A positron emission tomography imaging probe selectively targeting the BD1 bromodomain and extra-terminal domain.” Chemical Communications 58(69): 9654-9657.
26. Bajorat, R., et al. (2022). “Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [18F] F-FDG PET-CT in a Mouse Model of Cardiac Arrest and Cardiopulmonary Resuscitation.” Molecular Imaging and Biology 24(3): 466-478.
27. Bakrania, P., et al. (2022). “Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease.” Molecular Psychiatry 27(2): 840-848.
28. Bao, F., et al. (2022). “Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms.” Science advances 8(15): eabk2376.
29. Barta, P., et al. (2022). “Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors.” Bioconjugate Chemistry 33(10): 1825-1836.
30. Bartos, L. M., et al. (2022). “18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model.” Frontiers in Medicine: 2848.
31. Baz, A. H. C., et al. (2022). “CXCR4-directed [68Ga] Ga-PentixaFor PET/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS).” BMJ Open 12(8): e060779.
32. Baz, A. H. C., et al. (2022). “Protocol: CXCR4-directed [68Ga] Ga-PentixaFor PET/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS).” BMJ Open 12(8).
33. Becker, G., et al. (2022). “Exercise against cocaine sensitization in mice: a [18F] fallypride micro-PET study.” Brain Communications 4(1): fcab294.
34. Beindorff, N., et al. (2022). “Monitoring orthodontic tooth movement in rats after piezocision by bone scintigraphy.” Nuklearmedizin-NuclearMedicine 61(05): 402-409.
35. Belmar-López, C., et al. (2022). “Mesenchymal Stem Cells Delivery in Individuals with Different Pathologies: Multimodal Tracking, Safety and Future Applications.” International Journal of Molecular Sciences 23(3): 1682.
36. Benčurová, K., et al. (2022). “CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga] Ga-Pentixafor in CRC Imaging.” Cancers 14(22): 5549.
37. Bengs, S., et al. (2022). “Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice.” Journal of Nuclear Cardiology: 1-12.
38. Bertoglio, D., et al. (2022). “Development of a ligand for in vivo imaging of mutant huntingtin in Huntington’s disease.” Science translational medicine 14(630): eabm3682.
39. Bertoglio, D., et al. (2022). “SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury.” Journal of Nuclear Medicine.
40. Bertoglio, D., et al. (2022). “Longitudinal preclinical evaluation of the novel radioligand [11C] CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease.” European Journal of Nuclear Medicine and Molecular Imaging 49(4): 1166-1175.
41. Bertoglio, D., et al. (2022). “Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.” Journal of Nuclear Medicine 63(6): 942-947.
42. Bertoglio, D., et al. (2022). “Validation, kinetic modeling, and test-retest reproducibility of [18F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice.” Journal of Cerebral Blood Flow & Metabolism: 0271678X221101648.
43. Biechele, G., et al. (2022). “Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease.” Journal of Nuclear Medicine 63(1): 117-124.
44. Boisson, F., et al. (2022). “Performance evaluation of the IRIS XL-220 PET/CT system, a new camera dedicated to non-human primates.” EJNMMI physics 9(1): 1-14.
45. Bonaventura, J., et al. (2022). “Target deconvolution studies of (2R, 6R)-hydroxynorketamine: an elusive search.” Molecular Psychiatry: 1-13.
46. Bossart, M., et al. (2022). “Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist.” Cell Metabolism 34(1): 59-74. e10.
47. Bouter, C., et al. (2022). “F-18-FDG and F-18-Florbetaben-PET for in vivo therapy monitoring of a vaccine approach against Alzheimer’s disease targeting a novel pseudo β-hairpin structure of N-truncated amyloid-β.” Nuklearmedizin-NuclearMedicine 61(02): L48.
48. Boyle, A. J., et al. (2022). “PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[18F] fluoro-6-deoxy-D-fructose.” Molecules 27(23): 8529.
49. Bratanovic, I. J., et al. (2022). “A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer.” Journal of Nuclear Medicine 63(3): 424-430.
50. Breuil, L., et al. (2022). “Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging.” Pharmaceutics 14(8): 1658.
51. Breuil, L., et al. (2022). “Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?” Journal of Cerebral Blood Flow & Metabolism 42(1): 175-185.
52. Breuil, L., et al. (2022). “Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [11C] metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier.” Pharmaceutics 14(12): 2650.
53. Bun, S., et al. (2022). “Findings of 18F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample.” Neuropsychopharmacology Reports 42(4): 437-448.
54. Campanholo, K., et al. (2022). “Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study.” Multiple Sclerosis and Related Disorders 57: 103331.
55. Campos-Sánchez, J. C., et al. (2022). “Ultrasonography and X-ray micro-computed tomography characterization of the effects caused by carrageenin in the muscle of gilthead seabream (Sparus aurata).” Fish & Shellfish Immunology 123: 431-441.
56. Capelli, G., et al. (2022). “18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.” Nuclear Medicine Communications: 10.1097.
57. Castaldo, R., et al. (2022). “A Complex Radiomic Signature in Luminal Breast Cancer from a Weighted Statistical Framework: A Pilot Study.” Diagnostics 12(2): 499.
58. Ceccarini, J., et al. (2022). “Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study.” Addiction Biology 27(3): e13167.
59. Chan, C. Y., et al. (2022). “Imaging PARP with [18F] rucaparib in pancreatic cancer models.” European Journal of Nuclear Medicine and Molecular Imaging: 1-11.
60. Chan, C. Y., et al. (2022). “Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F] olaparib in mouse models of glioma.” EJNMMI research 12(1): 1-10.
61. Chan, S.-C., et al. (2022). “Prospective Investigation of 18FDG-PET/MRI with Intravoxel Incoherent Motion Diffusion-Weighted Imaging to Assess Survival in Patients with Oropharyngeal or Hypopharyngeal Carcinoma.” Cancers 14(24): 6104.
62. Chen, K.-T., et al. (2022). “Individual cerebrocerebellar functional network analysis decoding symptomatologic dynamics of postoperative cerebellar mutism syndrome.” Cerebral cortex communications 3(1): tgac008.
63. Chen, M.-L. and R.-M. Wu (2022). “Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism.” Journal of Biomedical Science 29(1): 60.
64. Chen, X., et al. (2022). “Cerebral amyloid angiopathy is associated with glymphatic transport reduction and time-delayed solute drainage along the neck arteries.” Nature Aging 2(3): 214-223.
65. Chen, Y.-A., et al. (2022). “Monitoring HDAC4 Expression in Alzheimer’s Disease Using.” Future Trends and Challenges of Molecular Imaging and AI Innovation: Proceedings of FASMI 2020 272: 61.
66. Chen, Z., et al. (2022). “Imaging leucine-rich repeat kinase 2 in vivo with 18F-labeled positron emission tomography ligand.” Journal of Medicinal Chemistry 66(3): 1712-1724.
67. Chen, Z., et al. (2022). “PET Imaging of Bromodomain and Extra-Terminal Domain Inhibitors for the Noninvasive Assessment of Metabolic Changes in the Liver and Brain of Early-Stage Alcoholic Liver Disease.” Molecular Pharmaceutics.
68. Cheng, G., et al. (2022). “Ultrasmall coordination polymers for alleviating ROS-mediated inflammatory and realizing neuroprotection against Parkinson’s disease.” Research 2022.
69. Cheng, M.-F., et al. (2022). “Neuroinflammation in Low-Level PM2. 5-Exposed Rats Illustrated by PET via an Improved Automated Produced [18F] FEPPA: A Feasibility Study.” Molecular Imaging 2022.
70. Cherix, A., et al. (2022). “Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior.” Molecular Psychiatry 27(11): 4485-4501.
71. Choi, H., et al. (2022). “Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with 89Zr Radioisotope in Mice and Rats.” Pharmaceutics 14(6): 1118.
72. Chong, A., et al. (2022). “Pattern of F-18 FDG Uptake in Colon Cancer after Bacterial Cancer Therapy Using Engineered Salmonella Typhimurium: A Preliminary In Vivo Study.” Molecular Imaging 2022.
73. Clauß, O., et al. (2022). “Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F] BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain.” Pharmaceuticals 15(3): 324.
74. Collantes, M., et al. (2022). “Preclinical safety of negatively charged microspheres (NCMs): optimization of radiolabeling for in vivo and ex vivo biodistribution studies after topical administration on full-thickness wounds in a rat model.” European Journal of Pharmaceutics and Biopharmaceutics.
75. Convert, L., et al. (2022). “The ultra high sensitivity blood counter: a compact, MRI-compatible, radioactivity counter for pharmacokinetic studies in μl volumes.” Biomedical Physics & Engineering Express 8(3): 035022.
76. Craveiro, R. B., et al. (2022). “[68Ga] Ga-Pentixafor and Sodium [18F] Fluoride PET Can Non-Invasively Identify and Monitor the Dynamics of Orthodontic Tooth Movement in Mouse Model.” Cells 11(19): 2949.
77. Curdt, N., et al. (2022). “Search strategy analysis of Tg4-42 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficits.” Scientific Reports 12(1): 1-14.
78. Da Pieve, C., et al. (2022). “New Fully Automated Preparation of High Apparent Molar Activity 68Ga-FAPI-46 on a Trasis AiO Platform.” Molecules 27(3): 675.
79. Dalby, S., et al. (2022). “PET/CT imaging detects intestinal inflammation in a mouse model of doxorubicin-induced mucositis.” Frontiers in Oncology 12: 1061804.
80. Damuka, N., et al. (2022). “Initial Evaluations of the Microtubule-Based PET Radiotracer,[11C] MPC-6827 in a Rodent Model of Cocaine Abuse.” Frontiers in Medicine 9.
81. Daněk, J., et al. (2022). “Sulforaphane ameliorates metabolic changes associated with status epilepticus in immature rats.” Frontiers in Cellular Neuroscience: 97.
82. Dardano, A., et al. (2022). “Brain effect of bariatric surgery in people with obesity.” International Journal of Obesity: 1-7.
83. Daruich de Souza, C., et al. (2022). “Synthesis, In Vitro Testing, and Biodistribution of Surfactant-Free Radioactive Nanoparticles for Cancer Treatment.” Nanomaterials 12(2): 187.
84. Dassanayake, P., et al. (2022). “caliPER: A software for blood-free parametric Patlak mapping using PET/MRI input function.” NeuroImage 256: 119261.
85. de Laat, B., et al. (2022). “Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F] JNJ42259152 PET study in rats.” European Journal of Nuclear Medicine and Molecular Imaging 49(2): 492-502.
86. de Oliveira, J. V., et al. (2022). “Tumor vascular heterogeneity and the impact of subtumoral nanoemulsion biodistribution.” Nanomedicine 17(27): 2073-2088.
87. de Paula Faria, D., et al. (2022). “Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study.” International Journal of Molecular Sciences 23(3): 1076.
88. DE PAULA, J. J., et al. (2022). “Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings.” PloS one.
89. de Souza, G., et al. (2022). Evaluation of MR-less in brain amyloid-β PET Centiloid quantification. Medical Imaging 2022: Biomedical Applications in Molecular, Structural, and Functional Imaging, SPIE.
90. de Souza, G. S., et al. (2022). “Amyloid-β PET classification on cognitive aging stages using the Centiloid scale.” Molecular Imaging and Biology 24(3): 394-403.
91. de Vor, L., et al. (2022). “Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm.” Elife 11: e67301.
92. Degro, C. E., et al. (2022). “Evolving acidic microenvironments during colitis provide selective analgesic targets for a pH-sensitive opioid.” Pain: 10.1097.
93. Dehghankelishadi, P., et al. (2022). “Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.” Journal of Controlled Release 346: 98-109.
94. Delva, A., et al. (2022). “Synaptic damage and its clinical correlates in people with early Huntington disease: a PET study.” Neurology 98(1): e83-e94.
95. Dewulf, J., et al. (2022). “Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments.” Pharmaceutics 14(5): 939.
96. Dias, A. H., et al. (2022). “Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients.” EJNMMI research 12(1): 1-14.
97. Dias, A. H., et al. (2022). “Clinical feasibility and impact of data-driven respiratory motion compensation studied in 200 whole-body 18F-FDG PET/CT scans.” EJNMMI research 12(1): 1-11.
98. Diniz, D. M., et al. (2022). “Mapping of Brain Activity in the Analgesia Induced by Ph α 1 β and Morphine.” Frontiers in Molecular Biosciences 8: 770471.
99. Doot, R. K., et al. (2022). “[18F] NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease.” Cells 11(19): 3081.
100. Drieu, A., et al. (2022). “Persistent neuroinflammation and behavioural deficits after single mild traumatic brain injury.” Journal of Cerebral Blood Flow & Metabolism 42(12): 2216-2229.
101. Engbjerg, J. S., et al. (2022). “The Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo.” Molecular Imaging 2022.
102. Eriksen, P. L., et al. (2022). “Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved.” BMC gastroenterology 22(1): 1-10.
103. Estrada, S., et al. (2022). “Preclinical evaluation of [11C] GW457427 as a tracer for neutrophil elastase.” Nuclear Medicine and Biology 106: 62-71.
104. Fan, D., et al. (2022). “Chronic hypoperfusion due to intracranial large artery stenosis is not associated with cerebral β-amyloid deposition and brain atrophy.” Chinese Medical Journal 135(05): 591-597.
105. Fan, Z., et al. (2022). “Cyanidin 3-O-β-Galactoside Alleviated Cognitive Impairment in Mice by Regulating Brain Energy Metabolism During Aging.” Journal of Agricultural and Food Chemistry 70(4): 1111-1121.
106. Faria, D. d. P., et al. (2022). “Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study.” International Journal of Molecular Sciences.
107. Fedorova, T. D., et al. (2022). “Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up.” Parkinsonism & Related Disorders 101: 99-104.
108. Feletto, L., et al. (2022). “Influence of the use of autogenous bone particles to close the access window after maxillary sinus floor augmentation: a micro‐computed tomography and positron emission tomography study in rabbits.” Oral and Maxillofacial Surgery: 1-7.
109. Ferraro, D. A., et al. (2022). “Hot needles can confirm accurate lesion sampling intraoperatively using [18F] PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer.” European Journal of Nuclear Medicine and Molecular Imaging 49(5): 1721-1730.
110. Finze, A., et al. (2022). “Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy.” Frontiers in aging neuroscience 13: 786143.
111. Fragoso Costa, P., et al. (2022). “Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.” BMC cancer 22(1): 1-18.
112. Freyssin, A., et al. (2022). “Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.” Frontiers in Neuroscience 15: 803927.
113. Frisch, K., et al. (2022). “N-(4-[18F] fluorobenzyl) cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/CT study in pigs.” Nuclear Medicine and Biology 114: 49-57.
114. Gan, Y.-L., et al. (2022). “FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus.” Journal of Neuroinflammation 19(1): 1-21.
115. Garcia-Varela, L., et al. (2022). “Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F] MC225 and PET.” Journal of Controlled Release 347: 500-507.
116. Garnier‐Crussard, A., et al. (2022). “White matter hyperintensity topography in Alzheimer’s disease and links to cognition.” Alzheimer’s & Dementia 18(3): 422-433.
117. Ghazanfari, N., et al. (2022). “Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D2 and Histamine H3 Receptors: A PET Study in Healthy Rats.” Molecular Pharmaceutics.
118. Ghazanfari, N., et al. (2022). “Pharmacokinetic Modeling of [11C] GSK-189254, PET Tracer Targeting H3 Receptors, in Rat Brain.” Molecular Pharmaceutics 19(3): 918-928.
119. Giacobbo, B. L., et al. (2022). “The aged striatum: evidence of molecular and structural changes using a longitudinal multimodal approach in mice.” Frontiers in aging neuroscience: 9.
120. Girard, A., et al. (2022). “Impact of point-spread function reconstruction on dynamic and static 18F-DOPA PET/CT quantitative parameters in glioma.” Quantitative Imaging in Medicine and Surgery 12(2): 1397.
121. Giridharan, V. V., et al. (2022). “A crosstalk between gut and brain in sepsis-induced cognitive decline.” Journal of Neuroinflammation 19(1): 1-16.
122. Glatting, F. M., et al. (2022). “Repetitive early 68Ga-FAPI PET acquisition comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: methodologic and diagnostic implications for malignant, inflammatory/reactive, and degenerative lesions.” Journal of Nuclear Medicine 63(12): 1844-1851.
123. Glemser, P., et al. (2022). “Hybrid imaging with [68Ga] PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer.” Cancer Imaging 22(1): 1-14.
124. Glorie, D., et al. (2022). “Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [11C] ABP688 and [18F] FPEB Positron Emission Tomography in the Sapap3 Knockout Mouse Model for Obsessive-Compulsive–like Behavior.” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 7(6): 607-615.
125. Goldstein, D. S. and C. Holmes (2022). “Is 18F-DOPA a valid cardiac sympathetic neuroimaging agent?” Clinical Autonomic Research 32(6): 445-453.
126. Gonzalez, J. P., et al. (2022). “Propuesta metodológica para la creación de una base de datos de pacientes normales en protocolo cerebral PET/MR FDG.” Revista Brasileira de Física Médica 16: 682-682.
127. González-Mancebo, D., et al. (2022). “Neodymium doped lanthanide fluoride nanoparticles as contrast agents for luminescent bioimaging and X-ray computed tomography.” Boletín de la Sociedad Española de Cerámica y Vidrio 61: S40-S49.
128. Graziani, F., et al. (2022). “Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease.” Cardiovascular Imaging.
129. Griebsch, N.-I., et al. (2022). “Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.” Brain Sciences 12(11): 1437.
130. Guenther, T., et al. (2022). “Substitution of L-Trp by α-methyl-L-Trp in 177Lu-RM2 results in 177Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability.” Journal of Nuclear Medicine.
131. Gündel, D., et al. (2022). “Structure-Based Design, Optimization, and Development of [18F] LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET.” Journal of Medicinal Chemistry.
132. Gündel, D., et al. (2022). “Quantitation of the A2A Adenosine Receptor Density in the Striatum of Mice and Pigs with [18F] FLUDA by Positron Emission Tomography.” Pharmaceuticals 15(5): 516.
133. Günther, T., et al. (2022). “Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability.” Journal of Nuclear Medicine 63(9): 1364-1370.
134. Guo, J., et al. (2022). “Microglia Loss and Astrocyte Activation Cause Dynamic Changes in Hippocampal [18F] DPA-714 Uptake in Mouse Models of Depression.” Frontiers in Cellular Neuroscience 16.
135. Haider, A., et al. (2022). “Role of sex hormones in modulating myocardial perfusion and coronary flow reserve.” European Journal of Nuclear Medicine and Molecular Imaging 49(7): 2209-2218.
136. Haider, A., et al. (2022). “Assessment of cholesterol homeostasis in the living human brain.” Science translational medicine 14(665): eadc9967.
137. Haj-Hosseini, N., et al. (2022). “Early Detection of Oral Potentially Malignant Disorders: A Review on Prospective Screening Methods with Regard to Global Challenges.” Journal of Maxillofacial and Oral Surgery: 1-10.
138. Hamilton, J., et al. (2022). “Unpredictable chronic mild stress differentially impacts resting brain glucose metabolism in fatty acid-binding protein 7 deficient mice.” Psychiatry Research: Neuroimaging 323: 111486.
139. Handschuh, P. A., et al. (2022). “Effect of MAOA DNA methylation on human in vivo protein expression measured by [11C] harmine PET in healthy and depressed individuals.” medRxiv.
140. Handschuh, P. A., et al. (2022). “Effects of gender-affirming hormone therapy on gray matter density, microstructure and monoamine oxidase A levels in transgender subjects.” medRxiv.
141. Hanna, C., et al. (2022). “Brain Mapping the Effects of Chronic Aerobic Exercise in the Rat Brain Using FDG PET.” Journal of Personalized Medicine 12(6): 860.
142. Hanna, C., et al. (2022). “Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine.” Journal of Personalized Medicine 12(12): 1976.
143. Haskali, M. B., et al. (2022). “Effective Preparation of [18F] Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor.” Molecules 27(18): 5931.
144. He, Y., et al. (2022). “Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold.” Nuclear Medicine and Biology 108: 24-32.
145. He, Y., et al. (2022). “Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain.” European Journal of Medicinal Chemistry 243: 114750.
146. He, Y., et al. (2022). “Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging.” Journal of Medicinal Chemistry 65(3): 2191-2207.
147. He, Y., et al. (2022). “Design, synthesis, and preliminary evaluation of [18F]-aryl flurosulfates PET radiotracers via SuFEx methods for β-amyloid plaques in Alzheimer’s disease.” Bioorganic & Medicinal Chemistry 75: 117087.
148. He, Z., et al. (2022). “SOX2 modulated astrocytic process plasticity is involved in arsenic-induced metabolic disorders.” Journal of Hazardous Materials 435: 128942.
149. Henriksen, A. C., et al. (2022). “Non-invasive quantification of cerebral glucose metabolism using Gjedde-Patlak plot and image-derived input function from the aorta.” NeuroImage 253: 119079.
150. Hermanns, N., et al. (2022). “Molecular imaging of the brain–heart axis provides insights into cardiac dysfunction after cerebral ischemia.” Basic Research in Cardiology 117(1): 52.
151. Hernandez Vargas, S., et al. (2022). “High-contrast detection of somatostatin receptor subtype-2 for fluorescence-guided surgery.” Molecular Pharmaceutics 19(11): 4241-4253.
152. Hiroyama, S., et al. (2022). “Usefulness of 18F-FPP-RGD2 PET in pathophysiological evaluation of lung fibrosis using a bleomycin-induced rat model.” European Journal of Nuclear Medicine and Molecular Imaging 49(13): 4358-4368.
153. Horimoto, Y., et al. (2022). “Effects of repetitive transcranial magnetic stimulation on cerebral glucose metabolism.” Neurological Sciences 43(3): 1879-1883.
154. Hsiao, T., et al. (2022). “Comparisons of vesicular monoamine transporter type 2 signals in Parkinson’s disease and parkinsonism secondary to carbon monoxide poisoning.” Neurotoxicology 88: 178-186.
155. Hsieh, C.-J., et al. (2022). “[18F] ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice.” bioRxiv.
156. Hsueh, Y.-C., et al. (2022). “A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo.” Journal of Investigative Dermatology.
157. Hsueh, Y.-C., et al. (2022). “Keratinocyte-tethering modification for biologics enables location-precise treatment in mouse vitiligo.” bioRxiv.
158. Huang, T., et al. (2022). “Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1.” Nuclear Medicine and Biology 110: 18-27.
159. Hugon, G., et al. (2022). “Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F] 2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide.” Frontiers in Neuroscience 16.
160. Hwang, J. J. and K. Pak (2022). “Development of automated segmentation of visceral adipose tissue in computed tomography.” European Journal of Radiology 157: 110559.
161. Iaccarino, L., et al. (2022). “rPOP: robust PET-only processing of community acquired heterogeneous amyloid-PET data.” NeuroImage 246: 118775.
162. Iikuni, S., et al. (2022). “Development of an 111In-labeled glucagon-like peptide-1 receptor-targeting exendin-4 derivative that exhibits reduced renal uptake.” Molecular Pharmaceutics 19(3): 1019-1027.
163. Ikoma, Y., et al. (2022). “Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C] Raclopride.” Frontiers in Psychiatry 13: 811136.
164. Ishibashi, K., et al. (2022). “Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.” Clinical Nuclear Medicine: 10.1097.
165. Issa, A. S. M., et al. (2022). “A detector block-pairwise dead time correction method for improved quantitation with a dedicated BrainPET scanner.” Physics in Medicine & Biology 67(23): 235004.
166. Ito, Y., et al. (2022). “Novel approach to semi‐quantification of tracer accumulation in dopamine transporter scan.” Journal of Applied Clinical Medical Physics: e13626.
167. Ivanidze, J., et al. (2022). “Dynamic 68Ga-DOTATATE PET/MRI in the Diagnosis and Management of Intracranial Meningiomas.” Radiology: Imaging Cancer 4(2).
168. Iwao, Y., et al. (2022). “Brain PET motion correction using 3D face-shape model: the first clinical study.” Annals of Nuclear Medicine 36(10): 904-912.
169. Jackson, L. R., et al. (2022). “Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma.” Frontiers in Oncology 12: 939260.
170. Jehl, M., et al. (2022). “Attenuation Correction Using Template PET Registration for Brain PET: A Proof-of-Concept Study.” Journal of Imaging 9(1): 2.
171. Jensen, J. B., et al. (2022). “A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.” JCI insight 7(19).
172. Jeong, E. H., et al. (2022). “Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson’s disease: Analysis of the PPMI data.” Frontiers in Neurology 13: 976101.
173. Jessen, F., et al. (2022). “Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.” Alzheimer’s & Dementia.
174. Jonker, I., et al. (2022). “Antiviral treatment of neuroinflammation in schizophrenia.” as a transdiagnostic factor in the development of psychopathology and somatic symptoms: 41.
175. Kagerer, S. M., et al. (2022). “Low Subicular Volume as an Indicator of Dementia-Risk Susceptibility in Old Age.” Frontiers in aging neuroscience 14: 811146.
176. Kaneko, K.-i., et al. (2022). “[18F] DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus.” European Journal of Nuclear Medicine and Molecular Imaging: 1-11.
177. Kang, S., et al. (2022). “MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6× Tg Alzheimer’s Disease Model Mice.” International Journal of Molecular Sciences 23(10): 5485.
178. Kang, Y., et al. (2022). “Longitudinal alterations in GABAA receptor availability over∼ one year following traumatic brain injury.” Brain Communications.
179. Kapoor, S., et al. (2022). “The effect of sulforaphane on perinatal hypoxic-ischemic brain injury in rats.” Physiological Research.
180. Kaulen, N., et al. (2022). “mGluR5 and GABAA receptor‐specific parametric PET atlas construction—PET/MR data processing pipeline, validation, and application.” Human brain mapping 43(7): 2148-2163.
181. Kersting, D., et al. (2022). “First experiences with dynamic renal [68Ga] Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate.” European Journal of Nuclear Medicine and Molecular Imaging: 1-14.
182. Kesarwani, P., et al. (2022). “Quinolinate promotes alternatively activated macrophage-induced immune tolerance in glioblastoma through the NMDA/PPARγ signaling axis.” bioRxiv: 2022.2007. 2012.499609.
183. Keshavjee, B., et al. (2022). “Stress-Induced Premature Senescence Related to Oxidative Stress in the Developmental Programming of Nonalcoholic Fatty Liver Disease in a Rat Model of Intrauterine Growth Restriction.” Antioxidants 11(9): 1695.
184. Kim, D., et al. (2022). “Application of 18F-FDG brain PET for survival prediction in a rat model of hanging-induced hypoxic brain injury.” Annals of Nuclear Medicine 36(6): 570-578.
185. Kim, D.-Y., et al. (2022). “In vivo imaging of invasive aspergillosis with 18F-fluorodeoxysorbitol positron emission tomography.” Nature Communications 13(1): 1-11.
186. Kim, H. Y., et al. (2022). “Screening of σ2 receptor ligands and in vivo evaluation of 11C-labeled 6, 7-Dimethoxy-2-[4-(4-methoxyphenyl) butan-2-yl]-1, 2, 3, 4-tetrahydroisoquinoline for potential use as a σ2 receptor brain PET tracer.” Journal of Medicinal Chemistry 65(8): 6261-6272.
187. Kim, I., et al. (2022). “Quantitative PET imaging of the CD4 pool in nonhuman primates.” European Journal of Nuclear Medicine and Molecular Imaging 50(1): 14-26.
188. Kim, J.-H., et al. (2022). “Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder.” Neuropsychiatric Disease and Treatment: 2041-2053.
189. Kim, S., et al. (2022). “Association between Visceral Adipose Tissue Metabolism and Alzheimer’s Disease Pathology.” Metabolites 12(3): 258.
190. Kim, S. B., et al. (2022). “Preclinical evaluation of a companion diagnostic radiopharmaceutical,[18F] PSMA-1007, in a subcutaneous prostate cancer xenograft mouse model.” Molecular Pharmaceutics 20(2): 1050-1060.
191. Kimura, T., et al. (2022). “A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.” European Journal of Nuclear Medicine and Molecular Imaging 49(13): 4298-4311.
192. Kimura, Y., et al. (2022). “Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand,[11C] TASP457.” European Journal of Nuclear Medicine and Molecular Imaging 49(4): 1127-1135.
193. Klose, J. M., et al. (2022). “Administration routes for SSTR-/PSMA-and FAP-directed theranostic radioligands in mice.” Journal of Nuclear Medicine.
194. Kobayashi, R., et al. (2022). “Comparing medial temporal atrophy between early-onset semantic dementia and early-onset Alzheimer’s disease using voxel-based morphometry: A multicenter MRI study.” Current Alzheimer Research 19(7): 503-510.
195. Koike, T., et al. (2022). “Preclinical characterization of [18F] T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase.” European Journal of Nuclear Medicine and Molecular Imaging 49(4): 1148-1156.
196. Kojima, K., et al. (2022). “Brain 5-HT2A receptor binding and its neural network related to behavioral inhibition system.” Brain Imaging and Behavior 16(3): 1337-1348.
197. Koustoulidou, S., et al. (2022). “Synthesis and evaluation of two long-acting SSTR2 antagonists for radionuclide therapy of neuroendocrine tumors.” Pharmaceuticals 15(9): 1155.
198. Krämer, S. D., et al. (2022). “Changes of cerebral network activity after invasive stimulation of the mesencephalic locomotor region in a rat stroke model.” Experimental Neurology 347: 113884.
199. Krämer, S. D., et al. (2022). “Deep brain stimulation in the subthalamic nucleus can improve skilled Forelimb movements and retune dynamics of striatal networks in a rat stroke model.” International Journal of Molecular Sciences 23(24): 15862.
200. Kritikos, M., et al. (2022). “Assessment of Alzheimer’s Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife.” World Journal of Nuclear Medicine 21(04): 267-275.
201. Kumamoto, K., et al. (2022). “Continuous bed motion in a silicon photomultiplier-based scanner provides equivalent spatial resolution and image quality in whole body PET images at similar acquisition times using the step-and-shoot method.” Journal of Nuclear Medicine Technology.
202. Kumar, M., et al. (2022). PET Imaging of Estrogen Receptors Using 18 F-Based Radioligands. Estrogen Receptors, Springer: 129-151.
203. Kuo, C. Y., et al. (2022). “Serotonin Modulates the Correlations between Obsessive-compulsive Trait and Heart Rate Variability in Normal Healthy Subjects: A SPECT Study with [123I] ADAM and Heart Rate Variability Measurement.” Clinical Psychopharmacology and Neuroscience 20(2): 271.
204. Kwan, C., et al. (2022). “Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset.” Neuroscience 480: 143-154.
205. Ladraa, S., et al. (2022). “PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption.” Science advances 8(49): eade7823.
206. Lafontaine, D., et al. (2022). “TriDFusion (3DF) image viewer.” EJNMMI physics 9(1): 1-19.
207. Laing, B. T., et al. (2022). “Anterior hypothalamic parvalbumin neurons are glutamatergic and promote escape behavior.” Current Biology.
208. Laing, B. T., et al. (2022). “Activation of the fear-responsive anterior hypothalamic area promotes avoidance and triggers compulsive grooming behavior in mice.” bioRxiv: 2022.2009. 2006.506804.
209. Le, T. M., et al. (2022). “18F-FDG PET visualizes systemic STING agonist-induced lymphocyte activation in preclinical models.” Journal of Nuclear Medicine.
210. Leal, G. N., et al. (2022). “Segmental cardiac strain assessment by two‐dimensional speckle‐tracking echocardiography in surviving MIS‐c patients: Correlations with myocardial flow reserve (MFR) by 13 N‐ammonia PET‐CT.” Microcirculation 29(3): e12750.
211. Leccisotti, L., et al. (2022). “Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report.” Cardiovascular diabetology 21(1): 1-10.
212. Lee, H., et al. (2022). “Synthesis and Evaluation of a 18F-Labeled Ligand for PET Imaging of Colony-Stimulating Factor 1 Receptor.” Pharmaceuticals 15(3): 276.
213. Lee, H., et al. (2022). “Preliminary Evaluation of 68Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate Cancer.” Molecular Imaging and Biology: 1-11.
214. Lee, J., et al. (2022). “Development of Amyloid PET Analysis Pipeline Using Deep Learning-Based Brain MRI Segmentation—A Comparative Validation Study.” Diagnostics 12(3): 623.
215. Lee, J.-H., et al. (2022). “In vivo evaluation of six analogs of 11C-ER176 as candidate 18F-labeled radioligands for translocator protein 18 kDa (TSPO).” Journal of Nuclear Medicine.
216. Lee, J.-I., et al. (2022). “Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.” PloS one 17(2): e0262224.
217. Lehner, E., et al. (2022). “Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear.” Drug Delivery and Translational Research 12(1): 257-266.
218. Lehnert, W., et al. (2022). “Whole-body biodistribution and radiation dosimetry of [18F] PR04. MZ: a new PET radiotracer for clinical management of patients with movement disorders.” EJNMMI research 12(1): 1-9.
219. Li, E. J., et al. (2022). “Efficient delay correction for total-body PET kinetic modeling using pulse timing methods.” Journal of Nuclear Medicine 63(8): 1266-1273.
220. Li, J., et al. (2022). “Association between long‐term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using 18F‐AV‐45 and 18F‐AV‐1451 PET.” Journal of Neuroscience Research 100(2): 670-680.
221. Li, P., et al. (2022). “Early-stage differentiation between Alzheimer’s disease and frontotemporal lobe degeneration: Clinical, neuropsychology, and neuroimaging features.” Frontiers in aging neuroscience 14: 981451.
222. Li, Y., et al. (2022). “Tracer‐specific reference tissues selection improves detection of 18F‐FDG, 18F‐florbetapir, and 18F‐flortaucipir PET SUVR changes in Alzheimer’s disease.” Human brain mapping 43(7): 2121-2133.
223. Lillethorup, T. P., et al. (2022). “Spontaneous Partial Recovery of Striatal Dopaminergic Uptake Despite Nigral Cell Loss in Asymptomatic MPTP-Lesioned Female Minipigs.” Neurotoxicology.
224. Lim, M. K. Y., et al. (2022). “Inflammation, Calcification, and Bone Metabolism in the Tibiofemoral Joint as Early Biomarkers of Osteoarthritis.” BONE-D-22-00084.
225. Liu, G., et al. (2022). “Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of 18F-FDG in healthy volunteers.” European Journal of Nuclear Medicine and Molecular Imaging 49(8): 2493-2503.
226. Liu, Q., et al. (2022). “Impact Short-Lived of TOF 11C-Labeled on Brain PET Tracers With Among Suspected Patients With AD/PD: Using Hybrid PET/MRI.” Clinical Impact of Technological Innovations in Nuclear Medicine.
227. Liu, Z., et al. (2022). “Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigation.” European Journal of Nuclear Medicine and Molecular Imaging 49(4): 1157-1165.
228. Loenen, A. C., et al. (2022). “Local bone metabolism during the consolidation process of spinal interbody fusion.” Journal of Bone and Mineral Metabolism 40(2): 220-228.
229. Löffler, J., et al. (2022). “Blocking studies to evaluate receptor-specific radioligand binding in the CAM model by PET and MR imaging.” Cancers 14(16): 3870.
230. Lombardi, G., et al. (2022). “PET/MR in recurrent glioblastoma patients treated with regorafenib:[18F] FET and DWI-ADC for response assessment and survival prediction.” The British Journal of Radiology 95(1129): 20211018.
231. Løndalen, A., et al. (2022). “FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?” Molecular Imaging and Biology: 1-11.
232. Lu, M., et al. (2022). “A Pilot Study of Dynamic 18F-DCFPyL PET/CT Imaging of Prostate Adenocarcinoma in High-Risk Primary Prostate Cancer Patients.” Molecular Imaging and Biology 24(3): 444-452.
233. Lu, T.-H., et al. (2022). “Striatal Dopamine Transporter Availability is Associated with Sleep Disturbance among Patients with Bipolar I Disorder: A Single-photon Emission Computed Tomography Study Using [99mTc] TRODAT-1.” Clinical Psychopharmacology and Neuroscience 20(4): 768.
234. Lue, K.-H., et al. (2022). “Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.” Annals of Nuclear Medicine 36(3): 256-266.
235. Lue, K.-H., et al. (2022). “Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy.” Cancers 14(2): 309.
236. Mac, C.-H., et al. (2022). “Engineering a biomimetic bone scaffold that can regulate redox homeostasis and promote osteogenesis to repair large bone defects.” Biomaterials 286: 121574.
237. Marie, S., et al. (2022). “[11C] glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body.” Biomedicine & Pharmacotherapy 156: 113994.
238. Marie, S., et al. (2022). “Pharmacokinetic Imaging Using 99mTc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats.” Pharmaceuticals 15(4): 392.
239. Martínez-Gregorio, H., et al. (2022). “Early detection of colorectal cancer somatic mutations using cfDNA liquid biopsies in a murine carcinogenesis model.” Journal of Cancer 13(13): 3404.
240. Martinez-Orengo, N., et al. (2022). “Assessing organ-level immunoreactivity in a rat model of sepsis using TSPO PET imaging.” Frontiers in Immunology 13: 1010263.
241. Matsuoka, K., et al. (2023). “Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy.” Journal of the Neurological Sciences 444: 120514.
242. Mazzoletti, A., et al. (2022). “Comparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13N-NH3 PET/CT.” Journal of Nuclear Cardiology 29(3): 1248-1253.
243. Meneghetti, M., et al. (2022). “Mapping whole brain effects of infrared neural stimulation with positron emission tomography.” bioRxiv: 2022.2012. 2024.521746.
244. Michiels, L., et al. (2022). “Simplified Edinburgh and modified Boston criteria in relation to amyloid PET for lobar intracerebral hemorrhage.” NeuroImage: Clinical 35: 103107.
245. Michiels, L., et al. (2022). “Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study.” Journal of Cerebral Blood Flow & Metabolism 42(2): 303-314.
246. Miranda, A., et al. (2022). “Spatiotemporal Kernel Reconstruction for Linear Parametric Neurotransmitter PET Kinetic Modeling in Motion Correction Brain PET of Awake Rats.” Frontiers in Neuroscience 16.
247. Miskowiak, K. W., et al. (2022). “Cerebral metabolic rate of glucose and cognitive tests in long COVID patients.” Brain Sciences 13(1): 23.
248. Miyazaki, T., et al. (2022). “Epileptic discharges initiate from brain areas with elevated accumulation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors.” Brain Communications 4(2): fcac023.
249. Mizutani, A., et al. (2022). “Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood–Brain Barrier Permeability in Mice.” Pharmaceutics 14(5): 1026.
250. Molinet-Dronda, F., et al. (2022). “Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.” Neurobiology of Disease 167: 105669.
251. Momota, Y., et al. (2022). “Case report: Non-Alzheimer’s disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET.” Frontiers in Neurology 13: 1049113.
252. Monte, B., et al. (2022). “Characterization of perivascular space pathology in a rat model of cerebral small vessel disease by in vivo magnetic resonance imaging.” Journal of Cerebral Blood Flow & Metabolism: 0271678X221105668.
253. Moog, S., et al. (2022). “Preclinical evaluation of targeted therapies in Sdhb-mutated tumors.” Endocrine-Related Cancer 29(6): 375-388.
254. Moraga-Amaro, R., et al. (2022). “A single dose of ketamine cannot prevent protracted stress-induced anhedonia and neuroinflammation in rats.” Stress 25(1): 145-155.
255. Müller, E. G., et al. (2022). “Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer’s disease.” Quantitative Imaging in Medicine and Surgery 12(1): 493.
256. Müller, M., et al. (2022). “Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.” Journal of Neuro-oncology 159(3): 519-529.
257. Munk, D. E., et al. (2022). “Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study.” Scientific Reports 12(1): 14714.
258. Murayama, C., et al. (2022). “Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study.” Molecular Psychiatry 27(4): 2106-2113.
259. Murillo, O., et al. (2022). “High value of [64Cu] CuCl2 PET as a non-invasive tool to evaluate the restoration of physiological copper excretion after VTX-801 gene therapy in a mouse model of Wilson’s disease.” Molecular Therapy-Methods & Clinical Development.
260. Nakaoka, T., et al. (2022). “Clinical evaluation of [18F] pitavastatin for quantitative analysis of hepatobiliary transporter activity.” Drug Metabolism and Pharmacokinetics 44: 100449.
261. Nakaza, M., et al. (2022). “Dual-VENC 4D flow MRI can detect abnormal blood flow in the left atrium that potentially causes thrombosis formation after left upper lobectomy.” Magnetic Resonance in Medical Sciences 21(3): 433-443.
262. Nakladal, D., et al. (2022). “Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats.” Vascular pharmacology 142: 106945.
263. Nguyen, D., et al. (2022). “Lymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds: Preliminary preclinical and clinical results.” Journal of Surgical Oncology 125(2): 113-122.
264. Nguyen, G. A., et al. (2022). “[124I] IBETA: A New Aβ Plaque Positron Emission Tomography Imaging Agent for Alzheimer’s Disease.” Molecules 27(14): 4552.
265. Ni, R., et al. (2022). “Coregistered transcranial optoacoustic and magnetic resonance angiography of the human brain.” bioRxiv.
266. Ni, R., et al. (2022). “Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice.” Nature Biomedical Engineering 6(9): 1031-1044.
267. Nihashi, T., et al. (2022). “Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer’s Disease Continuum.” Journal of Alzheimer’s Disease 85(1): 223-234.
268. Nikolaus, S., et al. (2022). “The 5-HT1A receptor antagonist WAY-100635 decreases motor/exploratory behaviors and nigrostriatal and mesolimbocortical dopamine D2/3 receptor binding in adult rats.” Pharmacology Biochemistry and Behavior 215: 173363.
269. Nogami, T., et al. (2022). “Effect of DL-Methylephedrine on Dopamine Transporter Using Positron Emission Tomography With [18F] FE-PE2I.” Frontiers in Psychiatry: 1097.
270. Øen, S. K., et al. (2022). “Diagnostic value of 18F-FACBC PET/MRI in brain metastases.” Clinical Nuclear Medicine 47(12): 1030.
271. Okazawa, H., et al. (2022). “Cerebral Oxidative Stress in Early Alzheimer’s Disease Evaluated by 64Cu-ATSM PET/MRI: A Preliminary Study.” Antioxidants 11(5): 1022.
272. Okita, K., et al. (2022). “Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography.” Frontiers in Pharmacology 13.
273. Ono, M., et al. (2022). “Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.” Aging Cell: e13615.
274. Ordonez, A. A., et al. (2022). “11C-Para-aminobenzoic acid PET imaging of S. aureus and MRSA infection in preclinical models and humans.” JCI insight 7(1).
275. Oyama, K., et al. (2022). “Chemogenetic disconnection between the orbitofrontal cortex and the rostromedial caudate nucleus disrupts motivational control of goal-directed action.” bioRxiv.
276. Oyama, K., et al. (2022). “Chronic behavioral manipulation via orally delivered chemogenetic actuator in macaques.” Journal of Neuroscience 42(12): 2552-2561.
277. Oyarzabal, E. A., et al. (2022). “Chemogenetic stimulation of tonic locus coeruleus activity strengthens the default mode network.” Science advances 8(17): eabm9898.
278. Pak, K., et al. (2022). “Serotonin transporter is negatively associated with body mass index after glucose loading in humans.” Brain Imaging and Behavior 16(3): 1246-1251.
279. Pak, K., et al. (2022). “Brain glucose metabolism and ageing: A 5-year longitudinal study in a large PET cohort.” bioRxiv: 2022.2009. 2015.508088.
280. Pak, K., et al. (2022). “SLC6A3 gene polymorphisms are associated with striatal dopamine transporter changes after glucose loading.” Synapse 76(1-2): e22223.
281. Pak, K., et al. (2022). “Limited power of dopamine transporter mRNA mapping for predicting dopamine transporter availability.” Synapse 76(5-6): e22226.
282. Pak, K., et al. (2022). “Hedonic rating of sucrose is sub-regionally associated with striatal dopamine transporter in humans.” Neuroendocrinology 112(4): 338-344.
283. Palillo, M., et al. (2022). “Anesthesia with Tricaine Methanesulfonate (MS222) and Propofol and Its Use for Computed Tomography of Red Swamp Crayfish (Procambarus clarkii).” Journal of the American Association for Laboratory Animal Science 61(3): 275-282.
284. Park, D. G., et al. (2022). “Association of plasma α-synuclein with cardiac 123I-MIBG scintigraphy in early Parkinson’s disease.” Neuroscience Letters 770: 136399.
285. Park, D. G., et al. (2022). “Factors associated with motor severity in vascular parkinsonism with normal dopamine transporter imaging.” Parkinsonism & Related Disorders 94: 99-103.
286. Park, S., et al. (2022). “Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans.” Clinical and Translational Science 15(12): 2938-2946.
287. Peters, S., et al. (2022). “[68Ga] Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu] Lu-PSMA-617 treatment.” European Journal of Nuclear Medicine and Molecular Imaging 49(4): 1101-1112.
288. Piron, S., et al. (2022). “Preclinical comparative study of [18F] AlF-PSMA-11 and [18F] PSMA-1007 in varying PSMA expressing tumors.” Scientific Reports 12(1): 15744.
289. Pisaneschi, F., et al. (2022). “Imaging of innate immunity activation in vivo with a redox-tuned PET reporter.” Nature biotechnology: 1-9.
290. Pitombeira, M. S., et al. (2022). “Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.” European Journal of Nuclear Medicine and Molecular Imaging 49(13): 4551-4566.
291. Polvoy, I., et al. (2022). “Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans.” European Journal of Nuclear Medicine and Molecular Imaging: 1-11.
292. Poojari, R., et al. (2022). “Combinatorial cetuximab targeted polymeric nanocomplexes reduce PRC1 level and abrogate growth of metastatic hepatocellular carcinoma in vivo with efficient radionuclide uptake.” Nanomedicine: Nanotechnology, Biology and Medicine 41: 102529.
293. Prasad, K., et al. (2022). “Impact of an adenosine A2A receptor agonist and antagonist on binding of the dopamine D2 receptor ligand [11C] raclopride in the rodent striatum.” Molecular Pharmaceutics 19(8): 2992-3001.
294. Presotto, L., et al. (2022). “Development of a new toolbox for mouse PET–CT brain image analysis fully based on CT images and validation in a PD mouse model.” Scientific Reports 12(1): 15822.
295. Prieto, E., et al. (2022). “Performance evaluation of a preclinical SPECT/CT system for multi-animal and multi-isotope quantitative experiments.” Scientific Reports 12(1): 18161.
296. Puuvuori, E., et al. (2022). “PET-CT imaging of pulmonary inflammation using [68Ga] Ga-DOTA-TATE.” EJNMMI research 12(1): 1-10.
297. Qiu, L., et al. (2022). “Radiosynthesis and evaluation of a fluorine-18 radiotracer [18 F] FS1P1 for imaging sphingosine-1-phosphate receptor 1.” Organic & Biomolecular Chemistry 20(5): 1041-1052.
298. Qiu, T., et al. (2022). “Dynamic Microglial Activation is Associated with LPS-induced Depressive-like Behavior in Mice: An [18F] DPA-714 PET Imaging Study.” Bosnian Journal of Basic Medical Sciences.
299. Raffel, D. M., et al. (2022). “Quantifying cardiac sympathetic denervation: first studies of 18F-fluorohydroxyphenethylguanidines in cardiomyopathy patients.” European Journal of Nuclear Medicine and Molecular Imaging 49(2): 619-631.
300. Raijmakers, R., et al. (2022). “No signs of neuroinflammation in women with chronic fatigue syndrome or Q fever fatigue syndrome using the TSPO ligand [11C]-PK11195.” Neurology-Neuroimmunology Neuroinflammation 9(1).
301. Ramakrishnan, N. K., et al. (2022). “Automated radiosynthesis and preclinical in vivo evaluation of [18F] Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET.” Nuclear Medicine and Biology 114: 71-77.
302. Ramírez-Hernández, D., et al. (2022). “Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs.” Pharmaceutics 14(8): 1651.
303. Rampidis, G. P., et al. (2022). “Protocol: Role of cardiac CT in the diagnostic evaluation and risk stratification of patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): rationale and design of the MINOCA-GR study.” BMJ Open 12(2).
304. Rampidis, G. P., et al. (2022). “Role of cardiac CT in the diagnostic evaluation and risk stratification of patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): rationale and design of the MINOCA-GR study.” BMJ Open 12(2): e054698.
305. Rapp, C., et al. (2022). “Alcohol binge drinking decreases brain glucose metabolism and functional connectivity in adolescent rats.” Metabolic Brain Disease: 1-8.
306. Raval, N. R., et al. (2022). “Evaluation of the α-synuclein PET radiotracer (d3)-[11C] MODAG-001 in pigs.” bioRxiv.
307. Raval, N. R., et al. (2022). “An in vivo pig model for testing novel PET radioligands targeting cerebral protein aggregates.” bioRxiv: 2021.2012. 2031.473908.
308. Raval, N. R., et al. (2022). “An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates.” Frontiers in Neuroscience 16.
309. Reincke, M., et al. (2022). “Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma.” Hepatology Communications 6(11): 3223-3233.
310. Reverte, V., et al. (2022). “Integrative Cardiovascular Physiology and Pathophysiology: SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet.” American Journal of Physiology-Heart and Circulatory Physiology 322(4): H523.
311. Reverte, V., et al. (2022). “SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet.” American Journal of Physiology-Heart and Circulatory Physiology 322(4): H523-H536.
312. Richard, G., et al. (2022). “High-fructose feeding suppresses cold-stimulated brown adipose tissue glucose uptake in young men independently of changes in thermogenesis and the gut microbiome.” bioRxiv.
313. Richer, K., et al. (2022). “Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain.” Brain Research 1780: 147799.
314. Rischka, L., et al. (2022). “Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C] Me-NB1.” EJNMMI research 12(1): 1-8.
315. Rischka, L., et al. (2022). “First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1.” Journal of Nuclear Medicine 63(6): 936-941.
316. Rissanen, E., et al. (2022). “Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.” Neurology-Neuroimmunology Neuroinflammation 9(2).
317. Roczkowsky, A., et al. (2022). “Peroxisome injury in multiple sclerosis: protective effects of 4-phenylbutyrate in CNS-associated macrophages.” Journal of Neuroscience 42(37): 7152-7165.
318. Röhrich, M., et al. (2022). “Fibroblast activation protein–specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.” Journal of Nuclear Medicine 63(1): 127-133.
319. Rudroff, T., et al. (2022). “On the Effects of Transcranial Direct Current Stimulation on Cerebral Glucose Uptake During Walking: A Report of Three Patients With Multiple Sclerosis.” Frontiers in human neuroscience 16.
320. Rudroff, T., et al. (2022). “Differences in Inhibitory Control and Resting Brain Metabolism between Older Chronic Users of Tetrahydrocannabinol (THC) or Cannabidiol (CBD)—A Pilot Study.” Brain Sciences 12(7): 819.
321. Ruiz-Bedoya, C. A., et al. (2022). “High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis.” The Journal of clinical investigation 132(6).
322. Rullmann, M., et al. (2022). “Multicenter 18F-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer’s disease.” Biomolecules 12(3): 458.
323. Sakarya, A. H., et al. (2022). “Vascularized lymph node transplantation successfully reverses lymphedema and maintains immunity in a rat lymphedema model.” Bioengineering & Translational Medicine: e10301.
324. Sakurai, K., et al. (2022). “Age-related increase of monoamine oxidase B in amyloid-negative cognitively unimpaired elderly subjects.” Annals of Nuclear Medicine 36(8): 777-784.
325. Samanta, S., et al. (2022). “Heparin‐Derived Theranostic Nanoprobes Overcome the Blood–Brain Barrier and Target Glioma in Murine Model.” Advanced Therapeutics: 2200001.
326. Sanaat, A., et al. (2022). “Deep‐TOF‐PET: Deep learning‐guided generation of time‐of‐flight from non‐TOF brain PET images in the image and projection domains.” Human brain mapping 43(16): 5032-5043.
327. Sandahl, T. D., et al. (2022). “The pathophysiology of Wilson’s disease visualized: A human 64Cu PET study.” Hepatology 75(6): 1461-1470.
328. Sandbhor, P., et al. (2022). “Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.” Nanoscale 14(1): 108-126.
329. Sanders, K. J., et al. (2022). “Brown adipose tissue activation is not related to hypermetabolism in emphysematous chronic obstructive pulmonary disease patients.” Journal of cachexia, sarcopenia and muscle 13(2): 1329-1338.
330. Sardana, M., et al. (2022). “Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging.” Pharmaceuticals 15(12): 1568.
331. Sari, H., et al. (2022). “First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients.” European Journal of Nuclear Medicine and Molecular Imaging 49(6): 1997-2009.
332. Say, F. M., et al. (2022). “Effects of chronic cocaine and ethanol self‐administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse.” Addiction Biology 27(5): e13219.
333. Schrader, J. M., et al. (2022). “Emergent White Matter Degeneration in the rTg-DI Rat Model of Cerebral Amyloid Angiopathy Exhibits Unique Proteomic Changes.” The American Journal of Pathology 192(3): 426-440.
334. Schramm, G., et al. (2022). “Regional Accuracy of ZTE-Based Attenuation [18F] FDG and Correction Dynamic [18F] PE2I in Static Brain PET/MR.” Quantification in Nuclear Medicine Imaging.
335. Schuster, S., et al. (2022). “Impact of Partial Volume Correction on [18F] GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome.” Brain Sciences 12(2): 204.
336. Schweickert de Palma, E., et al. (2022). “Availability of central α4β2* nicotinic acetylcholine receptors in human obesity.” Brain Sciences 12(12): 1648.
337. Scott, N., et al. (2022). “Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging.” British journal of cancer 126(4): 598-605.
338. Seiffert, A. P., et al. (2022). “Differences in Striatal Metabolism in [18F] FDG PET in Parkinson’s Disease and Atypical Parkinsonism.” Diagnostics 13(1): 6.
339. Sekine, T., et al. (2022). “4D Flow MR Imaging of the Left Atrium: What is Non-physiological Blood Flow in the Cardiac System?” Magnetic Resonance in Medical Sciences 21(2): 293-308.
340. Serrano, M. E., et al. (2022). “Imaging Synaptic Density: The Next Holy Grail of Neuroscience?” Frontiers in Neuroscience 16.
341. Shah, S., et al. (2022). “PET imaging of TSPO expression in immune cells can assess organ-level pathophysiology in high-consequence viral infections.” Proceedings of the National Academy of Sciences 119(15): e2110846119.
342. Shi, Y., et al. (2022). “Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO).” Nature Neuroscience 25(3): 317-329.
343. Shidahara, M., et al. (2022). “Noninvasive estimation of human radiation dosimetry of 18F-FDG by whole-body small animal PET imaging in rats.” Applied Radiation and Isotopes 181: 110071.
344. Shin, H.-J., et al. (2022). “Classification of Alzheimer’s Disease Using Dual-Phase 18F-Florbetaben Image with Rank-Based Feature Selection and Machine Learning.” Applied Sciences 12(15): 7355.
345. Shokri‐Kojori, E., et al. (2022). “Brain opioid segments and striatal patterns of dopamine release induced by naloxone and morphine.” Human brain mapping 43(4): 1419-1430.
346. Shukla, P., et al. (2022). “ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications.” Cancer Gene Therapy 29(12): 1908-1917.
347. Shukuri, M., et al. (2022). “Synthesis and Preclinical Evaluation of 18F-labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation.” Journal of Nuclear Medicine.
348. Skjærbæk, C., et al. (2022). “Intestinal Transit in Early Moderate Parkinson’s Disease Correlates with Probable RBD: Subclinical Esophageal Dysmotility Does Not Correlate.” Parkinson’s Disease 2022.
349. Solas, M., et al. (2022). “The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity.” International Journal of Molecular Sciences 23(21): 13591.
350. Song, A. K., et al. (2022). “Amphetamine-induced dopamine release and impulsivity in Parkinson’s disease.” Brain 145(10): 3488-3499.
351. SOUZA, C. D. d., et al. (2022). “Synthesis, in vitro testing, and biodistribution of surfactant-free radioactive nanoparticles for cancer treatment.” Nanomaterials.
352. Stabin, M. G., et al. (2022). “RADAR guide: standard methods for calculating radiation doses for radiopharmaceuticals, part 2—data analysis and dosimetry.” Journal of Nuclear Medicine 63(3): 485-492.
353. Staudacher, A. H., et al. (2022). “Fc gamma receptor is not required for in vivo processing of radio-and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®.” Biomedicine & Pharmacotherapy 151: 113090.
354. Stavropoulou, A. P., et al. (2022). “Bimetallic gold-platinum nanoparticles as a drug delivery system coated with a new drug to target glioblastoma.” Colloids and Surfaces B: Biointerfaces 214: 112463.
355. Stormezand, G. N., et al. (2022). “Imaging of neuroinflammation due to repetitive head injury in currently active kickboxers.” European Journal of Nuclear Medicine and Molecular Imaging: 1-11.
356. Suchacki, K. J., et al. (2022). “The effects of caloric restriction on adipose tissue and metabolic health are sex-and age-dependent.” bioRxiv.
357. Sugisawa, E., et al. (2022). “Nociceptor-derived Reg3γ prevents endotoxic death by targeting kynurenine pathway in microglia.” Cell Reports 38(10): 110462.
358. Sukprakun, C., et al. (2022). “A Novel method of seizure onset zone localization by serial Tc-99 m ECD brain perfusion SPECT clearance patterns.” Brain Imaging and Behavior: 1-11.
359. Tagai, K., et al. (2022). “An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607).” medRxiv.
360. Takahashi, M., et al. (2022). “Small nuclei identification with a hemispherical brain PET.” EJNMMI physics 9(1): 69.
361. Takahata, K., et al. (2022). “First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401.” European Journal of Nuclear Medicine and Molecular Imaging: 1-12.
362. Takamura, Y., et al. (2022). “Teratogenicity and Fetal-Transfer Assessment of the Retinoid X Receptor Agonist Bexarotene.” ACS Pharmacology & Translational Science 5(9): 811-818.
363. Talkington, A. M., et al. (2022). “A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes.” Journal of Controlled Release 343: 518-527.
364. Tan, Q., et al. (2022). “Imaging Study on Acupuncture Inhibiting Inflammation and Bone Destruction in Knee Osteoarthritis Induced by Monosodium Iodoacetate in Rat Model.” Journal of Pain Research 15: 93.
365. Tanaka, A., et al. (2022). “Reproducibility of standardized uptake values including volume metrics between TOF-PET-MR and TOF-PET-CT.” Frontiers in Medicine: 455.
366. Tang, Z., et al. (2022). “Chemical Factory‐Guaranteed Enhanced Chemodynamic Therapy for Orthotopic Liver Cancer.” Advanced Science: 2201232.
367. Taubel, J. C., et al. (2022). “Design, Synthesis, and Preliminary Evaluation of [68Ga] Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model.” Bioconjugate Chemistry 33(5): 892-906.
368. Teng, Y.-H. and T.-L. Kung (2022). Super-Connectivity of Locally Twisted Cubes. International Conference on Innovative Mobile and Internet Services in Ubiquitous Computing, Springer.
369. Terada, T., et al. (2022). “Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease.” European Journal of Neurology 29(5): 1324-1334.
370. Tomadesso, C., et al. (2022). “Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer’s Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden.” Frontiers in aging neuroscience 14.
371. Toramatsu, C., et al. (2022). “Measurement of biological washout rates depending on tumor vascular status in 15O in-beam rat-PET.” Physics in Medicine & Biology.
372. Tram, N. K., et al. (2022). “Novel Application of 18F-NaF PET/CT Imaging for Evaluation of Active Bone Remodeling in Diabetic Patients With Charcot Neuropathy: A Proof-of-Concept Report.” Frontiers in Medicine 9.
373. Trotta, N., et al. (2022). “Comparison of PMT‐based TF64 and SiPM‐based Vereos PET/CT systems for 90Y imaging and dosimetry optimization: A quantitative study.” Medical Physics 49(12): 7567-7582.
374. Trujillo, P., et al. (2022). “Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients.” npj Parkinson’s Disease 8(1): 1-7.
375. Truong, V. A., et al. (2022). “Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats.” Molecular Therapy 30(1): 92-104.
376. Tsai, C.-J., et al. (2022). “3, 4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging.” International Journal of Molecular Sciences 23(13): 7035.
377. Tseng, J.-R., et al. (2022). “Impact of Three-Month Androgen Deprivation Therapy on [68Ga] Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer—Results from a Pilot Prospective Study.” Cancers 14(5): 1329.
378. Uchida, Y., et al. (2022). “APOE ɛ4 dose associates with increased brain iron and β-amyloid via blood–brain barrier dysfunction.” Journal of Neurology, Neurosurgery & Psychiatry.
379. Ueno-Pardi, L. M., et al. (2022). “Effects of exercise training on brain metabolism and cognitive functioning in sleep apnea.” Scientific Reports 12(1): 1-12.
380. Vainio, S., et al. (2022). “Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation.” EJNMMI research 12(1): 1-11.
381. Valda, A., et al. (2022). “Estudio preclínico en primate no-humano con [18F] Fluorotimidina. dosimetría y biodistribución.” Medicina (Buenos Aires) 82(2): 231-237.
382. van Aalst, J., et al. (2022). “Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study.” European Journal of Nuclear Medicine and Molecular Imaging 49(2): 664-680.
383. van der Weijden, C. W., et al. (2022). “Quantitative assessment of myelin density using [11C] MeDAS PET in patients with multiple sclerosis: a first-in-human study.” European Journal of Nuclear Medicine and Molecular Imaging: 1-16.
384. van der Weijden, C. W., et al. (2022). “Diffusion-derived parameters in lesions, peri-lesion, and normal-appearing white matter in multiple sclerosis using tensor, kurtosis, and fixel-based analysis.” Journal of Cerebral Blood Flow & Metabolism: 0271678X221107953.
385. Van Der Wildt, B., et al. (2022). “Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain.” Nuclear Medicine and Biology 114: 99-107.
386. van Dijken, B. R., et al. (2022). “Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.” Neuroradiology 64(2): 247-252.
387. van Hooijdonk, C. F., et al. (2022). “The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11. 2 Deletion Syndrome: A Cross-Sectional, Multimodal 1H-MRS and 18F-Fallypride PET Study.” Genes 13(9): 1672.
388. Vehof, V., et al. (2022). “Hybrid CMR-and FDG-PET-Imaging Gives New Insights Into the Relationship of Myocardial Metabolic Activity and Fibrosis in Patients With Becker Muscular Dystrophy.” Frontiers in Cardiovascular Medicine 9.
389. Velikyan, I., et al. (2022). “Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences.” Pharmaceuticals 16(1): 61.
390. Victorio, C. B. L., et al. (2022). “Preclinical evaluation of [18F] FDG-PET as a biomarker of lymphoid tissue disease and inflammation in Zika virus infection.” European Journal of Nuclear Medicine and Molecular Imaging 49(13): 4516-4528.
391. Villemagne, V. L., et al. (2022). “First-in-human evaluation of 18F-SMBT-1, a novel 18F-labeled MAO-B PET tracer for imaging reactive astrogliosis.” Journal of Nuclear Medicine.
392. Viswanath, V., et al. (2022). “Abbreviated scan protocols to capture 18F-FDG kinetics for long axial FOV PET scanners.” European Journal of Nuclear Medicine and Molecular Imaging: 1-11.
393. Von Rohr, K., et al. (2022). “Can Radiomics Provide Additional Information in [18F] FET-Negative Gliomas?” Cancers 14(19): 4860.
394. Vrist, M. H., et al. (2022). “Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy.” American Journal of Nephrology: 1-13.
395. Wagatsuma, K., et al. (2022). “Determination of optimal regularization factor in Bayesian penalized likelihood reconstruction of brain PET images using [18F] FDG and [11C] PiB.” Medical Physics.
396. Wakabayashi, Y., et al. (2022). “First-in-human evaluation of 18F-PF-06445974, a PET radioligand that preferentially labels phosphodiesterase-4B.” Journal of Nuclear Medicine.
397. Wang, C., et al. (2022). “Association between cigarette smoking and Parkinson’s disease: a neuroimaging study.” Therapeutic advances in neurological disorders 15: 17562864221092566.
398. Wang, H., et al. (2022). “Evaluation of N-(6-[18F] Fluoropyridin-3-yl) glycine PET renography to detect renal function progression in a rat model of diabetic nephropathy.” Nuclear Medicine and Biology 112: 59-65.
399. Wang, L., et al. (2022). “Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimer’s Disease.” bioRxiv: 2022.2011. 2021.517280.
400. Wang, L., et al. (2022). “Interferometrical single-molecule localization based on dynamic PSF engineering.” Optics Letters 47(7): 1770-1773.
401. Warashina, S., et al. (2022). “64Cu-labeling of small extracellular vesicle surfaces via a cross-bridged macrocyclic chelator for pharmacokinetic study by positron emission tomography imaging.” International Journal of Pharmaceutics: 121968.
402. Watanabe, H., et al. (2022). “Characterization of Radioiodinated Diaryl Oxadiazole Derivatives as SPECT Probes for Detection of Myelin in Multiple Sclerosis.” ACS Chemical Neuroscience 13(3): 363-369.
403. Wenzel, B., et al. (2022). “Radiosynthesis and Preclinical Evaluation of an 18F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A).” Pharmaceuticals 15(10): 1272.
404. Wetherill, R. R., et al. (2022). “Using 18F-NOS PET Imaging to Measure Pulmonary Inflammation in Electronic and Combustible Cigarette Users: A Pilot Study.” medRxiv.
405. Wheelis, S. E., et al. (2022). “Effects of Dicationic Imidazolium-Based Ionic Liquid Coatings on Oral Osseointegration of Titanium Implants: A Biocompatibility Study in Multiple Rat Demographics.” Genes 13(4): 642.
406. Willekens, S. M., et al. (2022). “An MR-based brain template and atlas for optical projection tomography and light sheet fluorescence microscopy.” bioRxiv: 2022.2011. 2014.516420.
407. Wiltgen, T., et al. (2022). “18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio (chemo) therapy.” Radiation Oncology 17(1): 198.
408. Winter, G., et al. (2022). “Preclinical PET and MR Evaluation of 89Zr-and 68Ga-Labeled Nanodiamonds in Mice over Different Time Scales.” Nanomaterials 12(24): 4471.
409. Wu, K.-Y., et al. (2022). “Decreased Cerebral Amyloid-β Depositions in Patients With a Lifetime History of Major Depression With Suspected Non-Alzheimer Pathophysiology.” Frontiers in aging neuroscience 14.
410. Wuli, W., et al. (2022). “Targeting PSEN1 by lnc-CYP3A43-2/miR-29b-2-5p to reduce β amyloid plaque formation and improve cognition function.” International Journal of Molecular Sciences 23(18): 10554.
411. Wurzer, A., et al. (2022). “Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands (RhPSMAs) for Endoradiotherapy of Prostate Cancer.” Journal of Nuclear Medicine.
412. Xu, J., et al. (2022). “Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein-α Recombinant Antibodies.” Cancer Biotherapy & Radiopharmaceuticals.
413. Xu, Y., et al. (2022). “Accelerated HF-rTMS Modifies SERT Availability in the Subgenual Anterior Cingulate Cortex: A Canine [11C] DASB Study on the Serotonergic System.” Journal of clinical medicine 11(6): 1531.
414. Xu, Y., et al. (2022). “Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies.” European Journal of Medicinal Chemistry: 114468.
415. Xue, Y., et al. (2022). “Sustained glymphatic transport and impaired drainage to the nasal cavity observed in multiciliated cell ciliopathies with hydrocephalus.” Fluids and barriers of the CNS 19(1): 1-20.
416. Yahata, N., et al. (2022). “Neural network of superiority illusion predicts the level of dopamine in striatum.” bioRxiv.
417. Yakushev, I., et al. (2022). “Mapping covariance in brain FDG uptake to structural connectivity.” European Journal of Nuclear Medicine and Molecular Imaging 49(4): 1288-1297.
418. Yamabe, S., et al. (2022). “Association of resting left ventricular global longitudinal strain with myocardial perfusion abnormalities evaluated by 13N‐ammonia positron emission tomography in patients with stable angina pectoris and normal left ventricular ejection fraction.” Echocardiography 39(12): 1555-1562.
419. Yamaguchi, T., et al. (2022). “Arterial spin labeling imaging for the detection of cerebral blood flow asymmetry in patients with corticobasal syndrome.” Neuroradiology: 1-9.
420. Yamamoto, M., et al. (2022). “Delivery of aPD-L1 antibody to ip tumors via direct penetration by ip route: Beyond EPR effect.” Journal of Controlled Release 352: 328-337.
421. Yamamoto, Y., et al. (2022). “Radiosynthesis and in Vivo and ex Vivo Evaluation of Isomeric [11C] methoxy Analogs of Nimesulide as Brain Cyclooxygenase-2-Targeted Imaging Agents.” Biological and Pharmaceutical Bulletin 45(1): 94-103.
422. Yamauchi, H., et al. (2022). “Visit-to-Visit Blood PressureVariations and Hemodynamic Deterioration in Atherosclerotic Major Cerebral ArteryDisease.” Journal of Stroke and Cerebrovascular Diseases 31(1): 106206.
423. Yanai, S., et al. (2022). “Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice.” Frontiers in Pharmacology 13: 1031637.
424. Yang, C. Y., et al. (2022). “Enhancing lymphangiogenesis and lymphatic drainage to vascularized lymph nodes with nanofibrillar collagen scaffolds.” Journal of Surgical Oncology 126(7): 1169-1175.
425. Yang, K.-C., et al. (2022). “Role of Dopamine Transporter in the Relationship Between Plasma Cortisol and Cognition.” Psychosomatic Medicine 84(6): 685-694.
426. Yasuno, F., et al. (2022). “Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713.” Nuclear Medicine and Biology 108: 76-84.
427. Yasuno, F., et al. (2022). “Estimation of blood-based biomarkers of glial activation related to neuroinflammation.” Brain, Behavior, & Immunity-Health 26: 100549.
428. Yeh, S. H.-H., et al. (2022). “Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors.” Cancer Biotherapy & Radiopharmaceuticals 37(1): 30-40.
429. Yeh, S. H.-H., et al. (2022). “Preliminary results on the long-term effects of dextromethorphan on MDMA-mediated serotonergic deficiency and volumetric changes in primates based on 4-[18F]-ADAM PET/MRI.” Frontiers in Neuroscience 16.
430. Yeh, S. H.-H., et al. (2022). “99mTc-TRODAT-1 SPECT Revealed That Striatal Dopamine Transport Availability Significantly Decreases in Late Mid-Aged Healthy Taiwanese and Then Remains Stable.” Clinical Nuclear Medicine 47(3): 201-208.
431. Ying, W., et al. (2022). “Correlation between 18 F-S16 PET imaging and glucose metabolism pattern in behavioral variant frontotemporal dementia.” Chinese Journal of Contemporary Neurology & Neurosurgery 22(12).
432. Ylä-Herttuala, S., et al. (2022). “Decreased Gray—White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea.” The Journal of Prevention of Alzheimer’s Disease: 1-8.
433. Yoshimatsu, S., et al. (2022). “Multimodal analyses of a non-human primate model harboring mutant amyloid precursor protein transgenes driven by the human EF1α promoter.” Neuroscience Research 185: 49-61.
434. Young, A. J., et al. (2022). “Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1–Targeted 18F-Fluorthanatrace PET Images of Ovarian Cancer.” Journal of Nuclear Medicine 63(1): 44-50.
435. Yu, F., et al. (2022). “Spatiotemporal dynamics of brain function during the natural course in a dental pulp injury model.” European Journal of Nuclear Medicine and Molecular Imaging: 1-7.
436. Yu Koh, X., et al. (2022). “Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy.” Scientific Reports 12(1): 22564.
437. Yu, S., et al. (2022). “Circadian rhythm modulates endochondral bone formation via MTR1/AMPKβ1/BMAL1 signaling axis.” Cell Death & Differentiation 29(4): 874-887.
438. Yun, J.-Y. and Y.-K. Kim (2022). “Deficits of Neurotransmitter Systems and Altered Brain Connectivity in Major Depression: A Translational Neuroscience Perspective.” Translational Research Methods for Major Depressive Disorder: 311-324.
439. Zanovello, M., et al. (2022). “Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An 18F-FDG PET/MRI Study.” Journal of Nuclear Medicine 63(5): 777-784.
440. Zarrouki, F., et al. (2022). “Abnormal Expression of Synaptic and Extrasynaptic GABAA Receptor Subunits in the Dystrophin-Deficient mdx Mouse.” International Journal of Molecular Sciences 23(20): 12617.
441. Zatcepin, A., et al. (2022). “Reduced Acquisition Time [18F] GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model.” Frontiers in Medicine 9.
442. Zerweck, L., et al. (2022). “Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O] water PET.” Neuroradiology 64(3): 553-563.
443. Zhang, J., et al. (2022). “18F-FDG PET Combined With MR Spectroscopy Elucidates the Progressive Metabolic Cerebral Alterations After Blast-Induced Mild Traumatic Brain Injury in Rats.” Advanced PET, SPECT, MR and Optical Imaging in Clinical and Pre-Clinical Research of Neuropsychiatric Disorders.
444. Zhang, K., et al. (2022). “Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studies.” European Journal of Nuclear Medicine and Molecular Imaging 49(5): 1456-1469.
445. Zhang, Q., et al. (2022). “Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia.” Diabetes Research and Clinical Practice 186: 109806.
446. Zhang, S.-s., et al. (2022). “Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice.” Journal of Neuroinflammation 19(1): 1-21.
447. Zhao, Q., et al. (2022). “Enhanced therapeutic efficacy of combining losartan and chemo-immunotherapy for triple negative breast cancer.” Frontiers in Immunology 13: 938439.
448. Zhu, G., et al. (2022). “Design, synthesis, and evaluation of novel O-alkyl ferulamide derivatives as multifunctional ligands for treating Alzheimer’s disease.” Journal of Enzyme Inhibition and Medicinal Chemistry 37(1): 1375-1388.
449. Zhu, X.-X., et al. (2022). “Efficient and automatic synthesis of TSPO PET ligand [18F]-GE-180 and its application in rheumatoid arthritis model.” Applied Radiation and Isotopes 184: 110213.
450. Zia, N., et al. (2022). “Glycol-Chitosan-Based Technetium-99m-Loaded Multifunctional Nanomicelles: Synthesis, Evaluation, and In Vivo Biodistribution.” Nanomaterials 12(13): 2198.
451. Zorick, T., et al. (2022). “The Effects of Citalopram and Thalamic Dopamine D2/3 Receptor Availability on Decision-Making and Loss Aversion in Alcohol Dependence.” Psychiatry Journal 2022.
452. Zuo, Y., et al. (2022). “Comparison of brain nicotine uptake from electronic cigarettes and combustible cigarettes.” Neuropsychopharmacology 47(11): 1939-1944.
- Adams MP, Rahmim A, Tang J: Improved motor outcome prediction in Parkinson’s disease applying deep learning to DaTscan SPECT images. Computers in Biology and Medicine 2021, 132:104312.
- Aertker BM, Kumar A, Cardenas F, Gudenkauf F, Sequeira D, Prossin AR, Srivastava AK, Cox Jr CS, Bedi SS: PET Imaging of Peripheral Benzodiazepine Receptor Standard Uptake Value Increases After Controlled Cortical Impact, a Rodent Model of Traumatic Brain Injury. ASN neuro 2021, 13:17590914211014135.
- Ahmed H, Wallimann R, Haider A, Hosseini V, Gruber S, Robledo M, Nguyen TA, Herde AM, Iten I, Keller C: Preclinical development of 18F-OF-NB1 for imaging GluN2B-containing N-methyl-D-aspartate receptors and its utility as a biomarker for amyotrophic lateral sclerosis. Journal of Nuclear Medicine 2021, 62(2):259-265.
- Akerele MI, Zein SA, Pandya S, Nikolopoulou A, Gauthier SA, Raj A, Henchcliffe C, Mozley PD, Karakatsanis NA, Gupta A: Population-based input function for TSPO quantification and kinetic modeling with [11 C]-DPA-713. EJNMMI physics 2021, 8(1):1-17.
- Albrecht J, Exner S, Grötzinger C, Prasad S, Konietschke F, Beindorff N, Kühl AA, Prasad V, Brenner W, Koziolek EJ: Multimodal Imaging of 2-Cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model. Journal of nuclear medicine 2021, 62(3):393-398.
- Alizadeh E, Behlol Ayaz Ahmed K, Raja Solomon V, Gaja V, Bernhard W, Makhlouf A, Gonzalez C, Barreto K, Casaco A, Geyer CR: 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo. Cancers 2021, 13(3):560.
- Almeida CGM, Costa-Higuchi K, Piovesan AR, Moro CF, Venturin GT, Greggio S, Costa-Ferro ZS, Salamoni SD, Peigneur S, Tytgat J: Neurotoxic and convulsant effects induced by jack bean ureases on the mammalian nervous system. Toxicology 2021, 454:152737.
- Almeida RF, Nonose Y, Ganzella M, Loureiro SO, Rocha A, Machado DG, Bellaver B, Fontella FU, Leffa DT, Pettenuzzo LF: Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse Model. Frontiers in Psychiatry 2021, 12.
- An Y-S, Kim S-H, Roh TH, Park SH, Kim T-G, Kim J-H: Correlation Between 18F-FDG Uptake and Immune Cell Infiltration in Metastatic Brain Lesions. Frontiers in Oncology 2021, 11:2451.
- An Y-S, Yoon JH, Son SJ, Hong CH, Lee SJ, Yoon J-K: Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated. Scientific reports 2021, 11(1):1-8.
- Antons M, Lindner M, Grosch M, Oos R, Palumbo G, Brendel M, Ziegler S, Bartenstein P, Dieterich M, Zwergal A: Structural and Functional Neuroplasticity Following Bilateral Vestibular Loss: A Longitudinal [18F]-UCB-H/[18F]-FDG Dual Tracer Rat Study. 2021.
- Attarwala AA, Hardiansyah D, Romanó C, Jiménez-Franco LD, Roscher M, Wängler B, Glatting G: Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99m Tc imaging. Annals of Nuclear Medicine 2021, 35(1):111-120.
- Aung W, Tsuji AB, Sugyo A, Fujinaga M, Zhang M-R, Higashi T: Quantitative Radionuclide Imaging Analysis of Enhanced Drug Delivery Induced by Photoimmunotherapy. International Journal of Molecular Sciences 2021, 22(15):8316.
- Auvity S, Goutal S, Caillé F, Vodovar D, Pruvost A, Wimberley C, Leroy C, Tonietto M, Bottlaender M, Tournier N: Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo. Neuropsychopharmacology 2021, 46(6):1220-1228.
- Avendaño-Estrada A, Rios C, Aguirre-Aranda I, Ávila-Rodríguez MÁ, Manjarrez-Marmolejo J, Franco-Pérez J, Morales J, Olayo R, Méndez-Armenta M, Díaz-Ruíz A: Characterization of metabolic activity induced by kainic acid in adult rat whole brain at the early stage: A 18FDG-PET study. Brain Research 2021, 1769:147621.
- Backhaus P, Gierse F, Burg M, Büther F, Asmus I, Dorten P, Cufe J, Roll W, Neri D, Cazzamalli S: Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga] Ga-OncoFAP-DOTAGA. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
- Baharikhoob P: Investigating Translocator Protein Binding in Borderline Personality Disorder with Serious Self-Harm Behavior: An [18 F] Feppa Positron Emission Tomography Study. University of Toronto (Canada); 2021.
- Bai P, Lan Y, Patnaik D, Wang H, Liu Y, Chen Z, Yuan G, Afshar S, Striar R, Zagaroli JS: Design, Synthesis, and Evaluation of Thienodiazepine Derivatives as Positron Emission Tomography Imaging Probes for Bromodomain and Extra-Terminal Domain Family Proteins. Journal of Medicinal Chemistry 2021, 64(19):14745-14756.
- Bai P, Lan Y, Wang H, Liu Y, Striar R, Yuan G, Afshar S, Zagaroli JS, Tocci DR, Langan AG: Synthesis and Characterization of a Positron Emission Tomography Imaging Probe Selectively Targeting the Second Bromodomain of Bromodomain Protein BRD4. Bioconjugate Chemistry 2021.
- Bajaj NS, Bhambhvani P: SPECT-derived absolute myocardial perfusion measures: A step in the right direction. In., vol. 28: Springer International Publishing; 2021: 1919-1922.
- Bajorat R, Kurth J, Stenzel J, Vollmar B, Krause BJ, Reuter DA, Schuerholz T, Bergt S: Early post-ischemic glucose metabolism is dependent on function of TLR2: a study using [18F] FDG PET-CT in a mouse model of cardiac arrest and cardiopulmonary resuscitation. 2021.
- Bakrania P, Hall G, Bouter Y, Bouter C, Beindorff N, Cowan R, Davies S, Price J, Mpamhanga C, Love E: Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease. Molecular psychiatry 2021:1-9.
- Balieiro LM, de Oliveira HB, Silva LFT, Bellini MH, Matsuda MMN, de Araujo EB: Study of the automated synthesis of the radiopharmaceutical fluoroestradiol-18F. Brazilian Journal of Radiation Sciences 2021, 9(3).
- Baraibar-Argota I: Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade. 2021.
- Barret O, Zhang L, Alagille D, Constantinescu CC, Sandiego C, Papin C, Sullivan JM, Morley T, Carroll VM, Seibyl J: Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates. Journal of Nuclear Medicine 2021, 62(9):1307-1313.
- Bascuñana P, Wolf BJ, Jahreis I, Brackhan M, García-García L, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: 99mTc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus. Metabolic brain disease 2021, 36(8):2597-2602.
- Bauer M, Bamminger K, Pichler V, Weber M, Binder S, Maier‐Salamon A, Tahir A, Jäger W, Haslacher H, Tournier N: Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology & Therapeutics 2021, 109(3):754-761.
- Bauer M, Barna S, Blaickner M, Prosenz K, Bamminger K, Pichler V, Tournier N, Hacker M, Zeitlinger M, Karanikas G: Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [11 C] Metoclopramide. Molecular imaging and biology 2021, 23(2):180-185.
- Becker G, Lespine L-F, Bahri MA, Serrano ME, Lemaire C, Luxen A, Tirelli E, Plenevaux A: Exercise against cocaine sensitization in mice: a [18F] fallypride micro-PET study. Brain Communications 2021.
- Beindorff N, Schmitz-Peiffer F, Messroghli D, Brenner W, Eary JF: Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae). Scientific Reports 2021, 11(1):1-8.
- Bellés L, Dimiziani A, Herrmann FR, Ginovart N: Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D2/3 receptor signaling in a rat model of vulnerability to drug abuse. Psychopharmacology 2021, 238(12):3543-3557.
- Bellés L, Dimiziani A, Tsartsalis S, Millet P, Herrmann FR, Ginovart N: Dopamine D2/3 receptor availabilities and evoked dopamine release in striatum differentially predict impulsivity and novelty preference in Roman high-and low-avoidance rats. International Journal of Neuropsychopharmacology 2021, 24(3):239-251.
- Benetos G, Benz DC, Rampidis GP, Giannopoulos AA, von Felten E, Bakula A, Sustar A, Fuchs TA, Pazhenkottil AP, Gebhard C: Coronary artery lumen volume index as a marker of flow-limiting atherosclerosis—validation against 13 N-ammonia positron emission tomography. European Radiology 2021:1-11.
- Bengs S, Haider A, Warnock GI, Fiechter M, Pargaetzi Y, Rampidis G, Etter D, Wijnen WJ, Portmann A, Osto E: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(6):1806-1812.
- Bengs S, Warnock GI, Portmann A, Mikail N, Rossi A, Ahmed H, Etter D, Gisler L, Jie C, Meisel A: Rest/Stress Myocardial Perfusion Imaging by Positron Emission Tomography with 18F-Flurpiridaz: A Feasibility Study in Mice. bioRxiv 2021.
- Bennett KA, Sergeev E, MacSweeney CP, Bakker G, Cooper AE: Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies. Journal of Pharmacology and Experimental Therapeutics 2021, 377(1):157-168.
- Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, Patriki D, Giannopoulos AA, Fuchs TA, Gräni C: Role of quantitative myocardial blood flow and 13N-ammonia washout for viability assessment in ischemic cardiomyopathy. Journal of Nuclear Cardiology 2021, 28(1):263-273.
- Benz DC, Kaufmann PA, von Felten E, Benetos G, Rampidis G, Messerli M, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C: Prognostic value of quantitative metrics from positron emission tomography in ischemic heart failure. Cardiovascular Imaging 2021, 14(2):454-464.
- Berberat J, Roelcke U, Remonda L, Schwyzer L: Long-term apparent diffusion coefficient value changes in patients undergoing radiosurgical treatment of meningiomas. Acta Neurochirurgica 2021, 163(1):89-95.
- Berger A, Araújo-Filho I, Piffoux M, Nicolás-Boluda A, Grangier A, Boucenna I, Real CC, Marques FLN, de Paula Faria D, do Rego ACM: Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula. Nanoscale 2021, 13(1):218-232.
- Bertoglio D, Amhaoul H, Goossens J, Ali I, Jonckers E, Bijnens T, Siano M, Verhaeghe J, Van der Linden A, Staelens S: TSPO PET upregulation predicts epileptic phenotype at disease onset independently from chronic TSPO expression in a rat model of temporal lobe epilepsy. NeuroImage: Clinical 2021:102701.
- Bertoglio D, Bard J, Hessmann M, Liu L, Gärtner A, De Lombaerde S, Huscher B, Zajicek F, Miranda A, Peters F: A novel imaging ligand as a biomarker for mutant huntingtin-lowering in Huntington’s disease. BioRxiv 2021.
- Bertoglio D, Deleye S, Miranda A, Stroobants S, Staelens S, Verhaeghe J: Estimation of the net influx rate Ki and the cerebral metabolic rate of glucose MRglc using a single static [18F] FDG PET scan in rats. NeuroImage 2021, 233:117961.
- Bertoglio D, Verhaeghe J, Miranda A, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M, Bard J, Liu L, Munoz-Sanjuan I: Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington’s Disease mice and post-mortem human HD brain. Journal of Nuclear Medicine 2021.
- Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Dominguez C, Munoz-Sanjuan I, Skinbjerg M, Liu L, Staelens S: Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D 1 R Radioligand [11 C] SCH23390 in Healthy and Diseased Mice. Molecular imaging and biology 2021, 23(2):208-219.
- Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Mrzljak L, Khetarpal V, Skinbjerg M, Liu L, Dominguez C: Longitudinal preclinical evaluation of the novel radioligand [11C] CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
- Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Sauerbeck J, Scheifele M, Prix C, Unterrainer M, Catak C, Pogarell O: Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. NeuroImage: Clinical 2021, 29:102535.
- Biechele G, Blume T, Deussing M, Zott B, Shi Y, Xiang X, Franzmeier N, Kleinberger G, Peters F, Ochs K: Pre-therapeutic Microglia Activation and Sex Determine Therapy Effects of Chronic Immunomodulation. bioRxiv 2021.
- Biechele G, Monasor LS, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus F-J: Glitter in the Darkness? Non-fibrillar β-amyloid Plaque Components Significantly Impact the β-amyloid PET Signal in Mouse Models of Alzheimer’s Disease. Journal of Nuclear Medicine 2021.
- Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S: Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in AppNL-GF mice. NeuroImage 2021, 230:117707.
- Bindini E, Ramirez MdlA, Rios X, Cossío U, Simó C, Gomez‐Vallejo V, Soler‐Illia G, Llop J, Moya SE: In Vivo Tracking of the Degradation of Mesoporous Silica through 89Zr Radio‐Labeled Core–Shell Nanoparticles. Small 2021:2101519.
- Bolcaen J, Descamps B, Deblaere K, De Vos F, Boterberg T, Hallaert G, Van den Broecke C, Vanhove C, Goethals I: Assessment of the effect of therapy in a rat model of glioblastoma using [18F] FDG and [18F] FCho PET compared to contrast-enhanced MRI. Plos one 2021, 16(3):e0248193.
- Bonaventura J, Lam S, Carlton M, Boehm MA, Gomez JL, Solís O, Sánchez-Soto M, Morris PJ, Fredriksson I, Thomas CJ: Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Molecular Psychiatry 2021:1-19.
- Borelli WV, Leal-Conceição E, Andrade MA, Esper NB, Feltes PK, Soder RB, Matushita CS, Hartmann LM, Radaelli G, Schilling LP: Increased Glucose Activity in Subgenual Anterior Cingulate and Hippocampus of High Performing Older Adults, Despite Amyloid Burden. Journal of Alzheimer’s Disease 2021(Preprint):1-10.
- Bossart M, Wagner M, Elvert R, Evers A, Hübschle T, Kloeckener T, Lorenz K, Moessinger C, Eriksson O, Velikyan I: Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. Cell Metabolism 2021.
- Bouter C, Irwin C, Franke TN, Beindorff N, Bouter Y: Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations. Frontiers in Medicine 2021, 8.
- Bratanovic IJ, Zhang C, Zhang Z, Kuo H-T, Colpo N, Zeisler J, Merkens H, Uribe C, Lin K-S, Bénard F: A Novel Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor Positive Prostate Cancer. Journal of Nuclear Medicine 2021.
- Breuil L, Marie S, Goutal S, Auvity S, Truillet C, Saba W, Langer O, Caillé F, Tournier N: Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice? Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211045444.
- Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S: Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo. Neoplasia 2021, 23(1):80-98.
- Brodsky L, Chesnais H, Piri R, Høilund-Carlsen PF: Association of baseline subject characteristics with changes 18 in coronary calcification assessed by F-sodium fluoride PET/CT. 2021.
- Broqueza J: Developing radioimmunotherapy for osteosarcoma using comparative oncology. University of Saskatchewan; 2021.
- Broqueza J, Prabaharan CB, Andrahennadi S, Allen KJ, Dickinson R, MacDonald-Dickinson V, Dadachova E, Uppalapati M: Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma. Cancers 2021, 13(9):2208.
- Brosch-Lenz J: Towards personalized internal radionuclide therapies with 90Y SIRT and 177Lu-PSMA: an investigation of 3D image based dosimetry. lmu; 2021.
- Brosch-Lenz J, Uribe C, Gosewisch A, Kaiser L, Todica A, Ilhan H, Gildehaus FJ, Bartenstein P, Rahmim A, Celler A: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. EJNMMI physics 2021, 8(1):1-17.
- Brumberg J, Kuzkina A, Lapa C, Mammadova S, Buck A, Volkmann J, Sommer C, Isaias IU, Doppler K: Dermal and cardiac autonomic fiber involvement in Parkinson’s disease and multiple system atrophy. Neurobiology of Disease 2021, 153:105332.
- Bu L-L, Liu Y-Q, Shen Y, Fan Y, Yu W-B, Jiang D-L, Tang Y-L, Yang Y-J, Wu P, Zuo C-T: Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy. Neurotherapeutics 2021:1-17.
- Bucci M, Savitcheva I, Farrar G, Salvadó G, Collij L, Doré V, Gispert JD, Gunn R, Hanseeuw B, Hansson O: A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F] flutemetamol amyloid PET images. European journal of nuclear medicine and molecular imaging 2021, 48(7):2183-2199.
- Bunai T, Hirosawa T, Kikuchi M, Fukai M, Yokokura M, Ito S, Takata Y, Terada T, Ouchi Y: tDCS-induced modulation of GABA concentration and dopamine release in the human brain: A combination study of magnetic resonance spectroscopy and positron emission tomography. Brain Stimulation 2021, 14(1):154-160.
- Burvenich IJG, Goh YW, Guo N, Gan HK, Rigopoulos A, Cao D, Liu Z, Ackermann U, Wichmann CW, McDonald AF: Radiolabelling and preclinical characterization of 89 Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European journal of nuclear medicine and molecular imaging 2021:1-14.
- Busatto Filho G, Duran FLdS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGdF, da Costa NA, Porto FHdG, Carvalho CL: Hippocampal subregional volume changes in elders classified using positron emission tomography‐based Alzheimer’s biomarkers of β‐amyloid deposition and neurodegeneration. Journal of Neuroscience Research 2021, 99(2):481-501.
- Calsbeek JJ, González EA, Boosalis CA, Zolkowska D, Bruun DA, Rowland DJ, Saito NH, Harvey DJ, Chaudhari AJ, Rogawski MA: Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus. Neurotoxicology 2021, 87:43-50.
- Caminiti SP, Sala A, Presotto L, Chincarini A, Sestini S, Perani D, Schillaci O, Berti V, Calcagni ML, Cistaro A: Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps. European journal of nuclear medicine and molecular imaging 2021:1-14.
- Campanholo K, Pitombeira M, Rimkus C, Mendes M, Apóstolos-Pereira S, Busatto Filho G, Callegaro D, Buchpiguel C, Duran F, Faria DDP: Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study. Multiple Sclerosis and Related Disorders 2021:103331.
- Campoy A-DT, Liang C, Ladwa RM, Patel KK, Patel IH, Mukherjee J: [18F] Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease. Molecules 2021, 26(23):7360.
- Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE: Dosimetry for radiopharmaceutical therapy: current practices and commercial resources. Journal of Nuclear Medicine 2021, 62(Supplement 3):3S-11S.
- Castro-Balado A, Mondelo-García C, Barbosa-Pereira L, Varela-Rey I, Novo-Veleiro I, Vázquez-Agra N, Antúnez-López JR, Bandín-Vilar EJ, Sendón-García R, Busto-Iglesias M: Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection. Pharmaceutics 2021, 13(3):342.
- Cavalcante MF, Adorne MD, Turato WM, Kemmerer M, Uchiyama MK, Asbahr ACC, Alves AdCS, Farsky SHP, Drewes C, Spatti MC: scFv-Anti-LDL (-)-Metal-Complex Multi-Wall Functionalized-Nanocapsules as a Promising Tool for the Prevention of Atherosclerosis Progression. Frontiers in medicine 2021, 8:446.
- Cawthorne C, Maguire P, Mercier J, Sciberras D, Serdons K, Bormans G, de Hoon J, Van Laere K, Koole M: Human biodistribution and dosimetry of [11 C]-UCB-J, a PET radiotracer for imaging synaptic density. EJNMMI physics 2021, 8(1):1-11.
- Cecchini MA, Yassuda MS, Squarzoni P, Coutinho AM, de Paula Faria D, de Souza Duran FL, da Costa NA, de Gobbi Porto FH, Nitrini R, Forlenza OV: Deficits in short-term memory binding are detectable in individuals with brain amyloid deposition in the absence of overt neurodegeneration in the Alzheimer’s disease continuum. Brain and Cognition 2021, 152:105749.
- Ceccon G, Lohmann P, Werner J-M, Tscherpel C, Dunkl V, Stoffels G, Rosen J, Rapp M, Sabel M, Herrlinger U: Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy. Journal of Nuclear Medicine 2021, 62(7):918-925.
- Cerri G, Tognon M, Avesani S, Oxtoby N, Altmann A, Giugno R: Multi view based imaging genetics analysis on Parkinson disease. bioRxiv 2021.
- Ceyzériat K, Gloria Y, Tsartsalis S, Fossey C, Cailly T, Fabis F, Millet P, Tournier BB: Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer’s disease. Brain Communications 2021, 3(2):fcab029.
- Chan CY, Hopkins SL, Guibbal F, Pacelli A, Torres JB, Mosley M, Lau D, Isenegger P, Chen Z, Wilson TC: PET Imaging Using [18F] olaparib in Mouse Models of Malignant Glioma: Considerations for Molecular Imaging and Radionuclide Therapy Targeting PARP. 2021.
- Chan S-C, Ng S-H, Yeh C-H, Chang K-P: Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and 18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure. Tzu-Chi Medical Journal 2021, 33(1):61.
- Chan S-C, Yeh C-H, Chang JT-C, Chang K-P, Wang J-H, Ng S-H: Combing MRI Perfusion and 18F-FDG PET/CT Metabolic Biomarkers Helps Predict Survival in Advanced Nasopharyngeal Carcinoma: A Prospective Multimodal Imaging Study. Cancers 2021, 13(7):1550.
- Chaney AM, Lopez-Picon FR, Serrière S, Wang R, Bochicchio D, Webb SD, Vandesquille M, Harte MK, Georgiadou C, Lawrence C: Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study. Theranostics 2021, 11(14):6644.
- Chang C-W, Chiu C-H, Lin M-H, Wu H-M, Yu T-H, Wang P-Y, Kuo Y-Y, Huang Y-Y, Shiue C-Y, Huang W-S: GMP-compliant fully automated radiosynthesis of [18 F] FEPPA for PET/MRI imaging of regional brain TSPO expression. EJNMMI research 2021, 11(1):1-15.
- Chanisa C, Monchaya N, Anchisa K, Chetsadaporn P, Attapon J: Analysis of amyloid and tau deposition in Alzheimer’s disease using 11C-Pittsburgh compound B and 18F-THK 5351 positron emission tomography imaging. World Journal of Nuclear Medicine 2021, 20(1):61.
- Charifi W, Fauveau V, Francese L, Grosfeld A, Le Gall M, Ourabah S, Ellero-Simatos S, Viel T, Cauzac M, Gueddouri D: Loss of intestinal ChREBP impairs absorption of dietary sugars and prevents glycemic excursion curves. bioRxiv 2021.
- Chen TB, Lin K-J, Lin S-Y, Lee Y-J, Lin Y-C, Wang C-J, Chen J-P, Wang P-N: Prediction of cerebral amyloid pathology based on plasma amyloid and tau related markers. Frontiers in Neurology 2021:1765.
- Chen X, Zhang Q, Zhang Y, Fang J, Jiang D, Mou Z, Liu H, Su R, Wang C, He F: 18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson’s disease. European Journal of Medicinal Chemistry 2021, 214:113245.
- Chen Y, Li L, Yu X, Wang J, Wang Y, Huang G, Liu J: Is Dynamic Total-body PET Imaging Feasible in the Clinical Daily Practice? 2021.
- Chen Y-A, Lu C-H, Ke C-C, Chiu S-J, Chang C-W, Yang B-H, Gelovani JG, Liu R-S: Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease. International journal of molecular sciences 2021, 22(16):8633.
- Chen Y-A, Lu C-H, Ke C-C, Chiu S-J, Jeng F-S, Chang C-W, Yang B-H, Liu R-S: Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits. Biomedicines 2021, 9(6):594.
- Chen Y-H, Chu S-C, Wang L-Y, Wang T-F, Lue K-H, Lin C-B, Chang B-S, Liu D-W, Liu S-H, Chan S-C: Prognostic Value of Combing Primary Tumor and Nodal Glycolytic–Volumetric Parameters of 18F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis. Diagnostics 2021, 11(6):1065.
- Chen Y-J, Lin C-W, Peng Y-J, Huang C-W, Chien Y-S, Huang T-H, Liao P-X, Yang W-Y, Wang M-H, Mersmann HJ: Overexpression of Adiponectin Receptor 1 Inhibits Brown and Beige Adipose Tissue Activity in Mice. International journal of molecular sciences 2021, 22(2):906.
- Cherix A, Donati G, Lizarbe B, Lanz B, Poitry-Yamate C, Lei H, Gruetter R: Excitatory/inhibitory neuronal metabolic balance in mouse hippocampus upon infusion of [U-13C6] glucose. Journal of Cerebral Blood Flow & Metabolism 2021, 41(2):282-297.
- Cheung P, Zhang B, Puuvuori E, Estrada S, Amin MA, Ye S, Korsgren O, Odell LR, Eriksson J, Eriksson O: PET Imaging of GPR44 by Antagonist [11C] MK-7246 in Pigs. Biomedicines 2021, 9(4):434.
- Chin W-C, Liu F-Y, Huang Y-S, Hsiao I-T, Wang C-H, Chen Y-C: Different positron emission tomography findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study. Journal of Clinical Sleep Medicine 2021, 17(4):739-748.
- Choi K-M, Kim JH, Kong X, Isik M, Zhang J, Lim H-W, Yoon JC: Defective brown adipose tissue thermogenesis and impaired glucose metabolism in mice lacking Letmd1. Cell reports 2021, 37(11):110104.
- Chotipanich C, Jantarato A, Kunawudhi A, Kongthai S, Promteangtrong C: 11C-Pittsburgh compound B and 18F-THK 5351 positron emission tomography brain imaging in cognitively normal individuals. World Journal of Nuclear Medicine 2021, 20(2):133.
- Chotiwan N, Willekens SM, Schexnaydre E, Hahn M, Morini F, Zhang J, Nilsson E, Carlson L-A, Ahlgren U, Marcellino D: Whole-brain fluorescence-MRI coregistration for precise anatomical mapping of virus infection. bioRxiv 2021.
- Chun K, Kong E, Cho I: Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders. Medicine 2021, 100(34).
- Chung S-Y, Hung Y-P, Pan Y-R, Chang Y-C, Wu C-E, Hsu DS-S, Chang PM-H, Lu M-L, Huang C-YF, Su Y: Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the jak2/stat1/3/aldh1a3 Pathway. 2021.
- Chung Y-H, Tsai C-K, Yu C-F, Wang W-L, Yang C-L, Hong J-H, Yen T-C, Chen F-H, Lin G: Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from 18F-FDG PET Imaging and Tissue NMR Metabolomics in a Mouse Model for Hepatocellular Carcinoma. Molecules 2021, 26(9):2573.
- Clemente GS, Antunes IF, Kurhade S, van den Berg M, Sijbesma JW, van Waarde A, Buijsmam RC, Willemsen-Seegers N, Gosens R, Meurs H: Mapping arginase expression with 18F-fluorinated late-generation arginase inhibitors derived from quaternary α-amino acids. Journal of Nuclear Medicine 2021.
- Clemente GS, Antunes IF, Sijbesma JrW, van Waarde A, Lammertsma AA, Dömling A, Elsinga PH: [18F] Atorvastatin Pharmacokinetics and Biodistribution in Healthy Female and Male Rats. Molecular pharmaceutics 2021, 18(9):3378-3386.
- Coda A, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G: In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18 F] DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. European journal of nuclear medicine and molecular imaging 2021, 48(1):40-52.
- Connell NJ, Doligkeit D, Andriessen C, Kornips-Moonen E, Bruls YM, Schrauwen-Hinderling VB, van de Weijer T, van Marken-Lichtenbelt WD, Havekes B, Kazak L: No evidence for brown adipose tissue activation after creatine supplementation in adult vegetarians. Nature Metabolism 2021, 3(1):107-117.
- Corral A, Olmo A, Risco R: Use of X-Ray Computed Tomography for Monitoring Tissue Permeation Processes. In: Cryopreservation and Freeze-Drying Protocols. edn.: Humana, New York, NY; 2021: 317-330.
- Corroyer-Dulmont A, Valable S, Fantin J, Chatre L, Toutain J, Teulier S, Bazille C, Letissier E, Levallet J, Divoux D: Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy. Scientific reports 2021, 11(1):1-15.
- Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Azad BB, Holt DP, Fan H, Lesniak WG, Minn I: First-in-human neuroimaging of soluble epoxide hydrolase using [18 F] FNDP PET. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-7.
- Crimì F, Stramare R, Spolverato G, Aldegheri V, Barison A, D’Alimonte L, Bao Q, Spimpolo A, Albertoni L, Cecchin D: T2-weighted, apparent diffusion coefficient and 18 F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy. Techniques in Coloproctology 2021, 25(5):569-577.
- Cui Y: [18F] DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus. 2021.
- d’Abadie P, Walrand S, Hesse M, Annet L, Borbath I, Van den Eynde M, Lhommel R, Jamar F: Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nuclear Medicine Communications 2021, 42(7):747-754.
- D’Amore F, Grinberg F, Mauler J, Galldiks N, Blazhenets G, Farrher E, Filss C, Stoffels G, Mottaghy FM, Lohmann P: Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes. Neuro-oncology advances 2021, 3(1):vdab044.
- D’Amore F, Grinberg F, Mauler J, Galldiks N, Blazhenets G, Farrher E, Filss C, Stoffels G, Mottaghy FM, Lohmann P: Neuro-Oncology Advances. 2021.
- Damian A, Pineyro MM, Quagliata A, Risso M, Montiglia P, Lima R, Alonso O: 18F-fallypride and 11C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series. World Journal of Nuclear Medicine 2021, 20(3):286.
- Darr C, Costa PF, Kesch C, Krafft U, Püllen L, Harke NN, Hess J, Szarvas T, Haubold J, Reis H: Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls. Translational Andrology and Urology 2021, 10(10):3972.
- de Laat B, Kling YE, Schroyen G, Ooms M, Hooker JM, Bormans G, Van Laere K, Ceccarini J: Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F] JNJ42259152 PET study in rats. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
- de Vor L, van Dijk B, van Kessel KP, Kavanaugh JS, de Haas CJ, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM: Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro biofilm and in vivo implant infections. bioRxiv 2021.
- Delage C, Vignal N, Guerin C, Taib T, Barboteau C, Mamma C, Khacef K, Margaill I, Sarda-Mantel L, Rizzo-Padoin N: From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury. Scientific Reports 2021, 11(1):1-11.
- Delage JA, Gnesin S, Prior JO, Barbet J, Le Saëc P, Marionneau-Lambot S, Gouard S, Chérel M, Bourgeois M, Schaefer N: Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety. Cancers 2021, 13(23):5936.
- DEPIERREUX F: Multimodal Imaging In Parkinson’s Disease: Exploring Iron–, Neuromelanin-Sensitive MRI And FDOPA PET Relationships. Université de Liège, Liège, Belgique; 2021.
- Depierreux F, Parmentier E, Mackels L, Baquero K, Degueldre C, Balteau E, Salmon E, Phillips C, Bahri MA, Maquet P: Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. npj Parkinson’s Disease 2021, 7(1):1-10.
- Dewulf J, Vangestel C, Verhoeven Y, De Waele J, Zwaenepoel K, van Dam PA, Elvas F, Van den Wyngaert T: Immuno-PET Molecular Imaging of RANKL in Cancer. Cancers 2021, 13(9):2166.
- Deyev SM, Xu T, Liu Y, Schulga A, Konovalova E, Garousi J, Rinne SS, Larkina M, Ding H, Gräslund T: Influence of the position and composition of radiometals and radioiodine labels on imaging of Epcam expression in prostate cancer model using the DARPin Ec1. Cancers 2021, 13(14):3589.
- Di Ciano P, de Wit H, Mansouri E, Houle S, Boileau I, Le Foll B: The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence. Scientific Reports 2021, 11(1):1-7.
- Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC: Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body 18 F-FDG PET/CT scans. European journal of nuclear medicine and molecular imaging 2021, 48(3):837-850.
- Diaz AMA, Drumeva GO, Laporte P, Martinez LMA, Petrenyov DR, Carrier J-F, DaSilva JN: Evaluation of the high affinity [18F] fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors. Nuclear Medicine and Biology 2021, 96:41-49.
- Diggelmann F, Bengs S, Haider A, Epprecht G, Beeler AL, Etter D, Wijnen WJ, Portmann A, Warnock GI, Treyer V: Potential Impact of Statins on Neuronal Stress Responses in Patients at Risk for Cardiovascular Disease. Journal of Personalized Medicine 2021, 11(4):261.
- Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48:21-39.
- Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use. In: Seminars in Nuclear Medicine: 2021: Elsevier; 2021.
- Ding J, Tong A, Zhang Y, Wen J, Zhang H, Hacker M, Huo L, Li X: Functional characterization of adrenocortical masses in nononcological patients using [68Ga]-pentixafor. Journal of Nuclear Medicine 2021.
- do Carmo Barbosa JV, Gontijo RMG, de Albuquerque Souza GC, Mendes BM, da Silva JB, Mamede M, Ferreira AV: Influence of image reconstruction protocols on the image quality of a small animal PET scanner using 18F and 11C. Brazilian Journal of Radiation Sciences 2021, 9(3).
- Dockx R, Baeken C, Vermeire S, Waelbers T, Xu Y, Dobbeleir A, Audenaert K, Peremans K: Brain SPECT in the Behaviourally Disordered Dog. In: PET and SPECT in Psychiatry. edn.: Springer, Cham; 2021: 817-839.
- Dockx Y, Vangestel C, Van den Wyngaert T, Huizing M, De Bruycker S, Pauwels P, Staelens S, Stroobants S: Early Changes in [18F] FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts. Molecular imaging 2021, 2021.
- Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM: Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig. European Neuropsychopharmacology 2021, 42:1-11.
- Dorraji ES, Oteiza A, Kuttner S, Martin-Armas M, Kanapathippillai P, Garbarino S, Kalda G, Scussolini M, Piana M, Fenton KA: Positron emission tomography and single photon emission computed tomography imaging of tertiary lymphoid structures during the development of lupus nephritis. International Journal of Immunopathology and Pharmacology 2021, 35:20587384211033683.
- Duong MT, Chen YJ, Doot RK, Young AJ, Lee H, Cai J, Pilania A, Wolk DA, Nasrallah IM: Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology. Nuclear Medicine Communications 2021, 42(11):1261-1269.
- Dupont A-C, Serrière S, Barantin L, Vercouillie J, Tauber C, Gissot V, Bodard S, Chicheri G, Chalon S, Bonnet-Brilhault PF: Study of influence of the glutamatergic concentration of [18 F] FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers. Translational Psychiatry 2021, 11(1):1-10.
- Durán‐Carabali LE, Odorcyk FK, Greggio S, Venturin GT, Sanches EF, Schu GG, Carvalho AS, Pedroso TA, de Sá Couto‐Pereira N, Da Costa JC: Pre‐and early postnatal enriched environmental experiences prevent neonatal hypoxia‐ischemia late neurodegeneration via metabolic and neuroplastic mechanisms. Journal of Neurochemistry 2021, 157(6):1911-1929.
- Durand-Panteix S, Monteil J, Sage M, Garot A, Clavel M, Saidi A, Torgue J, Cogne M, Quelven I: Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma. British journal of cancer 2021, 125(12):1657-1665.
- El Biali M, Karch R, Philippe C, Haslacher H, Tournier N, Hacker M, Zeitlinger M, Schmidl D, Langer O, Bauer M: ABCB1 and ABCG2 together limit the distribution of ABCB1/ABCG2 substrates to the human retina and the ABCG2 single nucleotide polymorphism Q141K (c. 421C> A) may lead to increased drug exposure. Frontiers in pharmacology 2021, 12.
- Eriksson O, Velikyan I, Haack T, Bossart M, Evers A, Lorenz K, Laitinen I, Larsen PJ, Plettenburg O, Johansson L: Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography. Diabetes 2021, 70(4):842-853.
- Eriksson O, Velikyan I, Haack T, Bossart M, Laitinen I, Larsen PJ, Berglund JE, Antoni G, Johansson L, Pierrou S: Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes. Journal of Nuclear Medicine 2021.
- Espes D, Carlsson P-O, Selvaraju RK, Rosestedt M, Cheung P, Ahlström H, Korsgren O, Eriksson O: Longitudinal assessment of 11C-5-Hydroxytryptophan uptake in pancreas after debut of Type 1 Diabetes. Diabetes 2021, 70(4):966-975.
- Eu WZ, Chen Y-J, Chen W-T, Wu K-Y, Tsai C-Y, Cheng S-J, Carter RN, Huang G-J: The effect of nerve growth factor on supporting spatial memory depends upon hippocampal cholinergic innervation. Translational psychiatry 2021, 11(1):1-13.
- Ezura M, Kikuchi A, Okamura N, Ishiki A, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T: 18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies. Frontiers in Aging Neuroscience 2021, 13.
- Fairley LH, Sahara N, Aoki I, Ji B, Suhara T, Higuchi M, Barron AM: Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy. Journal of Neuroinflammation 2021, 18(1):1-13.
- Fan X, He S, Song H, Yin W, Zhang J, Peng Z, Yang K, Zhai X, Zhao L, Gong H: Human endometrium-derived stem cell improves cardiac function after myocardial ischemic injury by enhancing angiogenesis and myocardial metabolism. Stem cell research & therapy 2021, 12(1):1-16.
- Farn S-S, Chang K-W, Lin W-C, Yu H-M, Lin K-L, Tseng Y-C, Chang Y, Yu C-S, Lin W-J: Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [68Ga] IPCAT-NOTA as an Imaging Agent for Dopamine Transporter. Drug Design, Development and Therapy 2021, 15:2577.
- Feiner IV, Pulagam KR, Uribe KB, Passannante R, Simó C, Zamacola K, Gómez-Vallejo V, Herrero-Álvarez N, Cossío U, Baz Z: Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy. Journal of Materials Chemistry B 2021, 9(2):410-420.
- Félix‐Soriano E, Sáinz N, Gil‐Iturbe E, Collantes M, Fernández‐Galilea M, Castilla‐Madrigal R, Ly L, Dalli J, Moreno‐Aliaga MJ: Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice. The FASEB Journal 2021, 35(6):e21592.
- Ferraro DA, Laudicella R, Zeimpekis K, Mebert I, Müller J, Maurer A, Grünig H, Donati O, Sapienza MT, Rueschoff JH: Hot needles can confirm accurate lesion sampling intraoperatively using [18F] PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer. European journal of nuclear medicine and molecular imaging 2021:1-10.
- Ferrer-Ugalde A, Sandoval S, Pulagam KR, Muñoz-Juan A, Laromaine A, Llop J, Tobias G, Núñez R: Radiolabeled Cobaltabis (dicarbollide) Anion–Graphene Oxide Nanocomposites for In Vivo Bioimaging and Boron Delivery. ACS Applied Nano Materials 2021, 4(2):1613-1625.
- Ferté L, Marino A, Battault S, Bultot L, Van Steenbergen A, Bol A, Cumps J, Ginion A, Koepsell H, Dumoutier L: New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans. American Journal of Physiology-Heart and Circulatory Physiology 2021, 320(2):H838-H853.
- Fiedorowicz K, Wargocka-Matuszewska W, Ambrożkiewicz KA, Rugowska A, Cheda Ł, Fiedorowicz M, Zimna A, Drabik M, Borkowski S, Świątkiewicz M: Molecular Imaging of Human Skeletal Myoblasts (huSKM) in Mouse Post-Infarction Myocardium. International journal of molecular sciences 2021, 22(19):10885.
- Filip T, Mairinger S, Neddens J, Sauberer M, Flunkert S, Stanek J, Wanek T, Okamura N, Langer O, Hutter-Paier B: Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling. Alzheimer’s research & therapy 2021, 13(1):1-13.
- Fleury Curado T, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG: Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing. American journal of respiratory and critical care medicine 2021, 203(1):102-110.
- Florea A, Sigl JP, Morgenroth A, Vogg A, Sahnoun S, Winz OH, Bucerius J, Schurgers LJ, Mottaghy FM: Sodium [18F] Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment. Cells 2021, 10(2):275.
- Fois GR, Valla C, Jouberton E, Sas N, Billoux T, Auzeloux P, Cachin F, Miot‐Noirault E, Maigne L: Internal dosimetry of [99mTc] NTP15‐5 radiotracer for cartilage imaging in preclinical and clinical models using the GATE Monte Carlo platform. Medical Physics 2021, 48(1):477-487.
- Fraz MSA, Moe N, Revheim M-E, Stavrinou ML, Durheim MT, Nordøy I, Macpherson ME, Aukrust P, Jørgensen SF, Aaløkken TM: Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency—Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease. Frontiers in immunology 2021:3606.
- Fung LK, Flores RE, Gu M, Sun KL, James D, Schuck RK, Jo B, Park JH, Lee BC, Jung JH: Thalamic and prefrontal GABA concentrations but not GABAA receptor densities are altered in high-functioning adults with autism spectrum disorder. Molecular psychiatry 2021, 26(5):1634-1646.
- Gade S, Hjørnevik T, Park JH, Shen B, Gu M, Tseng J, Barbosa D, Leuze C, Pitteri S, Jung J: The first awake simultaneous PET-MR study of an adult with fragile X syndrome: A case report. 2021.
- Gao Y, Li Z, Song C, Li L, Li M, Schmall J, Liu H, Yuan J, Wang Z, Zeng T: Automatic rat brain image segmentation using triple cascaded convolutional neural networks in a clinical PET/MR. Physics in Medicine & Biology 2021, 66(4):04NT01.
- Gao Y, Wu S, Pan J, Zhang K, Li X, Xu Y, Jin C, He X, Shi J, Ma L: CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(3):708-720.
- García-Varela L, García DV, Aguiar P, Kakiuchi T, Ohba H, Harada N, Nishiyama S, Tago T, Elsinga PH, Tsukada H: Head-to-head comparison of (R)-[11C] verapamil and [18F] MC225 in non-human primates, tracers for measuring P-glycoprotein function. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
- García-Varela L, Rodríguez-Pérez M, Custodia A, Moraga-Amaro R, Colabufo NA, Aguiar P, Sobrino T, Dierckx RA, van Waarde A, Elsinga PH: In Vivo Induction of P-Glycoprotein Function can be Measured with [18F] MC225 and PET. Molecular pharmaceutics 2021.
- Garnier‐Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B, Gonneaud J, De Flores R, de la Sayette V, Vivien D: White matter hyperintensity topography in Alzheimer’s disease and links to cognition. Alzheimer’s & Dementia 2021.
- Garrido V, Piñero‐Lambea C, Rodriguez‐Arce I, Paetzold B, Ferrar T, Weber M, Garcia‐Ramallo E, Gallo C, Collantes M, Peñuelas I: Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo. Molecular systems biology 2021, 17(10):e10145.
- Gasiorek A, Dobosz E, Potempa B, Ciaston I, Wilamowski M, Oruba Z, Lamont RJ, Jura J, Potempa J, Koziel J: Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts. Mbio 2021, 12(3):e00502-00521.
- Gelston D, Brosler SC, Vazquez J, Sorci O, Griffith AH, Chatterjee S, Buchner A, Høilund-Carlsen PF, Alavi A, Rajapakse CS: Utility of FDG PET/CT in assessing bowel inflammation. American Journal of Nuclear Medicine and Molecular Imaging 2021, 11(4):271.
- Geraldo LH, Xu Y, Jacob L, Pibouin-Fragner L, Rao R, Maissa N, Verreault M, Lemaire N, Knosp C, Lesaffre C: SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia. bioRxiv 2021.
- Ghodoosi EK: Improving Quantitative Imaging Accuracy for Dosimetry of Lutetium-177-PSMA Imaging &Therapy. Technische Universität München; 2021.
- Ghosh KK, Padmanabhan P, Yang C-T, Wang Z, Palanivel M, Ng KC, Lu J, Carlstedt-Duke J, Halldin C, Gulyás B: An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [11C] PBR28 and [18F] flumazenil PET Imaging. International Journal of Molecular Sciences 2021, 22(2):951.
- Giglio J, Fernandez S, Martinez A, Zeni M, Reyes L, Rey A, Cerecetto H: Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer’s Disease: 11C-Synthesis and In Vivo Proof of Concept. Journal of Medicinal Chemistry 2021.
- Girard A, Francois M, Chaboub N, Le Reste P-J, Devillers A, Saint-Jalmes H, Le Jeune F, Palard-Novello X: Impact of point-spread function reconstruction on dynamic and static F-18-DOPA PET/CT quantitative parameters in glioma. Quantitative Imaging in Medicine and Surgery 2021.
- Girard A, Le Reste P-J, Metais A, Chaboub N, Devillers A, Saint-Jalmes H, Jeune FL, Palard-Novello X: Additive Value of Dynamic FDOPA PET/CT for Glioma Grading. Frontiers in Medicine 2021, 8:1106.
- Glorie D, Verhaeghe J, Miranda A, De Lombaerde S, Stroobants S, Staelens S: Quantification of metabotropic glutamate receptor 5 availability with both [11C] ABP688 and [18F] FPEB positron emission tomography in the Sapap3 knockout mouse model for obsessive compulsive-like behavior. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2021.
- Golan S, Aviv T, Groshar D, Yakimov M, Zohar Y, Prokocimer Y, Nadu A, Baniel J, Domachevsky L, Bernstine H: Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study. Journal of Nuclear Medicine 2021, 62(6):773-778.
- Gomez JL, Bonaventura J, Keighron J, Wright KM, Marable DL, Rodriguez LA, Lam S, Carlton ML, Ellis RJ, Jordan CJ: Synaptic Zn2+ potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior. Translational psychiatry 2021, 11(1):1-15.
- Gonzalez-Galofre ZN, Alcaide-Corral CJ, Tavares AA: Effects of administration route on uptake kinetics of 18 F-sodium fluoride positron emission tomography in mice. Scientific reports 2021, 11(1):1-8.
- González-Mancebo D, Becerro AI, Calderón-Olvera RM, Cantelar E, Corral A, Balcerzyk M, Jesús M, Ocaña M: Neodymium doped lanthanide fluoride nanoparticles as contrast agents for luminescent bioimaging and X-ray computed tomography. Boletín de la Sociedad Española de Cerámica y Vidrio 2021.
- Gordon O, Lee DE, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K: Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant–associated infections. Science translational medicine 2021, 13(622):eabl6851.
- Goutal S, Guillermier M, Becker G, Gaudin M, Bramoullé Y, Luxen A, Lemaire C, Plenevaux A, Salmon E, Hantraye P: The pharmacokinetics of [18 F] UCB-H revisited in the healthy non-human primate brain. EJNMMI research 2021, 11(1):1-9.
- Grachev ID, Meyer PM, Becker GA, Bronzel M, Marsteller D, Pastino G, Voges O, Rabinovich L, Knebel H, Zientek F: Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18 F] fluspidine and [18 F] fallypride PET study. European journal of nuclear medicine and molecular imaging 2021, 48(4):1103-1115.
- Grecco GG, Mork BE, Huang J-Y, Metzger CE, Haggerty DL, Reeves KC, Gao Y, Hoffman H, Katner SN, Masters AR: Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry. Elife 2021, 10:e66230.
- Grosch M: Metabolic brain connectivity after acute unilateral vestibulopathy: Longitudinal analysis and single subject classification in the rat. lmu; 2021.
- Grosch M, Beyer L, Lindner M, Kaiser L, Ahmadi S-A, Stockbauer A, Bartenstein P, Dieterich M, Brendel M, Zwergal A: Metabolic connectivity-based single subject classification by multi-regional linear approximation in the rat. NeuroImage 2021, 235:118007.
- Grosch M, Lindner M, Bartenstein P, Brandt T, Dieterich M, Ziegler S, Zwergal A: Dynamic whole-brain metabolic connectivity during vestibular compensation in the rat. NeuroImage 2021, 226:117588.
- Gullberg GT, Shrestha UM, Veress AI, Segars WP, Liu J, Ordovas K, Seo Y: Novel Methodology for Measuring Regional Myocardial Efficiency. IEEE Transactions on Medical Imaging 2021, 40(6):1711-1725.
- Gündel D, Sadeghzadeh M, Deuther-Conrad W, Wenzel B, Cumming P, Toussaint M, Ludwig F-A, Moldovan R-P, Kranz M, Teodoro R: Preclinical Evaluation of [18F] FACH in Healthy Mice and Piglets: An 18F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET. International journal of molecular sciences 2021, 22(4):1645.
- Günther T: Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies. Technische Universität München; 2021.
- Guttman ZR: Impulsivity or Aversion to Ambiguity? Decision-Making under Uncertainty in Stimulant Use Disorder. University of California, Los Angeles; 2021.
- Hack RI, Becker AS, Bode-Lesniewska B, Exner GU, Müller DA, Ferraro DA, Warnock GI, Burger IA, Britschgi C: When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma. Life 2021, 11(9):869.
- Haider A, Bengs S, Diggelmann F, Epprecht G, Etter D, Beeler AL, Wijnen WJ, Treyer V, Portmann A, Warnock GI: Age-and sex-dependent changes of resting amygdalar activity in individuals free of clinical cardiovascular disease. Journal of Nuclear Cardiology 2021, 28(2):427-432.
- Han Y-H, Jeong H-J, Kim E-M, Boud F, Lim ST, Lee SY, Sohn M-H: Effect of Ursodeoxycholic Acid on the Biodistribution and Excretion of Technetium-99m Radiopharmaceuticals in Rat: A Potential Image Quality Enhancer. Yonsei Medical Journal 2021, 62(6):555.
- Hashimoto F, Ohba H, Ote K, Kakimoto A, Tsukada H, Ouchi Y: 4D deep image prior: Dynamic PET image denoising using an unsupervised four-dimensional branch convolutional neural network. Physics in Medicine & Biology 2021, 66(1):015006.
- Hatano M, Miyazaki T, Ishiwata Y, Nakajima W, Arisawa T, Kuroki Y, Kobayashi A, Takada Y, Ogawa M, Kawamura K: Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor,[11 C] K-2, in healthy human subjects. Scientific reports 2021, 11(1):1-10.
- Hatashita S, Wakebe D: Longitudinal assessment of amyloid-beta deposition in initially amyloid-negative non-demented individuals with [11C]-PIB PET imaging. Medicine 2021, 100(35).
- Hattori Y, Matsuda S, Baba R, Matsumiya K, Iwasaki S, Constantinescu CC, Morley TJ, Carroll VM, Papin C, Gouasmat A: Design, Synthesis, and Evaluation of (2-Aminocyclopropyl) phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain. Journal of Medicinal Chemistry 2021, 64(7):3780-3793.
- Hayashi H, Kobayashi R, Kawakatsu S, Ohba M, Morioka D, Otani K: Comparison of the decreases in regional cerebral blood flow in the posterior cingulate cortex, precuneus, and parietal lobe between suspected non‐Alzheimer’s disease pathophysiology and Alzheimer’s disease. Psychogeriatrics 2021.
- Heing‐Becker I, Grötzinger C, Beindorff N, Prasad S, Erdmann S, Exner S, Haag R, Licha K: A Cyanine‐Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation. ChemBioChem 2021, 22(7):1307.
- Hirabayashi T, Nagai Y, Hori Y, Inoue K-i, Aoki I, Takada M, Suhara T, Higuchi M, Minamimoto T: Chemogenetic sensory fMRI reveals behaviorally relevant bidirectional changes in primate somatosensory network. Neuron 2021, 109(20):3312-3322. e3315.
- Hori Y, Nagai Y, Mimura K, Suhara T, Higuchi M, Bouret S, Minamimoto T: D1-and D2-like receptors differentially mediate the effects of dopaminergic transmission on cost/benefit evaluation and motivation in monkeys. bioRxiv 2021:2020.2011. 2027.400911.
- Horimoto Y, Sato C, Inagaki A, Hayashi E, Nozue T, Morita S, Kondo Y, Funaki M, Iida A, Tajima T: Effects of repetitive transcranial magnetic stimulation on cerebral glucose metabolism. Neurological Sciences 2021:1-5.
- Hsu J-W, Nien C-Y, Chen H-W, Tsai F-Y, Yeh S-C, Kao Y-H, Tsou T-C: Di (2-ethylhexyl) phthalate exposure exacerbates metabolic disorders in diet-induced obese mice. Food and Chemical Toxicology 2021, 156:112439.
- Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG: 18F-labeled radiotracers for In Vivo imaging of DREADD with positron emission tomography. European Journal of Medicinal Chemistry 2021, 213:113047.
- Huang CW, Chang YC, Hsiao HY, Liu JW, Chang FCS, Huang JJ: Creation of a rat lymphedema model using extensive lymph node dissection and circumferential soft tissue resection: Is this a reliable model? Microsurgery 2021, 41(8):762-771.
- Huang K-L, Hsiao T, Chang T-Y, Yang S-Y, Chang Y-J, Wu H-C, Liu C-H, Wu Y-M, Lin K-J, Ho M-Y: Neurodegeneration and Vascular Burden on Cognition After Midlife: A Plasma and Neuroimaging Biomarker Study. Frontiers in Human Neuroscience 2021, 15.
- Huang S, Wu Y, Li C, Xu L, Huang J, Huang Y, Cheng W, Xue B, Zhang L, Liang S: Tailoring morphologies of mesoporous polydopamine nanoparticles to deliver high-loading radioiodine for anaplastic thyroid carcinoma imaging and therapy. Nanoscale 2021, 13(35):15021-15030.
- Huang S, Zhang L, Xu M, Li C, Fu H, Huang J, Jin X, Liang S, Wang H: Co‐Delivery of 131I and Prima‐1 by Self‐Assembled CD44‐Targeted Nanoparticles for Anaplastic Thyroid Carcinoma Theranostics. Advanced Healthcare Materials 2021, 10(3):2001029.
- Hugon G, Goutal S, Dauba A, Breuil L, Larrat B, Winkeler A, Novell A, Tournier N: [18F] 2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood–Brain Barrier Permeability Induced by Focused Ultrasound. Pharmaceutics 2021, 13(11):1752.
- Hugon G, Goutal S, Dauba A, Breuil L, Winkeler A, Novell A, Tournier N: [18F] 2-fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Estimation of Blood-brain Barrier Permeability in vivo. 2021.
- Hwang J-H, Han Y-H, Rahman M, Lee C-S: Quantitative assessment of dry mouth in scrub typhus using salivary scintigraphy. Scientific reports 2021, 11(1):1-7.
- Iikuni S, Okada Y, Shimizu Y, Watanabe H, Ono M: Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. Molecular Pharmaceutics 2021, 18(3):966-975.
- Ikoma Y, Takuwa H, Nishino A, Maeda J, Kawamura K, Obata T, Zhang M-R, Higuchi M, Suhara T: Measurement of changes in endogenous serotonin level by positron emission tomography with [18F] altanserin. Annals of Nuclear Medicine 2021:1-11.
- Imanli H, Smith M, Mahat J, Chen W, Restrepo AJ, Sawan MA, Abdelmegid MA-KF, Abd el Rahman Helmy H, Demitry S, See V: Metabolic Scar Assessment with 18F-FDG-PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites. Journal of Nuclear Medicine 2021.
- Inubushi T, Ito M, Mori Y, Futatsubashi M, Sato K, Ito S, Yokokura M, Shinke T, Kameno Y, Kakimoto A: Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release. NeuroImage 2021, 224:117434.
- Ishibashi K, Miura Y, Wagatsuma K, Kameyama M, Ishii K: Brain 11C‐ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer’s disease. Journal of Neuroimaging 2021.
- Jacques S, Arjomand A, Perée H, Collins P, Mayer A, Lavergne A, Wéry M, Mni M, Hego A, Thuillier V: Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma. Scientific reports 2021, 11(1):1-15.
- Jantarato A, Vachatimanont S, Boonkawin N, Yaset S, Kunawudhi A, Promteangtrong C, Assanasen J, Mahanonda N, Chotipanich C: The Evaluation of Tau Deposition with [18F] PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease. Molecular Imaging 2021, 2021.
- Jensen JB, Dollerup OL, Moeller AB, Billeskov TB, Dalbram E, Chubanava S, Dellinger RW, Trost K, Moritz T, Ringgaard S: A randomized placebo-controlled clinical trial of Nicotinamide Riboside and Pterostilbene supplementation in experimental muscle injury in elderly subjects. medRxiv 2021.
- Jeong EH, Sunwoo MK, Hyung SW, Han S-K, Lee JY: Correlation of Dopaminergic Denervation and the Progression of Autonomic Dysfunctions in Different Clinical Subtypes of Parkinson’s Disease. Parkinson’s Disease 2021, 2021.
- Jeong YJ, Park HS, Jeong JE, Yoon HJ, Jeon K, Cho K, Kang D-Y: Restoration of amyloid PET images obtained with short-time data using a generative adversarial networks framework. Scientific reports 2021, 11(1):1-11.
- Jeschke J, Collignon E, Al Wardi C, Krayem M, Bizet M, Jia Y, Garaud S, Wimana Z, Calonne E, Hassabi B: Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors. Nature Cancer 2021, 2(6):611-628.
- Ji B, Ono M, Yamasaki T, Fujinaga M, Zhang M-R, Seki C, Aoki I, Kito S, Sawada M, Suhara T: Detection of Alzheimer’s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X21992457.
- Jiang H, Joshi S, Liu H, Mansor S, Qiu L, Zhao H, Whitehead T, Gropler RJ, Wu GF, Cross AH: In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H] CS1P1 and [11C] CS1P1. ACS Chemical Neuroscience 2021, 12(19):3733-3744.
- Jiang M, Chen X, Zhang L, Liu W, Yu X, Wang Z, Zheng M: Electroacupuncture suppresses glucose metabolism and GLUT-3 expression in medial prefrontal cortical in rats with neuropathic pain. Biological Research 2021, 54(1):1-9.
- Johannessen K, Berntsen EM, Johansen H, Solheim TS, Karlberg A, Eikenes L: 18 F-FACBC PET/MRI in the evaluation of human brain metastases: a case report. European Journal of Hybrid Imaging 2021, 5(1):1-12.
- Joo Y-H, Kim J-H, Kim H-K, Son Y-D, Cumming P, Kim J-H: Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study. Life 2021, 11(6):506.
- Joya A, Ardaya M, Montilla A, Garbizu M, Plaza-García S, Gómez-Vallejo V, Padro D, Gutiérrez JJ, Rios X, Ramos-Cabrer P: In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke. Theranostics 2021, 11(1):410.
- Juri C, Kramer V, Riss PJ, Soza-Ried C, Haeger A, Pruzzo R, Rösch F, Amaral H, Chana-Cuevas P: [18F] PR04. MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease. Clinical nuclear medicine 2021, 46(2):119.
- Kaewchur T, Chamroonrat W, Thientunyakit T, Khiewvan B, Wongsurawat N, Chotipanich C, Chinvarun Y, Bunyaratavej K, Amnuaywattakorn S, Poon-iad N: Thai National Guideline for Nuclear Medicine Investigation in Epilepsy. Asia Oceania Journal of Nuclear Medicine and Biology 2021.
- Kagitani-Shimono K, Kato H, Kuwayama R, Tominaga K, Nabatame S, Kishima H, Hatazawa J, Taniike M: Clinical evaluation of neuroinflammation in child-onset focal epilepsy: a translocator protein PET study. Journal of Neuroinflammation 2021, 18(1):1-13.
- Kang KJ, Oh SJ, Nam KR, Ahn H, Park J, Lee KC, Choi JY: Validation of Image Qualities of a Novel Four-Mice Bed PET System as an Oncological and Neurological Analysis Tool. Journal of Imaging 2021, 7(3):43.
- Kang Y, Pandya S, Zinger N, Michaelson N, Gauthier SA: Longitudinal change in TSPO PET imaging in progressive multiple sclerosis. Annals of clinical and translational neurology 2021, 8(8):1755-1759.
- Kapoor S, Kala D, Svoboda J, Brnoliakova Z, Otahal J: The Effect of Sulphoraphane on Brain Glucose Uptake during Neonatal Hypoxic-Ischemic Encephalopathy in Newborn Rats. European Pharmaceutical Journal 2021, 68(1):136-138.
- Karlsson H, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Preoperative mu-opioid receptor availability predicts weight loss following bariatric surgery. medRxiv 2021.
- Karlsson HK, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Mesolimbic opioid-dopamine interaction is disrupted in obesity but recovered by weight loss following bariatric surgery. Translational Psychiatry 2021, 11(1):1-7.
- Karlsson HK, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Preoperative brain μ-opioid receptor availability predicts weight development following bariatric surgery in women. JCI insight 2021, 6(10).
- Katayama D, Yanagawa M, Matsunaga K, Watabe H, Watabe T, Kato H, Kijima T, Takeda Y, Kumanogoh A, Shimosegawa E: Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival. Scientific reports 2021, 11(1):1-8.
- Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, Nakatsuji Y, Hatazawa J: Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET. Journal of Cerebral Blood Flow & Metabolism 2021, 41(2):369-379.
- Kersemans V, Gilchrist S, Allen PD, Wallington S, Kinchesh P, Prentice J, Tweedie M, Warner JH, Smart SC: A System-Agnostic, Adaptable and Extensible Animal Support Cradle System for Cardio-Respiratory-Synchronised, and Other, Multi-Modal Imaging of Small Animals. Tomography 2021, 7(1):39-54.
- Kersting D, Jentzen W, Fragoso Costa P, Sraieb M, Sandach P, Umutlu L, Conti M, Zarrad F, Rischpler C, Fendler W: Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124. Scientific Reports 2021, 11(1):1-15.
- Kessler L, Kupusovic J, Ferdinandus J, Hirmas N, Umutlu L, Zarrad F, Nader M, Fendler WP, Totzeck M, Wakili R: Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET. Clinical Nuclear Medicine 2021, 46(10):807-813.
- Kim D, Moon BS, Park SM, Lee SJ, Kang SY, Park S, Oh SJ, Kim BS, Yoon H-J: Feasibility of TSPO-Specific Positron Emission Tomography Radiotracer for Evaluating Paracetamol-Induced Liver Injury. Diagnostics 2021, 11(9):1661.
- Kim D-Y, Min J-J: Synthesis and Evaluation of 18 F-Labeled Fluoroalkyl Triphenylphosphonium Salts as Mitochondrial Voltage Sensors in PET Myocardial Imaging. In: Mitochondrial Medicine. edn.: Springer; 2021: 49-64.
- Kim H-S, Lee B-i, Ahn J-S: Assessment of MicroPET Image Quality Based on Reconstruction Methods and Post-Filtering. Applied Sciences 2021, 11(18):8707.
- Kim J-H, Son Y-D, Kim H-K, Kim J-H: Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C] DASB. Neuropsychiatric Disease and Treatment 2021, 17:3195.
- Kim K, Choi H-y, Pak K, Jeon H: Changes in brain glucose metabolism following traumatic optic neuropathy in rats. All Life 2021, 14(1):49-57.
- Kim M, Kim E-M, Oh P-S, Lim ST, Sohn M-H, Song E-K, Park KU, Kim JY, Won KS, Jeong H-J: Usefulness of cyclic thermal therapy and red blood cell scintigraphy in patients with chemotherapy-induced peripheral neuropathy. The Korean Journal of Pain 2021, 34(4):427.
- Kimura K, Nagai Y, Hatanaka G, Fang Y, Zheng A, Fujiwara M, Nakano M, Hori Y, Takeuchi R, Inagaki M: A mosaic adeno-associated virus vector as a versatile tool that exhibits high levels of transgene expression and neuron specificity in primate brain. bioRxiv 2021.
- Kimura Y, Takahata K, Shimazaki T, Kitamura S, Seki C, Ikoma Y, Ichise M, Kawamura K, Yamada M, Zhang M-R: Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand,[11C] TASP457. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-9.
- Kinzi J, Grube M, Zu Schwabedissen HEM: OATP2B1-the underrated member of the Organic Anion Transporting Polypeptide Family of drug transporters? Biochemical Pharmacology 2021:114534.
- Kiraga Ł, Kucharzewska P, Paisey S, Cheda Ł, Domańska A, Rogulski Z, Rygiel TP, Boffi A, Król M: Nuclear imaging for immune cell tracking in vivo–Comparison of various cell labeling methods and their application. Coordination Chemistry Reviews 2021, 445:214008.
- Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM: PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook. Frontiers in oncology 2021, 11.
- Kjærgaard K, Frisch K, Sørensen M, Munk OL, Hofmann AF, Horsager J, Schacht AC, Erickson M, Shapiro D, Keiding S: Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. Journal of Hepatology 2021, 74(1):58-65.
- Klein J, Yan X, Johnson A, Tomljanovic Z, Zou J, Polly K, Honig LS, Brickman AM, Stern Y, Devanand D: Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer’s disease. Journal of Alzheimer’s Disease 2021(Preprint):1-16.
- Klinge MW, Sutter N, Mark EB, Haase A-M, Borghammer P, Schlageter V, Lund S, Fleischer J, Knudsen K, Drewes AM: Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy. Journal of Neurogastroenterology and Motility 2021, 27(3):390-399.
- Kobayashi M, Mizutani A, Okamoto T, Muranaka Y, Nishi K, Nishii R, Shikano N, Nakanishi T, Tamai I, Kleinerman ES: Assessment of drug transporters involved in the urinary secretion of [99mTc] dimercaptosuccinic acid. Nuclear Medicine and Biology 2021, 94:92-97.
- Koike T, Constantinescu CC, Ikeda S, Nishi T, Sunahara E, Miyamoto M, Cole P, Barret O, Alagille D, Papin C: Preclinical characterization of [18F] T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-9.
- Kojima K, Hirano S, Kimura Y, Seki C, Ikoma Y, Takahata K, Ito T, Yokokawa K, Hashimoto H, Kawamura K: Serotonergic neural network related to behavioral inhibition system. bioRxiv 2021.
- Kolinger GD, García DV, Lohith TG, Hostetler ED, Sur C, Struyk A, Boellaard R, Koole M: A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F] MK-6240. EJNMMI research 2021, 11(1):1-13.
- Kolinger GD, Vállez García D, Willemsen AT, Reesink FE, de Jong BM, Dierckx RA, De Deyn PP, Boellaard R: Amyloid burden quantification depends on PET and MR image processing methodology. PloS one 2021, 16(3):e0248122.
- Kong X, Luo S, Wang YF, Yang GF, Lu GM, Zhang LJ: [18F] PBR146 and [18F] DPA-714 in vivo Imaging of Neuroinflammation in Chronic Hepatic Encephalopathy Rats. Frontiers in Neuroscience 2021:1056.
- Kong Y, Huang L, Li W, Liu X, Zhou Y, Liu C, Zhang S, Xie F, Zhang Z, Jiang D: The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment. Frontiers in cell and developmental biology 2021, 9.
- Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, Schroeder FA, Hooker JM, Bormans G, de Hoon J: Clinical validation of the novel HDAC6 radiotracer [18 F] EKZ-001 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(2):596-611.
- Kranz GS, Spies M, Vraka C, Kaufmann U, Klebermass E-M, Handschuh PA, Ozenil M, Murgaš M, Pichler V, Rischka L: High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report. Psychoneuroendocrinology 2021, 133:105381.
- Kreuzer A, Sauerbeck J, Scheifele M, Stockbauer A, Schönecker S, Prix C, Wlasich E, Loosli SV, M Kazmierczak P, Unterrainer M: Detection gap of right-asymmetric neuronal degeneration by CERAD test battery in Alzheimer’s disease. Frontiers in Aging Neuroscience 2021, 13:5.
- Kubota M, Seki C, Kimura Y, Takahata K, Shimada H, Takado Y, Matsuoka K, Tagai K, Sano Y, Yamamoto Y: A first-in-human study of 11 C-MTP38, a novel PET ligand for phosphodiesterase 7. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
- Kühnel C, Seifert P, Drescher R, Freesmeyer M: Reframing multiple reconstructed early dynamic PET images for smooth image rendering. Nuklearmedizin 2021, 60(02):P15.
- Kupitz D, Wissel H, Wuestemann J, Bluemel S, Pech M, Amthauer H, Kreissl MC, Grosser OS: Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT. EJNMMI physics 2021, 8(1):1-14.
- Kwon IG, Kang CW, Park J-P, Oh JH, Wang EK, Kim TY, Sung JS, Park N, Lee YJ, Sung H-J: Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 2021, 70(10):1847-1856.
- Labrador-Espinosa MA, Grothe MJ, Macías-García D, Jesús S, Adarmes-Gómez A, Muñoz-Delgado L, Fernández-Rodríguez P, Martín-Rodríguez JF, Huertas I, García-Solís D: Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum. Clinical Nuclear Medicine 2021, 46(6):e296-e306.
- Lahnif H, Grus T, Pektor S, Greifenstein L, Schreckenberger M, Rösch F: Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach. Molecules 2021, 26(21):6332.
- Lai TH, Schröder S, Toussaint M, Dukić-Stefanović S, Kranz M, Ludwig F-A, Fischer S, Steinbach J, Deuther-Conrad W, Brust P: Development of 18F-labeled radiotracers for PET imaging of the adenosine A2A receptor: Synthesis, radiolabeling and preliminary biological evaluation. International journal of molecular sciences 2021, 22(5):2285.
- Lai TH, Toussaint M, Teodoro R, Dukić-Stefanović S, Gündel D, Ludwig F-A, Wenzel B, Schröder S, Sattler B, Moldovan R-P: Improved in vivo PET imaging of the adenosine A 2A receptor in the brain using [18 F] FLUDA, a deuterated radiotracer with high metabolic stability. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
- Lai TH, Toussaint M, Teodoro R, Dukić-Stefanović S, Kranz M, Deuther-Conrad W, Moldovan R-P, Brust P: Synthesis and biological evaluation of a novel 18F-labeled radiotracer for PET imaging of the adenosine A2A receptor. International journal of molecular sciences 2021, 22(3):1182.
- Lan Y, Bai P, Liu Y, Afshar S, Striar R, Rattray AK, Meyer TN, Langan AG, Posner AM, Shen S: Visualization of Receptor-Interacting Protein Kinase 1 (RIPK1) by Brain Imaging with Positron Emission Tomography. Journal of Medicinal Chemistry 2021, 64(20):15420-15428.
- Landau AM, Lillethorup TP, Noer O, Alstrup AKO, Stokholm K, Thomsen MB, Zaer H, Orlowski D, Mikkelsen TW, Glud AN: Spontaneous Partial Recovery of Striatal Dopaminergic Uptake Despite Nigral Cell Loss in Asymptomatic MPTP-Lesioned Minipigs. 2021.
- Langaa SS, Lauridsen TG, Mose FH, Fynbo CA, Theil J, Bech JN: Estimation of renal perfusion based on measurement of rubidium-82 clearance by PET/CT scanning in healthy subjects. EJNMMI physics 2021, 8(1):1-20.
- Latorre Moreno L: Image processing software for seizure onset zone localization in refractory epilepsy. 2021.
- Laymon CM, Minhas DS, Royse SK, Aizenstein HJ, Cohen AD, Tudorascu DL, Klunk WE: Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [11C] PiB amyloid imaging. EJNMMI physics 2021, 8(1):1-16.
- Ledermann K, von Känel R, Berna-Renella C, Sprott H, Jenewein J, Garland E, Martin-Sölch C: Understanding And Restoring Dopaminergic Function In Fibromyalgia Patients Using A Mindfulness-Based Psychological Intervention: A [18F]-DOPA PET StudyStudy Protocol For The FIBRODOPA Study-A Randomized Controlled Trial. 2021.
- Lee B-C, Tsai H-H, Huang AP-H, Lo Y-L, Tsai L-K, Chen Y-F, Wu W-C: Arterial Spin Labeling Imaging Assessment of Cerebrovascular Reactivity in Hypertensive Small Vessel Disease. Frontiers in Neurology 2021, 12:1004.
- Lee C-C, Liao Y-C, Lee M-C, Lin K-J, Hsu H-Y, Chiou S-Y, Young S-L, Lin J-S, Huang C-C, Watanabe K: Lactobacillus plantarum TWK10 attenuates aging-associated muscle weakness, bone loss, and cognitive impairment by modulating the gut microbiome in mice. Frontiers in nutrition 2021:753.
- Lee C-H, Choi Y-A, Heo S-J, Song P: The Effect of Hyperbaric Therapy on Brown Adipose Tissue in Rats. International journal of environmental research and public health 2021, 18(17):9165.
- Lee J-H, Veronese M, Liow J-S, Morse CL, Santamaria JAM, Haskali MB, Zoghbi SS, Pike VW, Innis RB, Zanotti-Fregonara P: Region-and voxel-based quantification in human brain of [18 F] LSN3316612, a radioligand for O-GlcNAcase. EJNMMI research 2021, 11(1):1-9.
- Lee JW, Song YS, Kim H, Ku BD, Lee WW: Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data. Plos one 2021, 16(2):e0246881.
- Lee JW, Song YS, Kim H, Ku BD, Lee WW: Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data. Medicine 2021, 100(26).
- Lee MJ, Pak K, Kim H-K, Nudelman KN, Kim JH, Kim YH, Kang J, Baek MS, Lyoo CH: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease. npj Parkinson’s Disease 2021, 7(1):1-9.
- Lee N, Oh S-J, Park J-W, Nam K-R, Kang K-J, Lee K-C, Lee Y-J, Choi J-S, Seok J-H, Choi J-Y: Evaluation of the Effects of Developmental Trauma on Neurotransmitter Systems Using Functional Molecular Imaging. International journal of molecular sciences 2021, 22(5):2522.
- Lee S, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH: Radiosynthesis and characterization of [18F] BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism. Eur J Nucl Med Mol Imaging 2021.
- Lehner E, Menzel M, Gündel D, Plontke SK, Mäder K, Klehm J, Kielstein H, Liebau A: Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear. Drug Delivery and Translational Research 2021:1-10.
- Lenka A, Lamotte G, Goldstein DS: Cardiac 18F‐Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA. Movement Disorders Clinical Practice 2021, 8(4):582-586.
- Lerche CW, Radomski T, Lohmann P, Caldeira L, Brambilla CR, Tellmann L, Scheins J, Kops ER, Galldiks N, Langen K-J: A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs. IEEE Transactions on Medical Imaging 2021.
- Lhamyani S, Gentile A-M, Giráldez-Pérez RM, Feijóo-Cuaresma M, Romero-Zerbo SY, Clemente-Postigo M, Zayed H, Oliva-Olivera W, Bermúdez-Silva FJ, Salas J: miR-21 mimic blocks obesity in mice: A novel therapeutic option. Molecular Therapy-Nucleic Acids 2021, 26:401-416.
- Li E, Spencer BA, Schmall JP, Abdelhafez Y, Badawi RD, Wang G, Cherry SR: Efficient delay correction for total-body PET kinetic modeling using pulse timing methods. Journal of Nuclear Medicine 2021.
- Li J, Zheng C, Ge Q, Yan S, Paranjpe MD, Hu S, Zhou Y, Initiative AsDN: Association between long‐term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using 18F‐AV‐45 and 18F‐AV‐1451 PET. Journal of neuroscience research 2021.
- Li M-H, Lo S-N, Chen M-W, Lo W-L, Huang Y-R, Lee S-Y, Chen S-J, Lo S-W, Wang S-M, Chang C-H: Molecular Imaging for Radiolabeling a PSMA-Targeted Long Circulating Peptide as a Theranostic Agent in Mice Bearing a Human Prostate Tumor. Journal of Medical and Biological Engineering 2021, 41(3):360-368.
- Li S, Daamen M, Scheef L, Gaertner FC, Buchert R, Buchmann M, Buerger K, Catak C, Dobisch L, Drzezga A: Abnormal regional and global connectivity measures in subjective cognitive decline depending on cerebral amyloid status. Journal of Alzheimer’s Disease 2021(Preprint):1-17.
- Li W, Wang Y, Rubins D, Bennacef I, Holahan M, Haley H, Purcell M, Gantert L, Hseih S, Judo M: PET/CT Imaging of 89 Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys. Molecular imaging and biology 2021, 23(2):250-259.
- Li Y, Liu K, Li C, Guo Y, Fang J, Tong H, Tang Y, Zhang J, Sun J, Jiao F: 18F-FDG PET Combined With MR Spectroscopy Elucidates the Progressive Metabolic Cerebral Alterations After Blast-Induced Mild Traumatic Brain Injury in Rats. Frontiers in neuroscience 2021, 15:243.
- Li Z, Kaiser L, Holzgreve A, Ruf VC, Suchorska B, Wenter V, Quach S, Herms J, Bartenstein P, Tonn J-C: Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F] FET PET radiomics. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(13):4415-4425.
- Liang K, Abt ER, Le TM, Cho A, Dann AM, Cui J, Li L, Rashid K, Creech AL, Wei L: STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F] FLT PET imaging. Proceedings of the National Academy of Sciences 2021, 118(36).
- Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH: Positron Emission Tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® following cisplatin chemotherapy in lung and ovarian cancer xenograft models. Molecular Imaging and Biology 2021:1-15.
- Lien VT, Celen S, Nuruddin S, Attili B, Doumont G, Van Simaeys G, Bormans G, Klaveness J, Olberg DE: Preclinical evaluation of [18F] cabozantinib as a PET imaging agent in a prostate cancer mouse model. Nuclear medicine and biology 2021, 93:74-80.
- Lin C-Y, Wu R-C, Huang C-Y, Lai C-H, Chao A-S, Li H-P, Tsai C-L, Kuek EJ-W, Hsu C-L, Chao A: A Patient-Derived Xenograft Model of Dedifferentiated Endometrial Carcinoma: A Proof-of-Concept Study for the Identification of New Molecularly Informed Treatment Approaches. Cancers 2021, 13(23):5962.
- Lin J-J, Chuang C-P, Lin J-Y, Huang F-T: Development and preclinical evaluation of [68Ga] Ga-Alb-FAPtp-01, a novel tumour-associated fibroblast activation protein tracer for PET imaging of xenograft glioma. 2021.
- Lin J-J, Chuang C-P, Lin J-Y, Huang F-T, Huang C-W: Rational Design, Pharmacomodulation, and Synthesis of [68Ga] Ga-Alb-FAPtp-01, a Selective Tumor-Associated Fibroblast Activation Protein Tracer for PET Imaging of Glioma. ACS sensors 2021, 6(9):3424-3435.
- Lin S-H, Chi MH, Lee IH, Chen KC, Tai YC, Yao WJ, Chiu NT, Yang D-Y, Lin C-Y, Chen PS: A pilot study on the association between the blood oxygen level-dependent signal in the reward system and dopamine transporter availability in adults with attention deficit hyperactivity disorder. CNS spectrums 2021, 26(3):299-306.
- Lindberg A, Knight AC, Sohn D, Rakos L, Tong J, Radelet A, Mason NS, Stehouwer JS, Lopresti BJ, Klunk WE: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F] CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies. ACS Chemical Neuroscience 2021, 12(4):596-602.
- Lisec J, Kobelt D, Walther W, Mokrizkij M, Grötzinger C, Jaeger C, Baum K, Simon M, Wolf J, Beindorff N: Systematic identification of MACC1-driven metabolic networks in colorectal cancer. Cancers 2021, 13(5):978.
- Liu G, Yu H, Shi D, Hu P, Hu Y, Tan H, Zhang Y, Yin H, Shi H: Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of 18F-FDG in healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
- Liu L, Johnson PD, Prime ME, Khetarpal V, Lee MR, Brown CJ, Chen X, Clark-Frew D, Coe S, Conlon M: [11C] CHDI-626, a PET tracer candidate for imaging mutant Huntingtin aggregates with reduced binding to AD pathological proteins. Journal of Medicinal Chemistry 2021, 64(16):12003-12021.
- Liu Y, Hong H, Xue J, Luo J, Liu Q, Chen X, Pan Y, Zhou J, Liu Z, Chen T: Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood–Brain Barrier Crossing and Protection for Parkinsonian Therapy. ACS Applied Materials & Interfaces 2021, 13(31):37746-37760.
- Liu Z, Cheng T, Düwel S, Jian Z, Topping GJ, Steiger K, Wang Q, Braren R, Reder S, Mittelhäuser M: Proof of Concept of a Multimodal Intravital Molecular Imaging System for Tumour Transpathology Investigation. 2021.
- Loeffler J, Koch A, Hamp C, Solbach C, Li H, Glatting G, Rasche V, Beer A, Winter G: Evaluation of the biodistribution of 18F-siPSMA-14 in the HET-CAM model. In.: Soc Nuclear Med; 2021.
- Loenen AC, Peters MJ, Wierts R, Bevers RT, van Rhijn LW, Arts JJ, Willems PC: Local bone metabolism during the consolidation process of spinal interbody fusion. Journal of Bone and Mineral Metabolism 2021:1-9.
- Löffler J, Hamp C, Scheidhauer E, Di Carlo D, Solbach C, Abaei A, Hao L, Glatting G, Beer AJ, Rasche V: Comparison of Quantification of Target-Specific Accumulation of [18F] F-siPSMA-14 in the HET-CAM Model and in Mice Using PET/MRI. Cancers 2021, 13(16):4007.
- Lombardi G, Spimpolo A, Berti S, Campi C, Anglani MG, Simeone R, Evangelista L, Causin F, Zorzi G, Gorgoni G: PET/MR in recurrent glioblastoma patients treated with regorafenib:[18F] FET and DWI-ADC for response assessment and survival prediction. The British Journal of Radiology 2021, 95(1129):20211018.
- López-Vega JM, Álvarez I, Antón A, Illarramendi JJ, Llombart A, Boni V, García-Velloso MJ, Martí-Climent JM, Pina L, García-Foncillas J: Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer. Cancers 2021, 13(14):3511.
- Löser J, Luthardt J, Rullmann M, Weise D, Sabri O, Meixensberger J, Hesse S, Winkler D: Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson’s disease. Journal of Neurosurgery 2021, 1(aop):1-7.
- Lu M, Lindenberg L, Mena E, Turkbey B, Seidel J, Ton A, McKinney Y, Eclarinal P, Merino M, Pinto P: A Pilot Study of Dynamic 18F-DCFPyL PET/CT Imaging of Prostate Adenocarcinoma in High-Risk Primary Prostate Cancer Patients. Molecular Imaging and Biology 2021:1-9.
- Lue K-H, Chu S-C, Wang L-Y, Chen Y-C, Li M-H, Chang B-S, Chan S-C, Chen Y-H, Lin C-B, Liu S-H: Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma. Annals of Nuclear Medicine 2021:1-11.
- Luong TV, Pedersen MGB, Kjærulff MLBG, Madsen S, Lauritsen KM, Tolbod LP, Søndergaard E, Gormsen LC: Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study. Metabolism 2021, 123:154862.
- Luyten K, Van Loy T, Cawthorne C, Deroose CM, Schols D, Bormans G, Cleeren F: D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy. Pharmaceutics 2021, 13(10):1619.
- Ma X, Xiao W, Li H, Pang P, Xue F, Wan L, Pei L, Yan H: Metformin restores hippocampal neurogenesis and learning and memory via regulating gut microbiota in the obese mouse model. Brain, Behavior, and Immunity 2021.
- MacAskill MG, Stadulyte A, Williams L, Morgan TE, Sloan NL, Alcaide-Corral CJ, Walton T, Wimberley C, McKenzie C-A, Spath N: Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism. Journal of Nuclear Medicine 2021, 62(4):536-544.
- MacAskill MG, Wimberley C, Morgan TE, Alcaide-Corral CJ, Newby DE, Lucatelli C, Sutherland A, Pimlott SL, Tavares AA: Modelling [18F] LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-9.
- Malbert CH, Chauvin A, Horowitz M, Jones KL: Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals. Diabetes 2021, 70(1):99-110.
- Manell E, Puuvuori E, Svensson A, Velikyan I, Hulsart-Billström G, Hedenqvist P, Holst JJ, Waern MJ, Eriksson O: Exploring the GLP-1–GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography. BMJ Open Diabetes Research and Care 2021, 9(1):e002083.
- Mann LG, Hay KR, Song AK, Errington SP, Trujillo P, Zald DH, Yan Y, Kang H, Logan GD, Claassen DO: D2-Like Receptor Expression in the Hippocampus and Amygdala Informs Performance on the Stop-Signal Task in Parkinson’s Disease. Journal of Neuroscience 2021, 41(48):10023-10030.
- Mannheim JG, Cheng J-CK, Vafai N, Shahinfard E, English C, McKenzie J, Zhang J, Barlow L, Sossi V: Cross-validation study between the HRRT and the PET component of the SIGNA PET/MRI system with focus on neuroimaging. EJNMMI physics 2021, 8(1):1-22.
- Mapelli P, Callea M, Fallanca F, Castellano A, Bailo M, Scifo P, Bettinardi V, Conte GM, Monterisi C, Rancoita PMV: 18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: Correlation with hypoxia immunohistochemical biomarkers. Nuclear Medicine Communications 2021, 42(7):763-771.
- Marie S, Hernández-Lozano I, Breuil L, Truillet C, Hu S, Sparreboom A, Tournier N, Langer O: Imaging-Based Characterization of a Slco2b1 (-/-) Mouse Model Using [11C] Erlotinib and [99mTc] Mebrofenin as Probe Substrates. Pharmaceutics 2021, 13(6):918.
- Massa F, Bauckneht M, Peira E, Lapucci C, Picco A, Capitanio S, Arnaldi D, Roccatagliata L, Chincarini A, Nobili F: Neuroimaging findings in mild cognitive impairment. In: PET and SPECT in Neurology. edn.: Springer, Cham; 2021: 367-425.
- Matsuda S, Hattori Y, Matsumiya K, McQuade P, Yamashita T, Aida J, Sandiego CM, Gouasmat A, Carroll VM, Barret O: Design, Synthesis, and Evaluation of [18F] T-914 as a Novel Positron-Emission Tomography Tracer for Lysine-Specific Demethylase 1. Journal of Medicinal Chemistry 2021, 64(17):12680-12690.
- Matsumoto H, Watabe T, Igarashi C, Tachibana T, Hihara F, Waki A, Zhang M-R, Tashima H, Yamaya T, Ooe K: Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates. Pharmaceuticals 2021, 14(10):950.
- Mazzoletti A, Albano D, Bertagna F, Mesquita CT, Giubbini R: Comparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13 N-NH 3 PET/CT. Journal of Nuclear Cardiology 2021:1-6.
- McMurray L, Macdonald JA, Ramakrishnan NK, Zhao Y, Williamson DW, Tietz O, Zhou X, Kealey S, Fagan SG, Smolek T: Synthesis and assessment of novel probes for imaging tau pathology in transgenic mouse and rat models. ACS chemical neuroscience 2021, 12(11):1885-1893.
- Messerli M, Muehlematter UJ, Fassbind S, Franzen D, Ferraro DA, Huellner MW, Treyer V, Curioni-Fontecedro A, Burger IA: A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET. The British Journal of Radiology 2021, 94(1119):20200244.
- Meyer M, Lamare F, Asselineau J, Foubert‐Samier A, Mazère J, Zanotti‐Fregonara P, Rizzo G, Delamarre A, Spampinato U, Rascol O: Brain 5‐HT1A Receptor Binding in Multiple System Atrophy: An [18F]‐MPPF PET Study. Movement Disorders 2021, 36(1):246-251.
- Michalski K, Kemna L, Asberger J, Grosu AL, Meyer PT, Ruf J, Sprave T: Gastrin-Releasing Peptide Receptor Antagonist [68Ga] RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer. Cancers 2021, 13(23):6106.
- Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, Koole M, Lemmens R, Van Laere K: Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study. NeuroImage 2021, 232:117877.
- Michiels L, Mertens N, Thijs L, Radwan A, Sunaert S, Vandenbulcke M, Verheyden G, Koole M, Van Laere K, Lemmens R: Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211047759.
- Michiels L, Van Weehaeghe D, Vandenberghe R, Demeestere J, Van Laere K, Lemmens R: The Role of Amyloid PET in Diagnosing Possible Transmissible Cerebral Amyloid Angiopathy in Young Adults with a History of Neurosurgery: A Case Series. Cerebrovascular Diseases 2021, 50(3):356-360.
- Miller B, Vunnam R, Mesubi O, Smith MF, Chen W, Mahat JB, Bentzen SM, See V, Restrepo A, Shorofsky S: Metabolic Heterogeneous Zone Assessed by 18FDG‐PET is Predictive of Post‐Ablation Mortality in Patients with Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 2021.
- Miranda A, Bertoglio D, Stroobants S, Staelens S, Verhaeghe J: Low activity [11C] raclopride kinetic modeling in the mouse brain using the spatiotemporal kernel method. Physics in Medicine & Biology 2021, 66(11):115005.
- Misslinger M, Petrik M, Pfister J, Hubmann I, Bendova K, Decristoforo C, Haas H: Desferrioxamine B-mediated pre-clinical in vivo imaging of infection by the mold fungus Aspergillus fumigatus. Journal of Fungi 2021, 7(9):734.
- Miyagawa S, Mizoguchi H, Fukushima S, Imanishi Y, Watabe T, Harada A, Sakai Y, Sawa Y: New regional drug delivery system by direct epicardial placement of slow-release prostacyclin agonist promise therapeutic angiogenesis in a porcine chronic myocardial infarction. Journal of Artificial Organs 2021:1-8.
- Mohamed-Ahmed S, Yassin MA, Rashad A, Espedal H, Idris SB, Finne-Wistrand A, Mustafa K, Vindenes H, Fristad I: Comparison of bone regenerative capacity of donor-matched human adipose–derived and bone marrow mesenchymal stem cells. Cell and Tissue Research 2021, 383(3):1061-1075.
- Mohammed F, He X, Lin Y: An easy-to-use deep-learning model for highly accurate diagnosis of Parkinson’s disease using SPECT images. Computerized Medical Imaging and Graphics 2021, 87:101810.
- Moldovan R-P, Gündel D, Teodoro R, Ludwig F-A, Fischer S, Toussaint M, Schepmann D, Wünsch B, Brust P, Deuther-Conrad W: Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant 18F-Labelled σ2 Receptor Ligand. International journal of molecular sciences 2021, 22(11):5447.
- Mondal R, Campoy A-DT, Liang C, Mukherjee J: [18F] FDG PET/CT studies in transgenic Hualpha-Syn (A53T) Parkinson’s disease mouse model of α-synucleinopathy. Frontiers in neuroscience 2021:718.
- Moon BS, Park HS, Sunwoo J, Lee IH, Kim A, Moon SJ, Lee H, Son MH, Kim SB, Park SM: Tissue pharmacokinetics of DHP107, a novel lipid‐based oral formulation of paclitaxel, in mice and patients by positron emission tomography. Clinical and Translational Science 2021.
- Moreno JM, Martinez CM, de Jodar C, Reverte V, Bernabé A, Salazar FJ, Llinás MT: Gender differences in the renal changes induced by a prolonged high-fat diet in rats with altered renal development. Journal of Physiology and Biochemistry 2021:1-11.
- Mori H, Taki J, Wakabayashi H, Hiromasa T, Inaki A, Ogawa K, Shiba K, Kinuya S: Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by 14 C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT. Annals of Nuclear Medicine 2021, 35(2):253-259.
- Mosleh-Shirazi MA, Nasiri-Feshani Z, Ghafarian P, Alavi M, Haddadi G, Ketabi A: Tumor volume-adapted SUV N as an alternative to SUV peak for quantification of small lesions in PET/CT imaging: a proof-of-concept study. Japanese Journal of Radiology 2021:1-13.
- Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog A-B, Revheim M-E: Evaluation of semi-quantitative measures of 18 F-Flutemetamol PET for the clinical diagnosis of Alzheimer’s disease. Quant Imaging Med Surg 2021.
- Müller L, Power Guerra N, Stenzel J, Rühlmann C, Lindner T, Krause BJ, Vollmar B, Teipel S, Kuhla A: Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice. Nutrients 2021, 13(3):985.
- Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, Nikula CJ, Dexter A, Murta T, Race AM: The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nature Genetics 2021, 53(1):16-26.
- Nakae R, Sekine T, Tagami T, Murai Y, Kodani E, Warnock G, Sato H, Morita A, Yokota H, Yokobori S: Rapidly progressive brain atrophy in septic ICU patients: a retrospective descriptive study using semiautomatic CT volumetry. Critical Care 2021, 25(1):1-9.
- Nakashima K, Iikuni S, Okada Y, Watanabe H, Shimizu Y, Nakamoto Y, Ono M: Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX. Nuclear Medicine and Biology 2021, 93:46-53.
- Nam H-Y, Seo S, Lee MJ, Kim K, Kim IJ, Pak K: No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjects. Nuklearmedizin-NuclearMedicine 2021, 60(06):434-437.
- Narayanaswami V, Tong J, Schifani C, Bloomfield PM, Dahl K, Vasdev N: Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation. PET clinics 2021, 16(2):233-247.
- Nascimento EB, Moonen MP, Remie CM, Gariani K, Jörgensen JA, Schaart G, Hoeks J, Auwerx J, van Marken Lichtenbelt WD, Schrauwen P: Nicotinamide riboside enhances in vitro beta-adrenergic brown adipose tissue activity in humans. The Journal of Clinical Endocrinology & Metabolism 2021, 106(5):1437-1447.
- Navalkar A, Pandey S, Singh N, Patel K, Datta D, Mohanty B, Jadhav S, Chaudhari P, Maji SK: Direct evidence of cellular transformation by prion-like p53 amyloid infection. Journal of Cell Science 2021, 134(11):jcs258316.
- Nguyen D, Zaitseva TS, Zhou A, Rochlin D, Sue G, Deptula P, Tabada P, Wan D, Loening A, Paukshto M: Lymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds: Preliminary preclinical and clinical results. Journal of Surgical Oncology 2021.
- Nguyen N: Characterizing the metabolic fate of (2S, 4R)-4-[18F] fluoroglutamine and its applications in cancer imaging and treatment response monitoring. 2021.
- Nguyen NTK, Chang Y-H, Truong VA, Hsu M-N, Pham NN, Chang C-W, Wu Y-H, Chang Y-H, Li H, Hu Y-C: CRISPR Activation of Long Non-coding RNA DANCR Promotes Bone Regeneration. Biomaterials 2021:120965.
- Ni R, Herde AM, Haider A, Keller C, Louloudis G, Vaas M, Schibli R, Ametamey SM, Klohs J, Mu L: In vivo imaging of cannabinoid type 2 receptors, functional and structural alterations in mouse model of cerebral ischemia by PET and MRI. bioRxiv 2021.
- Nihashi T, Sakurai K, Kato T, Iwata K, Kimura Y, Ikenuma H, Yamaoka A, Takeda A, Arahata Y, Washimi Y: Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer’s Disease Continuum. Journal of Alzheimer’s Disease 2021(Preprint):1-12.
- Nishibe H, Tateno A, Sakayori T, Yamamoto M, Kim W, Kakuyama H, Okubo Y: Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia. International Journal of Neuropsychopharmacology 2021, 24(2):108-117.
- Novy Z, Janousek J, Barta P, Petrik M, Hajduch M, Trejtnar F: Preclinical evaluation of anti‐VEGFR2 monoclonal antibody ramucirumab labelled with zirconium‐89 for tumour imaging. Journal of Labelled Compounds and Radiopharmaceuticals 2021.
- Nuebling GS, Prix C, Brendel M, Beyer L, Wlasich E, Loosli SV, Barthel H, Sabri O, Bartenstein P, Vöglein J: Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease. Neurobiology of Aging 2021, 103:147. e141-147. e145.
- Obokata N, Seki C, Hirata T, Maeda J, Ishii H, Nagai Y, Matsumura T, Takakuwa M, Fukuda H, Minamimoto T: Synthesis and preclinical evaluation of [11 C] MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-12.
- Oh M, Lee N, Kim C, Son HJ, Sung C, Oh SJ, Lee SJ, Chung SJ, Lee CS, Kim JS: Diagnostic accuracy of dual-phase 18F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism. Scientific Reports 2021, 11(1):1-8.
- Okita K, Kato K, Shigemoto Y, Sato N, Matsumoto T, Matsuda H: Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography. Frontiers in Neuroscience 2021:1173.
- Okonkwo DO, Puffer RC, Minhas DS, Beers SR, Edelman KL, Sharpless J, Laymon CM, Lopresti BJ, Benso S, Puccio AM: PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline. Neurotrauma Editor’s Pick 2021 2021.
- Oleshchuk D, Šálek P, Dvořáková J, Kučka J, Pavlova E, Francová P, Šefc L, Proks V: Biocompatible polypeptide nanogel: Effect of surfactants on nanogelation in inverse miniemulsion, in vivo biodistribution and blood clearance evaluation. Materials Science and Engineering: C 2021, 126:111865.
- Ono M, Takahashi M, Shimozawa A, Fujinaga M, Mori W, Nagai Y, Mimura K, Minamihisamatsu T, Uchida S, Kumata K: In vivo visualization of propagating α-synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05. bioRxiv 2021:2020.2010. 2023.349860.
- Onuki Y, Ono S, Nakajima T, Kojima K, Taga N, Ikeda T, Kuwajima M, Kurokawa Y, Kato M, Kawai K: Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency. Brain Communications 2021.
- Ørntoft NW, Gormsen LC, Keiding S, Munk OL, Ott P, Sørensen M: Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans. JHEP Reports 2021, 3(3):100288.
- Otaki Y, Manabe O, Miller RJ, Manrique A, Nganoa C, Roth N, Berman DS, Germano G, Slomka PJ, Agostini D: Quantification of myocardial blood flow by CZT-SPECT with motion correction and comparison with 15O-water PET. Journal of Nuclear Cardiology 2021, 28(4):1477-1486.
- Oyama K, Hori Y, Nagai Y, Miyakawa N, Mimura K, Hirabayashi T, Inoue K-i, Suhara T, Takada M, Higuchi M: Chemogenetic dissection of the primate prefronto-subcortical pathways for working memory and decision-making. Science Advances 2021, 7(26):eabg4246.
- Pajouhesh P, Fan A, Castillo J, Shen B, Cipriano P, Yoon D, Biswal S: Increased sigma-1 receptor binding observed in the pain matrix of patients suffering from chronic pain. In.: Soc Nuclear Med; 2021.
- Pak K, Lee MJ: SLC63 Gene Polymorphisms is Associated with Striatal Dopamine Transporter Changes after Glucose Loading. 2021.
- Pak K, Lee MJ, Kim K, Kim IJ: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects. Annals of Nuclear Medicine 2021, 35(11):1187-1192.
- Pak K, Seo S, Lee MJ, Im H-J, Kim K, Kim IJ: Limited predictive power of DAT mRNA mappings for DAT protein expressions. 2021.
- Pak K, Seo S, Lee MJ, Kim K, Suh S, Im H-J, Kim IJ: Striatal DAT availability does not change after supraphysiological glucose loading dose in humans. Endocrine Connections 2021, 10(10):1266-1272.
- Pak K, Seo S, Lee MJ, Kim K, Suh S, Lee J, Kim S-J, Kim IJ: Hedonic rating of sucrose is sub-regionally associated with striatal dopamine transporter in humans. Neuroendocrinology 2021.
- Pak K, Seok JW, Nam H-Y, Seo S, Lee MJ, Kim K, Kim IJ: The association of DAT gene methylation with striatal DAT availability in healthy subjects. EJNMMI research 2021, 11(1):1-6.
- Papadopoulos N, Beindorff N, Hoffmann S, Jost-Brinkmann P-G, Präger TM: Impact of piezocision on orthodontic tooth movement. Korean Journal of Orthodontics 2021, 51(6):366-374.
- Park DG, Kang J, An Y-S, Chang J, Yoon JH: Association of Plasma α-synuclein with Cardiac 123I-MIBG Scintigraphy in Early Parkinson’s Disease. Neuroscience Letters 2021:136399.
- Park DG, Kim JW, An Y-S, Chang J, Yoon JH: Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease. Journal of Neural Transmission 2021, 128(12):1853-1861.
- Pascual B, Funk Q, Zanotti-Fregonara P, Cykowski MD, Veronese M, Rockers E, Bradbury K, Yu M, Nakawah MO, Román GC: Neuroinflammation is highest in areas of disease progression in semantic dementia. Brain 2021, 144(5):1565-1575.
- Patterson R: Neurophysiological Features of Working Memory Performance and their Relationships with Demographic, Clinical, Genetic, Neurochemical, and Neuro-structural Characteristics in Older Adults at Risk for Dementia. University of Toronto (Canada); 2021.
- Peng C, Chen H, Li Y, Yang H, Qin P, Ma B, Duan Q, Wang B, Mao F, Guo D: LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma. Frontiers in oncology 2021, 11:54.
- Peretti DE, Renken RJ, Reesink FE, de Jong BM, De Deyn PP, Dierckx RA, Doorduin J, Boellaard R, García DV: Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis. NeuroImage: Clinical 2021, 30:102625.
- Peters S, Hofferber R, Privé BM, de Bakker M, Gotthardt M, Janssen M, de Lange F, Muselaers CH, Mehra N, Witjes JA: [68Ga] Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu] Lu-PSMA-617 treatment. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-12.
- Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Pfister J, Mair C, Novy Z, Popper M, Hajduch M: 68 Ga-labelled desferrioxamine-B for bacterial infection imaging. European journal of nuclear medicine and molecular imaging 2021, 48(2):372-382.
- Pfister J, Petrik M, Bendova K, Matuszczak B, Binder U, Kühbacher A, Gsaller F, Misslinger M, Haas H, Decristoforo C: Antifungal siderophore conjugates for theranostic applications in invasive pulmonary aspergillosis using low molecular TAFC scaffolds. bioRxiv 2021.
- Philippe C, Klebermass EM, Balber T, Kulterer OC, Zeilinger M, Egger G, Dumanic M, Herz CT, Kiefer FW, Scheuba C: Discovery of melanin‐concentrating hormone receptor 1 in brown adipose tissue. Annals of the New York Academy of Sciences 2021, 1494(1):70-86.
- Pierling AL, Elmenhorst E-M, Lange D, Hennecke E, Baur DM, Beer S, Kroll T, Neumaier B, Aeschbach D, Bauer A: Cerebral A1 adenosine receptor availability in female and male participants and its relationship to sleep. NeuroImage 2021, 245:118695.
- Pintado‐Berninches L, Montes‐Worboys A, Manguan‐García C, Arias‐Salgado EG, Serrano A, Fernandez‐Varas B, Guerrero‐López R, Iarriccio L, Planas L, Guenechea G: GSE4‐loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage. The FASEB Journal 2021, 35(3):e21422.
- Piron S, Verhoeven J, De Coster E, Descamps B, Kersemans K, Pieters L, Vral A, Vanhove C, De Vos F: Impact of the molar activity and PSMA expression level on [18F] AlF-PSMA-11 uptake in prostate cancer. Scientific reports 2021, 11(1):1-10.
- Polyak A, Bankstahl JP, Besecke KF, Hozsa C, Triebert W, Pannem RR, Manstein F, Borcholte T, Furch M, Zweigerdt R: Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells. Pharmaceutics 2021, 13(7):1097.
- Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU: Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Movement Disorders 2021, 36(1):124-132.
- Prieto E, García-Velloso MJ, Aquerreta JD, Rosales JJ, Bastidas JF, Soriano I, Irazola L, Rodríguez-Otero P, Quincoces G, Martí-Climent JM: Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma. Physica Medica 2021, 84:1-9.
- Proesmans S, Raedt R, Germonpré C, Christiaen E, Descamps B, Boon P, De Herdt V, Vanhove C: Voxel-based analysis of [18F]-FDG brain PET in rats using data-driven normalization. Frontiers in Medicine 2021, 8.
- Puig O, Henriksen OM, Andersen FL, Lindberg U, Højgaard L, Law I, Ladefoged CN: Deep-learning-based attenuation correction in dynamic [15O] H2O studies using PET/MRI in healthy volunteers. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211029178.
- Pulagam KR, Henriksen-Lacey M, B. Uribe K, Renero-Lecuna C, Kumar J, Charalampopoulou A, Facoetti A, Protti N, Gómez-Vallejo V, Baz Z: In Vivo Evaluation of Multifunctional Gold Nanorods for Boron Neutron Capture and Photothermal Therapies. ACS Applied Materials & Interfaces 2021, 13(42):49589-49601.
- Qian Y, Liu Q, Li P, Han Y, Zhang J, Xu J, Sun J, Wu A, Song S, Lu W: Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization. ACS nano 2021, 15(2):2933-2946.
- Raffel DM, Crawford TC, Jung Y-W, Koeppe RA, Gu G, Rothley J, Frey KA: Quantifying Cardiac Sympathetic Denervation: First Studies of 18F-Fluorohydroxyphenethylguanidines in Cardiomyopathy Patients. 2021.
- Rahman FU, Kim Y-R, Kim E-K, Kim H-r, Cho S-M, Lee C-S, Kim SJ, Araki K, Yamamura K-i, Lee M-N: Topoisomerase IIIβ Deficiency Induces Neuro-Behavioral Changes and Brain Connectivity Alterations in Mice. International Journal of Molecular Sciences 2021, 22(23):12806.
- Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, Knoop H, Klein H, Bleeker-Rovers C, Doorduin J: No signs of neuroinflammation in women with chronic fatigue syndrome or Q fever fatigue syndrome using the TSPO ligand [11C]-PK11195. Neurology-Neuroimmunology Neuroinflammation 2022, 9(1).
- Ramakrishnan NK, Hird M, Thompson S, Williamson DJ, Qiao L, Owen DR, Brooks AF, Scott PJ, Bacallado S, O’Brien JT: Preclinical evaluation of (S)-[18F] GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971. European Journal of Nuclear Medicine and Molecular Imaging 2021, 49(1):125-136.
- Raval NR, Gudmundsen F, Juhl M, Andersen IV, Speth N, Videbæk A, Petersen IN, Mikkelsen JD, Fisher PM, Herth MM: Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease. Frontiers in synaptic neuroscience 2021, 13.
- Rey-Bretal D, Moscoso A, Gómez-Lado N, Fernández-Ferreiro A, Silva-Rodríguez J, Ruibal Á, Aguiar P: Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats. Molecular Imaging and Biology 2021, 23(3):350-360.
- Reyes ST, Deacon RM, Guo SG, Castillo JB, van der Wildt B, Morales AP, Park JH, Klamer D, Rosenberg J, Oberman LM: Effects of the Sigma-1 Receptor Agonist Blarcamesine in a Murine Model of Fragile X Syndrome: Neurobehavioral Phenotypes and Receptor Occupancy. 2021.
- Rischka L, Vraka C, Pichler V, Rasul S, Nics L, Gryglewski G, Handschuh P, Murgas M, Godbersen G, Silberbauer L: First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1. Journal of Nuclear Medicine 2021.
- Rocha NP, Charron O, Latham LB, Colpo GD, Zanotti-Fregonara P, Yu M, Freeman L, Stimming EF, Teixeira AL: Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology. Neurology-Neuroimmunology Neuroinflammation 2021, 8(3).
- Röhrich M, Leitz D, Glatting FM, Wefers AK, Weinheimer O, Flechsig P, Kahn N, Mall MA, Giesel FL, Kratochwil C: Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. Journal of nuclear medicine 2021.
- Ros T, Kwiek J, Andriot T, Michela A, Vuilleumier P, Garibotto V, Ginovart N: PET imaging of dopamine neurotransmission during EEG neurofeedback. Frontiers in Physiology 2021:1749.
- Rosar F, Bohnenberger H, Moon ES, Rösch F, Denig A, Vincenz-Zörner D, Hoffmann MA, Khreish F, Ezziddin S, Schreckenberger M: Impact of prompt gamma emission of 44Sc on quantification in preclinical and clinical PET systems. Applied Radiation and Isotopes 2021, 170:109599.
- Rosen J, Stoffels G, Lohmann P, Bauer EK, Werner JM, Wollring M, Rapp M, Felsberg J, Kocher M, Fink G: Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement. 2021.
- Rosestedt M, Velikyan I, Rosenström U, Estrada S, Åberg O, Weis J, Westerlund C, Ingvast S, Korsgren O, Nordeman P: Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nuclear Medicine and Biology 2021, 93:54-62.
- Rowe CC, Krishnadas N, Ackermann U, Doré V, Goh RY, Guzman R, Chong L, Bozinovski S, Mulligan R, Kanaan R: PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study. Psychiatry Research: Neuroimaging 2021, 316:111354.
- Rühling S: Neurodegeneration in multiple sclerosis mouse models. lmu; 2021.
- Rühlmann C, Dannehl D, Brodtrück M, Adams AC, Stenzel J, Lindner T, Krause BJ, Vollmar B, Kuhla A: Neuroprotective Effects of the FGF21 Analogue LY2405319. Journal of Alzheimer’s Disease 2021(Preprint):1-13.
- Ruze R, Xu Q, Liu G, Li Y, Chen W, Cheng Z, Xiong Y, Liu S, Zhang G, Hu S: Central GLP-1 contributes to improved cognitive function and brain glucose uptake after duodenum-jejunum bypass on obese and diabetic rats. American Journal of Physiology-Endocrinology and Metabolism 2021, 321(3):E392-E409.
- Sachpekidis C, Hassel JC, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A: Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors. Cancers 2021, 13(5):1019.
- Sachpekidis C, Merz M, Raab M-S, Bertsch U, Weru V, Kopp-Schneider A, Jauch A, Goldschmidt H, Dimitrakopoulou-Strauss A: The prognostic significance of [18F] FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs). EJNMMI research 2021, 11(1):1-12.
- Sakayori T, Tateno A, Arakawa R, Kim W-c, Okubo Y: Evaluation of dopamine D 3 receptor occupancy by blonanserin using [11 C]-(+)-PHNO in schizophrenia patients. Psychopharmacology 2021, 238(5):1343-1350.
- Salmon E, Bahri MA, Plenevaux A, Becker G, Seret A, Delhaye E, Degueldre C, Balteau E, Lemaire C, Luxen A: In vivo exploration of synaptic projections in frontotemporal dementia. Scientific reports 2021, 11(1):1-10.
- Sanaat A, Mirsadeghi E, Razeghi B, Ginovart N, Zaidi H: Fast Dynamic Brain PET Imaging Using Stochastic Variational Prediction for Recurrent Frame Generation. Medical physics 2021.
- Sanaat A, Shooli H, Ferdowsi S, Shiri I, Arabi H, Zaidi H: DeepTOFSino: A deep learning model for synthesizing full-dose time-of-flight bin sinograms from their corresponding low-dose sinograms. NeuroImage 2021, 245:118697.
- Sanches E, Dos Santos T, Odorcyk F, Untertriefallner H, Rezena E, Hoeper E, Avila T, Martini A, Venturin G, da Costa JC: Pregnancy swimming prevents early brain mitochondrial dysfunction and causes sex-related long-term neuroprotection following neonatal hypoxia-ischemia in rats. Experimental Neurology 2021, 339:113623.
- Sandahl TD, Gormsen LC, Kjærgaard K, Vendelbo MH, Munk DE, Munk OL, Bender D, Keiding S, Vase KH, Frisch K: The pathophysiology of Wilson disease visualised: A human 64Cu PET study. Hepatology 2021.
- Sandbhor P, Goda J, Mohanty B, Chaudhari P, Dutt S, Banerjee R: Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models. Nanoscale 2021.
- Sander CY, Bovo S, Torrado-Carvajal A, Albrecht D, Deng H, Napadow V, Price JC, Hooker JM, Loggia ML: [11C] PBR28 radiotracer kinetics are not driven by alterations in cerebral blood flow. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211023387.
- Sari H, Hong J, Eriksson L, Shi K, Conti M, Alberts I, Cumming P, Rominger A: Kinetic modelling of dynamic 18F-FDG datasets from long axial field-of-view PET scanner. In.: Soc Nuclear Med; 2021.
- Sato H, Takado Y, Toyoda S, Tsukamoto-Yasui M, Minatohara K, Takuwa H, Urushihata T, Takahashi M, Shimojo M, Ono M: Neurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model. Science advances 2021, 7(43):eabd5046.
- Sato T, Furuta T, Liu Y, Naka S, Nagamori S, Kanai Y, Watabe T: Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model. EJNMMI physics 2021, 8(1):1-16.
- Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B, Nics L, Philippe C, Pfaff S, Pichler V: Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical 2021, 32:102813.
- Schadt F, Israel I, Samnick S: Development and validation of a semi-automated, preclinical, MRI-template based PET image data analysis tool for rodents. Frontiers in Neuroinformatics 2021, 15.
- Schaffernicht G, Shang Q, Stievenard A, Bötzel K, Dening Y, Kempe R, Toussaint M, Gündel D, Kranz M, Reichmann H: Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson’s Disease. Frontiers in neurology 2021, 12:363.
- Schaner PE, Tran L-B-A, Zaki BI, Swartz HM, Demidenko E, Williams BB, Siegel A, Kuppusamy P, Flood AB, Gallez B: The impact of particulate electron paramagnetic resonance oxygen sensors on fluorodeoxyglucose imaging characteristics detected via positron emission tomography. Scientific reports 2021, 11(1):1-8.
- Schmitt J, Palleis C, Sauerbeck J, Unterrainer M, Harris S, Prix C, Weidinger E, Katzdobler S, Wagemann O, Danek A: Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome. Frontiers in aging neuroscience 2021, 13:214.
- Schmitz F, Silveira JS, Venturin GT, Greggio S, Peixoto G, Zimmer E, Costa J, Wyse A: Evidence that methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks. 2021.
- Scott N, Teoh E, Flight H, Jones B, Niederer J, Mustata L, MacLean G, Roy P, Remoundos D, Snell C: Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging. British journal of cancer 2021:1-8.
- Sébastien G, Martine G, Becker G, Mylène G, Yann B, André L, Lemaire C, Alain P, Salmon E, Philippe H: The pharmacokinetics of [18 F] UCB-H revisited in the healthy non-human primate brain. EJNMMI Research 2021, 11(1).
- Sekar S, Viswas RS, Miranzadeh Mahabadi H, Alizadeh E, Fonge H, Taghibiglou C: Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study. International journal of molecular sciences 2021, 22(16):9005.
- Senda M, Ishii K, Ito K, Ikeuchi T, Matsuda H, Iwatsubo T, Iwata A, Ihara R, Suzuki K, Kasuga K: A Japanese multicenter study on PET and other biomarkers for subjects with potential preclinical and prodromal Alzheimer’s disease. The Journal of Prevention of Alzheimer’s Disease 2021:1-8.
- Shanbhag S, Suliman S, Mohamed-Ahmed S, Kampleitner C, Hassan MN, Heimel P, Dobsak T, Tangl S, Bolstad AI, Mustafa K: Bone regeneration in rat calvarial defects using dissociated or spheroid mesenchymal stromal cells in scaffold-hydrogel constructs. Stem cell research & therapy 2021, 12(1):1-17.
- Sharda N, Ahlschwede KM, Curran GL, Lowe VJ, Kandimalla KK: Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endothelium. Journal of Pharmacology and Experimental Therapeutics 2021, 376(3):482-490.
- Sheybani ND, Breza VR, Paul S, McCauley KS, Berr SS, Miller GW, Neumann KD, Price RJ: ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma. Journal of Controlled Release 2021, 331:19-29.
- Shidahara M, Funaki Y, Watabe H: Noninvasive estimation of human radiation dosimetry of 18F-FDG by whole-body small animal PET imaging in rats. Applied Radiation and Isotopes 2021:110071.
- Shimojo M, Ono M, Takuwa H, Mimura K, Nagai Y, Fujinaga M, Kikuchi T, Okada M, Seki C, Tokunaga M: A genetically targeted reporter for PET imaging of deep neuronal circuits in mammalian brains. The EMBO journal 2021, 40(22):e107757.
- Shin S, Nam H-Y, Lee MJ, Pak K, Kim K, Kim IJ: Effect of sex on aging-related decline of dopamine transporter in healthy subjects. Annals of Nuclear Medicine 2021, 35(1):76-82.
- Shinotoh H, Hirano S, Shimada H: PET imaging of acetylcholinesterase. In: PET and SPECT of Neurobiological Systems. edn.: Springer, Cham; 2021: 193-220.
- Shokri-Kojori E, Wang G-J, Volkow ND: Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men. Translational psychiatry 2021, 11(1):1-7.
- Shrestha UM, Sciammarella M, Pampaloni MH, Botvinick EH, Gullberg GT, DeMarco T, Seo Y: Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82 Rb PET. The International Journal of Cardiovascular Imaging 2021, 37(4):1461-1472.
- Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T: Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET. Molecular psychiatry 2021, 26(3):1009-1018.
- Sinharay S, Srinivasula S, Schreiber-Stainthorp W, Shah S, Degrange P, Bonvillain A, Wang J, Dodd L, Carrasquillo JA, Hammoud DA: Monitoring Immune Activation with Whole-Body Fluorodeoxyglucose–Positron-Emission Tomography in Simian Immunodeficiency Virus–Infected Rhesus Macaques. ImmunoHorizons 2021, 5(7):557-567.
- Slania SLL: MOLECULAR IMAGING OF INFLAMMATION-RELATED BIOMARKERS IN CANCER, FIBROSIS, AND NEURODEGENERATIVE DISEASE. Johns Hopkins University; 2021.
- Smigielski L, Wotruba D, Treyer V, Rössler J, Papiol S, Falkai P, Grünblatt E, Walitza S, Rössler W: The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study. Schizophrenia Bulletin 2021.
- Soeder JM, Luthardt J, Rullmann M, Becker GA, Hankir MK, Patt M, Meyer PM, Schütz T, Ding Y-S, Hilbert A: Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity. Obesity Surgery 2021, 31(11):4868-4876.
- Sohara K, Sekine T, Tateno A, Mizumura S, Suda M, Sakayori T, Okubo Y, Kumita S-i: Multi-Atlas MRI-Based Striatum Segmentation for 123I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson’s Disease/Syndrome. Frontiers in Medicine 2021, 8.
- Son HJ, Oh JS, Oh M, Lee SJ, Oh SJ, Chung SJ, Kim JS: Test–retest reproducibility of dopamine transporter density measured with [18 F] FP-CIT PET in patients with essential tremor and Parkinson’s disease. Annals of Nuclear Medicine 2021, 35(3):299-306.
- Song AK, Hay KR, Trujillo P, Aumann M, Stark AJ, Yan Y, Kang H, Donahue MJ, Zald DH, Claassen DO: Amphetamine-induced dopamine release and impulsivity in Parkinson disease. Brain 2021.
- Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K, Nitschmann A, Scheifele M, Palleis C, Respondek G: Binding characteristics of [18F] PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211018904.
- Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K, Eckenweber F, Palleis C, Kaiser L, Finze A: Feasibility of short imaging protocols for [18 F] PI-2620 tau-PET in progressive supranuclear palsy. European journal of nuclear medicine and molecular imaging 2021:1-14.
- Sørensen M, Fode MM, Petersen JB, Holt MI, Høyer M: Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F] FDGal PET/CT. Radiation Oncology 2021, 16(1):1-7.
- Sourdon J, Facchin C, Certain A, Viel T, Robin B, Lager F, Marchiol C, Balvay D, Yoganathan T, Favier J: Sunitinib-induced cardiac hypertrophy and the endothelin axis. Theranostics 2021, 11(8):3830.
- Spimpolo A, Lombardi G, Berti S, Campi C, Anglani MG, Simeone R, Evangelista L, Causin F, Zorzi G, Gorgoni G: Preliminary results using PET/MR in glioblastoma patients treated with regorafenib: an 18F-FET and DWI-ADC comparison. 2021.
- Staniszewska M, Fragoso Costa P, Eiber M, Klose JM, Wosniack J, Reis H, Szarvas T, Hadaschik B, Lückerath K, Herrmann K: Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. International journal of molecular sciences 2021, 22(14):7431.
- Stojakovic A, Chang S-Y, Nesbitt J, Pichurin NP, Ostroot MA, Aikawa T, Kanekiyo T, Trushina E: Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice. Journal of Alzheimer’s Disease 2021(Preprint):1-19.
- Stojakovic A, Trushin S, Sheu A, Khalili L, Chang S-Y, Li X, Christensen T, Salisbury JL, Geroux RE, Gateno B: Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice. Communications biology 2021, 4(1):1-20.
- Stormezand GN, Doorduin J, Chaves LT, García DV, Nienhuis FJ, Schoevers RA, Kremer BP, Booij J, Dierckx RA: No evidence for decreased D2/3 receptor availability and frontal hypoperfusion in subjects with compulsive pornography use. Psychiatry Research: Neuroimaging 2021, 311:111284.
- Stormezand GN, Doorduin J, Rakers SE, Spikman JM, van der Naalt J, García DV, van der Hoorn A, van der Weijden CW, Kremer BP, Renken RJ: Imaging of Neuroinflammation Due to Repetitive Head Injury in Currently Active Kickboxers. 2021.
- Streffer J, Treyer V, Buck A, Ametamey SM, Blagoev M, Maguire RP, Gautier A, Auberson YP, Schmidt ME, Vranesic I-T: Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers. NeuroImage 2021, 230:117785.
- Subramanian S, Daquinag AC, AghaAmiri S, Ghosh SC, Azhdarinia A, Kolonin MG: Characterization of peptides targeting metastatic tumor cells as probes for cancer detection and vehicles for therapy delivery. Cancer Research 2021, 81(22):5756-5764.
- Suchacki KJ, Alcaide-Corral CJ, Nimale S, Macaskill MG, Stimson RH, Farquharson C, Freeman TC, Tavares AA: A Systems-Level Analysis of Total-Body PET Data Reveals Complex Skeletal Metabolism Networks in vivo. Frontiers in Medicine 2021:1592.
- Sucunza D, Rico AJ, Roda E, Collantes M, González-Aseguinolaza G, Rodríguez-Pérez AI, Peñuelas I, Vázquez A, Labandeira-García JL, Broccoli V: Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques. International Journal of Molecular Sciences 2021, 22(9):4825.
- Sugita S, Yamato M, Hatabu T, Kataoka Y: Involvement of cancer-derived EMT cells in the accumulation of 18 F-fluorodeoxyglucose in the hypoxic cancer microenvironment. Scientific reports 2021, 11(1):1-11.
- Sukprakun C, Limotai C, Khamwan K, Pasawang P, Tepmongkol S: A Novel Method of Seizure Onset Zone Localization by Serial Tc-99m ECD Brain Perfusion SPECT Clearance Patterns. 2021.
- Sullivan KJ, Liu A, Chang C-CH, Cohen AD, Lopresti BJ, Minhas DS, Laymon CM, Klunk WE, Aizenstein H, Nadkarni NK: Alzheimer’s disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study. Brain imaging and behavior 2021, 15(3):1355-1363.
- Suurs FV, Lorenczewski G, Bailis JM, Stienen S, Friedrich M, Lee F, van der Vegt B, de Vries EG, de Groot D-JA, Lub-de Hooge MN: Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues. Journal of Nuclear Medicine 2021.
- Taddei C, Morse CL, Kim M-J, Liow J-S, Montero Santamaria J, Zhang A, Manly LS, Zanotti-Fregonara P, Gladding RL, Zoghbi SS: Synthesis of [18F] PS13 and Evaluation as a PET Radioligand for Cyclooxygenase-1 in Monkey. ACS Chemical Neuroscience 2021, 12(3):517-530.
- Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y: High-contrast in vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies. Neuron 2021, 109(1):42-58. e48.
- Tago T, Toyohara J, Ishii K: Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain. ACS Chemical Neuroscience 2021, 12(4):746-755.
- Takahashi K, Hosoya T, Onoe K, Mori T, Tazawa S, Mawatari A, Wada Y, Watanabe Y, Watanabe Y: PET imaging of brain aromatase in humans and rhesus monkeys by 11C-labeled cetrozole analogs. Scientific reports 2021, 11(1):1-9.
- Takahata K, Seki C, Kimura Y, Kubota M, Ichise M, Sano Y, Yamamoto Y, Tagai K, Shimada H, Kitamura S: First-In-Human in Vivo Imaging and Quantification of Monoacylglycerol Lipase in The Brain: A PET Study With 18F-T-401. 2021.
- Takhsha FS, Vangestel C, Tanc M, De Bruycker S, Berg M, Pintelon I, Stroobants S, De Meyer GR, Van Der Veken P, Martinet W: ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2021, 11:750259-750259.
- Tamm S, Lensmar C, Andreasson A, Axelsson J, Morén AF, Grunewald J, Gyllfors P, Karshikoff B, Kosek E, Lampa J: Objective and Subjective Sleep in Rheumatoid Arthritis and Severe Seasonal Allergy: Preliminary Assessments of the Role of Sickness, Central and Peripheral Inflammation. Nature and Science of Sleep 2021, 13:775.
- Teodoro R, Gündel D, Deuther-Conrad W, Ueberham L, Toussaint M, Bormans G, Brust P, Moldovan R-P: Development of [18F] LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain. International Journal of Molecular Sciences 2021, 22(15):8051.
- Terada T, Therriault J, Kang MSP, Savard M, Pascoal TA, Lussier F, Tissot C, Wang Y-T, Benedet A, Matsudaira T: Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease. Molecular Neurodegeneration 2021, 16(1):1-12.
- Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, Suzuki N, Morimoto A, Nakahara T, Iwabuchi Y: Evaluation of [18F] PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies. Brain communications 2021, 3(4):fcab190.
- Thanos PK, Lamoshi A, Nubelo A, Hamilton J, Chernoguz A, Hoffman AB, Quattrin T, Harmon C: Clinical and Preclinical Bariatric Surgery Approaches to Studying Obesity. Animal Models of Eating Disorders 2021:187-201.
- Thomsen MB, Ferreira SA, Schacht AC, Jacobsen J, Simonsen M, Betzer C, Jensen PH, Brooks DJ, Landau AM, Romero-Ramos M: PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease 2021, 149:105229.
- Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C] UCB-J PET. Journal of Cerebral Blood Flow & Metabolism 2021, 41(4):819-830.
- Thorne M, Cash M, Reid G, Burley D, Luke D, Pottie I, Darvesh S: Imaging butyrylcholinesterase in multiple sclerosis. Molecular Imaging and Biology 2021, 23(1):127-138.
- Tien H-J, Yang H-C, Shueng P-W, Chen J-C: Cone-beam CT image quality improvement using Cycle-Deblur consistent adversarial networks (Cycle-Deblur GAN) for chest CT imaging in breast cancer patients. Scientific Reports 2021, 11(1):1-12.
- Tiepolt S, Becker G-A, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J: (+)-[18 F] Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls. European journal of nuclear medicine and molecular imaging 2021, 48(3):731-746.
- Tjörnstrand A, Casar‐Borota O, Heurling K, Schöll M, Gjertsson P, Ragnarsson O, Filipsson Nyström H: Pre‐and postoperative 68Ga‐DOTATOC positron emission tomography for hormone‐secreting pituitary neuroendocrine tumours. Clinical Endocrinology 2021, 94(6):956-967.
- Todisco M, Zangaglia R, Minafra B, Pisano P, Trifirò G, Bossert I, Pozzi NG, Brumberg J, Ceravolo R, Isaias IU: Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus. Neurology 2021, 96(23):e2861-e2873.
- Tournier N, Goutal S, Mairinger S, Hernández-Lozano I, Filip T, Sauberer M, Caillé F, Breuil L, Stanek J, Freeman AF: Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C] erlotinib. Journal of Cerebral Blood Flow & Metabolism 2021, 41(7):1634-1646.
- Tournier N, Pottier G, Caillé F, Coulon C, Goislard M, Jégo B, Negroni J, Leroy C, Saba W: Nalmefene alleviates the neuroimmune response to repeated binge‐like ethanol exposure: A TSPO PET imaging study in adolescent rats. Addiction Biology 2021, 26(3):e12962.
- Toyohara J, Sakata M, Ishibashi K, Mossel P, Imai M, Wagatsuma K, Tago T, Imabayashi E, Colabufo NA, Luurtsema G: First clinical assessment of [18F] MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood–brain barrier. Annals of nuclear medicine 2021, 35(11):1240-1252.
- Treyer V, Meyer RS, Buchmann A, Crameri GA, Studer S, Saake A, Gruber E, Unschuld PG, Nitsch RM, Hock C: Physical activity is associated with lower cerebral beta-amyloid and cognitive function benefits from lifetime experience–a study in exceptional aging. PloS one 2021, 16(2):e0247225.
- Truong VA, Lin Y-H, Nguyen NTK, Hsu M-N, Pham NN, Chang Y-H, Chang C-W, Shen C-C, Lee H-S, Lai P-L: Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats. Molecular Therapy 2021.
- Tsubaki Y, Kitamura T, Shimokawa N, Akamatsu G, Sasaki M: Improved accuracy of amyloid PET quantification with adaptive template-based anatomical standardization. Journal of Nuclear Medicine Technology 2021.
- Turnock S: PET imaging to monitor NET-1 and GD2 expression in neuroblastoma. 2021.
- Tyan Y-S, Lee Y-P, Chuang H-Y, Wang W-H, Hwang J-J: Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model. Bioscience reports 2021, 41(5):BSR20204203.
- Valli M, Cho SS, Masellis M, Chen R, Koshimori Y, Diez‐Cirarda M, Mihaescu A, Christopher L, Strafella AP: Extra‐striatal dopamine in Parkinson’s disease with rapid eye movement sleep behavior disorder. Journal of Neuroscience Research 2021, 99(4):1177-1187.
- van Aalst J, Ceccarini J, Sunaert S, Dupont P, Koole M, Van Laere K: In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X20981502.
- van Aalst J, Devrome M, Van Weehaeghe D, Rezaei A, Radwan A, Schramm G, Ceccarini J, Sunaert S, Koole M, Van Laere K: Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-17.
- Van Der Heiden K, Barrett H, Meester E, van Gaalen K, Krenning B, Beekman F, de Blois E, de Swart J, Verhagen H, van der Lugt A: SPECT/CT imaging of inflammation and calcification in human carotid atherosclerosis to identify the plaque at risk of rupture. Journal of Nuclear Cardiology 2021:1-10.
- van der Weijden MC, Rodriguez‐Contreras D, Delnooz CC, Robinson BG, Condon AF, Kielhold ML, Stormezand GN, Ma KY, Dufke C, Williams JT: A gain‐of‐function variant in dopamine D2 receptor and progressive chorea and dystonia phenotype. Movement Disorders 2021, 36(3):729-739.
- van der Wildt B, Miao Z, Reyes ST, Park JH, Klockow JL, Zhao N, Romero A, Guo SG, Shen B, Windhorst AD: BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain. Nuclear Medicine and Biology 2021.
- van Dijken BR, Schuuring B, Jeltema H-R, van Laar PJ, Enting RH, Dierckx RA, Stormezand GN, van Der Hoorn A: Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma. Neuroradiology 2021:1-6.
- van Ton AMP, Duindam HB, van Tuijl J, Li WW, Dieker H-J, Riksen NP, Meijer FA, Kessels RP, Kohn N, van der Hoeven JG: Neuroinflammation in cognitive decline post-cardiac surgery (the FOCUS study): an observational study protocol. BMJ open 2021, 11(5):e044062.
- van Ton AMP, Leijte GP, Franssen GM, Bruse N, Booij J, Doorduin J, Rijpkema M, Kox M, Abdo WF, Pickkers P: Human in vivo neuroimaging to detect reprogramming of the cerebral immune response following repeated systemic inflammation. Brain, Behavior, and Immunity 2021, 95:321-329.
- van Wolfswinkel E, Wielaard J, Lavalaye J, Hoff J, Habraken J: Artificial Intelligence-Based Assistance in Clinical 123I-FP-CIT SPECT Scan Interpretation. 2021.
- Varela LG, García DV, Aguiar P, Kakiuchi T, Ohba H, Harada N, Nishiyama S, Tago T, Elsinga PH, Tsukada H: Head to head comparison of (R)-[11C] verapamil and [18F] MC225 in non-human primates, tracers for measuring P-glycoprotein function. 2021.
- Varnäs K, Finnema SJ, Johnström P, Arakawa R, Halldin C, Eriksson LI, Farde L: Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo. British Journal of Anaesthesia 2021, 126(1):238-244.
- Veal M, Dias G, Kersemans V, Sneddon D, Faulkner S, Cornelissen B: A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes. Journal of Nuclear Medicine 2021.
- Velikyan I, Rosenström U, Rosestedt M, Eriksson O, Antoni G: Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of Fibrosis. Pharmaceuticals 2021, 14(10):990.
- Vera JH, Eftychiou N, Schuerer M, Rullmann M, Barthel H, Sabri O, Gisslen M, Zetterberg H, Blennow K, O’Brien C: Clinical Utility of β-Amyloid PET Imaging in People Living With HIV With Cognitive Symptoms. JAIDS Journal of Acquired Immune Deficiency Syndromes 2021, 87(2):826-833.
- Vermeulen K, Cools R, Briard E, Auberson Y, Schoepfer J, Koole M, Cawthorne C, Bormans G: Preclinical Evaluation of [11C] YC-72-AB85 for In Vivo Visualization of Heat Shock Protein 90 in Brain and Cancer with Positron Emission Tomography. ACS Chemical Neuroscience 2021, 12(20):3915-3927.
- Vestergaard MB, Calvo OP, Hansen AE, Rosenbaum S, Larsson HB, Henriksen OM, Law I: Validation of kinetic modeling of [15O] H2O PET using an image derived input function on hybrid PET/MRI. NeuroImage 2021, 233:117950.
- Viswanath V, Zhou R, Lee H, Li S, Cragin A, Doot RK, Mankoff DA, Pantel AR: Kinetic modeling of 18F-(2S, 4R) 4-fluoroglutamine in mouse models of breast cancer to estimate glutamine pool size as an indicator of tumor glutamine metabolism. Journal of Nuclear Medicine 2021, 62(8):1154-1162.
- Völter F, Mittlmeier L, Gosewisch A, Brosch-Lenz J, Gildehaus FJ, Zacherl MJ, Beyer L, Stief CG, Holzgreve A, Rübenthaler J: Correlation of An Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy. Diagnostics 2021, 11(3):428.
- von Felten E, Benz DC, Benetos G, Baehler J, Patriki D, Rampidis GP, Giannopoulos AA, Bakula A, Gräni C, Pazhenkottil AP: Prognostic value of regional myocardial flow reserve derived from 13N-ammonia positron emission tomography in patients with suspected coronary artery disease. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
- Vrist M, Bech J, Lauridsen T, Fynbo C, Theil J: Comparison of [18F] NaF PET/CT dynamic analysis methods and a static analysis method including derivation of a semi-population input function for site-specific measurements of bone formation in a population with chronic kidney disease-mineral and bone disorder. EJNMMI research 2021, 11(1):1-13.
- Wagner JM, Sichler ME, Schleicher EM, Franke TN, Irwin C, Löw MJ, Beindorff N, Bouter C, Bayer TA, Bouter Y: Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s. Frontiers in Behavioral Neuroscience-Editor’s Pick 2021 2021.
- Wakabayashi T, Hirose Y, Miyake K, Arakawa Y, Kagawa N, Nariai T, Narita Y, Nishikawa R, Tsuyuguchi N, Fukami T: Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials. Annals of Nuclear Medicine 2021, 35(12):1279-1292.
- Wang C, Zhou C, Guo T, Huang P, Xu X, Zhang M: Neural Substrates for the Association Between Cigarette Smoking and Parkinson’s Disease. 2021.
- Wang H, Zhao Q, Dong W, Yang L, Lu K, Guo X, Liu H, Wei H, Cheng Y, Wu Z: Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging. Nuclear Medicine and Biology 2021, 94:98-105.
- Wang SJ, Lee C-H, Kang HG, Kim KW, Kim M, Jeong H-J, Shin B-S: Peripheral vasoreactivity in acute ischemic stroke with hemiplegia. Scientific reports 2021, 11(1):1-7.
- Wang Y, Cai L, Zhou K, Cui M, Yao S: Biodistribution and Dosimetry Evaluation for A Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease. 2021.
- Wang Y, Lou F, Li Y, Liu F, Wang Y, Cai L, Gordon ML, Zhang Y, Zhang N: Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid-positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer’s Disease and Amnestic Mild Cognitive Impairment. Current Alzheimer Research 2021.
- Wang Z, Manion MM, Laidlaw E, Rupert A, Lau C-Y, Smith BR, Nath A, Sereti I, Hammoud DA: Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation. AIDS 2021, 35(8):1209-1219.
- Willuweit A, Schöneck M, Schemmert S, Lohmann P, Bremen S, Honold D, Burda N, Jiang N, Beer S, Ermert J: Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography. Frontiers in neuroscience 2021:1248.
- Wong SW, Vivash L, Mudududdla R, Nguyen N, Hermans SJ, Shackleford DM, Field J, Xue L, Aprico A, Hancock NC: Development of [18F] MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease. European Journal of Medicinal Chemistry 2021, 226:113822.
- Wu C-Y, Lin Y-H, Hsieh H-H, Lin J-J, Peng S-L: Sex Differences in the Effect of Diabetes on Cerebral Glucose Metabolism. Biomedicines 2021, 9(11):1661.
- Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A: Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Science Translational Medicine 2021, 13(615):eabe5640.
- Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S: In vivo imaging of synaptic density with [11C] UCB-J PET in two mouse models of neurodegenerative disease. NeuroImage 2021:118302.
- Xu Q, Ding H, Li S, Dong S, Li L, Shi B, Zhong M, Zhang G: Sleeve Gastrectomy Ameliorates Diabetes-Induced Cardiac Hypertrophy Correlates With the MAPK Signaling Pathway. Frontiers in physiology 2021:2037.
- Xu Y, Chen Z, Wey HY, Liang Y, Tanzi RE, Zhang C, Wang C: Molecular imaging of NAD+‐dependent deacetylase SIRT1 in the brain. Alzheimer’s & Dementia 2021.
- Xu Y, Xu Y, Biby S, Bai P, Liu Y, Zhang C, Wang C, Zhang S: Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I. ACS chemical neuroscience 2021.
- Yakushev I, Ripp I, Wang M, Savio A, Schutte M, Lizarraga A, Bogdanovic B, Diehl-Schmid J, Hedderich DM, Grimmer T: Mapping covariance in brain FDG uptake to structural connectivity. European journal of nuclear medicine and molecular imaging 2021:1-10.
- Yamagishi S, Iga Y, Ikegaya S, Kakiuchi T, Ohba H, Nishiyama S, Fukomoto D, Kanazawa M, Harada N, Tsukada H: In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study. Journal of neuroinflammation 2021, 18(1):1-15.
- Yamamoto Y, Takahata K, Kubota M, Takano H, Takeuchi H, Kimura Y, Sano Y, Kurose S, Ito H, Mimura M: Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain. NeuroImage 2021, 226:117543.
- Yan S, Zheng C, Paranjpe MD, Li Y, Li W, Wang X, Benzinger TL, Lu J, Zhou Y, Initiative AsDN: Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals. Brain 2021.
- Yan X, Telu S, Dick RM, Liow J-S, Zanotti-Fregonara P, Morse CL, Manly LS, Gladding RL, Shrestha S, Lerchner W: [11C] deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211007949.
- Yan Z, Li Y, Zhang X, Li L, Gao Y, Chen Q, Tian M, Cong B: PET neuroimaging reveals upregulation of dopamine D2 receptor contributes to amygdaloid dysfunction in rat acute restraint stress model. Biochemical and Biophysical Research Communications 2021, 561:45-51.
- Yang K-C, Liu M-N, Liou Y-J, Hu L-Y, Yang B-H, Chou Y-H: Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study. Journal of Psychiatric Research 2021, 135:174-180.
- Yang K-C, Yang B-H, Lirng J-F, Liu M-N, Hu L-Y, Liou Y-J, Chan L-A, Chou Y-H: Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study. Neurotoxicology 2021, 82:26-34.
- Yang X, Ignozzi AJ, He R, Zhu D, Wang X, Chordia MD, Pan D, Cui Q: Detection of Osteoarthritis Inflammation by Single-Photon Emission Computed Tomography Based on an Inflammation-Targeting Peptide cFLFLF. Molecular Imaging and Biology 2021:1-10.
- Yeh CI, Cheng MF, Xiao F, Chen YC, Liu CC, Chen HY, Yen RF, Ju YT, Chen Y, Bodduluri M: Effects of Focal Radiation on [18F]‐Fluoro‐D‐Glucose Positron Emission Tomography in the Brains of Miniature Pigs: Preliminary Findings on Local Metabolism. Neuromodulation: Technology at the Neural Interface 2021, 24(5):863-869.
- Yeh SH-H, Chang W-C, Hsu S-M, Lin MH, Chung M-C, Ke C-S, Lee Y-C, Hwang C-J, Yang DJ: Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors. Cancer Biotherapy and Radiopharmaceuticals 2021.
- Yeh SH-H, Chiu C-H, Kuo Y-Y, Tsai C-J, Yu T-H, Huang W-S, Ma K-H: Amitriptyline Accelerates SERT Binding Recovery Rate in MDMA-Induced Rat Model: In Vivo 4-[18F]-ADAM PET Imaging. 2021.
- Yeh SH-H, Huang W-S, Chiu C-H, Chen C-L, Chen H-T, Chi DY, Ge Z, Yu T-H, Wang P-Y, Kuo Y-Y: Automated Synthesis and Initial Evaluation of (4-Amino-5, 8-difluoro-1H-spiro [piperidine-4, 2-quinazolin]-1-yl)(4-[18F] fluorophenyl) methanone for PET/MR Imaging of Inducible Nitric Oxide Synthase. Molecular Imaging 2021, 2021.
- Yeh SH-H, Lin MH, Leo Garcia Flores I, Mukhopadhyay U, Young D, Ogawa K, Jeong J-H, Tong W, Gelovani JG, Fukumitsu N: In Vivo Evaluation of the Combined Anticancer Effects of Cisplatin and SAHA in Nonsmall Cell Lung Carcinoma Using [18F] FAHA and [18F] FDG PET/CT Imaging. Molecular imaging 2021, 2021.
- Yin L, Wang A, Shi H, Gao M: Quantitatively visualizing the activity of MMP-2 enzyme in vivo using a ratiometric photoacoustic probe. Methods in enzymology 2021, 657:59-87.
- Yokokura M, Takebasashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y: In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study. Molecular Psychiatry 2021, 26(9):4958-4967.
- Yoon H-J, Kim BS, Jeong JH, Kim GH, Park HK, Chun MY: Asymmetric Amyloid Deposition as an Early Sign of Progression in Mild Cognitive Impairment Due to Alzheimer Disease. Clinical Nuclear Medicine 2021, 46(7):527-531.
- Yoon H-J, Kim BS, Jeong JH, Kim GH, Park HK, Chun MY, Ha S: Dual-phase 18F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer’s disease. NeuroImage: Clinical 2021, 31:102773.
- Young AJ, Pantel AR, Viswanath V, Dominguez TL, Makvandi M, Lee H, Li S, Schubert EK, Pryma DA, Farwell MD: Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer. Journal of Nuclear Medicine 2021.
- Yousefi-Koma A, Haseli S, Bakhshayeshkaram M, Raad N, Karimi-Galougahi M: Multimodality imaging with PET/CT and MRI reveals hypometabolism in tertiary olfactory cortex in parosmia of COVID-19. Academic Radiology 2021.
- Yuan G, Dhaynaut M, Guehl NJ, Afshar S, Huynh D, Moon S-H, Iyengar S, Kang HJ, Ondrechen MJ, El Fakhri G: Design, synthesis, and characterization of [18F] mG2P026 as a high contrast PET imaging ligand for metabotropic glutamate receptor 2. bioRxiv 2021.
- Yuan G, Dhaynaut M, Guehl NJ, Neelamegam R, Moon S-H, Qu X, Poutiainen P, Afshar S, El Fakhri G, Brownell A-L: PET imaging studies to investigate functional expression of mGluR2 using [11C] mG2P001. bioRxiv 2021.
- Yuan G, Dhaynaut M, Lan Y, Guehl NJ, Huynh D, Iyengar S, Afshar S, Wang H, Moon S-H, Ondrechen MJ: Synthesis and characterization of 5-(2-fluoro-4-[11C] methoxyphenyl)-2, 2-dimethyl-3, 4-dihydro-2H-pyrano [2, 3-b] pyridine-7-carboxamide as a PET imaging ligand for metabotropic glutamate receptor 2. bioRxiv 2021.
- Yuan G, Guehl NJ, Zheng B, Qu X, Moon S-H, Dhaynaut M, Shoup TM, Afshar S, Kang HJ, Zhang Z: Synthesis and Characterization of [18 F] JNJ-46356479 as the First 18 F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2. Molecular Imaging and Biology 2021:1-10.
- Zangooei MH, Margolis R, Hoyt K: Multiscale computational modeling of cancer growth using features derived from microCT images. Scientific reports 2021, 11(1):1-17.
- Zanovello M, Sorarù G, Campi C, Anglani M, Spimpolo A, Berti S, Bussè C, Mozzetta S, Cagnin A, Cecchin D: Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a 18F-FDG PET/MR study. Journal of Nuclear Medicine 2021.
- Zerweck L, Roder C, Hauser T-K, Thurow J, Mengel A, Tatagiba M, Khan N, Meyer PT, Ernemann U, Klose U: Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O] water PET. Neuroradiology 2021:1-11.
- Zhang K, Mizuma H, Nakatani Y, Kanayama Y, Takahashi K, Matsumoto Y, Wada Y, Onoe K, Owada S, Hayashinaka E: Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studies. European journal of nuclear medicine and molecular imaging 2021:1-14.
- Zhao J, Chen S, Zhu L, Zhang L, Liu J, Xu D, Tian G, Jiang Ta: Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer. Frontiers in Oncology 2021, 10:3376.
- Zhao Z-H, Du K-J, Wang T, Wang J-Y, Cao Z-P, Chen X-M, Song H, Zheng G, Shen X-F: Maternal Lead Exposure Impairs Offspring Learning and Memory via Decreased GLUT4 Membrane Translocation. Frontiers in Cell and Developmental Biology 2021, 9:374.
- Zheng EW, Yu-Ju C, Wei-Ting C, Kuan-Yu W, Cheng-Yu T, Sin-Jhong C, Carter RN, Guo-Jen H: The effect of nerve growth factor on supporting spatial memory depends upon hippocampal cholinergic innervation. Translational Psychiatry 2021, 11(1).
- Zhong Y, Yang S, Cui J, Wang J, Li L, Chen Y, Chen J, Feng P, Huang S, Li H: Novel 18F-Labeled Isonicotinamide-Based Radioligands for Positron Emission Tomography Imaging of Glycogen Synthase Kinase-3β. Molecular Pharmaceutics 2021, 18(3):1277-1284.
- Zhou Y, Flores S, Mansor S, Hornbeck RC, Tu Z, Perlmutter JS, Ances B, Morris JC, Gropler RJ, Benzinger TL: Spatially constrained kinetic modeling with dual reference tissues improves 18 F-flortaucipir PET in studies of Alzheimer disease. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-15.
- Zhu P, Wu M, Ma B, Wang S: Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine. Experimental and Therapeutic Medicine 2021, 21(1):1-1.
- Zubair M, Murris SR, Isa K, Onoe H, Koshimizu Y, Kobayashi K, Vanduffel W, Isa T: Divergent whole brain projections from the ventral midbrain in macaques. Cerebral Cortex 2021, 31(6):2913-2931.
- Zürcher N, Loggia M, Mullett J, Tseng C, Bhanot A, Richey L, Hightower B, Wu C, Parmar A, Butterfield R: [11C] PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder. Molecular psychiatry 2021, 26(5):1659-1669.
- Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevigné A, Ectors F, Plenevaux A, Pirotte B, Beckers A: GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G s and G q/11. Nature communications 2020, 11(1):1-16.
- Ahlstedt J, Johansson E, Sydoff M, Karlsson H, Thordarsson E, Gram M, Eriksson O: Non-invasive imaging methodologies for assessment of radiation damage to bone marrow and kidneys from peptide receptor radionuclide therapy. Neuroendocrinology 2020.
- Ahmed H, Wallimann R, Haider A, Hosseini V, Gruber S, Robledo M, Nguyen TA, Herde AM, Iten I, Keller C: Preclinical development of 18F-OF-NB1 for imaging GluN2B-containing N-methyl-D-aspartate receptors and its utility as a biomarker for amyotrophic lateral sclerosis. Journal of Nuclear Medicine 2020:jnumed. 120.246785.
- Akerele MI, Zein S, Pandya S, Nikolopoulou A, Gauthier SA, Raj A, Henchcliffe C, Mozley PD, Karakatsanis NA, Gupta A: Feasibility of Population-Based Input Function for Kinetic Modeling of [11C]-DPA-713. 2020.
- Albrecht J, Exner S, Groetzinger C, Prasad S, Konietschke F, Beindorff N, Kuehl AA, Prasad V, Brenner W, Koziolek EJ: Multimodal imaging of two-cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an orthotopic neuroendocrine xenograft tumor mouse model. Journal of Nuclear Medicine 2020:jnumed. 120.250274.
- Alia-Klein N, Preston-Campbell RN, Kim SW, Pareto D, Logan J, Wang G-J, Moeller SJ, Fowler JS, Biegon A: Human Cognitive Ability Is Modulated by Aromatase Availability in the Brain in a Sex-Specific Manner. Frontiers in Neuroscience 2020, 14.
- Ando T, Kemp B, Warnock G, Sekine T, Kaushik S, Wiesinger F, Delso G: Zero Echo Time MRAC on FDG-PET/MR Maintains Diagnostic Accuracy for Alzheimer’s Disease; A Simulation Study Combining ADNI-Data. Frontiers in Neuroscience 2020, 14.
- Ando T, Sekine T, Murai Y, Orita E, Takagi R, Amano Y, Iwata K, Nakaza M, Ogawa M, Obara M: Multiparametric flow analysis using four-dimensional flow magnetic resonance imaging can detect cerebral hemodynamic impairment in patients with internal carotid artery stenosis. Neuroradiology 2020.
- Andrews JP, Portal C, Walton T, Macaskill MG, Hadoke PW, Alcaide Corral C, Lucatelli C, Wilson S, Wilson I, MacNaught G: Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer. European Heart Journal-Cardiovascular Imaging 2020, 21(6):673-682.
- Aohara K, Minatani S, Kimura H, Takeuchi J, Takeda A, Kawabe J, Wada Y, Mawatari A, Watanabe Y, Shimada H: Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease. Neurology and Clinical Neuroscience 2020, 8(2):61-67.
- Aoyama M, Takizawa H, Otani T, Inoue S, Kawakita N, Tsuboi M, Bando Y, Uehara H, Kondo K, Tangoku A: Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT. Oncology Reports 2020, 44(4):1709-1716.
- Arakawa R, Takano A, Stenkrona P, Stepanov V, Nag S, Jahan M, Grybäck P, Bolin M, Chen L, Zhang L: PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18 F] PF-06684511. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
- Ardaya M, Joya A, Padro D, Plaza-García S, Gómez-Vallejo V, Sánchez M, Garbizu M, Cossío U, Matute C, Cavaliere F: In vivo PET imaging of gliogenesis after cerebral ischemia in rats. Frontiers in Neuroscience 2020, 14.
- Auditore L, Amato E, Boughdad S, Meyer M, Testart N, Cicone F, Beigelman-Aubry C, Prior JO, Schaefer N, Gnesin S: Monte Carlo 90Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation. Physics in Medicine & Biology 2020, 65(23):235014.
- Azevedo PN, Zanirati G, Venturin GT, Schu GG, Durán–Carabali LE, Odorcyk FK, Soares AV, de Oliveira Laguna G, Netto CA, Zimmer ER: Long-term changes in metabolic brain network drive memory impairments in rats following neonatal hypoxia-ischemia. Neurobiology of Learning and Memory 2020:107207.
- Babin V, Tournier BB, Davis A, Dubost E, Pigrée G, Lohier J-F, Reboul V, Cailly T, Bouillon J-P, Millet P: Design of iodinated radioligands for SPECT imaging of central human 5-HT4R using a ligand lipophilicity efficiency approach. Bioorganic Chemistry 2020, 96:103582.
- Backhaus P, Büther F, Wachsmuth L, Frohwein L, Buchholz R, Karst U, Schäfers K, Hermann S, Schäfers M, Faber C: Toward precise arterial input functions derived from DCE‐MRI through a novel extracorporeal circulation approach in mice. Magnetic Resonance in Medicine 2020.
- Bai P, Bai S, Placzek MS, Lu X, Fiedler SA, Ntaganda B, Wey H-Y, Wang C: A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging. Molecules 2020, 25(5):1018.
- Bai P, Lan Y, Wang H, Chen Z, Fiedler S, Striar R, Lu X, Wang C: Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins. Frontiers in molecular biosciences 2020, 7:198.
- Bai P, Lu X, Lan Y, Chen Z, Patnaik D, Fiedler S, Striar R, Haggarty SJ, Wang C: Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins. Nuclear Medicine and Biology 2020.
- Balcerzyk M, De-Miguel M, Guerrero C, Fernandez B: Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography. Cells 2020, 9(9):2084.
- Baraibar I, Roman M, Rodríguez-Remírez M, López I, Vilalta A, Guruceaga E, Ecay M, Collantes M, Lozano T, Alignani D: Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells. Cancers 2020, 12(11):3169.
- Barrett HE, Meester EJ, van Gaalen K, van der Heiden K, Krenning BJ, Beekman FJ, de Blois E, de Swart J, Verhagen H, Maina T: Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
- Barron AM, Ji B, Fujinaga M, Zhang M-R, Suhara T, Sahara N, Aoki I, Tsukada H, Higuchi M: In vivo PET imaging of mitochondrial abnormalities in a mouse model of tauopathy. Neurobiology of Aging 2020.
- Bascuñana P, Brackhan M, Leiter I, Keller H, Jahreis I, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism. Journal of Cerebral Blood Flow & Metabolism 2020, 40(1):204-213.
- Bascuñana P, Hess A, Borchert T, Wang Y, Wollert KC, Bengel FM, Thackeray JT: 11C-Methionine PET Identifies Astroglia Involvement in Heart–Brain Inflammation Networking After Acute Myocardial Infarction. Journal of Nuclear Medicine 2020, 61(7):977-980.
- Bascuñana P, Wolf BJ, Jahreis I, Brackhan M, García-García L, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: 99mTc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus. 2020.
- Bashir A, Binderup T, Vestergaard MB, Broholm H, Marner L, Ziebell M, Fugleholm K, Kjaer A, Law I: In vivo imaging of cell proliferation in meningioma using 3′-deoxy-3′-[18 F] fluorothymidine PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-14.
- Bashir A, Vestergaard MB, Binderup T, Broholm H, Marner L, Ziebell M, Fugleholm K, Mathiesen T, Kjær A, Law I: Pharmacokinetic analysis of [68 Ga] Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-12.
- Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, Becker G, Seret A, Mella C, Giacomelli F: In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(2):390-402.
- Bauer EK, Stoffels G, Blau T, Reifenberger G, Felsberg J, Werner JM, Lohmann P, Rosen J, Ceccon G, Tscherpel C: Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18 F]-fluoroethyl)-l-tyrosine PET. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
- Bauer M, Bamminger K, Pichler V, Weber M, Binder S, Maier‐Salamon A, Tahir A, Jäger W, Haslacher H, Tournier N: Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology & Therapeutics 2020.
- Becker G, Dammicco S, Bahri MA, Salmon E: The Rise of Synaptic Density PET Imaging. Molecules 2020, 25(10):2303.
- Beinat C, Patel CB, Haywood T, Shen B, Naya L, Gandhi H, Holley D, Khalighi M, Iagaru A, Davidzon G: Human biodistribution and radiation dosimetry of [18 F] DASA-23, a PET probe targeting pyruvate kinase M2. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-8.
- Belderbos S, González-Gómez MA, Cleeren F, Wouters J, Piñeiro Y, Deroose CM, Coosemans A, Gsell W, Bormans G, Rivas J: Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe 3 O 4@ Al (OH) 3 nanoparticles: Comparison of nanoparticle and nanoparticle-labeled stem cell distribution. EJNMMI research 2020, 10(1):1-13.
- Bellés L, Dimiziani A, Tsartsalis S, Millet P, Herrmann FR, Ginovart N: Dopamine D2/3 receptor availabilities and evoked dopamine release in striatum differentially predict impulsivity and novelty preference in Roman high-and low-avoidance rats. International Journal of Neuropsychopharmacology 2020.
- Bengs S, Haider A, Warnock GI, Fiechter M, Pargaetzi Y, Rampidis G, Etter D, Wijnen WJ, Portmann A, Osto E: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-7.
- Benz DC, Kaufmann PA, von Felten E, Benetos G, Rampidis G, Messerli M, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C: Prognostic value of quantitative metrics from positron emission tomography in ischemic heart failure. JACC: Cardiovascular Imaging 2020.
- Berberat J, Roelcke U, Remonda L, Schwyzer L: Long-term apparent diffusion coefficient value changes in patients undergoing radiosurgical treatment of meningiomas. Acta Neurochirurgica 2020:1-7.
- Berger A, Araújo-Filho I, Piffoux M, Nicolás-Boluda A, Grangier A, Boucenna I, Real CC, Marques FLN, de Paula Faria D, do Rego ACM: Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula. Nanoscale 2020.
- Bertoglio D, Verhaeghe J, Korat Š, Miranda A, Cybulska K, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M: Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington’s Disease: a Longitudinal PET Study. Molecular neurobiology 2020:1-10.
- Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C: Validation and noninvasive kinetic modeling of [11C] UCB-J PET imaging in mice. Journal of Cerebral Blood Flow & Metabolism 2020, 40(6):1351-1362.
- Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Dominguez C, Munoz-Sanjuan I, Skinbjerg M, Liu L, Staelens S: Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D 1 R Radioligand [11 C] SCH23390 in Healthy and Diseased Mice. Molecular Imaging and Biology 2020:1-12.
- Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J: Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer’s Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer’s Disease 2020(Preprint):1-12.
- Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Sauerbeck J, Scheifele M, Prix C, Unterrainer M, Catak C, Pogarell O: Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. NeuroImage: Clinical 2020:102535.
- Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G: Early-phase [18 F] PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-12.
- Biechele G, Franzmeier N, Blume T, Ewers M, Luque JM, Eckenweber F, Sacher C, Beyer L, Ruch-Rubinstein F, Lindner S: Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. Journal of Neuroinflammation 2020, 17(1):1-10.
- Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S: Microglial Activation in the Right Amygdala-Entorhinal-Hippocampal Complex is Associated with Preserved Spatial Learning in AppNL-GF mice. NeuroImage 2020:117707.
- Biegon A, Shroyer KR, Franceschi D, Dhawan J, Tahmi M, Pareto D, Bonilla P, Airola K, Cohen J: Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer. Journal of Nuclear Medicine 2020, 61(6):807-813.
- Boles Ponto LL, Magnotta VA, Menda Y, Moser DJ, Oleson JJ, Harlynn EL, DeVries SD, Wemmie JA, Schultz SK: Comparison of T1Rho MRI, Glucose Metabolism, and Amyloid Burden Across the Cognitive Spectrum: A Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences 2020:appi. neuropsych. 19100221.
- Borchert T, Hess A, Lukačević M, Ross TL, Bengel FM, Thackeray JT: Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. European journal of nuclear medicine and molecular imaging 2020:1-12.
- Bremova-Ertl T, Sztatecsny C, Brendel M, Moser M, Möller B, Clevert DA, Beck-Wödl S, Kun-Rodrigues C, Bras J, Rominger A: Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity. Neurology 2020, 94(16):e1702-e1715.
- Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S: Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo. Neoplasia 2020, 23(1):80-98.
- Brosch J, Gosewisch A, Kaiser L, Seidensticker M, Ricke J, Zellmer J, Bartenstein P, Ziegler S, Ilhan H, Todica A: 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Physica Medica 2020, 80:317-326.
- Brosch J, Uribe C, Gosewisch A, Kaiser L, Todica A, Ilhan H, Gildehaus FJ, Bartenstein P, Rahmim A, Celler A: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. 2020.
- Brumberg J, Schröter N, Blazhenets G, Frings L, Volkmann J, Lapa C, Jost WH, Isaias IU, Meyer PT: Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. NPJ Parkinson’s disease 2020, 6(1):1-7.
- Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H: Evaluation of Dosimetry, Quantitative Methods, and Test–Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain. Journal of Nuclear Medicine 2020, 61(6):920-927.
- Busatto Filho G, Duran FLdS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGdF, da Costa NA, Porto FHdG, Carvalho CL: Hippocampal subregional volume changes in elders classified using positron emission tomography‐based Alzheimer’s biomarkers of β‐amyloid deposition and neurodegeneration. Journal of Neuroscience Research 2020.
- Cai L, Liow J-S, Morse CL, Telu S, Davies R, Frankland MP, Zoghbi S, Cheng K, Hall M, Innis RB: Evaluation of 11C-NR2B-SMe and its Enantiomers as PET Radioligands for Imaging the NR2B Subunit within the NMDA Receptor Complex in Rats. Journal of Nuclear Medicine 2020:jnumed. 119.235143.
- Cai M, Yang EJ: Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model. Frontiers in Pharmacology 2020, 11.
- Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H: Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 2020, 231:119678.
- Cantero JL, Atienza M, Ramos-Cejudo J, Fossati S, Wisniewski T, Osorio RS: Plasma tau predicts cerebral vulnerability in aging. Aging (Albany NY) 2020, 12(21):21004.
- Cao R, Chen X, Xie C, Hu P, Wang K: Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder. Frontiers in Neuroscience 2020, 14:349.
- Ceballos‐Francisco D, Carrillo NG, Pardo‐Fernández FJ, Cuesta A, Esteban MÁ: Radiological characterization of gilthead seabream (Sparus aurata) by X‐ray computed tomography. Journal of Fish Biology 2020, 97(5):1440-1447.
- Ceballos-Francisco D, García-Carrillo N, Cuesta A, Esteban MÁ: Radiological characterization of gilthead seabream (Sparus aurata) fat by X-ray micro-computed tomography. Scientific Reports 2020, 10(1):1-11.
- Ceccon G, Lohmann P, Werner J-M, Tscherpel C, Dunkl V, Stoffels G, Rosen J, Rapp M, Sabel M, Herrlinger U: Early treatment response assessment using 18F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy. Journal of Nuclear Medicine 2020:jnumed. 120.254243.
- Chan S-C, Ng S-H, Yeh C-H, Chang K-P: Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonanceimaging functional parameters and 18 F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure. 2020.
- Chang C-W, Chiu C-H, Lin M-H, Wu H-M, Yu T-H, Wang P-Y, Kuo Y-Y, Huang Y-Y, Shiue C-Y, Huang W-S: In Vivo Brain Region-specific TSPO Imaging by PET/MRI [18F] FEPPA. 2020.
- Chang WH, Chen KC, Tseng H-H, Chiu NT, Lee IH, Chen PS, Yang YK: Bridging the associations between dopamine, brain volumetric variation and IQ in drug-naïve schizophrenia. Schizophrenia Research 2020.
- Chastel A, Worm DJ, Alves ID, Vimont D, Petrel M, Fernandez S, Garrigue P, Fernandez P, Hindié E, Beck-Sickinger AG: Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides. EJNMMI research 2020, 10(1):1-12.
- Chen K-H, Miao Y-B, Shang C-Y, Huang T-Y, Yu Y-T, Yeh C-N, Song H-L, Chen C-T, Mi F-L, Lin K-J: A bubble bursting-mediated oral drug delivery system that enables concurrent delivery of lipophilic and hydrophilic chemotherapeutics for treating pancreatic tumors in rats. Biomaterials 2020:120157.
- Chen Y, Goorden MC, Vastenhouw B, Beekman FJ: Optimized sampling for high resolution multi-pinhole brain SPECT with stationary detectors. Physics in Medicine & Biology 2020, 65(1):015002.
- Chen Y-H, Wang T-F, Chu S-C, Lin C-B, Wang L-Y, Lue K-H, Liu S-H, Chan S-C: Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. PloS one 2020, 15(12):e0244502.
- Cherix A, Donati G, Lizarbe B, Lanz B, Poitry-Yamate C, Lei H, Gruetter R: Excitatory/inhibitory neuronal metabolic balance in mouse hippocampus upon infusion of [U-13C6] glucose. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20910535.
- Cherix A, Poitry-Yamate C, Lanz B, Zanoletti O, Grosse J, Sandi C, Gruetter R, Cardinaux J-R: Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior. bioRxiv 2020.
- Chin W-C, Liu F-Y, Huang Y-S, Hsiao I-T, Wang C-H, Chen Y-C: Different PET findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study. Journal of Clinical Sleep Medicine 2020:jcsm. 9032.
- Choi BW, Kim S, Kang S, Won KS, Yi H-A, Kim HW: Relationship between thyroid hormone levels and the pathology of Alzheimer’s disease in euthyroid subjects. Thyroid 2020(ja).
- Choi C-H, Stegmayr C, Shymanskaya A, Worthoff WA, da Silva NA, Felder J, Langen K-J, Shah NJ: An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems. 2020.
- Chotipanich C, Nivorn M, Kunawudhi A, Promteangtrong C, Boonkawin N, Jantarato A: Evaluation of Imaging Windows for Tau PET Imaging Using 18F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients. Molecular Imaging 2020, 19:1536012120947582.
- Chung Y-H, Tsai C-K, Yu C-F, Wang W-L, Yang C-L, Hong J-H, Yen T-C, Chen F-H, Lin G: Radiation-induced Metabolic Shifts in the Hepatic Parenchyma: Findings from 18F-FDG PET Imaging and Tissue NMR Metabolomics in a Mouse Model for Hepatocellular Carcinoma. 2020.
- Cisbani G, Koppel A, Knezevic D, Suridjan I, Mizrahi R, Bazinet RP: Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: an exploratory study. Brain, Behavior, and Immunity 2020.
- Coda A, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G: In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18 F] DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
- Cole K, Pugh T, Cornejo K, Chareonthaitawee P, Johnson G, Kemp B: Clinical evaluation of software for processing 13N-ammonia rest-stress cardiac perfusion PET/CT studies. Journal of Nuclear Medicine 2020, 61(supplement 1):3060-3060.
- Contat C, Ancey P-B, Zangger N, Sabatino S, Pascual J, Escrig S, Jensen L, Goepfert C, Lanz B, Lepore M: Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth. Elife 2020, 9:e53618.
- Craciun L, de Wind R, Demetter P, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G: Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy. BMC cancer 2020, 20(1):1-10.
- Cuenoud B, Hartweg M, Godin J-P, Croteau E, Maltais M, Castellano C-A, Carpentier AC, Cunnane SC: Metabolism of exogenous D-beta-hydroxybutyrate, an energy substrate avidly consumed by the heart and kidney. Frontiers in nutrition 2020, 7:13.
- Damuka N, Czoty PW, Davis AT, Nader MA, Nader SH, Craft S, Macauley SL, Galbo LK, Epperly PM, Whitlow CT: PET Imaging of [11C] MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains. Molecules 2020, 25(10):2289.
- Darr C, Harke N, Radtke JP, Yirga L, Kesch C, Grootendorst M, Fendler W, Costa PF, Rischpler C, Praus C: Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy–a feasibility study. Journal of Nuclear Medicine 2020:jnumed. 119.240424.
- Dawicki W, Allen KJ, Garg R, Geoghegan EM, Berger MS, Ludwig DL, Dadachova E: Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy. Oncotarget 2020, 11(39):3571-3581.
- de Arcocha-Torres M, Quincoces G, Martínez-López A, Erhard A, Collantes M, Martínez-Rodríguez I, Ecay M, Banzo I, Irache J, Peñuelas I: Preparación, radiomarcaje con 99mTc y 67Ga y estudios de biodistribución de nanopartículas de albúmina con recubrimientos poliméricos. Revista Española de Medicina Nuclear e Imagen Molecular 2020, 39(4):225-232.
- De Leo TC, dos Santos SN, Andrade CDC, Ricci E, Turato WM, Lopes NP, Oliveira RS, Bernardes ES, Dias-Baruffi M: Engineering of galectin-3 for glycan-binding optical imaging. Biochemical and Biophysical Research Communications 2020, 521(3):674-680.
- de Lima LI, Faria RS, Franco MS, Roque MC, Arruda Pacheco TJ, Rodrigues MC, Muehlmann LA, Moya SE, Azevedo RB, de Oliveira MC: Combined paclitaxel-doxorubicin liposomal results in positive prognosis with infiltrating lymphocytes in lung metastasis. Nanomedicine 2020, 15(29):2753-2770.
- de Redín IL, Expósito F, Agüeros M, Collantes M, Peñuelas I, Allemandi D, Llabot JM, Calvo A, Irache JM: In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer. Drug Delivery and Translational Research 2020:1-11.
- de-Arcocha-Torres M: Radiomarcaje de nanopartículas de albúmina con radiometales (Tecnecio-99M, Galoo-67, Zirconio-89) y estudio de su biodistribución mediante imagen molecular. 2020.
- Delage J, Faivre-Chauvet A, Fierle J, Gnesin S, Schaefer N, Coukos G, Dunn S, Viertl D, Prior J: 177 Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma. EJNMMI research 2020, 10(1):1-14.
- Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K: Quantification and discriminative power of 18 F-FE-PE2I PET in patients with Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2020, 47(8):1913-1926.
- Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC: Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body 18 F-FDG PET/CT scans. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-14.
- Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging 2020.
- Donat CK, Hansen HH, Hansen HD, Mease RC, Horti AG, Pomper MG, L’Estrade ET, Herth MM, Peters D, Knudsen GM: In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [125I] Iodo-ASEM and [18F] ASEM as Radiotracers of Homo-and Heteromeric α7 Nicotinic Acetylcholine Receptors. Molecules 2020, 25(6):1425.
- Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM: Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig. European Neuropsychopharmacology 2020.
- Doot RK, Young AJ, Daube-Witherspoon ME, Alexoff D, Labban KJ, Lee H, Wu Z, Zha Z, Choi SR, Ploessl KH: Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga] Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies. Nuclear Medicine and Biology 2020.
- Drescher R, Seifert P, Gühne F, Kühnel C, Aschenbach R, Freesmeyer M: Transarterial Radioembolization with Yttrium-90 Glass Microspheres: Distribution of Residual Activity and Flow Dynamics during Administration. Journal of Vascular and Interventional Radiology 2020, 31(9):1467-1474.
- Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG: PET imaging of soluble epoxide hydrolase in non-human primate brain with [18 F] FNDP. EJNMMI research 2020, 10(1):1-12.
- Dubol M, Trichard C, Leroy C, Granger B, Tzavara ET, Martinot J-L, Artiges E: Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging. Journal of Affective Disorders 2020, 262:273-277.
- Durán‐Carabali LE, Kawa Odorcyk F, Greggio S, Teribele Venturin G, Farias Sanches E, Garcia Schu G, Soares Carvalho A, Avila Pedroso T, de Sá Couto‐Pereira N, Costa da Costa J: Pre‐and early postnatal enriched environmental experiences prevent neonatal hypoxia‐ischemia late neurodegeneration via metabolic and neuroplastic mechanisms. Journal of Neurochemistry 2020.
- Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, Deussing M, Briel N, Lindner S, Boening G: Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. Journal of neuroinflammation 2020, 17(1):1-12.
- Facchin C, Perez-Liva M, Garofalakis A, Viel T, Certain A, Balvay D, Yoganathan T, Woszczyk J, De Sousa K, Sourdon J: Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment. Theranostics 2020, 10(8):3518.
- Falciani C, Zevolini F, Brunetti J, Riolo G, Gracia R, Marradi M, Loinaz I, Ziemann C, Cossío U, Llop J: Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections. International Journal of Nanomedicine 2020, 15:1117.
- Fan D-Y, Li H-Y, Chen D-W, Chen Y, Yi X, Yang H, Shi Q-Q, Jiao F-Y, Tang Y, Li Q-M: Chronic hypoperfusion is not associated with cerebral amyloidosis. 2020.
- Fang J, Ohba H, Hashimoto F, Tsukada H, Chen F, Liu H: Imaging mitochondrial complex I activation during a vibrotactile stimulation: A PET study using [18F] BCPP-EF in the conscious monkey brain. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X19900034.
- Fedorova TD, Knudsen K, Hartmann B, Holst JJ, Viborg Mortensen F, Krogh K, Borghammer P: In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients. Neurogastroenterology & Motility 2020, 32(3):e13759.
- Feiner IV, Pulagam KR, Gómez‐Vallejo V, Zamacola K, Baz Z, Caffarel MM, Lawrie CH, Ruiz‐de‐Angulo A, Carril M, Llop J: Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy. Particle & Particle Systems Characterization 2020, 37(12):2000200.
- Feiner IV, Pulagam KR, Uribe KB, Passannante R, Simó C, Zamacola K, Gómez-Vallejo V, Herrero-Álvarez N, Cossío U, Baz Z: Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy. Journal of Materials Chemistry B 2020.
- Feng DD, Chen K, Wen L: Noninvasive Input Function Acquisition and Simultaneous Estimations With Physiological Parameters for PET Quantification: A Brief Review. IEEE Transactions on Radiation and Plasma Medical Sciences 2020, 4(6):676-683.
- Fiedorowicz M, Khan M, Strzemecki D, Orzeł J, Wełniak-Kamińska M, Sobiborowicz A, Wieteska M, Rogulski Z, Cheda L, Wargocka-Matuszewska W: Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo. Scientific reports 2020, 10(1):1-19.
- Flanigan M, Tollefson S, Himes ML, Jordan R, Roach K, Stoughton C, Lopresti B, Mason NS, Ciccocioppo R, Narendran R: Acute elevations in cortisol increase the in vivo binding of [11C] NOP-1A to nociceptin receptors: A novel imaging paradigm to study the interaction between stress-and antistress-regulating neuropeptides. Biological Psychiatry 2020, 87(6):570-576.
- Fleury Curado T, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG: DREADD Approach to Treatment of Sleep Disordered Breathing. American Journal of Respiratory and Critical Care Medicine 2020(ja).
- Franke TN, Irwin C, Bayer TA, Brenner W, Beindorff N, Bouter C, Bouter Y: In vivo imaging with 18F-FDG-and 18F-Florbetaben-PET/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer’s disease. Frontiers in Medicine 2020, 7:529.
- Freitas RD, Muradás TC, Dagnino APA, Rost FL, Costa KM, Venturin GT, Greggio S, da Costa JC, Campos MM: Targeting FFA1 and FFA4 receptors in cancer-induced cachexia. American Journal of Physiology-Endocrinology and Metabolism 2020, 319(5):E877-E892.
- Fuenfgeld B, Mächler P, Fischer DR, Esposito G, Rushing EJ, Kaufmann PA, Stolzmann P, Huellner MW: Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination. Plos one 2020, 15(4):e0230618.
- Fung LK, Flores RE, Gu M, Sun KL, James D, Schuck RK, Jo B, Park JH, Lee BC, Jung JH: Thalamic and prefrontal GABA concentrations but not GABA A receptor densities are altered in high-functioning adults with autism spectrum disorder. Molecular Psychiatry 2020:1-13.
- Gao Y, Wu S, Pan J, Zhang K, Li X, Xu Y, Jin C, He X, Shi J, Ma L: CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
- García-Varela L, Arif WM, Vállez García D, Kakiuchi T, Ohba H, Harada N, Tago T, Elsinga PH, Tsukada H, Colabufo NA: Pharmacokinetic Modeling of [18F] MC225 for Quantification of the P-Glycoprotein Function at the Blood–Brain Barrier in Non-Human Primates with PET. Molecular pharmaceutics 2020, 17(9):3477-3486.
- García-Varela L, García DV, Kakiuchi T, Ohba H, Nishiyama S, Tago T, Elsinga PH, Tsukada H, Colabufo NA, Dierckx RA: Pharmacokinetic Modeling of (R)-[11C] verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates. Molecular Pharmaceutics 2020.
- García-Varela L, Vállez García D, Rodríguez-Pérez M, van Waarde A, Sijbesma JrW, Schildt A, Kwizera C, Aguiar P, Sobrino T, Dierckx RA: Test–Retest Repeatability of [18F] MC225-PET in Rodents: A Tracer for Imaging of P-gp Function. ACS chemical neuroscience 2020, 11(4):648-658.
- Garg PK, Putegnat B, Truong L, Reynolds C, Sanchez I, Nedrelow JK, Uffman J, Lokitz SJ, Nazih R, Garg S: Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism. Plos one 2020, 15(10):e0241243.
- Garrido A, Iranzo A, Stefani A, Serradell M, Muñoz‐Lopetegi A, Marrero P, Högl B, Gaig C, Santamaria J, Tolosa E: Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects. Movement Disorders 2020.
- Garrow AA, Andrews JP, Gonzalez ZN, Corral CA, Portal C, Morgan TE, Walton T, Wilson I, Newby DE, Lucatelli C: Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers. Scientific reports 2020, 10(1):1-11.
- Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP: The interaction between neuroinflammation and β-amyloid in cognitive decline in Parkinson’s Disease. Molecular neurobiology 2020, 57(1):492-501.
- Giacobbo BL, Doorduin J, Moraga-Amaro R, Nazario LR, Schildt A, Bromberg E, Dierckx RA, de Vries EF: Chronic harmine treatment has a delayed effect on mobility in control and socially defeated rats. Psychopharmacology 2020:1-12.
- Giovannella M, Andresen B, Andersen JB, El-Mahdaoui S, Contini D, Spinelli L, Torricelli A, Greisen G, Durduran T, Weigel UM: Validation of diffuse correlation spectroscopy against 15O-water PET for regional cerebral blood flow measurement in neonatal piglets. Journal of Cerebral Blood Flow & Metabolism 2020, 40(10):2055-2065.
- Girard A, Saint-Jalmes H, Chaboub N, Le Reste P-J, Metais A, Devillers A, Le Jeune F, Palard-Novello X: Optimization of time frame binning for FDOPA uptake quantification in glioma. Plos one 2020, 15(4):e0232141.
- Girardet R, Boughdad S, Digklia A, Beigelman C, Meyer M, Schaefer N, Vermersch M, Hocquelet A, Tsoumakidou G, Denys A: Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium. Cardiovascular and interventional radiology 2020, 43(11):1712-1715.
- Giridharan VV, Collodel A, Generoso JS, Scaini G, Wassather R, Selvaraj S, Hasbun R, Dal-Pizzol F, Petronilho F, Barichello T: Neuroinflammation trajectories precede cognitive impairment after experimental meningitis—evidence from an in vivo PET study. Journal of Neuroinflammation 2020, 17(1):1-20.
- Glorie D, Verhaeghe J, Miranda A, De Lombaerde S, Stroobants S, Staelens S: Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11 C] UCB-J PET study in a model of obsessive–compulsive disorder-like behaviour. EJNMMI research 2020, 10(1):1-13.
- Glorie D, Verhaeghe J, Miranda A, Kertesz I, Wyffels L, Stroobants S, Staelens S: Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [11C] ABP688 PET study. Neuropharmacology 2020:108160.
- Gnesin S, Kieffer C, Zeimpekis K, Papazyan J-P, Guignard R, Prior JO, Verdun FR, Lima TV: Phantom-based image quality assessment of clinical 18 F-FDG protocols in digital PET/CT and comparison to conventional PMT-based PET/CT. EJNMMI physics 2020, 7(1):1-16.
- Gnesin S, Müller J, Burger IA, Meisel A, Siano M, Früh M, Choschzick M, Müller C, Schibli R, Ametamey SM: Radiation dosimetry of 18 F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI research 2020, 10:1-12.
- Golan S, Aviv T, Groshar D, Yakimov M, Zohar Y, Nadu A, Baniel J, Domachevsky L, Bernstine H: Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study. Journal of Nuclear Medicine 2020:jnumed. 120.251272.
- Gómez-Gónzalez E, Núñez NO, Caro C, García-Martín ML, Fernández-Afonso Y, de la Fuente JsM, Balcerzyk M, Ocaña M: Dysprosium and Holmium Vanadate Nanoprobes as High-Performance Contrast Agents for High-Field Magnetic Resonance and Computed Tomography Imaging. Inorganic Chemistry 2020.
- Gómez-Lado N, López-Arias E, Iglesias-Rey R, Díaz-Platas L, Medín-Aguerre S, Fernández-Ferreiro A, Posado-Fernández A, García-Varela L, Rodríguez-Pérez M, Campos F: [18F]-FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage. Molecular Pharmaceutics 2020.
- Gorbenko I, Mikołajczyk K, Jasionowska M, Narloch J, Kałużyński K: Automatic segmentation of facial soft tissue in MRI data based on non-rigid normalization in application to soft tissue thickness measurement. Biomedical Signal Processing and Control 2020, 56:101698.
- Goutal S, Guillermier M, Becker G, Gaudin M, Bramoullé Y, Luxen A, Lemaire C, Plenevaux A, Salmon E, Hantraye P: The Pharmacokinetics of [18F] UCB-H Revisited in The Healthy Non-Human Primate Brain. 2020.
- Goutal S, Tournier N, Guillermier M, Van Camp N, Barret O, Gaudin M, Bottlaender M, Hantraye P, Lavisse S: Comparative test-retest variability of outcome parameters derived from brain [18F] FDG PET studies in non-human primates. Plos one 2020, 15(10):e0240228.
- Grachev ID, Meyer PM, Becker GA, Bronzel M, Marsteller D, Pastino G, Voges O, Rabinovich L, Knebel H, Zientek F: Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18 F] fluspidine and [18 F] fallypride PET study. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
- Grecco GG, Mork B, Huang JY, Metzger CE, Haggerty DL, Reeves KC, Gao Y, Hoffman H, Katner SN, Masters AR: Prenatal Methadone Exposure Disrupts Behavioral Development and Alters Motor Neuron Intrinsic Properties and Local Circuitry. bioRxiv 2020.
- Grimmer T, Shi K, Diehl-Schmid J, Natale B, Drzezga A, Förster S, Förstl H, Schwaiger M, Yakushev I, Wester H-J: 18 F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases. Molecular psychiatry 2020, 25(10):2608-2619.
- Grosch M, Lindner M, Bartenstein P, Brandt T, Dieterich M, Ziegler S, Zwergal A: Dynamic whole-brain metabolic connectivity during vestibular compensation in the rat. NeuroImage 2020, 226:117588.
- Gruber L, Jimenez-Franco LD, Decristoforo C, Uprimny C, Glatting G, Hohenberger P, Schoenberg SO, Reindl W, Orlandi F, Mariani M: MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients. Journal of Nuclear Medicine 2020:jnumed. 119.238808.
- Guarra F, Terenzi A, Pirker C, Passannante R, Baier D, Zangrando E, Gómez V, Biver T, Gabbiani C, Berger W: 124I-radiolabeling of a Au (III)-NHC complex for in vivo biodistribution studies. 2020.
- Guibbal F, Hopkins SL, Pacelli A, Isenegger PG, Mosley M, Torres JB, Dias GM, Mahaut D, Hueting R, Gouverneur V: [18 F] AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET Imaging. Molecular Imaging and Biology 2020, 22(5):1226-1234.
- Haider A, Gobbi L, Kretz J, Ullmer C, Brink A, Honer M, Woltering TJ, Muri D, Iding H, Bürkler M: Identification and Preclinical Development of a 2, 5, 6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of Medicinal Chemistry 2020, 63(18):10287-10306.
- Harris DA, Mina A, Cabarkapa D, Heshmati K, Subramaniam R, Banks AS, Tavakkoli A, Sheu EG: Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss. American Journal of Physiology-Endocrinology and Metabolism 2020, 318(5):E678-E688.
- Hartley SL, Handen BL, Devenny D, Tudorascu D, Piro‐Gambetti B, Zammit MD, Laymon CM, Klunk WE, Zaman S, Cohen A: Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer’s disease in Down syndrome. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12096.
- Hashimoto F, Ohba H, Ote K, Kakimoto A, Tsukada H, Ouchi Y: 4D deep image prior: dynamic PET image denoising using an unsupervised four-dimensional branch convolutional neural network. Physics in Medicine & Biology 2020.
- Hauser EB, Venturin GT, Greggio S, Borelli WV, DaCosta J: Carotid arterial input function as an inverse problem in kinetic modeling of [18F] 2-fluoro-2 deoxy-D-glucose (FDG). Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2020, 8(3):273-276.
- Hayashi H, Kobayashi R, Kawakatsu S, Morioka D, Otani K: Utility of Easy Z-Score Imaging System-Assisted SPECT in Detecting Onset Age-Dependent Decreases in Cerebral Blood Flow in the Posterior Cingulate Cortex, Precuneus, and Parietal Lobe in Alzheimer’s Disease with Amyloid Accumulation. Dementia and Geriatric Cognitive Disorders Extra 2020, 10(2):63-68.
- He RY, Lai XM, Sun CS, Kung TS, Hong JY, Jheng YS, Liao WN, Chen JK, Liao YF, Tu PH: Nanoscopic insights of amphiphilic peptide against the oligomer assembly process to treat Huntington’s disease. Advanced Science 2020, 7(2):1901165.
- He Y, Whitehead DM, Briard E, Numao S, Mu L, Schibli R, Ametamey SM, Auberson YP: Evaluation of 5H‐Thiazolo [3, 2‐α] pyrimidin‐5‐ones as Potential GluN2A PET Tracers. ChemMedChem 2020, 15(24):2448-2461.
- Hepp T, Othman A, Liebgott A, Kim JH, Pfannenberg C, Gatidis S: Effects of simulated dose variation on contrast-enhanced CT-based radiomic analysis for Non-Small Cell Lung Cancer. European Journal of Radiology 2020, 124:108804.
- Hernández Lozano I, Langer O: Use of imaging to assess the activity of hepatic transporters. Expert Opinion on Drug Metabolism & Toxicology 2020, 16(2):149-164.
- Hirai N, Watabe T, Nagamori S, Wiriyasermkul P, Tanaka Y, Romanov V, Naka S, Kanai Y, Liu Y, Tani N: Evaluation of D-isomer of 18F-FBPA for oncology PET focusing on the differentiation of glioma and inflammation. Asia Oceania Journal of Nuclear Medicine and Biology 2020, 8(2):102.
- Hiroyama S, Rokugawa T, Ito M, Iimori H, Morita I, Maeda H, Fujisawa K, Matsunaga K, Shimosegawa E, Abe K: Quantitative evaluation of hepatic integrin α v β 3 expression by positron emission tomography imaging using 18 F-FPP-RGD 2 in rats with non-alcoholic steatohepatitis. EJNMMI research 2020, 10(1):1-12.
- Holodňáková N: In vitro saturačné štúdie gáliom-67 a zirkóniom-89 značenej monoklonálnej protilátky ramucirumab na SKOV-3 bunkovej línii. 2020.
- Hori Y, Nagai Y, Mimura K, Suhara T, Higuchi M, Bouret S, Minamimoto T: Differential Contribution of Dopaminergic Transmission at D1-and D2-like Receptors to Cost/Benefit Evaluation for Motivation in Monkeys. bioRxiv 2020.
- Houben RH, Kotsougiani D, Friedrich PF, Shin AY, Bishop AT: Outcomes of vascularized bone allotransplantation with surgically induced autogenous angiogenesis in a large animal model: bone healing, remodeling, and material properties. Journal of reconstructive microsurgery 2020, 36(02):082-092.
- Houben RH, Thaler R, Kotsougiani D, Friedrich PF, Shin AY, van Wijnen AJ, Bishop AT: Neo‐Angiogenesis, Transplant Viability, and Molecular Analyses of Vascularized Bone Allotransplantation Surgery in a Large Animal Model. Journal of Orthopaedic Research® 2020, 38(2):288-296.
- Hsu J-L, Chen S-H, Hsiao T, Lu C-S, Yen T-C, Okamura N, Lin K-J, Weng Y-H: 18 F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty. Scientific reports 2020, 10(1):1-10.
- Hsu M-N, Huang K-L, Yu F-J, Lai P-L, Truong AV, Lin M-W, Nguyen NTK, Shen C-C, Hwang S-M, Chang Y-H: Coactivation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSC osteogenesis and promotes calvarial bone regeneration. Molecular Therapy 2020, 28(2):441-451.
- Hsu M-N, Yu F-J, Chang Y-H, Huang K-L, Pham NN, Truong VA, Lin M-W, Nguyen NTK, Hwang S-M, Hu Y-C: CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials 2020:120094.
- Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG: 18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography. European Journal of Medicinal Chemistry 2020:113047.
- Hu W, Pan D, Wang Y, Bao W, Zuo C, Guan Y, Hua F, Yang M, Zhao J: PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F] DPA714. Frontiers in Neuroscience 2020, 14.
- Huang C, Ding F, Hu Z, Wang M, Peng W, Li W, Wang C, Tang D: 18F-VUIIS1009B Features a Superior Imaging Performance to 18F-DPA-714 in TSPO Density Characterization for Neuroinflammatory PET Imaging. 2020.
- Huang CW, Chang YH, Lee HH, Wu JY, Huang JX, Chung YH, Hsu ST, Chow LP, Wei KC, Huang FT: Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma. The FASEB Journal 2020.
- Huang K-L, Hsiao T, Ho M-Y, Hsu J-L, Chang Y-J, Chang T-Y, Liu C-H, Chang C-H, Wu Y-M, Wu K-Y: Investigation of reactive astrogliosis effect on post-stroke cognitive impairment. Journal of neuroinflammation 2020, 17(1):1-14.
- Huang S, Zhang L, Xu M, Li C, Fu H, Huang J, Jin X, Liang S, Wang H: Co‐Delivery of 131I and Prima‐1 by Self‐Assembled CD44‐Targeted Nanoparticles for Anaplastic Thyroid Carcinoma Theranostics. Advanced Healthcare Materials 2020:2001029.
- Huang S-Y, Hsu J-L, Lin K-J, Hsiao I-T: A novel Individual metabolic brain network for 18F-FDG PET imaging. Frontiers in Neuroscience 2020, 14:344.
- Huber FA, Schumann P, Von Spiczak J, Wurnig MC, Klarhöfer M, Finkenstaedt T, Bedogni A, Guggenberger R: Medication-Related Osteonecrosis of the Jaw—Comparison of Bone Imaging Using Ultrashort Echo-Time Magnetic Resonance Imaging and Cone-Beam Computed Tomography. Investigative Radiology 2020, 55(3):160-167.
- Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R: Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement disorders 2020, 35(4):595-605.
- Hunt BC, Stanford D, Xu X, Li J, Gaggar A, Rowe SM, Raju SV, Swords WE: Haemophilus influenzae persists in biofilm communities in a smoke-exposed ferret model of COPD. ERJ Open Research 2020, 6(3).
- Iikuni S, Watanabe H, Shimizu Y, Nakamoto Y, Ono M: PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide. Plos one 2020, 15(12):e0243327.
- Inubushi T, Ito M, Mori Y, Futatsubashi M, Sato K, Ito S, Yokokura M, Shinke T, Kameno Y, Kakimoto A: Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release. NeuroImage 2020, 224:117434.
- Ito Y, Fujita N, Hara K, Tada T, Abe S, Katsuno M, Naganawa S, Kato K: New Semi-Quantification Approach for Dopamine Transporter Scan: Quantification of Accumulation by Examining the Approximate Image. 2020.
- Ito Y, Tada T, Murayama R, Ikeda H, Ochi Y, Tamura M, Tsutsumi Y, Kato K: Studies on Calculation of the Specific Binding Ratio with the Minimum Partial Volume Effect for the Caudate and Putamen by Generating the Analogy Image to the Image Obtained by SPECT Imaging. Journal of Nuclear Medicine 2020, 61(supplement 1):3130-3130.
- Jeuken RM, Roth AK, Peters MJ, Welting TJ, van Rhijn LW, Koenen J, Peters RJ, Thies JC, Emans PJ: In vitro and in vivo study on the osseointegration of BCP‐coated versus uncoated nondegradable thermoplastic polyurethane focal knee resurfacing implants. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2020, 108(8):3370-3382.
- Jiang D, Kong Y, Ren S, Cai H, Zhang Z, Huang Z, Peng F, Hua F, Guan Y, Xie F: Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT. Nuclear Medicine and Biology 2020, 82:89-95.
- Jiang D, Qiu X, Ren S, Hua F, Kong Y, Guan Y, Xie F: Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study. Neuroscience Letters 2020:134864.
- Jiang D, Shao D, Huang Q, Ren S, Li J, Xiao J, Guan Y, Lai B, Zhao J, Hua F: Brain Glucose Metabolism and Dopamine Transporters Change in Addiction and Environmental Cue-Induced Memory. 2020.
- Jiménez-González S, Marín-Royo G, Jurado-López R, Bartolomé MV, Romero-Miranda A, Luaces M, Islas F, Nieto ML, Martínez-Martínez E, Cachofeiro V: The Crosstalk between Cardiac Lipotoxicity and Mitochondrial Oxidative Stress in the Cardiac Alterations in Diet-Induced Obesity in Rats. Cells 2020, 9(2):451.
- Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M: A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease. Progress in Neurobiology 2020:101789.
- Joo Y-H, Kim Y-K, Choi I-G, Kim H-J, Son Y-D, Kim H-K, Cumming P, Kim J-H: In vivo glucose metabolism and glutamate levels in mGluR5 knockout mice: a multimodal neuroimaging study using [18 F] FDG microPET and MRS. EJNMMI research 2020, 10(1):1-10.
- Kang Y, Rúa SMH, Kaunzner UW, Perumal J, Nealon N, Qu W, Kothari PJ, Vartanian T, Kuceyeski A, Gauthier SA: A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis. multiple sclerosis 2020, 4:12-14.
- Karlsson HK, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Mesolimbic opioid-dopamine interaction is disrupted in obesity but recovered by weight loss following bariatric surgery. bioRxiv 2020.
- Katayama D, Yanagawa M, Matsunaga K, Watabe H, Watabe T, Kato H, Kijima T, Takeda Y, Kumanogoh A, Shimosegawa E: 15O-Water Dynamic Positron Emission Tomography in Patients with Non-Small Cell Lung Cancer: Early Decrease in Blood Flow After Anti-Angiogenic Treatment is Correlated with a Shorter Time to Tumour Progression. 2020.
- Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, Nakatsuji Y, Hatazawa J: Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20911469.
- Kautzky A, Vanicek T, Philippe C, Kranz G, Wadsak W, Mitterhauser M, Hartmann A, Hahn A, Hacker M, Rujescu D: Machine learning classification of ADHD and HC by multimodal serotonergic data. Translational psychiatry 2020, 10(1):1-9.
- Kessler M, Mamach M, Beutelmann R, Lukacevic M, Eilert S, Bascuñana P, Fasel A, Bengel F, Bankstahl J, Ross T: GABA A receptors in the mongolian gerbil: A PET study using [18 F] flumazenil to determine receptor binding in young and old animals. Molecular imaging and biology 2020, 22(2):335-347.
- Key MC: The effects of HIV-1 transactivator of transcription (Tat) on synaptic density in the Tat mouse model of HIV-1 associated neurocognitive disorder (HAND)(Under the direction of Sylvia Fitting). 2020.
- Khalmuratova R, Lee M, Park J-W, Shin H-W: Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model. Allergy, Asthma & Immunology Research 2020, 12(2):306-321.
- Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park M-A, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H: Quantitative [18 F] florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. European journal of nuclear medicine and molecular imaging 2020, 47(8):1998-2009.
- Kim D, Ko HY, Lee S, Lee Y-h, Ryu S, Kim SY, Chung J-i, Lee M, Moon JH, Chang JH: Glucose Loading Enhances the Value of 18F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas. Cancers 2020, 12(7):1977.
- Kim K, Son SM, Goh TS, Pak K, Kim I-J, Lee JS, Kim S-J: Prediction of Response to Tumor Necrosis Value–α Blocker Is Suggested by 18F-NaF SUVmax But Not by Quantitative Pharmacokinetic Analysis in Patients With Ankylosing Spondylitis. American Journal of Roentgenology 2020:1-7.
- Kim M-J, Lee J-H, Anaya FJ, Hong J, Miller W, Telu S, Singh P, Cortes MY, Henry K, Tye GL: First-in-human evaluation of [11C] PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain. European journal of nuclear medicine and molecular imaging 2020.
- Kim SE, Joo YH, Son YD, Kim HK, Lee SY, Lee MW, Ido T, Kim JH: Association between human gray matter metabotropic glutamate receptor‑5 availability in vivo and white matter properties: a [11C] ABP688 PET and diffusion tensor imaging study. Brain Structure & Function 2020.
- Kjærgaard K, Frisch K, Sørensen M, Munk OL, Hofmann AF, Horsager J, Schacht AC, Erickson M, Shapiro D, Keiding S: Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. Journal of Hepatology 2020, 74(1):58-65.
- Kjærgaard K, Sandahl TD, Frisch K, Vase KH, Keiding S, Vilstrup H, Ott P, Gormsen LC, Munk OL: Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu] copper PET/CT. 2020.
- Kjærgaard K, Weber B, Alstrup AKO, Petersen JBB, Hansen R, Hamilton-Dutoit SJ, Mortensen FV, Sørensen M: Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs. Scientific Reports 2020, 10(1):1-10.
- Klein J, Yan X, Johnson A, Tomljanovic Z, Zou J, Polly K, Honig LS, Brickman A, Stern Y, Devanand D: Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer’s disease. medRxiv 2020.
- Klinge MW, Borghammer P, Lund S, Fedorova T, Knudsen K, Haase AM, Christiansen JJ, Krogh K: Enteric cholinergic neuropathy in patients with diabetes: Non‐invasive assessment with positron emission tomography. Neurogastroenterology & Motility 2020, 32(1):e13731.
- Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart S: Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling. Journal of Nuclear Medicine 2020, 61(7):1006-1013.
- Ko K-Y, Wang S-Y, Yen R-F, Shiau Y-C, Hsu J-C, Tsai H-Y, Lee C-L, Chiu K-M, Wu Y-W: Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy. Journal of Nuclear Cardiology 2020, 27(1):269-279.
- Kode J, Kovvuri J, Nagaraju B, Jadhav S, Barkume M, Sen S, Kasinathan NK, Chaudhari P, Mohanty BS, Gour J: Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. Bioorganic Chemistry 2020, 105:104447.
- Koh XY, Koh XH, Spiegelberg D, Jha P, Nestor M, Hwang L-a, Tan BX, Lane D: Picomolar Binding Selective Human Ron Inhibitory Antibodies Directed to Surface Displayed Conformational Epitopes for Imaging and Therapy. 2020.
- Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S: Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain. NeuroImage 2020, 223:117270.
- Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, Schroeder FA, Hooker JM, Bormans G, de Hoon J: Clinical validation of the novel HDAC6 radiotracer [18 F] EKZ-001 in the human brain. European journal of nuclear medicine and molecular imaging 2020:1-16.
- Kosinski M, Figiel-Dabrowska A, Lech W, Wieprzowski L, Strzalkowski R, Strzemecki D, Cheda L, Lenart J, Domanska-Janik K, Sarnowska A: Bone Defect Repair Using a Bone Substitute Supported by Mesenchymal Stem Cells Derived from the Umbilical Cord. Stem Cells International 2020, 2020.
- Kostiv U, Kučka J, Lobaz V, Kotov N, Janoušková O, Šlouf M, Krajnik B, Podhorodecki A, Francová P, Šefc L: Highly colloidally stable trimodal 125 I-radiolabeled PEG-neridronate-coated upconversion/magnetic bioimaging nanoprobes. Scientific reports 2020, 10(1):1-14.
- Kramer V, Brooks AF, Haeger A, Kuljis RO, Rafique W, Koeppe RA, Raffel DM, Frey KA, Amaral H, Scott PJ: Evaluation of [18F]-N-Methyl lansoprazole as a Tau PET Imaging Agent in First-in-Human Studies. ACS Chemical Neuroscience 2020, 11(3):427-435.
- Kramer V, Dyssegaard A, Flores J, Soza-Ried C, Rösch F, Knudsen GM, Amaral H, Herth MM: Characterization of the serotonin 2A receptor selective PET tracer (R)-[18 F] MH. MZ in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(2):355-365.
- Kramer V, Juri C, Riss PJ, Pruzzo R, Soza-Ried C, Flores J, Hurtado A, Rösch F, Chana-Cuevas P, Amaral H: Pharmacokinetic evaluation of [18 F] PR04. MZ for PET/CT imaging and quantification of dopamine transporters in the human brain. European journal of nuclear medicine and molecular imaging 2020, 47(8):1927-1937.
- Kristoffer K, Weber B, Olsen AAK, Baltzer PJB, Hansen R, Hamilton-Dutoit SJ, Mortensen FV, Sørensen M: Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs. Scientific Reports (Nature Publisher Group) 2020, 10(1).
- Kubota M, Fujino J, Tei S, Takahata K, Matsuoka K, Tagai K, Sano Y, Yamamoto Y, Shimada H, Takado Y: Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study. Cerebral Cortex 2020, 30(12):6458-6468.
- Kuhla A, Meuth L, Stenzel J, Lindner T, Lappe C, Kurth J, Krause BJ, Teipel S, Glass Ä, Kundt G: Longitudinal [18 F] FDG-PET/CT analysis of the glucose metabolism in ApoE-deficient mice. EJNMMI research 2020, 10(1):1-11.
- Kühnel C, Seifert P, Mulik C, Winkens T, Freesmeyer M: 3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration. Nuklearmedizin 2020, 59(01):12-19.
- Kumamoto K, Katsube S, Tsubaki Y, Sato H, Tsutsui Y, Himuro K, Baba S, Sasaki M: Comparison of continuous bed motion and step-and-shoot method in SiPM PET/CT. Journal of Nuclear Medicine 2020, 61(supplement 1):3017-3017.
- Kushchayeva YS, Startzell M, Cochran E, Auh S, Sekizkardes H, Soldin SJ, Kushchayev SV, Dieckmann W, Skarulis M, Abdul Sater Z: Thyroid hormone effects on glucose disposal in patients with insulin receptor mutations. The Journal of Clinical Endocrinology & Metabolism 2020, 105(3):e158-e171.
- Kwon IG, Kang CW, Park J-P, Oh JH, Wang EK, Kim TY, Sung JS, Park N, Lee YJ, Sung H-J: Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 2020.
- LAN Y, Bai P, Wang H, Wang C: Design and preclinical evaluation of [18F] CNY-05, a next generation of sigma-1 receptor (ó1R) radiotracer for brain imaging of positron emission tomography (PET). Journal of Nuclear Medicine 2020, 61(supplement 1):202-202.
- LAN Y, Bai P, Wang H, Wang C: Design and preclinical evaluation of [11C] CNY-06, the firest generation of RIPK1/necroptosis radiotracer for brain imaging of positron emission tomography (PET). Journal of Nuclear Medicine 2020, 61(supplement 1):1035-1035.
- Landau AM, Noer O, Alstrup AKO, Audrain H, Wegener G, Gjedde A, Doudet DJ, Winterdahl M: Type of Anaesthetic Influences [11 C] MDL100, 907 Binding to 5HT 2A Receptors in Porcine Brain. Molecular Imaging and Biology 2020:1-8.
- Langaa SS, Lauridsen TG, Mose FH, Fynbo CA, Theil J, Bech JN: Estimation of renal perfusion based on measurement of Rubidium-82 clearance by PET/CT scanning in healthy subjects. 2020.
- Larsen B, Olafsson V, Calabro F, Laymon C, Tervo-Clemmens B, Campbell E, Minhas D, Montez D, Price J, Luna B: Maturation of the human striatal dopamine system revealed by PET and quantitative MRI. Nature communications 2020, 11(1):1-10.
- Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M, Keinänen J, Mäntylä T, Paju J, Ilonen T: Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Translational psychiatry 2020, 10(1):1-14.
- Ledermann K, Hasler G, Jenewein J, Sprott H, Schnyder U, Martin‐Soelch C: 5ʹUTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls—Preliminary evidence. Synapse 2020, 74(5):e22147.
- Lee J-H, Go Y, Kim D-Y, Lee SH, Kim O-H, Jeon YH, Kwon TK, Bae J-H, Song D-K, Lee I-K: Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue. Experimental & molecular medicine 2020, 52(2):238-252.
- L’Estrade ET, Shalgunov V, Edgar FG, Strebl‐Bantillo MG, Xiong M, Crestey F, Neelamegam R, Dyssegaard A, Lehel S, Erlandsson M: Radiosynthesis and preclinical evaluation of [11C] Cimbi‐701–Towards the imaging of cerebral 5‐HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals 2020, 63(2):46-55.
- Lew R, Constantinescu CC, Holden D, Carson RE, Carroll V, Galluppi G, Koblan KS, Hopkins SC: The rate of dasotraline brain entry is slow following intravenous administration. Psychopharmacology 2020, 237(11):3435-3446.
- Lhamyani S, Gentile A-M, Giraldez-Perez RM, Feijoo-Cuaresma M, Romero-Zerbo SY, Clemente-Postigo M, Zayed H, Oliva-Olivera W, Bermudez-Silva FJ, Salas J: miR-21 blocks obesity in mice: a potential therapy for humans. medRxiv 2020.
- Li CH, Fan SP, Chen TF, Chiu MJ, Yen RF, Lin CH: Frontal variant of Alzheimer’s disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review. Brain and Behavior 2020, 10(3):e01548.
- Li F, Taylor E, Yeung I, Jaffray D, Metser U, Dhani N, Hedley DW, Lee T-Y: Pharmacokinetic Analysis of Dynamic [18F] FAZA PET Imaging in Pancreatic Cancer Patient. 2020.
- Li J, Joseph T, Ghorbani Asl M, Kolekar S, Krasheninnikov A, Batzill M: Publications Repository-Helmholtz-Zentrum Dresden-Rossendorf. Physical Review B 2020, 101:054438.
- Li LLL, Kuo H-T, Wang X, Merkens H, Colpo N, Radchenko V, Schaffer P, Lin K-S, Benard F, Orvig C: tBu4octapa-alkyl-NHS for Metalloradiopeptide Preparation. Dalton Transactions 2020.
- Li M-H, Chang H-C, Feng C-F, Yu H-W, Shiue C-Y: Synthesis and Evaluation of 18F-INER-1577-3 as a Central Nervous System (CNS) Histone Deacetylase Imaging Agent. Current Medical Imaging 2020, 16(8):978-990.
- Li S, Daamen M, Scheef L, Gaertner FC, Buchert R, Buchmann M, Buerger K, Catak C, Dobisch L, Drzezga A et al: Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status. J Alzheimers Dis 2020.
- Li W, Wang Y, Rubins D, Bennacef I, Holahan M, Haley H, Purcell M, Gantert L, Hseih S, Judo M: PET/CT Imaging of 89 Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys. Molecular Imaging and Biology 2020:1-10.
- Liapis V, Tieu W, Rudd SE, Donnelly PS, Wittwer NL, Brown MP, Staudacher AH: Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®. EJNMMI radiopharmacy and chemistry 2020, 5(1):1-15.
- Liapis V, Tieu W, Wittwer N, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH: Positron Emission Tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models. 2020.
- Lien VT, Celen S, Nuruddin S, Attili B, Doumont G, Van Simaeys G, Bormans G, Klaveness J, Olberg DE: Preclinical evaluation of [18F] cabozantinib as a PET imaging agent in a prostate cancer mouse model. Nuclear Medicine and Biology 2020.
- Lin H-C, Chan S-C, Cheng N-M, Liao C-T, Hsu C-L, Wang H-M, Lin C-Y, Chang JT-C, Ng S-H, Yang L-Y: Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma. Oral Oncology 2020, 104:104628.
- Lin S-H, Chi MH, Lee IH, Chen KC, Tai YC, Yao WJ, Chiu NT, Yang D-Y, Lin C-Y, Chen PS: A pilot study on the association between the blood oxygen level-dependent signal in the reward system and dopamine transporter availability in adults with attention deficit hyperactivity disorder. CNS spectrums 2020:1-8.
- Lindemann M, Moldovan R-P, Hinz S, Deuther-Conrad W, Gündel D, Dukic-Stefanovic S, Toussaint M, Teodoro R, Juhl C, Steinbach J: Development of a Radiofluorinated Adenosine A2B Receptor Antagonist as Potential Ligand for PET Imaging. International journal of molecular sciences 2020, 21(9):3197.
- Lindner T, Stenzel J, Koslowski N, Hohn A, Glass Ä, Schwarzenböck SM, Krause BJ, Vollmar B, Reisinger EC, Sombetzki M: Anatomical MRI and [18 F] FDG PET/CT imaging of Schistosoma mansoni in a NMRI mouse model. Scientific Reports 2020, 10(1):1-11.
- Little P: Penumbra oxygen metabolism and acute neuroinflammation in ischemic stroke: MRI and PET imaging of a M2 occlusion model in rat. 2020.
- Liu R, Umbach DM, Tröster AI, Huang X, Chen H: Non-motor symptoms and striatal dopamine transporter binding in early Parkinson’s disease. Parkinsonism & Related Disorders 2020, 72:23-30.
- Liu S, Li Y, Fan X, Li K, Xu C, Zhang L, Luo M, Wang L, Li R, Wu J: Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity. Adipocyte 2020, 9(1):170-178.
- Lobeek D, Rijpkema M, Terry S, Molkenboer-Kuenen J, Joosten L, van Genugten E, van Engen-van Grunsven A, Kaanders J, Pegge S, Boerman O: Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68 Ga] Ga-DOTA-E-[c (RGDfK)] 2 PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-9.
- Lohmann P, Elahmadawy MA, Gutsche R, Werner J-M, Bauer EK, Ceccon G, Kocher M, Lerche CW, Rapp M, Fink GR: FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation. Cancers 2020, 12(12):3835.
- London ED, Okita K, Kinney KR, Dean AC, McClintick MN, Rizor EJ, Johnson MC, Mahmoudie T, Brody AL, Nurmi EL: No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users. Drug and Alcohol Dependence 2020:108104.
- Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, Brendel M, Cumming P, Lu H, Xiao Z: Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism. Frontiers in neuroscience 2020, 14:604.
- Lu J, Bao W, Li M, Li L, Zhang Z, Song J, Alberts I, Brendel M, Cumming P, Zuo C: Study of Tau Deposition in Patients of Alzheimer’s Disease with [18F]-APN-1607 PET tracer and Its Relationship with Cerebral Glucose Metabolism. Journal of Nuclear Medicine 2020, 61(supplement 1):1549-1549.
- Lu S, Haskali MB, Ruley KM, Dreyfus NJ-F, DuBois SL, Paul S, Liow J-S, Morse CL, Kowalski A, Gladding RL: PET ligands [18F] LSN3316612 and [11C] LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain. Science Translational Medicine 2020, 12(543).
- Lubberink M, Eriksson O: [11C] 5-Hydroxy-tryptophan model for quantitative assessment of in vivo serotonin biosynthesis, retention and degradation in the endocrine pancreas. American Journal of Nuclear Medicine and Molecular Imaging 2020, 10(5):226.
- Lukas M, Kluge A, Beindorff N, Brenner W: Multi-Isotope Capabilities of a Small-Animal Multi-Pinhole SPECT System. Journal of Nuclear Medicine 2020, 61(1):152-161.
- Lundsten S, Spiegelberg D, Raval NR, Nestor M: The radiosensitizer Onalespib increases complete remission in 177 Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
- MacAskill MG, McDougald W, Alcaide-Corral C, Newby DE, Tavares AA, Hadoke PW, Wu J: Characterisation of an atherosclerotic micro-calcification model using ApoE−/− mice and PET/CT. International Journal of cardiology Heart & Vasculature 2020, 31.
- MacAskill MG, Stadulyte A, Williams L, Morgan TE, Sloan NL, Alcaide-Corral CJ, Walton T, Wimberley C, McKenzie C-A, Spath NB: Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism. Journal of Nuclear Medicine 2020:jnumed. 120.243600.
- Mahmud FJ, Du Y, Greif E, Boucher T, Dannals RF, Mathews WB, Pomper MG, Sysa-Shah P, Pate KAM, Lyons C: Osteopontin/Secreted Phosphoprotein-1 Behaves as a Molecular Brake Regulating the Brain Translocator Protein-Dependent Neuroinflammatory Response to Chronic Viral Infection. 2020.
- Mahmud FJ, Du Y, Greif E, Boucher T, Dannals RF, Mathews WB, Pomper MG, Sysa-Shah P, Pate KAM, Lyons C: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection. Journal of neuroinflammation 2020, 17(1):1-16.
- Malbert CH, Chauvin A, Horowitz M, Jones KL: Pancreatic GLP-1r binding potential is reduced in insulin-resistant pigs. BMJ Open Diabetes Res Care 2020, 8(2).
- Malbert CH, Chauvin A, Horowitz M, Jones KL: Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals. Diabetes 2021, 70(1):99-110.
- Malviya G, Patel R, Salji M, Martinez RS, Repiscak P, Mui E, Champion S, Mrowinska A, Johnson E, AlRasheedi M: 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. EJNMMI research 2020, 10(1):1-10.
- Mancebo DG, Becerro AI, Corral A, García-Embid S, Balcerzyk M, García ML, Jesús M, Ocaña M: Design of a nanoprobe for high field magnetic resonance imaging, dual energy X-ray computed tomography and luminescent imaging. Journal of Colloid and Interface Science 2020.
- Mandrup CM, Roland CB, Egelund J, Nyberg M, Enevoldsen LH, Kjaer A, Clemmensen A, Christensen AN, Suetta C, Frikke-Schmidt R: Effects of High-Intensity Exercise Training on Adipose Tissue Mass, Glucose Uptake and Protein Content in Pre-and Post-menopausal Women. Frontiers in Sports and Active Living 2020, 2.
- Manell E: Refinement of porcine models in diabetes and transplantation research. 2020.
- Manza P, Wiers CE, Shokri-Kojori E, Kroll D, Feldman D, Schwandt M, Wang G-J, Tomasi D, Volkow ND: Brain Network Segregation and Glucose Energy Utilization: Relevance for Age-Related Differences in Cognitive Function. Cerebral Cortex 2020, 30(11):5930-5942.
- Maredziak M, Bengs S, Portmann A, Haider A, Wijnen WJ, Warnock GI, Etter D, Froehlich S, Fiechter M, Meisel A: Microvascular dysfunction and sympathetic hyperactivity in women with supra-normal left ventricular ejection fraction (snLVEF). European Journal of Nuclear Medicine and Molecular Imaging 2020.
- Marie S, Hernández-Lozano I, Breuil L, Saba W, Novell A, Gennisson J-L, Langer O, Truillet C, Tournier N: Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc] mebrofenin Imaging in Rats. Pharmaceutics 2020, 12(6):486.
- Masaki Y, Kashiwagi Y, Rokugawa T, Ito M, Iimori H, Abe K: Pharmacological MRI responses of raclopride in rats: The relationship with D2 receptor occupancy and cataleptic behavior. Synapse 2020, 74(12):e22180.
- Masuoka T, Tateno A, Sakayori T, Tiger M, Kim W, Moriya H, Ueda S, Arakawa R, Okubo Y: Electroconvulsive Therapy Decreases Striatal Dopamine Transporter Binding in Patients with Depression: A Positron Emission Tomography Study with [18F] FE-PE2I. Psychiatry Research: Neuroimaging 2020:111086.
- Matsudaira T, Terada T, Obi T, Yokokura M, Takahashi Y, Ouchi Y: Coexistence of cerebral hypometabolism and neuroinflammation in the thalamo-limbic-brainstem region in young women with functional somatic syndrome. EJNMMI research 2020, 10(1):1-11.
- Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Nakamura S, Jinzaki M: Development of 68 Ga-labeled tin colloids for evaluating phagocytic function of Kupffer cells using preclinical PET imaging. Annals of Nuclear Medicine 2020, 34(11):807-814.
- Matsuyama K, Yamamoto Y, Sora I: Effect of Feru‐guard 100M on amyloid‐beta deposition in individuals with mild cognitive impairment. Psychogeriatrics 2020, 20(5):726-736.
- McDonald ES, Doot RK, Young AJ, Schubert EK, Tchou J, Pryma DA, Farwell MD, Nayak A, Ziober A, Feldman MD: Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine 2020, 61(5):665-670.
- McGregor M, Richer K, Ananth M, Thanos PK: The functional networks of a novel environment: Neural activity mapping in awake unrestrained rats using positron emission tomography. Brain and behavior 2020, 10(8):e01646.
- McNitt-Gray M, Napel S, Jaggi A, Mattonen S, Hadjiiski L, Muzi M, Goldgof D, Balagurunathan Y, Pierce L, Kinahan P: Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets. Tomography 2020, 6(2):118.
- Meabon JS, Cook DG, Yagi M, Terry GE, Cross DJ, Muzi M, Pagulayan KF, Logsdon AF, Schindler AG, Ghai V: Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure. Journal of the neurological sciences 2020, 417:117049.
- Mehta V, Bouchareb Y, Ramaswamy S, Ahmad A, Wodehouse T, Haroon A: Metabolic Imaging of Pain Matrix Using 18F Fluoro‐deoxyglucose Positron Emission Tomography/Computed Tomography for Patients Undergoing L2 Dorsal Root Ganglion Stimulation for Low Back Pain. Neuromodulation: Technology at the Neural Interface 2020, 23(2):222-233.
- Meyer M, Lamare F, Asselineau J, Foubert‐Samier A, Mazère J, Zanotti‐Fregonara P, Rizzo G, Delamarre A, Spampinato U, Rascol O: Brain 5‐HT1A Receptor Binding in Multiple System Atrophy: An [18F]‐MPPF PET Study. Movement Disorders 2020.
- Miceli A, Cossu V, Marini C, Castellani P, Raffa S, Donegani MI, Bruno S, Ravera S, Emionite L, Orengo AM: 18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress. International journal of molecular sciences 2020, 21(21):8154.
- Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR: Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity. Molecular psychiatry 2020, 25(9):2058-2069.
- Michalski K, Laubner K, Stoykow C, Omrane MA, Maecke HR, Seufert J, Goetz C, Meyer PT, Ruf J: Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT. Clinical Nuclear Medicine 2020, 45(7):519-524.
- Michalski K, Stoykow C, Bronsert P, Juhasz-Böss I, Meyer PT, Ruf J, Erbes T, Asberger J: Association between gastrin-releasing peptide receptor expression as assessed with [68Ga] Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer. Nuclear Medicine and Biology 2020.
- Miederer I, Wiegand V, Bausbacher N, Leukel P, Maus S, Hoffmann MA, Lutz B, Schreckenberger M: Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain. Frontiers in Neuroanatomy 2020, 14:95.
- Mihov Y, Treyer V, Akkus F, Toman E, Milos G, Ametamey SM, Johayem A, Hasler G: Metabotropic glutamate receptor 5 in bulimia nervosa. Scientific reports 2020, 10(1):1-10.
- Miyamoto M, Miyamoto T, Saitou J, Sato T: Longitudinal study of striatal aromatic l-amino acid decarboxylase activity in patients with idiopathic rapid eye movement sleep behavior disorder. Sleep Medicine 2020, 68:50-56.
- Miyaoka RS, Lehnert AL: Small animal PET: a review of what we have done and where we are going. Physics in Medicine & Biology 2020, 65(24):24TR04.
- Miyatake Y, Mishima Y, Tsutsumi R, Otani T, Suemasa N, Masumoto S, Kuroda M, Sakaue H: Assessment of insulin resistance in the skeletal muscle of mice using positron emission tomography/computed tomography imaging. Biochemical and Biophysical Research Communications 2020.
- Miyazaki T, Nakajima W, Hatano M, Shibata Y, Kuroki Y, Arisawa T, Serizawa A, Sano A, Kogami S, Yamanoue T: Visualization of AMPA receptors in living human brain with positron emission tomography. Nature medicine 2020, 26(2):281-288.
- Mohamed-Ahmed S, Yassin MA, Rashad A, Espedal H, Idris SB, Finne-Wistrand A, Mustafa K, Vindenes H, Fristad I: Comparison of bone regenerative capacity of donor-matched human adipose–derived and bone marrow mesenchymal stem cells. Cell and Tissue Research 2020:1-15.
- Mohammed F, He X, Lin Y: An easy-to-use deep-learning model for highly accurate diagnosis of Parkinson’s disease using SPECT images. Computerized Medical Imaging and Graphics 2020, 87:101810.
- Moon ES, Elvas F, Vliegen G, De Lombaerde S, Vangestel C, De Bruycker S, Bracke A, Eppard E, Greifenstein L, Klasen B: Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators. 2020.
- Moriguchi S, Takahata K, Shimada H, Kubota M, Kitamura S, Kimura Y, Tagai K, Tarumi R, Tabuchi H, Meyer JH et al: Excess tau PET ligand retention in elderly patients with major depressive disorder. Molecular Psychiatry 2020.
- Moriya H, Tiger M, Tateno A, Sakayori T, Masuoka T, Kim W, Arakawa R, Okubo Y: Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression. Psychiatry and Clinical Neurosciences 2020.
- Mosley M, Torres JB, Allen D, Cornelissen B: Immuno-imaging of ICAM-1 in tumours by SPECT. Nuclear Medicine and Biology 2020.
- Mu L, Krämer SD, Warnock GI, Haider A, Bengs S, Cartolano G, Bräm DS, Keller C, Schibli R, Ametamey SM: [11 C] mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [18 F] LMI1195 uptake is NET-independent. EJNMMI research 2020, 10(1):1-12.
- Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A: Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study. Journal of Nuclear Medicine 2020, 61(6):911-919.
- Nagachinta S, Becker G, Dammicco S, Serrano ME, Leroi N, Bahri MA, Plenevaux A, Lemaire C, Lopez R, Luxen A: Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces 2020, 188:110793.
- Nagai Y, Miyakawa N, Takuwa H, Hori Y, Oyama K, Ji B, Takahashi M, Huang X-P, Slocum ST, DiBerto JF: Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. Nature neuroscience 2020, 23(9):1157-1167.
- Nakaoka T, Uetake Y, Kaneko K-i, Niwa T, Ochiai H, Irie S, Suezaki Y, Otsuka N, Hayashinaka E, Wada Y: Practical synthesis of [18F] pitavastatin and evaluation of hepatobiliary transport activity in rats by positron emission tomography. Molecular Pharmaceutics 2020.
- Nakashima K, Iikuni S, Okada Y, Watanabe H, Shimizu Y, Nakamoto Y, Ono M: Synthesis and Evaluation of 68Ga-labeled Imidazothiadiazole Sulfonamide Derivatives for PET Imaging of Carbonic Anhydrase-IX. Nuclear Medicine and Biology 2020.
- Nascimento Dos Santos S, Zhang Z, Turato M, Chammas R, Lin K, Carvalho I: Synthesis and Evaluation of [18F] FEtLos and [18F] AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors. Molecules (Basel, Switzerland) 2020, 25(8).
- Nedelcu J, Reinbach C, Riedler P, Brendel M, Rominger A, Kaye J, Behrangi N, Jiangshan Z, Schmitz C, Kipp M: Laquinimod ameliorates secondary brain inflammation. Neurobiology of disease 2020, 134:104675.
- Neth BJ, Mintz A, Whitlow C, Jung Y, Sai KS, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J: Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: A pilot study. Neurobiology of aging 2020, 86:54-63.
- Neveu M-A, Beziere N, Daniels R, Bouzin C, Comment A, Schwenck J, Fuchs K, Kneilling M, Pichler BJ, Schmid AM: Lactate Production Precedes Inflammatory Cell Recruitment in Arthritic Ankles: an Imaging Study. Molecular Imaging and Biology 2020.
- Nicolas CT, Kaiser RA, Hickey RD, Allen KL, Du Z, VanLith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B: Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver Failure. Molecular Therapy-Methods & Clinical Development 2020, 18:738-750.
- Nikolaus S, Beu M, Wittsack H-J, Müller-Lutz A, Antke C, Hautzel H, Mori Y, Mamlins E, Antoch G, Müller H-W: GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat. Reviews in the Neurosciences 2020, 1(ahead-of-print).
- Niñerola-Baizán A, Aguiar P, Cabrera-Martín M, Vigil C, Gómez-Grande A, Lorenzo C, Rubí S, Sopena P, Camacho V: Relevancia de la cuantificación en los estudios PET cerebrales con 18F-FDG. Revista Española de Medicina Nuclear e Imagen Molecular 2020.
- Nishibe H, Tateno A, Sakayori T, Yamamoto M, Kim W, Kakuyama H, Okubo Y: Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia. International Journal of Neuropsychopharmacology 2020.
- Niu N, Xing H, Wang X, Ding J, Hao Z, Ren C, Ba J, Zheng L, Fu C, Zhao H: Comparative [18F] FDG and [18F] DPA714 PET imaging and time-dependent changes of brown adipose tissue in tumor-bearing mice. Adipocyte 2020, 9(1):542-549.
- Nomura S, Takahashi M, Kato AH, Wada Y, Watanabe Y, Yamashita F, Mukai H: Biosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography. International Journal of Pharmaceutics 2020, 590:119950.
- Novy Z, Lobaz V, Vlk M, Kozempel J, Stepanek P, Popper M, Vrbkova J, Hajduch M, Hruby M, Petrik M: Head-To-Head Comparison of Biological Behavior of Biocompatible Polymers Poly (Ethylene Oxide), Poly (2-Ethyl-2-Oxazoline) and Poly [N-(2-Hydroxypropyl) Methacrylamide] as Coating Materials for Hydroxyapatite Nanoparticles in Animal Solid Tumor Model. Nanomaterials 2020, 10(9):1690.
- Nugent S, Croteau E, Potvin O, Castellano C-A, Dieumegarde L, Cunnane SC, Duchesne S: Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer’s disease. Scientific Reports 2020, 10(1):1-8.
- Núñez Álvarez NO, Cussó F, Cantelar E, Martín Gracia B, Martínez de la Fuente J, Corral Sousa A, Balcerzyk M, Ocaña Jurado M: Bimodal Nd-Doped LuVO4 Nanoprobes Functionalized with Polyacrilic Acid for X-Ray Computed Tomography and NIR Luminescent Imaging. 2020.
- Nuñez NO, Cussó F, Cantelar E, Martin-Gracia B, de la Fuente JM, Corral A, Balcerzyk M, Ocaña M: Bimodal Nd-Doped LuVO4 Nanoprobes Functionalized with Polyacrilic Acid for X-Ray Computed Tomography and NIR Luminescent Imaging. Nanomaterials 2020, 10(1):149.
- O’Farrell AC, Jarzabek MA, Lindner AU, Carberry S, Conroy E, Miller IS, Connor K, Shiels L, Zanella ER, Lucantoni F: Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. Cancers 2020, 12(10):2978.
- O’Neill E, Kersemans V, Allen PD, Terry SY, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA: Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. Journal of Nuclear Medicine 2020, 61(5):743-750.
- Obokata N, Seki C, Hirata T, Maeda J, Ishii H, Nagai Y, Matsumura T, Takakuwa M, Fukuda H, Minamimoto T: Synthesis and preclinical evaluation of [11C] MTP38 as a novel PET ligand for phophodiesterase 7 in the brain. bioRxiv 2020.
- Ogata A, Kimura Y, Ikenuma H, Yamada T, Abe J, Koyama H, Suzuki M, Ichise M, Kato T, Ito K: Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents. Nuclear Medicine and Biology 2020.
- Oh SJ, Ahn H, Jung K-H, Han SJ, Nam KR, Kang KJ, Park J-A, Lee KC, Lee YJ, Choi JY: Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson’s Animal Model. Molecular Imaging and Biology 2020:1-12.
- Oh SJ, Lee H-J, Jeong YJ, Nam KR, Kang KJ, Han SJ, Lee KC, Lee YJ, Choi JY: evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging. Scientific Reports 2020, 10(1):1-9.
- Okazawa H, Ikawa M, Tsujikawa T, Makino A, Mori T, Kiyono Y, Kosaka H: Noninvasive Measurement of [11C] PiB Distribution Volume Using Integrated PET/MRI. Diagnostics 2020, 10(12):993.
- Ono M, Takahashi M, Shimozawa A, Fujinaga M, Mori W, Nagai Y, Mimura K, Minamihisamatsu T, Uchida S, Shimojo M: In vivo visualization of propagating α-synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05. bioRxiv 2020.
- Ordonez AA, Wang H, Magombedze G, Ruiz-Bedoya CA, Srivastava S, Chen A, Tucker EW, Urbanowski ME, Pieterse L, Cardozo EF: Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions. Nature medicine 2020, 26(4):529-534.
- Ote K, Hashimoto F, Kakimoto A, Isobe T, Inubushi T, Ota R, Tokui A, Saito A, Moriya T, Omura T: Kinetics-Induced Block Matching and 5-D Transform Domain Filtering for Dynamic PET Image Denoising. IEEE Transactions on Radiation and Plasma Medical Sciences 2020, 4(6):720-728.
- Ott J, Spilhaug MM, Maschauer S, Rafique W, Jakobsson JE, Hartvig K, Hübner H, Gmeiner P, Prante O, Riss PJ: Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with 18F-Labeled Derivatives in Rats. Journal of medicinal chemistry 2020, 63(17):9484-9499.
- Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis KA, Carlisle R: Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release 2020, 319:222-233.
- Pak K, Seo S, Kim K, Lee MJ, Shin MJ, Suh S, Im HJ, Park JJ, Kim SJ, Kim IJ: Striatal dopamine transporter changes after glucose loading in humans. Diabetes, Obesity and Metabolism 2020, 22(1):116-122.
- Palomar-Bonet M, Atienza M, Cantero JL: Blood total antioxidant status is associated with cortical glucose uptake and factors related to accelerated aging. Brain Structure and Function 2020, 225(2):841-851.
- Pan Y-R, Wu C-E, Chen M-H, Huang W-K, Shih H-J, Lan K-L, Yeh C-N: Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model. Vaccines 2020, 8(4):703.
- Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, Smart S, Gilchrist S, Gouverneur V, Sibson NR: Imaging of translocator protein upregulation is selective for pro‐inflammatory polarized astrocytes and microglia. Glia 2020, 68(2):280-297.
- Parente A, Maciel ES, JO Dierckx RA, Langendijk JA, de Vries EF, Doorduin J: Delayed effects of a single-dose whole-brain radiation therapy on glucose metabolism and myelin density: a longitudinal PET study. International Journal of Radiation Biology 2020, 96(9):1135-1143.
- Park B-N, Kim J-H, Lim TS, Park SH, Kim T-G, Yoon BS, Son KS, Yoon J-K, An Y-S: Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer’s disease evaluated by β-amyloid positron emission tomography imaging. Australian & New Zealand Journal of Psychiatry 2020:0004867420917467.
- Park HS, Song YS, Moon BS, Yoo S-E, Lee JM, Chung Y-T, Kim E, Lee BC, Kim SE: Neurorestorative Effects of a Novel Fas-Associated Factor 1 Inhibitor in the MPTP Model: An [18F] FE-PE2I Positron Emission Tomography Analysis Study. Frontiers in Pharmacology 2020, 11:953.
- Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu M, Spann B, Román GC, Schulz PE, Karmonik C: Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network. Journal of Nuclear Medicine 2020, 61(2):263-269.
- Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G: [18 F] AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68 Ga] Ga-DOTATATE in neuroendocrine tumour patients. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(13):3033-3046.
- Pellegrin M, Bouzourène K, Aubert J-F, Bielmann C, Gruetter R, Rosenblatt-Velin N, Poitry-Yamate C, Mazzolai L: Impact of aerobic exercise type on blood flow, muscle energy metabolism, and mitochondrial biogenesis in experimental lower extremity artery disease. Scientific reports 2020, 10(1):1-14.
- Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Pfister J, Mair C, Novy Z, Popper M, Hajduch M: 68 Ga-labelled desferrioxamine-B for bacterial infection imaging. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
- Petropoulou P-I, Mosialou I, Shikhel S, Hao L, Panitsas K, Bisikirska B, Luo N, Bahna F, Kim J, Carberry P: Lipocalin-2 is an anorexigenic signal in primates. Elife 2020, 9:e58949.
- Pfister J, Summer D, Petrik M, Khoylou M, Lichius A, Kaeopookum P, Kochinke L, Orasch T, Haas H, Decristoforo C: Hybrid imaging of Aspergillus fumigatus pulmonary infection with fluorescent, 68Ga-labelled siderophores. Biomolecules 2020, 10(2):168.
- Pinterić M, Podgorski II, Hadžija MP, Bujak IT, Dekanić A, Bagarić R, Farkaš V, Sobočanec S, Balog T: Role of Sirt3 in Differential Sex-Related Responses to a High-Fat Diet in Mice. Antioxidants 2020, 9(2):174.
- Polinder-Bos HA, Elting JWJ, Aries MJ, García DV, Willemsen AT, van Laar PJ, Kuipers J, Krijnen WP, Slart RH, Luurtsema G: Changes in cerebral oxygenation and cerebral blood flow during hemodialysis–A simultaneous near-infrared spectroscopy and positron emission tomography study. Journal of Cerebral Blood Flow & Metabolism 2020, 40(2):328-340.
- Possner M, Buechel RR, Vontobel J, Mikulicic F, Gräni C, Benz DC, Clerc OF, Fuchs TA, Tobler D, Stambach D: Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries. International Journal of Cardiology 2020, 299:110-115.
- Potemkin R, Strauch B, Kuwert T, Prante O, Maschauer S: Development of 18F-fluoroglycosylated PSMA-ligands with improved renal clearance behavior. Molecular Pharmaceutics 2020, 17(3):933-943.
- Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU: Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus. Movement Disorders 2020.
- Puig O, Henriksen OM, Vestergaard MB, Hansen AE, Andersen FL, Ladefoged CN, Rostrup E, Larsson HB, Lindberg U, Law I: Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states. Journal of Cerebral Blood Flow & Metabolism 2020, 40(8):1621-1633.
- Purup MM, Knudsen K, Karlsson P, Terkelsen AJ, Borghammer P: Skin Temperature in Parkinson’s Disease Measured by Infrared Thermography. Parkinson’s Disease 2020, 2020.
- Pyo A, Kim D-Y, Kim H, Lim D, Kwon SY, Kang S-R, Kim H-S, Bom H-S, Min J-J: Ultrasensitive detection of malignant melanoma using PET molecular imaging probes. Proceedings of the National Academy of Sciences 2020, 117(23):12991-12999.
- Quelven I, Monteil J, Sage M, Saidi A, Mounier J, Bayout A, Garrier J, Cogne M, Durand-Panteix S: 212Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study. Journal of Nuclear Medicine 2020, 61(7):1058-1065.
- Quevenco FC, van Bergen JM, Treyer V, Studer ST, Kagerer SM, Meyer R, Gietl AF, Kaufmann PA, Nitsch RM, Hock C: Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4. Frontiers in Aging Neuroscience 2020, 12:46.
- Quirino TdC, Ortolan LdS, Sercundes MK, Marinho CRF, Turato WM, Epiphanio S: Lung aeration in experimental malaria-associated acute respiratory distress syndrome by SPECT/CT analysis. Plos one 2020, 15(5):e0233864.
- Rey-Bretal D, Moscoso A, Gómez-Lado N, Fernández-Ferreiro A, Silva-Rodríguez J, Ruibal Á, Aguiar P: Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats. Molecular Imaging and Biology 2020:1-11.
- Rhodes S, Batzdorf A, Sorci O, Peng M, Jankelovits A, Hornyak J, An J, Noël PB, Høilund-Carlsen PF, Alavi A: Assessment of femoral neck bone metabolism using 18F-sodium fluoride PET/CT imaging. Bone 2020:115351.
- Rodríguez-Chinchilla T, Quiroga-Varela A, Molinet-Dronda F, Belloso-Iguerategui A, Merino-Galan L, Jimenez-Urbieta H, Gago B, Rodriguez-Oroz MC: [18 F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
- Rosa Fois G, Valla C, Jouberton E, Sas N, Billoux T, Auzeloux P, Cachin F, Miot‐Noirault E, Maigne L: Internal dosimetry of [99mTc] NTP15‐5 radiotracer for cartilage imaging in preclinical and clinical models using the GATE Monte Carlo platform. Medical Physics 2020.
- Rosar F, Buchholz H-G, Michels S, Hoffmann MA, Piel M, Waldmann CM, Rösch F, Reuss S, Schreckenberger M: Image quality analysis of 44 Sc on two preclinical PET scanners: a comparison to 68 Ga. EJNMMI physics 2020, 7(1):1-17.
- Rosestedt M, Velikyan I, Rosenström U, Estrada S, Åberg O, Weis J, Westerlund C, Ingvast S, Korsgren O, Nordeman P: Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nuclear Medicine and Biology 2020, 93:54-62.
- Ruivo E, Elvas F, Adhikari K, Vangestel C, Van Haesendonck G, Lemière F, Staelens S, Stroobants S, Van der Veken P, Wyffels L: Preclinical Evaluation of a Novel 18F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging. ACS omega 2020, 5(9):4449-4456.
- Ruiz-Bedoya CA, Ordonez AA, Werner RA, Plyku D, Klunk MH, Leal J, Lesniak WG, Holt DP, Dannals RF, Higuchi T: 11C-PABA as a Novel PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Studies. Journal of Nuclear Medicine 2020:jnumed. 119.239806.
- Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveillé A, Capet M, Duvauchelle T, Schwartz JC, Robert P: Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET. British Journal of Pharmacology 2020.
- Sachpekidis C, Kopp-Schneider A, Merz M, Jauch A, Raab M-S, Goldschmidt H, Dimitrakopoulou-Strauss A: Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma? Cancers 2020, 12(5):1335.
- Sadeghzadeh M, Wenzel B, Gündel D, Deuther-Conrad W, Toussaint M, Moldovan R-P, Fischer S, Ludwig F-A, Teodoro R, Jonnalagadda S: Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging. Molecules 2020, 25(10):2309.
- Sahylí Ortega Pijeira M, Sérgio Gonçalves Nunes P, Nascimento dos Santos S, Zhang Z, Pérez Nario A, Araujo Perini E, Miguel Turato W, Rodríguez Riera Z, Chammas R, H Elsinga P: Synthesis and Evaluation of [18F] FEtLos and [18F] AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors. Molecules 2020, 25(8):1872.
- Sakayori T, Tateno A, Arakawa R, Kim W-c, Okubo Y: Evaluation of dopamine D 3 receptor occupancy by blonanserin using [11 C]-(+)-PHNO in schizophrenia patients. Psychopharmacology 2020:1-8.
- Samimi R, Kamali-Asl A, Geramifar P, van den Hoff J, Rahmim A: Short-duration dynamic FDG PET imaging: Optimization and clinical application. Physica Medica 2020, 80:193-200.
- Sanaat A, Arabi H, Mainta I, Garibotto V, Zaidi H: Projection-space implementation of deep learning-guided low-dose brain PET imaging improves performance over implementation in image-space. Journal of Nuclear Medicine 2020:jnumed. 119.239327.
- Sánchez Sánchez de Rojas L: Reparación de daño cerebral mediante biomateriales y terapia celular: estudio experimental. 2020.
- Sang Z, Wang K, Bai P, Wu A, Shi J, Liu W, Zhu G, Wang Y, Lan Y, Chen Z: Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry 2020:112265.
- Sato T, Furuta T, Liu Y, Naka S, Nagamori S, Kanai Y, Watabe T: Individual Dosimetry System for Targeted Alpha Therapy Based on PHITS Coupled with Microdosimetric Kinetic Model. 2020.
- Schaffernicht G, Shang Q, Stievenard A, Bötzel K, Dening Y, Kempe R, Toussaint M, Gündel D, Kranz M, Reichmann H: Physiological and pathological changes in the enteric nervous system of rotenone-exposed mice as potential early biomarkers for Parkinson’s disease. bioRxiv 2020.
- Schidlitzki A, Bascuñana P, Srivastava PK, Welzel L, Twele F, Töllner K, Käufer C, Gericke B, Feleke R, Meier M: Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy. Neurobiology of Disease 2020, 134:104664.
- Schmidt E, Schinke C, Rullmann M, Luthardt J, Becker G-A, Haars S, Stoppe M, Lobsien D, Hoffmann K-T, Sabri O: Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients. Scientific Reports 2020, 10(1):1-9.
- Schmidt ME, Janssens L, Moechars D, Rombouts FJ, Timmers M, Barret O, Constantinescu CC, Madonia J, Russell DS, Sandiego CM: Clinical evaluation of [18 F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
- Schneider D, Oskamp A, Holschbach M, Neumaier B, Bier D, Bauer A: Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor. Nuclear Medicine and Biology 2020, 82:1-8.
- Schröder S, Lai TH, Toussaint M, Kranz M, Chovsepian A, Shang Q, Dukić-Stefanović S, Deuther-Conrad W, Teodoro R, Wenzel B: PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [18F] FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy. Molecules 2020, 25(7):1633.
- Sekine T, Buck A, Delso G, Kemp B, ter Voert EE, Huellner M, Veit-Haibach P, Kaushik S, Wiesinger F, Warnock G: The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases—A simulation study combining multi-center data and ADNI-data. Plos one 2020, 15(6):e0233886.
- Serrano ME, Bahri MA, Becker G, Seret A, Germonpré C, Lemaire C, Giacomelli F, Mievis F, Luxen A, Salmon E: Exploring with [18 F] UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular imaging and biology 2020:1-11.
- Shah S, Sinharay S, Matsuda K, Schreiber-Stainthorp W, Muthusamy S, Lee D, Wakim P, Hirsch V, Nath A, Di Mascio M: 11C-DASB PET. Identifying Neuroimaging-Based Markers for Distinguishing Brain Disorders 2020.
- Shalgunov V, Xiong M, L’Estrade ET, Raval NR, Andersen IV, Edgar FG, Speth NR, Baerentzen SL, Hansen HD, Donovan LL: Blocking of efflux transporters in rats improves translational validation of brain radioligands. EJNMMI research 2020, 10(1):1-11.
- Shannon AH, Chordia MD, Spinosa MD, Su G, Ladd Z, Pan D, Upchurch Jr GR, Sharma AK: Single-Photon Emission Computed Tomography Imaging Using Formyl Peptide Receptor 1 Ligand Can Diagnose Aortic Aneurysms in a Mouse Model. journal of surgical research 2020, 251:239-247.
- Shiiba T, Arimura Y, Nagano M, Takahashi T, Takaki A: Improvement of classification performance of Parkinson’s disease using shape features for machine learning on dopamine transporter single photon emission computed tomography. PloS one 2020, 15(1):e0228289.
- Shimada H, Minatani S, Takeuchi J, Takeda A, Kawabe J, Wada Y, Mawatari A, Watanabe Y, Shimada H, Higuchi M: Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation. International journal of molecular sciences 2020, 21(12):4443.
- Shimojo M, Takuwa H, Takado Y, Tokunaga M, Tsukamoto S, Minatohara K, Ono M, Seki C, Maeda J, Urushihata T: Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model. Journal of Neuroscience 2020, 40(17):3491-3501.
- Shimokawa N, Akamatsu G, Kadosaki M, Sasaki M: Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation. Ann Nucl Med 2020, 34(9):629-635.
- Shin S, Nam H-Y, Lee MJ, Pak K, Kim K, Kim IJ: Effect of sex on aging-related decline of dopamine transporter in healthy subjects. Annals of Nuclear Medicine 2020:1-7.
- Shin U, Kim J, Lee J, Park D, Lee C, Jung HC, Park J, Lee K, Lee MW, Kim SW: Development of 64Cu-loaded Perfluoropentane Nanodroplet: A Potential Tumor Theragnostic Nano-carrier and Dual-Modality PET-Ultrasound Imaging Agents. Ultrasound in Medicine & Biology 2020, 46(10):2775-2784.
- Shinotoh H, Hirano S, Shimada H: PETImagingofAcetylcholinesterase 7. PET and SPECT of Neurobiological Systems 2020:193.
- Shrestha S, Kim M-J, Eldridge M, Lehmann ML, Frankland M, Liow J-S, Yu Z-X, Cortes-Salva M, Telu S, Henter ID: PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. Journal of Neuroinflammation 2020, 17:1-17.
- Shrestha UM, Sciammarella M, Pampaloni MH, Botvinick EH, Gullberg GT, DeMarco T, Seo Y: Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82 Rb PET. The International Journal of Cardiovascular Imaging 2020:1-12.
- Singhal T, Cicero S, Pan H, Carter K, Dubey S, Chu R, Glanz B, Hurwitz S, Tauhid S, Park M-A: Regional microglial activation in the substantia nigra is linked with fatigue in MS. Neurology-Neuroimmunology Neuroinflammation 2020, 7(5).
- Smith R, Schöll M, Leuzy A, Jögi J, Ohlsson T, Strandberg O, Hansson O: Head-to-head comparison of tau positron emission tomography tracers [18 F] flortaucipir and [18 F] RO948. European journal of nuclear medicine and molecular imaging 2020, 47(2):342-354.
- Smyczyńska U, Strzemecki D, Czarnecka AM, Fendler W, Fiedorowicz M, Wełniak-Kamińska M, Guzowska M, Synoradzki K, Cheda Ł, Rogulski Z: TP53-Deficient Angiosarcoma Expression Profiling in Rat Model. Cancers 2020, 12(6):1525.
- Snitz BE, Tudorascu DL, Yu Z, Campbell E, Lopresti BJ, Laymon CM, Minhas DS, Nadkarni NK, Aizenstein HJ, Klunk WE: Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12018.
- Son Y, Jeong YJ, Shin N-R, Oh SJ, Nam KR, Choi H-D, Choi JY, Lee H-J: Inhibition of colony-stimulating factor 1 Receptor by PLX3397 prevents amyloid beta pathology and rescues dopaminergic signaling in aging 5xFAD mice. International journal of molecular sciences 2020, 21(15):5553.
- Souza Vieira S, Antonio EL, de Melo BL, Neves dos Santos LF, Santana ET, Feliciano R, Marques FLN, de Paula Faria D, Buchpiguel CA, Silva JA: Increased Myocardial Retention of Mesenchymal Stem Cells Post-MI by Pre-Conditioning Exercise Training. Stem Cell Reviews and Reports 2020:1-12.
- Spath N, Tavares A, Gray GA, Baker AH, Lennen RJ, Alcaide-Corral CJ, Dweck MR, Newby DE, Yang PC, Jansen MA: Manganese-enhanced T 1 mapping to quantify myocardial viability: validation with 18 F-fluorodeoxyglucose positron emission tomography. Scientific Reports 2020, 10(1):1-10.
- Squarzoni P, Faria DdP, Yassuda MS, Porto FHdG, Coutinho AM, Costa NAd, Nitrini R, Forlenza OV, Duran FLdS, Brucki SMD: Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects. Journal of Alzheimer’s Disease 2020(Preprint):1-16.
- Stær K, Iranzo A, Stokholm MG, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Santamaria J: Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder. Parkinsonism & Related Disorders 2020, 81:89-93.
- Stanford D, Kim H, Bodduluri S, LaFontaine J, Byzek SA, Schoeb TR, Harris ES, Nath HP, Bhatt SP, Raju SV: Airway Remodeling in Ferrets with Cigarette Smoke Induced COPD using µCT Imaging. American Journal of Physiology-Lung Cellular and Molecular Physiology 2020.
- Staudacher AH, Liapis V, Tieu W, Wittwer NL, Brown MP: Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody. Journal of Controlled Release 2020, 327:779-787.
- Stegmayr C, Surges R, Choi C-H, Burda N, Stoffels G, Filß C, Willuweit A, Neumaier B, Heinzel A, Shah NJ: Investigation of Cerebral O-(2-[18 F] Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models. Molecular imaging and biology 2020.
- Stojakovic A, Chang S-Y, Nesbitt J, Pichurin NP, Ostroot MA, Aikawa T, Kanekiyo T, Trushina E: Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice. Journal of Alzheimer’s Disease 2020(Preprint):1-19.
- Strähl M, Schindler M, Keller LS, Holy E, Jakob P, Siegrist PT, Templin C, Maier W, Buechel RR, Kaufmann PA: Diagnostic performance of angiography-based quantitative flow ratio for the identification of myocardial ischemia as assessed by 13N-ammonia myocardial perfusion imaging positron emission tomography. International Journal of Cardiology 2020.
- Stutvoet TS, van der Veen EL, Kol A, Antunes IF, de Vries EF, Hospers GA, de Vries EG, de Jong S, Lub-de Hooge MN: Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer 18F-BMS-986192. Journal of Nuclear Medicine 2020:jnumed. 119.241364.
- Sullivan KJ, Liu A, Chang C-CH, Cohen AD, Lopresti BJ, Minhas DS, Laymon CM, Klunk WE, Aizenstein H, Nadkarni NK: Alzheimer’s disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study. Brain Imaging and Behavior 2020:1-9.
- Suurs FV, Lorenczewski G, Stienen S, Friedrich M, de Vries EG, De Groot DJA, Lub-de Hooge MN: Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm. Journal of Nuclear Medicine 2020:jnumed. 120.241877.
- Švec P, Nový Zk, Kučka J, Petřík M, Sedláček Oe, Kuchař M, Lišková B, Medvedíková M, Kolouchová Kn, Groborz Oe: Iodinated Choline Transport-Targeted Tracers. Journal of Medicinal Chemistry 2020.
- Svirydenka H, Muehlematter UJ, Nagel HW, Delso G, Ferraro DA, Kudura K, Burger IA, Ter Voert EE: 68 Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions. European Radiology 2020:1-10.
- Tada T, Ito Y, Murayama R, Tamura M, Tsutsumi Y, Kato K, Ochi Y, Ikeda H: Comparative Study of Various Reference Regions for Standardized Uptake Value Ratio Using11C-Pittsburgh Compound-B PET and MR Images. Journal of Nuclear Medicine 2020, 61(supplement 1):3099-3099.
- Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y: High-contrast in vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies. Neuron 2020.
- Tago T, Toyohara J, Ishii K: Radiosynthesis and preliminary evaluation of an 18F‐labeled tubastatin A analog for PET imaging of histone deacetylase 6. Journal of Labelled Compounds and Radiopharmaceuticals 2020, 63(2):85-95.
- Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N: Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice. npj Vaccines 2020, 5(1):1-11.
- Talalwa L, Natour G, Bauer A, Drzezga A, Beer S: Radiological characteristics of a new experimental rubber elastomeric polymer used in three-dimensional printing with different infill densities and patterns. Journal of Physics Communications 2020.
- Tang J: An approach for the in-vivo characterization of brain and heart inflammation in Duchenne Muscular Dystrophy. 2020.
- Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, Futatsubashi M, Tsukada H, Ouchi Y: In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology 2020, 94(15):e1592-e1604.
- Térence T, Cawthorne C, Kim S, Elin P, Willy G, Guy B, Deroose CM, Frederik C: Automated GMP compliant production of [18 F] AlF-NOTA-octreotide. EJNMMI Radiopharmacy and Chemistry 2020, 5(1).
- Thiele S, Sörensen A, Weis J, Braun F, Meyer PT, Coenen VA, Döbrössy MD: Deep Brain Stimulation of the Medial Forebrain Bundle in a Rodent Model of Depression: Exploring Dopaminergic Mechanisms with Raclopride and Micro-PET. Stereotactic and Functional Neurosurgery 2020, 98(1):8-20.
- Thomsen MB, Ferreira SA, Schacht AC, Jacobsen J, Simonsen M, Betzer C, Jensen PH, Brooks DJ, Landau AM, Romero-Ramos M: PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease 2020:105229.
- Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C] UCB-J PET. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20931140.
- Thomsen MB, Schacht AC, Alstrup AKO, Jacobsen J, Lillethorup TP, Bærentzen SL, Noer O, Orlowski D, Elfving B, Müller HK: Preclinical PET Studies of [11 C] UCB-J Binding in Minipig Brain. Molecular Imaging and Biology 2020.
- Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV: The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2020, 39(8):1652-1664.
- Thorne M, Cash M, Reid G, Burley D, Luke D, Pottie I, Darvesh S: Imaging Butyrylcholinesterase in Multiple Sclerosis. Molecular Imaging and Biology 2020:1-12.
- Tiepolt S, Becker G-A, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J: (+)-[18 F] Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-16.
- Tiepolt S, Rullmann M, Jochimsen TH, Gertz H-J, Schroeter ML, Patt M, Sabri O, Barthel H: Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls–A hybrid PET/MRI study. European Journal of Radiology 2020, 131:109243.
- Tiwari AK, Zhang Y, Yamasaki T, Kumari N, Fujinaga M, Mori W, Hatori A, Nengaki N, Mishra AK, Zhang H: Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [11C] N′-MPB for visualization of 18 kDa TSPO in brain. New Journal of Chemistry 2020, 44(19):7912-7922.
- Tjerkaski J, Cervenka S, Farde L, Matheson GJ: Kinfitr–an open source tool for reproducible PET modelling: validation and evaluation of test-retest reliability. BioRxiv 2020.
- Tjörnstrand A: Pituitary Tumors-Epidemiology and the Diagnostic Value of 68Ga-DOTATOC PET. 2020.
- Tjörnstrand A, Casar‐Borota O, Heurling K, Schöll M, Gjertsson P, Himmelman J, Itsenko O, Ragnarsson O, Filipsson Nyström H: Lower 68Ga‐DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof‐of‐concept study. Clinical Endocrinology 2020, 92(3):222-231.
- Tobey H, Lucas T, Paul S, Berr SS, Mehrkens B, Brolinson PG, Klein BG, Costa BM: Mechanoceutics Alters Alzheimer’s Disease Phenotypes in Transgenic Rats: A Pilot Study. Journal of Alzheimer’s Disease 2020(Preprint):1-7.
- Toledano M, Gutierrez-Pérez JL, Gutierrez-Corrales A, Serrera-Figallo MA, Toledano-Osorio M, Rosales-Leal JI, Aguilar M, Osorio R, Torres-Lagares D: Novel non-resorbable polymeric-nanostructured scaffolds for guided bone regeneration. Clinical oral investigations 2020, 24(6):2037-2049.
- Toledano M, Toledano-Osorio M, Osorio R, Carrasco-Carmona Á, Gutiérrez-Pérez J-L, Gutiérrez-Corrales A, Serrera-Figallo M-A, Lynch CD, Torres-Lagares D: Doxycycline and Zinc Loaded Silica-Nanofibrous Polymers as Biomaterials for Bone Regeneration. Polymers 2020, 12(5):1201.
- Toms J, Kogler J, Maschauer S, Daniel C, Schmidkonz C, Kuwert T, Prante O: Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-labeled FAP Inhibitor. Journal of Nuclear Medicine 2020:jnumed. 120.242958.
- Toramatsu C, Mohammadi A, Wakizaka H, Seki C, Nishikido F, Sato S, Kanno I, Takahashi M, Karasawa K, Hirano Y: Biological washout modelling for in-beam PET: rabbit brain irradiation by 11C and 15O ion beams. Physics in Medicine & Biology 2020, 65(10):105011.
- Torres JB, Mosley M, Koustoulidou S, Hopkins S, Knapp S, Chaikuad A, Kondoh M, Tachibana K, Kersemans V, Cornelissen B: Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer. Journal of Nuclear Medicine 2020:jnumed. 120.243113.
- Tournier BB, Tsartsalis S, Ceyzériat K, Medina Z, Fraser BH, Grégoire M-C, Kövari E, Millet P: Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. Journal of Cerebral Blood Flow & Metabolism 2020, 40(6):1242-1255.
- Tournier N, Goutal S, Mairinger S, Hernández-Lozano I, Filip T, Sauberer M, Caillé F, Breuil L, Stanek J, Freeman AF: Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C] erlotinib. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20965500.
- Tournier N, Pottier G, Caillé F, Coulon C, Goislard M, Jégo B, Negroni J, Leroy C, Saba W: Nalmefene alleviates the neuroimmune response to repeated binge‐like ethanol exposure: A TSPO PET imaging study in adolescent rats. Addiction Biology 2020:e12962.
- Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig F-A, Juratli TA, Patt M, Wünsch B, Schackert G, Sabri O: Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[18F] Fluspidine in Glioblastoma. Molecules 2020, 25(9):2170.
- Toyohara J, Harada N, Kakiuchi T, Ohba H, Kanazawa M, Tago T, Sakata M, Ishiwata K: Synthesis and evaluation of N-isopropyl-p-[11 C] methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography. EJNMMI research 2020, 10(1):1-13.
- Tran T, Esposito B, Montabord M, Rajau JT, Gruel N, Lenoir O, Ait-Oufella H, Stockmann C, Mallat Z, Tedgui A: Pro-atherogenic diet accelerates tumor growth in mice through IL-1β and myeloid cell-derived VEGF-A. 2020.
- Tsai C-N, Yu S-C, Lee C-W, Pang J-HS, Wu C-H, Lin S-E, Chung Y-H, Tsai C-L, Hsieh S-Y, Yu M-C: SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Oncogene 2020:1-16.
- Tsartsalis S, Tournier BB, Millet P: In vivo absolute quantification of striatal and extrastriatal D 2/3 receptors with [123 I] epidepride SPECT. EJNMMI research 2020, 10(1):1-14.
- Tshibangu T, Cawthorne C, Serdons K, Pauwels E, Gsell W, Bormans G, Deroose CM, Cleeren F: Automated GMP compliant production of [18 F] AlF-NOTA-octreotide. EJNMMI radiopharmacy and chemistry 2020, 5(1):4.
- Tu T-W, Kovacs ZI, Sundby M, Witko JA, Papadakis GZ, Reid WC, Hammoud DA, Frank JA: Diffusion Tensor Imaging and Chemical Exchange Saturation Transfer MRI Evaluation on the Long-Term Effects of Pulsed Focused Ultrasound and Microbubbles Blood Brain Barrier Opening in the Rat. Frontiers in neuroscience 2020, 14:908.
- Van Camp N, Balbastre Y, Herard A-S, Lavisse S, Tauber C, Wimberley C, Guillermier M, Berniard A, Gipchtein P, Jan C: Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate. Journal of Cerebral Blood Flow & Metabolism 2020, 40(5):1103-1116.
- van der Veen EL, Giesen D, Pot-de Jong L, Jorritsma-Smit A, De Vries EG, Lub-de Hooge MN: 89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs. Journal for immunotherapy of cancer 2020, 8(2).
- van der Veen EL, Suurs FV, Cleeren F, Bormans G, Elsinga PH, Hospers GA, Lub-de Hooge MN, de Vries EG, de Vries EF, Antunes IF: Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice. Journal of Nuclear Medicine 2020:jnumed. 119.238782.
- van der Weide H, Cossío U, Gracia R, Te Welscher YM, Marian T, van der Meijden A, Marradi M, Ritsema JA, Vermeulen-de Jongh DM, Storm G: Therapeutic efficacy of novel antimicrobial peptide AA139-nanomedicines in a multidrug-resistant Klebsiella pneumoniae pneumonia-septicemia model in rats. Antimicrobial Agents and Chemotherapy 2020, 64(9).
- van Duin ED, Ceccarini J, Booij J, Kasanova Z, Vingerhoets C, van Huijstee J, Heinzel A, Mohammadkhani-Shali S, Winz O, Mottaghy F: Lower [18 F] fallypride binding to dopamine D 2/3 receptors in frontal brain areas in adults with 22q11. 2 deletion syndrome: a positron emission tomography study. Psychological medicine 2020, 50(5):799-807.
- Van Weehaeghe D, Babu S, De Vocht J, Zürcher NR, Chew S, Tseng C-EJ, Loggia ML, Koole M, Rezaei A, Schramm G: Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands. Journal of Nuclear Medicine 2020, 61(11):1621-1627.
- Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G: TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study. Journal of Nuclear Medicine 2020, 61(4):604-607.
- Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng K-W, Smith DR, Russell SJ, Suksanpaisan L: Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer Gene Therapy 2020, 27(3):179-188.
- Vanhaute H, Ceccarini J, Michiels L, Koole M, Sunaert S, Lemmens R, Triau E, Emsell L, Vandenbulcke M, Van Laere K: In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment. Neurology 2020.
- Varnäs K, Finnema SJ, Johnström P, Arakawa R, Halldin C, Eriksson LI, Farde L: Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo. British Journal of Anaesthesia 2020.
- Vega SC, Leiss V, Piekorz R, Calaminus C, Pexa K, Vuozzo M, Schmid AM, Devanathan V, Kesenheimer C, Pichler BJ: Selective protection of murine cerebral G i/o-proteins from inactivation by parenterally injected pertussis toxin. Journal of Molecular Medicine 2020, 98(1):97-110.
- Velikyan I, Doverfjord JG, Estrada S, Steen H, Van Scharrenburg G, Antoni G: GMP production of [68Ga] Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study. Nuclear Medicine and Biology 2020, 88:73-85.
- Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, Raedt R, Vanhove C, De Vos F, Goethals I: 2-[18F] FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nuclear Medicine and Biology 2020, 82:9-16.
- Vetel S, Vercouillie J, Buron F, Vergote J, Tauber C, Busson J, Chicheri G, Routier S, Sérrière S, Chalon S: Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18 F] ASEM in a Rat Model of Parkinson’s Disease. Molecular Imaging and Biology 2020, 22(2):348-357.
- Vignal N, Boulay A-C, San C, Cohen-Salmon M, Rizzo-Padoin N, Sarda-Mantel L, Declèves X, Cisternino S, Hosten B: Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F] FEPPA. Cells 2020, 9(2):389.
- Vigne J, Cabella C, Dézsi L, Rustique E, Couffin A-C, Aid R, Anizan N, Chauvierre C, Letourneur D, Le Guludec D: Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE−/− mice. Nanomedicine: Nanotechnology, Biology and Medicine 2020, 25:102157.
- Viswanath V, Pantel AR, Daube-Witherspoon ME, Doot R, Muzi M, Mankoff DA, Karp JS: Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scanner. IEEE Transactions on Radiation and Plasma Medical Sciences 2020, 4(6):735-749.
- Viswanath V, Zhou R, Lee H, Li S, Cragin A, Doot RK, Mankoff DA, Pantel AR: Kinetic Modeling of 18F-(2S, 4R) 4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism. Journal of Nuclear Medicine 2020:jnumed. 120.250977.
- Vrist MH, Bech JN, Lauridsen TG, Fynbo CA, Theil J: Validation and Comparison of [18F] NaF PET/CT Analysis Methods and Derivation of a Semi-population Input Function for Site Specific Measurements of Bone Formation in a Population with Chronic Kidney Disease Mineral and Bone Disorder. 2020.
- Wakabayashi Y, Telu S, Dick RM, Fujita M, Ooms M, Morse CL, Liow J-S, Hong JS, Gladding RL, Manly LS: Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D. ACS Chemical Neuroscience 2020, 11(9):1311-1323.
- Wanek T, Zoufal V, Brackhan M, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Pahnke J: Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model. International Journal of Molecular Sciences 2020, 21(21):8245.
- Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y-J, Liu C-F, Xing M-J, Cheng X, Wei S: Comparative strategies for stem cell biodistribution in a preclinical study. Acta Pharmacologica Sinica 2020, 41(4):572-580.
- Wang PN, Lin KJ, Liu HC, Andreasson U, Blennow K, Zetterberg H, Yang SY: Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12029.
- Wani M, Jagdale S, Khanna P, Gholap R, Baheti A: Formulation and Evaluation of Ophthalmic In-Situ Gel using Moxifloxacin Coated Silver Nanoparticles. Research Journal of Pharmacy and Technology 2020, 13(8):3623-3630.
- Weerasekera A, Crabbé M, Tomé SO, Gsell W, Sima D, Casteels C, Dresselaers T, Deroose C, Van Huffel S, Thal DR: Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: A PET-MR study. NeuroImage: Clinical 2020, 27:102327.
- Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM: On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D 2/3 receptor agonist radioligand study. Translational psychiatry 2020, 10(1):1-11.
- Weng C-C, Hsiao I-T, Yang Q-F, Yao C-H, Tai C-Y, Wu M-F, Yen T-C, Jang M-K, Lin K-J: Characterization of 18F-PM-PBB3 (18F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy. Molecules 2020, 25(7):1750.
- Werner G, Damme M, Schludi M, Gnörich J, Wind K, Fellerer K, Wefers B, Wurst W, Edbauer D, Brendel M: Loss of TMEM 106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice. EMBO reports 2020, 21(10):e50241.
- Workman CD, Fietsam AC, Ponto LLB, Kamholz J, Rudroff T: Individual Cerebral Blood Flow Responses to Transcranial Direct Current Stimulation at Various Intensities. Brain sciences 2020, 10(11):855.
- Workman CD, Kindred JH, Boles Ponto LL, Kamholz J, Rudroff T: The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. Applied Physiology, Nutrition, and Metabolism 2020, 45(4):450-452.
- Workman CD, Ponto LLB, Kamholz J, Rudroff T: No immediate effects of transcranial direct current stimulation at various intensities on cerebral blood flow in people with multiple sclerosis. Brain Sciences 2020, 10(2):82.
- Xu H, Jiang S, Wang J, Li X, Wu T, Xu P, Santos-Oliveira R, Zhang A: Radioactive Gold Nanoparticle in Two Forms (198 79Au GNPs and 99mTc-GNPs) for Lung Cancer Antiproliferative Induction and Intralesional Imaging: A Proof of Concept. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2020, 20(14):1648-1653.
- Xu Y, Wang C, Wey H-Y, Liang Y, Chen Z, Choi SH, Ran C, Rynearson KD, Bernales DR, Koegel RE: Molecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates. Journal of Experimental Medicine 2020, 217(12).
- Xue Y, Liu X, Koundal S, Constantinou S, Dai F, Santambrogio L, Lee H, Benveniste H: In vivo T1 mapping for quantifying glymphatic system transport and cervical lymph node drainage. Scientific reports 2020, 10(1):1-13.
- Yamagishi S, Iga Y, Ikegaya S, Kakiuchi T, Ohba H, Nishiyama S, Kanazawa M, Tsukada H, Sato K, Ouchi Y: In Vivo Elevation of Mitochondrial Activity and Amyloid Deposition, but Inversely Correlated, in Early-stage Senescence-Accelerated Mice: A Positron Emission Tomography Study. 2020.
- Yamamoto Y, Takahata K, Kubota M, Takano H, Takeuchi H, Kimura Y, Sano Y, Kurose S, Ito H, Mimura M: Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain. NeuroImage 2020, 226:117543.
- Yan S, Zheng C, Paranjpe MD, Li J, Benzinger TL, Lu J, Zhou Y: Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer’s disease. Theranostics 2020, 10(23):10563.
- Yang K-C, Yang B-H, Lirng J-F, Liu M-N, Hu L-Y, Liou Y-J, Chan L-A, Chou Y-H: Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study. Neurotoxicology 2020, 82:26-34.
- Yang Y-J, Bu L-L, Shen C, Ge J-J, He S-J, Yu H-L, Tang Y-L, Jue Z, Sun Y-M, Yu W-B: Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson’s Disease by Autophagy Activation. Journal of Parkinson’s disease 2020(Preprint):1-11.
- Yeh CI, Cheng MF, Xiao F, Chen YC, Liu CC, Chen HY, Yen RF, Ju YT, Chen Y, Bodduluri M: Effects of Focal Radiation on [18F]‐Fluoro‐D‐Glucose Positron Emission Tomography in the Brains of Miniature Pigs: Preliminary Findings on Local Metabolism. Neuromodulation: Technology at the Neural Interface 2020.
- Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, Chen L-M, Hsu S-M, Chao L-J, Wu K-W: A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiology of aging 2020, 90:60-74.
- Yoan M, Valerie T, Funda A, Toman E, Gabriella M, Anass J, Hasler G: Metabotropic glutamate receptor 5 in bulimia nervosa. Scientific Reports (Nature Publisher Group) 2020, 10(1).
- Yokokura M, Takebasashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y: In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study. Molecular Psychiatry 2020:1-10.
- Yoon J-K, Byeon HE, Ko SA, Park B-N, An Y-S, Lee H-Y, Lee YW, Lee SJ: cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer. Scientific reports 2020, 10(1):1-7.
- Yoshimura Y, Kikuchi M, Saito DN, Hirosawa T, Takahashi T, Munesue T, Kosaka H, Naito N, Ouchi Y, Minabe Y: Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder. Scientific Reports 2020, 10(1):1-10.
- Yuan G, Qu X, Zheng B, Neelamegam R, Afshar S, Iyengar S, Pan C, Wang J, Kang HJ, Ondrechen MJ: Design, Synthesis, and Characterization of Benzimidazole Derivatives as Positron Emission Tomography Imaging Ligands for Metabotropic Glutamate Receptor 2. Journal of Medicinal Chemistry 2020, 63(20):12060-12072.
- Zaer H, Glud AN, Schneider BM, Lukacova S, Hansen KV, Adler JR, Høyer M, Jensen MB, Hansen R, Hoffmann L: Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model. Scientific Reports 2020, 10(1):1-12.
- Zaibaq NG, Pollard AC, Collins MJ, Pisaneschi F, Pagel MD, Wilson LJ: Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene. Nanomaterials 2020, 10(1):143.
- Zech J, Mader M, Gündel D, Metz H, Odparlik A, Agarwal S, Mäder K, Greiner A: Noninvasive characterization (EPR, μCT, NMR) of 3D PLA electrospun fiber sponges for controlled drug delivery. International journal of pharmaceutics: X 2020, 2:100055.
- Zhang Y, García-Gabilondo M, Grayston A, Feiner IV, Anton-Sales I, Loiola RA, Llop J, Ramos-Cabrer P, Barba I, Garcia-Dorado D: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities. Nanoscale 2020, 12(8):4988-5002.
- Zhao J, Wen X, Li T, Shi S, Xiong C, Wang YA, Li C: Concurrent Injection of Unlabeled Antibodies Allows Positron Emission Tomography Imaging of Programmed Cell Death Ligand 1 Expression in an Orthotopic Pancreatic Tumor Model. ACS omega 2020, 5(15):8474-8482.
- Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM: Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment. CNS neuroscience & therapeutics 2020, 26(1):117-125.
- Zhu P, Wu M, Ma B, Wang S: Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine. Experimental and Therapeutic Medicine 2020, 21(1):1-1.
- Zou J, Tao S, Johnson A, Tomljanovic Z, Polly K, Klein J, Razlighi QR, Brickman AM, Lee S, Stern Y: Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment. Neurobiology of aging 2020, 85:11-21.
- Zoufal V, Mairinger S, Brackhan M, Krohn M, Filip T, Sauberer M, Stanek J, Wanek T, Tournier N, Bauer M: Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET. Journal of Nuclear Medicine 2020, 61(7):1050-1057.
- Zoufal V, Mairinger S, Krohn M, Wanek T, Filip T, Sauberer M, Stanek J, Kuntner C, Pahnke J, Langer O: Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2020, 40(5):954-965.
- Zoufal V, Wanek T, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Bauer M, Pahnke J: Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET. Journal of Cerebral Blood Flow & Metabolism 2020, 40(1):150-162.
- Zürcher N, Loggia M, Mullett J, Tseng C, Bhanot A, Richey L, Hightower B, Wu C, Parmar A, Butterfield R: [11 C] PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder. Molecular Psychiatry 2020:1-11.
- Abou Ezzeddine OF, Kemp BJ, Borlaug BA, Mullan BP, Behfar A, Pislaru SV, Fudim M, Redfield MM, Chareonthaitawee P: Myocardial Energetics in Heart Failure With Preserved Ejection Fraction. Circulation: Heart Failure 2019, 12(10):e006240.
- Ahlstedt J, Johansson E, Sydoff M, Karlsson H, Thordarsson E, Gram M, Eriksson O: Non-invasive imaging methodologies for assessment of radiation damage to bone marrow and kidneys from peptide receptor radionuclide therapy. Neuroendocrinology 2019.
- Ahmed H, Haider A, Varisco J, Stanković M, Wallimann R, Gruber S, Iten I, Häne S, Müller Herde A, Keller C: Structure–Affinity Relationships of 2, 3, 4, 5-Tetrahydro-1 H-3-benzazepine and 6, 7, 8, 9-Tetrahydro-5 H-benzo [7] annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2, 3, 4, 5-Tetrahydro-1 H-3-benzazepine Congener for Imaging GluN2B Subunit-Containing N-Methyl-d-aspartate Receptors. Journal of medicinal chemistry 2019, 62(21):9450-9470.
- Akamatsu G, Tashima H, Iwao Y, Wakizaka H, Maeda T, Yoshida E, Yamaya T: A 3-dimensional hemispherical brain phantom for compact dedicated brain PET scanners. Biomedical Physics & Engineering Express 2019, 5(2):025013.
- Albrecht DS, Forsberg A, Sandström A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Höglund CO, Catana C: Brain glial activation in fibromyalgia–A multi-site positron emission tomography investigation. Brain, behavior, and immunity 2019, 75:72-83.
- Allen KJ, Jiao R, Malo ME, Frank C, Fisher DR, Rickles D, Dadachova E: Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium. Pharmaceutics 2019, 11(7):348.
- Ametamey SM: Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F] PSS232 in the Rat Brain. Targets, Tracers and Translation–Novel Radiopharmaceuticals Boost Nuclear Medicine 2019, 11:84.
- Avendaño-Estrada A, Velasco F, Velasco AL, Cuellar-Herrera M, Saucedo-Alvarado PE, Marquez-Franco R, Rivera-Bravo B, Ávila-Rodríguez MA: Quantitative Analysis of [18F] FFMZ and [18F] FDG PET Studies in the Localization of Seizure Onset Zone in Drug-Resistant Temporal Lobe Epilepsy. Stereotactic and functional neurosurgery 2019, 97(4):232-240.
- Avendaño-Estrada A, Velasco-Campos F, Carrillo-Ruiz J, Ávila-Rodríguez M: On the use of quantitative PET imaging to study human brain in healthy controls and epileptic patients: A 18FGD and 18FMMZ study. In: AIP Conference Proceedings: 2019: AIP Publishing; 2019: 030001.
- Bailey JJ, Kaiser L, Lindner S, Wüst M, Thiel A, Soucy J-P, Rosa-Neto P, Scott PJ, Unterrainer M, Kaplan DR: First-in-Human Brain Imaging of [18F] TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS chemical neuroscience 2019, 10(6):2697-2702.
- Baldinger-Melich P, Gryglewski G, Philippe C, James GM, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J: The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography. Brain stimulation 2019.
- Bascuñana P, García-García L, Javela J, de la Rosa RF, Shiha AA, Kelly J, Delgado M, Pozo MÁ: PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis. Neuroscience 2019, 409:101-110.
- Bascuñana P, Gendron T, Sander K, Jahreis I, Polyak A, Ross TL, Bankstahl M, Arstad E, Bankstahl JP: Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers. Epilepsia 2019.
- Bascuñana P, Heß A, Borchert T, Wang Y, Wollert KC, Bengel FM, Thackeray JT: 11C-Methionine PET Identifies Astroglia Involvement in Heart-Brain Inflammation Networking after Acute Myocardial Infarction. Journal of Nuclear Medicine 2019:jnumed. 119.236885.
- Bascuñana P, Thackeray JT, Bankstahl M, Bengel FM, Bankstahl JP: Anesthesia and Preconditioning Induced Changes in Mouse Brain [18 F] FDG Uptake and Kinetics. Molecular Imaging and Biology 2019:1-8.
- Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, Becker G, Seret A, Mella C, Giacomelli F: In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H Positron Emission Tomography. European journal of nuclear medicine and molecular imaging 2019:1-13.
- Bauman MD, Lesh TA, Rowland DJ, Schumann CM, Smucny J, Kukis DL, Cherry SR, McAllister AK, Carter CS: Preliminary evidence of increased striatal dopamine in a nonhuman primate model of maternal immune activation. Translational psychiatry 2019, 9(1):135.
- Becker G, Lespine L-F, Bahri MA, Serrano ME, Lemaire C, Luxen A, Tirelli E, Plenevaux A: Neuro-functional correlates of protective effects of wheel-running exercise against cocaine locomotor sensitization in mice: a [18F] fallypride microPET study. bioRxiv 2019:855791.
- Bellaver B, da Rocha AS, Souza DG, Leffa DT, De Bastiani MA, Schu G, Ferreira PCL, Venturin GT, Greggio S, Ribeiro CT: Activated peripheral blood mononuclear cell mediators trigger astrocyte reactivity. Brain, behavior, and immunity 2019, 80:879-888.
- Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, Patriki D, Giannopoulos AA, Fuchs TA, Grani C et al: Role of quantitative myocardial blood flow and (13)N-ammonia washout for viability assessment in ischemic cardiomyopathy. J Nucl Cardiol 2019.
- Benz DC, Gräni C, Ferro P, Neumeier L, Messerli M, Possner M, Clerc OF, Gebhard C, Gaemperli O, Pazhenkottil AP: Corrected coronary opacification decrease from coronary computed tomography angiography: validation with quantitative 13N-ammonia positron emission tomography. Journal of Nuclear Cardiology 2019, 26(2):561-568.
- Benz DC, von Dahlen AP, Huang W, Messerli M, von Felten E, Benetos G, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C: No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy. European journal of nuclear medicine and molecular imaging 2019, 46(11):2322-2328.
- Berroterán-Infante N, Kalina T, Fetty L, Janisch V, Velasco R, Vraka C, Hacker M, Haug AR, Pallitsch K, Wadsak W: (R)-[18F] NEBIFQUINIDE: A promising new PET tracer for TSPO imaging. European journal of medicinal chemistry 2019.
- Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C: Validation and noninvasive kinetic modeling of [11C] UCB-J PET imaging in mice. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19864081.
- Beyer L, Schnabel J, Kazmierczak P, Ewers M, Schönecker S, Prix C, Meyer-Wilmes J, Unterrainer M, Catak C, Pogarell O: Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer’s disease. NeuroImage: Clinical 2019, 24:101949.
- Beziere N, Fuchs K, Maurer A, Reischl G, Brück J, Ghoreschi K, Fehrenbacher B, Berrio DC, Schenke-Layland K, Kohlhofer U: Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix. Theranostics 2019, 9(10):2868.
- Biegon A, Shroyer KR, Franceschi D, Dhawan J, Tahmi M, Pareto D, Bonilla P, Airola K, Cohen J: Initial studies with [11C] vorozole positron emission tomography detect over-expression of intra-tumoral aromatase in breast cancer. Journal of Nuclear Medicine 2019:jnumed. 119.231589.
- Billington S, Shoner S, Lee S, Clark-Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB: Positron Emission Tomography Imaging of [11 C] Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A. Clinical pharmacology and therapeutics 2019, 106(5):1056-1066.
- Billington S, Shoner S, Lee S, Clark-Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB: PET Imaging of [11C] Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporine A. Clinical Pharmacology & Therapeutics 2019.
- Bohórquez SS, Marik J, Ogasawara A, Tinianow JN, Gill HS, Barret O, Tamagnan G, Alagille D, Ayalon G, Manser P: [18 F] GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2019, 46(10):2077-2089.
- Bolaños-Puchet S: xgrid3d: A free software tool for quantitative image analysis and internal dosimetry. In: AIP Conference Proceedings: 2019: AIP Publishing; 2019: 030003.
- Bonaventura J, Eldridge MA, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm MA, Ruiz C, Farrell MR: High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nature communications 2019, 10(1):1-12.
- Borelli WV, Leal-Conceiao E, Andrade MA, Esper NB, Feltes PK, Soder RB, Matushita CS, Hartmann LM, Radaelli G, Schilling LP: Neural correlates of exceptional memory ability in SuperAgers: A multimodal approach using FDG-PET, PIB-PET, and MRI. bioRxiv 2019:666438.
- Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A: Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau. Alzheimer’s research & therapy 2019, 11(1):67.
- Brown D, Sarkar G, Decklever T, Curran G, Sarkar A: K16ApoE Enhances Aβ-associated 11C-PiB Deposition and PET Signal in APP/PS1 Transgenic Mice. J Alzheimers Dis Parkinsonism 2019, 9(468):2.
- Brown EE, Rashidi-Ranjbar N, Caravaggio F, Gerretsen P, Pollock BG, Mulsant BH, Rajji TK, Fischer CE, Flint A, Mah L et al: Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment. J Neuroimaging 2019, 29(6):721-729.
- Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A: Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer’s Disease. Journal of Alzheimer’s Disease 2019(Preprint):1-12.
- Brumberg J, Tran-Gia J, Lapa C, Isaias IU, Samnick S: PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time. Annals of nuclear medicine 2019, 33(2):69-77.
- Buchert R, Lange C, Spehl TS, Apostolova I, Frings L, Jonsson C, Meyer PT, Hellwig S: Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting. EJNMMI research 2019, 9(1):37.
- Buchsbaum MS, DeCastro A: Positron Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tool for Developing Novel Pharmacotherapeutics for Obesity and Diabetes. In: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. edn.: Springer, Cham; 2019: 191-210.
- Bui DV, Kanda A, Kobayashi Y, Sakata Y, Kono Y, Kamakura Y, Jinno T, Yun Y, Suzuki K, Sawada S: A Novel Approach for Investigating Upper Airway Hyperresponsiveness Using Micro-CT in Eosinophilic Upper Airway Inflammation such as Allergic Rhinitis Model. Biomolecules 2019, 9(7):252.
- Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H: Evaluation of dosimetry, quantitative methods and test-retest variability of 18F-PI-2620 PET for the assessment of tau deposits in the human brain. Journal of Nuclear Medicine 2019:jnumed. 119.236240.
- Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJ, Harrington KJ, Smith G, Kramer-Marek G: Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models. Journal of Nuclear Medicine 2019, 60(3):353-361.
- Büther F, Seifert R, Backhaus P, Schäfers M: Einfluss der Detektorsensitivität eines Blutsamplers auf die kinetische Modellierung von PET-Daten: Ergebnisse einer numerischen Simulationsstudie. Nuklearmedizin 2019, 58(02):P114.
- Cai M, Lee J-H, Yang EJ: Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model. Journal of Neuroinflammation 2019, 16(1):1-12.
- Cai N-S, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, Billing AS, Massey E, Wagner M, Wish ED: Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids. The Journal of clinical investigation 2019, 129(7).
- Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H: Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 2019, 231:119678.
- Cao Q, Huang Q, Mohan C, Li C: μPET/CT imaging of local and systemic immune response using 64Cu-αCD11b. Journal of Nuclear Medicine 2019:jnumed. 118.220350.
- Cao Y, Gathaiya N, Han Q, Kemp BJ, Jensen MD: Subcutaneous Adipose Tissue Free Fatty Acid Uptake Measured Using Positron Emission Tomography and Adipose Biopsies in Humans. American Journal of Physiology-Endocrinology and Metabolism 2019.
- Carvalho RH, Real CC, Cinini S, Garcez AT, Duran FL, Marques FL, Mello LE, Busatto Filho G, de Vries EF, de Britto LR: [11C] PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis. Multiple sclerosis and related disorders 2019, 35:108-115.
- Castaño-Castaño S, Feijoo-Cuaresma M, Paredes-Pacheco J, Morales-Navas M, Ruiz-Guijarro J, Sanchez-Santed F, Nieto-Escámez F: tDCS recovers depth perception in adult amblyopic rats and reorganizes visual cortex activity. Behavioural brain research 2019, 370:111941.
- Castellano C-A, Hudon C, Croteau E, Fortier M, St-Pierre V, Vandenberghe C, Nugent S, Tremblay S, Paquet N, Lepage M: Links Between Metabolic and Structural Changes in the Brain of Cognitively Normal Older Adults: A 4-Year Longitudinal Follow-Up. Frontiers in aging neuroscience 2019, 11.
- Castrellon JJ, Young JS, Dang LC, Cowan RL, Zald DH, Samanez-Larkin GR: Mesolimbic dopamine D2 receptors and neural representations of subjective value. Scientific Reports 2019, 9(1):1-12.
- Ceccarini J, Ahmad R, Van de Vliet L, Casteels C, Vandenbulcke M, Vandenberghe W, Van Laere K: Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB1R levels. Journal of Nuclear Medicine 2019, 60(1):115-121.
- Ceccarini J, Casteels C, Ahmad R, Crabbé M, Van de Vliet L, Vanhaute H, Vandenbulcke M, Vandenberghe W, Van Laere K: Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2019, 46(11):2348-2357.
- Ceccarini J, Leurquin-Sterk G, Crunelle C, de Laat B, Bormans G, Peuskens H, Van Laere K: Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients. Journal of Nuclear Medicine 2019:jnumed. 119.228825.
- Chan K, Robert F, Oertlin C, Kapeller-Libermann D, Avizonis D, Gutierrez J, Handly-Santana A, Doubrovin M, Park J, Schoepfer C: eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. Nature communications 2019, 10(1):1-16.
- Chang Y-J, Ho C-L, Cheng K-H, Kuo W-I, Lee W-C, Lan K-L, Chang C-H: Biodistribution, pharmacokinetics and radioimmunotherapy of 188 Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice. Investigational new drugs 2019:1-12.
- Chen Y, Goorden MC, Vastenhouw B, Beekman FJ: Optimized sampling for high resolution multi-pinhole brain SPECT with stationary detectors. Physics in Medicine & Biology 2019.
- Chen Y-H, Chang K-P, Chu S-C, Yen T-C, Wang L-Y, Chang JT-C, Hsu C-L, Ng S-H, Liu S-H, Chan S-C: Value of early evaluation of treatment response using 18 F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma. European journal of nuclear medicine and molecular imaging 2019, 46(3):650-660.
- Chen Y-H, Lue K-H, Chu S-C, Chang B-S, Wang L-Y, Liu D-W, Liu S-H, Chao Y-K, Chan S-C: Combining the radiomic features and traditional parameters of 18 F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. Annals of Nuclear Medicine 2019:1-14.
- Cheng M-F, Huang Y-Y, Ho B-Y, Kuo T-C, Hsin L-W, Shiue C-Y, Kuo H-C, Jeng Y-M, Yen R-F, Tien Y-W: Prospective comparison of (4S)-4-(3-18 F-fluoropropyl)-l-glutamate versus 18 F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study. European journal of nuclear medicine and molecular imaging 2019:1-11.
- Chiu C-C, Lu C-S, Weng Y-H, Chen Y-L, Huang Y-Z, Chen R-S, Cheng Y-C, Huang Y-C, Liu Y-C, Lai S-C: PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Molecular neurobiology 2019, 56(6):3835-3853.
- Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J, Tamagnan G, Marek K, Luk KC, Trojanowski JQ: Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain 2019, 142(11):3565-3579.
- Chung Y-H, Yu C-F, Chiu S-C, Chiu H, Hsu S-T, Wu C-R, Yang C-L, Hong J-H, Yen T-C, Chen F-H: Diffusion-weighted MRI and 18 F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. European journal of nuclear medicine and molecular imaging 2019:1-12.
- Cicone F, Gnesin S, Denoël T, Stora T, van der Meulen NP, Müller C, Vermeulen C, Benešová M, Köster U, Johnston K: Internal radiation dosimetry of a 152 Tb-labeled antibody in tumor-bearing mice. EJNMMI research 2019, 9(1):53.
- Cil O, Anderson MO, Yen R, Kelleher B, Huynh TL, Seo Y, Nilsen SP, Turner JR, Verkman AS: Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A. The FASEB Journal 2019, 33(10):11247-11257.
- Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K: Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers. Molecular Imaging and Biology 2019, 21(3):509-518.
- Corral A, López R, Balcerzyk M, Parrado-Gallego A, Fernández-Gómez I, Olmo A, Risco R: Use of X-Ray Computed Tomography for Ice Detection Applied to Organ Cryopreservation. Biopreservation and biobanking 2019, 17(2):119-128.
- Coughlin JM, Du Y, Crawford JL, Rubin LH, Azad BB, Lesniak WG, Horti AG, Schretlen DJ, Sawa A, Pomper MG: Use of 18F-ASEM PET to Determine the Availability of the α7-Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis. Journal of Nuclear Medicine 2019, 60(2):241-243.
- Crabbé M, Dirkx N, Casteels C, Van Laere K: Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study. Scientific reports 2019, 9(1):1-10.
- Crabbé M, Van der Perren A, Kounelis S, Lavreys T, Bormans G, Baekelandt V, Casteels C, Van Laere K: Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy. Experimental neurology 2019, 320:112964.
- da Cunha-Bang S, Ettrup A, Mc Mahon B, Skibsted AP, Schain M, Lehel S, Dyssegaard A, Jørgensen LM, Møller K, Gillings N: Measuring endogenous changes in serotonergic neurotransmission with [11 C] Cimbi-36 positron emission tomography in humans. Translational psychiatry 2019, 9(1):134.
- Dagnino APA, da Silva RBM, Chagastelles PC, Pereira TCB, Venturin GT, Greggio S, da Costa JC, Bogo MR, Campos MM: Nociceptin/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia. Pain 2019, 160(6):1383-1401.
- Dahlsson Leitao C, Rinne SS, Mitran B, Vorobyeva A, Andersson KG, Tolmachev V, Ståhl S, Löfblom J, Orlova A: Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers. International journal of molecular sciences 2019, 20(5):1080.
- Dávalos-Salas M, Montgomery MK, Reehorst CM, Nightingale R, Ng I, Anderton H, Al-Obaidi S, Lesmana A, Scott CM, Ioannidis P: Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity. Nature communications 2019, 10(1):1-14.
- De Bruycker S, Vangestel C, Staelens S, Detrez J, Verschuuren M, De Vos WH, Pauwels P, Van den Wyngaert T, Stroobants S: Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18 F] HX4 PET imaging study in colorectal cancer xenografts. EJNMMI research 2019, 9(1):74.
- De Bruycker S, Vangestel C, Van den Wyngaert T, Pauwels P, Staelens S, Stroobants S: 18F-flortanidazole hypoxia PET holds promise as a prognostic and predictive imaging biomarker in a lung cancer xenograft model treated with metformin and radiotherapy. Journal of Nuclear Medicine 2019, 60(1):34-40.
- De Carli F, Nobili F, Pagani M, Bauckneht M, Massa F, Grazzini M, Jonsson C, Peira E, Morbelli S, Arnaldi D: Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease. European journal of nuclear medicine and molecular imaging 2019, 46(2):334-347.
- de Laat B, Weerasekera A, Leurquin-Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K: Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18F-FPEB and 1H-MRS study in rats. Addiction biology 2019, 24(4):696-706.
- De Leo TC, dos Santos SN, Andrade CDC, Ricci E, Turato WM, Lopes NP, Oliveira RS, Bernardes ES, Dias-Baruffi M: Engineering of galectin-3 for glycan-binding optical imaging. Biochemical and biophysical research communications 2019, 521(3):674-680.
- De Lombaerde S, Devisscher L, Verhoeven J, Neyt S, Van Vlierberghe H, Vanhove C, De Vos F: Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F] FCA in mouse models of liver disease. Nuclear medicine and biology 2019, 68:40-48.
- De Lombaerde S, Neyt S, Vanhove C, De Vos F: In Vivo Measurement of Hepatic Drug Transporter Inhibition with Radiolabeled Bile Acids. In: Experimental Cholestasis Research. edn.: Springer; 2019: 87-98.
- De Picker L, Ottoy J, Verhaeghe J, Deleye S, Fransen E, Kosten L, Sabbe B, Coppens V, Timmers M, de Boer P: State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis? Brain, behavior, and immunity 2019, 77:46-54.
- Delgado H, Agrati D, Machado L, Reyes L, Savio E, Engler H, Ferreira A: Cocaine treatment before pregnancy differentially affects the anxiety and brain glucose metabolism of lactating rats if performed during adulthood or adolescence. Behavioural brain research 2019, 372:112070.
- Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K: Quantification and discriminative power of 18 F-FE-PE2I PET in patients with Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2019:1-14.
- Di Ciano P, Mansouri E, Tong J, Wilson AA, Houle S, Boileau I, Duvauchelle T, Robert P, Schwartz JC, Le Foll B: Occupancy of dopamine D 2 and D 3 receptors by a novel D3 partial agonist BP1. 4979: a [11 C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 2019, 44(7):1284.
- Dmochowska N, Tieu W, Keller MD, Wardill HR, Mavrangelos C, Campaniello MA, Takhar P, Hughes PA: Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis. Journal of Nuclear Medicine 2019, 60(6):858-863.
- Donovan L, Magnussen J, Dyssegaard A, Lehel S, Hooker J, Knudsen G, Hansen H: Imaging HDACs In Vivo: Cross-Validation of the [11 C] Martinostat Radioligand in the Pig Brain. Molecular imaging and biology 2019:1-9.
- Drescher R, Gühne F, Seifert P, Kühnel C, Freesmeyer M: Ex Vivo Evaluation of Residual Activity and Infusion Dynamics in a Commercially Available Yttrium-90 Resin Microsphere Administration System. Journal of Vascular and Interventional Radiology 2019, 30(9):1504-1511.
- Dubol M, Trichard C, Leroy C, Granger B, Tzavara ET, Martinot J-L, Artiges E: Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging. Journal of affective disorders 2019, 262:273-277.
- Dyke JP, Garfinkel JH, Volpert L, Sanders A, Newcomer M, Dutruel SP, Sofka CM, Ellis SJ, Demetracopoulos CA: Imaging of Bone Perfusion and Metabolism in Subjects Undergoing Total Ankle Arthroplasty Using 18F-Fluoride Positron Emission Tomography. Foot & ankle international 2019:1071100719882717.
- Ebert SE, Jensen P, Ozenne B, Armand S, Svarer C, Stenbaek DS, Moeller K, Dyssegaard A, Thomsen G, Steinmetz J: Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I-CLINDE SPECT study. European journal of neurology 2019.
- Elmi A, Makvandi M, Weng C-C, Hou C, Clark AS, Mach RH, Mankoff DA: Cell-proliferation imaging for monitoring response to CDK4/6 inhibition combined with endocrine-therapy in breast cancer: Comparison of [18F] FLT and [18F] ISO-1 PET/CT. Clinical Cancer Research 2019, 25(10):3063-3073.
- Elvas F, Berghe TV, Adriaenssens Y, Vandenabeele P, Augustyns K, Staelens S, Stroobants S, Van der Veken P: Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy. Organic & biomolecular chemistry 2019, 17(19):4801-4824.
- Endo H, Shimada H, Sahara N, Ono M, Koga S, Kitamura S, Niwa F, Hirano S, Kimura Y, Ichise M: In vivo binding of a tau imaging probe,[11C] PBB3, in patients with progressive supranuclear palsy. Movement Disorders 2019.
- Erdmann S, Niederstadt L, Koziolek EJ, Gómez JDC, Prasad S, Wagener A, von Hacht JL, Hallmann S, Exner S, Bandholtz S: CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer. bioRxiv 2019, 9(22):575902.
- Eriksen PL, Thomsen KL, Larsen LP, Grønbæk H, Vilstrup H, Sørensen M: Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver–a human galactose positron emission tomography study. Alimentary pharmacology & therapeutics 2019.
- Eriksson J, Roy T, Sawadjoon S, Bachmann K, Sköld C, Larhed M, Weis J, Selvaraju RK, Korsgren O, Eriksson O: Synthesis and preclinical evaluation of the CRTH2 antagonist [11C] MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass. Nuclear medicine and biology 2019, 71:1-10.
- Eriksson O, Selvaraju RK, Berglund M, Espes D: Metabolically Active Brown Adipose Tissue Is Found in Adult Subjects with Type 1 Diabetes. International journal of molecular sciences 2019, 20(23):5827.
- Eriksson O, Velikyan I, Haack T, Bossart M, Evers A, Laitinen I, Larsen PJ, Plettenburg O, Takano A, Halldin C: Assessment of glucagon receptor occupancy by positron emission tomography in non-human primates. Scientific reports 2019, 9(1):1-11.
- Escudero-Castellanos A, Ocampo-García B, Ferro-Flores G, Santos-Cuevas C, Morales-Ávila E, Luna-Gutiérrez M, Isaac-Olivé K: Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA (inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer. Nuclear medicine communications 2019, 40(3):278-286.
- Espes D, Manell E, Rydén A, Carlbom L, Weis J, Jensen-Waern M, Jansson L, Eriksson O: Pancreatic perfusion and its response to glucose as measured by simultaneous PET/MRI. Acta diabetologica 2019:1-8.
- Ezura M, Kikuchi A, Ishiki A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T: Longitudinal changes in 18F-THK 5351 positron emission tomography in corticobasal syndrome. European journal of neurology 2019.
- Faria DdP, Duran FL, Squarzoni P, Coutinho AM, Garcez AT, Santos PP, Brucki SM, de Oliveira MO, Trés ES, Forlenza OV: Topography of 11C-Pittsburgh compound B uptake in Alzheimer’s disease: a voxel-based investigation of cortical and white matter regions. Brazilian Journal of Psychiatry 2019, 41(2):101-111.
- Fassbender TF, Schiller F, Mix M, Maecke HR, Kiefer S, Drendel V, Meyer PT, Jilg CA: Accuracy of [68Ga] Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology. Nuclear medicine and biology 2019, 70:32-38.
- Fedorova TD, Knudsen K, Hartmann B, Holst JJ, Mortensen FV, Krogh K, Borghammer P: In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients. Neurogastroenterology & Motility 2019:e13759.
- Fernandez P, Zanotti-Fregonara P, Eimer S, Gimbert E, Monteil P, Penchet G, Lamare F, Perez P, Vimont D, Ledure S: Combining 3′-Deoxy-3′-[18F] fluorothymidine and MRI increases the sensitivity of glioma volume detection. Nuclear medicine communications 2019, 40(10):1066-1071.
- Fiechter M, Bengs S, Roggo A, Haider A, Marędziak M, Portmann A, Treyer V, Burger IA, Messerli M, Patriki D: Association between vertebral bone mineral density, myocardial perfusion, and long-term cardiovascular outcomes: A sex-specific analysis. Journal of Nuclear Cardiology 2019:1-11.
- Fiechter M, Haider A, Bengs S, Marędziak M, Burger IA, Roggo A, Portmann A, Schade K, Warnock GI, Treyer V: Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function. European journal of nuclear medicine and molecular imaging 2019:1-6.
- Fiechter M, Haider A, Bengs S, Marȩdziak M, Burger IA, Roggo A, Portmann A, Warnock GI, Schade K, Treyer V: Sex Differences in the Association between Inflammation and Ischemic Heart Disease. Thrombosis and haemostasis 2019.
- Fiechter M, Roggo A, Burger IA, Bengs S, Treyer V, Becker A, Marȩdziak M, Haider A, Portmann A, Messerli M: Association between resting amygdalar activity and abnormal cardiac function in women and men: a retrospective cohort study. European Heart Journal-Cardiovascular Imaging 2019, 20(6):625-632.
- Fiechter M, Roggo A, Haider A, Bengs S, Burger IA, Marędziak M, Portmann A, Treyer V, Becker AS, Messerli M: Metabolic Activity in Central Neural Structures of Patients With Myocardial Injury. Journal of the American Heart Association 2019, 8(19):e013070.
- Flanigan M, Tollefson S, Himes ML, Jordan R, Roach K, Stoughton C, Lopresti B, Mason NS, Ciccocioppo R, Narendran R: Acute Elevations in Cortisol Increase the In Vivo Binding of [11C] NOP-1A to Nociceptin Receptors: A Novel Imaging Paradigm to Study the Interaction Between Stress-and Antistress-Regulating Neuropeptides. Biological psychiatry 2019.
- Focke C, Blume T, Zott B, Shi Y, Deussing M, Peters F, Schmidt C, Kleinberger G, Lindner S, Gildehaus F-J: Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice. Journal of nuclear medicine 2019, 60(4):548-554.
- Forsberg A, Lampa J, Estelius J, Cervenka S, Farde L, Halldin C, Lekander M, Hoglund CO, Kosek E: Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C] PBR28 positron emission tomography. Journal of Neuroimmunology 2019:577000.
- Fortier M, Castellano C-A, Croteau E, Langlois F, Bocti C, St-Pierre V, Vandenberghe C, Bernier M, Roy M, Descoteaux M: A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer’s & Dementia 2019, 15(5):625-634.
- Freesmeyer M, Winkens T, Kühnel C, Opfermann T, Seifert P: Technetium-99m SPECT/US Hybrid Imaging Compared with Conventional Diagnostic Thyroid Imaging with Scintigraphy and Ultrasound. Ultrasound in medicine & biology 2019, 45(5):1243-1252.
- Frisch K, Kjærgaard K, Horsager J, Schacht AC, Munk OL: Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C] cholylsarcosine. Nuclear medicine and biology 2019, 72:55-61.
- Fujimoto A, Hori Y, Nagai Y, Kikuchi E, Oyama K, Suhara T, Minamimoto T: Signaling incentive and drive in the primate ventral pallidum for motivational control of goal-directed action. Journal of Neuroscience 2019, 39(10):1793-1804.
- Fujiwara K, Tsuji AB, Sudo H, Sugyo A, Akiba H, Iwanari H, Kusano-Arai O, Tsumoto K, Momose T, Hamakubo T: 111 In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis. Annals of nuclear medicine 2019:1-11.
- Fukai M, Bunai T, Hirosawa T, Kikuchi M, Ito S, Minabe Y, Ouchi Y: Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: a study with positron emission tomography. Translational psychiatry 2019, 9(1):115.
- Gammon ST, Pisaneschi F, Bandi ML, Smith MG, Sun Y, Rao Y, Muller F, Wong F, De Groot J, Ackroyd J: Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F] FAZA PET In Vivo. Cells 2019, 8(12):1487.
- Garcia-Arevalo M, Lorza-Gil E, Leite N, Brunetto S, Boschero AC, Carneiro EM: The 17-Beta-Estradiol Improves Insulin Sensitivity in a Rapid Estrogen Receptor Alpha-Dependent Manner in an Animal Model of Malnourishment. Journal of Endocrinology and Metabolism 2019, 9(5):133-146.
- Gebhard CE, Marędziak M, Portmann A, Bengs S, Haider A, Fiechter M, Herzog BA, Messerli M, Treyer V, Kudura K: Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging. European journal of nuclear medicine and molecular imaging 2019, 46(10):2032-2041.
- Geisler S, Stegmayr C, Niemietz N, Lohmann P, Rapp M, Stoffels G, Willuweit A, Galldiks N, Filss CP, Sabel M: Treatment-related uptake of O-(2-[18F] fluoroethyl)-L-tyrosine and L-[methyl-3H]-methionine after tumor resection in rat glioma models. Journal of Nuclear Medicine 2019, 60(10):jnumed. 119.225680.
- Gelston D, Alavi A, Rajapakse C: A study on the use of FDG180 via PET-CT for assessing bowel inflammation. Journal of Nuclear Medicine 2019, 60(supplement 1):369-369.
- Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP: The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease. Molecular neurobiology 2019:1-10.
- Ghotbi AA, Clemmensen A, Kyhl K, Follin B, Hasbak P, Engstrøm T, Ripa RS, Kjaer A: Rubidium-82 PET imaging is feasible in a rat myocardial infarction model. Journal of Nuclear Cardiology 2019, 26(3):798-809.
- Gilbert TM, Zürcher NR, Catanese MC, Tseng C-EJ, Di Biase MA, Lyall AE, Hightower BG, Parmar AJ, Bhanot A, Wu CJ: Neuroepigenetic signatures of age and sex in the living human brain. Nature communications 2019, 10(1):1-9.
- Giovannella M, Andresen B, Andersen JB, El-Mahdaoui S, Contini D, Spinelli L, Torricelli A, Greisen G, Durduran T, Weigel UM: Validation of diffuse correlation spectroscopy against 15O-water PET for regional cerebral blood flow measurement in neonatal piglets. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19883751.
- Giridharan VV, Barichello T, Selvaraj S: Molecular Imaging of Blood–Brain Barrier Permeability in Preclinical Models Using PET and SPECT. In: Blood-Brain Barrier. edn.: Springer; 2019: 329-342.
- Glud AN, Jakobsen S, Landau AM, Alstrup AKO, Sørensen JCH: Visualization of intrathecal delivery by PET-imaging. Journal of neuroscience methods 2019, 317:45-48.
- Golub MS, Hogrefe CE, Campos LJ, Fox AS: Serotonin Transporter Binding Potentials in Brain of Juvenile Monkeys 1 Year After Discontinuation of a 2-Year Treatment With Fluoxetine. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2019, 4(11):948-955.
- González Mancebo D, Becerro AI, Corral A, Moros M, Balcerzyk M, Fuente JsMdl, Ocaña M: Enhancing Luminescence and X-ray Absorption Capacity of Eu3+: LaF3 Nanoparticles by Bi3+ Codoping. ACS Omega 2019, 4(1):765-774.
- González Pardo H, Arias Pérez JL, Vallejo Seco G, Conejo Jiménez NM: Influence of environmental enrichment on the volume of brain regions sensitive to early life stress by maternal separation in rats= Influencia del enriquecimiento ambiental en el volumen de regiones cerebrales sensibles a estrés vital temprano por separación materna en ratas. Psicothema 2019.
- González-Gómez MA, Belderbos S, Yañez-Vilar S, Piñeiro Y, Cleeren F, Bormans G, Deroose CM, Gsell W, Himmelreich U, Rivas J: Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging. Nanomaterials 2019, 9(11):1626.
- González-Mancebo D, Becerro AI, Corral A, Balcerzyk M, Ocaña M: Luminescence and X-ray Absorption Properties of Uniform Eu3+:(H3O) Lu3F10 Nanoprobes. Nanomaterials 2019, 9(8):1153.
- Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K: Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial. European journal of nuclear medicine and molecular imaging 2019, 46(7):1-9.
- Guenthoer P, Fuchs K, Reischl G, Quintanilla-Martinez L, Gonzalez-Menendez I, Laufer S, Pichler BJ, Kneilling M: Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis. Inflammopharmacology 2019, 27(6):1-11.
- Haider A, Bengs S, Maredziak M, Messerli M, Fiechter M, Giannopoulos AA, Treyer V, Schwyzer M, Kamani CH, Patriki D: Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women. European journal of nuclear medicine and molecular imaging 2019:1-11.
- Haider A, Herder AM, Krämer SD, Varisco J, Keller C, Frauenknecht K, Auberson YP, Temme L, Robaa D, Sippl W: Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)-and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and Tightrope Walk between GluN2B-and Sigma1 Receptor-Targeted PET Imaging. Journal of Nuclear Medicine 2019:jnumed. 118.221051.
- Haider A, Iten I, Ahmed H, Herde AM, Gruber S, Krämer SD, Keller C, Schibli R, Wünsch B, Mu L: Identification and Preclinical Evaluation of a Radiofluorinated Benzazepine Derivative for Imaging the GluN2B Subunit of the Ionotropic NMDA Receptor. Journal of Nuclear Medicine 2019, 60(2):259-266.
- Haider A, Kretz J, Gobbi LC, Ahmed H, Atz K, Bürkler M, Bartelmus C, Fingerle J, Guba W, Ullmer C: Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of medicinal chemistry 2019, 62(24):11165-11181.
- Hammoud DA, Sinharay S, Shah S, Schreiber-Stainthorp W, Maric D, Muthusamy S, Lee DE, Lee CA, Basuli F, Reid WC: Neuroinflammatory Changes in Relation to Cerebrospinal Fluid Viral Load in Simian Immunodeficiency Virus Encephalitis. mBio 2019, 10(3):e00970-00919.
- Harris DA, Mina A, Cabarkapa D, Heshmati K, Subramaniam R, Banks AS, Tavakkoli A, Sheu EG: Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss. bioRxiv 2019:779033.
- Hatashita S, Wakebe D: Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer’s disease. Future science OA 2019, 5(3):FSO356.
- Hatashita S, Wakebe D, Kikuchi Y, Ichijo A: Longitudinal assessment of amyloid-beta deposition by [18F]-flutemetamol PET imaging compared with [11C]-PIB across the spectrum of Alzheimer’s disease. Frontiers in aging neuroscience 2019, 11:251.
- Hattori Y, Aoyama K, Maeda J, Arimura N, Takahashi Y, Sasaki M, Fujinaga M, Seki C, Nagai Y, Kawamura K: Design, synthesis, and evaluation of (4R)-1-{3-[2-(18F) fluoro-4-methylpyridin-3-yl] phenyl}-4-[4-(1, 3-thiazol-2-ylcarbonyl) piperazin-1-yl] pyrrolidin-2-one ([18F] T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase. Journal of medicinal chemistry 2019.
- Hauser EB, Venturin GT, Greggio S, Borelli WV, DaCosta J: Carotid arterial input function as an inverse problem in kinetic modeling of [18F] 2-fluoro-2 deoxy-D-glucose (FDG). Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2019:1-4.
- Hauser T-K, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, Tatagiba M, Meyer PT, Khan N, Roder C: Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. NeuroImage: Clinical 2019, 22:101713.
- Hayer S, Zeilinger M, Weiss V, Dumanic M, Seibt M, Niederreiter B, Shvets T, Pichler F, Wadsak W, Podesser BK: Multimodal [18F] FDG PET/CT is a direct readout for inflammatory bone repair: a longitudinal study in TNFα transgenic mice. Journal of Bone and Mineral Research 2019.
- He RY, Lai XM, Sun CS, Kung TS, Hong JY, Jheng YS, Liao WN, Chen JK, Liao YF, Tu PH: Nanoscopic Insights of Amphiphilic Peptide against the Oligomer Assembly Process to Treat Huntington’s Disease. Advanced Science 2019.
- He X, Jin C, Ma M, Zhou R, Wu S, Huang H, Li Y, Chen Q, Zhang M, Zhang H: PET imaging on neurofunctional changes after optogenetic stimulation in a rat model of panic disorder. Frontiers of medicine 2019, 13(5):602-609.
- Hellwig S, Frings L, Bormann T, Vach W, Buchert R, Meyer PT: Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18 F] FDG PET. European journal of nuclear medicine and molecular imaging 2019, 46(2):312-323.
- Herde AM, Mihov Y, Krämer SD, Mu L, Adamantidis A, Ametamey SM, Hasler G: Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats. Neurotoxicity research 2019:1-11.
- Herde AM, Schibli R, Weber M, Ametamey SM: Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients. European journal of nuclear medicine and molecular imaging 2019, 46(2):407-420.
- Hernández Lozano I, Bauer M, Wulkersdorfer B, Traxl A, Philippe C, Weber M, Häusler S, Stieger B, Jäger W, Mairinger S: Measurement of hepatic ABCB1 and ABCG2 transport activity with [11C] tariquidar and PET in humans and mice. Molecular Pharmaceutics 2019.
- Hobson BA, Rowland DJ, Sisó S, Guignet MA, Harmany ZT, Bandara S, Saito N, Harvey DJ, Bruun DA, Garbow JR: TSPO PET Using [18F] PBR111 Reveals Persistent Neuroinflammation Following Acute Diisopropylfluorophosphate Intoxication in the Rat. Toxicological Sciences 2019.
- Hochstrasser T, Rühling S, Hecher K, Fabisch KH, Chrzanowski U, Brendel M, Eckenweber F, Sacher C, Schmitz C, Kipp M: Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination. Cells 2019, 8(9):1024.
- Hofheinz F, Maus J, Zschaeck S, Rogasch J, Schramm G, Oehme L, Apostolova I, Kotzerke J, van den Hoff J: Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET. EJNMMI research 2019, 9(1):23.
- Horakova O, Kroupova P, Bardova K, Buresova J, Janovska P, Kopecky J, Rossmeisl M: Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Scientific reports 2019, 9(1):6156.
- Hosomi S, Koyama Y, Watabe T, Ohnishi M, Ogura H, Yamashita T, Shimazu T: Myeloid-Derived Suppressor Cells Infiltrate the Brain and Suppress Neuroinflammation in a Mouse Model of Focal Traumatic Brain Injury. Neuroscience 2019, 406:457-466.
- Houben RH, Kotsougiani D, Friedrich PF, Shin AY, Bishop AT: Outcomes of Vascularized Bone Allotransplantation with Surgically Induced Autogenous Angiogenesis in a Large Animal Model: Bone Healing, Remodeling, and Material Properties. Journal of reconstructive microsurgery 2019.
- Houben RH, Thaler R, Kotsougiani D, Friedrich PF, Shin AY, van Wijnen AJ, Bishop AT: Neo-angiogenesis, transplant viability and molecular analyses of vascularized bone allotransplantation surgery in a large animal model. Journal of Orthopaedic Research® 2019.
- Hsieh M-H, Tsai H-W, Lin K-J, Wu Z-Y, Hu H-Y, Chang Y, Wei H-J, Sung H-W: An in situ slow-releasing H2S donor depot with long-term therapeutic effects for treating ischemic diseases. Materials Science and Engineering: C 2019, 104:109954.
- Hsu M-N, Huang K-L, Yu F-J, Lai P-L, Truong AV, Lin M-W, Nguyen NTK, Shen C-C, Hwang S-M, Cheng Y-H: Co-Activation of Endogenous Wnt10b and Foxc2 by CRISPR Activation (CRISPRa) Enhances BMSCs Osteogenesis and Promotes Calvarial Bone Regeneration. Molecular Therapy 2019.
- Huang C, Wang Z, Liu L, Liu X, Dong J, Xu Q, Zhang B, Miao L: Predicting the dopamine D2 receptor occupancy of ropinirole in rats using positron emission tomography and pharmacokinetic–pharmacodynamic modeling. Xenobiotica 2019, 49(2):143-151.
- Huang C-C, Hsiao T, Huang C-Y, Weng Y-C, Huang K-L, Liu C-H, Chang T-Y, Wu H-C, Yen T-C, Lin K-J: Tau PET With 18F-THK-5351 Taiwan Patients With Familial Alzheimer’s Disease With the APP p. D678H Mutation. Frontiers in neurology 2019, 10:503.
- Huang C-Y, Hsiao T, Lin K-J, Huang K-L, Fung H-C, Liu C-H, Chang T-Y, Weng Y-C, Hsu W-C, Yen T-C: Amyloid PET pattern with dementia and amyloid angiopathy in Taiwan familial AD with D678H APP mutation. Journal of the neurological sciences 2019, 398:107-116.
- Huang EL, Steffen IG, Lukas M, Huang K, Aschenbach JR, Eary JF, Brenner W, Beindorff N: Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm. Nuklearmedizin 2019, 58(01):39-49.
- Huang K-L, Hsiao T, Kuo H-C, Hsieh C-J, Hsieh Y-C, Wu Y-M, Wey S-P, Yen T-C, Lin K-J, Huang C-C: Correlation between visual association memory test and structural changes in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Journal of the Formosan Medical Association 2019, 118(9):1325-1332.
- Huang T, Okauchi T, Hu D, Shigeta M, Wu Y, Wada Y, Hayashinaka E, Wang S, Kogure Y, Noguchi K: Pain matrix shift in the rat brain following persistent colonic inflammation revealed by voxel-based statistical analysis. Molecular pain 2019, 15:1744806919891327.
- Huang W-S, Chen G-J, Tsai T-H, Cheng C-Y, Shiue C-Y, Ma K-H, Yeh SH-H: In vivo long-lasting alterations of central serotonin transporter activity and associated dopamine synthesis after acute repeated administration of methamphetamine. EJNMMI research 2019, 9(1):1-10.
- Huang Y-Y, Chiu M-J, Yen R-F, Tsai C-L, Hsieh H-Y, Chiu C-H, Wu C-H, Hsin L-W, Tzen K-Y, Cheng C-Y: An one-pot two-step automated synthesis of [18F] T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans. PloS one 2019, 14(7):e0217384.
- Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R: Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement disorders 2019.
- Huhtala T, Poutiainen P, Rytkönen J, Lehtimäki K, Parkkari T, Kasanen I, Airaksinen AJ, Koivula T, Sweeney P, Kontkanen O: Improved synthesis of [18 F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors. EJNMMI radiopharmacy and chemistry 2019, 4(1):1-10.
- Hulpia F, Verhoeven J, Van Calenbergh S, De Vos F, Kersemans K, Bolcaen J, Goeman J, De Lombaerde S, Descamps B, Hallaert G: New Quick And Easy Publication-Will be edited by Biblio team. Quick And Easy Journal Title 2019.
- Ikoma Y, Kimura Y, Yamada M, Obata T, Ito H, Suhara T: Correction of head movement by frame-to-frame image realignment for receptor imaging in positron emission tomography studies with [11 C] raclopride and [11 C] FLB 457. Annals of nuclear medicine 2019, 33(12):916-929.
- Inoue Ki, Miyachi S, Nishi K, Okado H, Nagai Y, Minamimoto T, Nambu A, Takada M: Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism. Movement Disorders 2019, 34(2):200-209.
- Isaac-Olivé K, Ocampo-García BE, Aranda-Lara L, Santos-Cuevas CL, Jiménez-Mancilla NP, Luna-Gutiérrez MA, Medina LA, Nagarajan B, Sabnis N, Raut S: [99m Tc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging. Nanoscale 2019, 11(2):541-551.
- Ishibashi K, Miura Y, Toyohara J, Ishiwata K, Ishii K: Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer’s disease: A study using 11C-ITMM positron emission tomography. NeuroImage: Clinical 2019:101783.
- Jacob A, Ma Y, Nasiri E, Ochani M, Carrion J, Peng S, Brenner M, Huerta PT, Wang P: Extracellular cold inducible RNA-binding protein mediates binge alcohol-induced brain hypoactivity and impaired cognition in mice. Molecular Medicine 2019, 25(1):24.
- Jadoul A, Bernard C, Lovinfosse P, Gérard L, Lilet H, Cornet O, Hustinx R: Comparative dosimetry between 99m Tc-MAA SPECT/CT and 90 Y PET/CT in primary and metastatic liver tumors. European journal of nuclear medicine and molecular imaging 2019:1-10.
- Jeong J, Jeong YJ, Park KW, Kang D-Y: Cerebral Amyloid Quantification in Cognitively Normal Korean Adults Using F-18 Florbetaben PET. Nuclear medicine and molecular imaging 2019, 53(5):334-339.
- Jeong J, Jeong YJ, Park KW, Kang D-Y: Correlation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer’s Disease and Normal Brain. Nuclear medicine and molecular imaging 2019, 53(5):328-333.
- Jiao F, Gao Z, Shi K, Jia X, Wu P, Jiang C, Ge J, Su H, Guan Y, Shi S: Frequency-Dependent Relationship Between Resting-State fMRI and Glucose Metabolism in the Elderly. Frontiers in neurology 2019, 10.
- Jiao R, Allen KJ, Malo ME, Helal M, Jiang Z, Smart K, Buhl SV, Rickles D, Bryan RA, Dadachova E: Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Cancer medicine 2019, 8(11):5289-5300.
- Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M: A multimodal approach to identify clinically relevant parameters to monitor disease progression in a preclinical model of neuropediatric disease. bioRxiv 2019:522011.
- Juarez EJ, Castrellon JJ, Green MA, Crawford JL, Seaman KL, Smith CT, Dang LC, Matuskey D, Morris ED, Cowan RL: Reproducibility of the correlative triad among aging, dopamine receptor availability, and cognition. Psychology and aging 2019, 34(7):921.
- Jung KH, Oh SJ, Kang KJ, Han SJ, Nam KR, Park JA, Lee KC, Lee YJ, Choi JY: Effects of P-gp and Bcrp as brain efflux transporters on the uptake of [18F] FPEB in the murine brain. Synapse 2019.
- Kaeopookum P, Petrik M, Summer D, Klinger M, Zhai C, Rangger C, Haubner R, Haas H, Hajduch M, Decristoforo C: Comparison of 68Ga-labeled RGD mono-and multimers based on a clickable siderophore-based scaffold. Nuclear medicine and biology 2019, 78:1-10.
- Kaeopookum P, Summer D, Pfister J, Orasch T, Lechner BE, Petrik M, Novy Z, Matuszczak B, Rangger C, Haas H: Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection. Molecular Imaging and Biology 2019, 21(6):1-10.
- Kanda A, Kondo K, Hosaka N, Kobayashi Y, Bui DV, Yun Y, Suzuki K, Sawada S, Asako M, Nakamura A: Eosinophilic Upper Airway Inflammation in a Murine Model Using an Adoptive Transfer System Induces Hyposmia and Epithelial Layer Injury with Convex Lesions. Medical Sciences 2019, 7(2):22.
- Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, Mozley PD: 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson’s Disease. Journal of Neuroimaging 2019, 29(1):97-103.
- Karkare S, Allen KJ, Jiao R, Malo ME, Dawicki W, Helal M, Godson DL, Dickinson R, MacDonald-Dickinson V, Yang R: Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors. Scientific reports 2019, 9(1):1-10.
- Karlberg A, Berntsen EM, Johansen H, Skjulsvik AJ, Reinertsen I, Dai HY, Xiao Y, Rivaz H, Borghammer P, Solheim O: 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas. Clinical nuclear medicine 2019, 44(7):550-559.
- Kawamura K, Yamasaki T, Zhang Y, Wakizaka H, Hatori A, Xie L, Fujinaga M, Zhang M-R: Change in the Binding of [11 C] BU99008 to Imidazoline I 2 Receptor Using Brain PET in Zucker Rats. Molecular Imaging and Biology 2019, 21(1):105-112.
- Kazuya M, Ohnishi A, Sasaki M, Ikari Y, Aita K, Watanabe Y, Kusuhara H, Sugiyama Y, Senda M: Quantitative investigation of hepatobiliary transport of [11C] telmisartan in humans by PET imaging. Drug Metabolism and Pharmacokinetics 2019.
- Kersemans V, Gilchrist S, Wallington S, Allen PD, Gomes AL, Dias GM, Cornelissen B, Kinchesh P, Smart SC: A Carbon-Fiber Sheet Resistor for MR-, CT-, SPECT-, and PET-Compatible Temperature Maintenance in Small Animals. Tomography 2019, 5(2):274.
- Kessler M, Mamach M, Beutelmann R, Lukacevic M, Eilert S, Bascuñana P, Fasel A, Bengel F, Bankstahl J, Ross T: GABA A Receptors in the Mongolian Gerbil: a PET Study Using [18 F] Flumazenil to Determine Receptor Binding in Young and Old Animals. Molecular Imaging and Biology 2019:1-13.
- Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park M-A, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H: Quantitative [18 F] florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. European Journal of Nuclear Medicine and Molecular Imaging 2019:1-12.
- Kim D, Yoon H-J, Lee WJ, Woo SH, Kim BS: Prognostic value of 18 F-FDG brain PET as an early indicator of neurological outcomes in a rat model of post-cardiac arrest syndrome. Scientific reports 2019, 9(1):1-9.
- Kim HJ, Lim TS, Lee SM, Kim T-S, Kim Y, An Y-S, Youn YC, Park SA, Chang J, Moon SY: Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients. Journal of Clinical Neurology 2019, 15(3):353-359.
- Kim J, Choi K-H, Cho S-G, Kang S-R, Yoo SW, Kwon SY, Min J-J, Bom H-S, Song H-C: Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects. Scientific reports 2019, 9(1):949.
- Kim J, Ghadery C, Cho SS, Mihaescu A, Christopher L, Valli M, Houle S, Strafella AP: Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease. Molecular neurobiology 2019:1-10.
- Kim JH, Choe YS, Cumming P, Son YD, Kim HK, Joo YH, Kim JH: Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: an [18F] fallypride PET and fMRI study. Synapse 2019.
- Kim J-H, Joo Y-H, Son Y-D, Kim J-H, Kim Y-K, Kim H-K, Lee S-Y, Ido T: In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression. European Neuropsychopharmacology 2019, 29(2):278-290.
- Kim MJ, Lee CH, Lee Y, Youn H, Kang KW, Kwon J, Alavi A, Carlin S, Cheon GJ, Chung JK: Glucose-6-phosphatase Expression-Mediated [(18)F]FDG Efflux in Murine Inflammation and Cancer Models. Mol Imaging Biol 2019, 21(5):917-925.
- Kim Y-H, Bang J-I, Son H-J, Kim Y, Kim J, Bae H, Han S, Yoon H-J, Kim B: Protective effects of extracorporeal shockwave on rat chondrocytes and temporomandibular joint osteoarthritis; preclinical evaluation with in vivo 99mTc-HDP SPECT and ex vivo micro-CT. Osteoarthritis and cartilage 2019, 27(11):1692-1701.
- Kimura H, Yagi Y, Mikamo M, Maeda K, Kagawa S, Arimitsu K, Higashi T, Nishii R, Ono M, Nakamoto Y: Evaluation of transporter-mediated hepatobiliary transport of newly developed 18F-labeled pitavastatin derivative, PTV-F1, in rats by PET imaging. Drug metabolism and pharmacokinetics 2019, 34(5):317-324.
- Kircher M, Ihne S, Brumberg J, Morbach C, Knop S, Kortüm KM, Störk S, Buck AK, Reiter T, Bauer WR: Detection of cardiac amyloidosis with 18 F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. European journal of nuclear medicine and molecular imaging 2019:1-10.
- Klinge MW, Borghammer P, Lund S, Fedorova T, Knudsen K, Haase AM, Christiansen JJ, Krogh K: Enteric cholinergic neuropathy in patients with diabetes: Non-invasive assessment with positron emission tomography. Neurogastroenterology & Motility 2019, 32(1):e13731.
- Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart SC: Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signalling. Journal of Nuclear Medicine 2019:jnumed. 119.234708.
- Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Haase A-M, Svendsen KB, Otto M, Østergaard K, Krogh K, Borghammer P: Objective intestinal function in patients with idiopathic REM sleep behavior disorder. Parkinsonism & related disorders 2019, 58:28-34.
- Kobayashi R, Hayashi H, Kawakatsu S, Okamura N, Yoshioka M, Otani K: Assessment of amyloid deposition in patients with probable REM sleep behavior disorder as a prodromal symptom of dementia with Lewy bodies using PiB-PET. Frontiers in Neurology 2019, 10:671.
- Kolb H, Barret O, Bhattacharya A, Chen G, Constantinescu C, Huang C, Letavic M, Tamagnan G, Xia C, Zhang W: Preclinical evaluation and non-human primate receptor occupancy study of 18F-JNJ-64413739, a novel PET radioligand for P2X7 receptors. Journal of Nuclear Medicine 2019:jnumed. 118.212696.
- Kosten L, Deleye S, Stroobants S, Wyffels L, Mingote S, Rayport S, Staelens S: Molecular Imaging of mGluR5 Availability with [11 C] ABP68 in Glutaminase Heterozygous Mice. Cellular and molecular neurobiology 2019, 39(2):255-263.
- Kotsougiani D, Hundepool CA, Bulstra LF, Friedrich PF, Shin AY, Bishop AT: Bone vascularized composite allotransplantation model in swine tibial defect: Evaluation of surgical angiogenesis and transplant viability. Microsurgery 2019, 39(2):160-166.
- Kramer V, Dyssegaard A, Flores J, Soza-Ried C, Rösch F, Knudsen GM, Amaral H, Herth MM: Characterization of the serotonin 2A receptor selective PET tracer (R)-[18 F] MH. MZ in the human brain. European journal of nuclear medicine and molecular imaging 2019:1-11.
- Kramer V, Juri C, Riss PJ, Pruzzo R, Soza-Ried C, Flores J, Hurtado A, Rösch F, Chana-Cuevas P, Amaral H: Pharmacokinetic evaluation of [18 F] PR04. MZ for PET/CT imaging and quantification of dopamine transporters in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2019:1-11.
- Kreimerman I, Reyes L, Paolino A, Pardo T, Porcal W, Oliver P, Savio E, Engler H: Biological assessment of a 18F-labelled Sulforhodamine 101 in a mouse model of Alzheimer’s Disease as a potential astrocytosis marker. Frontiers in neuroscience 2019, 13:734.
- Kubik T, Kałużyński K, Burger C, Passeri A, Margiacchi S, Saletti P, Bonini R, Lorenzini E, Sciagrà R: Novel 3D heart left ventricle muscle segmentation method for PET-gated protocol and its verification. Annals of nuclear medicine 2019, 33(8):1-10.
- Kuehnel C, Winkens T, Freesmeyer M: Design, construction, and validation of a hybrid phantom for nuclear medicine and ultrasound fusion imaging. Applied Radiation and Isotopes 2019, 145:120-125.
- Kühnel C, Seifert P, Mulik C, Winkens T, Freesmeyer M: 3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration. Nuklearmedizin 2019.
- Kushchayeva YS, Startzell M, Cochran E, Auh S, Sekizkardes H, Soldin SJ, Kushchayev SV, Dieckmann W, Skarulis M, Abdul Sater Z: Thyroid hormone effects on glucose disposal in patients with insulin receptor mutations. The Journal of Clinical Endocrinology & Metabolism 2019.
- Kuttner S, Wickstrøm KK, Kalda G, Dorraji SE, Martin-Armas M, Oteiza A, Jenssen R, Fenton K, Sundset R, Axelsson J: Machine learning derived input-function in a dynamic 18 F-FDG PET study of mice. Biomedical Physics & Engineering Express 2019.
- Laguna M, Nuñez NO, Becerro AI, Lozano G, Moros M, Jesús M, Corral A, Balcerzyk M, Ocaña M: Synthesis, functionalization and properties of uniform europium-doped sodium lanthanum tungstate and molybdate (NaLa (XO4) 2, X= Mo, W) probes for luminescent and X-ray computed tomography bioimaging. Journal of colloid and interface science 2019, 554:520-530.
- Lahiri S, Kim H, Garcia-Perez I, Reza MM, Martin KA, Kundu P, Cox LM, Selkrig J, Posma JM, Zhang H: The gut microbiota influences skeletal muscle mass and function in mice. Science translational medicine 2019, 11(502):eaan5662.
- Lan Y, Bai P, Chen Z, Neelamegam R, Placzek MS, Wang H, Fiedler SA, Yang J, Yuan G, Qu X: Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). Acta Pharmaceutica Sinica B 2019, 9(6):1204-1215.
- Lane N, Nyman J, Uppuganti S, Chaudhari A, Aguirre J, Shidara K, Liu X, Yao W, Kimmel D: Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions. Bone Reports 2019:100210.
- Lavisse S, Williams S, Lecourtois S, van Camp N, Guillermier M, Gipchtein P, Jan C, Goutal S, Eymin L, Valette J: Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates. Neurobiology of disease 2019, 130:104484.
- Ledermann K, Hasler G, Jenewein J, Sprott H, Schnyder U, Martin-Soelch C: 5’UTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls–preliminary evidence. Synapse 2019.
- Lee HS, Kang Y-k, Lee H, Han JH, Moon BS, Byun S-S, Chae D-W, Kang KW, Lee WW: Compartmental-modelling-based measurement of murine glomerular filtration rate using 18 F-fluoride PET/CT. Scientific reports 2019, 9(1):1-9.
- Lee JW, Song YS, Kim H, Ku BD, Lee WW: Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson’s disease: analysis of the PPMI cohort. Frontiers in neurology 2019, 10:471.
- Lee M, Lee H-J, Jeong YJ, Oh SJ, Kang KJ, Han SJ, Nam KR, Lee YJ, Lee KC, Ryu YH: Age dependency of mGluR5 availability in 5xFAD mice measured by PET. Neurobiology of Aging 2019, 84:208-216.
- Lee MJ, Pak K, Kim JH, Kim YJ, Yoon J, Lee J, Lyoo CH, Park HJ, Lee J-H, Jung N-Y: Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease. Neurology 2019, 93(7):e665-e674.
- Legrand M, Galineau L, Novell A, Planchez B, Brizard B, Leman S, Tauber C, Escoffre J-M, Lefèvre A, Gosset P: Efficacy of chronic ultrasound neurostimulation on behaviors and distributed brain metabolism in depressive-like mice. BioRxiv 2019:813006.
- Lehner E, Gündel D, Liebau A, Plontke S, Mäder K: Intracochlear PLGA based implants for dexamethasone release: challenges and solutions. International Journal of Pharmaceutics: X 2019, 1:100015.
- Leiter I, Bascuñana P, Bengel FM, Bankstahl JP, Bankstahl M: Attenuation of epileptogenesis by 2-deoxy-d-glucose is accompanied by increased cerebral glucose supply, microglial activation and reduced astrocytosis. Neurobiology of disease 2019:104510.
- Leonel ECR, Corral A, Risco R, Camboni A, Taboga SR, Kilbride P, Vazquez M, Morris J, Dolmans M-M, Amorim CA: Stepped vitrification technique for human ovarian tissue cryopreservation. Scientific Reports 2019, 9(1):1-12.
- Lesniak WG, Chu C, Jablonska A, Azad BB, Zwaenepoel O, Zawadzki M, Lisok A, Pomper MG, Walczak P, Gettemans J: PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration. European journal of nuclear medicine and molecular imaging 2019, 46(9):1-12.
- Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M: A distinct advantage to intraarterial delivery of 89Zr-bevacizumab in PET imaging of mice with and without osmotic opening of the blood–brain barrier. Journal of Nuclear Medicine 2019, 60(5):617-622.
- L’Estrade ET, Shalgunov V, Edgar FG, Strebl-Bantillo MG, Xiong M, Crestey F, Neelamegam R, Dyssegaard A, Lehel S, Erlandsson M: Radiosynthesis and preclinical evaluation of [11C] Cimbi-701–Towards the imaging of cerebral 5-HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals 2019.
- Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K: Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging 2019:1-12.
- LEVY CdS, COSTA FGdB, FARIA DdP, STEFANO JT, COGLIATI B, OLIVEIRA CP: 18F-FDG PET/CT as an assessment tool of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease development in experimental model. Arquivos de gastroenterologia 2019(AHEAD).
- Li D, Zou S, Cheng S, Song S, Wang P, Zhu X: Monitoring the response of PD-L1 expression to EGFR-TKIs in NSCLC xenografts by immuno-PET imaging. Molecular Pharmaceutics 2019.
- Li R, Li K, Zhang L, Wang L, Chen N, Deng X, Luo M, Wu J: Autologous transplantation of photoactivated subcutaneous adipose tissue improves glucose homeostasis in high-fat diet-induced obese mice. Journal of Tissue Engineering and Regenerative Medicine 2019, 13(9):1609-1617.
- Lin PY, Chen KH, Miao YB, Chen HL, Lin KJ, Chen CT, Yeh CN, Chang Y, Sung HW: Phase-Changeable Nanoemulsions for Oral Delivery of a Therapeutic Peptide: Toward Targeting the Pancreas for Antidiabetic Treatments Using Lymphatic Transport. Advanced Functional Materials 2019:1809015.
- Lindberg A, Lu S, Nag S, Schou M, Liow J-S, Zoghbi SS, Frankland MP, Gladding RL, Morse CL, Takano A: Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors. Nuclear medicine and biology 2019, 70:1-13.
- Liu X, Ye J, Zhang Y, Liu Q, Bai R, Yuan W, Cai D, Zheng X, Bian Y, Zhou S: Ocular Biodistribution of 89 Zr-Bevacizumab in New Zealand Rabbits Determined Using PET/MRI: A Feasibility Study. Iranian Journal of Radiology 2019, 16(2).
- Lobaz V, Konefał R, Pánek J, Vlk M, Kozempel J, Petřík M, Novy Z, Gurská S, Znojek P, Štěpánek P: In Situ In Vivo radiolabeling of polymer-coated hydroxyapatite nanoparticles to track their biodistribution in mice. Colloids and Surfaces B: Biointerfaces 2019.
- Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas CA, Declercq R, Reynders T, Telan-Choing NF, Riffel K, Celen S: Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles. Journal of Nuclear Medicine 2019, 60(1):107-114.
- Lohmann P, Stavrinou P, Lipke K, Bauer EK, Ceccon G, Werner J-M, Neumaier B, Fink GR, Shah NJ, Langen K-J: FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma. European journal of nuclear medicine and molecular imaging 2019, 46(3):591-602.
- López-González FJ, Paredes-Pacheco J, Thurnhofer-Hemsi K, Rossi C, Enciso M, Toro-Flores D, Murcia-Casas B, Gutiérrez-Cardo AL, Roé-Vellvé N: QModeling: a Multiplatform, Easy-to-Use and Open-Source Toolbox for PET Kinetic Analysis. Neuroinformatics 2019, 17(1):103-114.
- Lopez-Pastor AR, Gomez-Hernandez A, Diaz-Castroverde S, Gonzalez-Aseguinolaza G, Gonzalez-Rodriguez A, Garcia G, Fernandez S, Escribano O, Benito M: Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity. Disease models & mechanisms 2019, 12(2):dmm036186.
- Lozano IH, Karch R, Bauer M, Blaickner M, Matsuda A, Wulkersdorfer B, Hacker M, Zeitlinger M, Langer O: Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography. The AAPS journal 2019, 21(4):61.
- Luft C, Greggio S, Venturin GT, da Costa MS, da Costa JC, Donadio MVF: Sex differences in the effects of acute stress on cerebral glucose metabolism: A microPET study. Brain research 2019, 1722:146355.
- Macaisa CM, Watabe T, Liu Y, Romanov V, Kanai Y, Horitsugi G, Kato H, Shimosegawa E, Hatazawa J: Preserved Cerebral Oxygen Metabolism in Astrocytic Dysfunction: A Combination Study of 15O-Gas PET with 14C-Acetate Autoradiography. Brain sciences 2019, 9(5):101.
- MacAskill MG, Walton T, Williams L, Morgan TE, Alcaide-Corral CJ, Dweck MR, Gray GA, Newby DE, Lucatelli C, Sutherland A: Kinetic modelling and quantification bias in small animal PET studies with [18F] AB5186, a novel 18 kDa translocator protein radiotracer. PloS one 2019, 14(5):e0217515.
- Maier FC, Schweifer A, Damaraju VL, Cass CE, Bowden GD, Ehrlichmann W, Kneilling M, Pichler BJ, Hammerschmidt F, Reischl G: 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, 18F-Labeling and Preclinical PET Imaging. Pharmaceuticals 2019, 12(1):31.
- Malbert CH, Genissel M, Divoux JL, Henry C: Chronic abdominal vagus stimulation increased brain metabolic connectivity, reduced striatal dopamine transporter and increased mid-brain serotonin transporter in obese miniature pigs. J Transl Med 2019, 17(1):78.
- Maleki-Balajoo S, Rahmani F, Khosrowabadi R, Meng C, Grimmer T, Drzezga A, Zarei M, Sorg C, Tahmasian M: Decoupling of inter-regional functional connectivity and regional neural activity in Alzheimer Disease. bioRxiv 2019:642629.
- Mannheim JG, Mamach M, Reder S, Traxl A, Mucha N, Disselhorst JA, Mittelhäuser M, Kuntner C, Thackeray JT, Ziegler S: Reproducibility and comparability of preclinical PET imaging data: A multi-center small animal PET study. Journal of Nuclear Medicine 2019:jnumed. 118.221994.
- Manos-Turvey A, Becker G, Francotte P, Serrano ME, Luxen A, Pirotte B, Plenevaux A, Lemaire C: Fully automated synthesis and evaluation of [18F] BPAM121: Potential of an AMPA receptor positive allosteric modulator as PET radiotracer. ChemMedChem 2019, 14(7):788-795.
- Manzano-Crespo M, Atienza M, Cantero JL: Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging. Translational neurodegeneration 2019, 8(1):34.
- Maschauer S, Ott JJ, Bernhardt G, Kuwert T, Keller M, Prante O: 18 F-labelled triazolyl-linked argininamides targeting the neuropeptide YY 1 R for PET imaging of mammary carcinoma. Scientific reports 2019, 9(1):1-12.
- McDonald ES, Doot RK, Young AJ, Schubert EK, Pryma DA, Farwell MD, Tchou J, Nayak A, Ziober A, Feldman MD: Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine 2019:jnumed. 119.232363.
- Michelson D, Grundman M, Magnuson K, Fisher R, Levenson J, Aisen P, Marek K, Gray M, Hefti F: Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer’s Disease. The journal of prevention of Alzheimer’s disease 2019, 6(4):228-231.
- Miller IS, Shiels LP, Conroy E, Connor K, Dicker P, Gallagher WM, O’Donovan N, Kerbel RS, Crown J, Byrne AT: Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents. Scientific Reports 2019, 9(1):9204.
- Min B-K, Oh CJ, Park S, Lee J-M, Go Y, Park B-Y, Kang H-J, Kim DW, Kim J-E, Yoo EK: Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation. Experimental & Molecular Medicine 2019, 51(10):1-12.
- Minn I, Huss DJ, Ahn H-H, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y: Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Science advances 2019, 5(7):eaaw5096.
- Miranda A, Glorie D, Bertoglio D, Vleugels J, De Bruyne G, Stroobants S, Staelens S, Verhaeghe J: Awake 18F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice. Journal of Nuclear Medicine 2019, 60(6):844-850.
- Miranda A, Kang MS, Blinder S, Bouhachi R, Soucy JP, Aliaga-Aliaga A, Massarweh G, Stroobants S, Staelens S, Rosa-Neto P et al: PET imaging of freely moving interacting rats. Neuroimage 2019, 191:560-567.
- Missault S, Anckaerts C, Blockx I, Deleye S, Van Dam D, Barriche N, De Pauw G, Aertgeerts S, Valkenburg F, De Deyn PP: Neuroimaging of subacute brain inflammation and microstructural changes predicts long-term functional outcome after experimental traumatic brain injury. Journal of neurotrauma 2019, 36(5):768-788.
- Mitran B, Andersson KG, Lindström E, Garousi J, Rosestedt M, Tolmachev V, Ståhl S, Orlova A, Löfblom J: Affibody‑mediated imaging of EGFR expression in prostate cancer using radiocobalt‑labeled DOTA‑ZEGFR: 2377. Oncology reports 2019, 41(1):534-542.
- Miyamoto M, Miyamoto T, Saitou J, Sato T: Longitudinal study of striatal aromatic l-amino acid decarboxylase activity in patients with idiopathic rapid eye movement sleep behavior disorder. Sleep Medicine 2019.
- Møller A, Rømer Thomsen K, Brooks DJ, Mouridsen K, Blicher JU, Hansen KV, Lou HC: Attenuation of dopamine-induced GABA release in problem gamblers. Brain and behavior 2019:e01239.
- Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A: Tau PET imaging with 18F-PI-2620 in patients with Alzheimer’s disease and healthy controls: a first-in-human study. Journal of Nuclear Medicine 2019:jnumed. 119.236224.
- Mukai H, Hatanaka K, Yagi N, Warashina S, Zouda M, Takahashi M, Narushima K, Yabuuchi H, Iwano J, Kuboyama T: Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis. Journal of controlled release 2019, 294:185-194.
- Müller-Vahl K, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, Berding G: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder. Scientific reports 2019, 9(1):972.
- Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P: Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models. Cells 2019, 8(2):94.
- Nagai Y, Miyakawa N, Takuwa H, Hori Y, Oyama K, Ji B, Takahashi M, Huang X-P, Slocum S, DiBerto JF: Deschloroclozapine: a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. bioRxiv 2019:854513.
- Nakamura T, Hiraoka K, Harada R, Matsuzawa T, Ishikawa Y, Funaki Y, Yoshikawa T, Tashiro M, Yanai K, Okamura N: Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine. Pharmacology research & perspectives 2019, 7(4):e00499.
- Narendran R, Tollefson S, Fasenmyer K, Paris J, Himes ML, Lopresti B, Ciccocioppo R, Mason NS: Decreased nociceptin receptors are related to resilience and recovery in college women who have experienced sexual violence: therapeutic implications for posttraumatic stress disorder. Biological psychiatry 2019.
- Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Peñin A, Jimenez-Urbieta H, Delgado-Alvarado M, Gago B, Quiroga-Varela A, Rodriguez-Oroz MC: Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders. European journal of nuclear medicine and molecular imaging 2019, 46(10):2065-2076.
- Nazir MS, Gould S-M, Milidonis X, Reyes E, Ismail TF, Neji R, Roujol S, O’Doherty J, Xue H, Barrington SF: Simultaneous 13 N-Ammonia and gadolinium first-pass myocardial perfusion with quantitative hybrid PET-MR imaging: a phantom and clinical feasibility study. European journal of hybrid imaging 2019, 3(1):1-14.
- Neth BJ, Mintz A, Whitlow C, Jung Y, Sai KS, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J: Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study. Neurobiology of aging 2019.
- Neves LT, Neves PFR, Paz LV, Zancan M, Milanesi BB, Lazzari GZ, da Silva RB, de Oliveira MMBP, Venturin GT, Greggio S: Increases in dendritic spine density in BLA without metabolic changes in a rodent model of PTSD. Brain Structure and Function 2019, 224(8):2857-2870.
- Nicolas CT, Hickey RD, Allen KL, Du Z, VanLith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B, Francipane MG: Ectopic hepatocyte transplantation cures the pig model of tyrosinemia. bioRxiv 2019:648493.
- Nikolaus S, Wittsack H-J, Beu M, Antke C, Hautzel H, Wickrath F, Müller-Lutz A, Silva MADS, Huston JP, Antoch G: Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity. Pharmacology Biochemistry and Behavior 2019, 179:156-170.
- Nikolaus S, Wittsack H-J, Wickrath F, Müller-Lutz A, Hautzel H, Beu M, Antke C, Mamlins E, Silva MADS, Huston JP: Differential effects of D-cycloserine and amantadine on motor behavior and D 2/3 receptor binding in the nigrostriatal and mesolimbic system of the adult rat. Scientific reports 2019, 9(1):1-14.
- No H-J, Yi H-A, Won KS, Chang HW, Kim HW: Association between white matter lesions and cerebral glucose metabolism in patients with cognitive impairment. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019.
- No H-J, Yi H-A, Won KS, Chang HW, Kim HW: Asociación entre daños en la sustancia blanca y metabolismo de la glucosa cerebral en pacientes con disfunción cognitiva. Revista Española de Medicina Nuclear e Imagen Molecular 2019, 38(3):160-166.
- Normand G, Lemoine S, Le Bars D, Merida I, Irace Z, Troalen T, Costes N, Juillard L: PET [11C] acetate is also a perfusion tracer for kidney evaluation purposes. Nuclear medicine and biology 2019, 76:10-14.
- Novy Z, Stepankova J, Hola M, Flasarova D, Popper M, Petrik M: Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme. Molecules 2019, 24(13):2496.
- Okonkwo DO, Puffer RC, Minhas DS, Beers SR, Edelman KL, Sharpless JM, Laymon CM, Lopresti BJ, Benso S, Puccio AM: [18F] FDG,[11C] PiB, and [18F] AV-1451 PET imaging of neurodegeneration in two subjects with a history of repetitive trauma and cognitive decline. Frontiers in neurology 2019, 10:831.
- O’Neill E, Kersemans V, Allen PD, Terry SY, Torres JB, Mosley M, Smart SC, Lee BQ, Falzone N, Vallis KA: Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy. Journal of Nuclear Medicine 2019:jnumed. 119.232934.
- Ooms M, Tsujikawa T, Lohith TG, Mabins SN, Zoghbi SS, Sumitomo A, Jaaro-Peled H, Kimura Y, Telu S, Pike VW: [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice. Journal of Cerebral Blood Flow & Metabolism 2019, 39(7):1306-1313.
- Orteca G, Pisaneschi F, Rubagotti S, Liu TW, Biagiotti G, Piwnica-Worms D, Iori M, Capponi PC, Ferrari E, Asti M: Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules 2019, 24(3):644.
- Otaki Y, Manabe O, Miller RJ, Manrique A, Nganoa C, Roth N, Berman DS, Germano G, Slomka PJ, Agostini D: Quantification of myocardial blood flow by CZT-SPECT with motion correction and comparison with 15 O-water PET. Journal of Nuclear Cardiology 2019:1-10.
- Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C: Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid-and 18F-FDG-PET imaging. NeuroImage: Clinical 2019, 22:101771.
- Ottoy J, Verhaeghe J, Niemantsverdriet E, De Roeck E, Ceyssens S, Van Broeckhoven C, Engelborghs S, Stroobants S, Staelens S: 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer’s disease: Validation against 15O-H2O PET. Alzheimer’s & Dementia 2019, 15(9):1172-1182.
- Ouach A, Vercouillie J, Bertrand E, Rodrigues N, Pin F, Serriere S, Boiaryna L, Chartier A, Percina N, Tangpong P: Bis (het) aryl-1, 2, 3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity,[18F]-radiolabeling and PET study in rats. European Journal of Medicinal Chemistry 2019.
- Overgaard MD, Duvald CS, Vendelbo MH, Pedersen SB, Jakobsen S, Alstrup AKO, Mikkelsen E, Ovesen PG, Pedersen M: Biodistribution of [11C]-Metformin and mRNA Expression of Placentae Metformin Transporters in the Pregnant Chinchilla. Contrast Media & Molecular Imaging 2019, 2019:9787340.
- Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis K, Carlisle R: Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release 2019.
- Pak K, Kim H, Seok JW, Lee MJ, Shin S, Kim K, Lee JM, Seo Y, Kim BS, Jun S: Prediction of future weight change with dopamine transporter in patients with Parkinson’s disease. Journal of Neural Transmission 2019:1-7.
- Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Prediction of future weight change with the dopamine transporter. Brain imaging and behavior 2019, 13(3):588-593.
- Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün P-Y, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H: Comparison of 18 F-Choline PET/CT and MRI functional parameters in prostate cancer. Annals of nuclear medicine 2019, 33(1):47-54.
- Pang H-H, Chen P-Y, Wei K-C, Huang C-W, Shiue Y-L, Huang C-Y, Yang H-W: Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors. Theranostics 2019, 9(6):1752.
- Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, Smart S, Gilchrist S, Gouverneur V, Sibson NR: Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia. Glia 2019.
- Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wang R, Pomper MG, Wong DF, Benzinger TL, Zhou Y: The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. NeuroImage: Clinical 2019, 22.
- Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N: Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nature neuroscience 2019, 22(2):191.
- Park H, Kim HS, Hong YJ, Min J-J, Kim HB, Kim MC, Sim DS, Kim JH, Kim D-Y, Lee JS: Therapeutic Effect of Fimasartan in a Rat Model of Myocardial Infarction Evaluated by Cardiac Positron Emission Tomography with [18F] FPTP. Chonnam Medical Journal 2019, 55(2):109-115.
- Park J, Kim S-E, Kim E-J, Lee BI, Jeong JH, Na HR, Choi SH, Kang D-Y, Park KW: Effect of 12-week home-based cognitive training on cognitive function and brain metabolism in patients with amnestic mild cognitive impairment. Clinical interventions in aging 2019, 14:1167.
- Park J-H, Hong J-H, Lee S-W, Ji HD, Jung J-A, Yoon K-W, Lee J-I, Won KS, Song B-I, Kim HW: The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer’s disease: A positron emission tomography study in rats. Scientific reports 2019, 9(1):1-9.
- Park SH, Song YS, Moon BS, Lee BC, Park HS, Kim SE: Combination of In Vivo [123I] FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum. Experimental neurobiology 2019, 28(5):602.
- Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu MM, Spann B, Román GC, Schulz PE, Karmonic C: Multimodal 18F-AV-1451 and MRI findings in non-fluent variant primary progressive aphasia: possible insights on nodal propagation of tau protein across the syntactic network. Journal of Nuclear Medicine 2019:jnumed. 118.225508.
- Paul S, Gallagher E, Liow J-S, Mabins S, Henry K, Zoghbi SS, Gunn RN, Kreisl WC, Richards EM, Zanotti-Fregonara P: Building a database for brain 18 kDa translocator protein imaged using [11C] PBR28 in healthy subjects. Journal of Cerebral Blood Flow & Metabolism 2019, 39(6):1138-1147.
- Paul S, Haskali MB, Liow J-S, Zoghbi SS, Barth VN, Kolodrubetz MC, Bond MR, Morse CL, Gladding RL, Frankland MP: Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse. Journal of Nuclear Medicine 2019, 60(1):129-134.
- Pauwelyn G, Vlerick L, Dockx R, Verhoeven J, Dobbeleir A, Peremans K, Goethals I, Bosmans T, Vanhove C, De Vos F: PET quantification of [18F] MPPF in the canine brain using blood input and reference tissue modelling. PloS one 2019, 14(6):e0218237.
- Peng S-L, Chiu H, Wu C-Y, Huang C-W, Chung Y-H, Shih C-T, Shen W-C: The effect of caffeine on cerebral metabolism during alpha-chloralose anesthesia differs from isoflurane anesthesia in the rat brain. Psychopharmacology 2019, 236(6):1-9.
- Pereira HR, Ferreira HA: Classification of Patients with Parkinson’s Disease Using Medical Imaging and Artificial Intelligence Algorithms. In: Mediterranean Conference on Medical and Biological Engineering and Computing: 2019: Springer; 2019: 2043-2056.
- Peretti DE, García DV, Reesink FE, Doorduin J, de Jong BM, De Deyn PP, Dierckx RA, Boellaard R: Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease. EJNMMI research 2019, 9(1):1-9.
- Peretti DE, García DV, Reesink FE, van der Goot T, De Deyn PP, de Jong BM, Dierckx RA, Boellaard R: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies. PloS one 2019, 14(1):e0211000.
- Philippe C, Zeilinger M, Dumanic M, Pichler F, Fetty L, Vraka C, Balber T, Wadsak W, Pallitsch K, Spreitzer H: SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18 F] FE@ SNAP and [11 C] SNAP-7941. Molecular Imaging and Biology 2019, 21(2):257-268.
- Ponto LLB, Moser DJ, Menda Y, Harlynn EL, DeVries SD, Oleson JJ, Magnotta VA, Schultz SK: Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures. J Neuroimaging 2019, 29(1):85-96.
- Prando S, Carneiro CdG, Otsuki DA, Sapienza MT: Effects of ketamine/xylazine and isoflurane on rat brain glucose metabolism measured by 18F-fluorodeoxyglucose-positron emission tomography. European Journal of Neuroscience 2019, 49(1):51-61.
- Prando S, Carneiro CdG, Robilotta CC, Sapienza MT: Comparison of different quantification methods for 18F-fluorodeoxyglucose-positron emission tomography studies in rat brains. Clinics 2019, 74:e1273.
- Puig O, Henriksen OM, Vestergaard MB, Hansen AE, Andersen FL, Ladefoged CN, Rostrup E, Larsson HB, Lindberg U, Law I: Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19874643.
- Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB: Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states–A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system. Journal of Cerebral Blood Flow & Metabolism 2019, 39(12):2368-2378.
- Pulagam KR, Gona KB, Gómez-Vallejo V, Meijer J, Zilberfain C, Estrela-Lopis I, Baz Z, Cossío U, Llop J: Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation. Molecules 2019, 24(19):3609.
- Pyo A, Kim HS, Kim HS, Yun M, Kim D-Y, Min J-J: N-(2-(Dimethylamino) Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma. Journal of Nuclear Medicine 2019, 60(7):924-929.
- Qiao L, Fisher E, McMurray L, Milicevic Sephton S, Hird M, Kuzhuppilly-Ramakrishnan N, Williamson DJ, Zhou X, Werry E, Kassiou M: Radiosynthesis of (R, S)-[18F] GE387: A Potential PET Radiotracer for Imaging Translocator Protein 18 kDa (TSPO) with Low Binding Sensitivity to the Human Gene Polymorphism rs6971. ChemMedChem 2019, 14(9):982-993.
- Qin C, Shao F, Hu F, Song W, Song Y, Guo J, Lan X: 18 F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. European Journal of Nuclear Medicine and Molecular Imaging 2019:1-11.
- QUELVEN I, Monteil J, Sage M, Saidi A, Mounier J, Bayout A, Garrier J, Cogne M, Durand-Panteix S: 212Pb Alpha-Radioimmunotherapy targeting CD38 in Multiple Myeloma: a preclinical study. Journal of Nuclear Medicine 2019:jnumed. 119.239491.
- Quevenco FC, Schreiner SJ, Preti MG, van Bergen J, Kirchner T, Wyss M, Steininger SC, Gietl A, Leh SE, Buck A: GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults. NeuroImage: Clinical 2019, 22:101776.
- Radaram B, Pisaneschi F, Rao Y, Yang P, Piwnica-Worms D, Alauddin MM: Novel derivatives of anaplastic lymphoma kinase inhibitors: Synthesis, radiolabeling, and preliminary biological studies of fluoroethyl analogues of crizotinib, alectinib, and ceritinib. European journal of medicinal chemistry 2019, 182:111571.
- Raychaudhuri S, Abria C, Harmany ZT, Smith CM, Kundu-Raychaudhuri S, Raychaudhuri SP, Chaudhari AJ: Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo 18F-FDG PET. International journal of rheumatic diseases 2019.
- Real CC, Doorduin J, Kopschina Feltes P, Vállez García D, de Paula Faria D, Britto LR, de Vries EF: Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson’s disease using [11C] PBR28 and [18F] FDOPA PET. Journal of Cerebral Blood Flow & Metabolism 2019, 39(6):989-1004.
- Reilly SW, Puentes LN, Schmitz A, Hsieh C-J, Weng C-C, Hou C, Li S, Kuo Y-M, Padakanti P, Lee H: Synthesis and evaluation of an AZD2461 [18F] PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant. Bioorganic chemistry 2019, 83:242-249.
- Reisinger SN, Wanek T, Langer O, Pollak DD: PET imaging of the mouse brain reveals a dynamic regulation of SERT density in a chronic stress model. Translational psychiatry 2019, 9(1):80.
- Ren Q, Mohri K, Warashina S, Wada Y, Watanabe Y, Mukai H: Improved immuno-PET imaging of HER2-positive tumors in mice: Urokinase injection-triggered clearance enhancement of 64Cu-trastuzumab. Molecular pharmaceutics 2019, 16(3):1065-1073.
- Rezaei A, Schramm G, Willekens SM, Delso G, Van Laere K, Nuyts J: A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF-PET/MR Brain Imaging. Journal of Nuclear Medicine 2019, 60(11):jnumed. 118.220871.
- Richter N, Nellessen N, Dronse J, Dillen K, Jacobs HI, Langen K-J, Dietlein M, Kracht L, Neumaier B, Fink GR: Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD. NeuroImage: Clinical 2019, 24:101978.
- Ricobaraza A, Mora-Jimenez L, Puerta E, Sanchez-Carpintero R, Mingorance A, Artieda J, Nicolas MJ, Besne G, Bunuales M, Gonzalez-Aparicio M: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation. Scientific reports 2019, 9(1):1-15.
- Ritawidya R, Wenzel B, Teodoro R, Toussaint M, Kranz M, Deuther-Conrad W, Dukic-Stefanovic S, Ludwig F-A, Scheunemann M, Brust P: Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography. Molecules 2019, 24(22):4149.
- Rivera-Marrero S, Fernández-Maza L, León-Chaviano S, Sablón-Carrazana M, Bencomo-Martínez A, Perera-Pintado A, Prats-Capote A, Zoppolo F, Kreimerman I, Pardo T: [18F] Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations. Current radiopharmaceuticals 2019, 12(1):58-71.
- Román M, López I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Echavarri-de Miguel M: Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network. Cancer research 2019, 79(3):625-638.
- Rosestedt M, Andersson KG, Rinne SS, Leitao CD, Mitran B, Vorobyeva A, Ståhl S, Löfblom J, Tolmachev V, Orlova A: Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake. Scientific reports 2019, 9(1):6779.
- Rubinstein E, Salhov M, Nidam-Leshem M, White V, Golan S, Baniel J, Bernstine H, Groshar D, Averbuch A: Unsupervised tumor detection in Dynamic PET/CT imaging of the prostate. Medical image analysis 2019, 55:27-40.
- Rudisile S, Gosewisch A, Wenter V, Unterrainer M, Böning G, Gildehaus F, Fendler W, Auernhammer C, Spitzweg C, Bartenstein P: Salvage PRRT with 177 Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival. BMC cancer 2019, 19(1):1-9.
- Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, Deussing M, Albert NL, Unterrainer M, Lindner S: Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model. Journal of Nuclear Medicine 2019, 60(12):1787-1793.
- Sachpekidis C, Karampinis I, Jakob J, Kasper B, Nowak K, Pilz L, Attenberger U, Gaiser T, Derigs H-G, Schwarzbach M: Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group. Cancers 2019, 11(6):790.
- Sachpekidis C, Kopp-Schneider A, Hakim-Meibodi L, Dimitrakopoulou-Strauss A, Hassel JC: 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Melanoma research 2019, 29(2):178-186.
- Sah B-R, Sommerauer M, Mu L, Gonzalez GP, Geistlich S, Treyer V, Schibli R, Buck A, Warnock G, Ametamey SM: Radiation dosimetry of [18 F]-PSS232—a PET radioligand for imaging mGlu5 receptors in humans. EJNMMI research 2019, 9(1):56.
- Sakai K, Passioura T, Sato H, Ito K, Furuhashi H, Umitsu M, Takagi J, Kato Y, Mukai H, Warashina S: Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor. Nature chemical biology 2019, 15(6):598.
- Salerno M, Ferrer E, Wei S, Li X, Gao W, Ouellette D, Balanoff A, Vaska P: Behavioral neuroimaging in birds using PET. Journal of neuroscience methods 2019, 317:157-164.
- Sandiego CM, Barret O, Lee H, Alagille D, Amenta A, Fowles K, Holden D, Seibyl JP, Tamagnan G: Imaging histamine H3 receptors with [18F] FMH3: Test–retest and occupancy studies in the non-human primate. Synapse 2019, 73(7):e22096.
- Sarnyai Z, Nagy K, Patay G, Molnár M, Rosenqvist G, Tóth M, Takano A, Gulyás B, Major P, Halldin C: Performance Evaluation of a High-Resolution Nonhuman Primate PET/CT System. Journal of Nuclear Medicine 2019, 60(12):1818-1824.
- Satoh Y, Sekine T, Omiya Y, Onishi H, Motosugi U: Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography. EJNMMI physics 2019, 6(1):1-11.
- Schiano C, Franzese M, Pane K, Garbino N, Soricelli A, Salvatore M, de Nigris F, Napoli C: Hybrid 18F-FDG-PET/MRI Measurement of Standardized Uptake Value Coupled with Yin Yang 1 Signature in Metastatic Breast Cancer. A Preliminary Study. Cancers 2019, 11(10):1444.
- Schiller F, Frings L, Thurow J, Meyer PT, Mix M: Limits for reduction of acquisition time or administered activity in 18F-FDG PET studies in Alzheimer’s and frontotemporal dementia. Journal of Nuclear Medicine 2019:jnumed. 119.227132.
- Schinke C, Hesse S, Rullmann M, Becker G-A, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K: Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress 2019, 22(1):93-102.
- Schneider D, Oskamp A, Holschbach M, Neumaier B, Bier D, Bauer A: Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor. Nuclear Medicine and Biology 2019, 82-83:1-8.
- Schönecker S, Brendel M, Palleis C, Beyer L, Höglinger GU, Schuh E, Rauchmann B-S, Sauerbeck J, Rohrer G, Sonnenfeld S: PET imaging of astrogliosis and tau facilitates diagnosis of parkinsonian syndromes. Frontiers in aging neuroscience 2019, 11:249.
- Schramm G, Koole M, Willekens S, Rezaei A, Van Weehaeghe D, Delso G, Peeters R, Mertens N, Nuyts J, Van Laere K: Regional accuracy of ZTE-based attenuation correction in static [18 F] FDG and dynamic [18 F] PE2I brain PET/MR. Frontiers in Physics 2019, 7:211.
- Seifert P, Winkens T, Knichel L, Kühnel C, Freesmeyer M: Stitching of 3D ultrasound datasets for the determination of large thyroid volumes–phantom study part II: mechanically-swept probes. Medical ultrasonography 2019, 21(4):389-398.
- Seifert P, Winkens T, Kühnel C, Gühne F, Freesmeyer M: I-124-PET/US Fusion Imaging in Comparison to Conventional Diagnostics and Tc-99m Pertechnetate SPECT/US Fusion Imaging for the Function Assessment of Thyroid Nodules. Ultrasound in medicine & biology 2019, 45(9):2298-2308.
- Serrano ME, Becker G, Bahri MA, Seret A, Mestdagh N, Mercier J, Mievis F, Giacomelli F, Lemaire C, Salmon E: Evaluating the In Vivo Specificity of [18F] UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules 2019, 24(9):1705.
- Servaes S, Kara F, Glorie D, Stroobants S, Van Der Linden A, Staelens S: In Vivo Preclinical Molecular Imaging of Repeated Exposure to an N-methyl-d-aspartate Antagonist and a Glutaminase Inhibitor as Potential Glutamatergic Modulators. J Pharmacol Exp Ther 2019, 368(3):382-390.
- Shin S, Kim K, Lee JM, Kim E-J, Kim S-J, Kim IJ, Pak K, Lee MJ: Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson’s Disease. Journal of Clinical Neurology 2019, 15(1):102-107.
- Shin S, Kim K, Pak K, Nam H-Y, Kim S-J, Kim IJ: Effects of Maturation on Striatal Dopamine Transporter Availability in Rats. Nuklearmedizin 2019, 58(05):395-400.
- Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S: Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology 2019, 92(2):e136-e147.
- Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T: Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET. Molecular psychiatry 2019:1-10.
- Singhal T, O’Connor K, Dubey S, Pan H, Chu R, Hurwitz S, Cicero S, Tauhid S, Silbersweig D, Stern E: Gray matter microglial activation in relapsing vs progressive MS: A [F-18] PBR06-PET study. Neurology-Neuroimmunology Neuroinflammation 2019, 6(5):e587.
- Sinharay S, Tu T-W, Kovacs ZI, Schreiber-Stainthorp W, Sundby M, Zhang X, Papadakis GZ, Reid WC, Frank JA, Hammoud DA: In vivo imaging of sterile microglial activation in rat brain after disrupting the blood-brain barrier with pulsed focused ultrasound:[18F] DPA-714 PET study. Journal of neuroinflammation 2019, 16(1):155.
- Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR: Lack of consistent sex differences in d-amphetamine-induced dopamine release measured with [18 F] fallypride PET. Psychopharmacology 2019, 236(2):581-590.
- Smith R, Schöll M, Leuzy A, Jögi J, Ohlsson T, Strandberg O, Hansson O: Head-to-head comparison of tau positron emission tomography tracers [18 F] flortaucipir and [18 F] RO948. European journal of nuclear medicine and molecular imaging 2019:1-13.
- Smith R, Wibom M, Pawlik D, Englund E, Hansson O: Correlation of in vivo [18F] Flortaucipir with postmortem Alzheimer disease tau pathology. JAMA neurology 2019, 76(3):310-317.
- Socan A, Petrik M, Peitl PK, Krošelj M, Rangger C, Novy Z, Svajger U, Gmeiner T, Decristoforo C: Novel cell labelling method for PET. Nuclear Medicine and Biology 2019.
- Socan A, Petrik M, Peitl PK, Krošelj M, Rangger C, Novy Z, Svajger U, Gmeiner T, Decristoforo C: On-cartridge preparation and evaluation of 68Ga-, 89Zr-and 64Cu-precursors for cell radiolabelling. Nuclear medicine and biology 2019, 71:23-31.
- Sorci O, Batzdorf AS, Mayer M, Rhodes S, Peng M, Jankelovits AR, Hornyak JN, Gerke O, Høilund-Carlsen PF, Alavi A: 18 F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification. European journal of nuclear medicine and molecular imaging 2019:1-10.
- Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA, Diazgranados N, Preston KL, Herscovitch P, Tomasi D: Striatal Dopamine Release in response to Morphine: a [11C]-raclopride positron emission tomography study in Healthy Men. Biological Psychiatry 2019, 86(5):356-364.
- Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R: Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18 F] GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Molecular Imaging and Biology 2019:1-10.
- Stegmayr C, Stoffels G, Kops ER, Lohmann P, Galldiks N, Shah NJ, Neumaier B, Langen K-J: Influence of Dexamethasone on O-(2-[18 F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake. Molecular Imaging and Biology 2019, 21(1):168-174.
- Steimle A, Michaelis L, Di Lorenzo F, Kliem T, Münzner T, Maerz JK, Schäfer A, Lange A, Parusel R, Gronbach K: Weak Agonistic LPS Restores Intestinal Immune Homeostasis. Molecular Therapy 2019, 27(11):1974-1991.
- Steinemann G, Dittmer A, Schmidt J, Josuttis D, Fähling M, Biersack B, Beindorff N, Koziolek EJ, Schobert R, Brenner W: Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer. Molecular oncology 2019, 13(12):2679-2696.
- Stenzel J, Rühlmann C, Lindner T, Polei S, Teipel S, Kurth J, Rominger A, Krause B, Vollmar B, Kuhla A: [18F]-florbetaben PET/CT Imaging in the Alzheimer’s Disease Mouse Model APPswe/PS1dE9. Current Alzheimer Research 2019, 16(1):49-55.
- Stergiou N, Nagel J, Pektor S, Heimes A-S, Jäkel J, Brenner W, Schmidt M, Miederer M, Kunz H, Roesch F: Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer. International journal of medical sciences 2019, 16(9):1188.
- Stieb S, Riesterer O, Boss A, Weiss T, Guckenberger M, Özbay PS, Nanz D, Rossi C: Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies. Neuroradiology 2019, 61(7):1-11.
- Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Fedorova TD, Santamaria J: Cholinergic denervation in idiopathic rapid eye movement sleep behaviour disorder patients. European journal of neurology 2019.
- Suchacki KJ, Tavares AA, Mattiucci D, Scheller EL, Papanastasiou G, Gray C, Sinton MC, Ramage LE, McDougald WA, Lovdel A: Bone marrow adipose tissue is a unique adipose subtype with distinct roles in systemic glucose homeostasis. bioRxiv 2019:673129.
- Sugyo A, Aung W, Tsuji AB, Sudo H, Takashima H, Yasunaga M, Matsumura Y, Saga T, Higashi T: Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer. Oncology reports 2019, 41(4):2371-2378.
- Sundar LK, Muzik O, Rischka L, Hahn A, Rausch I, Lanzenberger R, Hienert M, Klebermass E-M, Füchsel F-G, Hacker M: Towards quantitative [18F] FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates. Journal of Cerebral Blood Flow & Metabolism 2019, 39(8):1516-1530.
- Svoboda J, Litvinec A, Kala D, Pošusta A, Vávrová L, Jiruška P, Otáhal J: Strain Differences in Intraluminal Thread Model of Middle Cerebral Artery Occlusion in Rats. Physiological research 2019, 68(1):37-48.
- Tai YC, Chi MH, Chu C-L, Chiu NT, Yao WJ, Chen PS, Yang YK: Availability of striatal dopamine transporter in healthy individuals with and without a family history of ADHD. Journal of attention disorders 2019, 23(7):665-670.
- Takamura Y, Shibahara O, Watanabe M, Fujihara M, Yamada S, Akehi M, Sasaki T, Hirano H, Kakuta H: Fluorine-18 (18F)-labeled Retinoid X Receptor (RXR) Partial Agonist whose Tissue Transferability is Affected by Other RXR Ligands. Bioorganic & Medicinal Chemistry 2019.
- Takano A, Chen L, Nag S, Brodney MA, Arakawa R, Chang C, Amini N, Doran SD, Dutra JK, McCarthy TJ: Quantitative Analysis of 18F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate Brain. Journal of Nuclear Medicine 2019, 60(7):992-997.
- Takeuchi J, Kikukawa T, Saito H, Hasegawa I, Takeda A, Hatsuta H, Kawabe J, Wada Y, Mawatari A, Igesaka A: Amyloid-Negative Dementia in the Elderly is Associated with High Accumulation of Tau in the Temporal Lobes. The Open Biomedical Engineering Journal 2019, 13(1).
- Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC: Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18 F] Fluoroethoxy) phenyl)-5-Methylpyrazolo [1, 5-a] Pyrimidin-3-yl)-N, N-Diethylacetamide (18 F-VUIIS1018A) to Image Glioma. Molecular Imaging and Biology 2019, 21(1):113-121.
- Tang J, Yang B, Adams MP, Shenkov NN, Klyuzhin IS, Fotouhi S, Davoodi-Bojd E, Lu L, Soltanian-Zadeh H, Sossi V: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging Features. Molecular Imaging and Biology 2019:1-9.
- Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, Shimada H, Suhara T, Higuchi M, Ouchi Y: In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 2019:1-11.
- Thapa N, Jeong Y-J, Kang H, Choi G-E, Yoon H-J, Kang D-Y: A Comparative Study of [F-18] Florbetaben (FBB) PET Imaging, Pathology, and Cognition between Normal and Alzheimer Transgenic Mice. Biomedical Science Letters 2019, 25(1):7-14.
- Thomas E, Menon JU, Owen J, Skaripa-Koukelli I, Wallington S, Gray M, Mannaris C, Kersemans V, Allen D, Kinchesh P: Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. Theranostics 2019, 9(19):5595.
- Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV: The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2019:1-13.
- Thonglim P, Chotipanich C, Buranasiri P: Optimized uptake time of 18F-THK5351 PET/CT in normal Thai brain. Journal of Physics Communications 2019, 3(7):075011.
- Thonglim P, Chotipanich C, Iamsa-art C, Jantarato A, Buranasiri P: Surface of quantitative uptake value of radiopharmaceutical PET/CT in normal Thai population. In: Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVII: 2019: International Society for Optics and Photonics; 2019: 108681I.
- Tible M, Mouton Liger F, Schmitt J, Giralt A, Farid K, Thomasseau S, Gourmaud S, Paquet C, Rondi Reig L, Meurs E: PKR knockout in the 5xFAD model of Alzheimer’s disease reveals beneficial effects on spatial memory and brain lesions. Aging cell 2019, 18(3):e12887.
- Tiepolt S, Luthardt J, Patt M, Hesse S, Hoffmann KT, Weise D, Gertz HJ, Barthel H: Early after Administration [11C] PiB PET Images Correlate with Cognitive Dysfunction Measured by the CERAD Test Battery. Journal of Alzheimer’s Disease 2019, 68(Preprint):1-12.
- Tjörnstrand A, Casar-Borota O, Heurling K, Schöll M, Gjertsson P, Himmelman J, Itsenko O, Ragnarsson O, Nyström HF: Lower 68Ga-DOTATOC Uptake in Non-Functioning Pituitary Neuroendocrine Tumors Compared to Normal Pituitary Gland–a Proof-of-Concept Study. Clinical Endocrinology 2019.
- Tobey H, Lucas T, Bledsoe D, Mykins M, Campbell C, Berr SS, Sasser T, Helm R, Brolinson P, Klein B: Effect of Osteopathic Cranial Manipulative Medicine on an Aged Rat Model of Alzheimer Disease. The Journal of the American Osteopathic Association 2019, 119(11):713.
- Tobon G, Hesterman J, Patel S, Lackas C: High-Level Story: Data Analysis in Multimodal Preclinical Imaging—Methods and Tools. In: Image Fusion in Preclinical Applications. edn.: Springer; 2019: 1-24.
- Toledano M, Gutierrez-Pérez JL, Gutierrez-Corrales A, Serrera-Figallo MA, Toledano-Osorio M, Rosales-Leal JI, Aguilar M, Osorio R, Torres-Lagares D: Novel non-resorbable polymeric-nanostructured scaffolds for guided bone regeneration. Clinical oral investigations 2019:1-13.
- Tollefson S, Gertler J, Himes ML, Paris J, Kendro S, Lopresti B, Scott Mason N, Narendran R: Imaging phosphodiesterase-10a availability in cocaine use disorder with [11C] IMA107 and PET. Synapse 2019, 73(1):e22070.
- Tomadesso C, Gonneaud J, Egret S, Perrotin A, Pélerin A, de Flores R, de la Sayette V, Desgranges B, Chételat G, La Joie R: Is there a specific memory signature associated with Aβ-PET positivity in patients with amnestic mild cognitive impairment? Neurobiology of aging 2019, 77:94-103.
- Tomasi DG, Wiers CE, Shokri-Kojori E, Zehra A, Ramirez V, Freeman C, Burns J, Kure Liu C, Manza P, Kim SW: Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity. International Journal of Neuropsychopharmacology 2019, 22(9):548-559.
- Tool K: Positron Emission Tomography. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development 2019:191.
- Tournier BB, Tsartsalis S, Ceyzériat K, Medina Z, Fraser BH, Grégoire M-C, Kövari E, Millet P: Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19860408.
- Tournier N, Bauer M, Pichler V, Nics L, Klebermass E-M, Bamminger K, Matzneller P, Weber M, Karch R, Caille F: Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans. Journal of Nuclear Medicine 2019, 60(7):jnumed. 118.219972.
- Toyohara J, Yamamoto H, Tago T: Searching for diagnostic properties of novel fluorine-18-labeled d-allose. Annals of nuclear medicine 2019, 33(11):855-865.
- Tran VH, Park H, Park J, Kwon Y-D, Kang S, Jung JH, Chang K-A, Lee BC, Lee S-Y, Kang S: Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo [1, 5-a] pyrimidin-3-yl acetamide. Bioorganic & medicinal chemistry 2019, 27(18):4069-4080.
- Truong VA, Hsu M-N, Nguyen K, Thi N, Lin M-W, Shen C-C, Lin C-Y, Hu Y-C: CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration. Nucleic acids research 2019, 47(13):e74.
- Tsai H-H, Pasi M, Tsai L-K, Chen Y-F, Lee B-C, Tang S-C, Fotiadis P, Huang C-Y, Yen R-F, Jeng J-S: Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology 2019, 92(8):e774-e781.
- Tsai S-Y, Wu Y-W, Wang S-Y, Shiau Y-C, Chiu K-M, Tsai H-Y, Lee C-L, Hsu J-C, Tu C-M, Lin H-H: Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction. European journal of nuclear medicine and molecular imaging 2019, 46(12):2601-2609.
- Tseng J-R, Chang Y-H, Yang L-Y, Wu C-T, Chen S-Y, Wan C-H, Hsiao T, Yen T-C: Potential usefulness of 68 Ga-citrate PET/CT in detecting infected lower limb prostheses. EJNMMI research 2019, 9(1):2.
- Tsukada H: PET Imaging of Mitochondrial Function in the Living Brain. In: Mitochondrial and Brain Disorders. edn.: IntechOpen; 2019.
- Tuura ROG, Warnock G, Ametamey S, Treyer V, Noeske R, Buck A, Sommerauer M: Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study. NeuroImage 2019, 184:826-833.
- Ulke C, Rullmann M, Huang J, Luthardt J, Becker G-A, Patt M, Meyer PM, Tiepolt S, Hesse S, Sabri O: Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S, S)-O-[11 C] methylreboxetine positron emission tomography study. Translational psychiatry 2019, 9(1):1-10.
- Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J: Comparison of 18 F-GE-180 and dynamic 18 F-FET PET in high grade glioma: a double-tracer pilot study. European journal of nuclear medicine and molecular imaging 2019, 46(3):580-590.
- Vainio S, Dickens A, Tuisku J, Eskola O, Solin O, Löyttyniemi E, Anthony D, Rinne J, Airas L, Haaparanta-Solin M: Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation. EJNMMI research 2019, 9(1):38.
- Vairo C, Collantes M, Quincoces G, Villullas S, Peñuelas I, Pastor M, Gil A, Gainza E, Hernandez R, Igartua M: Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies. International journal of pharmaceutics 2019, 569:118484.
- Valli M, Cho SS, Masellis M, Chen R, Rusjan P, Kim J, Koshimori Y, Mihaescu A, Strafella AP: DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum. Molecular neurobiology 2019, 56(9):1-9.
- Van Camp N, Balbastre Y, Herard A-S, Lavisse S, Tauber C, Wimberley C, Guillermier M, Berniard A, Gipchtein P, Jan C: Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19859034.
- van Leyen K, Roelcke U, Gruber P, Remonda L, Berberat J: Susceptibility and Tumor Size Changes During the Time Course of Standard Treatment in Recurrent Glioblastoma. Journal of Neuroimaging 2019, 29(5):645-649.
- Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G: TSPO versus P2X7 as target for neuroinflammation–an in vitro and in vivo study. Journal of Nuclear Medicine 2019:jnumed. 119.231985.
- Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng K-W, Smith DR, Russell SJ, Suksanpaisan L: Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer gene therapy 2019:1.
- Vassena E, Van Opstal F, Goethals I, Verguts T: Striatal dopamine D2 binding correlates with locus of control: Preliminary evidence from [11C] raclopride Positron Emission Tomography. International Journal of Psychophysiology 2019, 146:117-124.
- Vega SC, Leiss V, Piekorz R, Calaminus C, Pexa K, Vuozzo M, Schmid AM, Devanathan V, Kesenheimer C, Pichler BJ: Selective protection of murine cerebral G i/o-proteins from inactivation by parenterally injected pertussis toxin. Journal of Molecular Medicine 2019:1-14.
- Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, Raedt R, Vanhove C, De Vos F, Goethals I: 2-[18F] FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nuclear Medicine and Biology 2019.
- Verhoeven J, Bolcaen J, De Meulenaere V, Kersemans K, Descamps B, Donche S, Van den Broecke C, Boterberg T, Kalala J-P, Deblaere K: Technical feasibility of [18 F] FET and [18 F] FAZA PET guided radiotherapy in a F98 glioblastoma rat model. Radiation Oncology 2019, 14(1):89.
- Verhoeven J, Hulpia F, Kersemans K, Bolcaen J, De Lombaerde S, Goeman J, Descamps B, Hallaert G, Van den Broecke C, Deblaere K: New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma. Scientific reports 2019, 9(1):2878.
- Vermeulen K, Ahamed M, Luyten K, Bormans G: Evaluation of [11C] KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16. F10 melanoma. Nuclear medicine and biology 2019, 74:1-11.
- Vermeulen K, Naus E, Ahamed M, Attili B, Siemons M, Luyten K, Celen S, Schymkowitz J, Rousseau F, Bormans G: Evaluation of [11C] NMS-E973 as a PET tracer for in vivo visualisation of HSP90. Theranostics 2019, 9(2):554.
- Vetel S, Vercouillie J, Buron F, Vergote J, Tauber C, Busson J, Chicheri G, Routier S, Sérrière S, Chalon S: Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18 F] ASEM in a Rat Model of Parkinson’s Disease. Molecular imaging and biology 2019:1-10.
- Vlachavas EI, Pilalis E, Papadodima O, Koczan D, Willis S, Klippel S, Cheng C, Pan L, Sachpekidis C, Pintzas A: Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape. Computational and structural biotechnology journal 2019, 17:177-185.
- von Hacht JL, Erdmann S, Niederstadt L, Prasad S, Wagener A, Exner S, Beindorff N, Brenner W, Grötzinger C: Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model. PloS one 2019, 14(6):e0217883.
- von Witting E, Garousi J, Lindbo S, Vorobyeva A, Altai M, Oroujeni M, Mitran B, Orlova A, Hober S, Tolmachev V: Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6. European Journal of Pharmaceutics and Biopharmaceutics 2019, 140:109-120.
- Vottero GV, Morfoisse F, Durré T, Blacher S, Becker G, Bahri MA, Plenevaux A, Noel A, Nizet JL: Contralateral Vascularized Lymph Node Transfer: An Optimized Mouse Model. Journal of Reconstructive Microsurgery Open 2019, 4(02):e83-e91.
- Vraka C, Pichler V, Berroterán-Infante N, Wollenweber T, Pillinger A, Hohensinner M, Fetty L, Beitzke D, Li X, Philippe C: Optimization of the Automated Synthesis of [11C] mHED—Administered and Apparent Molar Activities. Pharmaceuticals 2019, 12(1):12.
- Vrselja Z, Daniele SG, Silbereis J, Talpo F, Morozov YM, Sousa AM, Tanaka BS, Skarica M, Pletikos M, Kaur N: Restoration of brain circulation and cellular functions hours post-mortem. Nature 2019, 568(7752):336.
- Wagner JM, Sichler ME, Schleicher EM, Franke TN, Irwin C, Löw MJ, Beindorff N, Bouter C, Bayer TA, Bouter Y: Analysis of motor function in the Tg4-42 mouse model of Alzheimer’s disease. Frontiers in Behavioral Neuroscience 2019, 13:107.
- Walker M, Kuebler L, Goehring CM, Pichler BJ, Herfert K: Imaging SERT Availability in a Rat Model of L-DOPA-Induced Dyskinesia. Molecular Imaging and Biology 2019:1-9.
- Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y-j, Liu C-f, Xing M-j, Cheng X, Wei S: Comparative strategies for stem cell biodistribution in a preclinical study. Acta pharmacologica Sinica 2019:1-9.
- Wang H, Dong W, Zhao Q, Lu K, Guo X, Liu H, Wu Z, Li S: Synthesis of N-(6-[18F] Fluoropyridin-3-yl) glycine as a potential renal PET agent. Nuclear medicine and biology 2019, 76:21-27.
- Wang Y, Li A: Regulatory effects of Ningdong granule on dopaminergic and serotonergic neurotransmission in a rat model of Tourette syndrome assessed by PET. Molecular medicine reports 2019, 20(1):191-197.
- Wang Y, Shi Z, Zhang N, Cai L, Li Y, Yang H, Yao S, Xing X, Ji Y, Gao S: Spatial patterns of hypometabolism and amyloid deposition in variants of alzheimer’s disease corresponding to brain networks: A prospective cohort study. Molecular Imaging and Biology 2019, 21(1):140-148.
- Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR: Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature medicine 2019, 25(1):141.
- Watanabe S, Shiga T, Hirata K, Magota K, Okamoto S, Toyonaga T, Higashikawa K, Yasui H, Kobayashi J, Nishijima K-i: Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18 F] DiFA and comparison with [18 F] FMISO. EJNMMI research 2019, 9(1):60.
- Weigend S, Holst SC, Treyer V, O’Gorman Tuura RL, Meier J, Ametamey SM, Buck A, Landolt H-P: Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep–wake cycle. Sleep 2019, 42(11):zsz161.
- Weiskirchen R, Weiskirchen S, Kim P, Winkler R: Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview. Journal of cheminformatics 2019, 11(1):16.
- Wilson TC, Xavier M-A, Knight J, Verhoog S, Torres JB, Mosley M, Hopkins SL, Wallington S, Allen PD, Kersemans V: PET Imaging of PARP Expression Using 18F-Olaparib. Journal of Nuclear Medicine 2019, 60(4):504-510.
- Winterdahl M, Noer O, Orlowski D, Schacht AC, Jakobsen S, Alstrup AK, Gjedde A, Landau AM: Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain. Scientific reports 2019, 9(1):1-11.
- Wolf F, Paefgen V, Winz O, Mertens M, Koch S, Gross-Weege N, Morgenroth A, Rix A, Schnoering H, Chalabi K: MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery. Biomaterials 2019, 216:119228.
- Wong C-K, Chan S-C, Ng S-H, Hsieh C-H, Cheng N-M, Yen T-C, Liao C-T: Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma. Medicine 2019, 98(33):e16608.
- Workman CD, Kindred JH, Boles Ponto LL, Kamholz J, Rudroff T: The Effects of Chronic Δ-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) use on Cerebral Glucose Metabolism in Multiple Sclerosis: A Pilot Study. Applied Physiology, Nutrition, and Metabolism 2019(ja).
- Wulkersdorfer B, Bauer M, Karch R, Stefanits H, Philippe C, Weber M, Czech T, Menet M-C, Declèves X, Hainfellner JA: Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography. EJNMMI research 2019, 9(1):110.
- Xiong C, Yin D, Li J, Huang Q, Ravoori MK, Kundra V, Zhu H, Yang Z, Lu Y, Li C: Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage. Molecular pharmaceutics 2019, 16(2):808-815.
- Xu J-G: Evaluation of Neuropathic Pain in a Rat Model of Total Brachial Plexus Avulsion from Behavior to Brain Metabolism. Pain Physician 2019, 22:E215-E224.
- Yagi Y, Kimura H, Okuda H, Ono M, Nakamoto Y, Togashi K, Saji H: Evaluation of [18F] pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function. Nuclear medicine and biology 2019, 74:25-31.
- Yajima S, Miyagawa S, Fukushima S, Isohashi K, Watabe T, Ikeda H, Horitsugi G, Harada A, Sakaniwa R, Hatazawa J: Microvascular Dysfunction Related to Progressive Left Ventricular Remodeling due to Chronic Occlusion of the Left Anterior Descending Artery in an Adult Porcine Heart. International heart journal 2019:18-346.
- Yakushiji H, Kobayashi K, Takenaka F, Kishi Y, Shinohara M, Akehi M, Sasaki T, Ohno E, Matsuura E: Novel single-chain variant of antibody against mesothelin established by phage library. Cancer science 2019, 110(9):2722-2733.
- Yamagishi S, Iga Y, Nakamura M, Takizawa C, Fukumoto D, Kakiuchi T, Nishiyama S, Ohba H, Tsukada H, Sato K: Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study. Journal of neuroinflammation 2019, 16(1):208.
- Yang K-C, Stepanov V, Amini N, Martinsson S, Takano A, Bundgaard C, Bang-Andersen B, Sanchez C, Halldin C, Farde L: Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain. Neuropsychopharmacology 2019, 44(10):1706-1713.
- Yang M, Kong DY, Chen JC: Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway. Journal of cellular physiology 2019.
- Yasuno F, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Fukuda T, Kazui H, Iida H, Nagatsuka K: Amyloid β deposition in subcortical stroke patients and effects of educational achievement: a pilot study. International journal of geriatric psychiatry 2019, 34(11):1651-1657.
- Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, Chen L-M, Hsu S-M, Chao L-J, Wu K-W: A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiology of Aging 2019.
- Yeow YL, Kotamraju VR, Wang X, Chopra M, Azme N, Wu J, Schoep TD, Delaney DS, Feindel K, Li J: Immune-mediated ECM depletion improves tumour perfusion and payload delivery. EMBO molecular medicine 2019, 11(12):e10923.
- Yin L, Sun H, Zhao M, Wang A, Qiu S, Gao Y, Ding J, Ji S-J, Shi H, Gao M: Rational Design and Synthesis of a Metalloproteinase-Activatable Probe for Dual-Modality Imaging of Metastatic Lymph Nodes in Vivo. The Journal of organic chemistry 2019, 84(10):6126-6133.
- Yokokura M, Terada T, Bunai T, Nakaizumi K, Kato Y, Yoshikawa E, Futatsubashi M, Suzuki K, Yamasue H, Ouchi Y: Alterations in serotonin transporter and body image-related cognition in anorexia nervosa. NeuroImage: Clinical 2019, 23:101928.
- Yoon HJ, Jeong YJ, Kang D-Y, Kang H, Yeo KK, Jeong JE, Park KW, Choi GE, Ha S-W: Effect of Data Augmentation of F-18-Florbetaben Positron-Emission Tomography Images by Using Deep Learning Convolutional Neural Network Architecture for Amyloid Positive Patients. Journal of the Korean Physical Society 2019, 75(8):597-604.
- Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M: Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease. Gut 2019, 68(1):25-39.
- Zeitler B, Froelich S, Marlen K, Shivak DA, Yu Q, Li D, Pearl JR, Miller JC, Zhang L, Paschon DE: Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease. Nature medicine 2019, 25(7):1131-1142.
- Zhao J, Zhang Z, Nie D, Ma H, Yuan G, Su S, Liu S, Liu S, Tang G: PET Imaging of Hepatocellular Carcinomas: 18F-Fluoropropionic Acid as a Complementary Radiotracer for 18F-Fluorodeoxyglucose. Molecular imaging 2019, 18:1536012118821032.
- Zhao M, Liu M, Leal JP, Tsui BMW, Wong DF, Pomper MG, Zhou Y: Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy. PLoS One 2019, 14(3):e0212573.
- Zhao Q, Liu M, Ha L, Zhou Y, Initiative AsDN: Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer’s Disease Patients. Frontiers in neurology 2019, 10:486.
- Zhao YH, Liu NW, Ke CC, Liu BW, Chen YA, Luo C, Zhang Q, Xia ZY, Liu RS: Combined treatment of sodium ferulate, n-butylidenephthalide, and ADSC s rehabilitates neurovascular unit in rats after photothrombotic stroke. Journal of cellular and molecular medicine 2019, 23(1):126-142.
- Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM: Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment. CNS neuroscience & therapeutics 2019, 26(1):117-125.
- Zhu Y, Fiedler SA, Hibert ML, Wang C: Synthesis of a carbon-11 radiolabeled BACE1 inhibitor. Medicinal Chemistry Research 2019:1-6.
- Zorick T, Okita K, Mandelkern MA, London ED, Brody AL: Effects of Citalopram on Cue-induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. International Journal of Neuropsychopharmacology 2019, 22(4):286-291.
- Zoufal V, Mairinger S, Brackhan M, Krohn M, Filip T, Sauberer M, Stanek J, Wanek T, Tournier N, Bauer M: Imaging P-glycoprotein Induction at the Blood-Brain Barrier of a Beta-Amyloidosis Mouse Model with 11C-Metoclopramide PET. Journal of Nuclear Medicine 2019:jnumed. 119.237198.
- Zoufal V, Mairinger S, Krohn M, Wanek T, Filip T, Sauberer M, Stanek J, Kuntner C, Pahnke J, Langer O: Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19854541.
- Ahmed S, Plazier M, Ost J, Stassijns G, Deleye S, Ceyssens S, Dupont P, Stroobants S, Staelens S, De Ridder D: The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging study. BMC neurology 2018, 18(1):191.
- Akamatsu G, Tashima H, Iwao Y, Wakizaka H, Maeda T, Yoshida E, Yamaya T: A 3-dimensional hemispherical brain phantom for compact dedicated brain PET scanners. Biomedical Physics & Engineering Express 2018.
- Akkus F, Mihov Y, Treyer V, Ametamey SM, Johayem A, Senn S, Rösner S, Buck A, Hasler G: Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Translational psychiatry 2018, 8(1):17.
- Albatly AA, Alsamarah AT, Alhawas A, Veit-Haibach P, Buck A, Stolzmann P, Burger IA, Kollias SS, Huellner MW: Value of 18F-FET PET in adult brainstem glioma. Clinical imaging 2018, 51:68-75.
- Alecxih A, Sorci O, Batzdorf A, Churilla J, Peng M, Jankelovits A, Rhodes S, Kim J, Johncola A, Hornyak J: Sodium Fluoride PET/CT Imaging as a Promising Tool for the Assessment of Coronary Plaque Deposition. Journal of Nuclear Medicine 2018, 59(supplement 1):298-298.
- Allen KJ, Jiao R, Malo ME, Dadachova E: Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188Rhenium. Cancer biotherapy & radiopharmaceuticals 2018, 33(8):349-355.
- Alves CR, das Neves W, Tobias GC, Almeida NR, Barreto RF, Melo CM, Carneiro CG, Garcez AT, Faria DP, Chammas R: High-intensity interval training slows down tumor progression in mice bearing Lewis lung carcinoma. JCSM Rapid Communications 2018, 1(2).
- Alves CR, Faria DdP, Carneiro CdG, Garcez AT, Gutierrez VP, das Neves W, de Almeida NR, Cury Y, Chammas R, Brum PC: 18F-Fluoride PET/CT and 99mTc-MDP SPECT/CT can detect bone cancer at early stage in rodents. Life sciences 2018, 206:29-34.
- Alves IL, García DVV, Parente A, Doorduin J, da Silva AMM, Koole M, Dierckx R, Willemsen A, Boellaard R: Parametric Imaging of [11 C] Flumazenil Binding in the Rat Brain. Molecular Imaging and Biology 2018, 20(1):114-123.
- Amato E, Cicone F, Auditore L, Baldari S, Prior JO, Gnesin S: A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures. Physica Medica 2018, 49:52-57.
- Amor D, Goutal S, Marie S, Caillé F, Bauer M, Langer O, Auvity S, Tournier N: Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats. EJNMMI research 2018, 8(1):81.
- Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A: Absolute number of new lesions on 18 F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. European journal of nuclear medicine and molecular imaging 2018, 45(3):376-383.
- Aoe J, Watabe T, Shimosegawa E, Kato H, Kanai Y, Naka S, Matsunaga K, Isohashi K, Tatsumi M, Hatazawa J: Evaluation of the default-mode network by quantitative 15 O-PET: comparative study between cerebral blood flow and oxygen consumption. Annals of Nuclear Medicine 2018:1-7.
- Arakawa R, Farde L, Matsumoto J, Kanegawa N, Yakushev I, Yang K-C, Takano A: Potential Effect of Prolonged Sevoflurane Anesthesia on the Kinetics of [11 C] Raclopride in Non-human Primates. Molecular Imaging and Biology 2018, 20(2):183-187.
- Asai K, Nakamura H, Watabe T, Nishida T, Sakaguchi M, Hatazawa J, Yoshimine T, Kishima H: X-ray angiography perfusion imaging with an intra-arterial injection: comparative study with 15O-gas/water positron emission tomography. Journal of neurointerventional surgery 2018, 10(8):780-783.
- Auvity S, Caillé F, Marie S, Wimberley C, Bauer M, Langer O, Buvat I, Goutal S, Tournier N: P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of 11C-Metoclopramide Across the Blood–Brain Barrier: A PET Study on Nonhuman Primates. Journal of Nuclear Medicine 2018, 59(10):1609-1615.
- Avendaño‐Estrada A, Ávila‐Rodríguez MA: Reference tissue models in the assessment of 11C‐DTBZ binding to the VMAT2 in rat striatum: A test‐retest reproducibility study. Synapse 2018, 72(6):e22029.
- Bahri S, Horowitz M, Malbert CH: Inward Glucose Transfer Accounts for Insulin‐Dependent Increase in Brain Glucose Metabolism Associated with Diet‐Induced Obesity. Obesity 2018.
- Baker LC, Sikka A, Price JM, Boult JK, Lepicard EY, Box G, Jamin Y, Spinks TJ, Kramer-Marek G, Leach MO: Evaluating imaging biomarkers of acquired resistance to targeted EGFR therapy in xenograft models of human head and neck squamous cell carcinoma. Frontiers in oncology 2018, 8:271.
- Bankstahl M, Breuer H, Leiter I, Märkel M, Bascuñana P, Michalski D, Bengel FM, Löscher W, Meier M, Bankstahl JP: Blood-Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit. eNeuro 2018:ENEURO. 0123-0118.2018.
- Barbagallo M, Albatly AA, Schreiner S, Hayward-Könnecke HK, Buck A, Kollias SS, Huellner MW: Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease—Preliminary Experience From a Retrospective Analysis. Clinical nuclear medicine 2018, 43(11):e385-e391.
- Barry RL, Byun NE, Williams JM, Siuta MA, Tantawy MN, Speed NK, Saunders C, Galli A, Niswender KD, Avison MJ: Brief exposure to obesogenic diet disrupts brain dopamine networks. PloS one 2018, 13(4):e0191299.
- Bascuñana P, Brackhan M, Leiter I, Keller H, Jahreis I, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18809886.
- Bauer M, Matsuda A, Wulkersdorfer B, Philippe C, Traxl A, Özvegy‐Laczka C, Stanek J, Nics L, Klebermass EM, Poschner S: Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography. Clinical Pharmacology & Therapeutics 2018, 104(1):139-147.
- Bauer M, Traxl A, Matsuda A, Karch R, Philippe C, Nics L, Klebermass E-M, Wulkersdorfer B, Weber M, Poschner S: Effect of Rifampicin on the Distribution of [11C] Erlotinib to the Liver, a Translational PET Study in Humans and in Mice. Molecular pharmaceutics 2018, 15(10):4589-4598.
- Baumgartner A, Frings L, Schiller F, Stich O, Mix M, Egger K, Schluh G, Rauer S, Meyer PT: Regional neuronal activity in patients with relapsing remitting multiple sclerosis. Acta Neurologica Scandinavica 2018, 138(6):466-474.
- Beaufils E, Vercouillie J, Vierron E, Cottier J-P, Camus V, Mondon K, Guilloteau D, Hommet C, Ribeiro MJ: Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes. Clinical nuclear medicine 2018, 43(4):e103-e108.
- Becker AS, Boss A, Klarhoefer M, Finkenstaedt T, Wurnig MC, Rossi C: Investigation of the pulsatility of cerebrospinal fluid using cardiac-gated Intravoxel Incoherent Motion imaging. Neuroimage 2018, 169:126-133.
- Beckers L, Ory D, Geric I, Declercq L, Koole M, Kassiou M, Bormans G, Baes M: Increased expression of translocator protein (TSPO) marks pro-inflammatory microglia but does not predict neurodegeneration. Molecular imaging and biology 2018, 20(1):94-102.
- Bejanin A, La Joie R, Landeau B, Belliard S, de La Sayette V, Eustache F, Desgranges B, Chételat G: Distinct Interplay Between Atrophy and Hypometabolism in Alzheimer’s Versus Semantic Dementia. Cerebral Cortex 2018.
- Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL: 18 F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. Journal of neuroinflammation 2018, 15(1):33.
- Bertelsen F, Landau AM, Vase KH, Jacobsen J, Scheel-Krüger J, Møller A: Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [11C] Ro15-4513 microPET study. Brain research 2018, 1680:110-114.
- Bertoglio D, Kosten L, Verhaeghe J, Thomae D, Wyffels L, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S: Longitudinal Characterization of mGluR5 Using 11C-ABP688 PET Imaging in the Q175 Mouse Model of Huntington Disease. Journal of Nuclear Medicine 2018, 59(11):1722-1727.
- Bertoglio D, Verhaeghe J, Kosten L, Thomae D, Van der Linden A, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S: MR-based spatial normalization improves [18F] MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington’s disease. PloS one 2018, 13(10):e0206613.
- Beshr R, Isohashi K, Watabe T, Naka S, Horitsugi G, Romanov V, Kato H, Miyatake S-I, Shimosegawa E, Hatazawa J: Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [18 F] fluoro-borono-phenylalanine PET/CT. Annals of nuclear medicine 2018, 32(10):702-708.
- Bhagat PN, Jadhav SH, Chattopadhyay S, Paknikar KM: Carbon nanospheres mediated nuclear delivery of SMAR1 protein (DNA binding domain) controls breast tumor in mice model. Nanomedicine 2018, 13(4):353-372.
- Blakkisrud J, Holtedahl JE, Løndalen A, Dahle J, Bach-Gansmo T, Holte H, Nygaard S, Kolstad A, Stokke C: Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody–Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018, 59(4):704-710.
- Blautzik J, Kotz S, Brendel M, Sauerbeck J, Vettermann F, Winter Y, Bartenstein P, Ishii K, Rominger A, Initiative AsDN: Relationship between body mass index, ApoE4 status, and PET-based amyloid and neurodegeneration markers in amyloid-positive subjects with normal cognition or mild cognitive impairment. Journal of Alzheimer’s Disease 2018, 65(3):781-791.
- Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus F-J, von Ungern-Sternberg B, Ozmen L, Baumann K: Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Journal of neuroinflammation 2018, 15(1):307.
- Bodart G, Farhat K, Renard-Charlet C, Becker G, Plenevaux A, Salvatori R, Geenen V, Martens H: The Severe Deficiency of the Somatotrope GH-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor 1 Axis of Ghrh−/− Mice Is Associated With an Important Splenic Atrophy and Relative B Lymphopenia. Frontiers in endocrinology 2018, 9.
- Bodart G, Farhat K, Renard-Charlet C, Becker G, Plenevaux A, Salvatori R, Geenen V, Martens H: The severe deficiency of the somatotrope GHRH/GH/IGF-1 axis of Ghrh-/-mice is associated with an important splenic atrophy and relative B lymphopenia. Frontiers in Endocrinology 2018, 9:296.
- Bonaventura J, Eldridge MA, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm M, Ruiz C, Farrell M: Chemogenetic ligands for translational neurotheranostics. bioRxiv 2018:487637.
- Brackhan M, Bascuñana P, Ross TL, Bengel FM, Bankstahl JP, Bankstahl M: [18F] GE 180 positron emission tomographic imaging indicates a potential double‐hit insult in the intrahippocampal kainate mouse model of temporal lobe epilepsy. Epilepsia 2018, 59(3):617-626.
- Breining P, Jensen JB, Sundelin EI, Gormsen LC, Jakobsen S, Busk M, Rolighed L, Bross P, Fernandez‐Guerra P, Markussen LK: Metformin Targets Brown Adipose Tissue in vivo and Reduces Oxygen Consumption in vitro. Diabetes, Obesity and Metabolism 2018.
- Brendel M, Sauerbeck J, Greven S, Kotz S, Scheiwein F, Blautzik J, Delker A, Pogarell O, Ishii K, Bartenstein P: Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer’s Disease Patients with Depressive Symptoms. Journal of Alzheimer’s Disease 2018(Preprint):1-14.
- Brendel M, Schönecker S, Höglinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F: [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy. Frontiers in aging neuroscience 2018, 9:440.
- Brendel M, Yousefi BH, Blume T, Herz M, Focke C, Deussing M, Peters F, Lindner S, von Ungern-Sternberg B, Drzezga A: Comparison of 18F-T807 and 18F-THK5117 PET in a mouse model of tau pathology. Frontiers in aging neuroscience 2018, 10.
- Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL: Effect of overnight smoking abstinence on a marker for microglial activation: a [11 C] DAA1106 positron emission tomography study. Psychopharmacology 2018, 235(12):3525-3534.
- Brunton B, Suksanpaisan L, Li H, Liu Q, Yu Y, Vrieze A, Zhang L, Jenks N, Jiang H, DeGrado TR: New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging. Scientific reports 2018, 8(1):14209.
- Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y: Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study. Journal of the neurological sciences 2018, 385:30-33.
- Burger IA, Lohmann C, Messerli M, Bengs S, Becker A, Maredziak M, Treyer V, Haider A, Schwyzer M, Benz DC: Age-and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging. PloS one 2018, 13(8):e0202302.
- Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJ, Harrington KJ, Smith G, Kramer-Marek G: Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models. Journal of Nuclear Medicine 2018:jnumed. 118.216069.
- Caillé F, Goutal S, Marie S, Auvity S, Cisternino S, Kuhnast B, Pottier G, Tournier N: Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide. Contrast media & molecular imaging 2018, 2018.
- Caravaggio F, Fervaha G, Browne CJ, Gerretsen P, Remington G, Graff-Guerrero A: Reward motivation in humans and its relationship to dopamine D2/3 receptor availability: A pilot study with dual [11C]-raclopride and [11C]-(+)-PHNO imaging. Journal of Psychopharmacology 2018, 32(3):357-366.
- Caravaggio F, Scifo E, Sibille EL, Hernandez-Da Mota SE, Gerretsen P, Remington G, Graff-Guerrero A: Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry. Experimental eye research 2018.
- Catarina AV, Luft C, Greggio S, Venturin GT, Ferreira F, Marques EP, Rodrigues L, Wartchow K, Leite MC, Gonçalves CA: Fructose-1, 6-bisphosphate preserves glucose metabolism integrity and reduces reactive oxygen species in the brain during experimental sepsis. Brain Research 2018.
- Ceccon G, Lazaridis L, Stoffels G, Rapp M, Weber M, Blau T, Lohmann P, Kebir S, Herrmann K, Fink GR: Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience. European journal of nuclear medicine and molecular imaging 2018:1-10.
- Chang C-W, Yeh C-N, Chung Y-H, Chen Y-R, Tien S-W, Chen T-W, Farn S-S, Huang Y-C, Yu C-S: synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging. Drug design, development and therapy 2018, 12:1467.
- Chang PMH, Cheng CT, Wu RC, Chung YH, Chiang KC, Yeh TS, Liu CY, Chen MH, Chen MH, Yeh CN: Nab‑paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma. Oncology Letters 2018, 16(1):566-572.
- Chantepie S, Hovhannisyan N, Guillouet S, Pelage J-P, Ibazizene M, Bodet-Milin C, Carlier T, Gac A-C, Réboursière E, Vilque J-P: 18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients. Journal of Nuclear Medicine 2018, 59(9):1380-1385.
- Chen B, Zhang W, Ji B, Ma Q, Li D, Gao S: Integrin αVβ3‑targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts. Oncology letters 2018, 15(4):4201-4206.
- Chen J, Pang W, Kan Y, Zhao L, He Z, Shi W, Yan B, Chen H, Hu J: Structure of a pectic polysaccharide from Pseudostellaria heterophylla and stimulating insulin secretion of INS-1 cell and distributing in rats by oral. International journal of biological macromolecules 2018, 106:456-463.
- Chen Q, Du Y, Zhang K, Liang Z, Li J, Yu H, Ren R, Feng J, Jin Z, Li F: Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease. ACS nano 2018, 12(2):1321-1338.
- Chen Y, Vastenhouw B, Wu C, Goorden MC, Beekman FJ: Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT. Physics in Medicine & Biology 2018, 63(22):225002.
- Chen Y-H, Chang K-P, Chu S-C, Yen T-C, Wang L-Y, Chang JT-C, Hsu C-L, Ng S-H, Liu S-H, Chan S-C: Value of early evaluation of treatment response using 18 F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma. European journal of nuclear medicine and molecular imaging 2018:1-11.
- Cheng CT, Chen YY, Wu RC, Tsai CY, Chiang KC, Yeh TS, Chen MH, Yeh CN: MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients. Oncology reports 2018, 40(3):1411-1421.
- Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G: Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia. Molecular psychiatry 2018, 23(7):1666.
- Chiu C-C, Lu C-S, Weng Y-H, Chen Y-L, Huang Y-Z, Chen R-S, Cheng Y-C, Huang Y-C, Liu Y-C, Lai S-C: PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Molecular neurobiology 2018:1-19.
- Chung Y-H, Lu K-Y, Chiu S-C, Lo C-J, Hung L-M, Huang J-P, Cheng M-L, Wang C-H, Tsai C-K, Lin Y-C: Early Imaging Biomarker of Myocardial Glucose Adaptations in High-Fat-Diet-Induced Insulin Resistance Model by Using 18F-FDG PET and [U-13C] glucose Nuclear Magnetic Resonance Tracer. Contrast Media & Molecular Imaging 2018, 2018.
- Cleeren E, Casteels C, Goffin K, Koole M, Van Laere K, Janssen P, Van Paesschen W: Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys. Epilepsia 2018, 59(5):959-970.
- Colás L, Domercq M, Ramos‐Cabrer P, Palma A, Gómez‐Vallejo V, Padro D, Plaza‐García S, Pulagam KR, Higuchi M, Matute C: In vivo imaging of α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia. Glia 2018.
- Cole LE, McGinnity TL, Irimata LE, Vargo-Gogola T, Roeder RK: Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications. Acta biomaterialia 2018, 82:122-132.
- Collignon A-M, Lesieur J, Anizan N, Azzouna RB, Poliard A, Gorin C, Letourneur D, Chaussain C, Rouzet F, Rochefort GY: Early angiogenesis detected by PET imaging with 64Cu-NODAGA-RGD is predictive of bone critical defect repair. Acta biomaterialia 2018, 82:111-121.
- Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K: Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers. Molecular Imaging and Biology 2018:1-10.
- Corral A, Balcerzyk M, Gallardo M, Amorim CA, Parrado-Gallego Á, Risco R: An optimized controlled rate slow cooling protocol for bovine ovarian tissue cryopreservation by means of X-ray computed tomography. Theriogenology 2018.
- Corral A, Clavero M, Gallardo M, Balcerzyk M, Amorim CA, Parrado-Gallego Á, Dolmans M-M, Paulini F, Morris J, Risco R: Ovarian tissue cryopreservation by stepped vitrification and monitored by X-ray computed tomography. Cryobiology 2018, 81:17-26.
- Corral A, López R, Balcerzyk M, Parrado-Gallego Á, Fernández-Gómez I, Olmo A, Risco R: Use of X-Ray Computed Tomography for Ice Detection Applied to Organ Cryopreservation. Biopreservation and biobanking 2018.
- Coughlin JM, Du Y, Rosenthal HB, Slania S, Koo SM, Park A, Solomon G, Vranesic M, Antonsdottir I, Speck CL: The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F] ASEM. NeuroImage 2018, 165:118-124.
- Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES: Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11 C] DPA-713 PET. Journal of neuroinflammation 2018, 15(1):346.
- Crabbé M, Van der Perren A, Weerasekera A, Himmelreich U, Baekelandt V, Van Laere K, Casteels C: Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson’s disease and levodopa-induced dyskinesia. Neurobiology of aging 2018, 61:82-92.
- Cui Q, Liu Y, Zhou M, Han Y, Yin C, Bai G: An optimized MicroPET imaging method for the distribution and synergies of natural products. Frontiers in pharmacology 2018, 9.
- da Silva N, Lohmann P, Fairney J, Magill A, Peusquens A-MO, Choi C-H, Stirnberg R, Stoffels G, Galldiks N, Golay X: Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI. European journal of nuclear medicine and molecular imaging 2018:1-10.
- Dang LC, Samanez-Larkin GR, Castrellon JJ, Perkins SF, Cowan RL, Zald DH: Individual differences in dopamine D 2 receptor availability correlate with reward valuation. Cognitive, Affective, & Behavioral Neuroscience 2018:1-9.
- Dang LC, Samanez-Larkin GR, Smith CT, Castrellon JJ, Perkins SF, Cowan RL, Claassen DO, Zald DH: FTO affects food cravings and interacts with age to influence age-related decline in food cravings. Physiology & behavior 2018, 192:188-193.
- Dasari PK, Jones JP, Casey ME, Liang Y, Dilsizian V, Smith MF: The effect of time-of-flight and point spread function modeling on 82 Rb myocardial perfusion imaging of obese patients. Journal of Nuclear Cardiology 2018:1-25.
- de Laat B, Weerasekera A, Leurquin‐Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K: Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18F‐FPEB and 1H‐MRS study in rats. Addiction biology 2018.
- de Lange C, Solberg R, Holtedahl JE, Tulipan A, Barlinn J, Trigg W, Wickstrøm T, Saugstad OD, Malinen E, Revheim ME: Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs. Nuclear medicine and biology 2018, 66:49-57.
- de Ligt M, Bruls YM, Hansen J, Habets M-F, Havekes B, Nascimento EB, Moonen-Kornips E, Schaart G, Schrauwen-Hinderling VB, van Marken Lichtenbelt W: Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. Molecular metabolism 2018, 12:39-47.
- De Lombaerde S, Devisscher L, Verhoeven J, Neyt S, Van Vlierberghe H, Vanhove C, De Vos F: Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F] FCA in mouse models of liver disease. Nuclear Medicine and Biology 2018.
- De Lombaerde S, Kersemans K, Neyt S, Verhoeven J, Vanhove C, De Vos F: Evaluating Hepatobiliary Transport with 18F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and In Vitro and In Vivo Performance. Contrast media & molecular imaging 2018, 2018.
- De Picker L, Ottoy J, Verhaeghe J, Deleye S, Fransen E, Kosten L, Sabbe B, Coppens V, Timmers M, de Boer P: State-associated changes in longitudinal [18F]-PBR111 TSPO PET Imaging of psychosis patients: evidence for the accelerated ageing hypothesis? Brain, behavior, and immunity 2018.
- de Souza GS, da Silva AMM: Investigation of Time-Activity Curve Behavior in Dynamic [11 C]-(R)-PK11195 PET in Cortical Brain Regions: Preliminary Results. In: World Congress on Medical Physics and Biomedical Engineering 2018: 2019: Springer; 2019: 699-702.
- Delso G, Kemp B, Kaushik S, Wiesinger F, Sekine T: Improving PET/MR brain quantitation with template-enhanced ZTE. NeuroImage 2018, 181:403-413.
- Delvaeye T, Deleye S, Lemeire K, Gonçalves A, Decrock E, Staelens S, Leybaert L, Vandenabeele P, Krysko DV: Noninvasive whole-body imaging of phosphatidylethanolamine as a cell death marker using 99mTc-duramycin during TNF-induced SIRS. Journal of Nuclear Medicine 2018, 59(7):1140-1145.
- Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B: Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F] GE180 PET quantification. Neuroimage 2018, 165:83-91.
- Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B: Data on specificity of [18F] GE180 uptake for TSPO expression in rodent brain and myocardium. Data in Brief 2018, 19:331-336.
- Devriese J, Beels L, Maes A, van de Wiele C, Pottel H: Patient-specific lean body mass can be estimated from limited-coverage computed tomography images. Nuclear medicine communications 2018, 39(6):521-526.
- Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H: Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria. EJNMMI physics 2018, 5(1):35.
- Dewandre D, Atienza M, Sanchez-Espinosa MP, Cantero JL: Effects of PER3 clock gene polymorphisms on aging-related changes of the cerebral cortex. Brain Structure and Function 2018, 223(2):597-607.
- Di Ciano P, Tyndale RF, Mansouri E, Hendershot CS, Wilson AA, Lagzdins D, Houle S, Boileau I, Le Foll B: Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers. International Journal of Neuropsychopharmacology 2018, 21(6):503-512.
- Di Liberto V, van Dijk RM, Brendel M, Waldron A-M, Möller C, Koska I, Seiffert I, Gualtieri F, Gildehaus FJ, von Ungern-Sternberg B: Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model. Neurobiology of Disease 2018.
- Dirckx N, Tower RJ, Mercken EM, Vangoitsenhoven R, Moreau-Triby C, Breugelmans T, Nefyodova E, Cardoen R, Mathieu C, Van der Schueren B: Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism. The Journal of clinical investigation 2018, 128(3).
- Dmochowska N, Tieu W, Keller M, Wardill H, Mavrangelos C, Campaniello M, Takhar P, Hughes PA: Immuno-PET of innate immune markers CD11b and IL-1β detect inflammation in murine colitis. Journal of Nuclear Medicine 2018:jnumed. 118.219287.
- Doot RK, Dubroff JG, Scheuermann JS, Labban KJ, Cai J, Hsieh C-J, Li S, Lee H, Schubert EK, Hou C: Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18 F] fluortriopride. EJNMMI physics 2018, 5(1):21.
- Dubol M, Trichard C, Leroy C, Sandu A-L, Rahim M, Granger B, Tzavara ET, Karila L, Martinot J-L, Artiges E: Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study. Neuropsychopharmacology 2018, 43(4):820.
- DuBose LE, Boles Ponto LL, Moser DJ, Harlynn E, Reierson L, Pierce GL: Higher Aortic Stiffness Is Associated With Lower Global Cerebrovascular Reserve Among Older Humans. Hypertension 2018, 72(2):476-482.
- DuBose LE, Ponto LLB, Moser DJ, Harlynn E, Reierson L, Pierce GL: Higher Aortic Stiffness Is Associated With Lower Global Cerebrovascular Reserve Among Older Humans. Hypertension 2018:HYPERTENSIONAHA. 118.11143.
- Eriksson O, Johnström P, Cselenyi Z, Jahan M, Selvaraju RK, Jensen-Waern M, Takano A, Winzell MS, Halldin C, Skrtic S: In vivo visualization of β-cells by targeting of GPR44. Diabetes 2018, 67(2):182-192.
- Faria DdP, Duran FL, Squarzoni P, Coutinho AM, Garcez AT, Santos PP, Brucki SM, de Oliveira MO, Trés ES, Forlenza OV: Topography of 11C-Pittsburgh compound B uptake in Alzheimer’s disease: a voxel-based investigation of cortical and white matter regions. Brazilian Journal of Psychiatry 2018(AHEAD):0-0.
- Fenoy AJ, Schulz PE, Selvaraj S, Burrows CL, Zunta-Soares G, Durkin K, Zanotti-Fregonara P, Quevedo J, Soares JC: A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression. Translational psychiatry 2018, 8(1):111.
- Fernandez-Maza L, Egea-Guerrero JJ, Balcerzyk M, Civantos-Jubera G, Gordillo-Escobar E, Vilches-Arenas A, Fernandez-Gomez I, Parrado-Gallego A, Murillo-Cabezas F: Rapid and simplified synthesis of [18F] Fluoromisonidazole and its use in PET imaging in an experimental model of subarachnoid hemorrhage. Applied Radiation and Isotopes 2018, 132:79-84.
- Fiorenzato E, Biundo R, Cecchin D, Frigo AC, Kim J, Weis L, Strafella AP, Antonini A: Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson’s Disease: The PPMI Dataset. Journal of Alzheimer’s Disease 2018(Preprint):1-9.
- Fjellaksel R, Oteiza A, Martin-Armas M, Riss PJ, Hjelstuen OK, Kuttner S, Hansen JH, Sundset R: First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor. BMC research notes 2018, 11(1):811.
- Focke C, Blume T, Zott B, Shi YY, Deussing M, Peters F, Schmidt C, Kleinberger G, Lindner S, Gildehaus F-J: Early and longitudinal microglial activation but not amyloid accumulation predict cognitive outcome in PS2APP mice. Journal of Nuclear Medicine 2018:jnumed. 118.217703.
- Follin B, Ghotbi AA, Clemmensen AE, Bentsen S, Juhl M, Søndergaard RH, Lund LD, Haack-Sørensen M, Hasbak P, Cohen S: Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction. Stem cells international 2018, 2018.
- Freesmeyer M, Knichel L, Kuehnel C, Winkens T: Stitching of sensor-navigated 3D ultrasound datasets for the determination of large thyroid volumes–a phantom study. Medical ultrasonography 2018, 20(4):480-486.
- Frings L, Hellwig S, Bormann T, Spehl TS, Buchert R, Meyer PT: Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer’s dementia in a memory clinic population. European journal of nuclear medicine and molecular imaging 2018, 45(8):1442-1448.
- Frisch K, Stimson DH, Venkatachalam T, Pierens GK, Keiding S, Reutens D, Bhalla R: N-(4-[18F] fluorobenzyl) cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: radiosynthesis and proof-of-concept studies in rats. Nuclear medicine and biology 2018, 61:56-62.
- Fujimoto A, Hori Y, Nagai Y, Kikuchi E, Oyama K, Suhara T, Minamimoto T: Signaling incentive and drive in the primate ventral pallidum for motivational control of goal-directed action. bioRxiv 2018:420851.
- Fukumitsu N, Yeh SH-H, Flores I, Garcia L, Mukhopadhyay U, Young D, Ogawa K, Jeong H-J, Tong W, Gelovani JG: In Vivo 6-([18F] Fluoroacetamido)-1-hexanoicanilide PET Imaging of Altered Histone Deacetylase Activity in Chemotherapy-Induced Neurotoxicity. Contrast media & molecular imaging 2018, 2018.
- Gallardo M, Paulini F, Corral A, Balcerzyk M, Lucci CM, Ambroise J, Merola M, Fernandez-maza L, Risco R, Dolmans M-M: Evaluation of a new freezing protocol containing 20% dimethyl sulphoxide concentration to cryopreserve human ovarian tissue. Reproductive biomedicine online 2018, 37(6):653-665.
- Galldiks N, Dunkl V, Ceccon G, Tscherpel C, Stoffels G, Law I, Henriksen OM, Muhic A, Poulsen HS, Steger J: Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine. European journal of nuclear medicine and molecular imaging 2018:1-10.
- García-García L, de la Rosa RF, Delgado M, Silván Á, Bascuñana P, Bankstahl JP, Gomez F, Pozo MA: Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-aminopyridine in rats. Neurochemistry international 2018, 113:92-106.
- García-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M: Validation of an automatic reference region extraction for the quantification of [18F] DPA-714 in dynamic brain PET studies. Journal of Cerebral Blood Flow & Metabolism 2018, 38(2):333-346.
- Gautier Y, Luneau I, Coquery N, Meurice P, Malbert C-H, Guerin S, Kemp B, Bolhuis JE, Clouard C, Le Huërou-Luron I: Maternal Western diet during gestation and lactation modifies adult offspring’s cognitive and hedonic brain processes, behavior, and metabolism in Yucatan minipigs. The FASEB Journal 2018:fj. 201701541.
- Gebhard C, Fiechter M, Herzog BA, Lohmann C, Bengs S, Treyer V, Messerli M, Benz DC, Giannopoulos AA, Gräni C: Sex differences in the long-term prognostic value of 13 N-ammonia myocardial perfusion positron emission tomography. European journal of nuclear medicine and molecular imaging 2018:1-11.
- Ghodoosi EK, D’Alessandria C, Li Y, Bartel A, Köhner M, Höllriegl V, Navab N, Eiber M, Li WB, Frey E: The effect of attenuation map, scatter energy window width, and volume of interest on the calibration factor calculation in quantitative 177Lu SPECT imaging: Simulation and phantom study. Physica Medica 2018, 56:74-80.
- Giglio J, Zeni M, Savio E, Engler H: Synthesis of an Al 18 F radiofluorinated GLU-UREA-LYS (AHX)-HBED-CC PSMA ligand in an automated synthesis platform. EJNMMI radiopharmacy and chemistry 2018, 3(1):4.
- Giubbini R, Peli A, Milan E, Sciagrà R, Camoni L, Albano D, Bertoli M, Bonacina M, Motta F, Statuto M: Comparison between the summed difference score and myocardial blood flow measured by 13 N-ammonia. Journal of Nuclear Cardiology 2018, 25(5):1621-1628.
- Gnesin S, Cicone F, Mitsakis P, Van der Gucht A, Baechler S, Miralbell R, Garibotto V, Zilli T, Prior JO: First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9. EJNMMI research 2018, 8(1):108.
- Golan S, Nidam M, Bernstine H, Baniel J, Groshar D: Dynamic 11C-Choline PET/CT for the primary diagnosis of prostate cancer. International braz j urol 2018, 44(5):900-905.
- Gómez-Pinedo U, Sanchez-Rojas L, Benito-Martin MS, Lendinez C, León-Espinosa G, Rascón-Ramirez FJ, Herrero J, Castro B, Moreno-Jiménez L, del Olmo M: Evaluation of the Safety and Efficacy of the Therapeutic Potential of Adipose-Derived Stem Cells Injected in the Cerebral Ischemic Penumbra. Journal of Stroke and Cerebrovascular Diseases 2018, 27(9):2453-2465.
- Gonzalez PS, O’Prey J, Cardaci S, Barthet VJ, Sakamaki J-i, Beaumatin F, Roseweir A, Gay DM, Mackay G, Malviya G: Mannose impairs tumour growth and enhances chemotherapy. Nature 2018, 563(7733):719.
- Gonzalez-Mancebo D, Becerro AI, Genevois C, Allix M, Corral A, Parrado-Gallego A, Ocana M: Structural, optical and X-ray attenuation properties of Tb 3+: Ba x Ce 1-x F 3-x (x= 0.18–0.48) nanospheres synthesized in polyol medium. Dalton Transactions 2018.
- González-Mancebo D, Becerro AI, Rojas TC, Olivencia A, Corral A, Balcerzyk M, Cantelar E, Cussó F, Ocaña M: Room temperature synthesis of water-dispersible Ln3+: CeF3 (Ln= Nd, Tb) nanoparticles with different morphology as bimodal probes for fluorescence and CT imaging. Journal of colloid and interface science 2018, 520:134-144.
- Gosewisch A, Delker A, Tattenberg S, Ilhan H, Todica A, Brosch J, Vomacka L, Brunegraf A, Gildehaus FJ, Ziegler S: Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA 0, Tyr 3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach. EJNMMI research 2018, 8(1):76.
- Goutal S, Gerstenmayer M, Auvity S, Caillé F, Mériaux S, Buvat I, Larrat B, Tournier N: Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. Journal of Controlled Release 2018, 292:210-220.
- Grimmer T, Shi K, Diehl-Schmid J, Natale B, Drzezga A, Förster S, Förstl H, Schwaiger M, Yakushev I, Wester H-J: 18 F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases. Molecular psychiatry 2018:1.
- Grkovski M, Gharzeddine K, Sawan P, Schöder H, Michaud L, Weber WA, Humm JL: 11C-choline pharmacokinetics in recurrent prostate cancer. Journal of Nuclear Medicine 2018, 59(11):1672-1678.
- Grosse GM, Bascuñana P, Schulz-Schaeffer WJ, Teebken OE, Wilhelmi M, Worthmann H, Ross TL, Wester H-J, Kropf S, Derlin T: Targeting Chemokine Receptor CXCR4 and Translocator Protein for Characterization of High-Risk Plaque in Carotid Stenosis Ex Vivo. Stroke 2018, 49(8):1988-1991.
- Guo M, Gao Z-G, Tyler R, Stodden T, Li Y, Ramsey J, Zhao W-J, Wang G-J, Wiers CE, Fowler JS: Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging. Journal of Medicinal Chemistry 2018, 61(22):9966-9975.
- Haider A, Iten I, Ahmed H, Herder AM, Gruber S, Krämer SD, Keller C, Schibli R, Wünsch B, Mu L: Identification and Preclinical Evaluation of a Radiofluorinated Benzazepine Derivative for Imaging the GluN2B Subunit of the Ionotropic NMDA Receptor. Journal of Nuclear Medicine 2018:jnumed. 118.212134.
- Haider A, Spinelli F, Herde AM, Mu B, Keller C, Margelisch M, Weber M, Schibli R, Mu L, Ametamey SM: Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue. European journal of medicinal chemistry 2018, 145:746-759.
- Hajdu I, Makhlouf A, Solomon VR, Michel D, Al-Dulaymi M, Wasan KM, Fonge H, Badea I: a 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior. International journal of nanomedicine 2018, 13:7801.
- Hamelin L, Lagarde J, Dorothée G, Potier MC, Corlier F, Kuhnast B, Caillé F, Dubois B, Fillon L, Chupin M: Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer’s disease. Brain 2018, 141(6):1855-1870.
- Hansson O, Palmqvist S, Ljung H, Cronberg T, van Westen D, Smith R: Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people. Alzheimer’s & Dementia 2018, 14(1):54-61.
- Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K: Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018, 59(4):671-674.
- Hashimoto H, Fukushima Y, Kumita S-i, Tomiyama T, Kiriyama T: Feasibility of myocardial flow reserve prediction without the use of dynamic data from myocardial perfusion positron emission tomography. The international journal of cardiovascular imaging 2018:1-7.
- Hashimoto N, Morita K, Tsutsui Y, Himuro K, Baba S, Sasaki M: Time-of-flight information improved the detectability of sub-centimeter sphere using clinical positron emission tomography/computed tomography scanner. Journal of nuclear medicine technology 2018:jnmt. 117.204735.
- Hellwig S, Frings L, Bormann T, Vach W, Buchert R, Meyer PT: Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18 F] FDG PET. European journal of nuclear medicine and molecular imaging 2018:1-12.
- Henriksen OM, Vestergaard MB, Lindberg U, Aachmann-Andersen NJ, Lisbjerg K, Christensen SJ, Rasmussen P, Olsen NV, Forman JL, Larsson HBW: Interindividual and regional relationship between cerebral blood flow and glucose metabolism in the resting brain. Journal of Applied Physiology 2018.
- Herde AM, Schibli R, Weber M, Ametamey SM: Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients. European journal of nuclear medicine and molecular imaging 2018:1-14.
- Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA: Decreased cannabinoid CB1 receptors in male tobacco smokers examined with positron emission tomography. Biological psychiatry 2018, 84(10):715-721.
- Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L: Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis. Acta dermato-venereologica 2018, 98(3-4):390-395.
- Hop H, de Boer S, Reijrink M, Kamphuisen P, de Borst M, Pol R, Zeebregts C, Hillebrands J, Slart R, Boersma H: 18 F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques. Journal of Nuclear Cardiology 2018:1-12.
- Hosomi S, Watabe T, Mori Y, Koyama Y, Adachi S, Hoshi N, Ohnishi M, Ogura H, Yoshioka Y, Hatazawa J: Inflammatory projections after focal brain injury trigger neuronal network disruption: An 18F-DPA714 PET study in mice. NeuroImage: Clinical 2018, 20:946-954.
- Hovhannisyan N, Fillesoye F, Guillouet S, Ibazizene M, Toutain J, Gourand F, Valable S, Plancoulaine B, Barré L: [18F] Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F] FDG in human xenograft models. Theranostics 2018, 8(16):4563.
- Hsiao H-Y, Yang C-Y, Liu J-W, Brey EM, Cheng M-H: Periosteal Osteogenic Capacity Depends on Tissue Source. Tissue Engineering 2018(ja).
- Hsieh YJ, Wu LC, Ke CC, Chang CW, Kuo JW, Huang WS, Chen FD, Yang BH, Tai HT, Chen SCJ: Effects of the Acute and Chronic Ethanol Intoxication on Acetate Metabolism and Kinetics in the Rat Brain. Alcoholism: Clinical and Experimental Research 2018, 42(2):329-337.
- Huang C, Wang Z, Liu L, Liu X, Dong J, Xu Q, Zhang B, Miao L: Predicting the dopamine D2 receptor occupancy of ropinirole in rats using positron emission tomography and pharmacokinetic–pharmacodynamic modeling. Xenobiotica 2018:1-9.
- Huang K-L, Hsiao T, Kuo H-C, Hsieh C-J, Hsieh Y-C, Wu Y-M, Wey S-P, Yen T-C, Lin K-J, Huang C-C: Correlation between visual association memory test and structural changes in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Journal of the Formosan Medical Association 2018.
- Huang M-H, Chen M-H, Tu P-C, Bai YM, Su T-P, Yang B-H, Liu R-S, Li C-T: Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression. Journal of affective disorders 2018, 235:250-256.
- Huang S-Y, Hsu J-L, Lin K-J, Liu H-L, Wey S-P, Hsiao T, Initiative AsDN: Characteristic patterns of inter-and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease. Scientific reports 2018, 8.
- Huang YC, Farn SS, Chou YC, Yeh CN, Chang CW, Chung YH, Chen TW, Huang WS, Yu CS: Synthesis of para‐[18F] Fluorofenbufen Octylamide for PET Imaging of Brain Tumors. Journal of the Chinese Chemical Society 2018.
- Huber G, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann P, von Schulthess G: Benefit of 18 F-fluorocholine PET imaging in parathyroid surgery. European radiology 2018, 28(6):2700-2707.
- Hulsart-Billström G, Selvaraju RK, Estrada S, Lubberink M, Asplund V, Bergman K, Marsell R, Larsson S, Antoni G: Non-invasive tri-modal visualisation via PET/SPECT/μCT of recombinant human bone morphogenetic protein-2 retention and associated bone regeneration: A proof of concept. Journal of Controlled Release 2018.
- Hunter RW, Hughey CC, Lantier L, Sundelin EI, Peggie M, Zeqiraj E, Sicheri F, Jessen N, Wasserman DH, Sakamoto K: Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nature medicine 2018, 24(9):1395.
- Ikawa M, Kimura H, Kitazaki Y, Sugimoto K, Matsunaga A, Hayashi K, Yamamura O, Tsujikawa T, Hamano T, Yoneda M: Arterial spin labeling MR imaging for the clinical detection of cerebellar hypoperfusion in patients with spinocerebellar degeneration. Journal of the neurological sciences 2018, 394:58-62.
- Inoue Ki, Miyachi S, Nishi K, Okado H, Nagai Y, Minamimoto T, Nambu A, Takada M: Recruitment of calbindin into nigral dopamine neurons protects against MPTP‐Induced parkinsonism. Movement Disorders 2018.
- Ishibashi K, Miura Y, Wagatsuma K, Toyohara J, Ishiwata K, Ishii K: Occupancy of adenosine A2A receptors by istradefylline in patients with Parkinson’s disease using 11C-preladenant PET. Neuropharmacology 2018, 143:106-112.
- Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S: In vivo visualization of tau accumulation, microglial activation, and brain atrophy in a mouse model of tauopathy rTg4510. Journal of Alzheimer’s Disease 2018, 61(3):1037-1052.
- Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y: Neuroimaging-pathological correlations of [18 F] THK5351 PET in progressive supranuclear palsy. Acta neuropathologica communications 2018, 6(1):53.
- Iwamoto T, Utsumi K, Kobayashi S, Yasumura S, Hatakeyama S, Hayashi A, Kawanishi C: Effect of Memantine on Brain Metabolic Activity and Perfusion in Drug-naïve Moderate Alzheimer’s Disease Patients. Neuropsychiatry (London) 2018, 8(2):546-554.
- James GM, Gryglewski G, Vanicek T, Berroterán-Infante N, Philippe C, Kautzky A, Nics L, Vraka C, Godbersen GM, Unterholzner J: Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo. Cerebral Cortex 2018, 29(1):372-382.
- Jeong EH, Sunwoo MK, Song YS: Serial I-123-FP-CIT SPECT image findings of Parkinson’s disease patients with levodopa-induced dyskinesia. Frontiers in Neurology 2018, 9:1133.
- Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT: Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE). Alzheimer’s research & therapy 2018, 10(1):15.
- Johansen A, Hansen HD, Svarer C, Lehel S, Leth-Petersen S, Kristensen JL, Gillings N, Knudsen GM: The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C] Cimbi-36 labeled in two positions. Journal of Cerebral Blood Flow & Metabolism 2018, 38(4):659-668.
- John WS, Martin TJ, Sai KKS, Nader SH, Gage HD, Mintz A, Nader MA: Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. Journal of Pharmacology and Experimental Therapeutics 2018, 364(2):300-310.
- Joo Y-H, Kim J-H, Son Y-D, Kim H-K, Shin Y-J, Lee S-Y, Kim J-H: The relationship between excitement symptom severity and extrastriatal dopamine D 2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18 F] fallypride. European archives of psychiatry and clinical neuroscience 2018, 268(6):529-540.
- Joya A, Padro D, Gómez-Vallejo V, Plaza-García S, Llop J, Martín A: PET Imaging of Crossed Cerebellar Diaschisis after Long-Term Cerebral Ischemia in Rats. Contrast Media & Molecular Imaging 2018, 2018.
- Juarez EJ, Castrellon JJ, Green MA, Crawford JL, Seaman KL, Smith CT, Dang LC, Matuskey D, Morris ED, Cowan RL: Reliability of the correlative triad among aging, dopamine D2-like receptor availability, and cognition. bioRxiv 2018:494765.
- Kaneko K-i, Tanaka M, Ishii A, Katayama Y, Nakaoka T, Irie S, Kawahata H, Yamanaga T, Wada Y, Miyake T: A clinical quantitative evaluation of hepatobiliary transport of [11C] Dehydropravastatin in humans using positron emission tomography. Drug Metabolism and Disposition 2018:dmd. 118.080408.
- Kang JM, Lee J-Y, Kim YK, Sohn BK, Byun MS, Choi JE, Son SK, Im H-J, Lee J-H, Ryu YH: Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer’s Disease in Mild Cognitive Impairment. Molecular diagnosis & therapy 2018:1-9.
- Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, Mozley PD: 18F‐FPEB PET/CT Shows mGluR5 Upregulation in Parkinson’s Disease. Journal of Neuroimaging 2018.
- Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J: Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson’s Disease. Journal of Neuroimaging 2018.
- Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA: Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11] PK11195. PloS one 2018, 13(8):e0201289.
- Kanno I, Seki C, Takuwa H, Jin Z-H, Boturyn D, Dumy P, Furukawa T, Saga T, Ito H, Masamoto K: Positron emission tomography of cerebral angiogenesis and TSPO expression in a mouse model of chronic hypoxia. Journal of Cerebral Blood Flow & Metabolism 2018, 38(4):687-696.
- Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, Heinzel A, Mottaghy FM, Myin-Germeys I: Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis. European Neuropsychopharmacology 2018, 28(12):1314-1324.
- Kato M, Yokoyama C, Kawasaki A, Takeda C, Koike T, Onoe H, Iriki A: Individual identity and affective valence in marmoset calls: in vivo brain imaging with vocal sound playback. Animal cognition 2018, 21(3):331-343.
- Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD: Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain 2018, 142(1):133-145.
- Kawamura K, Yamasaki T, Zhang Y, Wakizaka H, Hatori A, Xie L, Fujinaga M, Zhang M-R: Change in the Binding of [11 C] BU99008 to Imidazoline I 2 Receptor Using Brain PET in Zucker Rats. Molecular Imaging and Biology 2018:1-8.
- Kawashima S, Ueki Y, Kato T, Ito K, Matsukawa N: Reduced striatal dopamine release during motor skill acquisition in Parkinson’s disease. PloS one 2018, 13(5):e0196661.
- Kessler M, Mamach M, Beutelmann R, Bankstahl J, Bengel F, Klump G, Berding G: Activation in the auditory pathway of the gerbil studied with 18 F-FDG PET: effects of anesthesia. Brain Structure and Function 2018, 223(9):4293-4305.
- Kim JH, Cumming P, Son YD, Kim HK, Joo YH, Kim JH: Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [18F] fallypride PET and functional MRI study. Synapse 2018, 72(12):e22064.
- Kim J-H, Joo Y-H, Son Y-D, Kim J-H, Kim Y-K, Kim H-K, Lee S-Y, Ido T: In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression. European Neuropsychopharmacology 2018.
- Kim K-M, Zamaleeva AI, Lee YW, Ahmed MR, Kim E, Lee H-R, Pothineni VR, Tao J, Rhee S, Jayakumar M: Characterization of brain dysfunction induced by bacterial lipopeptides that alter neuronal activity and network in rodent brains. Journal of Neuroscience 2018, 38(50):10672-10691.
- Kim M-J, Shrestha SS, Cortes M, Singh P, Morse C, Liow J-S, Gladding RL, Brouwer C, Henry K, Gallagher E: Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018.
- Kim R, Lee J, Kim Y, Kim A, Jang M, Kim H-J, Jeon B, Kang UJ, Fahn S: Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson’s disease: An analysis of the PPMI cohort. Parkinsonism & related disorders 2018.
- Kim SW, Wiers CE, Tyler R, Shokri-Kojori E, Jang YJ, Zehra A, Freeman C, Ramirez V, Lindgren E, Miller G: Influence of alcoholism and cholesterol on TSPO binding in brain: PET [11 C] PBR28 studies in humans and rodents. Neuropsychopharmacology 2018:1.
- King A, Doepner A, Turton D, Ciobota DM, Da Pieve C, Te Fong A-CW, Kramer-Marek G, Chung Y-L, Smith G: Radiosynthesis of the anticancer nucleoside analogue Trifluridine using an automated 18 F-trifluoromethylation procedure. Organic & biomolecular chemistry 2018, 16(16):2986-2996.
- Kiraga Ł, Cheda Ł, Taciak B, Różańska K, Tonecka K, Szulc A, Kilian K, Gorka E, Rogulski Z, Rygiel TP: Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination. PloS one 2018, 13(11):e0206706.
- Kitamura S, Shimada H, Niwa F, Endo H, Shinotoh H, Takahata K, Kubota M, Takado Y, Hirano S, Kimura Y: Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2018:jnnp-2018-317970.
- Klawonn AM, Fritz M, Nilsson A, Bonaventura J, Shionoya K, Mirrasekhian E, Karlsson U, Jaarola M, Granseth B, Blomqvist A: Motivational valence is determined by striatal melanocortin 4 receptors. The Journal of clinical investigation 2018, 128(7).
- Knešaurek K, Warnock G, Kostakoglu L, Burger C: Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging. World journal of nuclear medicine 2018, 17(1):21.
- Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Haase A-M, Svendsen KB, Otto M, Østergaard K, Krogh K, Borghammer P: Objective intestinal function in patients with idiopathic REM sleep behavior disorder. Parkinsonism & related disorders 2018.
- Ko K-Y, Wang S-Y, Yen R-F, Shiau Y-C, Hsu J-C, Tsai H-Y, Lee C-L, Chiu K-M, Wu Y-W: Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy. Journal of Nuclear Cardiology 2018:1-11.
- Kobayashi R, Hayashi H, Kawakatsu S, Ishiki A, Okamura N, Arai H, Otani K: [18 F] THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review. BMC neurology 2018, 18(1):109.
- Konings G, Saarinen N, Delvoux B, Kooreman L, Koskimies P, Krakstad C, Fasmer K, Haldorsen I, Zaffagnini A, Häkkinen M: Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure. International journal of molecular sciences 2018, 19(9):2547.
- Kosten L, Deleye S, Stroobants S, Wyffels L, Mingote S, Rayport S, Staelens S: Molecular Imaging of mGluR5 Availability with [11 C] ABP68 in Glutaminase Heterozygous Mice. Cellular and molecular neurobiology 2018:1-9.
- Kosten L, Verhaeghe J, Wyffels L, Stroobants S, Staelens S: Acute Ketamine Infusion in Rat Does Not Affect In Vivo [11C] ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5. Molecular imaging 2018, 17:1536012118788636.
- Kotsougiani D, Hundepool CA, Bulstra LF, Friedrich PF, Shin AY, Bishop AT: Bone vascularized composite allotransplantation model in swine tibial defect: Evaluation of surgical angiogenesis and transplant viability. Microsurgery 2018.
- Kovacs ZI, Papadakis GZ, Tu T-W, Sinharay S, Reid WC, Lewis B, Hammoud DA, Frank JA: Therapeutic Ultrasound Conference 2017. Journal of Therapeutic Ultrasound 2018, 6(1):O1.
- Krämer SD, Betzel T, Mu L, Haider A, Herde AM, Boninsegni AK, Keller C, Szermerski M, Schibli R, Wünsch B: Evaluation of 11C-Me-NB1 as a potential PET radioligand for measuring GluN2B-containing NMDA receptors, drug occupancy, and receptor cross talk. Journal of Nuclear Medicine 2018, 59(4):698-703.
- Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J, Mitterhauser M, Wadsak W, Windischberger C, Kasper S: Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers. NeuroImage 2018, 171:1-5.
- Krishnan HS, Bernard-Gauthier V, Placzek MS, Dahl K, Narayanaswami V, Livni E, Chen Z, Yang J, Collier TL, Ran C: Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [11C] PBT2. Molecular pharmaceutics 2018, 15(2):695-702.
- Kuehnel C, Winkens T, Freesmeyer M: Design, Construction, and Validation of a Hybrid Phantom for Nuclear Medicine and Ultrasound Fusion Imaging. Applied Radiation and Isotopes 2018.
- Kumata K, Zhang Y, Fujinaga M, Ohkubo T, Mori W, Yamasaki T, Hanyu M, Xie L, Hatori A, Zhang M-R: [18F] DAA1106: Automated radiosynthesis using spirocyclic iodonium ylide and preclinical evaluation for positron emission tomography imaging of translocator protein (18 kDa). Bioorganic & medicinal chemistry 2018, 26(17):4817-4822.
- Kuo H-T, Merkens H, Zhang Z, Uribe CF, Lau J, Zhang C, Colpo N, Lin K-S, Benard F: Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies. Molecular pharmaceutics 2018, 15(11):5183-5191.
- Kwon Y-D, Kang S, Park H, Cheong I-k, Chang K-A, Lee S-Y, Jung JH, Lee BC, Lim ST, Kim H-K: Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET. European journal of medicinal chemistry 2018, 159:292-306.
- Laffon E, Calcagni M, Galli G, Giordano A, Capotosti A, Marthan R, Indovina L: Comparison of three-parameter kinetic model analysis to standard Patlak’s analysis in 18 F-FDG PET imaging of lung cancer patients. EJNMMI research 2018, 8(1):24.
- Lahesmaa M, Eriksson O, Gnad T, Oikonen V, Bucci M, Hirvonen J, Koskensalo K, Teuho J, Niemi T, Taittonen M: Cannabinoid Type 1 Receptors are Upregulated During Acute Activation of Brown Adipose Tissue. Diabetes 2018:db171366.
- Lai M, Lanz B, Poitry-Yamate C, Romero JF, Berset CM, Cudalbu C, Gruetter R: In vivo 13C MRS in the mouse brain at 14.1 Tesla and metabolic flux quantification under infusion of [1, 6-13C2] glucose. Journal of Cerebral Blood Flow & Metabolism 2018, 38(10):1701-1714.
- Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RG, Dairou J, Cardellini M: Genetic deficiency of indoleamine 2, 3-dioxygenase promotes gut microbiota-mediated metabolic health. Nature Medicine 2018:1.
- Laymon CM, Minhas DS, Becker CR, Matan C, Oborski MJ, Price JC, Mountz JM: Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging. Molecular Imaging and Biology 2018:1-9.
- Le Floc’h J, Zlitni A, Bilton HA, Yin M, Farhadi A, Janzen NR, Shapiro MG, Valliant JF, Foster FS: In vivo Biodistribution of Radiolabeled Acoustic Protein Nanostructures. Molecular Imaging and Biology 2018, 20(2):230-239.
- Lee J, Ahn S, Lee HA, Won KS, Chang HW, Oh JS, Kim HW: Dietary intake of pantothenic acid is associated with cerebral amyloid burden in patients with cognitive impairment. Food & Nutrition Research 2018, 62.
- Lee J-H, Lee M, Park J-A, Ryu YH, Lee KC, Kim KM, Choi JY: Effects of hypothyroidism on serotonin 1A receptors in the rat brain. Psychopharmacology 2018, 235(3):729-736.
- Lee M, Lee H-J, Park IS, Park J-A, Kwon YJ, Ryu YH, Kim CH, Kang JH, Hyun IY, Lee KC: Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer. Neuropharmacology 2018, 133:512-517.
- Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M: PET imaging of intra-arterial 89Zr bevacizumab in mice with and without osmotic opening of the blood-brain barrier: distinct advantage of intra-arterial delivery. Journal of Nuclear Medicine 2018:jnumed. 118.218792.
- Leurquin-Sterk G, Ceccarini J, Crunelle CL, de Laat B, Verbeek J, Deman S, Neels H, Bormans G, Peuskens H, Van Laere K: Lower limbic metabotropic glutamate receptor 5 availability in alcohol dependence. Journal of Nuclear Medicine 2018, 59(4):682-690.
- Leurquin‐Sterk G, Ceccarini J, Crunelle CL, Weerasekera A, de Laat B, Himmelreich U, Bormans G, Van Laere K: Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study. Addiction biology 2018, 23(3):931-944.
- Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G: Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer’s disease. Alzheimer’s & Dementia 2018, 14(5):652-663.
- Li C-T, Chen M-H, Juan C-H, Liu R-S, Lin W-C, Bai Y-M, Su T-P: Effects of prefrontal theta-burst stimulation on brain function in treatment-resistant depression: A randomized sham-controlled neuroimaging study. Brain stimulation 2018.
- Li D, Cheng S, Zou S, Zhu D, Zhu T, Wang P, Zhu X: Immuno-PET imaging of 89Zr labeled anti-PD-L1 domain antibody. Molecular pharmaceutics 2018, 15(4):1674-1681.
- Li Y-Y, Zhang B, Yu K-W, Li C, Xie H-Y, Bao W-Q, Kong Y-Y, Jiao F-Y, Guan Y-H, Bai Y-L: Effects of constraint-induced movement therapy on brain glucose metabolism in a rat model of cerebral ischemia: a micro PET/CT study. International Journal of Neuroscience 2018, 128(8):736-745.
- Lillethorup TP, Glud AN, Alstrup AK, Mikkelsen TW, Nielsen EH, Zaer H, Doudet DJ, Brooks DJ, Sørensen JCH, Orlowski D: Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs. Experimental neurology 2018, 303:142-152.
- Lillethorup TP, Glud AN, Alstrup AK, Noer O, Nielsen EH, Schacht AC, Landeck N, Kirik D, Orlowski D, Sørensen JCH: Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs. Scientific reports 2018, 8(1):15715.
- Lillethorup TP, Glud AN, Landeck N, Alstrup AKO, Jakobsen S, Vang K, Doudet DJ, Brooks DJ, Kirik D, Hinz R: In vivo quantification of glial activation in minipigs overexpressing human α‐synuclein. Synapse 2018, 72(12):e22060.
- Lin G, Lin K-J, Wang F, Chen T-C, Yen T-C, Yeh T-S: Synergistic anti-proliferative effect of mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity. Disease models & mechanisms 2018:dmm. 033050.
- Lin PY, Chiu YL, Huang JH, Chuang EY, Mi FL, Lin KJ, Juang JH, Sung HW, Leong KW: Oral Nonviral Gene Delivery for Chronic Protein Replacement Therapy. Advanced Science 2018:1701079.
- Lindbo S, Garousi J, Mitran B, Vorobyeva A, Oroujeni M, Orlova A, Hober S, Tolmachev V: Optimized molecular design of ADAPT-based HER2-imaging probes labelled with 111In and 68Ga. Molecular pharmaceutics 2018.
- Lindemann M, Hinz S, Deuther-Conrad W, Namasivayam V, Dukic-Stefanovic S, Teodoro R, Toussaint M, Kranz M, Juhl C, Steinbach J: Radiosynthesis and in vivo evaluation of a fluorine-18 labeled pyrazine based radioligand for PET imaging of the adenosine A2B receptor. Bioorganic & medicinal chemistry 2018, 26(16):4650-4663.
- Linnman C, Catana C, Petkov MP, Chonde DB, Becerra L, Hooker J, Borsook D: Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings. NeuroImage: Clinical 2018, 17:680-690.
- Liow J-S, Morse C, Lu S, Frankland M, Tye G, Zoghbi S, Gladding R, Shaik A, Innis R, Newman A: [O-methyl-11C] N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl) butyl)-1H-indole-2-carboxamide ([11C] BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey. Molecules 2018, 23(11):2737.
- Liu M, Chen X, Paranjpe M, Zhao Q, Leal J, Wang R, Smith G, Pomper M, Wong D, Zhou Y: Quantitative imaging APOE4 effects on brain tau deposition and glucose metabolism in mild cognitive impairment patients with [18F] AV1451 and [18F] FDG PET. Journal of Nuclear Medicine 2018, 59(supplement 1):80-80.
- Lohmann P, Kocher M, Ceccon G, Bauer EK, Stoffels G, Viswanathan S, Ruge MI, Neumaier B, Shah NJ, Fink GR: Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis. NeuroImage: Clinical 2018, 20:537-542.
- Lohmann P, Lerche C, Bauer EK, Steger J, Stoffels G, Blau T, Dunkl V, Kocher M, Viswanathan S, Filss CP: Predicting IDH genotype in gliomas using FET PET radiomics. Scientific reports 2018, 8(1):13328.
- Lohmann P, Piroth MD, Sellhaus B, Weis J, Geisler S, Oros-Peusquens A-M, Mohlberg H, Amunts K, Shah NJ, Galldiks N: Correlation of Dynamic O-(2-[18F] Fluoroethyl)-L-Tyrosine Positron Emission Tomography, Conventional Magnetic Resonance Imaging, and Whole-Brain Histopathology in a Pretreated Glioblastoma: A Postmortem Study. World neurosurgery 2018, 119:e653-e660.
- Lohmann P, Stavrinou P, Lipke K, Bauer EK, Ceccon G, Werner J-M, Neumaier B, Fink GR, Shah NJ, Langen K-J: FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma. European journal of nuclear medicine and molecular imaging 2018:1-12.
- Lokitz SJ, Garg S, Nazih R, Garg PK: Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[18 F] Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry. Molecular Imaging and Biology 2018:1-10.
- López-González FJ, Paredes-Pacheco J, Thurnhofer-Hemsi K, Rossi C, Enciso M, Toro-Flores D, Murcia-Casas B, Gutiérrez-Cardo AL, Roé-Vellvé N: QModeling: a Multiplatform, Easy-to-Use and Open-Source Toolbox for PET Kinetic Analysis. Neuroinformatics 2018:1-12.
- Luo S, Kong X, Wu JR, Wang CY, Tian Y, Zheng G, Su YY, Lu GM, Zhang LJ, Yang GF: Neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using 11 C-PK11195 and 18 F-DPA-714 micro-positron emission tomography. Metabolic brain disease 2018:1-10.
- Madru R, Budassi M, Benveniste H, Lee H, Smith SD, Schlyer DJ, Vaska P, Knutsson L, Strand S-E: Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free 64Cu-Labeled Nanoparticles. Cancer biotherapy & radiopharmaceuticals 2018, 33(6):213-220.
- Maldonado-Lasuncion I, Atienza M, Sanchez-Espinosa MP, Cantero JL: Aging-Related Changes in Cognition and Cortical Integrity are Associated With Serum Expression of Candidate MicroRNAs for Alzheimer Disease. Cerebral Cortex 2018.
- Malik S, Jacobs M, Cho S-S, Boileau I, Blumberger D, Heilig M, Wilson A, Daskalakis ZJ, Strafella AP, Zangen A: Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11 C] PHNO-PET pilot trial in healthy humans. Brain imaging and behavior 2018, 12(5):1306-1317.
- Mamach M, Kessler M, Bankstahl JP, Wilke F, Geworski L, Bengel FM, Kurt S, Berding G: Visualization of the auditory pathway in rats with 18F-FDG PET activation studies based on different auditory stimuli and reference conditions including cochlea ablation. PloS one 2018, 13(10):e0205044.
- Mandlik SK, Ranpise NS, Mohanty BS, Chaudhari PR: A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers. Drug delivery and translational research 2018, 8(3):797-805.
- Mandrup CM, Egelund J, Nyberg M, Enevoldsen LH, Kjær A, Clemmensen AE, Christensen AN, Suetta C, Frikke-Schmidt R, Steenberg DE: Effects of menopause and high-intensity training on insulin sensitivity and muscle metabolism. Menopause 2018, 25(2):165-175.
- Mann T, Kurth J, Hawlitschka A, Stenzel J, Lindner T, Polei S, Hohn A, Krause BJ, Wree A: [18F] fallypride-PET/CT Analysis of the Dopamine D2/D3 Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection. Molecules 2018, 23(3):587.
- Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell‐Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ: The Parkinson’s progression markers initiative (PPMI)–establishing a PD biomarker cohort. Annals of Clinical and Translational Neurology 2018, 5(12):1460-1477.
- Marín-Royo G, Gallardo I, Martínez-Martínez E, Gutiérrez B, Jurado-López R, López-Andrés N, Gutiérrez-Tenorio J, Rial E, Bartolomé MaV, Nieto ML: Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity. Disease models & mechanisms 2018:dmm. 032086.
- Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Ogata Y, Nishime C, Kajimura M, Jinzaki M: Preclinical evaluation of heat-denatured [18F] FDG-labeled red blood cells for detecting splenic tissues with PET in rats. Nuclear medicine and biology 2018, 56:26-30.
- Mauler J, Maudsley AA, Langen K-J, Nikoubashman O, Stoffels G, Sheriff S, Lohmann P, Filss C, Galldiks N, Kops ER: Spatial Relationship of Glioma Volume Derived from 18F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI Study. Journal of Nuclear Medicine 2018, 59(4):603-609.
- McGowan DR, Skwarski M, Papiez BW, Macpherson RE, Gleeson FV, Schnabel JA, Higgins GS, Fenwick JD: Whole tumor kinetics analysis of 18 F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow. EJNMMI research 2018, 8(1):73.
- McGraw T, Guayaquil-Sosa A: Hybrid rendering of exploded views for medical image atlas visualization. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2018, 6(6):668-677.
- Mendoza-Figueroa MJ, Escudero-Castellanos A, Ramirez-Nava GJ, Ocampo-García BE, Santos-Cuevas CL, Ferro-Flores G, Pedraza-Lopez M, Avila-Rodriguez MA: Preparation and preclinical evaluation of 68 Ga-iPSMA-BN as a potential heterodimeric radiotracer for PET-imaging of prostate cancer. Journal of Radioanalytical and Nuclear Chemistry 2018, 318(3):2097-2105.
- Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR: Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity. Molecular psychiatry 2018:1.
- Mignion L, Schmitz S, Michoux N, Caignet X, Goebbels R-M, Bol A, Neveu M-AC, Grégoire V, Duprez T, Lhommel R: 2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck. Oncotarget 2018, 9(47):28572.
- Milara J, Díaz-Platas L, Contreras S, Ribera P, Roger I, Ballester B, Montero P, Cogolludo Á, Morcillo E, Cortijo J: MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease. Respiratory research 2018, 19(1):226.
- Miranda A, Glorie D, Bertoglio D, Vleugels J, Debruyne G, Stroobants S, Staelens S, Verhaeghe J: Awake 18F-FDG PET imaging of memantine-induced brain activation and test-retest in freely running mice. Journal of Nuclear Medicine 2018:jnumed. 118.218669.
- Missault S, Anckaerts C, Blockx I, Deleye S, Van Dam D, Barriche N, De Pauw G, Aertgeerts S, Valkenburg F, De Deyn PP: Neuroimaging of subacute brain inflammation and microstructural changes predicts long-term functional outcome after experimental traumatic brain injury. Journal of neurotrauma 2018.
- Miyajima N, Ito M, Rokugawa T, Iimori H, Momosaki S, Omachi S, Shimosegawa E, Hatazawa J, Abe K: Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [18 F] DPA-714 imaging. EJNMMI research 2018, 8(1):43.
- Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED: Low striatal dopamine D2-type receptor availability is linked to simulated drug choice in methamphetamine users. Neuropsychopharmacology 2018, 43(4):751.
- Monazzam A, Lau J, Velikyan I, Li S-C, Razmara M, Rosenström U, Eriksson O, Skogseid B: Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68 Ga] Ga-DO3A-VS-Cys 40-Exendin-4/PET. Scientific reports 2018, 8(1):748.
- Moreno JM, Tapia A, Martinez CM, Reverte V, Oltra L, Llinas MT, Salazar FJ: Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high fat diet. American Journal of Physiology-Renal Physiology 2018.
- Mukai H, Hatanaka K, Yagi N, Warashina S, Zouda M, Takahashi M, Narushima K, Yabuuchi H, Iwano J, Kuboyama T: Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis. Journal of Controlled Release 2018.
- Mukherjee J, Lao PJ, Betthauser TJ, Samra GK, Pan Ml, Patel IH, Liang C, Metherate R, Christian BT: Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18 F] N ifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways. Journal of Comparative Neurology 2018, 526(1):80-95.
- Müller Herde A, Boss S, He Y, Schibli R, Mu L, Ametamey S: Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F] PSS232 in the Rat Brain. Pharmaceuticals 2018, 11(3):83.
- Musafargani S, Ghosh KK, Mishra S, Mahalakshmi P, Padmanabhan P, Gulyás B: PET/MRI: a frontier in era of complementary hybrid imaging. European journal of hybrid imaging 2018, 2(1):12.
- Nam SB, Kim K, Kim BS, Im H-J, Lee SH, Kim S-J, Kim IJ, Pak K: The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters. Scientific reports 2018, 8(1):4924.
- Napieczynska H, Kolb A, Katiyar P, Tonietto M, Ud-Dean M, Stumm R, Herfert K, Calaminus C, Pichler BJ: Impact of the Arterial Input Function Recording Method on Kinetic Parameters in Small-Animal PET. Journal of Nuclear Medicine 2018, 59(7):1159-1164.
- Nasrallah IM, Chen YJ, Hsieh M-K, Phillips JS, Ternes K, Stockbower GE, Sheline Y, McMillan CT, Grossman M, Wolk DA: 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2018, 59(2):299-306.
- Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I: The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction. Theranostics 2018, 8(10):2799.
- Nguyen DL, Wimberley C, Truillet C, Jego B, Caillé F, Pottier G, Boisgard R, Buvat I, Bouilleret V: Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows. Epilepsia 2018, 59(6):1234-1244.
- Ni R, Ji B, Ono M, Sahara N, Zhang M-R, Aoki I, Nordberg A, Suhara T, Higuchi M: Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine 2018:jnumed. 117.201632.
- Nicolas CT, Hickey RD, Allen KL, Du Z, Guthman RM, Kaiser RA, Amiot B, Bansal A, Pandey MK, Suksanpaisan L: Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models. Surgery 2018.
- Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge E-M: Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. European journal of nuclear medicine and molecular imaging 2018, 45(7):1119-1128.
- Nikolaus S, Wittsack H-J, Beu M, Antke C, De Souza Silva MA, Wickrath F, Müller-Lutz A, Huston JP, Antoch G, Müller H-W: GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain. Frontiers in behavioral neuroscience 2018, 12:38.
- Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y: 18 F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18 F-FPYBF-2 PET imaging. Annals of nuclear medicine 2018, 32(4):256-263.
- Nkoulou R, Fuchs T, Pazhenkottil AP, Wolfrum M, Buechel RR, Gaemperli O, Kaufmann PA: High efficiency gamma camera enables ultra-low fixed dose stress/rest myocardial perfusion imaging. European Heart Journal-Cardiovascular Imaging 2018.
- Nonose Y, Gewehr PE, Almeida RF, da Silva JS, Bellaver B, Martins LA, Zimmer ER, Greggio S, Venturin GT, Da Costa JC: Cortical bilateral adaptations in rats submitted to focal cerebral ischemia: emphasis on glial metabolism. Molecular neurobiology 2018, 55(3):2025-2041.
- Nummenmaa L, Saanijoki T, Tuominen L, Hirvonen J, Tuulari JJ, Nuutila P, Kalliokoski K: μ-opioid receptor system mediates reward processing in humans. Nature communications 2018, 9(1):1500.
- Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T: Value of FDG–PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer. Diseases of the Colon & Rectum 2018, 61(3):320-327.
- Oliveira FP, Faria DB, Costa DC, Castelo-Branco M, Tavares JMR: Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123 I] FP-CIT SPECT images. European journal of nuclear medicine and molecular imaging 2018, 45(6):1052-1062.
- Olsen M, Aguilar X, Sehlin D, Fang XT, Antoni G, Erlandsson A, Syvänen S: Astroglial responses to amyloid-beta progression in a mouse model of Alzheimer’s disease. Molecular Imaging and Biology 2018:1-10.
- Ooms M, Tsujikawa T, Lohith TG, Mabins SN, Zoghbi SS, Sumitomo A, Jaaro-Peled H, Kimura Y, Telu S, Pike VW: [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18758997.
- Ottoy J, De Picker L, Verhaeghe J, Deleye S, Kosten L, Sabbe B, Coppens V, Timmers M, Van Nueten L, Ceyssens S: 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test–Retest Reproducibility and Quantification of Neuroinflammation. Journal of Nuclear Medicine 2018, 59(8):1267-1274.
- Pak K, Kim BS, Kim K, Kim IJ, Jun S, Jeong YJ, Shim HK, Kim S-D, Cho K-S: Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis. American journal of otolaryngology 2018, 39(1):1-5.
- Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Correlation between the availability of dopamine transporter and olfactory function in healthy subjects. European radiology 2018, 28(4):1756-1760.
- Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Prediction of future weight change with the dopamine transporter. Brain imaging and behavior 2018:1-6.
- Pak K, Nam H-Y, Shin S, Kim K, Lee MJ, Kim E-J, Lee JM, Kim S-J, Kim IJ: Effects of rs591323 on serotonin transporter availability in healthy male subjects. Annals of nuclear medicine 2018:1-6.
- Pak K, Shin HK, Kim E-J, Lee J-H, Lyoo CH, Son J, Lee MJ: Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson’s disease. Parkinsonism & related disorders 2018.
- Palard-Novello X, Blin A-L, Bourhis D, Garin E, Salaün P-Y, Devillers A, Querellou S, Bourguet P, Le Jeune F, Saint-Jalmes H: Comparison of choline influx from dynamic 18 F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment. Annals of nuclear medicine 2018, 32(4):281-287.
- Palard-Novello X, Blin A-L, Le Jeune F, Garin E, Salaün P-Y, Devillers A, Gambarota G, Querellou S, Bourguet P, Saint-Jalmes H: Optimization of temporal sampling for 18 F-choline uptake quantification in prostate cancer assessment. EJNMMI research 2018, 8(1):49.
- Palmieri L, Elvas F, Vangestel C, Pak K, Gray B, Stroobants S, Staelens S: [99mTc] duramycin for cell death imaging: Impact of kit formulation, purification and species difference. Nuclear medicine and biology 2018, 56:1-9.
- Park S, Ha S, Lee S-H, Paeng JC, Keam B, Kim TM, Kim D-W, Heo DS: Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor. PloS one 2018, 13(1):e0189766.
- Paul S, Gallagher E, Liow J-S, Mabins S, Henry K, Zoghbi SS, Gunn RN, Kreisl WC, Richards EM, Zanotti-Fregonara P: Building a database for brain 18 kDa translocator protein imaged using [11C] PBR28 in healthy subjects. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18771250.
- Pauwelyn G, Laeken NV, Verhoeven J, De Vos F, Peremans K, Dockx R, Baeken C, Descamps B, Vanhove C, Kersemans K: The Signature of the Serotonin System in the Chronic Corticosterone Depression Model: A Study with [18F] MPPF,[18F] Altanserin and [11C] DASB. Neuropsychiatry 2018, 8(04):1377-1390.
- Perez-Liva M, Viel T, Yoganathan T, Garofalakis A, Sourdon J, Facchin C, Tanter M, Provost J, Tavitian B: Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument. Physics in Medicine & Biology 2018, 63(19):19NT01.
- Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Haas H, Novy Z, Dolezal D, Hajduch M, Decristoforo C: Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography. Scientific reports 2018, 8(1):15698.
- Pettorruso M, Martinotti G, Cocciolillo F, De Risio L, Cinquino A, Di Nicola M, Camardese G, Migliara G, Moccia L, Conte E: Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I‐FP‐CIT SPECT study. Addiction biology 2018.
- Pohl JM, Volke JK, Thiebes S, Brenzel A, Fuchs K, Beziere N, Ehrlichmann W, Pichler BJ, Squire A, Gueler F: CCR2‐dependent Gr1high monocytes promote kidney injury in shiga toxin‐induced hemolytic uremic syndrome in mice. European journal of immunology 2018.
- Polinder-Bos HA, Elting JWJ, Aries MJ, García DV, Willemsen AT, van Laar PJ, Kuipers J, Krijnen WP, Slart RH, Luurtsema G: Changes in cerebral oxygenation and cerebral blood flow during hemodialysis–A simultaneous near-infrared spectroscopy and positron emission tomography study. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18818652.
- Polinder-Bos HA, García DV, Kuipers J, Elting JWJ, Aries MJ, Krijnen WP, Groen H, Willemsen AT, van Laar PJ, Strijkert F: Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. Journal of the American Society of Nephrology 2018, 29(4):1317-1325.
- Ponto LLB: Principles and Potential Role in Understanding Brain Function. The Wiley Handbook on the Aging Mind and Brain 2018:164.
- Ponto LLB, Huang J, Walsh SA, Acevedo MR, Mundt C, Sunderland J, Donovan M: Demonstration of nucleoside transporter activity in the nose-to-brain distribution of [18 F] Fluorothymidine using PET imaging. The AAPS journal 2018, 20(1):16.
- Ponto LLB, Walsh S, Huang J, Mundt C, Thede-Reynolds K, Watkins GL, Sunderland J, Acevedo M, Donovan M: Pharmacoimaging of blood-brain barrier permeable (FDG) and impermeable (FLT) substrates after intranasal (IN) administration. The AAPS journal 2018, 20(1):15.
- Portilho FL, Helal-Neto E, Cabezas SS, Pinto SR, dos Santos SN, Pozzo L, Sancenón F, Martínez-Máñez R, Santos-Oliveira R: Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography. Artificial cells, nanomedicine, and biotechnology 2018:1-8.
- Prando S, Carneiro CdG, Otsuki DA, Sapienza MT: Effects of ketamine/xylazine and isoflurane on rat brain glucose metabolism measured by 18F‐fluorodeoxyglucose‐positron emission tomography. European Journal of Neuroscience 2018.
- Prause M, Niedermoser S, Wängler C, Decristoforo C, Seibold U, Riester S, Taguchi T, Schirrmacher R, Fricker G, Wängler B: Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors. Nuclear medicine and biology 2018, 57:1-11.
- Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB: Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states–A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18798762.
- Putzu A, Valtorta S, Di Grigoli G, Haenggi M, Belloli S, Malgaroli A, Gemma M, Landoni G, Beretta L, Moresco RM: Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18 F] FDG Positron Emission Tomography and Autoradiography. Neurocritical care 2018, 28(3):370-378.
- Pyo A, Kim H-S, Kim G, Kim H-S, Yun M, Kim D-Y, Min J-J: N-(2-(dimethylamino) ethyl)-4-18F-fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma. Journal of Nuclear Medicine 2018:jnumed. 118.221416.
- Raffel DM, Jung Y-W, Koeppe RA, Jang KS, Gu G, Scott PJ, Murthy VL, Rothley J, Frey KA: First-in-Human Studies of [18F] Fluorohydroxyphenethylguanidines: Positron Emission Tomography Radiotracers for Quantifying Regional Cardiac Sympathetic Nerve Density. Circulation: Cardiovascular Imaging 2018, 11(12):e007965.
- Reesink F, SNM DV, NM C, Peretti D, Willemsen A, Boellaard R, Meles S, Huitema R, de Jong B, Dierckx R: Crossed Cerebellar Diaschisis in Alzheimer’s Disease. Current Alzheimer Research 2018, 15(13):1267-1275.
- Reis ES, Berger N, Wang X, Koutsogiannaki S, Doot RK, Gumas JT, Foukas PG, Resuello RR, Tuplano JV, Kukis D: Safety profile after prolonged C3 inhibition. Clinical Immunology 2018, 197:96-106.
- Röhrich M, Huang K, Schrimpf D, Albert NL, Hielscher T, von Deimling A, Schüller U, Dimitrakopoulou-Strauss A, Haberkorn U: Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. European journal of nuclear medicine and molecular imaging 2018:1-12.
- Rokugawa T, Konishi H, Ito M, Iimori H, Nagai R, Shimosegawa E, Hatazawa J, Abe K: Evaluation of hepatic integrin αvβ3 expression in non-alcoholic steatohepatitis (NASH) model mouse by 18 F-FPP-RGD 2 PET. EJNMMI research 2018, 8(1):40.
- Rosenkranz AA, Slastnikova TA, Karmakova TA, Vorontsova MS, Morozova NB, Petriev VM, Abrosimov AS, Khramtsov YV, Lupanova TN, Ulasov AV: Antitumor activity of Auger electron emitter 111In delivered by modular nanotransporter for treatment of bladder cancer with EGFR overexpression. Frontiers in pharmacology 2018, 9:1331.
- Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG, Coughlin JM: Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy. AIDS (London, England) 2018, 32(12):1661.
- Saanijoki T, Tuominen L, Tuulari JJ, Nummenmaa L, Arponen E, Kalliokoski K, Hirvonen J: Opioid release after high-intensity interval training in healthy human subjects. Neuropsychopharmacology 2018, 43(2):246.
- Sabri O, Meyer PM, Gräf S, Hesse S, Wilke S, Becker G-A, Rullmann M, Patt M, Luthardt J, Wagenknecht G: Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia. Brain 2018, 141(6):1840-1854.
- Sachpekidis C, Anwar H, Winkler JK, Kopp-Schneider A, Larribere L, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A: Longitudinal studies of the 18 F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT. Cancer Immunology, Immunotherapy 2018:1-10.
- Sachpekidis C, Bäumer P, Kopka K, Hadaschik B, Hohenfellner M, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A: 68 Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer. European journal of nuclear medicine and molecular imaging 2018:1-9.
- Sachpekidis C, Pan L, Hadaschik BA, Kopka K, Haberkorn U, Dimitrakopoulou-Strauss A: 68Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis. American journal of nuclear medicine and molecular imaging 2018, 8(5):351.
- Sang S, Pan X, Chen Z, Zeng F, Pan S, Liu H, Jin L, Fei G, Wang C, Ren S: Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not. Alzheimer’s research & therapy 2018, 10(1):26.
- Sauerbeck J, Ishii K, Hosokawa C, Kaida H, Scheiwein FT, Hanaoka K, Rominger A, Brendel M, Bartenstein P, Murakami T: The correlation between striatal and cortical binding ratio of 11 C-PiB-PET in amyloid-uptake-positive patients. Annals of nuclear medicine 2018:1-6.
- Schinke C, Hesse S, Rullmann M, Becker G-A, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K: Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress 2018:1-10.
- Schramm G, Koole M, Willekens S, Rezaei A, Van Weehaeghe D, Delso G, Peeters R, Mertens N, Nuyts J, Van Laere K: Regional accuracy of ZTE-based attenuation correction in static and dynamic brain PET/MR. arXiv preprint arXiv:180603481 2018.
- Schreiber-Stainthorp W, Sinharay S, Srinivasula S, Shah S, Wang J, Dodd L, Lane HC, Di Mascio M, Hammoud DA: Brain 18 F-FDG PET of SIV-infected macaques after treatment interruption or initiation. Journal of neuroinflammation 2018, 15(1):207.
- Sciagrà R, Milan E, Giubbini R, Kubik T, Di Dato R, Gallo L, Camoni L, Allocca M, Calabretta R: Sub-endocardial and sub-epicardial measurement of myocardial blood flow using 13 NH 3 PET in man. Journal of Nuclear Cardiology 2018:1-10.
- Seith F, Martirosian P, Nikolaou K, la Fougère C, Schwenzer N, Schmidt H: Computed diffusion weighted imaging (cDWI) and voxelwise-computed diffusion weighted imaging (vcDWI) for oncologic liver imaging: A pilot study. European Journal of Radiology Open 2018, 5:108-113.
- Seo Y, Pak K, Nam H-Y, Seok JW, Lee MJ, Kim E-J, Lee JM, Kim SJ, Kim IJ: Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects. Yonsei medical journal 2018, 59(6):787-792.
- Serrano ME, Bahri MA, Becker G, Seret A, Mievis F, Giacomelli F, Lemaire C, Salmon E, Luxen A, Plenevaux A: Quantification of [18 F] UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology 2018:1-10.
- Shao G, Wang Y, Liu X, Zhao M, Song J, Huang P, Wang F, Wang Z: Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy. Contrast media & molecular imaging 2018, 2018.
- Shi X, Li N, Ding H, Dang Y, Hu G, Liu S, Cui J, Zhang Y, Li F, Zhang H: Comparison among Reconstruction Algorithms for Quantitative Analysis of 11C-Acetate Cardiac PET Imaging. Contrast media & molecular imaging 2018, 2018.
- Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S: Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology 2018:10.1212/WNL. 0000000000006736.
- Shokri-Kojori E, Wang G-J, Wiers CE, Demiral SB, Guo M, Kim SW, Lindgren E, Ramirez V, Zehra A, Freeman C: β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proceedings of the National Academy of Sciences 2018, 115(17):4483-4488.
- Shrestha S, Singh P, Cortes-Salva MY, Jenko KJ, Ikawa M, Kim M-J, Kobayashi M, Morse CL, Gladding RL, Liow J-S: 3-Substituted 1, 5-Diaryl-1 H-1, 2, 4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [11C] PS13 for Quantitative Imaging. ACS chemical neuroscience 2018.
- Silva RB, Greggio S, Venturin GT, da Costa JC, Gomez MV, Campos MM: Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis. Molecular neurobiology 2018:1-21.
- Silvester AJ, Aseer KR, Jang H-J, Ryu R, Kwon E-Y, Park JG, Cho K-H, Chaudhari HN, Choi M-S, Suh P-G: Loss of DJ-1 promotes browning of white adipose tissue in diet-induced obese mice. The Journal of nutritional biochemistry 2018, 61:56-67.
- Simón-Gracia L, Scodeller P, Fuentes SS, Vallejo VG, Ríos X, San Sebastián E, Sidorenko V, Di Silvio D, Suck M, De Lorenzi F: Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice. Oncotarget 2018, 9(27):18682.
- Singh N, Veronese M, O’Doherty J, Sementa T, Bongarzone S, Cash D, Simmons C, Arcolin M, Marsden PK, Gee A: Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging. Nuclear medicine and biology 2018, 66:32-39.
- Skriba A, Pluhacek T, Palyzova A, Novy Z, Lemr K, Hajduch M, Petrik M, Havlicek V: Early and non-invasive diagnosis of aspergillosis revealed by infection kinetics monitored in a rat model. Frontiers in Microbiology 2018, 9.
- Smit M, Vállez García D, De Jong BM, Zoons E, Booij J, Dierckx RA, Willemsen AT, de Vries EF, Bartels AL, Tijssen MA: Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C] DASB Positron Emission Tomography Study. Frontiers in neurology 2018, 9:88.
- Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR: Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18 F] fallypride PET. Psychopharmacology 2018:1-10.
- Smith CT, San Juan MD, Dang LC, Katz DT, Perkins SF, Burgess LL, Cowan RL, Manning HC, Nickels ML, Claassen DO: Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults. Translational psychiatry 2018, 8(1):269.
- Smith R, Schöll M, Londos E, Ohlsson T, Hansson O: 18 F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies. Scientific reports 2018, 8(1):4717.
- Smith R, Wibom M, Pawlik D, Englund E, Hansson O: Correlation of In Vivo [18F] Flortaucipir With Postmortem Alzheimer Disease Tau Pathology. JAMA neurology 2018.
- Son HJ, Jeong YJ, Yoon HJ, Lee SY, Choi G-E, Park J-A, Kim MH, Lee KC, Lee YJ, Kim MK: Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18 F-flutemetamol and 18 F-florbetaben. BMC neuroscience 2018, 19(1):45.
- Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, Komorowski A, Kautzky A, Silberbauer L, Pichler V: Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Translational psychiatry 2018, 8(1):198.
- Spinelli F, Haider A, Toscano A, Pati ML, Keller C, Berardi F, Colabufo NA, Abate C, Ametamey SM: Synthesis, radiolabelling, and evaluation of [11C] PB212 as a radioligand for imaging sigma-1 receptors using PET. American journal of nuclear medicine and molecular imaging 2018, 8(1):32.
- Stark AJ, Smith CT, Lin Y-C, Petersen KJ, Trujillo P, Van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH: Nigrostriatal and mesolimbic D2/3 receptor expression in Parkinson’s disease patients with compulsive reward-driven behaviors. Journal of Neuroscience 2018:3082-3017.
- Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, Kessler RM, Deutch AY, Zald DH, Claassen DO: [18F] fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson’s disease. NeuroImage: Clinical 2018, 18:433-442.
- Steffen DA, Giannopoulos AA, Grossmann M, Messerli M, Schwyzer M, Gräni C, Gebhard C, Pazhenkottil AP, Kaufmann PA, Buechel RR: “Apical thinning”: Relations between myocardial wall thickness and apical left ventricular tracer uptake as assessed with positron emission tomography myocardial perfusion imaging. Journal of Nuclear Cardiology 2018:1-9.
- Stegmayr C, Stoffels G, Kops ER, Lohmann P, Galldiks N, Shah NJ, Neumaier B, Langen K-J: Influence of Dexamethasone on O-(2-[18 F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake. Molecular Imaging and Biology 2018:1-7.
- Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Parbo P, Borghammer P: Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder. Neurobiology of disease 2018, 115:9-16.
- Summer D, Mayr S, Petrik M, Rangger C, Schoeler K, Vieider L, Matuszczak B, Decristoforo C: Pretargeted Imaging with Gallium-68—Improving the Binding Capability by Increasing the Number of Tetrazine Motifs. Pharmaceuticals 2018, 11(4):102.
- Sun H, Zhang B, Jiang X, Liu H, Deng S, Li Z, Shi H: Radiolabeled ultra-small Fe3O4 nanoprobes for tumor-targeted multimodal imaging. Nanomedicine 2018, 13(24).
- Sundar LK, Muzik O, Rischka L, Hahn A, Rausch I, Lanzenberger R, Hienert M, Klebermass E-M, Füchsel F-G, Hacker M: Towards quantitative [18F] FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18776820.
- Taddio MF, Mu L, Keller C, Schibli R, Krämer SD: Physiologically Based Pharmacokinetic Modelling with Dynamic PET Data to Study the In Vivo Effects of Transporter Inhibition on Hepatobiliary Clearance in Mice. Contrast Media & Molecular Imaging 2018, 2018.
- Takahashi K, Hosoya T, Onoe K, Takashima T, Tanaka M, Ishii A, Nakatomi Y, Tazawa S, Takahashi K, Doi H: Association between aromatase in human brains and personality traits. Scientific reports 2018, 8.
- Takano A, Chen L, Nag S, Brodney MA, Arakawa R, Chang C, Amini N, Doran SD, Dutra JK, McCarthy TJ: Quantitative Analysis of 18F-PF-06684511, a Novel PET Radioligand for Selective β-secretase 1 Imaging, in Non-human Primate Brain. Journal of Nuclear Medicine 2018:jnumed. 118.217372.
- Tang D, Fujinaga M, Hatori A, Zhang Y, Yamasaki T, Xie L, Mori W, Kumata K, Liu J, Manning HC: Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18F] fluoroethoxy) phenyl)-5-methylpyrazolo [1, 5-a] pyrimidin-3-yl)-N, N-diethylacetamide in a preclinical model of neuroinflammation. European journal of medicinal chemistry 2018, 150:1-8.
- Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC: Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18 F] Fluoroethoxy) phenyl)-5-Methylpyrazolo [1, 5-a] Pyrimidin-3-yl)-N, N-Diethylacetamide (18 F-VUIIS1018A) to Image Glioma. Molecular Imaging and Biology 2018:1-9.
- Tateno A, Sakayori T, Kim W-c, Honjo K, Nakayama H, Arakawa R, Okubo Y: Comparison of dopamine D3 and D2 receptor occupancies by a single dose of blonanserin in healthy subjects: A positron emission tomography study with [11C]-(+)-PHNO. International Journal of Neuropsychopharmacology 2018, 21(6):522-527.
- ter Voert EE, Muehlematter UJ, Delso G, Pizzuto DA, Müller J, Nagel HW, Burger IA: Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68 Ga-PSMA PET/MR. EJNMMI research 2018, 8(1):70.
- Testa A, Dall’Angelo S, Mingarelli M, Augello A, Schweiger L, Welch A, Elmore CS, Dawson D, Sharma P, Zanda M: Preclinical Evaluation of [18F] LCATD as a PET tracer to study drug-drug interactions caused by inhibition of hepatic transporters. Contrast Media & Molecular Imaging 2018.
- Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Thongpraparn T, Chanachai R, Gelovani J: Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer’s disease: first-hand experience in Thailand. Nuclear medicine communications 2018, 39(2):186-192.
- Thonglim P, Sungkarat W, Chotipanich C, Somphonsane R, Phoemphoonthanyakit S, Buranasiri P: The optimized time of 18 F-THK5351 PET/CT in normal thai population. In: Biophotonics: Photonic Solutions for Better Health Care VI: 2018: International Society for Optics and Photonics; 2018: 106852A.
- Toramatsu C, Yoshida E, Wakizaka H, Mohammadi A, Ikoma Y, Tashima H, Nishikido F, Kitagawa A, Karasawa K, Hirano Y: Washout effect in rabbit brain: in-beam PET measurements using 10C, 11C and 15O ion beams. Biomedical Physics & Engineering Express 2018, 4(3):035001.
- Tsai S-Y, Wang S-Y, Wu Y-W: Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction. Journal of Nuclear Medicine 2018, 59(supplement 1):226-226.
- Tsartsalis S, Tournier BB, Graf CE, Ginovart N, Ibáñez V, Millet P: Dynamic image denoising for voxel-wise quantification with Statistical Parametric Mapping in molecular neuroimaging. PloS one 2018, 13(9):e0203589.
- Tsartsalis S, Tournier BB, Habiby S, Hamadi MB, Barca C, Ginovart N, Millet P: Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D2/3 and 5-HT2A receptors. Neuroimage 2018, 176:528-540.
- Tseng J-R, Yang L-Y, Lin Y-C, Liu C-Y, Pang S-T, Hong J-H, Yen T-C, Wang L-J: Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer. Contrast media & molecular imaging 2018, 2018.
- Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J: Comparison of 18 F-GE-180 and dynamic 18 F-FET PET in high grade glioma: a double-tracer pilot study. European journal of nuclear medicine and molecular imaging 2018:1-11.
- Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic V: TSPO PET with [18 F] GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis. European journal of nuclear medicine and molecular imaging 2018, 45(8):1423-1431.
- van Duin ED, Kasanova Z, Hernaus D, Ceccarini J, Heinzel A, Mottaghy F, Mohammadkhani-Shali S, Winz O, Frank M, Beck MC: Striatal dopamine release and impaired reinforcement learning in adults with 22q11. 2 deletion syndrome. European Neuropsychopharmacology 2018.
- Van Laeken N, Pauwelyn G, Dockx R, Descamps B, Brans B, Peremans K, Baeken C, Goethals I, Vanhove C, De Vos F: Regional alterations of cerebral [18 F] FDG metabolism in the chronic unpredictable mild stress-and the repeated corticosterone depression model in rats. Journal of Neural Transmission 2018, 125(9):1381-1393.
- van Lierop ZY, Jentjens S, Anten MH, Wierts R, Stumpel CT, Havekes B, van Kroonenburgh MJ: Thyroid Gland 18F-FDG Uptake in Neurofibromatosis Type 1. European Thyroid Journal 2018, 7(3):155-161.
- Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack H-J, Kops ER, Galldiks N, Fink GR, Shah NJ: Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study. World Neurosurgery 2018, 113:e727-e737.
- Verger A, Stoffels G, Galldiks N, Lohmann P, Willuweit A, Neumaier B, Geisler S, Langen K-J: Investigation of cis-4-[18 F] Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment. Molecular Imaging and Biology 2018:1-9.
- Verhaeghe J, Bertoglio D, Kosten L, Thomae D, Verhoye M, Van Der Linden A, Wyffels L, Stroobants S, Wityak J, Dominguez C: Noninvasive relative quantification of [11C] ABP688 PET imaging in mice versus an input function measured over an arteriovenous shunt. Frontiers in Neurology 2018, 9:516.
- Vettermann FJ, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Meyer PM, McLeod A, Brendel M, Blüher M: Noradrenaline transporter availability on [11 C] MRB PET predicts weight loss success in highly obese adults. European journal of nuclear medicine and molecular imaging 2018:1-8.
- Vidal B, Fieux S, Colom M, Billard T, Bouillot C, Barret O, Constantinescu C, Tamagnan G, Newman-Tancredi A, Zimmer L: 18 F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT 1A receptor agonist for PET neuroimaging. Brain Structure and Function 2018:1-16.
- Vignal N, Cisternino S, Rizzo-Padoin N, San C: Fortune Hontonnou 4, Thibaut Gelé, Xavier Declèves 2, 5, Laure Sarda-Mantel and Benoît Hosten. Current Aspects of Radiopharmaceutical Chemistry 2018, 23:114.
- Vignal N, Cisternino S, Rizzo-Padoin N, San C, Hontonnou F, Gelé T, Declèves X, Sarda-Mantel L, Hosten B: [18F] FEPPA a TSPO Radioligand: Optimized Radiosynthesis and Evaluation as a PET Radiotracer for Brain Inflammation in a Peripheral LPS-Injected Mouse Model. Molecules 2018, 23(6).
- Vomacka L, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Ziegler S, Suchorska B, Kreth F-W, Tonn J-C: Voxel-wise analysis of dynamic 18 F-FET PET: a novel approach for non-invasive glioma characterisation. EJNMMI research 2018, 8(1):91.
- Von Spiczak J, Manka R, Gotschy A, Oebel S, Kozerke S, Hamada S, Alkadhi H: Fusion of CT coronary angiography and whole-heart dynamic 3D cardiac MR perfusion: building a framework for comprehensive cardiac imaging. The international journal of cardiovascular imaging 2018, 34(4):649-660.
- von Spiczak J, Mannil M, Kozerke S, Alkadhi H, Manka R: 3D image fusion of whole‐heart dynamic cardiac MR perfusion and late gadolinium enhancement: Intuitive delineation of myocardial hypoperfusion and scar. Journal of Magnetic Resonance Imaging 2018.
- Vorobyeva A, Westerlund K, Mitran B, Altai M, Rinne S, Sörensen J, Orlova A, Tolmachev V, Karlström AE: Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy. Scientific reports 2018, 8(1):9643.
- Wan H, Tan Z, Zheng Q, Yu J: Metabolic Brain Network Analysis of Hypothyroidism Symptom Based on [18 F] FDG-PET of Rats. Molecular Imaging and Biology 2018:1-9.
- Wang L, Liu Y, Xu Y, Sheng J, Pan D, Wang X, Yan J, Yang R, Yang M: Age-related change of GLP-1R expression in rats can be detected by [18F] AlF-NOTA-MAL-Cys39-exendin-4. Brain research 2018, 1698:213-219.
- Wang W, Song N, Jia F, Tang T, Bao W, Zuo C, Xie J, Jiang H: Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson’s disease mouse model. Neurochemistry international 2018, 114:71-79.
- Wang Y, Shi Z, Zhang N, Cai L, Li Y, Yang H, Yao S, Xing X, Ji Y, Gao S: Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer’s Disease Corresponding to Brain Networks: a Prospective Cohort Study. Molecular Imaging and Biology 2018:1-9.
- Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR: Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature medicine 2018:1.
- Warnock G, Özbay PS, Kuhn FP, Nanz D, Buck A, Boss A, Rossi C: Reduction of BOLD interference in pseudo-continuous arterial spin labeling: towards quantitative fMRI. Journal of Cerebral Blood Flow & Metabolism 2018, 38(5):847-856.
- Warnock G, Sommerauer M, Mu L, Gonzalez GP, Geistlich S, Treyer V, Schibli R, Buck A, Krämer SD, Ametamey SM: A first-in-man PET study of [18 F] PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5. European journal of nuclear medicine and molecular imaging 2018, 45(6):1041-1051.
- Wedekind F, Oskamp A, Lang M, Hawlitschka A, Zilles K, Wree A, Bauer A: Intrastriatal administration of botulinum neurotoxin A normalizes striatal D2R binding and reduces striatal D1R binding in male hemiparkinsonian rats. Journal of neuroscience research 2018, 96(1):75-86.
- Weigend S, Holst SC, Treyer V, Tuura RLG, Meier J, Ametamey SM, Buck A, Landolt H-P: Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep-wake cycle. bioRxiv 2018:458885.
- Weir G, Ramage LE, Akyol M, Rhodes JK, Kyle CJ, Fletcher AM, Craven TH, Wakelin SJ, Drake AJ, Gregoriades M-L: Substantial Metabolic Activity of Human Brown Adipose Tissue during Warm Conditions and Cold-Induced Lipolysis of Local Triglycerides. Cell metabolism 2018.
- Weng Y-C, Hsiao I-T, Huang C-Y, Huang K-L, Liu C-H, Chang T-Y, Yen T-C, Lin K-J, Huang C-C: Progress of Brain Amyloid Deposition in Familial Alzheimer’s Disease with Taiwan D678H APP Mutation. Journal of Alzheimer’s Disease 2018(Preprint):1-13.
- Wilson T, Xavier M-A, Knight J, Verhoog S, Torres JB, Mosley M, Hopkins S, Wallington S, Allen D, Kersemans V: PET imaging of PARP expression using [18F] olaparib. Journal of Nuclear Medicine 2018:jnumed. 118.213223.
- Wimberley C, Lavisse S, Brulon V, Peyronneau M-A, Leroy C, Bodini B, Remy P, Stankoff B, Buvat I, Bottlaender M: Impact of endothelial 18-kDa translocator protein on the quantification of 18F-DPA-714. J Nucl Med 2018, 59:307-314.
- Wirth M, Bejanin A, La Joie R, Arenaza-Urquijo EM, Gonneaud J, Landeau B, Perrotin A, Mézenge F, de La Sayette V, Desgranges B: Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer’s disease. Neurobiology of aging 2018, 63:140-151.
- Wu KY, Lin KJ, Chen CH, Chen CS, Liu CY, Huang SY, Yen TC, Hsiao IT: Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy. Brain and behavior 2018:e01016.
- Wu K-Y, Hsiao T, Chen C-H, Liu C-Y, Hsu J-L, Huang S-Y, Yen T-C, Lin K-J: Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18 F-florbetapir binding in non-demented patients with major depressive disorder. Scientific reports 2018, 8(1):2739.
- Xu L, Tetteh G, Lipkova J, Zhao Y, Li H, Christ P, Piraud M, Buck A, Shi K, Menze BH: Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on 68Ga-Pentixafor PET/CT Imaging Using Deep Learning Methods. Contrast media & molecular imaging 2018, 2018.
- Yajima S, Miyagawa S, Fukushima S, Sakai Y, Isohashi K, Watabe T, Ikeda H, Horitsugi G, Harada A, Sakaniwa R: A prostacyclin agonist and an omental flap increased myocardial blood flow in a porcine chronic ischemia model. The Journal of thoracic and cardiovascular surgery 2018.
- Yalcin H, Valenta I, Zhao M, Tahari A, Lu D-Y, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. Journal of Nuclear Cardiology 2018:1-11.
- Yamasaki T, Mori W, Zhang Y, Hatori A, Fujinaga M, Wakizaka H, Kurihara Y, Wang L, Nengaki N, Ohya T: First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [11C] SAR127303. NeuroImage 2018, 176:313-320.
- Yang K-C, Takano A, Halldin C, Farde L, Finnema SJ: Serotonin concentration enhancers at clinically relevant doses reduce [11 C] AZ10419369 binding to the 5-HT 1B receptors in the nonhuman primate brain. Translational psychiatry 2018, 8(1):132.
- Yi H-A, Won KS, Chang HW, Kim HW: Association between white matter lesions and cerebral Aβ burden. PloS one 2018, 13(9):e0204313.
- Yokoi T, Watanabe H, Yamaguchi H, Bagarinao E, Masuda M, Imai K, Ogura A, Ohdake R, Kawabata K, Hara K: Involvement of the precuneus/posterior cingulate cortex is significant for the development of Alzheimer’s disease: A PET (THK5351, PiB) and resting fMRI study. Frontiers in aging neuroscience 2018, 10:304.
- Yokokawa K, Ito T, Takahata K, Takano H, Kimura Y, Ichise M, Ikoma Y, Isato A, Zhang M-R, Kawamura K: Neuromolecular basis of faded perception associated with unreality experience. Scientific reports 2018, 8(1):8062.
- Yoo J, Kim BS, Yoon H-J: Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer. Annals of nuclear medicine 2018, 32(5):328-336.
- Yoon CW, Jeong HJ, Seo S, Lee S-Y, Suh MK, Heo J-H, Lee Y-B, Park KH, Okamura N, Lee K-M: 18F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia. Dementia and Neurocognitive Disorders 2018, 17(3):110-119.
- Yousaf T, Pagano G, Niccolini F, Politis M: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness. Sleep medicine 2018, 43:25-30.
- Zanirati G, Azevedo PN, Venturin GT, Greggio S, Alcará AM, Zimmer ER, Feltes PK, DaCosta JC: Depression comorbidity in epileptic rats is related to brain glucose hypometabolism and hypersynchronicity in the metabolic network architecture. Epilepsia 2018, 59(5):923-934.
- Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, Carter R, Appel SH, Atassi N, Masdeu JC: Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain. Journal of Nuclear Medicine 2018, 59(8):1260-1266.
- Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M: Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease. Gut 2018:gutjnl-2018-316023.
- Zeng Y, Hu D, Yang W, Hayashinaka E, Wada Y, Watanabe Y, Zeng Q, Cui Y: A voxel-based analysis of neurobiological mechanisms in placebo analgesia in rats. NeuroImage 2018.
- Zhou W, Bao W, Jiang D, Kong Y, Hua F, Lu X, Guan Y: [18F]-GE-179 positron emission tomography (PET) tracer for N-methyl-d-aspartate receptors: One-pot synthesis and preliminary micro-PET study in a rat model of MCAO. Nuclear medicine and biology 2018, 61:45-55.
- Zhu Z, Chung Y-M, Sergeeva O, Kepe V, Berk M, Li J, Ko H-K, Li Z, Petro M, DiFilippo FP: Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging. Journal of Biological Chemistry 2018, 293(46):17829-17837.
- Zoppolo F: Biological and dosimetric evaluation of [11 C] S-adenosyl Methionine as a potential agent for prostate cancer diagnosis. Cancer Research Frontiers 2018, 4(1):27-44.
- Zoufal V, Wanek T, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Bauer M, Pahnke J: Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET. Journal of Cerebral Blood Flow & Metabolism 2018:0271678X18806640.
- Zwirner K, Thorwarth D, Winter RM, Welz S, Weiss J, Schwenzer NF, Schmidt H, la Fougère C, Nikolaou K, Zips D: Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup. Strahlentherapie und Onkologie 2018:1-8.
- A Shiha A, Fernandez de la Rosa R, Delgado M, A Pozo M, Garcia-Garcia L: Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 2017, 16(6):694-704.
- Addolorato G, Antonelli M, Cocciolillo F, Vassallo GA, Tarli C, Sestito L, Mirijello A, Ferrulli A, Pizzuto DA, Camardese G: Deep Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex in Alcohol Use Disorder Patients: Effects on Dopamine Transporter Availability and Alcohol Intake. European Neuropsychopharmacology 2017, 27(5):450-461.
- Ahamed M, Attili B, van Veghel D, Ooms M, Berben P, Celen S, Koole M, Declercq L, Savinainen JR, Laitinen JT: Synthesis and preclinical evaluation of [11 C] MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL). European Journal of Medicinal Chemistry 2017, 136:104-113.
- Airan RD, Foss CA, Ellens NPK, Wang YC, Mease RC, Farahani K, Pomper MG: MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound. Molecular Imaging and Biology 2017, 19(1):24-30.
- Akamatsu G, Nishio T, Adachi K, Ikari Y, Senda M: Whole-body biodistribution and the influence of body activity on brain kinetic analysis of the 11C-PiB PET scan. Radiological physics and technology 2017, 10(4):464-474.
- Akhtar RS, Xie SX, Chen YJ, Rick J, Gross RG, Nasrallah IM, Van Deerlin VM, Trojanowski JQ, Chen-Plotkin AS, Hurtig HI: Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. PloS one 2017, 12(5):e0177924.
- Akkus F, Treyer V, Ametamey SM, Johayem A, Buck A, Hasler G: Metabotropic glutamate receptor 5 neuroimaging in schizophrenia. Schizophrenia research 2017, 183:95-101.
- Alexoff D, Doot R, Pryma D, Schubert E, Wu Z, Zha Z, Choi S, Ploessl K, Kao C, Zhu L: Preliminary kinetic analysis of [68Ga] P15-041, a novel 68Ga labeled bisphosphonate, from first-in-human studies. Journal of Nuclear Medicine 2017, 58(supplement 1):388-388.
- Alves IL, García DV, Parente A, Doorduin J, Dierckx R, da Silva AMM, Koole M, Willemsen A, Boellaard R: Pharmacokinetic modeling of [11C] flumazenil kinetics in the rat brain. EJNMMI research 2017, 7(1):17.
- Alves IL, Garcia DV, Parente A, Doorduin J, Dierckx R, da Silva AMM, Koole M, Willemsen ATM, Boellaard R: Parametric imaging of [C-11]flumazenil binding in the rat brain. Journal of Cerebral Blood Flow and Metabolism 2017, 37:152-153.
- Alves IL, Vallez Garcia D, Parente A, Doorduin J, Dierckx R, Marques da Silva AM, Koole M, Willemsen A, Boellaard R: Pharmacokinetic modeling of [11C]flumazenil kinetics in the rat brain. EJNMMI Res 2017, 7(1):17.
- Alves IL, Willemsen AT, Dierckx RA, da Silva AMM, Koole M: Dual time-point imaging for post-dose binding potential estimation applied to a [11C] raclopride PET dose occupancy study. Journal of Cerebral Blood Flow & Metabolism 2017, 37(3):866-876.
- Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A: Absolute number of new lesions on 18 F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. European Journal of Nuclear Medicine and Molecular Imaging 2017:1-8.
- Arakawa R, Farde L, Matsumoto J, Kanegawa N, Yakushev I, Yang K-C, Takano A: Potential Effect of Prolonged Sevoflurane Anesthesia on the Kinetics of [11C] Raclopride in Non-human Primates. Molecular Imaging and Biology 2017:1-5.
- Arenaza-Urquijo EM, Bejanin A, Gonneaud J, Wirth M, La Joie R, Mutlu J, Gaubert M, Landeau B, de la Sayette V, Eustache F: Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation. Neurobiology of aging 2017, 59:72-79.
- Asai K, Nakamura H, Watabe T, Nishida T, Sakaguchi M, Hatazawa J, Yoshimine T, Kishima H: X-ray angiography perfusion imaging with an intra-arterial injection: comparative study with 15O-gas/water positron emission tomography. Journal of neurointerventional surgery 2017:neurintsurg-2017-013487.
- Attarwala AA, Karanja YW, Hardiansyah D, Romanó C, Roscher M, Wängler B, Glatting G: Investigation of the imaging characteristics of the ALBIRA II small animal PET system for 18 F, 68 Ga and 64 Cu. Zeitschrift für Medizinische Physik 2017, 27(2):132-144.
- Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J, Caillé F, Bottlaender M, Cisternino S, Tournier N: Acute morphine exposure increases the brain distribution of [18F] DPA-714, a PET biomarker of glial activation in nonhuman primates. International Journal of Neuropsychopharmacology 2017, 20(1):67-71.
- Bahri MA, Plenevaux A, Aerts J, Bastin C, Becker G, Mercier J, Valade A, Buchanan T, Mestdagh N, Ledoux D: Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F] UCB-H. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 2017, 3(4):481-486.
- Bak-Fredslund KP, Eriksen PL, Munk OL, Villadsen GE, Keiding S, Sørensen M: Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential. EJNMMI research 2017, 7(1):71.
- Barret O, Alagille D, Sanabria S, Comley RA, Weimer RM, Borroni E, Mintun M, Seneca N, Papin C, Morley T et al: Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects. J Nucl Med 2017, 58(7):1124-1131.
- Bauer M, Karch R, Tournier N, Cisternino S, Wadsak W, Hacker M, Marhofer P, Zeitlinger M, Langer O: Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)-11C-Verapamil PET. Journal of Nuclear Medicine 2017, 58:678–681.
- Bauer M, Matsuda A, Wulkersdorfer B, Philippe C, Traxl A, Özvegy‐Laczka C, Stanek J, Nics L, Klebermass EM, Poschner S: Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography. Clinical Pharmacology & Therapeutics 2017.
- Becker AS, Boss A, Klarhoefer M, Finkenstaedt T, Wurnig MC, Rossi C: Investigation of the pulsatility of cerebrospinal fluid using cardiac-gated Intravoxel Incoherent Motion imaging. NeuroImage 2017.
- Becker G, Mohamed Ali B, Michel A, Hustadt F, Garraux G, Luxen A, Lemaire C, Plenevaux A: Comparative assessment of 6‐[18F] fluoro‐L‐m‐tyrosine and 6‐[18F] fluoro‐L‐dopa to evaluate dopaminergic presynaptic integrity in a Parkinson’s disease rat model. Journal of Neurochemistry 2017.
- Becker G, Warnier C, Serrano ME, Bahri MA, Mercier J, Lemaire C, Salmon E, Luxen A, Plenevaux A: Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain. Mol Pharm 2017.
- Beckers L, Ory D, Geric I, Declercq L, Koole M, Kassiou M, Bormans G, Baes M: Increased expression of translocator protein (TSPO) marks pro-inflammatory microglia but does not predict neurodegeneration. Molecular Imaging and Biology 2017:1-9.
- Beichel RR, Smith BJ, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, Gillies RJ, Goldgof D, Grkovski M, Hamarneh G: Multi‐site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data. Medical Physics 2017, 44(2):479-496.
- Benveniste H, Lee H, Ding F, Sun Q, Al-Bizri E, Makaryus R, Probst S, Nedergaard M, Stein EA, Lu H: Anesthesia with Dexmedetomidine and Low-dose Isoflurane Increases Solute Transport via the Glymphatic Pathway in Rat Brain When Compared with High-dose Isoflurane. Anesthesiology: The Journal of the American Society of Anesthesiologists 2017, 127(6):976-988.
- Benz DC, Gräni C, Ferro P, Neumeier L, Messerli M, Possner M, Clerc OF, Gebhard C, Gaemperli O, Pazhenkottil AP: Corrected coronary opacification decrease from coronary computed tomography angiography: validation with quantitative 13N-ammonia positron emission tomography. Journal of Nuclear Cardiology 2017:1-8.
- Bernard-Gauthier V, Bailey JJ, Mossine AV, Lindner S, Vomacka L, Aliaga A, Shao X, Quesada CA, Sherman P, Mahringer A: A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. Journal of medicinal chemistry 2017, 60(16):6897-6910.
- Bernier M, Croteau E, Castellano C-A, Cunnane SC, Whittingstall K: Spatial distribution of resting-state BOLD regional homogeneity as a predictor of brain glucose uptake: a study in healthy aging. Neuroimage 2017, 150:14-22.
- Bertelsen F, Landau AM, Vase KH, Jacobsen J, Scheel-Krüger J, Møller A: Acute in vivo effect of Valproic Acid on the GABAergic system in rat brain: A [11 C] Ro15-4513 microPET study. Brain research 2017.
- Bertoglio D, Verhaeghe J, Santermans E, Amhaoul H, Jonckers E, Wyffels L, Van Der Linden A, Hens N, Staelens S, Dedeurwaerdere S: Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbidities. Brain, behavior, and immunity 2017, 61:69-79.
- Beshr R, Isohashi K, Watabe T, MATSUNAGA K, Romanov V, Shimosegawa E, Hatazawa J: FBPA PET/CT: to distinguish radiation necrosis from recurrent brain tumor. Journal of Nuclear Medicine 2017, 58:1288–1288.
- Betts AM, McGoldrick MT, Dethlefs CR, Piotrowicz J, Van Avermaete T, Maki J, Gerstler S, Leevy W: Scaled Anatomical Model Creation of Biomedical Tomographic Imaging Data and Associated Labels for Subsequent Sub-surface Laser Engraving (SSLE) of Glass Crystals. JoVE (Journal of Visualized Experiments) 2017(122):e55340-e55340.
- Blakkisrud J, Holtedahl JE, Løndalen A, Dahle J, Bach-Gansmo T, Holte H, Nygaard S, Kolstad A, Stokke C: Biodistribution and dosimetry results from a phase 1 trial of 177Lu-lilotomab satetraxetan antibody-radionuclide conjugate therapy. Journal of Nuclear Medicine 2017:jnumed. 117.195347.
- Blautzik J, Kotz S, Brendel M, Sauerbeck J, Vettermann F, Winter Y, Bartenstein P, Ishii K, Rominger A: Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. Journal of Alzheimer’s Disease 2017(Preprint):1-11.
- Bolcaen J, Acou M, Boterberg T, Vanhove C, De Vos F, Van den Broecke C, Van Holen R, Deblaere K, Goethals I: 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria. Nuclear medicine communications 2017, 38(3):242-249.
- BonDurant LD, Ameka M, Naber MC, Markan KR, Idiga SO, Acevedo MR, Walsh SA, Ornitz DM, Potthoff MJ: FGF21 Regulates Metabolism Through Adipose-Dependent and-Independent Mechanisms. Cell Metabolism 2017, 25(4):935-944. e934.
- Boon MR, Bakker LE, Prehn C, Adamski J, Vosselman MJ, Jazet IM, Arias-Bouda LMP, van Lichtenbelt WDM, van Dijk KW, Rensen PC: LysoPC-acyl C16: 0 is associated with brown adipose tissue activity in men. Metabolomics 2017, 13(5):48.
- Brendel M, Focke C, Blume T, Peters F, Deussing M, Probst F, Jaworska A, Overhoff F, Albert N, Lindner S: Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study. Journal of Nuclear Medicine 2017, 58(12):1984-1990.
- Brendel M, Kleinberger G, Probst F, Jaworska A, Overhoff F, Blume T, Albert NL, Carlsen J, Lindner S, Gildehaus FJ: Increase of TREM2 during aging of an Alzheimer’s disease mouse model is paralleled by microglial activation and amyloidosis. Frontiers in aging neuroscience 2017, 9.
- Brendel M, Wagner L, Levin J, Zach C, Lindner S, Bartenstein P, Okamura N, Rominger A: Perfusion-Phase [18F] THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration. Journal of Alzheimer’s Disease Reports 2017, 1(1):109-113.
- Bresch A, Rullmann M, Luthardt J, Becker G, Patt M, Ding Y-S, Hilbert A, Sabri O, Hesse S: Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availability. Appetite 2017.
- Bresch A, Rullmann M, Luthardt J, Becker G, Reissig G, Patt M, Ding YS, Hilbert A, Sabri O, Hesse S: Emotional eating and in vivo norepinephrine transporter availability in obesity: A [11C] MRB PET pilot study. International Journal of Eating Disorders 2017, 50(2):152-156.
- Breuer H, Meier M, Schneefeld S, Härtig W, Wittneben A, Märkel M, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Multimodality imaging of blood–brain barrier impairment during epileptogenesis. Journal of Cerebral Blood Flow & Metabolism 2017, 37(6):2049-2061.
- Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA: Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C] DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology 2017.
- Brumberg J, Küsters S, Al‐Momani E, Marotta G, Cosgrove KP, Dyck CH, Herrmann K, Homola GA, Pezzoli G, Buck AK: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study. Annals of clinical and translational neurology 2017, 4(9):632-639.
- Buhour M-S, Doidy F, Laisney M, Pitel A-L, de La Sayette V, Viader F, Eustache F, Desgranges B: Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: a study combining MRI and FDG-PET. Brain imaging and behavior 2017, 11(1):240-252.
- Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y: Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study. Journal of the Neurological Sciences 2017.
- Busk M, Munk OL, Jakobsen S, Frøkiær J, Overgaard J, Horsman MR: FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach. Acta Oncologica 2017, 56(5):706-712.
- Busk M, Munk OL, Jakobsen SS, Horsman MR: Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificity. Acta Oncologica 2017, 56(11):1583-1590.
- Byun BH, Kim BI, Park SY, Ko IO, Lee KC, Kim KM, Kim YK, Lee J-Y, Bu SH, Kim JH: Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer’s disease patients. Medicine 2017, 96(12).
- C Mainta I, Perani D, MA Delattre B, Assal F, Haller S, I Vargas M, S Zekry D, B Frisoni G, Zaidi H, Ratib O: FDG PET/MR imaging in major neurocognitive disorders. Current Alzheimer Research 2017, 14(2):186-197.
- Cannella N, Cosa-Linan A, Roscher M, Takahashi TT, Vogler N, Wängler B, Spanagel R: [18F]-Fluorodeoxyglucose-Positron Emission Tomography in Rats with Prolonged Cocaine Self-Administration Suggests Potential Brain Biomarkers for Addictive Behavior. Frontiers in psychiatry 2017, 8.
- Caravaggio F, Chung JK, Gerretsen P, Fervaha G, Nakajima S, Plitman E, Iwata Y, Wilson A, Graff-Guerrero A: Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO. Social neuroscience 2017, 12(2):163-173.
- Caravaggio F, Ku Chung J, Plitman E, Boileau I, Gerretsen P, Kim J, Iwata Y, Patel R, Chakravarty MM, Remington G: The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11C]‐raclopride and [11C]‐(+)‐PHNO PET. Human brain mapping 2017, 38(11):5519-5534.
- Carpenet H, Cuvillier A, Perraud A, Martin O, Champier G, Jauberteau M-O, Monteil J, Quelven I: Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases. Oncotarget 2017, 8(49):85185.
- Castañón E, Soltermann A, López I, Román M, Ecay M, Collantes M, Redrado M, Baraibar I, López-Picazo JM, Rolfo C: The inhibitor of differentiation-1 (Id-1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Cancer Letters 2017.
- Castellano C-A, Paquet N, Dionne IJ, Imbeault H, Langlois F, Croteau E, Tremblay S, Fortier M, Matte JJ, Lacombe G: A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer’s Disease: Preliminary Results from a Neuroimaging Study. Journal of Alzheimer’s Disease 2017, 56(4):1459-1468.
- Cecchin D, Barthel H, Poggiali D, Cagnin A, Tiepolt S, Zucchetta P, Turco P, Gallo P, Frigo AC, Sabri O: A new integrated dual time-point amyloid PET/MRI data analysis method. European Journal of Nuclear Medicine and Molecular Imaging 2017, 44(12):2060-2072.
- Ceh J, Youd T, Mastrovich Z, Peterson C, Khan S, Sasser TA, Sander IM, Doney J, Turner C, Leevy WM: Bismuth Infusion of ABS Enables Additive Manufacturing of Complex Radiological Phantoms and Shielding Equipment. Sensors 2017, 17(3):459.
- Chacko A-M, Watanabe S, Herr KJ, Kalimuddin S, Tham JY, Ong J, Reolo M, Serrano RM, Cheung YB, Low JG: 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response. JCI insight 2017, 2(9).
- Chan SC, Chang KP, Fang YHD, Tsang NM, Ng SH, Hsu CL, Liao CT, Yen TC: Tumor heterogeneity measured on F‐18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein‐Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma. The Laryngoscope 2017, 127(1).
- Chan S-C, Cheng N-M, Hsieh C-H, Ng S-H, Lin C-Y, Yen T-C, Hsu C-L, Wan H-M, Liao C-T, Chang K-P: Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 2017, 5.
- Chang H-TY, Ng K-F, Wang L-J, Yen T-C: 11 C-choline PET/MRI for Characterization of Primary High-Risk Prostate Cancer: Correlations between Positron Emission Tomography Imaging Parameters and Clinical Features. Journal of Pharmacy and Pharmacology 2017, 7:391-400.
- Chang WH, Chen KC, Lee IH, Chi MH, Chen PS, Yao WJ, Chiu NT, Yang YK: Unaltered dopamine transporter availability in drug-naive patients with schizophrenia after 6 months of antipsychotics treatment: a naturalistic study. Journal of clinical psychopharmacology 2017, 37(1):21-26.
- Chen L-C, Chang Y-J, Chen S-J, Lee W-C, Chang C-H, Lee T-W, Shien J-H: Imaging, biodistribution and efficacy evaluation of 188Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model. International journal of radiation biology 2017, 93(5):477-486.
- Cheng YS, Liao TY, Lin C, Shen HCH, Wang YH, Chang CW, Liu RS, Chen RPY, Tu Ph: An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice. EMBO molecular medicine 2017, 9(5):703-715.
- Chételat G, Mézenge F, Tomadesso C, Landeau B, Arenaza-Urquijo E, Rauchs G, André C, Flores R, Egret S, Gonneaud J: Reduced age-associated brain changes in expert meditators: a multimodal neuroimaging pilot study. Scientific reports 2017, 7(1):10160.
- Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G: Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia. Molecular Psychiatry 2017.
- Cho H, Kim CH, Knight EQ, Oh HW, Park B, Kim DG, Park H-J: Changes in brain metabolic connectivity underlie autistic-like social deficits in a rat model of autism spectrum disorder. Scientific reports 2017, 7(1):13213.
- Cho S-G, Park KS, Kim J, Kang S-R, Song H-C, Kim JH, Cho JY, Hong YJ, Jabin Z, Park HJ: Coronary flow reserve and relative flow reserve measured by N-13 ammonia PET for characterization of coronary artery disease. Annals of nuclear medicine 2017, 31(2):144-152.
- Choi H, Ha S, Im HJ, Paek SH, Lee DS: Refining diagnosis of Parkinson’s disease with deep learning-based interpretation of dopamine transporter imaging. NeuroImage: Clinical 2017, 16:586-594.
- Choi H, Han JH, Lim SY, Lee I, Cho Y-S, Chun EJ, Lee WW: Imaging of Myocardial Ischemia–Reperfusion Injury Using Sodium [18F] Fluoride Positron Emission Tomography/Computed Tomography in Rats and Humans. Molecular Imaging 2017, 16:1536012117704767.
- Chung Y-H, Tsai C-K, Wang C-C, Chen H-M, Lu K-Y, Chiu H, Lin Y-C, Yen T-C, Lin G: Early Response Monitoring Following Radiation Therapy by Using [18F] FDG and [11C] Acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration. Molecules 2017, 22(11):1946.
- Cleeren F, Lecina J, Ahamed M, Raes G, Devoogdt N, Caveliers V, McQuade P, Rubins DJ, Li W, Verbruggen A: Al18F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging. Theranostics 2017, 7(11):2924.
- Clemmensen AE, Ghotbi AA, Bodholdt RP, Hag AMF, Hasbak P, Ripa RS, Kjaer A: Perfusion imaging using rubidium-82 (82Rb) PET in rats with myocardial infarction: first small animal cardiac 82Rb-PET. Journal of Nuclear Cardiology 2017, 24(2):750-752.
- Cochran BJ, Ryder WJ, Parmar A, Klaeser K, Reilhac A, Angelis GI, Meikle SR, Barter PJ, Rye K-A: Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT. JoVE (Journal of Visualized Experiments) 2017(123):e55184-e55184.
- Coleman RA, Liang C, Patel R, Ali S, Mukherjee J: Brain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using 18F-FDG PET Imaging. Molecular Imaging 2017, 16:1536012117704557.
- Collantes M, Pelacho B, García-Velloso MJ, Gavira JJ, Abizanda G, Palacios I, Rodriguez-Borlado L, Álvarez V, Prieto E, Ecay M: Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury. Journal of translational medicine 2017, 15(1):56.
- Conde V, Andreasen SH, Petersen TH, Larsen KB, Madsen K, Andersen KW, Akopian I, Madsen KH, Hansen CP, Poulsen I: Alterations in the brain’s connectome during recovery from severe traumatic brain injury: protocol for a longitudinal prospective study. BMJ open 2017, 7(6):e016286.
- Coughlin JM, Wang Y, Minn I, Bienko N, Ambinder EB, Xu X, Peters ME, Dougherty JW, Vranesic M, Koo SM: Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players. JAMA neurology 2017, 74(1):67-74.
- Courchesne-Loyer A, Croteau E, Castellano C-A, St-Pierre V, Hennebelle M, Cunnane SC: Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: a dual tracer quantitative positron emission tomography study. Journal of Cerebral Blood Flow & Metabolism 2017, 37(7):2485-2493.
- Czoty P, Gould R, Gage H, Nader M: Effects of social reorganization on dopamine D2/D3 receptor availability and cocaine self-administration in male cynomolgus monkeys. Psychopharmacology 2017:1-10.
- da Cunha-Bang S, Hjordt LV, Perfalk E, Beliveau V, Bock C, Lehel S, Thomsen C, Sestoft D, Svarer C, Knudsen GM: Serotonin 1B receptor binding is associated with trait anger and level of psychopathy in violent offenders. Biological psychiatry 2017, 82(4):267-274.
- da Ponte KF, Berro DH, Collet S, Constans J-M, Emery E, Valable S, Guillamo J-S: In vivo relationship between hypoxia and angiogenesis in human glioblastoma: a multimodal imaging study. Journal of Nuclear Medicine 2017:jnumed. 116.188557.
- Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A: Evaluation of early-phase [18 F]-florbetaben PET acquisition in clinical routine cases. NeuroImage: Clinical 2017, 14:77-86.
- Dammicco S, Goux M, Lemaire C, Becker G, Bahri MA, Plenevaux A, Cinier M, Luxen A: Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [18 F] FBEM and in vivo PET studies. Nuclear Medicine and Biology 2017, 51:33-39.
- Dang LC, Castrellon JJ, Perkins SF, Le NT, Cowan RL, Zald DH, Samanez-Larkin GR: Reduced effects of age on dopamine D2 receptor levels in physically active adults. NeuroImage 2017, 148:123-129.
- Dang LC, Samanez-Larkin GR, Castrellon JJ, Perkins SF, Cowan RL, Newhouse PA, Zald DH: Spontaneous eye blink rate (EBR) is uncorrelated with dopamine D2 receptor availability and unmodulated by dopamine agonism in healthy adults. eNeuro 2017, 4(5):ENEURO. 0211-0217.2017.
- Dang LC, Samanez-Larkin GR, Smith CT, Castrellon JJ, Perkins SF, Cowan RL, Claassen DO, Zald DH: FTO affects food cravings and interacts with age to influence age-related decline in food cravings. Physiology & behavior 2017.
- Dasari PK, Jones JP, Casey ME, Smith MF: The Effect of Time-of-Flight and Point Spread Function Modeling on Quantitative Cardiac PET of Large Patients: Phantom Studies. IEEE Transactions on Radiation and Plasma Medical Sciences 2017, 1(5):416-425.
- Declercq L, Rombouts F, Koole M, Fierens K, Mariën J, Langlois X, Andrés JI, Schmidt M, Macdonald G, Moechars D: Preclinical evaluation of 18F-JNJ64349311, a novel PET tracer for tau imaging. Journal of Nuclear Medicine 2017, 58(6):975-981.
- Deleye S, Waldron AM, Verhaeghe J, Bottelbergs A, Van Broeck B, Langlois X, Schmidt ME, Stroobants S, Staelens S: Evaluation of μPET outcome measures to detect disease modification induced by BACE inhibition in a transgenic mouse model of Alzheimer’s disease. Journal of Nuclear Medicine 2017:jnumed. 116.187625.
- Dewandre D, Atienza M, Sanchez-Espinosa MP, Cantero JL: Effects of PER3 clock gene polymorphisms on aging-related changes of the cerebral cortex. Brain Structure and Function 2017:1-11.
- Di Perri D, Lee JA, Bol A, Hanin F-X, Janssens G, Labar D, Robert A, Sterpin E, Geets X: Evolution of [18F] fluorodeoxyglucose and [18F] fluoroazomycin arabinoside PET uptake distributions in lung tumours during radiation therapy. Acta Oncologica 2017, 56(4):516-524.
- Di Perri D, Lee JA, Bol A, Hanin F-X, Janssens G, Labar D, Robert A, Sterpin E, Geets X: Correlation analysis of [18F] fluorodeoxyglucose and [18F] fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy. Acta Oncologica 2017:1-8.
- Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker G, Patt M, Schinke C, Bergh F: Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity. Translational Psychiatry 2017, 7(7):e1167.
- Dubol M, Trichard C, Leroy C, Sandu A-L, Rahim M, Granger B, Tzavara ET, Karila L, Martinot J-L, Artiges E: Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study. Neuropsychopharmacology 2017.
- Eberl S, Katsifis A, Peyronneau M, Wen L, Henderson D, Loc’h C, Greguric I, Verschuer J, Pham T, Lam P: Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F] PBR102 and [18F] PBR111. European journal of nuclear medicine and molecular imaging 2017, 44(2):296-307.
- El Arfani A, Parthoens J, Demuyser T, Servaes S, De Coninck M, De Deyn PP, Van Dam D, Wyckhuys T, Baeken C, Smolders I: Accelerated high-frequency repetitive transcranial magnetic stimulation enhances motor activity in rats. Neuroscience 2017, 347:103-110.
- Elvas F, Boddaert J, Vangestel C, Pak K, Gray B, Kumar-Singh S, Staelens S, Stroobants S, Wyffels L: 99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET. Journal of Nuclear Medicine 2017, 58(4):665-670.
- Eriksson O, Johnström P, Cselenyi Z, Jahan M, Selvaraju RK, Jensen-Waern M, Takano A, Winzell MS, Halldin C, Skrtic S: In Vivo Visualization of Beta Cells by Targeting of GPR44. Diabetes 2017:db170764.
- Fang XT, Eriksson J, Antoni G, Yngve U, Cato L, Lannfelt L, Sehlin D, Syvänen S: Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11 C] ABP688 PET imaging and ex vivo immunoblotting. Neuropharmacology 2017, 113:293-300.
- Feng L, Jensen P, Thomsen G, Dyssegaard A, Svarer C, Knudsen LV, Møller K, Thomsen C, Mikkelsen JD, Guilloteau D: The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo 123I-CLINDE SPECT Imaging: A Test–Retest Study. Journal of Nuclear Medicine 2017, 58(6):989-995.
- Fernandez AM, Hernandez-Garzón E, Perez-Domper P, Perez-Alvarez A, Mederos S, Matsui T, Santi A, Trueba-Saiz A, García-Guerra L, Pose-Utrilla J: Insulin regulates astrocytic glucose handling through cooperation with IGF-I. Diabetes 2017, 66(1):64-74.
- Fernández S, Giglio J, Reyes AL, Damián A, Pérez C, Pérez DI, González M, Oliver P, Rey A, Engler H: 3-(Benzyloxy)-1-(5-[18F] fluoropentyl)-5-nitro-1 H-indazole: a PET radiotracer to measure acetylcholinesterase in brain. Future medicinal chemistry 2017, 9(10):983-994.
- Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO: Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT. Nuclear Medicine and Biology 2017, 48:36-44.
- Fite BZ, Kheirolomoom A, Foiret JL, Seo JW, Mahakian LM, Ingham ES, Tam SM, Borowsky AD, Curry F-RE, Ferrara KW: Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin. Journal of Controlled Release 2017, 256:203-213.
- Fleisher AS, Joshi AD, Sundell KL, Chen Y-F, Kollack-Walker S, Lu M, Chen S, Devous MD, Seibyl J, Marek K: Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials. Alzheimer’s & Dementia 2017.
- Franks EM, Scott JE, McAbee KR, Scollan JP, Eastman MM, Ravosa MJ: Intracranial and hierarchical perspective on dietary plasticity in mammals. Zoology 2017.
- Freesmeyer M, Gabler AS, Kühnel C, Winkens T: Late 124I PET/CT Uptake Measurement—Assessment of Appropriate Examination Protocol in Benign Thyroid Diseases. Clinical Nuclear Medicine 2017, 42(7):514-519.
- Fujinaga M, Luo R, Kumata K, Zhang Y, Hatori A, Yamasaki T, Xie L, Mori W, Kurihara Y, Ogawa M: Development of a 18F-Labeled Radiotracer with Improved Brain Kinetics for Positron Emission Tomography Imaging of Translocator Protein (18 kDa) in Ischemic Brain and Glioma. Journal of Medicinal Chemistry 2017, 60(9):4047-4061.
- Fujita M, Richards EM, Niciu MJ, Ionescu DF, Zoghbi SS, Hong J, Telu S, Hines CS, Pike VW, Zarate C: cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Molecular psychiatry 2017, 22(5):754.
- Fukai M, Hirosawa T, Kikuchi M, Ouchi Y, Takahashi T, Yoshimura Y, Miyagishi Y, Kosaka H, Yokokura M, Yoshikawa E: Oxytocin effects on emotional response to others’ faces via serotonin system in autism: A pilot study. Psychiatry Research: Neuroimaging 2017.
- García DV, Doorduin J, de Paula Faria D, Dierckx RA, de Vries EF: Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis. Journal of Neuroimmune Pharmacology 2017:1-10.
- García-García L, de la Rosa RF, Delgado M, Silván Á, Bascuñana P, Bankstahl JP, Gomez F, Pozo MA: Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-Aminopyridine in rats. Neurochemistry international 2017.
- Garcia-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M: Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies. J Cereb Blood Flow Metab 2017:271678X17692599.
- Garg PK, Lokitz SJ, Nazih R, Garg S: Biodistribution and Radiation Dosimetry of 11C-Nicotine from Whole-Body PET Imaging in Humans. Journal of Nuclear Medicine 2017, 58(3):473-478.
- Garg PK, Lokitz SJ, Truong L, Putegnat B, Reynolds C, Rodriguez L, Nazih R, Nedrelow J, de la Guardia M, Uffman JK: Pancreatic uptake and radiation dosimetry of 6-[18F] fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism. PloS one 2017, 12(11):e0186340.
- Gaubert M, Villain N, Landeau B, Mezenge F, Egret S, Perrotin A, Belliard S, de La Sayette V, Eustache F, Desgranges B: Neural Correlates of Self-Reference Effect in Early Alzheimer’s Disease. Journal of Alzheimer’s Disease 2017, 56(2):717-731.
- Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A: Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment. Scientific reports 2017, 7(1):17490.
- Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, Houle S, Strafella AP: Microglial activation in Parkinson’s disease using [18 F]-FEPPA. Journal of neuroinflammation 2017, 14(1):8.
- Ghotbi AA, Clemmensen A, Kyhl K, Follin B, Hasbak P, Engstrøm T, Ripa RS, Kjaer A: Rubidium-82 PET imaging is feasible in a rat myocardial infarction model. Journal of Nuclear Cardiology 2017:1-12.
- Giacomazzi G, Holvoet B, Trenson S, Caluwé E, Kravic B, Grosemans H, Cortés-Calabuig Á, Deroose CM, Huylebroeck D, Hashemolhosseini S: MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors. Nature communications 2017, 8(1):1249.
- Giubbini R, Peli A, Milan E, Sciagrà R, Camoni L, Albano D, Bertoli M, Bonacina M, Motta F, Statuto M: Comparison between the summed difference score and myocardial blood flow measured by 13N-ammonia. Journal of Nuclear Cardiology 2017:1-8.
- Glorie D, Servaes S, Verhaeghe J, Wyckhuys T, Wyffels L, Vanderveken O, Stroobants S, Staelens S: MicroPET outperforms beta-microprobes in determining neuroreceptor availability under pharmacological restriction for cold mass occupancy. Frontiers in neuroscience 2017, 11.
- Gomez JC, Hagenbach A, Gerling-Driessen U, Koksch B, Beindorff N, Brenner W, Abram U: Thiourea derivatives as chelating agents for bioconjugation of rhenium and technetium. Dalton Transactions 2017, 46(42):14602-14611.
- Gonzalez-Escamilla G, Lange C, Teipel S, Buchert R, Grothe MJ, Initiative AsDN: PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET–Application to amyloid imaging with AV45-PET. NeuroImage 2017, 147:669-677.
- Gräni C, Benz DC, Possner M, Clerc OF, Mikulicic F, Vontobel J, Stehli J, Fuchs TA, Pazhenkottil AP, Gaemperli O: Fused cardiac hybrid imaging with coronary computed tomography angiography and positron emission tomography in patients with complex coronary artery anomalies. Congenital heart disease 2017, 12(1):49-57.
- Grkovski M, Emmas S-A, Carlin SD: 18F-fluoromisonidazole kinetic modeling for characterization of tumor perfusion and hypoxia in response to antiangiogenic therapy. Journal of Nuclear Medicine 2017:jnumed. 117.190892.
- Grkovski M, Lee NY, Schöder H, Carlin SD, Beattie BJ, Riaz N, Leeman JE, O’Donoghue JA, Humm JL: Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging 2017:1-10.
- Grkovski M, Schöder H, Lee N, Carlin SD, Beattie BJ, Riaz N, Leeman JE, O’Donoghue JA, Humm JL: Multiparametric imaging of tumor hypoxia and perfusion with 18F-FMISO dynamic PET in head and neck cancer. Journal of Nuclear Medicine 2017:jnumed. 116.188649.
- Gryglewski G, Rischka L, Philippe C, Hahn A, James G, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A: Simple and rapid quantification of serotonin transporter binding using [11 C] DASB bolus plus constant infusion. NeuroImage 2017, 149:23-32.
- Gühne F, Kühnel C, Freesmeyer M: Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders. Endocrine 2017, 56(1):43-53.
- Guo T, Brendel M, Grimmer T, Rominger A, Yakushev I: Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET. Journal of Nuclear Medicine 2017, 58(4):639-645.
- Häggkvist J, Tóth M, Tari L, Varnäs K, Svedberg M, Forsberg A, Nag S, Dominguez C, Munoz-Sanjuan I, Bard J: Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex. Journal of Nuclear Medicine 2017, 58(4):617-622.
- Hahn A, Schain M, Erlandsson M, Sjölin P, James GM, Strandberg OT, Hägerström D, Lanzenberger R, Jögi J, Olsson TG: Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology. Journal of Nuclear Medicine 2017, 58(4):623-631.
- Han Q, Cao Y, Gathaiya NW, Kemp BJ, Jensen MD: Free fatty acid flux measured using [1-11C] palmitate positron emission tomography and [U-13C] palmitate in humans. American Journal of Physiology-Endocrinology and Metabolism 2017:ajpendo. 00284.02017.
- Hansson O, Palmqvist S, Ljung H, Cronberg T, van Westen D, Smith R: Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people. Alzheimer’s & Dementia 2017.
- Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K: Correlations of 18F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer’s disease. Journal of Nuclear Medicine 2017:jnumed. 117.197426.
- Hatashita S, Wakebe D: Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer’s Disease Defined with Amyloid PET Imaging. Journal of Alzheimer’s Disease 2017(Preprint):1-9.
- Haylock A-K, Nilvebrant J, Mortensen A, Velikyan I, Nestor M, Falk R: Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers. Oncotarget 2017.
- Hendrikx G, Hackeng TM, van Gorp R, Bauwens M, Schurgers LJ, Mottaghy FM, Post MJ, Dijkgraaf I: Use of Cyclic Backbone NGR-Based SPECT to Increase Efficacy of Postmyocardial Infarction Angiogenesis Imaging. Contrast media & molecular imaging 2017, 2017.
- Herde AM, Ioanas H-I, Boss SD, Seifritz E, Ametamey SM, Saab BJ: Using tandem behaviour-PET to examine dopaminergic signalling underlying exploration. Matters 2017, 3(3):e201702000008.
- Hesse S, Becker G-A, Rullmann M, Bresch A, Luthardt J, Hankir MK, Zientek F, Reißig G, Patt M, Arelin K: Central noradrenaline transporter availability in highly obese, non-depressed individuals. European journal of nuclear medicine and molecular imaging 2017, 44(6):1056-1064.
- Hesse S, Müller U, Rullmann M, Luthardt J, Bresch A, Becker G-A, Zientek F, Patt M, Meyer PM, Blüher M: The association between in vivo central noradrenaline transporter availability and trait impulsivity. Psychiatry Research: Neuroimaging 2017.
- Hirosawa T, Kikuchi M, Ouchi Y, Takahashi T, Yoshimura Y, Kosaka H, Furutani N, Hiraishi H, Fukai M, Yokokura M: A pilot study of serotonergic modulation after long‐term administration of oxytocin in autism spectrum disorder. Autism Research 2017, 10(5):821-828.
- Hjørnevik T, Cipriano PW, Shen B, Park JH, Gulaka P, Holley D, Gandhi H, Yoon D, Mittra ES, Zaharchuk G: Biodistribution and radiation dosimetry of 18F-FTC-146 in humans. Journal of Nuclear Medicine 2017:jnumed. 117.192641.
- Hjuler K, Gormsen L, Vendelbo M, Egeberg A, Nielsen J, Iversen L: Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate‐to‐severe psoriasis. British Journal of Dermatology 2017.
- Hobson BA, Sisó S, Rowland DJ, Harvey DJ, Bruun DA, Garbow JR, Lein PJ: From the Cover: MagneticResonance Imaging Reveals Progressive Brain Injury in Rats Acutely Intoxicated With Diisopropylfluorophosphate. Toxicological Sciences 2017, 157(2):342-353.
- Holst SC, Sousek A, Hefti K, Saberi-Moghadam S, Buck A, Ametamey SM, Scheidegger M, Franken P, Henning A, Seifritz E: Cerebral mGluR5 availability contributes to elevated sleep need and behavioral adjustment after sleep deprivation. Elife 2017, 6.
- Horitsugi G, Watabe T, Kanai Y, Ikeda H, Kato H, Naka S, Ishibashi M, Matsunaga K, Isohashi K, Shimosegawa E: Oxygen-15 labeled CO 2, O 2, and CO PET in small animals: evaluation using a 3D-mode microPET scanner and impact of reconstruction algorithms. EJNMMI research 2017, 7(1):91.
- Hosoya T, Fukumoto D, Kakiuchi T, Nishiyama S, Yamamoto S, Ohba H, Tsukada H, Ueki T, Sato K, Ouchi Y: In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study. Journal of neuroinflammation 2017, 14(1):69.
- Hovhannisyan N, Dhilly M, Fidalgo M, Fillesoye F, Guillouet S, Sola B, Barré L: [18F] Fludarabine-PET in a murine model of multiple myeloma. PloS one 2017, 12(5):e0177125.
- Huang C-W, Hsieh W-C, Hsu S-T, Lin Y-W, Chung Y-H, Chang W-C, Chiu H, Lin YH, Wu C-P, Yen T-C: The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses. Theranostics 2017, 7(16):4013.
- Hussein AA, Niekoop M, Dilsizian V, Ghzally Y, Abdulghani M, Asoglu R, Chen W, Smith M, See V, Shorofsky SR: Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment. Journal of Interventional Cardiac Electrophysiology 2017, 48(3):247-254.
- Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, Da Settimo F, Fujita M, Pike VW: 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. Journal of Nuclear Medicine 2017, 58(2):320-325.
- Inui Y, Ito K, Kato T: Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease: A Multicenter Study. Journal of Alzheimer’s Disease 2017, 60(3):877-887.
- Ishibashi K, Miura Y, Toyohara J, Ishii K, Ishiwata K: Comparison of imaging using 11 C-ITMM and 18 F-FDG for the detection of cerebellar ataxia. Journal of the Neurological Sciences 2017, 375:97-102.
- Ishii T, Kimura Y, Ichise M, Takahata K, Kitamura S, Moriguchi S, Kubota M, Zhang M-R, Yamada M, Higuchi M: Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain. PloS one 2017, 12(12):e0189318.
- Ishiki A, Harada R, Okamura N, Tomita N, Rowe C, Villemagne V, Yanai K, Kudo Y, Arai H, Furumoto S: Tau imaging with [18F] THK‐5351 in progressive supranuclear palsy. European journal of neurology 2017, 24(1):130-136.
- Ito H, Ikoma Y, Seki C, Kimura Y, Kawaguchi H, Takuwa H, Ichise M, Suhara T, Kanno I: Visual evaluation of kinetic characteristics of PET probe for neuroreceptors using a two-phase graphic plot analysis. Annals of nuclear medicine 2017, 31(4):273-282.
- Ito H, Kawaguchi H, Kodaka F, Takuwa H, Ikoma Y, Shimada H, Kimura Y, Seki C, Kubo H, Ishii S: Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D 2 receptors. NeuroImage 2017.
- James GM, Baldinger-Melich P, Philippe C, Kranz GS, Vanicek T, Hahn A, Gryglewski G, Hienert M, Spies M, Traub-Weidinger T: Effects of selective serotonin reuptake inhibitors on interregional relation of serotonin transporter availability in major depression. Frontiers in human neuroscience 2017, 11.
- Jenkins N, Talbott J, Shah V, Pandit P, Seo Y, Dillon W, Majumdar S: [18F]-Sodium Fluoride PET MR–Based Localization and Quantification of Bone Turnover as a Biomarker for Facet Joint–Induced Disability. American Journal of Neuroradiology 2017, 38(10):2028-2031.
- Jeong YJ, Yoon HJ, Kang D-Y: Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET. Medicine 2017, 96(48).
- Johansen A, Hansen HD, Svarer C, Lehel S, Leth-Petersen S, Kristensen JL, Gillings N, Knudsen GM: The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C] Cimbi-36 labeled in two positions. Journal of Cerebral Blood Flow & Metabolism 2017:0271678X17746179.
- Joo Y-H, Kim J-H, Son Y-D, Kim H-K, Shin Y-J, Lee S-Y, Kim J-H: The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F] fallypride. European Archives of Psychiatry and Clinical Neuroscience 2017:1-12.
- Jørgensen LM, Weikop P, Villadsen J, Visnapuu T, Ettrup A, Hansen HD, Baandrup AO, Andersen FL, Bjarkam CR, Thomsen C: Cerebral 5-HT release correlates with [11C] Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. Journal of Cerebral Blood Flow & Metabolism 2017, 37(2):425-434.
- Jung J-h, Son SH, Kim D-H, Lee J, Jeong SY, Lee S-W, Park HY, Lee J, Ahn B-C: CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer. Medicine 2017, 96(46).
- Kaller S, Rullmann M, Patt M, Becker G-A, Luthardt J, Girbardt J, Meyer PM, Werner P, Barthel H, Bresch A: Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging. European journal of nuclear medicine and molecular imaging 2017, 44(6):1025-1032.
- Kanazawa M, Ohba H, Nishiyama S, Kakiuchi T, Tsukada H: Effects of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys. Journal of Nuclear Medicine 2017:jnumed–116.
- Kanno I, Seki C, Takuwa H, Jin Z-H, Boturyn D, Dumy P, Furukawa T, Saga T, Ito H, Masamoto K: Positron emission tomography of cerebral angiogenesis and TSPO expression in a mouse model of chronic hypoxia. Journal of Cerebral Blood Flow & Metabolism 2017:0271678X16689800.
- Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, Heinzel A, Mottaghy F, Myin-Germeys I: Striatal dopaminergic modulation of reinforcement learning predicts reward—oriented behavior in daily life. Biological Psychology 2017, 127:1–9.
- Katiyar P, Divine MR, Kohlhofer U, Quintanilla-Martinez L, Schölkopf B, Pichler BJ, Disselhorst JA: Spectral Clustering predicts tumor tissue heterogeneity using dynamic 18F-FDG PET: a complement to the standard compartmental modeling approach. Journal of Nuclear Medicine 2017, 58(4):651-657.
- Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, Mozley PD: Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation. Multiple Sclerosis and Related Disorders 2017, 15:27-33.
- Kautzky A, James G, Philippe C, Baldinger-Melich P, Kraus C, Kranz G, Vanicek T, Gryglewski G, Wadsak W, Mitterhauser M: The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning. Translational Psychiatry 2017, 7(6):e1150.
- Keliher EJ, Ye Y-X, Wojtkiewicz GR, Aguirre AD, Tricot B, Senders ML, Groenen H, Fay F, Perez-Medina C, Calcagno C: Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. Nature communications 2017, 8:14064.
- Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, Mizuma H, Takara S, Takahashi R, Inoue H: Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature 2017, 548(7669):592.
- Kim BS, Pak K, Yi K-I, Kim IJ, Roh H-J, Cho K-S: Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer. European Archives of Oto-Rhino-Laryngology 2017, 274(3):1437-1443.
- Kim H-S, Lee B-i, Kim JH, Bom H-S, Kim D-Y, Min J-J: Comparison of Reconstruction Methods in a Small Animal Cardiac Positron Emission Tomography Study Using a 18 F-Labeled Myocardial Agent,[18 F] FPTP. Iranian Journal of Radiology 2017, 14(1).
- Kim HW, Lee DG: Resting-State Metabolism of Hand Knob Area on 18F-FDG PET-CT According to Hand Function and Tractography of Corticospinal Tract After Stroke. Annals of rehabilitation medicine 2017, 41(2):171-177.
- Kim J, Miller-Ocuin J, Rahmim A, Oborski M, Laymon C, Zeh H, Mountz J: Dynamic 18F-FDG PET response to preoperative neoadjuvant chemotherapy in potentially resectable pancreatic ductal adenocarcinoma may predict overall survival. Journal of Nuclear Medicine 2017, 58:498–498.
- Kim J-H, Kim J-H, Son Y-D, Joo Y-H, Lee S-Y, Kim H-K, Woo M-K: Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11 C] DASB and [18 F] FDG. Schizophrenia research 2017, 182:55-65.
- Kim JW, Seo S, Kim HS, Kim D-Y, Lee H-Y, Kang KW, Lee DS, Bom H-S, Min J-J, Lee JS: Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP. Annals of nuclear medicine 2017:1-11.
- Kimura Y, Maeda J, Yamada M, Takahata K, Yokokawa K, Ikoma Y, Seki C, Ito H, Higuchi M, Suhara T: Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol. Psychopharmacology 2017, 234:323–328.
- Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, Focke C, Deußing M, Suárez‐Calvet M, Mazaheri F: The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. The EMBO Journal 2017:e201796516.
- Knollmann D, Genseke P, Schäfer WM: Update präinterventionelle Lungenquantifizierung. Der Nuklearmediziner 2017, 40:79–85.
- Knudsen K, Fedorova TD, Bekker AC, Iversen P, Østergaard K, Krogh K, Borghammer P: Objective colonic dysfunction is far more prevalent than subjective constipation in Parkinson’s disease: a colon transit and volume study. Journal of Parkinson’s Disease 2017, 7(2):359-367.
- Ko K-Y, Wu Y-W, Liu C-W, Cheng M-F, Yen R-F, Yang W-S: Longitudinal evaluation of myocardial glucose metabolism and contractile function in obese type 2 diabetic db/db mice using small-animal dynamic 18F-FDG PET and echocardiography. Oncotarget 2017, 8(50):87795.
- Kotsougiani D, Hundepool CA, Bulstra LF, Friedrich PF, Shin AY, Bishop AT: Recipient‐derived angiogenesis with short term immunosuppression increases bone remodeling in bone vascularized composite allotransplantation: A pilot study in a swine tibial defect model. Journal of Orthopaedic Research 2017, 35(6):1242-1249.
- Krämer SD, Betzel T, Mu L, Haider A, Müller AH, Boninsegni AK, Keller C, Szermerski M, Schibli R, Wünsch B: Evaluation of [11C] Me-NB1 as a potential PET radioligand for measuring GluN2B-containing NMDA receptors, drug occupancy and receptor crosstalk. Journal of Nuclear Medicine 2017:jnumed. 117.200451.
- Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J, Mitterhauser M, Wadsak W, Windischberger C, Kasper S: Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers. NeuroImage 2017.
- Kreisl WC, Lyoo CH, Liow J-S, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS: Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer’s disease. Neurobiology of aging 2017, 51:132-140.
- Kristian A, Holtedahl JE, Torheim T, Futsaether C, Hernes E, Engebraaten O, Mælandsmo GM, Malinen E: Dynamic 2-Deoxy-2-[18F] Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. Molecular Imaging and Biology 2017, 19(2):271-279.
- Krohn T, Birmes A, Winz OH, Drude NI, Mottaghy FM, Behrendt FF, Verburg FA: The reconstruction algorithm used for [68Ga] PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia. European journal of nuclear medicine and molecular imaging 2017, 44(4):662-669.
- Kubota M, Nagashima T, Takano H, Kodaka F, Fujiwara H, Takahata K, Moriguchi S, Kimura Y, Higuchi M, Okubo Y: Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia. International Journal of Neuropsychopharmacology 2017, 20(11):928-935.
- Kuo H-C, Hsiao T, Hsieh C-J, Huang C-Y, Huang K-L, Wai Y-Y, Chuang W-L, Kung M-P, Chu Y-C, Yen T-C: Dual-phase 18 F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer’s disease, and healthy controls: A preliminary study. Journal of the Formosan Medical Association 2017.
- Kurland BF, Peterson LM, Lee JH, Schubert EK, Currin ER, Link JM, Krohn KA, Mankoff DA, Linden HM: Estrogen receptor binding (18F-FES PET) and glycolytic activity (18F-FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer. Clinical Cancer Research 2017, 23(2):407-415.
- Kwee SA, Sato MM, Kuang Y, Franke A, Custer L, Miyazaki K, Wong LL: [18F] Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling. Molecular Imaging and Biology 2017, 19(3):446-455.
- Laguna M, Núñez NO, Garcia FJ, Corral A, Parrado‐Gallego Á, Balcerzyk M, Becerro AI, Ocaña M: Microemulsion‐Mediated Synthesis and Properties of Uniform Ln: CaWO4 (Ln= Eu, Dy) Nanophosphors with Multicolor Luminescence for Optical and CT Imaging. European Journal of Inorganic Chemistry 2017, 2017(44):5158-5168.
- Lai M, Lanz B, Poitry-Yamate C, Romero JF, Berset CM, Cudalbu C, Gruetter R: In vivo 13C MRS in the mouse brain at 14.1 Tesla and metabolic flux quantification under infusion of [1, 6-13C2] glucose. Journal of Cerebral Blood Flow & Metabolism 2017:0271678X17734101.
- Larue RT, Defraene G, De Ruysscher D, Lambin P, Van Elmpt W: Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures. The British journal of radiology 2017, 90(1070):20160665.
- Le Floc’h J, Zlitni A, Bilton HA, Yin M, Farhadi A, Janzen NR, Shapiro MG, Valliant JF, Foster FS: In vivo Biodistribution of Radiolabeled Acoustic Protein Nanostructures. Molecular Imaging and Biology 2017:1-10.
- Le Foll B, Thiruchselvam T, Lu SX, Mohammed S, Mansouri E, Lagzdins D, Nakajima S, Wilson AA, Graff‐Guerrero A, Di Ciano P: Investigating the effects of norepinephrine α1 receptor blockade on dopamine levels: A pilot PET study with [11C]‐(+)‐PHNO in controls. Synapse 2017, 71(7).
- Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C: Altered Dopamine Responses to Monetary Rewards in Female Fibromyalgia Patients with and without Depression: A [11C] Raclopride Bolus-plus-Infusion PET Study. Psychotherapy and Psychosomatics 2017, 86:181–182.
- Lee J-H, Lee M, Park J-A, Ryu YH, Lee KC, Kim KM, Choi JY: Effects of hypothyroidism on serotonin 1A receptors in the rat brain. Psychopharmacology 2017:1-8.
- Lee SB, Lee HW, Lee H, Jeon YH, Lee S-W, Ahn B-C, Lee J, Jeong SY: Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18 F-tetrafluoroborate for sodium/iodide symporter. EJNMMI research 2017, 7(1):32.
- Lee S-P, Im H-J, Kang S, Chung S-J, Cho YS, Kang H, Park HS, Hwang D-W, Park J-B, Paeng J-C: Noninvasive Imaging of Myocardial Inflammation in Myocarditis using 68Ga-tagged Mannosylated Human Serum Albumin Positron Emission Tomography. Theranostics 2017, 7(2):413.
- Lee T-H, Huang K-L, Chang T-Y, Ho M-Y, Wey S-P, Hsieh C-J, Yen T-C, Lin K-J, Hsiao I-T: Early-phase 18F-AV-45 PET Imaging can Detect Crossed Cerebellar Diaschisis Following Carotid Artery Stenosis and Cerebral Hypoperfusion. Current neurovascular research 2017, 14(3):258-265.
- Lerner RP, Francardo V, Fujita K, Bimpisidis Z, Jourdain VA, Tang CC, Dewey SL, Chaly T, Cenci MA, Eidelberg D: Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia. Scientific reports 2017, 7(1):16005.
- Leurquin‐Sterk G, Ceccarini J, Crunelle CL, Weerasekera A, Laat B, Himmelreich U, Bormans G, Van Laere K: Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study. Addiction biology 2017.
- Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Lubberink M, Wall A, Antoni G, Nordberg A: Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer’s disease. Alzheimer’s & Dementia 2017.
- Lewis C, Long J, Swanson T, Fischer N, Kemp B: A Comparison of SUVmax in High and Simulated Low Dose 11C-Choline PET/CT Imaging. Journal of Nuclear Medicine 2017, 58(supplement 1):832-832.
- Li KC, Lo SC, Sung LY, Liao YH, Chang YH, Hu YC: Improved calvarial bone repair by hASCs engineered with Cre/loxP‐based baculovirus conferring prolonged BMP‐2 and MiR‐148b co‐expression. Journal of tissue engineering and regenerative medicine 2017, 11(11):3068-3077.
- Li P, Hsiao T, Liu C-Y, Chen C-H, Huang S-Y, Yen T-C, Wu K-Y, Lin K-J: Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study. EJNMMI research 2017, 7(1):24.
- Li Y-Y, Zhang B, Yu K-W, Li C, Xie H-Y, Bao W-Q, Kong Y-Y, Jiao F-Y, Guan Y-H, Bai Y-L: Effects of constraint-induced movement therapy on brain glucose metabolism in a rat model of cerebral ischemia: a micro PET/CT study. International Journal of Neuroscience 2017(just-accepted):1-33.
- Liu M, Liu S: 99m Tc-3Cboroxime: a novel 99m Tc (iii) complex [99m TcCl (CDO)(CDOH) 2 B-3C](CDOH 2= cyclohexanedione dioxime; 3C-B (OH) 2= 3-(carbamoylphenyl) boronic acid) with high heart uptake and long myocardial retention. Dalton Transactions 2017.
- Liu M, Zhao Z, Fang W, Liu S: A Novel Approach for 99mTc-Labeling of Red Blood Cells: Evaluation of 99mTc-4SAboroxime as a Blood Pool Imaging Agent. Bioconjugate chemistry 2017.
- Liu N-W, Ke C-C, Zhao Y, Chen Y-A, Chan K-C, Tan DT-W, Lee J-S, Chen Y-Y, Hsu T-W, Hsieh Y-J: Evolutional characterization of photochemically induced stroke in rats: a multimodality imaging and molecular biological study. Translational stroke research 2017, 8(3):244-256.
- Liu W, Zhuo P, Li L, Jin H, Lin B, Zhang Y, Liang S, Wu J, Huang J, Wang Z: Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture. Free Radical Biology and Medicine 2017, 112:174-190.
- Lo S-C, Li K-C, Chang Y-H, Hsu M-N, Sung L-Y, Vu TA, Hu Y-C: Enhanced critical-size calvarial bone healing by ASCs engineered with Cre/loxP-based hybrid baculovirus. Biomaterials 2017, 124:1-11.
- Lohmann P, Stoffels G, Ceccon G, Rapp M, Sabel M, Filss CP, Kamp MA, Stegmayr C, Neumaier B, Shah NJ: Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans. European radiology 2017, 27(7):2916-2927.
- Lohmann P, Willuweit A, Neffe A, Geisler S, Gebauer T, Beer S, Coenen H, Fischer H, Hermanns-Sachweh B, Lendlein A: Bone regeneration induced by a 3D architectured hydrogel in a rat critical-size calvarial defect. Biomaterials 2017, 113:158-169.
- MacAskill MG, Tavares AS, Wu J, Lucatelli C, Mountford JC, Baker AH, Newby DE, Hadoke PW: PET Cell Tracking Using 18F-FLT is Not Limited by Local Reuptake of Free Radiotracer. Scientific reports 2017, 7.
- Madsen K, Hesby S, Poulsen I, Fuglsang S, Graff J, Larsen KB, Kammersgaard LP, Law I, Siebner HR: Comparison of analytical methods of brain [18F] FDG-PET after severe traumatic brain injury. Journal of neuroscience methods 2017, 291:176-181.
- Malik S, Jacobs M, Cho S-S, Boileau I, Blumberger D, Heilig M, Wilson A, Daskalakis ZJ, Strafella AP, Zangen A: Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11C] PHNO-PET pilot trial in healthy humans. Brain imaging and behavior 2017:1-12.
- Manninen S, Tuominen L, Dunbar R, Karjalainen T, Hirvonen J, Arponen E, Hari R, Jääskeläinen IP, Sams M, Nummenmaa L: Social laughter triggers endogenous opioid release in humans. Journal of Neuroscience 2017:0688-0616.
- Mateos L, Maioli S, Merino-Serrais P, Ali Z, Lodeiro M, Westman E, Leitersdorf E, Gulyás B, Olof-Wahlund L, Winblad B: 27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation. Journal of Experimental Medicine 2017, 214(3):699-717.
- Matsunaga K, Yanagawa M, Otsuka T, Hirata H, Kijima T, Kumanogoh A, Tomiyama N, Shimosegawa E, Hatazawa J: Quantitative pulmonary blood flow measurement using 15 OH 2 O PET with and without tissue fraction correction: a comparison study. EJNMMI research 2017, 7(1):102.
- Matsuo Y, Ogawa T, Yamamoto M, Shibamoto A, Sáenz JRV, Yokoyama M, Kanda Y, Toyohara J, Sasaki K: Evaluation of peri-implant bone metabolism under immediate loading using high-resolution Na18F-PET. Clinical oral investigations 2017, 21(6):2029-2037.
- Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Nishime C, Kajimura M, Jinzaki M: 18 F-FDG-labeled red blood cell PET for blood-pool imaging: preclinical evaluation in rats. EJNMMI research 2017, 7(1):19.
- Mazère J, Lamare F, Allard M, Fernandez P, Mayo W: 123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies. Journal of Nuclear Medicine 2017, 58(1):123-128.
- McDougald WA, Collins R, Green M, Tavares AA: High Dose MicroCT Does Not Contribute Toward Improved MicroPET/CT Image Quantitative Accuracy and Can Limit Longitudinal Scanning of Small Animals. Frontiers in Physics 2017, 5:50.
- McGraw T, Guayaquil-Sosa A: Hybrid rendering of exploded views for medical image atlas visualization. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2017:1-10.
- McHugh C, Raynor W, Werner T, Alavi A, Rajapakse C: Quantification of Bone Metabolism in the Hip and Spine Using PET/MRI/CT. Journal of Nuclear Medicine 2017, 58(supplement 1):1225-1225.
- Meletta R, Slavik R, Mu L, Rancic Z, Borel N, Schibli R, Ametamey SM, Krämer SD, Herde AM: Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalu1ation of the novel radiotracer [11 C] RS-016 targeting CB2 in atherosclerosis. Nuclear medicine and biology 2017, 47:31-43.
- Meyer M, Le-Bras L, Fernandez P, Zanotti-Fregonara P: Standardized Input Function for 18F-FDG PET Studies in Mice: A Cautionary Study. PloS one 2017, 12(1):e0168667.
- Miranda A, Staelens S, Stroobants S, Verhaeghe J: Markerless rat head motion tracking using structured light for brain PET imaging of unrestrained awake small animals. Physics in medicine and biology 2017, 62(5):1744.
- Miranda A, Staelens S, Stroobants S, Verhaeghe J: Fast and accurate rat head motion tracking with point sources for awake brain PET. IEEE Transactions on Medical Imaging 2017.
- Mishina M, Ishii K, Kimura Y, Suzuki M, Kitamura S, Ishibashi K, Sakata M, Oda K, Kobayashi S, Kimura K: Adenosine A1 receptors measured with 11C‐MPDX PET in early Parkinson’s disease. Synapse 2017.
- Mishina M, Kimura Y, Sakata M, Ishii K, Oda K, Toyohara J, Kimura K, Ishiwata K: Age-Related Decrease in Male Extra-Striatal Adenosine A1 Receptors Measured using 11C-MPDX PET. Frontiers in Pharmacology 2017, 8:903.
- Mitran B, Thisgaard H, Rosenström U, Dam JH, Larhed M, Tolmachev V, Orlova A: High contrast PET imaging of GRPR expression in prostate cancer using cobalt-labeled bombesin antagonist RM26. Contrast media & molecular imaging 2017, 2017.
- Mitsui K, Morimoto N, Niwa T, Yamaura Y, Ohba H, Tsukada H, Katsumata S: Quantification of ONO-2952 occupancy of translocator protein 18kDa in conscious monkey brain using positron emission tomography. Journal of Pharmacology and Experimental Therapeutics 2016, 360(3):457-465.
- Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED: Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Neuropsychopharmacology 2017.
- Momosaki S, Ito M, Yamato H, Iimori H, Sumiyoshi H, Morimoto K, Imamoto N, Watabe T, Shimosegawa E, Hatazawa J: Longitudinal imaging of the availability of dopamine transporter and D2 receptor in rat striatum following mild ischemia. Journal of Cerebral Blood Flow & Metabolism 2017, 37(2):605-613.
- Moriguchi S, Kimura Y, Ichise M, Arakawa R, Takano H, Seki C, Ikoma Y, Takahata K, Nagashima T, Yamada M: PET quantification of the norepinephrine transporter in human brain with (S, S)-18F-FMeNER-D2. Journal of Nuclear Medicine 2017, 58(7):1140-1145.
- Mukherjee J, Majji D, Kaur J, Constantinescu CC, Narayanan TK, Shi B, Nour MT, Pan ML: PET radiotracer development for imaging high‐affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine‐18 labeled aminotetralins in rodents. Synapse 2017, 71(3).
- Muthuramu I, Amin R, Postnov A, Mishra M, Aboumsallem JP, Dresselaers T, Himmelreich U, Van Veldhoven PP, Gheysens O, Jacobs F: Cholesterol-lowering gene therapy counteracts the development of non-ischemic cardiomyopathy in mice. Molecular Therapy 2017, 25(11):2513-2525.
- Muthuramu I, Amin R, Postnov A, Mishra M, Jacobs F, Gheysens O, Veldhoven PPV, Geest BD: Coconut oil aggravates pressure overload-induced cardiomyopathy without inducing obesity, systemic insulin resistance, or cardiac steatosis. International journal of molecular sciences 2017, 18(7):1565.
- Nakai N, Nagano M, Saitow F, Watanabe Y, Kawamura Y, Kawamoto A, Tamada K, Mizuma H, Onoe H, Watanabe Y: Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice. Science advances 2017, 3(6):e1603001.
- Napieczynska H, Severin GW, Fonslet J, Wiehr S, Menegakis A, Pichler BJ, Calaminus C: Imaging neuronal pathways with 52 Mn PET. Toxicity evaluation in rats. NeuroImage 2017.
- Nasrallah IM, Chen YJ, Hsieh M-K, Philips JS, Ternes K, Stockbower G, Sheline Y, McMillan CT, Grossman M, Wolk DA: 18F-Flortaucipir PET-MRI correlations in non-amnestic and amnestic variants of Alzheimer Disease. Journal of Nuclear Medicine 2017:jnumed. 117.194282.
- Nicolas C, Tauber C, Lepelletier F-X, Chalon S, Belujon P, Galineau L, Solinas M: Longitudinal changes in brain metabolic activity after withdrawal from escalation of cocaine self-administration. Neuropsychopharmacology 2017, 42(10):1981.
- Nikolaus S, Beu M, de Souza Silva MA, Huston JP, Antke C, Müller H-W, Hautzel H: GABAergic control of neostriatal dopamine D 2 receptor binding and behaviors in the rat. Pharmacology Biochemistry and Behavior 2017, 153:76-87.
- Njemanze PC, Kranz M, Amend M, Hauser J, Wehrl H, Brust P: Gender differences in cerebral metabolism for color processing in mice: A PET/MRI Study. PloS one 2017, 12(7):e0179919.
- Nonose Y, Gewehr PE, Almeida RF, da Silva JS, Bellaver B, Martins LA, Zimmer ER, Greggio S, Venturin GT, Da Costa JC: Cortical Bilateral Adaptations in Rats Submitted to Focal Cerebral Ischemia: Emphasis on Glial Metabolism. Molecular Neurobiology 2017:1-17.
- O’Doherty J, Chalampalakis Z, Schleyer P, Nazir MS, Chiribiri A, Marsden PK: The effect of high count rates on cardiac perfusion quantification in a simultaneous PET-MR system using a cardiac perfusion phantom. EJNMMI physics 2017, 4(1):31.
- O’Doherty J, Sammut E, Schleyer P, Stirling J, Nazir MS, Marsden PK, Chiribiri A: Feasibility of simultaneous PET-MR perfusion using a novel cardiac perfusion phantom. European Journal of Hybrid Imaging 2017, 1(1):4.
- O’Doherty J, Jauregui-Osoro M, Brothwood T, Szyszko T, Marsden P, O’Doherty M, Cook G, Blower P, Lewington V: 18F-tetrafluoroborate (18F-TFB), a PET probe for imaging sodium-iodide symporter expression: Whole-body biodistribution, safety and radiation dosimetry in thyroid cancer patients. Journal of Nuclear Medicine 2017:jnumed. 117.192252.
- Okita K, Morales A, Dean A, Johnson M, Lu V, Farahi J, Mandelkern M, London E: Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. Molecular psychiatry 2017.
- Oliveira FP, Faria DB, Costa DC, Castelo-Branco M, Tavares JMR: Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123 I] FP-CIT SPECT images. European Journal of Nuclear Medicine and Molecular Imaging 2017:1-11.
- Ooms M, Celen S, De Hoogt R, Lenaerts I, Liebregts J, Vanhoof G, Langlois X, Postnov A, Koole M, Verbruggen A: Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission. EJNMMI Radiopharmacy and Chemistry 2017, 1(1):3.
- Ørntoft NW, Munk OL, Frisch K, Ott P, Keiding S, Sørensen M: Hepatobiliary transport kinetics of the conjugated bile acid tracer 11 C-CSar quantified in healthy humans and patients by positron emission tomography. Journal of Hepatology 2017.
- Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease. Alzheimer’s research & therapy 2017, 9(1):95.
- Ottoy J, Verhaeghe J, Niemantsverdriet E, Engelborghs S, Stroobants S, Staelens S: A simulation study on the impact of the blood flow-dependent component in [18F] AV45 SUVR in Alzheimer’s disease. PloS one 2017, 12(12):e0189155.
- Ottoy J, Verhaeghe J, Niemantsverdriet E, Somers C, De Roeck E, Struyfs H, Soetewey F, Deleye S, Van den Bossche T, Van Mossevelde S et al: Validation of the semi-quantitative static SUVR method for [18F]-AV45 PET by pharmacokinetic modeling with an arterial input function. Journal of Nuclear Medicine 2017:jnumed–116.
- Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Correlation between the availability of dopamine transporter and olfactory function in healthy subjects. European radiology 2017:1-5.
- Pak K, Shin S, Kim SJ, Kim K, Kim BS, Kim SJ, Kim IJ: Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects. Scientific reports 2017, 7(1):13261.
- Pampaloni MH, Shrestha UM, Sciammarella M, Seo Y, Gullberg GT, Botvinick EH: Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients. Journal of Nuclear Cardiology 2017:1-11.
- Pan L, Cheng C, Haberkorn U, Dimitrakopoulou-Strauss A: Machine learning-based kinetic modeling: a robust and reproducible solution for quantitative analysis of dynamic PET data. Physics in Medicine and Biology 2017, 62(9):3566.
- Parente A, García DV, Shoji A, Alves IL, Maas B, Zijlma R, Dierckx RA, Buchpiguel CA, de Vries EF, Doorduin J: Contribution of neuroinflammation to changes in [11 C] flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue. Nuclear Medicine and Biology 2017, 49:50–56.
- Park JH, Kim CS, Won KS, Oh JS, Kim JS, Kim HW: Asymmetry of cerebral glucose metabolism in very low-birth-weight infants without structural abnormalities. PloS one 2017, 12(11):e0186976.
- Pastor Y, Camacho A, Gil AG, Ramos R, de Ceráin AL, Peñuelas I, Irache JM, Gamazo C: Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine. Journal of medical microbiology 2017, 66(7):946-958.
- Petersen I, Villadsen J, Hansen H, Madsen J, Jensen A, Gillings N, Lehel S, Herth M, Knudsen G, Kristensen J: 18 F-Labelling of electron rich iodonium ylides: application to the radiosynthesis of potential 5-HT 2A receptor PET ligands. Organic & Biomolecular Chemistry 2017, 15(20):4351-4358.
- Pfeifer P, Tüscher O, Buchholz HG, Gründer G, Vernaleken I, Paulzen M, Zimmermann US, Maus S, Lieb K, Eggermann T: Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2/D3 dopamine system. Addiction biology 2017, 22(5):1449-1458.
- Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, Barone P, Pellecchia MT: Association between dopaminergic dysfunction and anxiety in de novo Parkinson’s disease. Parkinsonism & Related Disorders 2017, 37:106-110.
- Pottier G, Gómez-Vallejo V, Padro D, Boisgard R, Dollé F, Llop J, Winkeler A, Martín A: PET imaging of cannabinoid type 2 receptors with [11C] A-836339 did not evidence changes following neuroinflammation in rats. Journal of Cerebral Blood Flow & Metabolism 2017, 37(3):1163-1178.
- Prabhu S, Goda JS, Mutalik S, Mohanty BS, Chaudhari P, Rai S, Udupa N, Rao BSS: A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin. Nanoscale 2017, 9(30):10919-10932.
- Preibisch C, Shi K, Kluge A, Lukas M, Wiestler B, Göttler J, Gempt J, Ringel F, Al Jaberi M, Schlegel J: Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study. NMR in Biomedicine 2017, 30(11).
- Pulagam KR, Colás L, Padro D, Plaza-García S, Gómez-Vallejo V, Higuchi M, Llop J, Martín A: Evaluation of the novel TSPO radiotracer [18 F] VUIIS1008 in a preclinical model of cerebral ischemia in rats. EJNMMI research 2017, 7(1):93.
- Putzu A, Valtorta S, Di Grigoli G, Haenggi M, Belloli S, Malgaroli A, Gemma M, Landoni G, Beretta L, Moresco RM: Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F] FDG Positron Emission Tomography and Autoradiography. Neurocritical care 2017:1-9.
- Quevenco FC, Preti MG, Van Bergen JM, Hua J, Wyss M, Li X, Schreiner SJ, Steininger SC, Meyer R, Meier IB: Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer’s disease. Alzheimer’s research & therapy 2017, 9(1):24.
- Rafii MS, Lukic AS, Andrews RD, Brewer J, Rissman RA, Strother SC, Wernick MN, Pennington C, Mobley WC, Ness S: PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Journal of Alzheimer’s Disease 2017, 60(2):439-450.
- Rahmim A, Huang P, Shenkov N, Fotouhi S, Davoodi-Bojd E, Lu L, Mari Z, Soltanian-Zadeh H, Sossi V: Improved prediction of outcome in Parkinson’s disease using radiomics analysis of longitudinal DAT SPECT images. NeuroImage: Clinical 2017, 16:539-544.
- Rapic S, Vangestel C, Elvas F, Verhaeghe J, Van den Wyngaert T, Pauwels P, Staelens S, Stroobants S: Evaluation of [18F] CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology. Molecular Imaging and Biology 2017:1-10.
- Rapic S, Vangestel C, Verhaeghe J, Thomae D, Pauwels P, Van den Wyngaert T, Staelens S, Stroobants S: Evaluation of [18F] fluorothymidine as a biomarker for early therapy response in a mouse model of colorectal cancer. Molecular imaging and biology 2017, 19(1):109-119.
- Rapic S, Vangestel C, Verhaeghe J, Van den Wyngaert T, Hinz R, Verhoye M, Pauwels P, Staelens S, Stroobants S: Characterization of an orthotopic colorectal cancer mouse model and its feasibility for accurate quantification in positron emission tomography. Molecular Imaging and Biology 2017:1-10.
- Real CC, Doorduin J, Kopschina Feltes P, Vállez García D, de Paula Faria D, Britto LR, de Vries EF: Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson’s disease using [11C] PBR28 and [18F] FDOPA PET. Journal of Cerebral Blood Flow & Metabolism 2017:0271678X17750351.
- Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Wall A, Nordberg A: Comparability of [18F] THK5317 and [11C] PIB blood flow proxy images with [18F] FDG positron emission tomography in Alzheimer’s disease. Journal of Cerebral Blood Flow & Metabolism 2017, 37(2):740-749.
- Rohde S, Lindner T, Polei S, Stenzel J, Borufka L, Achilles S, Hartmann E, Lange F, Maletzki C, Linnebacher M: Application of in vivo imaging techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer. Oncotarget 2017, 8(41):69756.
- Rosestedt M, Andersson KG, Mitran B, Rinne SS, Tolmachev V, Löfblom J, Orlova A, Ståhl S: Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression. International journal of oncology 2017, 51(6):1765-1774.
- Russmann V, Brendel M, Mille E, Helm-Vicidomini A, Beck R, Günther L, Lindner S, Rominger A, Keck M, Salvamoser JD: Identification of brain regions predicting epileptogenesis by serial [18 F] GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy. NeuroImage: Clinical 2017, 15:35-44.
- Sai KKS, Gage HD, Almaguel F, Neth B, Hughes TM, Tremblay S, Castellano C-A, Cunnane SC, Jorgensen MJ, Craft S: Automated synthesis of 1-[11C] acetoacetate on a TRASIS AIO module. Applied Radiation and Isotopes 2017, 129:57-61.
- Saiki H, Moulay G, Guenzel AJ, Liu W, Decklever TD, Classic KL, Pham L, Chen HH, Burnett JC, Russell SJ: Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction. American Journal of Physiology-Heart and Circulatory Physiology 2017, 313(2):H392-H407.
- Sakata M, Toyohara J, Ishibashi K, Wagatsuma K, Ishii K, Zhang M-R, Ishiwata K: Age and gender effects of 11 C-ITMM binding to metabotropic glutamate receptor type 1 in healthy human participants. Neurobiology of Aging 2017, 55:72-77.
- Sander IM, Liepert TT, Doney EL, Leevy WM, Liepert DR: Patient Education for Endoscopic Sinus Surgery: Preliminary Experience Using 3D-Printed Clinical Imaging Data. Journal of Functional Biomaterials 2017, 8(2):13.
- Santoro GC, Carrion J, Dewey SL: Imaging Sex Differences in Regional Brain Metabolism during Acute Opioid Withdrawal. Journal of alcoholism and drug dependence 2017, 5(2).
- Santoro GC, Carrion J, Patel K, Vilchez C, Veith J, Brodie JD, Dewey SL: Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement. Neuropsychopharmacology 2017.
- Sari H, Erlandsson K, Law I, Larsson HB, Ourselin S, Arridge S, Atkinson D, Hutton BF: Estimation of an image derived input function with MR-defined carotid arteries in FDG-PET human studies using a novel partial volume correction method. Journal of Cerebral Blood Flow & Metabolism 2017, 37(4):1398-1409.
- Savolainen H, Windhorst AD, Elsinga PH, Cantore M, Colabufo NA, Willemsen AT, Luurtsema G: Evaluation of [18F] MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood–brain barrier in rats: kinetics, metabolism, and selectivity. Journal of Cerebral Blood Flow & Metabolism 2017, 37(4):1286-1298.
- Schabel C, Gatidis S, Bongers M, Hüttig F, Bier G, Kupferschlaeger J, Bamberg F, la Fougère C, Nikolaou K, Pfannenberg C: Improving CT-Based PET Attenuation Correction in the Vicinity of Metal Implants by an Iterative Metal Artifact Reduction Algorithm of CT Data and Its Comparison to Dual-Energy–Based Strategies: A Phantom Study. Investigative radiology 2017, 52(1):61-65.
- Schiller F, Fechter T, Zamboglou C, Chirindel A, Salman N, Jilg C, Drendel V, Werner M, Meyer P, Grosu A-L: Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation. EJNMMI physics 2017, 4(1):21.
- Schipke CG, Koglin N, Bullich S, Joachim LK, Haas B, Seibyl J, Barthel H, Sabri O, Peters O: Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid. Psychiatry Research: Neuroimaging 2017, 265:98-101.
- Schmitt CC, Aranias T, Viel T, Chateau D, Le Gall M, Waligora-Dupriet A-J, Melchior C, Rouxel O, Kapel N, Gourcerol G: Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis. Molecular metabolism 2017, 6(1):61-72.
- Schmitt S, Delamare J, Tirel O, Fillesoye F, Dhilly M, Perrio C: N-[18 F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic. Nuclear medicine and biology 2017, 44:50-61.
- Schmuck S, Mamach M, Wilke F, von Klot CA, Henkenberens C, Thackeray JT, Sohns JM, Geworski L, Ross TL, Wester H-J: Multiple time-point 68Ga-PSMA I&T PET/CT for characterization of primary prostate cancer: Value of early dynamic and delayed imaging. Clinical nuclear medicine 2017, 42(6):e286-e293.
- Schönfeld L-M, Jahanshahi A, Lemmens E, Bauwens M, Hescham S-A, Schipper S, Lagiere M, Hendrix S, Temel Y: Motor cortex stimulation does not lead to functional recovery after experimental cortical injury in rats. Restorative Neurology and Neuroscience 2017(Preprint):1-11.
- Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA: Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non–Small Cell Lung Cancer. Journal of Nuclear Medicine 2017, 58(6):911-919.
- Schwarzenböck SM, Stenzel J, Otto T, Helldorff HV, Bergner C, Kurth J, Polei S, Lindner T, Rauer R, Hohn A: [68Ga] pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model–comparison with [18F] FDG PET/CT, MRI and ex vivo receptor expression. Oncotarget 2017, 8(56):95606.
- Sciagrà R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F, Olivotto I, Pupi A: Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study. European journal of nuclear medicine and molecular imaging 2017, 44(5):866-875.
- Seith F, Schmidt H, Gatidis S, Bezrukov I, Schraml C, Pfannenberg C, la Fougère C, Nikolaou K, Schwenzer N: SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissue. PloS one 2017, 12(5):e0177856.
- Seith F, Schmidt H, Kunz J, Kuestner T, Gatidis S, Nikolaou K, la Fougère C, Schwenzer NF: Simulation of tracer dose reduction in 18F-FDG-Positron emission tomography/magnetic resonance imaging (PET/MRI): Effects on oncologic reading, image quality and artifacts. Journal of Nuclear Medicine 2017:jnumed. 116.184440.
- Servaes S, Glorie D, Verhaeghe J, Stroobants S, Staelens S: Preclinical molecular imaging of glutamatergic and dopaminergic neuroreceptor kinetics in obsessive compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2017, 77:90-98.
- Shen B, Park JH, Hjørnevik T, Cipriano PW, Yoon D, Gulaka PK, Holly D, Behera D, Avery BA, Gambhir SS: Radiosynthesis and First-In-Human PET/MRI Evaluation with Clinical-Grade [18F] FTC-146. Molecular Imaging and Biology 2017:1-8.
- Shi K, Bayer C, Astner ST, Gaertner FC, Vaupel P, Schwaiger M, Huang S-C, Ziegler SI: Quantitative analysis of [18F] FMISO PET for tumor hypoxia: correlation of modeling results with immunohistochemistry. Molecular Imaging and Biology 2017, 19(1):120-129.
- Shi K, Bayer C, Gaertner FC, Astner ST, Wilkens JJ, Nüsslin F, Vaupel P, Ziegler SI: Matching the reaction-diffusion simulation to dynamic [18F] FMISO PET measurements in tumors: extension to a flow-limited oxygen-dependent model. Physiological measurement 2017, 38(2):188.
- Shimada H, Kitamura S, Shinotoh H, Endo H, Niwa F, Hirano S, Kimura Y, Zhang M-R, Kuwabara S, Suhara T: Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer’s disease spectrum brains: A [11 C] PBB3-PET study. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2017, 6:11-20.
- Shinohara K, Nakagawa P, Gomez J, Morgan DA, Littlejohn NK, Folchert MD, Weidemann BJ, Liu X, Walsh SA, Ponto LL: Selective deletion of renin-b in the brain alters drinking and metabolism. Hypertension 2017:HYPERTENSIONAHA. 117.09923.
- Shrestha U, Sciammarella M, Alhassen F, Yeghiazarians Y, Ellin J, Verdin E, Boyle A, Seo Y, Botvinick EH, Gullberg GT: Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and 99mtc-tetrofosmin: Method and validation. Journal of Nuclear Cardiology 2017, 24(1):268-277.
- Simon-Gracia L, Scodeller P, Fuentes SS, Vallejo VG, Rios X, San Sebastian E, Di Silvio D, Suck M, De Lorenzi F, Rizzo LY: Detection of small breast tumors using tumor penetrating-polymersomes engineered to target p32 protein. bioRxiv 2017:187716.
- Simonyan K, Cho H, Hamzehei Sichani A, Rubien-Thomas E, Hallett M: The direct basal ganglia pathway is hyperfunctional in focal dystonia. Brain 2017, 140(12):3179-3190.
- Sinharay S, Lee D, Shah S, Muthusamy S, Papadakis GZ, Zhang X, Maric D, Reid WC, Hammoud DA: Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV. Nuclear medicine and biology 2017, 55:27-33.
- Slastnikova TA, Rosenkranz AA, Khramtsov YV, Karyagina TS, Ovechko SA, Sobolev AS: Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors. Drug design, development and therapy 2017, 11:1315.
- Slastnikova TA, Rosenkranz AA, Morozova NB, Vorontsova MS, Petriev VM, Lupanova TN, Ulasov AV, Zalutsky MR, Yakubovskaya RI, Sobolev AS: Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters. International journal of nanomedicine 2017, 12:395.
- Smith C, Dang L, Buckholtz J, Tetreault A, Cowan R, Kessler R, Zald D: The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum. Translational psychiatry 2017, 7(4):e1091.
- Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, Hägerström D, Jögi J, Borroni E, Schöll M, Honer M: Increased basal ganglia binding of 18F‐AV‐1451 in patients with progressive supranuclear palsy. Movement Disorders 2017, 32(1):108-114.
- Song YS, Park HS, Lee BC, Jung JH, Lee H-Y, Kim SE: Imaging of Integrin αvβ3 Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer 99mTc-IDA-D-[c (RGDfK)] 2. Cancer Biotherapy and Radiopharmaceuticals 2017, 32(8):288-296.
- Sourdon J, Lager F, Viel T, Balvay D, Moorhouse R, Bennana E, Renault G, Tharaux P-L, Dhaun N, Tavitian B: Cardiac metabolic deregulation induced by the tyrosine kinase receptor inhibitor sunitinib is rescued by endothelin receptor antagonism. Theranostics 2017, 7(11):2757.
- Sridharan S, Lepelletier F-X, Trigg W, Banister S, Reekie T, Kassiou M, Gerhard A, Hinz R, Boutin H: Comparative evaluation of three TSPO PET radiotracers in a LPS-induced model of mild neuroinflammation in rats. Molecular Imaging and Biology 2017, 19(1):77-89.
- Stegmayr C, Bandelow U, Oliveira D, Lohmann P, Willuweit A, Filss C, Galldiks N, Lübke JH, Shah NJ, Ermert J: Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas. European journal of nuclear medicine and molecular imaging 2017, 44(3):408-416.
- Stegmayr C, Oliveira D, Niemietz N, Willuweit A, Lohmann P, Galldiks N, Shah NJ, Ermert J, Langen K-J: Influence of Bevacizumab on Blood–Brain Barrier Permeability and O-(2-18F-Fluoroethyl)-l-Tyrosine Uptake in Rat Gliomas. Journal of Nuclear Medicine 2017, 58(5):700-705.
- Stenbæk DS, Dam VH, Fisher PM, Hansen N, Hjordt LV, Frokjaer VG: No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study. PloS one 2017, 12(9):e0184403.
- Summer D, Garousi J, Oroujeni M, Mitran B, Andersson KG, Vorobyeva A, Löfblom J, Orlova A, Tolmachev V, Decristoforo C: Cyclic versus noncyclic chelating scaffold for 89Zr-labeled ZEGFR: 2377 affibody bioconjugates targeting epidermal growth factor receptor overexpression. Molecular pharmaceutics 2017.
- Summer D, Grossrubatscher L, Petrik M, Michalcikova T, Novy Z, Rangger C, Klingler M, Haas H, Kaeopookum P, von Guggenberg E: Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding. Bioconjugate Chemistry 2017.
- Sun Y, Xiong X, Pandya D, Jung Y, Mintz A, Hayasaka S, Wadas TJ, Li KC: Enhancing tissue permeability with MRI guided preclinical focused ultrasound system in rabbit muscle: From normal tissue to VX2 tumor. Journal of Controlled Release 2017, 256:1-8.
- Takahata K, Kimura Y, Seki C, Tokunaga M, Ichise M, Kawamura K, Ono M, Kitamura S, Kubota M, Moriguchi S: A human PET study of [11 C] HMS011, a potential radioligand for AMPA receptors. EJNMMI research 2017, 7(1):63.
- Takano H, Ito S, Zhang X, Ito H, Zhang M-R, Suzuki H, Maeda K, Kusuhara H, Suhara T, Sugiyama Y: Possible role of organic cation transporters in the distribution of [11C] sulpiride, a dopamine D2 receptor antagonist. Journal of Pharmaceutical Sciences 2017.
- Tavares de Melo MD, Giorgi MCP, Assuncao Jr AN, Dantas Jr RN, Araujo Filho JdA, Parga Filho JR, Bierrenbach ALdS, de Lima CR, Soares Jr J, Meneguetti JC: Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications. European Heart Journal-Cardiovascular Imaging 2017:jex036.
- Taylor JC, Fenner JW: Comparison of machine learning and semi-quantification algorithms for (I123) FP-CIT classification: the beginning of the end for semi-quantification? EJNMMI physics 2017, 4(1):29.
- Taylor O, Van Laeken N, Polis I, Dockx R, Vlerick L, Dobbeleir A, Goethals I, Saunders J, Sadones N, Baeken C: Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C] DASB. PloS one 2017, 12(6):e0179927.
- ter Voert EE, Delso G, de Galiza Barbosa F, Huellner M, Veit-Haibach P: The Effect of Defective PET Detectors in Clinical Simultaneous [18F] FDG Time-of-Flight PET/MR Imaging. Molecular Imaging and Biology 2017, 19(4):626-635.
- Testa A, Dall’Angelo S, Mingarelli M, Augello A, Schweiger L, Welch A, Elmore CS, Sharma P, Zanda M: Design, synthesis, in vitro characterization and preliminary imaging studies on fluorinated bile acid derivatives as PET tracers to study hepatic transporters. Bioorganic & medicinal chemistry 2017, 25(3):963-976.
- Thanos PK, Kim R, Delis F, Rocco MJ, Cho J, Volkow ND: Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain. Behavioural brain research 2017, 320:282-290.
- Theruvath AJ, Ilivitzki A, Muehe A, Theruvath J, Gulaka P, Kim C, Luna-Fineman S, Sakamoto KM, Yeom KW, Yang P: A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study. Radiology 2017, 285(3):971-979.
- Thiruchselvam T, Wilson AA, Boileau I, Le Foll B: A preliminary investigation of the effect of acute alcohol on dopamine transmission as assessed by [11C]‐(+)‐PHNO. Alcoholism: Clinical and Experimental Research 2017.
- Thompson AR, Dickinson RS, Murphy F, Thomson JP, Marriott HM, Tavares A, Willson J, Williams L, Lewis A, Mirchandani A: Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism. Science immunology 2017, 2(8).
- Thompson KD, Weiss-Bilka HE, McGough EB, Ravosa MJ: Bone Up: Craniomandibular Development and Hard-Tissue Biomineralization in Neonate Mice. Zoology 2017.
- Thunemann M, Schörg BF, Feil S, Lin Y, Voelkl J, Golla M, Vachaviolos A, Kohlhofer U, Quintanilla-Martinez L, Olbrich M: Cre/lox-assisted non-invasive in vivo tracking of specific cell populations by positron emission tomography. Nature communications 2017, 8(1):444.
- Tournier N, Goutal S, Auvity S, Traxl A, Mairinger S, Wanek T, Helal O-B, Buvat I, Soussan M, Caillé F: Strategies to Inhibit ABCB1-and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates. Journal of Nuclear Medicine 2017, 58(1):117-122.
- Tsai T-T, Tai C-L, Ho NY-J, Lai P-L, Fu T-S, Niu C-C, Chen L-H, Chen W-J: Effects of Strontium Ranelate on Spinal Interbody Fusion Surgery in an Osteoporotic Rat Model. PloS one 2017, 12(1):e0167296.
- Tsartsalis S, Tournier BB, Aoun K, Habiby S, Pandolfo D, Dimiziani A, Ginovart N, Millet P: A single-scan protocol for absolute D2/3 receptor quantification with [123I]IBZM SPECT. Neuroimage 2017, 147:461-472.
- Tsujikawa T, Yamamoto M, Shono K, Yamada S, Tsuyoshi H, Kiyono Y, Kimura H, Okazawa H, Yoshida Y: Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an 18F-FDG PET/CT texture analysis. Annals of nuclear medicine 2017, 31(10):752-757.
- Tuulari JJ, Tuominen L, de Boer FE, Hirvonen J, Helin S, Nuutila P, Nummenmaa L: Feeding releases endogenous opioids in humans. Journal of Neuroscience 2017, 37(34):8284-8291.
- Valdeolivas S, Sagredo O, Delgado M, Pozo MA, Fernández-Ruiz J: Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease. International journal of molecular sciences 2017, 18(4):684.
- Van Hée VF, Labar D, Dehon G, Grasso D, Grégoire V, Muccioli GG, Frédérick R, Sonveaux P: Radiosynthesis and validation of (±)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors. Oncotarget 2017, 8(15):24415.
- Vanicek T, Kutzelnigg A, Philippe C, Sigurdardottir HL, James GM, Hahn A, Kranz GS, Höflich A, Kautzky A, Traub‐Weidinger T: Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET. Human brain mapping 2017, 38(2):792-802.
- Vazquez N, Missault S, Vangestel C, Deleye S, Thomae D, Van der Veken P, Augustyns K, Staelens S, Dedeurwaerdere S: Evaluation of [18F] BR420 and [18F] BR351 as radiotracers for MMP‐9 imaging in colorectal cancer. Journal of Labelled Compounds and Radiopharmaceuticals 2017, 60(1):69-79.
- Vega SC, Weinl C, Calaminus C, Wang L, Harant M, Ehrlichmann W, Thiele D, Kohlhofer U, Reischl G, Hempel J-M: Characterization of a novel murine model for spontaneous hemorrhagic stroke using in vivo PET and MR multiparametric imaging. NeuroImage 2017, 155:245-256.
- Vestergaard MB, Lindberg U, Aachmann‐Andersen NJ, Lisbjerg K, Christensen SJ, Rasmussen P, Olsen NV, Law I, Larsson HBW, Henriksen OM: Comparison of global cerebral blood flow measured by phase‐contrast mapping MRI with 15O‐H2O positron emission tomography. Journal of Magnetic Resonance Imaging 2017, 45(3):692-699.
- Viana-Huete V, Guillén C, García G, Fernández S, García-Aguilar A, Kahn C, Benito M: Male brown fat-specific double knockout of IGFIR/IR: Atrophy, mitochondrial fission failure, impaired thermogenesis and obesity. Endocrinology 2017.
- Vomacka L, Albert NL, Lindner S, Unterrainer M, Mahler C, Brendel M, Ermoschkin L, Gosewisch A, Brunegraf A, Buckley C: TSPO imaging using the novel PET ligand [18 F] GE-180: quantification approaches in patients with multiple sclerosis. EJNMMI research 2017, 7(1):89.
- von Spiczak J, Manka R, Gotschy A, Oebel S, Kozerke S, Hamada S, Alkadhi H: Fusion of CT coronary angiography and whole-heart dynamic 3D cardiac MR perfusion: building a framework for comprehensive cardiac imaging. The International Journal of Cardiovascular Imaging 2017:1-12.
- von Spiczak J, Manka R, Mannil M, Oebel S, Hamada S, Higashigaito K, Klotz E, Ruschitzka F, Alkadhi H: 3D fusion of coronary CT angiography and CT myocardial perfusion imaging: Intuitive assessment of morphology and function. Journal of cardiovascular computed tomography 2017, 11(6):437-443.
- Wagner F, Hakami YA, Warnock G, Fischer G, Huellner MW, Veit-Haibach P: Comparison of Contrast-Enhanced CT and [18F] FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer. Molecular Imaging and Biology 2017:1-9.
- Wagner S, Teodoro R, Deuther‐Conrad W, Kranz M, Scheunemann M, Fischer S, Wenzel B, Egerland U, Hoefgen N, Steinbach J: Radiosynthesis and biological evaluation of the new PDE10A radioligand [18F] AQ28A. Journal of Labelled Compounds and Radiopharmaceuticals 2017, 60(1):36-48.
- Wakabayashi T, Iuchi T, Tsuyuguchi N, Nishikawa R, Arakawa Y, Sasayama T, Miyake K, Nariai T, Narita Y, Hashimoto N: Diagnostic performance and safety of positron emission tomography using 18F-fluciclovine in patients with clinically suspected high-or low-grade gliomas: a multicenter phase IIb trial. Asia Oceania Journal of Nuclear Medicine and Biology 2017, 5(1):10-21.
- Waldron A-M, Verhaeghe J, Richardson JC, Schmidt M, Stroobants S, Langlois X, Staelens S: Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model. Journal of Alzheimer’s Disease 2017, 55(4):1537-1548.
- Wallstén E, Axelsson J, Karlsson M, Riklund K, Larsson A: A Study of Dynamic PET Frame-Binning on the Reference Logan Binding Potential. IEEE Transactions on Radiation and Plasma Medical Sciences 2017, 1(2):128-135.
- Wang F, He Q, Wang J, Yuan Q, Guo H, Chai L, Wang S, Hu L, Zhang Y: Neuroprotective effect of salvianolate lyophilized injection against cerebral ischemia in type 1 diabetic rats. BMC complementary and alternative medicine 2017, 17(1):258.
- Wang Y, Coughlin JM, Ma S, Endres CJ, Kassiou M, Sawa A, Dannals RF, Petri M, Pomper MG: Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [11C] DPA-713 positron emission tomography. Lupus 2017, 26(2):170-178.
- Wangerin KA, Muzi M, Peterson LM, Linden HM, Novakova A, Mankoff DA, Kinahan PE: A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy. Physics in Medicine and Biology 2017, 62(9):3639.
- Warnock G, Özbay PS, Kuhn FP, Nanz D, Buck A, Boss A, Rossi C: Reduction of BOLD interference in pseudo-continuous arterial spin labeling: towards quantitative fMRI. Journal of Cerebral Blood Flow & Metabolism 2017:0271678X17704785.
- Warnock G, Sommerauer M, Mu L, Gonzalez GP, Geistlich S, Treyer V, Schibli R, Buck A, Krämer SD, Ametamey SM: A first-in-man PET study of [18F] PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5. European Journal of Nuclear Medicine and Molecular Imaging 2017:1-11.
- Weng C-C, Chen Z-A, Chao K-T, Ee T-W, Lin K-J, Chan M-H, Hsiao T, Yen T-C, Kung M-P, Hsu C-H: Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. PloS one 2017, 12(3):e0173503.
- Weng C-C, Huang S-L, Chen Z-A, Lin K-J, Hsiao T, Yen T-C, Kung M-P, Wey S-P, Hsu C-H: [18F] FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease. Annals of Nuclear Medicine 2017:1-8.
- Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G: N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging. Oncotarget 2017, 8(34):56185.
- Wimberley C, Lavisse S, Brulon V, Peyronneau M-A, Leroy C, Bodini B, Remy P, Stankoff B, Buvat I, Bottlaender M: Impact of endothelial TSPO on the quantification of 18F-DPA-714. Journal of Nuclear Medicine 2017:jnumed. 117.195396.
- Wirth M, Bejanin A, La Joie R, Arenaza-Urquijo EM, Gonneaud J, Landeau B, Perrotin A, Mézenge F, de La Sayette V, Desgranges B: Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer’s disease. Neurobiology of aging 2017.
- Wolfs E, Holvoet B, Ordovas L, Breuls N, Helsen N, Schönberger M, Raitano S, Struys T, Vanbilloen B, Casteels C: Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nucleases-mediated genome editing. Journal of Nuclear Medicine 2017:jnumed. 117.189779.
- Xu D, Zhao Z-Q, Chen S-T, Yang Y, Fang W, Liu S: Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides. Nuclear Medicine and Biology 2017, 48:1-8.
- Yamamoto M, Ogawa T, Yokoyama M, Funaki Y, Shobara K, Shibamoto A, Sáenz JRV, Sasaki K: Na 18 F accumulates on the compressive side of peri-implant bone under immediate loading. Odontology 2017:1-6.
- Yanai S, Toyohara J, Ishiwata K, Ito H, Endo S: Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier. Neuropharmacology 2017, 116:247-259.
- Yang K-C, Stepanov V, Amini N, Martinsson S, Takano A, Nielsen J, Bundgaard C, Bang-Andersen B, Grimwood S, Halldin C: Characterization of [11C] Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain. European journal of nuclear medicine and molecular imaging 2017, 44(2):308-320.
- Yang K-C, Stepanov V, Martinsson S, Ettrup A, Takano A, Knudsen GM, Halldin C, Farde L, Finnema SJ: Fenfluramine reduces [11C] Cimbi-36 binding to the 5-HT2A receptor in the nonhuman primate brain. International Journal of Neuropsychopharmacology 2017.
- Yasuno F, Kazui H, Kajimoto K, Ihara M, Morita N, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J: Mutual effect of cerebral amyloid β and peripheral lymphocytes in cognitively normal older individuals. International journal of geriatric psychiatry 2017.
- Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J: Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. NeuroImage: Clinical 2017, 13:209-214.
- Yeh H-H, Li C-H, Huang Y-Y, Huang F-L, Tsay H-J, Huang W-S: Neuroimaging of inflammation: high fat-induced exacerbation of Alzheimer disease. Journal of Nuclear Medicine 2017, 58:273–273.
- Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N: Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C] DPA713 versus [11C](R) PK11195. Journal of Cerebral Blood Flow & Metabolism 2017, 37(3):877-889.
- Yoshii Y, Yoshimoto M, Matsumoto H, Furukawa T, Zhang M-R, Inubushi M, Tsuji AB, Fujibayashi Y, Higashi T, Saga T: 64Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts. Oncotarget 2017, 8(51):88815.
- Yousaf T, Pagano G, Niccolini F, Politis M: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness. Sleep Medicine 2017.
- Yun M, Kim DY, Lee JJ, Kim HS, Kim HS, Pyo A, Ryu Y, Kim TY, Zheng JH, Yoo SW et al: A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors. Theranostics 2017, 7(10):2620-2633.
- Zeilinger M, Dumanic M, Pichler F, Budinsky L, Wadsak W, Pallitsch K, Spreitzer H, Lanzenberger R, Hacker M, Mitterhauser M: In vivo evaluation of radiotracers targeting the melanin-concentrating hormone receptor 1:[11 C] SNAP-7941 and [18 F] FE@ SNAP reveal specific uptake in the ventricular system. Scientific Reports 2017, 7(1):8054.
- Zhang L, Chen L, Beck EM, Chappie TA, Coelho RV, Doran SD, Fan K-H, Helal CJ, Humphrey JM, Hughes Z: The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging. Journal of medicinal chemistry 2017, 60(20):8538-8551.
- Zhang YC, Kagen AC: Machine learning interface for medical image analysis. Journal of digital imaging 2017, 30(5):615-621.
- Zhao Z, Liu M, Fang W, Liu S: Sulfonyl-Containing Boronate Caps for Optimization of Biological Properties of 99mTc (III) Radiotracers [99mTcCl (CDO)(CDOH) 2B-R](CDOH2= Cyclohexanedione Dioxime). Journal of medicinal chemistry 2017.
- Zheng J, Miao W, Huang C, Lin H: Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging. Annals of Nuclear Medicine 2017:1-9.
- Zhou X, Boellaard R, Ishiwata K, Sakata M, Dierckx RA, de Jong JR, Nishiyama S, Ohba H, Tsukada H, de Vries EF: In Vivo Evaluation of 11C-Preladenant for PET Imaging of Adenosine A2A Receptors in the Conscious Monkey. Journal of Nuclear Medicine 2017, 58(5):762-767.
- Zhou X, Khanapur S, de Jong JR, Willemsen AT, Dierckx RA, Elsinga PH, de Vries EF: In vivo evaluation of [11C] preladenant positron emission tomography for quantification of adenosine A2A receptors in the rat brain. Journal of Cerebral Blood Flow & Metabolism 2017, 37(2):577-589.
- Zuo Y, Garg PK, Nazih R, Garg S, Rose JE, Murugesan T, Mukhin AG: A programmable smoke delivery device for PET imaging with cigarettes containing 11 C-nicotine. Journal of Neuroscience Methods 2017, 283:55-61.
- Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert NL, Becker-Bense S: In vivo imaging of glial activation after unilateral labyrinthectomy in the rat: a [18F] GE180-PET study. Frontiers in Neurology 2017, 8:665.
- Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K: Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging 2016, 43:2219-2227.
- Airan RD, Foss CA, Ellens NP, Wang Y, Mease RC, Farahani K, Pomper MG: MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound. Molecular Imaging and Biology 2016:1-7.
- Akkus F, Treyer V, Johayem A, Ametamey SM, Mancilla BG, Sovago J, Buck A, Hasler G: Association of long-term nicotine abstinence with normal metabotropic glutamate receptor-5 binding. Biological psychiatry 2016, 79:474-480.
- Arakawa R, Tateno A, Kim W, Sakayori T, Ogawa K, Okubo Y: Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [11 C] DASB. Psychiatry Research: Neuroimaging 2016, 251:1-6.
- Aranda-Lara L, Ferro-Flores G, de María Ramírez F, Ocampo-García B, Santos-Cuevas C, Díaz-Nieto L, Isaac-Olivé K: Improved radiopharmaceutical based on 99mTc-Bombesin–folate for breast tumour imaging. Nuclear medicine communications 2016, 37:377-386.
- Aung W, Tsuji AB, Sudo H, Sugyo A, Furukawa T, Ukai Y, Kurosawa Y, Saga T: Immunotargeting of Integrin α6β4 for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model. Molecular Imaging 2016, 15:1536012115624917.
- Babiloni C, Del Percio C, Caroli A, Salvatore E, Nicolai E, Marzano N, Lizio R, Cavedo E, Landau S, Chen K: Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer’s disease: an EEG-PET study. Neurobiology of Aging 2016, 48:122-134.
- Bak-Fredslund KP, Munk OL, Keiding S, Sørensen M: 2-[18 F] fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose. Nuclear Medicine and Biology 2016.
- Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust WJ, Gorno‐Tempini ML, Rabinovici GD, Perani D: Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer’s disease. Human Brain Mapping 2016, 37:4234-4247.
- Bang J-I, Jung IS, Song YS, Park HS, Moon BS, Lee BC, Kim SE: PET imaging of dopamine transporters with [18 F] FE-PE2I: Effects of anti-Parkinsonian drugs. Nuclear Medicine and Biology 2016, 43:158–164.
- Barret O, Alagille D, Sanabria S, Comley RA, Weimer RM, Borroni E, Mintun M, Seneca N, Papin C, Morley T: Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer’s Disease Subjects. Journal of Nuclear Medicine 2016:jnumed. 116.182881.
- Barron AM, Tokunaga M, Zhang M-R, Ji B, Suhara T, Higuchi M: Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET. Journal of Neuroinflammation 2016, 13:221.
- Bascuas T, Moreno M, Mónaco A, Reyes L, Paolino A, Oliver P, Kramer MG, Engler H, Pacheco JP, Grille S: A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario. Journal of Translational Medicine 2016, 14:323.
- Bascuñana P, Javela J, Delgado M, de la Rosa RF, Shiha AA, García-García L, Pozo MÁ: [18F] FDG PET Neuroimaging Predicts Pentylenetetrazole (PTZ) Kindling Outcome in Rats. Molecular Imaging and Biology 2016:1-8.
- Bauer M, Karch R, Tournier N, Cisternino S, Wadsak W, Hacker M, Marhofer P, Zeitlinger M, Langer O: Assessment of P-glycoprotein Transport Activity at the Human Blood‐Retinal Barrier with (R)‐11C-verapamil PET. Journal of Nuclear Medicine 2016:jnumed. 116.182147.
- Benito AB, Aiertza MK, Marradi M, Gil-Iceta L, Shekhter Zahavi T, Szczupak B, Jiménez-González M, Reese T, Scanziani E, Passoni L: Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo. Biomacromolecules 2016, 17:3213-3221.
- Berti V, Sciagrà R, Neglia D, Pietilä M, Scholte AJ, Nekolla S, Rouzet F, Pupi A, Knuuti J: Segmental quantitative myocardial perfusion with PET for the detection of significant coronary artery disease in patients with stable angina. European journal of nuclear medicine and molecular imaging 2016:1-8.
- Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ: Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence. Neuropsychopharmacology 2016, 41:1179-1187.
- Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ: Heightened dopaminergic response to amphetamine at the D3 dopamine receptor in methamphetamine users. Neuropsychopharmacology 2016, 41:2994-3002.
- Bolcaen J, Lybaert K, Moerman L, Descamps B, Deblaere K, Boterberg T, Kalala J-P, Van den Broecke C, De Vos F, Vanhove C: Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the fiscrimination between high-grade glioma and radiation necrosis in rats. PloS one 2016, 11:e0161845.
- Brackhan M, Bascunana P, Postema JM, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Serial quantitative TSPO-targeted PET reveals peak microglial activation up to two weeks after an epileptogenic brain insult. Journal of Nuclear Medicine 2016:jnumed. 116.172494.
- Branger P, Arenaza-Urquijo EM, Tomadesso C, Mézenge F, André C, De Flores R, Mutlu J, de La Sayette V, Eustache F, Chételat G: Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiology of aging 2016, 41:107-114.
- Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y: Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models. Journal of Nuclear Medicine 2016, 57:792-798.
- Brendel M, Reinisch V, Kalinowski E, Levin J, Delker A, Därr S, Pogarell O, Förster S, Bartenstein P, Rominger A: Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects. Current Alzheimer Research 2016, 13:475-486.
- Bresch A, Rullmann M, Luthardt J, Arelin K, Becker GA, Patt M, Lobsien D, Baldofski S, Drabe M, Zeisig V: In-vivo serotonin transporter availability and somatization in healthy subjects. Personality and Individual Differences 2016, 94:354-359.
- Bresch A, Rullmann M, Luthardt J, Becker G, Reissig G, Patt M, Ding YS, Hilbert A, Sabri O, Hesse S: Emotional eating and in vivo norepinephrine transporter availability in obesity: A [11C] MRB PET pilot study. International Journal of Eating Disorders 2016.
- Buhour MS, Doidy F, Laisney M, Pitel AL, de La Sayette V, Viader F, Eustache F, Desgranges B: Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET. Brain Imaging and Behavior 2016:1–13.
- Butler T, Li Y, Tsui W, Friedman D, Maoz A, Wang X, Harvey P, Tanzi E, Morim S, Kang Y: Transient and chronic seizure‐induced inflammation in human focal epilepsy. Epilepsia 2016, 57.
- Capistrano R, Vangestel C, Wouters A, Dockx Y, Pauwels P, Stroobants S, Apers S, Lardon F, Pieters L, Staelens S: Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using 18F-FDG PET/CT for Monitoring Treatment Response. Cancer Biotherapy and Radiopharmaceuticals 2016, 31:99-109.
- Caravaggio F, Chung JK, Gerretsen P, Fervaha G, Nakajima S, Plitman E, Iwata Y, Wilson A, Graff-Guerrero A: Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO. Social neuroscience 2016:1-11.
- Caravaggio F, Fervaha G, Chung JK, Gerretsen P, Nakajima S, Plitman E, Iwata Y, Wilson A, Graff-Guerrero A: Exploring personality traits related to dopamine D 2/3 receptor availability in striatal subregions of humans. European Neuropsychopharmacology 2016, 26:644-652.
- Castagnoli H, Ferrantini C, Coppini R, Passeri A, Baldini K, Berti V, Cecchi F, Olivotto I, Sciagrà R: Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal. European journal of nuclear medicine and molecular imaging 2016, 43:2413-2422.
- Ceccon G, Lohmann P, Stoffels G, Judov N, Filss CP, Rapp M, Bauer E, Hamisch C, Ruge MI, Kocher M: Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy. Neuro-Oncology 2016:now149.
- Chakraborty S, Balogh L, Das T, Polyák A, Andócs G, Máthé D, Király R, Thuróczy J, R Chaudhari P, A Jánoki G et al: Evaluation of; 177Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy. Current radiopharmaceuticals 2016, 9:64–70.
- Chan S-C, Chang K-P, Fang Y-HD, Tsang N-M, Ng S-H, Hsu C-L, Liao C-T, Yen T-C: Tumor heterogeneity measured on F‐18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein‐Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma. The Laryngoscope 2016.
- Chapman S: Tetramodal Imaging using MRI/Pet or MRI/SPECT modalities: A simplified cross-platform and co-registration technique. Journal of Nuclear Medicine 2016, 57:1289-1289.
- Chekol R, Gheysens O, Ahamed M, Cleynhens J, Pokreisz P, Vanhoof G, Janssens S, Verbruggen A, Bormans GM: Carbon-11 and Fluorine-18 Radiolabeled Pyridopyrazinone Derivatives for PET Imaging of Phosphodiesterase-5 (PDE5). Journal of Medicinal Chemistry 2016.
- Chen Q, Meng X, McQuade P, Rubins D, Lin S-A, Zeng Z, Haley H, Miller P, González Trotter D, Low PS: Synthesis and Preclinical Evaluation of Folate-NOTA-Al18F for PET Imaging of Folate-Receptor-Positive Tumors. Molecular pharmaceutics 2016, 13:1520-1527.
- Chen X, Zhou Y, Wang R, Cao H, Reid S, Gao R, Han D, Initiative AsDN: Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer’s Disease Progression. PloS one 2016, 11:e0154406.
- Cheng N-M, Fang Y-HD, Tsan D-L, Hsu C-H, Yen T-C: Respiration-averaged CT for attenuation correction of PET images–impact on PET texture features in non-small cell lung cancer patients. PloS one 2016, 11:e0150509.
- Chiotellis A, Müller Herde A, Rössler SL, Brekalo A, Gedeonova E, Mu L, Keller C, Schibli R, Krämer SD, Ametamey SM: Synthesis, Radiolabelling and Biological Evaluation of 5-Hydroxy-2 [18F] Fluoroalkyl-Tryptophan Analogues as Potential PET Radiotracers for Tumor Imaging. Journal of medicinal chemistry 2016.
- Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G: Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm. European journal of nuclear medicine and molecular imaging 2016:1-14.
- Cho S-G, Park KS, Kim J, Kang S-R, Song H-C, Kim JH, Cho JY, Hong YJ, Jabin Z, Park HJ: Coronary flow reserve and relative flow reserve measured by N-13 ammonia PET for characterization of coronary artery disease. Annals of nuclear medicine 2016:1-9.
- Choi JY, Lyoo CH, Kim JS, Kim KM, Lee M, Ryu YH: Biodistribution and Radiation Dosimetry of [18F] Mefway in Humans. Molecular Imaging and Biology 2016:1-4.
- Choi JY, Song JS, Lee M, Cho W-K, Chung J, Lyoo CH, Kim CH, Park J, Lee KC, Kim KM: P-Glycoprotein, not BCRP, Limits the Brain Uptake of [18F] Mefway in Rodent Brain. Molecular Imaging and Biology 2016, 18:267-273.
- Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y: 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate-to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology 2016:160220.
- Choi WH, Um YH, Jung WS, Kim SH: Automated quantification of amyloid positron emission tomography: a comparison of PMOD and MIMneuro. Annals of Nuclear Medicine 2016, 30:682-689.
- Christensen AN, Rydhög JS, Søndergaard RV, Andresen TL, Holm S, af Rosenschöld PM, Conradsen K, Jølck RI: Injectable silver nanosensors: in vivo dosimetry for external beam radiotherapy using positron emission tomography. Nanoscale 2016, 8:11002-11011.
- Cleeren F, Lecina J, Koole M, Verbruggen A, Bormans G: RESTRAINED COMPLEXING AGENTS FOR AL 18 F-LABELLING OF HEAT-SENSITIVE BIOMOLECULES. 18 F-labelling of biomolecules for PET 2016:45.
- Clemmensen AE, Ghotbi AA, Bodholdt RP, Hag AMF, Hasbak P, Ripa RS, Kjaer A: Perfusion imaging using rubidium-82 (82Rb) PET in rats with myocardial infarction: First small animal cardiac 82Rb-PET. Journal of Nuclear Cardiology 2016:1-3.
- Cochran BJ, Ryder WJ, Parmar A, Tang S, Reilhac A, Arthur A, Charil A, Hamze H, Barter PJ, Kritharides L: In vivo PET imaging with [18F] FDG to explain improved glucose uptake in an apolipoprotein AI treated mouse model of diabetes. Diabetologia 2016:1-8.
- Collantes M, Serrano-Mendioroz I, Benito M, Molinet-Dronda F, Delgado M, Vinaixa M, Sampedro A, de Salamanca RE, Prieto E, Pozo MA: Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency. Human molecular genetics 2016:ddw013.
- Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S: Test–retest reproducibility of [11C] PBR28 binding to TSPO in healthy control subjects. European journal of nuclear medicine and molecular imaging 2016, 43:173–183.
- Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, Kim PK, Ford CN, Higgs C, Hayes LN: In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [ 11C] DPA-713 PET and analysis of CSF and plasma. Translational psychiatry 2016, 6:e777.
- Courchesne-Loyer A, Croteau E, Castellano C-A, St-Pierre V, Hennebelle M, Cunnane SC: Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study. J Cereb Blood Flow Metab doi 2016, 10.
- Cressier D, Dhilly M, Pham TTC, Fillesoye F, Gourand F, Maïza A, Martins AF, Morfin J-F, Geraldes CF, Tóth É: Gallium-68 Complexes Conjugated to Pittsburgh Compound B: Radiolabeling and Biological Evaluation. Molecular Imaging and Biology 2016, 18:334-343.
- da Cunha-Bang S, Hjordt LV, Perfalk E, Beliveau V, Bock C, Lehel S, Thomsen C, Sestoft D, Svarer C, Knudsen GM: Serotonin 1B Receptor Binding Is Associated With Trait Anger and Level of Psychopathy in Violent Offenders. Biological psychiatry 2016.
- da Silva ES, Gómez‐Vallejo V, Baz Z, Llop J, López‐Gallego F: Efficient Enzymatic Preparation of 13N‐Labelled Amino Acids: Towards Multipurpose Synthetic Systems. Chemistry-A European Journal 2016, 22:13619-13626.
- Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A: Evaluation of early-phase [18 F]-florbetaben PET acquisition in clinical routine cases. NeuroImage: Clinical 2016.
- Dang LC, Samanez-Larkin GR, Castrellon JJ, Perkins SF, Cowan RL, Zald DH: Associations between dopamine D2 receptor availability and BMI depend on age. NeuroImage 2016.
- De Bruycker S, Vangestel C, Van den Wyngaert T, Wouters A, Pauwels P, Staelens S, Stroobants S: Baseline [18F] FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model. Molecular Imaging and Biology 2016:1–11.
- Deleye S, Waldron A-M, Richardson JC, Schmidt M, Langlois X, Stroobants S, Staelens S: The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model. Molecular imaging 2016, 15:1536012115624919.
- Denis-Bacelar AM, Cronin SE, Da Pieve C, Paul RL, Eccles SA, Spinks TJ, Box C, Hall A, Sosabowski JK, Kramer-Marek G: Pre-clinical quantitative imaging and mouse-specific dosimetry for 111In-labelled radiotracers. EJNMMI research 2016, 6:85.
- Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H: Evaluation of CT-based SUV normalization. Physics in Medicine and Biology 2016, 61:6369.
- Doi H, Sato K, Shindou H, Sumi K, Koyama H, Hosoya T, Watanabe Y, Ishii S, Tsukada H, Nakanishi K: Blood–brain barrier permeability of ginkgolide: Comparison of the behavior of PET probes 7α-[18 F] fluoro-and 10-O-p-[11 C] methylbenzyl ginkgolide B in monkey and rat brains. Bioorganic & Medicinal Chemistry 2016, 24:5148-5157.
- Domercq M, Szczupak B, Gejo J, Gómez-Vallejo V, Padro D, Gona KB, Dollé F, Higuchi M, Matute C, Llop J: PET Imaging with [18F] FSPG Evidences the Role of System xc-on Brain Inflammation Following Cerebral Ischemia in Rats. Theranostics 2016, 6:1753.
- Dunet V, Klein R, Allenbach G, Renaud J, Prior JO: Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs. Journal of Nuclear Cardiology 2016, 23:499-510.
- Eberl S, Katsifis A, Peyronneau MA, Wen L, Henderson D, Loc’h C, Greguric I, Verschuer J, Pham T, Lam P: Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F] PBR102 and [18F] PBR111. European Journal of Nuclear Medicine and Molecular Imaging 2016:1-12.
- Elvas F, Boddaert J, Vangestel C, Pak K, Gray B, Kumar-Singh S, Staelens S, Stroobants S: 99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET. Journal of Nuclear Medicine 2016:jnumed. 116.182014.
- Elvas F, Vangestel C, Pak K, Vermeulen P, Gray B, Stroobants S, Staelens S, Wyffels L: Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin. Journal of Nuclear Medicine 2016, 57:805-811.
- Eriksson O, Selvaraju R, Eich T, Willny M, Brismar TB, Carlbom L, Ahlström H, Tufvesson G, Lundgren T, Korsgren O: Positron Emission Tomography to assess the outcome of intraportal islet transplantation. Diabetes 2016:db160222.
- Fan D, Liu S, Jiang S, Li Z, Mo X, Ruan H, Zou GM, Fan C: The use of SHP‐2 gene transduced bone marrow mesenchymal stem cells to promote osteogenic differentiation and bone defect repair in rat. Journal of Biomedical Materials Research Part A 2016.
- Fang XT, Eriksson J, Antoni G, Yngve U, Cato L, Lannfelt L, Sehlin D, Syvänen S: Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11 C] ABP688 PET imaging and ex vivo immunoblotting. Neuropharmacology 2017, 113:293-300.
- Feiock C, Yagi M, Maidman A, Rendahl A, Hui S, Seelig D: Central Nervous System Injury–A Newly Observed Bystander Effect of Radiation. PloS one 2016, 11:e0163233.
- Feng L, Jensen P, Thomsen G, Dyssegaard A, Svarer C, Knudsen LV, Møller K, Thomsen C, Mikkelsen JD, Guilloteau D: The variability of translocator protein signal in brain and blood of genotyped healthy humans using in vivo 123I-CLINDE SPECT imaging–a test-retest study. Journal of Nuclear Medicine 2016:jnumed. 116.183202.
- Feng L, Svarer C, Madsen K, Ziebell M, Dyssegaard A, Ettrup A, Hansen HD, Lehel S, Yndgaard S, Paulson OB: Design of Infusion Schemes for Neuroreceptor Imaging: Application to [11C] Flumazenil-PET Steady-State Study. BioMed research international 2016, 2016.
- Fernandez AM, Hernandez-Garzón E, Perez-Domper P, Perez-Alvarez A, Mederos S, Matsui T, Santi A, Trueba-Saiz A, García-Guerra L, Pose-Utrilla J: Insulin Regulates Astrocytic Glucose Handling Through Cooperation With Insulin-Like Growth Factor I. Diabetes 2016:db160861.
- Fervaha G, Caravaggio F, Mamo DC, Mulsant BH, Pollock BG, Nakajima S, Gerretsen P, Rajji TK, Mar W, Iwata Y: Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study. Psychopharmacology 2016, 233:3803-3813.
- Freeby MJ, Kringas P, Goland RS, Leibel RL, Maffei A, Divgi C, Ichise M, Harris PE: Cross-sectional and Test-Retest Characterization of PET with [18F] FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes. Molecular Imaging and Biology 2016, 18:292-301.
- Frings L, S Spehl T, Hüll M, T Meyer P: Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer’s Disease. Current Alzheimer Research 2016, 13:678-681.
- Fujita M, Richards EM, Niciu MJ, Ionescu DF, Zoghbi SS, Hong J, Telu S, Hines CS, Pike VW, Zarate CA: cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Molecular Psychiatry 2016.
- Gabler AS, Kühnel C, Winkens T, Freesmeyer M: Assessment of minimum activity of 124Iodine in pre-therapeutic uptake measurement prior to radioiodine therapy of benign thyroid diseases. Journal of Nuclear Medicine 2016:jnumed. 115.171066.
- Gabler AS, Kühnel C, Winkens T, Freesmeyer M: Assessment of Minimum 124I Activity Required in Uptake Measurements Before Radioiodine Therapy for Benign Thyroid Diseases. Journal of Nuclear Medicine 2016, 57:1201-1206.
- Gao R, Zhang G, Chen X, Yang A, Smith G, Wong DF, Zhou Y: CSF Biomarkers and Its Associations with 18 F-AV133 Cerebral VMAT2 Binding in Parkinson’s Disease—A Preliminary Report. PloS one 2016, 11:e0164762.
- García-Casares N, García-Arnés JA, Rioja J, Ariza MJ, Gutiérrez A, Alfaro F, Nabrozidis A, González-Alegre P, González-Santos P: Alzheimer’s like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients. Journal of diabetes and its complications 2016, 30:281-286.
- García-García L, Shiha AA, Bascuñana P, de Cristóbal J, de la Rosa RF, Delgado M, Pozo MA: Serotonin depletion does not modify the short-term brain hypometabolism and hippocampal neurodegeneration induced by the lithium–pilocarpine model of status epilepticus in rats. Cellular and molecular neurobiology 2016, 36:513-519.
- Garg PK, Lokitz SJ, Nazih R, Garg S: Biodistribution and Radiation Dosimetry of C-11 Nicotine from Whole Body PET Imaging in Humans. Journal of Nuclear Medicine 2016:jnumed. 116.180059.
- Garousi J, Andersson KG, Mitran B, Pichl M-L, Sta ahl S, Orlova A, Löfblom J, Tolmachev V: PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules. International Journal of Oncology.
- Gijs M, Becker G, Plenevaux A, Bahri MA, Aerts A, Impens N, Baatout S, Luxen A: Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice. Journal of Nuclear Medicine and Radiation Therapy 2016, 7.
- Gnesin S, Canetti L, Adib S, Cherbuin N, Monteiro MS, Bize P, Denys A, Prior JO, Baechler S, Boubaker A: Partition Model–Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison. Journal of Nuclear Medicine 2016, 57:1672-1678.
- Gnesin S, Leite Ferreira P, Malterre J, Laub P, Prior JO, Verdun FR: Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device. Computational and Mathematical Methods in Medicine 2016, 2016.
- Gómez-Vallejo V, Ugarte A, García-Barroso C, Cuadrado-Tejedor M, Szczupak B, Dopeso-Reyes IG, Lanciego JL, García-Osta A, Llop J, Oyarzabal J et al: Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels. Journal of neurochemistry 2016, 136:403–415.
- Gonneaud J, Arenaza-Urquijo EM, Fouquet M, Perrotin A, Fradin S, de La Sayette V, Eustache F, Chételat G: Relative effect of APOE ε4 on neuroimaging biomarker changes across the lifespan. Neurology 2016, 87:1696-1703.
- Gorbenko I, Kałużyński K, Mikołajczyk K: Template design for craniometric landmarks identification. In: Advanced Mechatronics Solutions. edn.: Springer; 2016: 461-466.
- Gräni C, Benz DC, Possner M, Clerc OF, Mikulicic F, Vontobel J, Stehli J, Fuchs TA, Pazhenkottil AP, Gaemperli O: Fused cardiac hybrid imaging with coronary computed tomography angiography and positron emission tomography in patients with complex coronary artery anomalies. Congenital Heart Disease 2016.
- Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A: Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. Journal of Nuclear Medicine 2016, 57:204-207.
- Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA: Feasibility of 18F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times. Journal of Nuclear Medicine 2016, 57:334-341.
- Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA: Reproducibility of 18 F-fluoromisonidazole intratumour distribution in non-small cell lung cancer. EJNMMI research 2016, 6:79.
- Groman SM, Smith NJ, Petrullli JR, Massi B, Chen L, Ropchan J, Huang Y, Lee D, Morris ED, Taylor JR: Dopamine D3 Receptor Availability Is Associated with Inflexible Decision Making. The Journal of Neuroscience 2016, 36:6732-6741.
- Guo T, Brendel M, Grimmer T, Rominger A, Yakushev I: Predicting regional pattern of longitudinal beta-amyloid accumulation by baseline positron emission tomography. Journal of Nuclear Medicine 2016:jnumed. 116.176115.
- Hahn A, Schain M, Erlandsson M, Sjölin P, James GM, Strandberg OT, Hägerström D, Lanzenberger R, Jögi J, Olsson TG: Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology. Journal of Nuclear Medicine 2016:jnumed. 116.174508.
- Haider A, Herde AM, Slavik R, Weber M, Mugnaini C, Ligresti A, Schibli R, Mu L, Ametamey SM: Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging. Frontiers in Neuroscience 2016, 10.
- Hamelin L, Lagarde J, Dorothée G, Leroy C, Labit M, Comley RA, de Souza LC, Corne H, Dauphinot L, Bertoux M: Early and protective microglial activation in Alzheimer’s disease: a prospective study using 18F-DPA-714 PET imaging. Brain 2016, 139:1252-1264.
- Hanssen MJ, van der Lans AA, Brans B, Hoeks J, Jardon KM, Schaart G, Mottaghy FM, Schrauwen P, van Marken Lichtenbelt WD: Short-term cold acclimation recruits brown adipose tissue in obese humans. Diabetes 2016, 65:1179-1189.
- Harada N, Kimura H, Onoe S, Watanabe H, Matsuoka D, Arimitsu K, Ono M, Saji H: Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer. Journal of Nuclear Medicine 2016, 57:1978-1984.
- Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M: 18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease. Journal of Nuclear Medicine 2016, 57:208-214.
- Haylock A-K, Spiegelberg D, Mortensen AC, Selvaraju RK, Nilvebrant J, Eriksson O, Tolmachev V, Nestor MV: Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma. International journal of oncology 2016, 48:461–470.
- Hendrikx G, Vries MH, Bauwens M, De Saint-Hubert M, Wagenaar A, Guillaume J, Boonen L, Post MJ, Mottaghy FM: Comparison of LDPI to SPECT perfusion imaging using 99mTc-sestamibi and 99mTc-pyrophosphate in a murine ischemic hind limb model of neovascularization. EJNMMI research 2016, 6:1-10.
- Hernandez‐Garzón E, Fernandez AM, Perez‐Alvarez A, Genis L, Bascuñana P, Fernandez de la Rosa R, Delgado M, Angel Pozo M, Moreno E, McCormick PJ: The insulin‐like growth factor I receptor regulates glucose transport by astrocytes. Glia 2016, 64:1962-1971.
- Hickey RD, Mao SA, Glorioso J, Elgilani F, Amiot B, Chen H, Rinaldo P, Marler R, Jiang H, DeGrado TR: Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. Science Translational Medicine 2016, 8:349ra399-349ra399.
- Hjorth S, Karlsson C, Jucaite A, Varnäs K, Hamrén UW, Johnström P, Gulyás B, Donohue SR, Pike VW, Halldin C et al: A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. Neuropharmacology 2016, 101:519–530.
- Hjuler KF, Gormsen L, Vendelbo MH, Egeberg A, Nielsen J, Iversen L: Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate‐to‐severe psoriasis. British Journal of Dermatology 2016.
- Ho K-C, Fang Y-HD, Chung H-W, Yen T-C, Ho T-Y, Chou H-H, Hong J-H, Huang Y-T, Wang C-C, Lai C-H: A preliminary investigation into textural features of intratumoral metabolic heterogeneity in 18F-FDG PET for overall survival prognosis in patients with bulky cervical cancer treated with definitive concurrent chemoradiotherapy. American journal of nuclear medicine and molecular imaging 2016, 6:166.
- Horsager J, Bak-Fredslund K, Larsen LP, Villadsen GE, Bogsrud TV, Sørensen M: Optimal 2-[18. EJNMMI research 2016, 6:1-7.
- Hou M, Acton PD: Understanding the tampon density and density gradient through computed tomography imaging. Textile Research Journal 2016, 86:573-579.
- Hovhannisyan N, Dhilly M, Guillouet S, Leporrier M, Barré L: Comparative Analysis between [18F] Fludarabine-PET and [18F] FDG-PET in a Murine Model of Inflammation. Molecular pharmaceutics 2016.
- Huang C-C, Pan W-Y, Tseng MT, Lin K-J, Yang Y-P, Tsai H-W, Hwang S-M, Chang Y, Wei H-J, Sung H-W: Enhancement of cell adhesion, retention, and survival of HUVEC/cbMSC aggregates that are transplanted in ischemic tissues by concurrent delivery of an antioxidant for therapeutic angiogenesis. Biomaterials 2016, 74:53–63.
- Huang Y-C, Li R-Y, Chen J-Y, Chen J-K: Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery. Carbohydrate Polymers 2016, 138:114–122.
- Huang Y-E, Huang Y-J, Ko M, Hsu C-C, Chen C-F: Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases. Annals of nuclear medicine 2016, 30:652-658.
- Huang Y-S, Liu F-Y, Lin C-Y, Hsiao T, Guilleminault C: Brain imaging and cognition in young narcoleptics. Sleep Medicine 2016.
- Huang Z-R, Tsai C-L, Huang Y-Y, Shiue C-Y, Tzen K-Y, Yen R-F, Hsin L-W: A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2. PloS one 2016, 11:e0161295.
- Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, Da Settimo F, Fujita M, Pike VW: 11C-ER176, a radioligand for 18-kDa translocator protein (TSPO), has adequate sensitivity to robustly image all three affinity genotypes in human brain. Journal of Nuclear Medicine 2016:jnumed. 116.178996.
- Ishibashi K, Miura Y, Ishikawa K, Zhang M-R, Toyohara J, Ishiwata K, Ishii K: Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia. Journal of neurology 2016, 263:2179-2187.
- Ishibashi K, Wagatsuma K, Ishiwata K, Ishii K: Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading. Human brain mapping 2016.
- Ishiki A, Harada R, Okamura N, Tomita N, Rowe CC, Villemagne VL, Yanai K, Kudo Y, Arai H, Furumoto S: Tau imaging with [18F] THK‐5351 in progressive supranuclear palsy. European Journal of Neurology 2016.
- Jarcho JM, Feier NA, Labus JS, Naliboff B, Smith SR, Hong J-Y, Colloca L, Tillisch K, Mandelkern MA, Mayer EA et al: Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response. NeuroImage: Clinical 2016, 10:107–114.
- Jensen JB, Sundelin EI, Jakobsen S, Gormsen LC, Munk OL, Frøkiær J, Jessen N: [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency. Diabetes 2016, 65:1724-1730.
- Ji B, Kaneko H, Minamimoto T, Inoue H, Takeuchi H, Kumata K, Zhang M-R, Aoki I, Seki C, Ono M: Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors. Journal of Neuroscience 2016, 36:11544-11558.
- Jochimsen TH, Zeisig V, Schulz J, Werner P, Patt M, Patt J, Dreyer AY, Boltze J, Barthel H, Sabri O: Fully automated calculation of image-derived input function in simultaneous PET/MRI in a sheep model. EJNMMI physics 2016, 3:1.
- Jørgensen LM, Weikop P, Villadsen J, Visnapuu T, Ettrup A, Hansen HD, Baandrup AO, Andersen FL, Bjarkam CR, Thomsen C et al: Cerebral 5-HT release correlates with [11C] Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. Journal of Cerebral Blood Flow & Metabolism 2016:0271678X16629483.
- Kaller S, Rullmann M, Luthardt J, Girbardt J, Meyer P, Werner P, Hesse S, Fritz T, Sabri O: Measurements of dopamine D1-type receptors using simultaneous PET-MRI scanner: Study on test-retest reliability. Journal of Nuclear Medicine 2016, 57:1795-1795.
- Kanazawa M, Ohba H, Harada N, Kakiuchi T, Muramatsu S-i, Tsukada H: Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys. Journal of Nuclear Medicine 2016, 57:303-308.
- Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J et al: In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain, behavior, and immunity 2016.
- Karjalainen T, Tuominen L, Manninen S, Kalliokoski KK, Nuutila P, Jääskeläinen IP, Hari R, Sams M, Nummenmaa L: Behavioural-Activation-System Sensitivity is Associated with Cerebral μ-opioid Receptor Availability. Social cognitive and affective neuroscience 2016:nsw044.
- Karmani L, Levêque P, Bouzin C, Bol A, Dieu M, Walrand S, Vander Borght T, Feron O, Grégoire V, Bonifazi D: Biodistribution of 125 I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. Nuclear medicine and biology 2016, 43:415-423.
- Kasanova Z, Ceccarini J, van Amelsvoort T, Frank M, Booij J, Heinzel A, Rong Y, Winz O, Mottaghy F, Myin-Germeys I: Striatal dopaminergic modulation of reward processing in healthy individuals at a genetic risk for psychosis. ENVIRONMENTAL REACTIVITY FOR BETTER OR WORSE 2016:23.
- Kasanova Z, Hernaus D, Vaessen T, Van Amelsvoort T, Winz O, Heinzel A, Pruessner J, Mottaghy FM, Collip D, Myin-Germeys I: Early-Life Stress Affects Stress-Related Prefrontal Dopamine Activity in Healthy Adults, but Not in Individuals with Psychotic Disorder. PloS one 2016, 11:e0150746.
- Kaschwich M, Lützen U, Zhao Y, Tjiong A, Marx M, Haenisch S, Wiedow O, Preuss S, Culman J, Zuhayra M: Biodistribution and pharmacokinetics of the 99m Tc labeled human elastase inhibitor, elafin, in rats. Drug Metabolism and Pharmacokinetics 2016.
- Katiyar P, Divine MR, Kohlhofer U, Quintanilla-Martinez L, Schölkopf B, Pichler BJ, Disselhorst JA: Spectral Clustering predicts tumor tissue heterogeneity using dynamic 18F-FDG PET: a complement to the standard compartmental modeling approach. Journal of Nuclear Medicine 2016:jnumed-116.
- Kawaguchi H, Shimada H, Kodaka F, Suzuki M, Shinotoh H, Hirano S, Kershaw J, Inoue Y, Nakamura M, Sasai T: Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density. PloS one 2016, 11:e0151191.
- Kikuchi A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Oshima R: In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. Neurology 2016, 87:2309-2316.
- Kim BS, Pak K, Yi K-I, Kim IJ, Roh H-J, Cho K-S: Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer. European Archives of Oto-Rhino-Laryngology 2016:1-7.
- Kim D-H, Jung J-h, Son SH, Kim C-Y, Jeong SY, Lee S-W, Lee J, Ahn B-C: Quantification of Intratumoral Metabolic Macroheterogeneity on 18F-FDG PET/CT and Its Prognostic Significance in Pathologic N0 Squamous Cell Lung Carcinoma. Clinical nuclear medicine 2016, 41:e70–e75.
- Kim H-S, Lee B-i, Kim JH, Bom H-S, Kim D-Y, Min J-J: Comparison of Reconstruction Methods in a Small Animal Cardiac PET Study Using a 18 F-Labeled Myocardial Agent,[18 F] FPTP. Iranian Journal of Radiology 2016.
- Kim J-H, Kim J-H, Son Y-D, Joo Y-H, Lee S-Y, Kim H-K, Woo M-K: Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11 C] DASB and [18 F] FDG. Schizophrenia Research 2016.
- Kim Y, Lee H-Y, Yoon H-J, Kim BS: Utility of 18 F-fluorodeoxy glucose and 18 F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model. Journal of Cranio-Maxillofacial Surgery 2016.
- Kimura Y, Maeda J, Yamada M, Takahata K, Yokokawa K, Ikoma Y, Seki C, Ito H, Higuchi M, Suhara T: Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol. Psychopharmacology 2016:1–6.
- Kimura Y, Seki C, Ikoma Y, Ichise M, Kawamura K, Takahata K, Moriguchi S, Nagashima T, Ishii T, Kitamura S: [11C] TASP457, a novel PET ligand for histamine H3 receptors in human brain. European journal of nuclear medicine and molecular imaging 2016:1-11.
- Knudsen GM, Jensen PS, Erritzoe D, Baaré WF, Ettrup A, Fisher PM, Gillings N, Hansen HD, Hansen LK, Hasselbalch SG et al: The Center for Integrated Molecular Brain Imaging (Cimbi) database. NeuroImage 2016, 124:1213–1219.
- Köfalvi A, Lemos C, Martín-Moreno AM, Pinheiro BS, García-García L, Pozo MA, Valério-Fernandes Â, Beleza RO, Agostinho P, Rodrigues RJ: Stimulation of brain glucose uptake by cannabinoid CB 2 receptors and its therapeutic potential in Alzheimer’s disease. Neuropharmacology 2016.
- Kong X, Luo S, Wu JR, Wu S, De Cecco CN, Schoepf UJ, Spandorfer AJ, Wang CY, Tian Y, Chen HJ: 18F-DPA-714 PET Imaging for Detecting Neuroinflammation in Rats with Chronic Hepatic Encephalopathy. Theranostics 2016, 6:1220.
- Kong Y, Guan Y, Hua F, Zhang Z, Lu X, Zhu T, Zhao B, Zhu J, Li C, Chen J: Optimization and Biodistribution of [11C]-TKF, An Analog of Tau Protein Imaging Agent [18F]-THK523. Molecules 2016, 21:1019.
- Kotsougiani D, Hundepool CA, Bulstra LF, Friedrich PF, Shin AY, Bishop AT: Recipient‐derived angiogenesis with short term immunosuppression increases bone remodeling in bone vascularized composite allotransplantation: A pilot study in a swine tibial defect model. Journal of Orthopaedic Research 2016.
- Kreisl WC, Lyoo CH, Liow J-S, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS: Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer’s disease. Neurobiology of Aging 2016.
- Kreisl WC, Lyoo CH, Liow J-S, Wei M, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW: 11 C-PBR28 binding to translocator protein increases with progression of Alzheimer’s disease. Neurobiology of Aging 2016, 44:53-61.
- Kristian A, Holtedahl JE, Torheim T, Futsaether C, Hernes E, Engebraaten O, Mælandsmo GM, Malinen E: Dynamic 2-Deoxy-2-[18F] Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. Molecular Imaging and Biology 2016:1-9.
- Krohn T, Birmes A, Winz OH, Drude NI, Mottaghy FM, Behrendt FF, Verburg FA: The reconstruction algorithm used for [68Ga] PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia. European Journal of Nuclear Medicine and Molecular Imaging 2016:1-8.
- Kurland BF, Peterson LM, Lee JH, Schubert EK, Currin ER, Link JM, Krohn KA, Mankoff DA, Linden HM: Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer. Clinical Cancer Research 2016.
- Kwee SA, Sato MM, Kuang Y, Franke A, Custer L, Miyazaki K, Wong LL: [18F] Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling. Molecular Imaging and Biology 2016:1-10.
- Le Foll B, Payer D, Di Ciano P, Guranda M, Nakajima S, Tong J, Mansouri E, Wilson AA, Houle S, Meyer JH: Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [ 11C]-(+)-PHNO PET Study in Humans. Neuropsychopharmacology 2016, 41:529-537.
- Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C: Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression–A [11 C] raclopride PET-study. European Neuropsychopharmacology 2016, 26:320-330.
- Lee J-H, Ryu YH, Lyoo CH, Choi S-H, Kim J-J, Choi JY: Optimal timing of [18 F] Mefway PET for imaging the serotonin 1A receptor in healthy male subjects. Applied Radiation and Isotopes 2016, 107:127–132.
- Lee SB, Ahn SB, Lee S-W, Jeong SY, Ghilsuk Y, Ahn B-C, Kim E-M, Jeong H-J, Lee J, Lim D-K: Radionuclide-embedded gold nanoparticles for enhanced dendritic cell-based cancer immunotherapy, sensitive and quantitative tracking of dendritic cells with PET and Cerenkov luminescence. NPG Asia Materials 2016, 8:e281.
- Lee SB, Yoon G, Lee SW, Jeong SY, Ahn BC, Lim DK, Lee J, Jeon YH: Combined Positron Emission Tomography and Cerenkov Luminescence Imaging of Sentinel Lymph Nodes Using PEGylated Radionuclide‐Embedded Gold Nanoparticles. Small 2016, 12:4894-4901.
- Lerner RP, Bimpisidis Z, Agorastos S, Scherrer S, Dewey SL, Cenci MA, Eidelberg D: Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model. Neurobiology of Disease 2016, 96:31-37.
- Leurquin-Sterk G, Van den Stock J, Crunelle CL, de Laat B, Weerasekera A, Himmelreich U, Bormans G, Van Laere K: Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: a 18F-FPEB PET study. Journal of Nuclear Medicine 2016:jnumed-116.
- Leurquin‐Sterk G, Postnov A, De Laat B, Casteels C, Celen S, Crunelle CL, Bormans G, Koole M, Van Laere K: Kinetic modeling and long‐term test‐retest reproducibility of the mGluR5 PET tracer 18F‐FPEB in human brain. Synapse 2016.
- Leyton CE, Cassidy B, Villemagne VL, Jones G, Kwok JB, Rowe CC, Ballard KJ, Piguet O, Hodges JR: Divergent Network Patterns of Amyloid-β Deposition in Logopenic and Amnestic Alzheimer’s Disease Presentations. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2016, 1:24–31.
- Li CT, Juan CH, Su TP, Liou YJ, Chen MH: Transcranial Magnetic Stimulation-Derived Motor Parameters and Regional Glucose Metabolism of Motor Cortex. J Neurol Neurophysiol 2016, 7:386.
- Li C-T, Chen M-H, Lin W-C, Hong C-J, Yang B-H, Liu R-S, Tu P-C, Su T-P: The effects of low‐dose ketamine on the prefrontal cortex and amygdala in treatment‐resistant depression: A randomized controlled study. Human brain mapping 2016, 37:1080-1090.
- Li K-C, Lo S-C, Sung L-Y, Liao Y-H, Chang Y-H, Hu Y-C: Improved calvarial bone repair by hASCs engineered with Cre/loxP‐based baculovirus conferring prolonged BMP‐2 and MiR‐148b co‐expression. Journal of Tissue Engineering and Regenerative Medicine 2016.
- Liga R, Vontobel J, Rovai D, Marinelli M, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G: Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population. Eur Heart J Cardiovasc Imaging 2016:jew038.
- Lin C-Y, Cheng Y-S, Liao T-Y, Lin C, Chen Z-t, Twu W-I, Chang C-W, Tan DT-W, Liu R-S, Tu P-h: Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-β Accumulation in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer’s Disease 2016:1-15.
- Lindbo S, Garousi J, AAstrand M, Honarvar H, Orlova A, Hober S, Tolmachev V: Influence of histidine-containing tags on the biodistribution of ADAPT scaffold proteins. Bioconjugate chemistry 2016.
- Liu M, Fang W, Liu S: Novel 99mTc (III) Complexes [99mTcCl (CDO)(CDOH) 2B–R](CDOH2= Cyclohexanedione Dioxime) Useful as Radiotracers for Heart Imaging. Bioconjugate Chemistry 2016, 27:2770-2779.
- Liu M, Zheng Y, Avcibasi U, Liu S: Novel 99m Tc (III)-azide complexes [99m Tc (N 3)(CDO)(CDOH) 2 BR](CDOH 2= cyclohexanedione dioxime) as potential radiotracers for heart imaging. Nuclear Medicine and Biology 2016.
- Liu N-W, Ke C-C, Zhao Y, Chen Y-A, Chan K-C, Tan DT-W, Lee J-S, Chen Y-Y, Hsu T-W, Hsieh Y-J: Evolutional Characterization of Photochemically Induced Stroke in Rats: a Multimodality Imaging and Molecular Biological Study. Translational Stroke Research 2016:1-13.
- Lohmann P, Stoffels G, Ceccon G, Rapp M, Sabel M, Filss CP, Kamp MA, Stegmayr C, Neumaier B, Shah NJ: Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans. European Radiology 2016:1-12.
- Lohmann P, Willuweit A, Neffe AT, Geisler S, Gebauer TP, Beer S, Coenen HH, Fischer H, Hermanns-Sachweh B, Lendlein A: Bone regeneration induced by a 3D architectured hydrogel in a rat critical-size calvarial defect. Biomaterials 2017, 113:158-169.
- Longo DL, Michelotti F, Consolino L, Bardini P, Digilio G, Xiao G, Sun PZ, Aime S: In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents. Investigative radiology 2016, 51:155-162.
- Lou HC, Rosenstand A, Brooks DJ, Bender D, Jakobsen S, Blicher JU, Hansen KV, Møller A: Exogenous dopamine reduces GABA receptor availability in the human brain. Brain and behavior 2016.
- Ma K-H, Liu T-T, Weng S-J, Chen C-FF, Huang Y-S, Chueh S-H, Liao M-H, Chang K-W, Sung C-C, Hsu T-H: Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT. Scientific Reports 2016, 6:38695.
- Martín A, Vázquez-Villoldo N, Gómez-Vallejo V, Padro D, Soria FN, Szczupak B, Plaza-García S, Arrieta A, Reese T, Llop J: In vivo imaging of system xc-as a novel approach to monitor multiple sclerosis. European journal of nuclear medicine and molecular imaging 2016, 43:1124-1138.
- Martínez-Vélez N, Xipell E, Vera B, de la Rocha AA, Zalacain M, Marrodán L, Gonzalez-Huarriz M, Toledo G, Cascallo M, Alemany R: The oncolytic adenovirus VCN-01 as therapeutic approach against pediatric osteosarcoma. Clinical Cancer Research 2016, 22:2217-2225.
- Matsuo Y, Ogawa T, Yamamoto M, Shibamoto A, Sáenz JRV, Yokoyama M, Kanda Y, Toyohara J, Sasaki K: Evaluation of peri-implant bone metabolism under immediate loading using high-resolution Na18F-PET. Clinical Oral Investigations 2016:1-9.
- Matsuoka K, Yasuno F, Shinkai T, Miyasaka T, Takahashi M, Kiuchi K, Kosaka J, Inoue M, Kichikawa K, Hasegawa M: Test-retest reproducibility of extrastriatal binding with 123 I-FP-CIT SPECT in healthy male subjects. Psychiatry Research: Neuroimaging 2016, 258:10-15.
- Matsuura Y, Ueda M, Higaki Y, Watanabe K, Habara S, Kamino S, Saji H, Enomoto S: Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [123 I] 5IA. Nuclear medicine and biology 2016, 43:372-378.
- Mazère J, Lamare F, Fernandez P, Allard M, Mayo W: 123I-iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies. Journal of Nuclear Medicine 2016:jnumed. 116.176180.
- McGuire SM, Bhatia SK, Sun W, Jacobson GM, Menda Y, Ponto LLB, Smith BJ, Gross BA, Bayouth JE, Sunderland J: Using FLT PET to quantify and reduce hematologic toxicity due to chemoradiation therapy for pelvic cancer patients. International Journal of Radiation Oncology* Biology* Physics 2016.
- Meckel M, Kubíček V, Hermann P, Miederer M, Rösch F: A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting. Nuclear Medicine and Biology 2016, 43:670-678.
- Médoc M, Dhilly M, Matesic L, Toutain J, Krause-Heuer AM, Delamare J, Fraser BH, Touzani O, Barré L, Greguric I et al: In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F] ML-10 in a Stroke Model in the Rat. Molecular Imaging and Biology 2016, 18:117–126.
- Meletta R, Herde AM, Dennler P, Fischer E, Schibli R, Krämer SD: Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis. EJNMMI research 2016, 6:1.
- Mitran B, Varasteh Z, Selvaraju RK, Lindeberg G, Sörensen J, Larhed M, Tolmachev V, Rosenström U, Orlova A: Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26. International journal of oncology 2016, 48:2124-2134.
- Mitsui K, Morimoto N, Niwa T, Yamaura Y, Ohba H, Tsukada H, Katsumata S: Quantification of ONO-2952 occupancy of translocator protein 18kDa in conscious monkey brain using positron emission tomography. Journal of Pharmacology and Experimental Therapeutics 2016:jpet. 116.238568.
- Momosaki S, Ito M, Yamato H, Iimori H, Sumiyoshi H, Morimoto K, Imamoto N, Watabe T, Shimosegawa E, Hatazawa J: Longitudinal imaging of the availability of dopamine transporter and D2 receptor in rat striatum following mild ischemia. Journal of Cerebral Blood Flow & Metabolism 2016:0271678X16635183.
- Moraga A, Gómez-Vallejo V, Cuartero MI, Szczupak B, San Sebastián E, Markuerkiaga I, Pradillo JM, Higuchi M, Llop J, Moro MÁ et al: Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2016:0271678X15627657.
- Moriguchi S, Kimura Y, Ichise M, Arakawa R, Takano H, Seki C, Ikoma Y, Takahata K, Nagashima T, Yamada M: PET quantification of the norepinephrine transporter in human brain with (S, S)-18F-FMeNER-D2. Journal of Nuclear Medicine 2016:jnumed-116.
- Mu L, Müller Herde A, Rüefli PM, Sladojevich F, Milicevic Sephton S, Krämer SD, Thompson AJ, Schibli R, Ametamey SM, Lochner M: Synthesis and Pharmacological Evaluation of [11C] granisetron and [18F] fluoropalonosetron as PET Probes for 5-HT3 Receptor Imaging. ACS chemical neuroscience 2016, 7:1552-1564.
- Mukherjee J, Majji D, Kaur J, Constantinescu CC, Narayanan TK, Shi B, Nour MT, Pan M-L: PET radiotracer development for imaging high‐affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine‐18 labeled aminotetralins in rodents. Synapse 2016.
- Nag S, Fazio P, Lehmann L, Kettschau G, Heinrich T, Thiele A, Svedberg M, Amini N, Leesch S, Catafau AM: In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl. Journal of Nuclear Medicine 2016, 57:315-320.
- Nagai Y, Kikuchi E, Lerchner W, Inoue K-i, Ji B, Eldridge MA, Kaneko H, Kimura Y, Oh-Nishi A, Hori Y: PET imaging-guided chemogenetic silencing reveals a critical role of primate rostromedial caudate in reward evaluation. Nature Communications 2016, 7:13605.
- Neveu M-A, De Preter G, Marchand V, Bol A, Brender JR, Saito K, Kishimoto S, Porporato PE, Sonveaux P, Grégoire V: Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo. Neoplasia 2016, 18:742-752.
- Neyt S, Vliegen M, Verreet B, De Lombaerde S, Braeckman K, Vanhove C, Huisman MT, Dumolyn C, Kersemans K, Hulpia F: Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function. Nuclear Medicine and Biology 2016, 43:642-649.
- Ng S-H, Liao C-T, Lin C-Y, Chan S-C, Lin Y-C, Yen T-C, Chang JT-C, Ko S-F, Fan K-H, Wang H-M: Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. European radiology 2016:1-11.
- Nikolaus S, Beu M, Angelica De Souza Silva M, Huston JP, Hautzel H, Antke C, Müller HW: DAT versus D2 receptor binding in the rat striatum: l‐DOPA‐induced motor activity is better predicted by reuptake than release of dopamine. Synapse 2016.
- Nishino A, Tajima Y, Takuwa H, Masamoto K, Taniguchi J, Wakizaka H, Kokuryo D, Urushihata T, Aoki I, Kanno I: Long-term effects of cerebral hypoperfusion on neural density and function using misery perfusion animal model. Scientific reports 2016, 6.
- Nitzsche B, Barthel H, Lobsien D, Boltze J, Zeisig V, Dreyer AY: Focal Cerebral Ischemia by Permanent Middle Cerebral Artery Occlusion in Sheep: Surgical Technique, Clinical Imaging, and Histopathological Results. Experimental Neurosurgery in Animal Models 2016:195-225.
- Nkoulou R, Fuchs TA, Pazhenkottil AP, Kuest SM, Ghadri JR, Stehli J, Fiechter M, Herzog BA, Gaemperli O, Buechel RR: Absolute Myocardial Blood Flow and Flow Reserve Assessed by Gated SPECT with Cadmium–Zinc–Telluride Detectors Using 99mTc-Tetrofosmin: Head-to-Head Comparison with 13N-Ammonia PET. Journal of Nuclear Medicine 2016, 57:1887-1892.
- Novy J, Allenbach G, Bien CG, Guedj E, Prior JO, Rossetti AO: FDG-PET hyperactivity pattern in anti-NMDAr encephalitis. Journal of Neuroimmunology 2016.
- Nugent S, Castellano CA, Bocti C, Dionne I, Fulop T, Cunnane SC: Relationship of metabolic and endocrine parameters to brain glucose metabolism in older adults: do cognitively-normal older adults have a particular metabolic phenotype? Biogerontology 2016, 17:241–255.
- Nummenmaa L, Tuominen L, Dunbar R, Hirvonen J, Manninen S, Arponen E, Machin A, Hari R, Jääskeläinen IP, Sams M: Social Touch Modulates Endogenous μ-opioid System Activity in Humans. NeuroImage 2016.
- Ohba H, Kanazawa M, Kakiuchi T, Tsukada H: Effects of acetaminophen on mitochondrial complex I activity in the rat liver and kidney: a PET study with 18F-BCPP-BF. EJNMMI research 2016, 6:82.
- Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED: Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug and alcohol dependence 2016, 161:163-170.
- Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED: Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals. International Journal of Neuropsychopharmacology 2016, 19:pyv129.
- Okita K, Mandelkern MA, London ED: Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence. International Journal of Neuropsychopharmacology 2016, 19:pyw074.
- Okita K, Petersen N, Robertson CL, Dean AC, Mandelkern MA, London ED: Sex differences in midbrain dopamine D2-type receptor availability and association with nicotine dependence. Neuropsychopharmacology 2016, 41:2913-2919.
- Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL: Brain penetrant small molecule 18 F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nuclear medicine and biology 2016, 43:478-489.
- Ory D, Celen S, Gijsbers R, Van Den Haute C, Postnov A, Koole M, Vandeputte C, Andrés J-I, De Angelis M, Langlois X: Preclinical evaluation of a P2X7 receptor selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in non-human primates. Journal of Nuclear Medicine 2016:jnumed. 115.169995.
- Ory D, Postnov A, Koole M, Celen S, de Laat B, Verbruggen A, Van Laere K, Bormans G, Casteels C: Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F] DPA-714 PET. European journal of nuclear medicine and molecular imaging 2016, 43:163–172.
- Overhoff F, Brendel M, Jaworska A, Korzhova V, Delker A, Probst F, Focke C, Gildehaus F-J, Carlsen J, Baumann K: Automated spatial brain normalization and hindbrain white matter reference tissue give improved [18F]-florbetaben PET quantitation in Alzheimer’s model mice. Frontiers in neuroscience 2016, 10.
- Özbay PS, Warnock G, Rossi C, Kuhn F, Akin B, Pruessmann KP, Nanz D: Probing neuronal activation by functional quantitative susceptibility mapping under a visual paradigm: A group level comparison with BOLD fMRI and PET. NeuroImage 2016.
- Pajak MZ, Volgyes D, Pimlott SL, Salvador CC, Asensi AS, McKeown C, Waldeck J, Anderson KI: NEMA NU4-2008 Performance Evaluation of Albira: A Two-Ring Small-Animal PET System Using Continuous LYSO Crystals. Open Medicine Journal 2016, 3.
- Pak K, Lee SH, Lee JG, Seok JW, Kim IJ: Comparison of Visceral Fat Measures with Cardiometabolic Risk Factors in Healthy Adults. PloS one 2016, 11:e0153031.
- Pan M-L, Mukherjee MT, Patel HH, Patel B, Constantinescu CC, Mirbolooki MR, Liang C, Mukherjee J: Evaluation of [11C] TAZA for amyloid β plaque imaging in postmortem human Alzheimer’s disease brain region and whole body distribution in rodent PET/CT. Synapse 2016.
- Parente A, Feltes PK, García DV, Sijbesma JW, Jeckel CMM, Dierckx RA, de Vries EF, Doorduin J: Pharmacokinetic Analysis of 11C-PBR28 in the Rat Model of Herpes Encephalitis: Comparison with (R)-11C-PK11195. Journal of Nuclear Medicine 2016, 57:785-791.
- Parthoens J, Verhaeghe J, Servaes S, Miranda A, Stroobants S, Staelens S: Performance Characterization of an Actively Cooled Repetitive Transcranial Magnetic Stimulation Coil for the Rat. Neuromodulation: Technology at the Neural Interface 2016.
- Pedersen L, Jensen JB, Wogensen L, Munk OL, Jessen N, Frøkia er J, Jakobsen S: Renal PET-imaging with 11 C-metformin in a transgenic mouse model for chronic kidney disease. EJNMMI research 2016, 6:54.
- Peng K-T, Hsieh M-Y, Lin CT, Chen C-F, Lee MS, Huang Y-Y, Chang P-J: Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel. BMC Musculoskeletal Disorders 2016, 17:286.
- Perrone M, Moon BS, Park HS, Laquintana V, Jung JH, Cutrignelli A, Lopedota A, Franco M, Kim SE, Lee BC: A novel PET imaging probe for the detection and monitoring of translocator protein 18 kDa expression in pathological disorders. Scientific reports 2016, 6.
- Petrik M, Zhai C, Novy Z, Urbanek L, Haas H, Decristoforo C: In vitro and in vivo comparison of selected Ga-68 and Zr-89 labelled siderophores. Molecular Imaging and Biology 2016, 18:344-352.
- Pfeifer P, Tüscher O, Buchholz HG, Gründer G, Vernaleken I, Paulzen M, Zimmermann US, Maus S, Lieb K, Eggermann T: Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2/D3 dopamine system. Addiction Biology 2016.
- Pflugrad H, Meyer G-J, Dirks M, Raab P, Tryc AB, Goldbecker A, Worthmann H, Wilke F, Boellaard R, Yaqub M et al: Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction. Journal of Viral Hepatitis 2016.
- Pluhacek T, Petrik M, Luptakova D, Benada O, Palyzova A, Lemr K, Havlicek V: Aspergillus infection monitored by multimodal imaging in a rat model. Proteomics 2016.
- Porrino LJ, Miller MD, Smith HR, Nader SH, Nader MA: Neural Correlates of Exposure to Cocaine Cues in Rhesus Monkeys: Modulation by the Dopamine Transporter. Biological psychiatry 2016.
- Portnoy E, Polyak B, Inbar D, Kenan G, Rai A, Wehrli SL, Roberts TP, Bishara A, Mann A, Shmuel M: Tracking inflammation in the epileptic rat brain by bi-functional fluorescent and magnetic nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 2016, 12:1335-1345.
- Pottier G, Marie S, Goutal S, Auvity S, Peyronneau M-A, Stute S, Boisgard R, Dollé F, Buvat I, Caillé F: Imaging the impact of the P-glycoprotein (ABCB1) function on the brain kinetics of metoclopramide. Journal of Nuclear Medicine 2016, 57:309-314.
- Pravenec M, Mlejnek P, Zidek V, Landa V, Simakova M, Silhavy J, Strnad H, Eigner S, Eigner-Henke K, Skop V: Autocrine effects of transgenic resistin reduce palmitate and glucose oxidation in brown adipose tissue in spontaneously hypertensive rat. Physiological genomics 2016:physiolgenomics. 00122.02015.
- Pretze M, Pallavi P, Roscher M, Klotz S, Caballero J, Binzen U, Greffrath W, Treede R-D, Harmsen MC, Hafner M: Radiofluorinated N-Octanoyl Dopamine ([18F] F-NOD) as tool to study tissue distribution and elimination of NOD in vitro and in vivo. Journal of Medicinal Chemistry 2016.
- Rahmim A, Salimpour Y, Jain S, Blinder SA, Klyuzhin IS, Smith GS, Mari Z, Sossi V: Application of texture analysis to DAT SPECT imaging: relationship to clinical assessments. NeuroImage: Clinical 2016.
- Ramage LE, Akyol M, Fletcher AM, Forsythe J, Nixon M, Carter RN, van Beek EJ, Morton NM, Walker BR, Stimson RH: Glucocorticoids Acutely Increase Brown Adipose Tissue Activity in Humans, Revealing Species-Specific Differences in UCP-1 Regulation. Cell Metabolism 2016, 24:130-141.
- Rapic S, Vangestel C, Verhaeghe J, Thomae D, Pauwels P, Van den Wyngaert T, Staelens S, Stroobants S: Evaluation of [18F] fluorothymidine as a biomarker for early therapy response in a mouse model of colorectal cancer. Molecular Imaging and Biology 2016:1-11.
- Reid WC, Casas R, Papadakis GZ, Muthusamy S, Lee DE, Ibrahim WG, Nair A, Koziol D, Maric D, Hammoud DA: Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18 F-FDG-PET. PloS one 2016, 11:e0152265.
- Rodríguez-Cueto C, Hernández-Gálvez M, Hillard CJ, Maciel P, García-García L, Valdeolivas S, Pozo MA, Ramos JA, Gómez-Ruiz M, Fernández-Ruiz J: Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. Neuroscience 2016, 339:191-209.
- Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A: Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer’s Disease. Journal of Nuclear Medicine 2016:jnumed. 115.168732.
- Roelcke U, Wyss MT, Nowosielski M, Rudà R, Roth P, Hofer S, Galldiks N, Crippa F, Weller M, Soffietti R: Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro-oncology 2016, 18:744-751.
- Roffman JL, Tanner AS, Eryilmaz H, Rodriguez-Thompson A, Silverstein NJ, Ho NF, Nitenson AZ, Chonde DB, Greve DN, Abi-Dargham A: Dopamine D1 signaling organizes network dynamics underlying working memory. Science Advances 2016, 2:e1501672.
- Rotstein BH, Placzek MS, Krishnan HS, Pekošak A, Collier TL, Wang C, Liang SH, Burstein ES, Hooker JM, Vasdev N: Preclinical PET neuroimaging of [11C] bexarotene. Molecular imaging 2016, 15.
- Rullmann M, Dukart J, Hoffmann K-T, Luthardt J, Tiepolt S, Patt M, Gertz H-J, Schroeter ML, Seibyl J, Schulz-Schaeffer WJ: Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans. Journal of Nuclear Medicine 2016, 57:198-203.
- Sachpekidis C, Kopka K, Eder M, Hadaschik BA, Freitag MT, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A: 68Ga-PSMA-11 Dynamic PET/CT imaging in primary prostate cancer. Clinical Nuclear Medicine 2016, 41:e473-e479.
- Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A: Regional tau deposition measured by [18 F] THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease. Alzheimer’s Research & Therapy 2016, 8:38.
- Santoro GC, Shukla S, Patel K, Kaczmarzyk J, Agorastos S, Choi YY, Veith C, Carrion J, Silverman R, Mullin D et al: A Novel Strategy for Attenuating Opioid Withdrawal in Neonates. J Addict Res Ther 2016, 7:2.
- Sasaki T, Kobayashi K, Kita S, Kojima K, Hirano H, Shen L, Takenaka F, Kumon H, Matsuura E: In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β 2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging. Autoimmunity Reviews 2016.
- Savolainen H, Meerlo P, Elsinga PH, Windhorst AD, Dierckx RA, Colabufo NA, van Waarde A, Luurtsema G: P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study. The AAPS Journal 2016, 18:1524-1531.
- Savolainen H, Windhorst AD, Elsinga PH, Cantore M, Colabufo NA, Willemsen AT, Luurtsema G: Evaluation of [18 F] MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood-brain barrier in rats; kinetics, metabolism, and selectivity. J Cereb Blood Flow Metab 2016.
- Schabel C, Gatidis S, Bongers M, Hüttig F, Bier G, Kupferschlaeger J, Bamberg F, la Fougère C, Nikolaou K, Pfannenberg C: Improving CT-Based PET Attenuation Correction in the Vicinity of Metal Implants by an Iterative Metal Artifact Reduction Algorithm of CT Data and Its Comparison to Dual-Energy–Based Strategies: A Phantom Study. Investigative Radiology 2017, 52:61-65.
- Schankin CJ, Maniyar FH, Seo Y, Kori S, Eller M, Chou DE, Blecha J, Murphy ST, Hawkins RA, Sprenger T: Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain 2016:aww096.
- Schipke CG, Koglin N, Bullich S, Joachim LK, Haas B, Seibyl J, Barthel H, Sabri O, Peters O: Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid. Psychiatry Research: Neuroimaging 2016.
- Schmitt CC, Aranias T, Viel T, Chateau D, Le Gall M, Waligora-Dupriet A-J, Melchior C, Rouxel O, Kapel N, Gourcerol G: Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis. Molecular Metabolism 2016.
- Schmitt S, Delamare J, Tirel O, Fillesoye F, Dhilly M, Perrio C: N-[18 F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic. Nuclear Medicine and Biology 2017, 44:50-61.
- Schweifer A, Maier F, Ehrlichmann W, Lamparter D, Kneilling M, Pichler BJ, Hammerschmidt F, Reischl G: [18 F] Fluoro-azomycin-2´-deoxy-β-d-ribofuranoside—A new imaging agent for tumor hypoxia in comparison with [18 F] FAZA. Nuclear Medicine and Biology 2016, 43:759-769.
- Seith F, Gatidis S, Schmidt H, Bezrukov I, la Fougère C, Nikolaou K, Pfannenberg C, Schwenzer N: Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance–and Computed Tomography–Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients. Investigative radiology 2016, 51:66–71.
- Sekine T, Buck A, Delso G, ter Voert EE, Huellner M, Veit-Haibach P, Warnock G: Evaluation of atlas-based attenuation correction for integrated PET/MR in human brain: application of a head atlas and comparison to true CT-based attenuation correction. Journal of Nuclear Medicine 2016, 57:215-220.
- Sekine T, Burgos N, Warnock G, Huellner MW, Buck A, ter Voert EE, Cardoso MJ, Hutton BF, Ourselin S, Veit-Haibach P et al: Multi atlas-based attenuation correction for brain FDG-PET imaging using a TOF-PET/MR scanner–comparison with clinical single atlas-and CT-based attenuation correction. Journal of Nuclear Medicine 2016:jnumed–115.
- Sekine T, ter Voert EE, Warnock G, Buck A, Huellner M, Veit-Haibach P, Delso G: Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction. Journal of Nuclear Medicine 2016, 57:1927–1932.
- Servaes S, Glorie D, Verhaeghe J, Stroobants S, Staelens S: [18F]-FDG PET neuroimaging in rats with quinpirole-induced checking behavior as a model for obsessive compulsive disorder. Psychiatry Research: Neuroimaging 2016, 257:31-38.
- Shah D, Deleye S, Verhoye M, Staelens S, Van der Linden A: Resting-state functional MRI and [18F]-FDG PET demonstrate differences in neuronal activity between commonly used mouse strains. NeuroImage 2016, 125:571–577.
- Shcherbinin S, Schwarz AJ, Joshi AD, Navitsky M, Flitter M, Shankle WR, Devous MD, Mintun MA: Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer’s disease. Journal of Nuclear Medicine 2016:jnumed–115.
- Shi K, Bayer C, Astner ST, Gaertner FC, Vaupel P, Schwaiger M, Huang S-C, Ziegler SI: Quantitative Analysis of [18F] FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry. Molecular Imaging and Biology 2016:1-10.
- Shingaki T, Katayama Y, Nakaoka T, Irie S, Onoe K, Okauchi T, Hayashinaka E, Yamaguchi M, Tanki N, Ose T et al: Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat. European Journal of Pharmaceutics and Biopharmaceutics 2016, 99:45–53.
- Shingaki T, Katayama Y, Nakaoka T, Takashima T, Onoe K, Okauchi T, Hayashinaka E, Wada Y, Cui Y, Watanabe Y: Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics. Pharmaceutical research 2016, 33:1235-1248.
- Shukuri M, Mawatari A, Ohno M, Suzuki M, Doi H, Watanabe Y, Onoe H: Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer’s disease model mice. Journal of Nuclear Medicine 2016, 57:291-296.
- Sijbesma JW, Zhou X, García DV, Houwertjes MC, Doorduin J, Kwizera C, Maas B, Meerlo P, Dierckx RA, Slart RH: Novel Approach to Repeated Arterial Blood Sampling in Small Animal PET: Application in a Test-Retest Study with the Adenosine A1 Receptor Ligand [11C] MPDX. Molecular Imaging and Biology 2016:1-9.
- Silva-Rodríguez J, García-Varela L, López-Arias E, Domínguez-Prado I, Cortés J, Pardo-Montero J, Fernández-Ferreiro A, Ruibal Á, Sobrino T, Aguiar P: Impact of benzodiazepines on brain FDG-PET quantification after single-dose and chronic administration in rats. Nuclear Medicine and Biology 2016, 43:827-834.
- Slavik R, Müller Herde A, Haider A, Krämer SD, Weber M, Schibli R, Ametamey SM, Mu L: Discovery of a fluorinated 4‐oxo‐quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. Journal of Neurochemistry 2016, 138:874-886.
- Smith CT, Dang LC, Cowan RL, Kessler RM, Zald DH: Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine. Neuropharmacology 2016, 108:394-402.
- Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, Hägerström D, Jögi J, Borroni E, Schöll M, Honer M: Increased basal ganglia binding of 18F‐AV‐1451 in patients with progressive supranuclear palsy. Movement Disorders 2016.
- Sneddon D, Niemans R, Bauwens M, Yaromina A, van Kuijk SJ, Lieuwes NG, Biemans R, Pooters I, Pellegrini PA, Lengkeek NA: Synthesis and in Vivo Biological Evaluation of 68Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography. Journal of Medicinal Chemistry 2016, 59:6431-6443.
- Son HJ, Jeong YJ, Yoon HJ, Wang L, Kim HJ, Park J-H, Kang D-Y: Visual Pattern and Serial Quantitation of 18F-Sodium Fluoride PET/CT in Asymptomatic Patients After Hip and Knee Arthroplasty. Nuclear Medicine and Molecular Imaging 2016, 50:308-321.
- Spiegelberg D, Mortensen AC, Selvaraju RK, Eriksson O, Stenerlöw B, Nestor M: Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model. European journal of nuclear medicine and molecular imaging 2016, 43:974-982.
- Sridharan S, Lepelletier F-X, Trigg W, Banister S, Reekie T, Kassiou M, Gerhard A, Hinz R, Boutin H: Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats. Molecular Imaging and Biology 2016:1-13.
- Stegmayr C, Schöneck M, Oliveira D, Willuweit A, Filss C, Galldiks N, Shah NJ, Coenen HH, Langen K-J: Reproducibility of O-(2-18F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas. European journal of nuclear medicine and molecular imaging 2016, 43:1115-1123.
- Suda M, Onoguchi M, Tomiyama T, Ishihara K, Takahashi N, Sakurai M, Matsumoto K, Kumita S-i: The reproducibility of time-of-flight PET and conventional PET for the quantification of myocardial blood flow and coronary flow reserve with 13N-ammonia. Journal of Nuclear Cardiology 2016, 23:457-472.
- Takaji M, Takemoto A, Yokoyama C, Watakabe A, Mizukami H, Ozawa K, Onoe H, Nakamura K, Yamamori T: Distinct roles for primate caudate dopamine D1 and D2 receptors in visual discrimination learning revealed using shRNA knockdown. Scientific Reports 2016, 6.
- Tamura Y, Takahashi K, Takata K, Eguchi A, Yamato M, Kume S, Nakano M, Watanabe Y, Kataoka Y: Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F] FLT-PET Imaging. Journal of Neuroscience 2016, 36:8123-8131.
- ter Voert EE, Delso G, de Galiza Barbosa F, Huellner M, Veit-Haibach P: The Effect of Defective PET Detectors in Clinical Simultaneous [18F] FDG Time-of-Flight PET/MR Imaging. Molecular Imaging and Biology 2016:1-10.
- ter Voert EE, Delso G, Porto M, Huellner M, Veit-Haibach P: Intravoxel Incoherent Motion Protocol Evaluation and Data Quality in Normal and Malignant Liver Tissue and Comparison to the Literature. Investigative Radiology 2016, 51:90–99.
- Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, Miyajima H, Hashizume T, Ouchi Y: Extrastriatal spreading of microglial activation in Parkinson’s disease: a positron emission tomography study. Annals of nuclear medicine 2016, 30:579-587.
- Testa A, Dall‘Angelo S, Mingarelli M, Augello A, Schweiger L, Welch A, Elmore CS, Sharma P, Zanda M: Design, Synthesis, In Vitro Characterization and Preliminary Imaging Studies on Fluorinated Bile Acid Derivatives as PET Tracers to Study Hepatic Transporters. Bioorganic & Medicinal Chemistry 2016.
- Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS: Chronic Methamphetamine Effects on Brain Structure and Function in Rats. PloS one 2016, 11:e0155457.
- Thanos PK, Kim R, Delis F, Rocco MJ, Cho J, Volkow ND: Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain. Behavioural Brain Research 2016.
- Thengone DJ, Voss HU, Fridman EA, Schiff ND: Local changes in network structure contribute to late communication recovery after severe brain injury. Science Translational Medicine 2016, 8:368re365-368re365.
- Thomas B, Molton J, Leek F, Totman J, Townsend D, Paton N: Comparison of 18F-FDG PET-CT and PET-MR imaging of pulmonary tuberculosis. Journal of Nuclear Medicine 2016, 57:546-546.
- Thomas BA, Cuplov V, Bousse A, Mendes A, Thielemans K, Hutton BF, Erlandsson K: PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography. Physics in Medicine and Biology 2016, 61:7975.
- Thongpraparn T, Ikoma Y, Shiraishi T, Yamaya T, Ito H: Effects of point spread function-based image reconstruction on neuroreceptor binding in positron emission tomography study with [11C] FLB 457. Radiological physics and technology 2016, 9:127–137.
- Tiepolt S, Hesse S, Patt M, Luthardt J, Schroeter ML, Hoffmann K-T, Weise D, Gertz H-J, Sabri O, Barthel H: Early [18F] florbetaben and [11C] PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging 2016:1-10.
- Tompkins VS, Sompallae R, Rosean TR, Walsh S, Acevedo M, Kovalchuk AL, Han SS, Jing X, Holman C, Rehg JE: Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia. Blood Cancer Journal 2016, 6:e488.
- Tóth M, Little P, Arnberg F, Häggkvist J, Mulder J, Halldin C, Gulyás B, Holmin S: Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking. Brain Structure and Function 2016, 221:1279-1290.
- Tournier N, Goutal S, Auvity S, Traxl A, Mairinger S, Wanek T, Helal O-B, Buvat I, Soussan M, Caillé F: Strategies to inhibit ABCB1-and ABCG2-mediated efflux transport of erlotinib at the blood-brain barrier: a PET study in non-human primates. Journal of Nuclear Medicine 2016:jnumed. 116.178665.
- Toyohara J, Okamoto M, Aramaki H, Zaitsu Y, Shimizu I, Ishiwata K: (R)-[11 C] Emopamil as a novel tracer for imaging enhanced P-glycoprotein function. Nuclear medicine and biology 2016, 43:52–62.
- Tsartsalis S, Tournier BB, Huynh-Gatz T, Dumas N, Ginovart N, Moulin-Sallanon M, Millet P: 5-HT2A receptor SPECT imaging with [123 I] R91150 under P-gp inhibition with tariquidar: More is better? Nuclear medicine and biology 2016, 43:81–88.
- Tsukada H, Nishiyama S, Takahashi K: Imaging of Muscarinic Receptors in the Central Nervous System. Muscarinic Receptor: From Structure to Animal Models 2016:181–203.
- Tuszynski T, Rullmann M, Luthardt J, Butzke D, Tiepolt S, Gertz H-J, Hesse S, Seese A, Lobsien D, Sabri O et al: Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease. European journal of nuclear medicine and molecular imaging 2016:1–11.
- van Bergen JMG, Li X, Hua J, Schreiner SJ, Steininger SC, Quevenco FC, Wyss M, Gietl AF, Treyer V, Leh SE: Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment. Scientific Reports 2016, 6.
- van der Lans AA, Vosselman MJ, Hanssen MJ, Brans B, van Marken Lichtenbelt WD: Supraclavicular skin temperature and BAT activity in lean healthy adults. The Journal of Physiological Sciences 2016, 66:77–83.
- Van Laeken N, Taylor O, Polis I, Neyt S, Kersemans K, Dobbeleir A, Saunders J, Goethals I, Peremans K, De Vos F: In Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [11 C] DASB in the Canine Brain. PloS one 2016, 11:e0148943.
- Vancraeynest D, Roelants V, Bouzin C, Hanin F-X, Walrand S, Bol V, Bol A, Pouleur A-C, Pasquet A, Gerber B: α V β 3 integrin-targeted microSPECT/CT imaging of inflamed atherosclerotic plaques in mice. EJNMMI research 2016, 6:1.
- Vangestel C, Thomae D, Van Soom J, Ides J, Pauwels P, Stroobants S, Van der Veken P, Magdolen V, Joossens J, Augustyns K: Preclinical evaluation of [111In] MICA‐401, an activity‐based probe for SPECT imaging of in vivo uPA activity. Contrast Media & Molecular Imaging 2016.
- Vanicek T, Kutzelnigg A, Philippe C, Sigurdardottir HL, James GM, Hahn A, Kranz GS, Höflich A, Kautzky A, Traub‐Weidinger T: Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET. Human Brain Mapping 2016.
- Verbrugghen T, Monnery BD, Glassner M, Stroobants S, Hoogenboom R, Staelens S: μPET imaging of the pharmacokinetic behavior of medium and high molar mass 89 Zr-labeled poly (2-ethyl-2-oxazoline) in comparison to poly (ethylene glycol). Journal of Controlled Release 2016, 235:63-71.
- Wakabayashi T, Iuchi T, Tsuyuguchi N, Nishikawa R, Arakawa Y, Sasayama T, Miyake K, Nariai T, Narita Y, Hashimoto N: Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High-or Low-grade Gliomas: A Multicenter Phase IIb Trial. Asia Oceania Journal of Nuclear Medicine and Biology 2016.
- Waldron A-M, Verhaeghe J, Richardson JC, Schmidt M, Stroobants S, Langlois X, Staelens S: Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model. Journal of Alzheimer’s Disease 2016:1-12.
- Wang C, Placzek MS, Van de Bittner GC, Schroeder FA, Hooker JM: A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography. ACS chemical neuroscience 2016, 7:484-489.
- Wang C, Schroeder FA, Hooker JM: Development of New Positron Emission Tomography Radiotracer for BET Imaging. ACS Chemical Neuroscience 2016.
- Warnier C, Lemaire C, Becker G, Zaragoza G, Giacomelli F, Aerts J, Otabashi M, Bahri MA, Mercier J, Plenevaux A: Enabling Efficient Positron Emission Tomography (PET) Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) with a Robust and One-Step Radiosynthesis of a Highly Potent 18F-Labeled Ligand ([18F] UCB-H). Journal of Medicinal Chemistry 2016, 59:8955-8966.
- Weng Y-H, Chen C-Y, Lin K-J, Chen Y-L, Yeh T-H, Hsiao T, Chen J, Lu C-S, Wang H-L: (R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model. Experimental neurology 2016, 275:104–115.
- Westerlund K, Honarvar H, Norrström E, Strand J, Mitran B, Orlova A, Eriksson Karlström A, Tolmachev V: Increasing the net negative charge by replacement of DOTA chelator with DOTAGA improves the biodistribution of radiolabeled second-generation synthetic Affibody molecules. Molecular pharmaceutics 2016, 13:1668-1678.
- Wollenweber FA, Därr S, Müller C, Duering M, Buerger K, Zietemann V, Malik R, Brendel M, Ertl-Wagner B, Bartenstein P: Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment. Stroke 2016, 47:2645-2648.
- Wu B, Warnock G, Zaiss M, Lin C, Chen M, Zhou Z, Mu L, Nanz D, Tuura R, Delso G: An overview of CEST MRI for non-MR physicists. EJNMMI physics 2016, 3:19.
- Wu K-Y, Liu C-Y, Chen C-S, Chen C-H, Hsiao T, Hsieh C-J, Lee C-P, Yen T-C, Lin K-J: Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study. European journal of nuclear medicine and molecular imaging 2016:1–10.
- Wu Y-W, Yang W-S: Time course of cardiometabolic alterations in obese diabetic male db/db mice model using small-animal dynamic FDG PET. Journal of Nuclear Medicine 2016, 57:1635-1635.
- Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, Kucukler N, Tahari A, Pozios I, Zhou Y: Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13 N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology 2016.
- Yanai S, Toyohara J, Ishiwata K, Ito H, Endo S: Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier. Neuropharmacology 2016.
- Yang K-C, Stepanov V, Amini N, Martinsson S, Takano A, Nielsen J, Bundgaard C, Bang-Andersen B, Grimwood S, Halldin C: Characterization of [11C] Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain. European Journal of Nuclear Medicine and Molecular Imaging 2016:1-13.
- Yang Y, Wang Z-H, Jin S, Gao D, Liu N, Chen S-P, Zhang S, Liu Q, Liu E, Wang X: Opposite monosynaptic scaling of BLP-vCA1 inputs governs hopefulness-and helplessness-modulated spatial learning and memory. Nature Communications 2016, 7.
- Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Kosaka J, Kudo T: High amyloid‐β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study. International journal of geriatric psychiatry 2016.
- Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J: Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. NeuroImage: Clinical 2016.
- Yokoyama C, Mawatari A, Kawasaki A, Takeda C, Onoe K, Doi H, Newman-Tancredi A, Zimmer L, Onoe H: Marmoset serotonin 5-HT1A receptor mapping with a biased agonist PET probe 18F-F13714: comparison with an antagonist tracer 18F-MPPF in awake and anesthetized states. International Journal of Neuropsychopharmacology 2016:pyw079.
- Zamboglou C, Schiller F, Fechter T, Wieser G, Jilg CA, Chirindel A, Salman N, Drendel V, Werner M, Mix M: 68Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison. Theranostics 2016, 6:1619.
- Zhang JL, Morey AM, Kadrmas DJ: Application of separable parameter space techniques to multi-tracer PET compartment modeling. Physics in medicine and biology 2016, 61:1238.
- Zhang M, Jasim DA, Ménard-Moyon C, Nunes A, Iijima S, Bianco A, Yudasaka M, Kostarelos K: Radiolabeling, whole-body single photon emission computed tomography/computed tomography imaging, and pharmacokinetics of carbon nanohorns in mice. International Journal of Nanomedicine 2016, 11:3317.
- Zhao R-J, Lin S-H, Lee L-T, Lee IH, Chen PS, Chen KC, Yang YK: Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM. Journal of addiction medicine 2016, 10:87-90.
- Zhao Z-Q, Yang Y, Fang W, Liu S: Comparison of biological properties of 99m Tc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging. Nuclear Medicine and Biology 2016.
- Zhou X, Khanapur S, de Jong JR, Willemsen AT, Dierckx RA, Elsinga PH, de Vries EF: In vivo evaluation of [11C] preladenant positron emission tomography for quantification of adenosine A2A receptors in the rat brain. Journal of Cerebral Blood Flow & Metabolism 2016:0271678X16634714.
- Zhu W, Yao S, Xing H, Zhang H, Tai Y-c, Zhang Y, Liu Y, Ma Y, Wu C, Wang H: Biodistribution and Radiation Dosimetry of the Enterobacteriaceae-Specific Imaging Probe [18F] Fluorodeoxysorbitol Determined by PET/CT in Healthy Human Volunteers. Molecular Imaging and Biology 2016:1-6.
- Zientek F, Winter K, Müller A, Rullmann M, Luthardt J, Becker G-A, Bresch A, Patt M, Sabri O, Hilbert A: Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non‐obese individuals. European Journal of Neuroscience 2016, 44:2460-2466.
- Abdulghani M, Duell J, Smith M, Chen W, Bentzen SM, Asoglu R, Klein T, Bob-Manuel T, Saliaris A, See V: Global and regional myocardial innervation before and after ablation of drug-refractory ventricular tachycardia assessed with 123I-MIBG. Journal of Nuclear Medicine 2015, 56(Supplement 4):52S-58S.
- Afshar-Oromieh A, Hetzheim H, Kratochwil C, Benesova M, Eder M, Neels OC, Eisenhut M, Kübler W, Holland-Letz T, Giesel FL: The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions. Journal of Nuclear Medicine 2015, 56(11):1697-1705.
- Airas L, Dickens AM, Elo P, Marjamäki P, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M: In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis. Journal of Nuclear Medicine 2015, 56(2):305-310.
- Akkus F, Treyer V, Johayem A, Ametamey SM, Gomez Mancilla B, Sovago J, Buck A, Hasler G: Association of Long Term Abstinence with Normal Metabotropic Glutamate Receptor-5 Binding. Biological Psychiatry 2015(0).
- Albertoni C, Leoni B, Rosi A, D’Alessio V, Carollo V, Spagnoli LG, van Echteld C, De Santis R: Radionuclide Therapy of Unresectable Tumors with AvidinOX and 90Y-biotinDOTA: Tongue Cancer Paradigm. Cancer Biotherapy and Radiopharmaceuticals 2015, 30(7):291-298.
- Amhaoul H, Hamaide J, Bertoglio D, Reichel SN, Verhaeghe J, Geerts E, Van Dam D, De Deyn PP, Kumar-Singh S, Katsifis A: Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis. Neurobiology of disease 2015.
- Andersen JB, Henning WS, Lindberg U, Ladefoged CN, Højgaard L, Greisen G, Law I: Positron emission tomography/magnetic resonance hybrid scanner imaging of cerebral blood flow using 15O-water positron emission tomography and arterial spin labeling magnetic resonance imaging in newborn piglets. Journal of Cerebral Blood Flow & Metabolism 2015.
- Anitua E, Pelacho B, Prado R, Aguirre JJ, Sánchez M, Padilla S, Aranguren XL, Abizanda G, Collantes M, Hernandez M: Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia. Journal of Controlled Release 2015, 202:31-39.
- Aquaro GD, Frijia F, Positano V, Menichetti L, Santarelli MF, Lionetti V, Giovannetti G, Recchia FA, Landini L: Cardiac Metabolism in a Pig Model of Ischemia–Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate. IJC Metabolic & Endocrine 2015, 6(0):17-23.
- Arsenault D, Coulombe K, Zhu A, Gong C, Kil K-E, Choi J-K, Poutiainen P, Brownell A-L: Loss of Metabotropic Glutamate Receptor 5 Function on Peripheral Benzodiazepine Receptor in Mice Prenatally Exposed to LPS. PloS one 2015, 10(11):e0142093.
- Bailly M, Ribeiro MJS, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D: 18F-FDG and 18F-Florbetapir PET in Clinical Practice: Regional Analysis in Mild Cognitive Impairment and Alzheimer Disease. Clinical nuclear medicine 2015, 40(2):e111-e116.
- Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S: Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. International Journal of Neuropsychopharmacology 2015, 18(4):pyu063.
- Baldinger P, Kraus C, Rami-Mark C, Gryglewski G, Kranz GS, Haeusler D, Hahn A, Spies M, Wadsak W, Mitterhauser M et al: Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding. NeuroImage 2015, 111(0):505-512.
- Ballard ME, Dean AC, Mandelkern MA, London ED, Morton JB: Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users. PloS one 2015(12).
- Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED: Low dopamine D2/D3 receptor availability is associated with steep discounting of delayed rewards in methamphetamine dependence. International Journal of Neuropsychopharmacology 2015:pyu119.
- Bang J-I, Jung IS, Song YS, Park HS, Moon BS, Lee BC, Kim SE: PET imaging of dopamine transporters with [18 F] FE-PE2I: Effects of anti-Parkinsonian drugs. Nuclear Medicine and Biology 2015.
- Barret O, Hannestad J, Vala C, Alagille D, Tavares A, Laruelle M, Jennings D, Marek K, Russell D, Seibyl J: Characterization in Humans of 18F-MNI-444, a PET Radiotracer for Brain Adenosine 2A Receptors. Journal of Nuclear Medicine 2015, 56(4):586-591.
- Bauer M, Karch R, Zeitlinger M, Philippe C, Römermann K, Stanek J, Maier-Salamon A, Wadsak W, Jäger W, Hacker M: Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[ 11C] verapamil PET study. Journal of Cerebral Blood Flow & Metabolism 2015, 35(5):743-746.
- Besson FL, La Joie R, Doeuvre L, Gaubert M, Mézenge F, Egret S, Landeau B, Barré L, Abbas A, Ibazizene M: Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer’s Disease. The Journal of Neuroscience 2015, 35(29):10402-10411.
- Bishara A, Meir M, Portnoy E, Shmuel M, Eyal S: Near infrared imaging of indocyanine green distribution in pregnant mice and effects of concomitant medications. Molecular pharmaceutics 2015.
- Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ: Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence. Neuropsychopharmacology 2015.
- Bolcaen J, Descamps B, Deblaere K, Boterberg T, Pharm FDV, Kalala J-P, Van den Broecke C, Decrock E, Leybaert L, Vanhove C: 18 F-fluoromethylcholine (FCho), 18 F-fluoroethyltyrosine (FET), and 18 F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: A PET study. Nuclear medicine and biology 2015, 42(1):38-45.
- Boonstra MC, Van Driel PB, Van Willigen DM, Stammes MA, Prevoo HA, Tummers QR, Mazar AP, Beekman FJ, Kuppen PJ, Van de Velde CJ: uPAR-targeted multimodal tracer for pre-and intraoperative imaging in cancer surgery. Oncotarget, 2015 2015.
- Boss SD, Betzel T, Müller C, Fischer CR, Haller S, Reber J, Groehn V, Schibli R, Ametamey SM: Comparative Studies of Three Pairs of α-and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18. Bioconjugate chemistry 2015.
- Brendel M, Högenauer M, Delker A, Sauerbeck J, Bartenstein P, Seibyl J, Rominger A: Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction. NeuroImage 2015, 108(0):450-459.
- Brendel M, Jaworska A, Griessinger E, Rotzer C, Burgold S, Gildehaus FJ, Carlsen J, Cumming P, Baumann K, Haass C et al: Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models. PLoS One 2015, 10(2):e0116678.
- Brendel M, Pogarell O, Xiong G, Delker A, Bartenstein P, Rominger A: Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients. European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(5):716-724.
- Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, Buchanan T, Otoul C, Koestler F, Mievis F et al: Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [18F]UCB-H: First-in-Human Study. Molecular Imaging and Biology 2015:1-8.
- Broeders EP, Nascimento EB, Havekes B, Brans B, Roumans KH, Tailleux A, Schaart G, Kouach M, Charton J, Deprez B: The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. Cell metabolism 2015, 22(3):418-426.
- Brownell A-L, Kuruppu D, Kil K-E, Jokivarsi K, Poutiainen P, Zhu A, Maxwell M: PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene. Journal of neuroinflammation 2015, 12(1):217.
- Buchholz H-G, Wenzel F, Gartenschläger M, Thiele F, Young S, Reuss S, Schreckenberger M: Construction and comparative evaluation of different activity detection methods in brain FDG-PET. Biomedical engineering online 2015, 14(1):79.
- Buchsbaum M, DeCastro A: Positron-Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tools for Developing Novel Pharmacotherapeutics for Obesity and Diabetes. In: Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. edn. Edited by Krentz AJ, Heinemann L, Hompesch M: Springer London; 2015: 121-137.
- Caravaggio F, Borlido C, Hahn M, Feng Z, Fervaha G, Gerretsen P, Nakajima S, Plitman E, Chung JK, Iwata Y: Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans. International Journal of Neuropsychopharmacology 2015, 18(7):pyv014.
- Caravaggio F, Raitsin S, Gerretsen P, Nakajima S, Wilson A, Graff-Guerrero A: Ventral striatum binding of a dopamine D 2/3 receptor agonist but not antagonist predicts normal body mass index. Biological psychiatry 2015, 77(2):196-202.
- Carluer L, Mondou A, Buhour M-S, Laisney M, Pélerin A, Eustache F, Viader F, Desgranges B: Neural substrate of cognitive theory of mind impairment in amyotrophic lateral sclerosis. Cortex 2015, 65:19-30.
- Castellano C, Baillargeon J, Nugent S, Tremblay S, Fortier M, Imbeault H, Duval J, Cunnane S: Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance. PloS one 2015, 10(12):e0144116.
- Castillo X, Rosafio K, Wyss MT, Drandarov K, Buck A, Pellerin L, Weber B, Hirt L: A probable dual mode of action for both L-and D-lactate neuroprotection in cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism 2015, 35(10):1561-1569.
- Ceccarini J, Kuepper R, Kemels D, Os J, Henquet C, Van Laere K: [18F] MK‐9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addiction biology 2015, 20(2):357-367.
- Chang CC, Hsiao IT, Huang SH, Lui CC, Yen TC, Chang WN, Huang CW, Hsieh CJ, Chang YY, Lin KJ: 18F-FP-(+)-DTBZ positron emission tomography detection of monoaminergic deficient network in patients with carbon monoxide related parkinsonism. European Journal of Neurology 2015, 22(5):845-e860.
- Chang WH, Lee L-T, Lee IH, Chi MH, Chen KC, Chiu NT, Yao WJ, Chen PS, Yang YK: Which demographic variables are necessary to correct in neuroimaging studies of serotonin transporter availability? A SPECT study with [123I]ADAM. Psychiatry Research: Neuroimaging 2015, 231(3):320-324.
- Chen YJ, Rosario BL, Mowrey W, Laymon CM, Lu X, Lopez OL, Klunk WE, Lopresti BJ, Mathis CA, Price JC: Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET. Journal of Nuclear Medicine 2015, 56(8):1199-1205.
- Cheng N-M, Fang Y-H, Lee L-y, Chang J-C, Tsan D-L, Ng S-H, Wang H-M, Liao C-T, Yang L-Y, Hsu C-H et al: Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(3):419-428.
- Cheng X, Li Z, Liu Z, Navab N, Huang SC, Keller U, Ziegler S, Shi K: Direct Parametric Image Reconstruction in Reduced Parameter Space for Rapid Multi-Tracer PET Imaging. IEEE transactions on medical imaging 2015.
- Cheng Z, Wei R, Wu C, Qing H, Jiang X, Lu H, Chen S, Li X, Xu G, Ai H: Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Nuclear medicine communications 2015.
- Cho S-G, Kim JH, Cho JY, Kim HS, Kwon SY, Bom H-S: Characteristics of anginal patients with high resting myocardial blood flow measured with N-13 ammonia PET/CT. Nuclear medicine communications 2015, 36(6):619-624.
- Choi HS, Kim HJ, Oh J-H, Park H-G, Ra JC, Chang K-A, Suh Y-H: Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson’s disease. Neurobiology of Aging 2015, 36(10):2885-2892.
- Choi JY, Lyoo CH, Kim JS, Kim KM, Kang JH, Choi S-H, Kim J-J, Ryu YH: 18F-Mefway PET Imaging of Serotonin 1A Receptors in Humans: A Comparison with 18F-FCWAY. PloS one 2015, 10(4).
- Choi JY, Song JS, Lee M, Cho W-K, Chung J, Lyoo CH, Kim CH, Park J, Lee KC, Kim KM: P-Glycoprotein, not BCRP, Limits the Brain Uptake of [18F] Mefway in Rodent Brain. Molecular Imaging and Biology 2015:1-7.
- Cicuendez M, Lorenzo-Bosquet C, Cuberas-Borrós G, Martinez-Ricarte F, Cordero E, Martinez-Saez E, Castell-Conesa J, Sahuquillo J: Role of [11 C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours. Clinical neurology and neurosurgery 2015, 139:328-333.
- Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S: Test–retest reproducibility of [11C] PBR28 binding to TSPO in healthy control subjects. European journal of nuclear medicine and molecular imaging 2015:1-11.
- Coughlin JM, Wang Y, Munro CA, Ma S, Yue C, Chen S, Airan R, Kim PK, Adams AV, Garcia C et al: Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study. Neurobiology of Disease 2015, 74(0):58-65.
- Cressier D, Dhilly M, Pham TTC, Fillesoye F, Gourand F, Maïza A, Martins AF, Morfin J-F, Geraldes CF, Tóth É: Gallium-68 Complexes Conjugated to Pittsburgh Compound B: Radiolabeling and Biological Evaluation. Molecular Imaging and Biology 2015:1-10.
- Cui Y, Toyoda H, Sako T, Onoe K, Hayashinaka E, Wada Y, Yokoyama C, Onoe H, Kataoka Y, Watanabe Y: A voxel-based analysis of brain activity in high-order trigeminal pathway in the rat induced by cortical spreading depression. NeuroImage 2015, 108(0):17-22.
- de Laat B, Leurquin-Sterk G, Celen S, Bormans G, Koole M, Van Laere K, Casteels C: Preclinical evaluation and quantification of 18F-FPEB as a radioligand for PET imaging of the metabotropic glutamate receptor 5. Journal of Nuclear Medicine 2015:jnumed. 115.162636.
- Deau E, Robin E, Voinea R, Percina N, Satała G, Fînaru A-L, Chartier A, Tamagnan GD, Alagille D, Bojarski AJ: Rational Design, Pharmacomodulation, Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptors Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain. Journal of medicinal chemistry 2015.
- Di Ciano P, Guranda M, Lagzdins D, Tyndale RF, Gamaleddin I, Selby P, Boileau I, Le Foll B: Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [ 11C]-(+)-PHNO PET Study. Neuropsychopharmacology 2015.
- Di Grigoli G, Monterisi C, Belloli S, Masiello V, Politi LS, Valenti S, Paolino M, Anzini M, Matarrese M, Cappelli A: Radiosynthesis and Preliminary Biological Evaluation of [18 F] VC701, a Radioligand for Translocator Protein. therapy 2015, 2:3.
- Dubroff J, Doot R, Falcone M, Schnoll R, Ray R, Tyndale R, Brody A, Hou C, Schmitz A, Lerman C: Decreased nicotinic receptor availability in smokers with slow rates of nicotine metabolism. Journal of Nuclear Medicine 2015:jnumed. 115.155002.
- Dumas N, Moulin-Sallanon M, Fender P, Tournier BB, Ginovart N, Charnay Y, Millet P: In Vivo Quantification of 5-HT2A Brain Receptors in Mdr1a KO Rats with 123I-R91150 Single-Photon Emission Computed Tomography. Molecular imaging 2015, 14:5-7.
- Dunet V, Klein R, Allenbach G, Renaud J, Prior JO: Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs. J Nucl Cardiol 2015:1-12.
- Elvas F, Vangestel C, Rapic S, Verhaeghe J, Gray B, Pak K, Stroobants S, Staelens S: Characterization of [99mTc] Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis. Molecular Imaging and Biology 2015:1-10.
- Eriksson O, Antoni G: [11 C] Carfentanil Binds Preferentially to µ-Opioid Receptor Subtype 1 Compared to Subtype 2. Molecular imaging 2015, 14.
- Eriksson O, Mikkola K, Espes D, Tuominen L, Virtanen K, Forsbäck S, Haaparanta-Solin M, Hietala J, Solin O, Nuutila P: The Cannabinoid Receptor-1 is an imaging biomarker of Brown Adipose Tissue. Journal of Nuclear Medicine 2015:jnumed. 115.156422.
- Evans E, Buonincontri G, Izquierdo D, Methner C, Hawkes RC, Ansorge RE, Krieg T, Carpenter TA, Sawiak SJ: Combining MRI with PET for partial volume correction improves image-derived input functions in mice. IEEE transactions on nuclear science 2015, 62(3 Pt 1):628-633.
- Fiz F, Morbelli S, Piccardo A, Bauckneht M, Ferrarazzo G, Pestarino E, Cabria M, Democrito A, Riondato M, Villavecchia G: 18F-NaF uptake by the atherosclerotic plaque at PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity. Journal of Nuclear Medicine 2015:jnumed. 115.154229.
- Freeby MJ, Kringas P, Goland RS, Leibel RL, Maffei A, Divgi C, Ichise M, Harris PE: Cross-sectional and Test-Retest Characterization of PET with [18F] FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes. Molecular Imaging and Biology 2015:1-10.
- Freesmeyer M, Kühnel C, Westphal J: Time efficient 124I-PET volumetry in benign thyroid disorders by automatic isocontour procedures: mathematic adjustment using manual contoured measurements in low-dose CT. Annals of Nuclear Medicine 2015, 29(1):8-14.
- Fresneau N, Dumas N, Tournier BB, Fossey C, Ballandonne C, Lesnard A, Millet P, Charnay Y, Cailly T, Bouillon J-P et al: Design of a serotonin 4 receptor radiotracer with decreased lipophilicity for single photon emission computed tomography. European Journal of Medicinal Chemistry 2015, 94(0):386-396.
- Frings L, Hellwig S, Spehl TS, Bormann T, Buchert R, Vach W, Minkova L, Heimbach B, Klöppel S, Meyer PT: Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer’s disease. Brain 2015, 138(10):3089-3099.
- Frokjaer VG, Pinborg A, Holst KK, Overgaard A, Henningsson S, Heede M, Larsen EC, Jensen PS, Agn M, Nielsen AP: Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study. Biological psychiatry 2015.
- Fukuyama Y, Yuki Y, Katakai Y, Harada N, Takahashi H, Takeda S, Mejima M, Joo S, Kurokawa S, Sawada S: Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal immunology 2015.
- García-Casares N, García-Arnés JA, Rioja J, Ariza MJ, Gutiérrez A, Alfaro F, Nabrozidis A, González-Alegre P, González-Santos P: Alzheimer’s like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients. Journal of Diabetes and its Complications 2015.
- García-García L, Delgado M, Al-Sayed A, Bascuñana P, Fernández de la Rosa R, Bermejo-Bescós P, Martín-Aragón S, Pozo M: In Vivo [18F] FDG PET Imaging Reveals that p-Chloroamphetamine Neurotoxicity is Associated with Long-Term Cortical and Hippocampal Hypometabolism. Molecular Imaging and Biology 2015, 17(2):239-247.
- García-García L, Shiha AA, Bascuñana P, de Cristóbal J, de la Rosa RF, Delgado M, Pozo MA: Serotonin Depletion Does not Modify the Short-Term Brain Hypometabolism and Hippocampal Neurodegeneration Induced by the Lithium–Pilocarpine Model of Status Epilepticus in Rats. Cellular and molecular neurobiology 2015:1-7.
- Gheysens O, Postnov A, Deroose CM, Vandermeulen C, de Hoon J, Declercq R, Dennie J, Mixson L, De Lepeleire I, Van Laere K: Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT. Journal of Nuclear Medicine 2015, 56(10):1520-1526.
- Gietl AF, Warnock G, Riese F, Kälin AM, Saake A, Gruber E, Leh SE, Unschuld PG, Kuhn FP, Burger C: Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner. Neurobiology of aging 2015, 36(4):1619-1628.
- Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA: Feasibility of 18F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times. Journal of Nuclear Medicine 2015:jnumed. 115.160168.
- Hae Kang J, Lee M, Hoon Ryu Y, Hyoung Lyoo C, Hoon Kim C, Chul Lee K, Hyun Choi T, Yong Choi J: [18F]FPEB and [18F]FDEGPECO comparative study of mGlu5 quantification in rodent brain. Applied Radiation and Isotopes 2015, 98(0):103-107.
- Han JH, Lim SY, Lee MS, Lee WW: Sodium [18F] Fluoride PET/CT in Myocardial Infarction. Molecular Imaging and Biology 2015, 17(2):214-221.
- Hansen AE, Petersen AL, Henriksen JR, Boerresen B, Rasmussen P, Elema DR, Rosenschoeld PM, Kristensen AT, Kjær A, Andresen TL: Positron Emission Tomography based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer using Copper-64 Liposomes. ACS Nano 2015.
- Hanssen MJ, Broeders E, Samms RJ, Vosselman MJ, van der Lans AA, Cheng CC, Adams AC, van Marken Lichtenbelt WD, Schrauwen P: Serum FGF21 levels are associated with brown adipose tissue activity in humans. Scientific reports 2015, 5.
- Hanssen MW, Wierts R, Hoeks J, Gemmink A, Brans B, Mottaghy F, Schrauwen P, van Marken Lichtenbelt W: Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance. Diabetologia 2015, 58(3):586-595.
- Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Hiraoka K, Watanuki S, Shidahara M, Miyake M et al: [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2015:1-10.
- Harrison S, Tyrer A, Levitan R, Xu X, Houle S, Wilson A, Nobrega J, Rusjan P, Meyer J: Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex. Acta Psychiatrica Scandinavica 2015.
- Hatano K, Sekimata K, Yamada T, Abe J, Ito K, Ogawa M, Magata Y, Toyohara J, Ishiwata K, Biggio G: Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides,[11C] CB184 and [11C] CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [11C](R)-PK11195. Annals of nuclear medicine 2015, 29(4):325-335.
- Heinzel A, Shali SM, Dafotakis M, Verburg FA, Mottaghy FM, Winz OH: Comparison of automatic versus manual procedures for the quantification of dopamine D2 receptor availability using I-123-IBZM-SPECT. Nuclear medicine communications 2015, 36(11):1120-1126.
- Hendrikx G, De Saint-Hubert M, Dijkgraaf I, Bauwens M, Douma K, Wierts R, Pooters I, Van den Akker N, Hackeng T, Post M et al: Molecular imaging of angiogenesis after myocardial infarction by 111In-DTPA-cNGR and 99mTc-sestamibi dual-isotope myocardial SPECT. EJNMMI research 2015, 5(1):1-10.
- Henriksen JR, Petersen AL, Hansen AE, Frankær CG, Harris P, Elema DR, Kristensen AT, Kjær A, Andresen TL: Remote Loading of 64Cu2+ into Liposomes without the Use of Ion Transport Enhancers. ACS applied materials & interfaces 2015, 7(41):22796-22806.
- Hernaus D, Collip D, Kasanova Z, Winz O, Heinzel A, van Amelsvoort T, Shali S, Booij J, Rong Y, Piel M: No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder. Translational psychiatry 2015, 5(4):e547.
- Hickey RD, Mao SA, Amiot B, Suksanpaisan L, Miller A, Nace R, Glorioso J, O’Connor MK, Peng KW, Ikeda Y: Noninvasive 3‐dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene. Liver Transplantation 2015, 21(4):442-453.
- Hiraoka K, Narita W, Kikuchi H, Baba T, Kanno S, Iizuka O, Tashiro M, Furumoto S, Okamura N, Furukawa K: Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus. Journal of the neurological sciences 2015, 356(1):124-128.
- Hiraoka K, Tashiro M, Grobosch T, Maurer M, Oda K, Toyohara J, Ishii K, Ishiwata K, Yanai K: Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine. Expert opinion on drug safety 2015, 14(2):199-206.
- Hjorth S, Karlsson C, Jucaite A, Varnäs K, Hamrén UW, Johnström P, Gulyás B, Donohue SR, Pike VW, Halldin C: A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. Neuropharmacology 2015.
- Holub J, Meckel M, Kubíček V, Rösch F, Hermann P: Gallium (III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imaging. Contrast media & molecular imaging 2015, 10(2):122-134.
- Holvoet B, Quattrocelli M, Belderbos S, Pollaris L, Wolfs E, Gheysens O, Gijsbers R, Vanoirbeek J, Verfaillie CM, Sampaolesi M: Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice. Stem cell reports 2015, 5(6):1183-1195.
- Hong J, Lu S, Xu R, Liow J-S, Woock AE, Jenko KJ, Gladding RL, Zoghbi SS, Innis RB, Pike VW: [carbonyl-11 C] 4-Fluoro-N-methyl-N-(4-(6-(methylamino) pyrimidin-4-yl) thiazol-2-yl) benzamide ([11 C] FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain. Nuclear medicine and biology 2015.
- Hosokawa C, Ishii K, Kimura Y, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, Yamazoe Y, Murakami T: Performance of 11C-PiB PET binding potential images in the equivocal static images in the detection of amyloid deposits. Journal of Nuclear Medicine 2015:jnumed. 115.156414.
- Hou M, Acton PD: Understanding the tampon density and density gradient through computed tomography imaging. Textile Research Journal 2015:0040517515595026.
- Hovhannisyan N, Guillouet S, Fillesoye F, Dhilly M, Patin D, Galateau F, Leporrier M, Barré L: Evaluation of the specificity of [18F] fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F] FDG and impact of rituximab therapy. EJNMMI research 2015, 5.
- Huang C-C, Pan W-Y, Tseng MT, Lin K-J, Yang Y-P, Tsai H-W, Hwang S-M, Chang Y, Wei H-J, Sung H-W: Enhancement of cell adhesion, retention, and survival of HUVEC/cbMSC aggregates that are transplanted in ischemic tissues by concurrent delivery of an antioxidant for therapeutic angiogenesis. Biomaterials 2015.
- Huang C-C, Wei H-J, Lin K-J, Lin W-W, Wang C-W, Pan W-Y, Hwang S-M, Chang Y, Sung H-W: Multimodality noninvasive imaging for assessing therapeutic effects of exogenously transplanted cell aggregates capable of angiogenesis on acute myocardial infarction. Biomaterials 2015, 73:12-22.
- Huang C-Y, Liu C-H, Tsao E, Hsieh C-J, Weng Y-H, Hsiao T, Yen T-C, Lin K-J, Huang C-C: Chronic manganism: A long-term follow-up study with a new dopamine terminal biomarker of 18 F-FP-(+)-DTBZ (18 F-AV-133) brain PET scan. Journal of the neurological sciences 2015, 353(1):102-106.
- Huang S-y, Bolch W, Lee C, Van Brocklin H, Pampaloni M, Hawkins R, Sznewajs A, DuBois S, Matthay K, Seo Y: Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma. Molecular Imaging and Biology 2015, 17(2):284-294.
- Hwang D-R, Hu E, Allen JR, Davis C, Treanor J, Miller S, Chen H, Shi B, Narayanan TK, Barret O: Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18 F] AMG 580 in non-human primates. Nuclear medicine and biology 2015.
- Iguchi Y, Michiue H, Kitamatsu M, Hayashi Y, Takenaka F, Nishiki T-i, Matsui H: Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model. Biomaterials 2015, 56:10-17.
- Ikoma Y, Sasaki T, Kimura Y, Seki C, Okubo Y, Suhara T, Ito H: Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with 18F-FE-PE2I. Annals of nuclear medicine 2015:1-12.
- Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, Joshi FR, Gallagher FA, Warburton EA, Bennett MR: Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography. Nature communications 2015, 6.
- Ishibashi K, Miura Y, Ishikawa K, Ishii K, Ishiwata K: Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A 11 C-ITMM PET study. Journal of the neurological sciences 2015, 355(1):202-205.
- Ishiki A, Okamura N, Furukawa K, Furumoto S, Harada R, Tomita N, Hiraoka K, Watanuki S, Ishikawa Y, Tago T: Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18 F] THK-5117 Positron Emission Tomography. PloS one 2015, 10(10):e0140311.
- Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY: The Alzheimer’s Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimer’s & dementia : the journal of the Alzheimer’s Association 2015, 11(7):757-771.
- Jahan M, Johnström P, Nag S, Takano A, Korsgren O, Johansson L, Halldin C, Eriksson O: Synthesis and biological evaluation of [11C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver. Nuclear Medicine and Biology 2015, 42(4):387-394.
- Jennings D, Seibyl J, Sabbagh M, Lai F, Hopkins W, Bullich S, Gimenez M, Reininger C, Putz B, Stephens A: Age dependence of brain β-amyloid deposition in Down syndrome An [18F] florbetaben PET study. Neurology 2015, 84(5):500-507.
- Jochimsen TH, Schulz J, Busse H, Werner P, Schaudinn A, Zeisig V, Kurch L, Seese A, Barthel H, Sattler B: Lean body mass correction of standardized uptake value in simultaneous whole-body positron emission tomography and magnetic resonance imaging. Physics in medicine and biology 2015, 60(12):4651.
- Kanazawa M, Ohba H, Harada N, Kakiuchi T, Muramatsu S-i, Tsukada H: Evaluation of 6-11C-Methyl-m-tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11-L-DOPA and 18F-FDOPA in Parkinson’s Disease Monkeys. Journal of Nuclear Medicine 2015:jnumed. 115.161802.
- Kanazawa M, Ohba H, Iwazaki A, Kakiuchi T, Tsukada H: Synthesis of 6-[11C]methyl-m-tyrosine ([11C]6MemTyr) for dopamine synthesis imaging in living brain using PET. Bioorganic & Medicinal Chemistry 2015, 23(4):729-734.
- Kang JH, Lee M, Ryu YH, Lyoo CH, Kim CH, Lee KC, Choi TH, Choi JY: [18 F] FPEB and [18 F] FDEGPECO comparative study of mGlu5 quantification in rodent brain. Applied Radiation and Isotopes 2015, 98:103-107.
- Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S, Salminen P, Nuutila P, Nummenmaa L: Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain. The Journal of Neuroscience 2015, 35(9):3959-3965.
- Kawamura K, Shimoda Y, Kumata K, Fujinaga M, Yui J, Yamasaki T, Xie L, Hatori A, Wakizaka H, Kurihara Y: In vivo evaluation of a new 18 F-labeled PET ligand,[18 F] FEBU, for the imaging of I 2-imidazoline receptors. Nuclear medicine and biology 2015, 42(4):406-412.
- Kikuta S, Nakamura Y, Yamamura Y, Tamura A, Homma N, Yanagawa Y, Tamura H, Kasahara J, Osanai M: Quantitative activation-induced manganese-enhanced MRI reveals severity of Parkinson’s disease in mice. Scientific reports 2015, 5.
- Kim CH, Lee KC, Choi TH, Choi JY: Jee Hae Kang, Minkyung Lee b, Young Hoon Ryu c, Chul Hyoung Lyoo d. Applied Radiation and Isotopes 2015, 98:103-107.
- Kim D-H, Jung J-h, Son SH, Kim C-Y, Jeong SY, Lee S-W, Lee J, Ahn B-C: Quantification of Intratumoral Metabolic Macroheterogeneity on 18F-FDG PET/CT and Its Prognostic Significance in Pathologic N0 Squamous Cell Lung Carcinoma. Clinical nuclear medicine 2015.
- Kim D-Y, Kim HS, Min J-J: Radiosynthesis and evaluation of 18F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography. Nuclear medicine communications 2015.
- Kim D-Y, Kim HS, Reder S, Zheng JH, Herz M, Higuchi T, Pyo A, Bom H-S, Schwaiger M, Min J-J: Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging. Journal of Nuclear Medicine 2015, 56(10):1581-1586.
- Kim D-Y, Min J-J: Synthesis and Evaluation of 18F-Labeled Fluoroalkyl Triphenylphosphonium Salts as Mitochondrial Voltage Sensors in PET Myocardial Imaging. In: Mitochondrial Medicine. Volume 1265, edn. Edited by Weissig V, Edeas M: Springer New York; 2015: 59-72.
- Kim J-H, Son Y-D, Kim J-H, Choi E-J, Lee S-Y, Joo Y-H, Kim Y-B, Cho Z-H: Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study. Brain research 2015, 1629:63-71.
- Kim JS, Kang SH, Moon HS, Lee ES, Kim SH, Sung JK, Lee BS, Jeong HY, Chung WS: Impact of Bowel Preparation Quality on Adenoma Identification During Colonoscopy and Optimal Timing of Surveillance. Digestive diseases and sciences 2015, 60(10):3092-3099.
- Kim K, Son YD, Bresler Y, Cho ZH, Ra JB, Ye JC: Dynamic PET reconstruction using temporal patch-based low rank penalty for ROI-based brain kinetic analysis. Physics in medicine and biology 2015, 60(5):2019.
- Kimura Y, Ichise M, Ito H, Shimada H, Ikoma Y, Seki C, Takano H, Kitamura S, Shinotoh H, Kawamura K: PET Quantification of Tau Pathology in Human Brain with 11C-PBB3. Journal of Nuclear Medicine 2015, 56(9):1359-1365.
- Knešaurek K: Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer’s Disease Studies. World journal of nuclear medicine 2015, 14(3):171.
- Knudsen GM, Jensen PS, Erritzoe D, Baaré WF, Ettrup A, Fisher PM, Gillings N, Hansen HD, Hansen LK, Hasselbalch SG: The Center for Integrated Molecular Brain Imaging (Cimbi) database. NeuroImage 2015.
- Kobayashi K, Sasaki T, Takenaka F, Yakushiji H, Fujii Y, Kishi Y, Kita S, Shen L, Kumon H, Matsuura E: A Novel PET Imaging Using 64 Cu-Labeled Monoclonal Antibody against Mesothelin Commonly Expressed on Cancer Cells. Journal of immunology research 2015, 2015.
- Koyasu S, Tsuji Y, Harada H, Nakamoto Y, Nobashi T, Kimura H, Sano K, Koizumi K, Hamaji M, Togashi K: Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and 18F Misonidazole PET in Murine Tumor Models. Radiology 2015:150416.
- Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S et al: High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People. Biol Psychiatry 2015, 78(8):525-533.
- Kreisl WC, Bhatia R, Morse CL, Woock AE, Zoghbi SS, Shetty HU, Pike VW, Innis RB: Increased Permeability-Glycoprotein Inhibition at the Human Blood–Brain Barrier Can Be Safely Achieved by Performing PET During Peak Plasma Concentrations of Tariquidar. Journal of Nuclear Medicine 2015, 56(1):82-87.
- Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA: Volumetric Modulated Arc Therapy Planning for Primary Prostate Cancer With Selective Intraprostatic Boost Determined by 18 F-Choline PET/CT. International Journal of Radiation Oncology* Biology* Physics 2015, 91(5):1017-1025.
- Kuhn FP, Warnock G, Schweingruber T, Sommerauer M, Buck A, Khan N: Quantitative H 2 [15 O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization. Journal of Stroke and Cerebrovascular Diseases 2015, 24(5):965-971.
- Lange C, Kurth J, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Hesse S: Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy. European radiology 2015:1-9.
- Lapa C, Spehl TS, Brumberg J, Isaias IU, Schlögl S, Lassmann M, Herrmann K, Meyer PT: Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I] FP-CIT. American journal of nuclear medicine and molecular imaging 2015, 5(3):278-286.
- Lavisse S, Inoue K, Jan C, Peyronneau MA, Petit F, Goutal S, Dauguet J, Guillermier M, Dollé F, Rbah-Vidal L et al: [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain. European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(3):478-494.
- Le Foll B, Payer D, Di Ciano P, Guranda M, Nakajima S, Tong J, Mansouri E, Wilson AA, Houle S, Meyer JH: Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [ 11C]-(+)-PHNO PET Study in Humans. Neuropsychopharmacology 2015.
- Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C: Relation of Dopamine Receptor 2 Binding to Pain Perception in Female Fibromyalgia Patients with and without Depression–an [11 C] raclopride PET-study. European Neuropsychopharmacology 2015.
- Lee DE, Yue X, Ibrahim WG, Lentz MR, Peterson KL, Jagoda EM, Kassiou M, Maric D, Reid WC, Hammoud DA: Lack of neuroinflammation in the HIV-1 transgenic rat: an [18 F]-DPA714 PET imaging study. Journal of neuroinflammation 2015, 12(1):171.
- Lee L-T, Tsai HC, Chi MH, Chang WH, Chen KC, Lee IH, Chen PS, Yao WJ, Chiu NT, Yang YK: Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study. International clinical psychopharmacology 2015, 30(3):175-178.
- Lee M, Ryu YH, Cho WG, Kang YW, Lee SJ, Jeon TJ, Lyoo CH, Kim CH, Kim DG, Lee K et al: Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system. Synapse 2015, 69(9):453-460.
- Li CT, Tu PC, Hsieh JC, Lee HC, Bai YM, Tsai CF, Wang SJ, Hsu JW, Huang KL, Hong CJ: Functional dysconnection in the prefrontal–amygdala circuitry in unaffected siblings of patients with bipolar I disorder. Bipolar disorders 2015, 17(6):626-635.
- Li C-T, Su T-P, Wang S-J, Tu P-C, Hsieh J-C: Prefrontal glucose metabolism in medication-resistant major depression. The British Journal of Psychiatry 2015, 206(4):316-323.
- Li F, Jørgensen JT, Madsen J, Kjaer A: Pharmacokinetic Analysis of 64Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice. Diagnostics 2015, 5(2):96-112.
- Lin C-Y, Wang Y-H, Li K-C, Sung L-Y, Yeh C-L, Lin K-J, Yen T-C, Chang Y-H, Hu Y-C: Healing of massive segmental femoral bone defects in minipigs by allogenic ASCs engineered with FLPo/Frt-based baculovirus vectors. Biomaterials 2015, 50:98-106.
- Lin H-C, Li C-T, Tat-Wei Tan D, Cheng C-W, Chou T-K, Kong F-L, Yu T-H, Huang W-S, Su D-P, Liu R-S: Non-Linear Alteration of Serotonin Transport Availability in Posttraumatic Stress Disorder Measured with 4-[18F] ADAM Positron Emission Tomography. Current Molecular Imaging 2015, 4(1):57-64.
- Lin S-H, Chen KC, Lee S-Y, Chiu NT, Lee IH, Chen PS, Yeh TL, Lu R-B, Chen C-C, Liao M-H et al: The association between heroin expenditure and dopamine transporter availability—A single-photon emission computed tomography study. Psychiatry Research: Neuroimaging 2015, 231(3):292-297.
- Lin S-H, Lee IH, Chen KC, Chen PS, Chiu NT, Yao WJ, Yang YK: Serotonin transporter availability may moderate the association between perceiving stress and depressive tendencies—A SPECT with 5-HTTLPR genotyping study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2015, 61:24-29.
- Liu L, Collier AC, Link JM, Domino KB, Mankoff DA, Eary JF, Spiekerman CF, Hsiao P, Deo AK, Unadkat JD: Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: a PET Imaging Study. Drug Metabolism and Disposition 2015:dmd. 114.058685.
- Liu S, Cai W, Liu S, Zhang F, Fulham M, Feng D, Pujol S, Kikinis R: Multimodal neuroimaging computing: the workflows, methods, and platforms. Brain Informatics 2015, 2(3):181-195.
- Lohmann P, Herzog H, Rota Kops E, Stoffels G, Judov N, Filss C, Galldiks N, Tellmann L, Weiss C, Sabel M et al: Dual-time-point O-(2-[18F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas. European radiology 2015:1-8.
- Lyoo CH, Ikawa M, Liow J-S, Zoghbi SS, Morse CL, Pike VW, Fujita M, Innis RB, Kreisl WC: Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein. Journal of Nuclear Medicine 2015, 56(5):701-706.
- Maier FC, Keller MD, Bukala D, Bender B, Mannheim JG, Brereton IM, Galloway GJ, Pichler BJ: Quantification of β-Amyloidosis and rCBF with Dedicated PET, 7 T MR Imaging, and High-Resolution Microscopic MR Imaging at 16.4 T in APP23 Mice. Journal of Nuclear Medicine 2015, 56(10):1593-1599.
- Martignani C, Diemberger I, Nanni C, Biffi M, Ziacchi M, Boschi S, Corzani A, Fanti S, Sambuceti G, Boriani G: Cardiac resynchronization therapy and cardiac sympathetic function. European journal of clinical investigation 2015, 45(8):792-799.
- Martín A, Szczupak B, Gómez-Vallejo V, Domercq M, Cano A, Padro D, Muñoz C, Higuchi M, Matute C, Llop J: In Vivo PET Imaging of the α4β2 Nicotinic Acetylcholine Receptor As a Marker for Brain Inflammation after Cerebral Ischemia. The Journal of Neuroscience 2015, 35(15):5998-6009.
- Martín A, Vázquez-Villoldo N, Gómez-Vallejo V, Padro D, Soria FN, Szczupak B, Plaza-García S, Arrieta A, Reese T, Llop J: In vivo imaging of system xc-as a novel approach to monitor multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging 2015:1-15.
- Martínez-Vélez N, Xipell E, Vera B, Zalacain M, Marrodan L, Gonzalez-Huarriz M, Toledo G, Cascallo M, Alemany R, Patiño-García A: The oncolytic adenovirus VCN-01 as therapeutic approach against pediatric osteosarcoma. Clinical Cancer Research 2015:clincanres. 1899.2015.
- Mathur A, Sharma AK, Murhekar V, Mallia MB, Pawade S, Sarma H, Chaudhari P, Sachdev S, Banerjee S: Syntheses and biological evaluation of 99m Tc-HYNIC-fatty acid complexes for myocardial imaging. RSC Advances 2015, 5(113):93374-93385.
- Mazère J, Mayo W, Pariscoat G, Schulz J, Allard M, Fernandez P, Lamare F: Simplified quantification method for in vivo SPECT imaging of the Vesicular Acetylcholine Transporter with 123I-IBVM. Journal of Nuclear Medicine 2015:jnumed. 114.147074.
- Médoc M, Dhilly M, Matesic L, Toutain J, Krause-Heuer AM, Delamare J, Fraser BH, Touzani O, Barré L, Greguric I: In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F] ML-10 in a Stroke Model in the Rat. Molecular Imaging and Biology 2015:1-10.
- Melasch J, Rullmann M, Hilbert A, Luthardt J, Becker G, Patt M, Villringer A, Arelin K, Meyer P, Lobsien D: The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight. International Journal of Obesity 2015.
- Mena-Romano P, Cheng C, Glowa C, Peschke P, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A, Karger CP: Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic 18F-FMISO-Pet-Ct and quantitative histology. American journal of nuclear medicine and molecular imaging 2015, 5(4):348.
- Milan E, Gallo L, Sartorello A, Giubbini R: Regadenoson vs Dypiridamole in the quantification of Myocardial Blood Flow. Initial Italian experience. Journal of Nuclear Medicine 2015, 56(supplement 3):1533-1533.
- Mirbolooki MR, Schade KN, Constantinescu CC, Pan ML, Mukherjee J: Enhancement of 18F‐fluorodeoxyglucose metabolism in rat brain frontal cortex using a β3 adrenoceptor agonist. Synapse 2015, 69(2):96-98.
- Mizutani A, Matsunari I, Kobayashi M, Nishi K, Fujita W, Miyazaki Y, Nekolla SG, Kawai K: Impact of injection dose, post-reconstruction filtering, and collimator choice on image quality of myocardial perfusion SPECT using cadmium-zinc telluride detectors in the rat. EJNMMI Phys 2015, 2(1):1-17.
- Molinet-Dronda F, Gago B, Quiroga-Varela A, Juri C, Collantes M, Delgado M, Prieto E, Ecay M, Iglesias E, Marín C et al: Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson’s disease: A longitudinal in-vivo study. Neurobiology of Disease 2015, 77(0):165-172.
- Mondal S, Roy D, Camacho-Pereira J, Khurana A, Chini E, Yang L, Baddour J, Stilles K, Padmabandu S, Leung S et al: HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget 2015.
- Moody JB, Lee BC, Corbett JR, Ficaro EP, Murthy VL: Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective. J Nucl Cardiol 2015:1-17.
- Moody JB, Murthy VL, Lee BC, Corbett JR, Ficaro EP: Variance Estimation for Myocardial Blood Flow by Dynamic PET. IEEE transactions on medical imaging 2015, 34(11):2343-2353.
- Morales A, Kohno M, Robertson C, Dean A, Mandelkern M, London E: Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Molecular psychiatry 2015, 20(6):764-771.
- Morgan DA, McDaniel LN, Yin T, Khan M, Jiang J, Acevedo MR, Walsh SA, Ponto LLB, Norris AW, Lutter M: Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus. Diabetes 2015, 64(6):1976-1987.
- Mukherjee J, Bajwa AK, Wooten DW, Hillmer AT, Pan ML, Pandey SK, Saigal N, Christian BT: Comparative assessment of 18F‐Mefway as a serotonin 5‐HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans. Journal of Comparative Neurology 2015.
- Mukherjee J, Constantinescu CC, Hoang AT, Jerjian T, Majji D, Pan ML: Dopamine D3 receptor binding of 18F‐Fallypride: Evaluation using in vitro and in vivo PET imaging studies. Synapse 2015.
- Muller I: Innovation Delivered. Immunology 2015.
- Muylle K, Flamen P, Vugts DJ, Guiot T, Ghanem G, Meuleman N, Bourgeois P, Vanderlinden B, van Dongen GA, Everaert H: Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab. European journal of nuclear medicine and molecular imaging 2015:1-11.
- Muzi M, Peterson LM, O’Sullivan JN, Fink JR, Rajendran JG, McLaughlin LJ, Muzi JP, Mankoff DA, Krohn KA: 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions. Journal of Nuclear Medicine 2015, 56(8):1223-1228.
- Nag S, Fazio P, Lehmann L, Kettschau G, Heinrich T, Thiele A, Svedberg M, Amini N, Leesch S, Catafau A: In Vivo/In Vitro Characterisation of a Novel MAO-B Inhibitor Radioligand, Fluorine-18 Labeled Deuterated Fluorodeprenyl (18F-Fluorodeprenyl-D2). Journal of Nuclear Medicine 2015:jnumed. 115.161083.
- Nahimi A, Jakobsen S, Munk OL, Vang K, Phan JA, Rodell A, Gjedde A: Mapping α2 Adrenoceptors of the Human Brain with 11C-Yohimbine. Journal of Nuclear Medicine 2015, 56(3):392-398.
- Nakajima S, Caravaggio F, Boileau I, Chung JK, Plitman E, Gerretsen P, Wilson AA, Houle S, Mamo DC, Graff-Guerrero A: Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study. J Cereb Blood Flow Metab 2015, 35(11):1812-1818.
- Nakajima S, Caravaggio F, Mamo DC, Mulsant BH, Chung JK, Plitman E, Iwata Y, Gerretsen P, Uchida H, Suzuki T: Dopamine D 2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia—A [11 C]-raclopride PET study. Schizophrenia research 2015, 164(1):263-267.
- Neveu M-A, Bol V, Bol A, Bouzin C, Grégoire V, Feron O, Jordan BF, Gallez B: The increase in tumor oxygenation under carbogen breathing induces a decrease in the uptake of [18 F]-fluoro-deoxy-glucose. Radiotherapy and Oncology 2015.
- Nguyen DH, Chou PY, Hsieh YH, Momeni A, Fang YHD, Patel KM, Yang CY, Cheng MH: Quantity of lymph nodes correlates with improvement in lymphatic drainage in treatment of hind limb lymphedema with lymph node flap transfer in rats. Microsurgery 2015.
- Nieto E, Delgado M, Sobrado M, de Ceballos ML, Alajarín R, García-García L, Kelly J, Lizasoain I, Pozo MA, Álvarez-Builla J: Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18 F] fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke. European journal of medicinal chemistry 2015, 101:604-615.
- Nishiyama S, Ohba H, Kanazawa M, Kakiuchi T, Tsukada H: Comparing α7 nicotinic acetylcholine receptor binding, amyloid‐β deposition, and mitochondria complex‐I function in living brain: A PET study in aged monkeys. Synapse 2015, 69(10):475-483.
- North AJ, Hayne DJ, Schieber C, Price K, White AR, Crouch PJ, Rigopoulos A, O’Keefe GJ, Tochon-Danguy H, Scott AM: Toward Hypoxia-Selective Rhenium and Technetium Tricarbonyl Complexes. Inorganic Chemistry 2015.
- Nugent S, Castellano C, Bocti C, Dionne I, Fulop T, Cunnane S: Relationship of metabolic and endocrine parameters to brain glucose metabolism in older adults: do cognitively-normal older adults have a particular metabolic phenotype? Biogerontology 2015:1-15.
- Nummenmaa L, Manninen S, Tuominen L, Hirvonen J, Kalliokoski KK, Nuutila P, Jääskeläinen IP, Hari R, Dunbar RIM, Sams M: Adult attachment style is associated with cerebral μ-opioid receptor availability in humans. Human brain mapping 2015, 36(9):3621-3628.
- Oborski M, Laymon C, Lieberman F, Drappatz J, Mountz J: A DCE-MRI based approach to FLT PET ROI definition for early therapy response assessment in GBM. Journal of Nuclear Medicine 2015, 56(supplement 3):1788-1788.
- Ofori E, Pasternak O, Planetta PJ, Burciu R, Snyder A, Febo M, Golde TE, Okun MS, Vaillancourt DE: Increased free water in the substantia nigra of Parkinson’s disease: a single-site and multi-site study. Neurobiology of aging 2015, 36(2):1097-1104.
- Oi N, Tokunaga M, Suzuki M, Nagai Y, Nakatani Y, Yamamoto N, Maeda J, Minamimoto T, Zhang M-R, Suhara T: Development of Novel PET Probes for Central 2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic Acid Receptors. Journal of medicinal chemistry 2015, 58(21):8444-8462.
- Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED: Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but not Methamphetamine-Dependent Individuals. International Journal of Neuropsychopharmacology 2015:pyv129.
- Oliveira FP, Castelo-Branco M: Computer-aided diagnosis of Parkinson’s disease based on [123I] FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines. Journal of neural engineering 2015, 12(2):026008.
- Ory D, Planas A, Dresselaers T, Gsell W, Postnov A, Celen S, Casteels C, Himmelreich U, Debyser Z, Van Laere K: PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide. Nuclear medicine and biology 2015, 42(10):753-761.
- Ory D, Postnov A, Koole M, Celen S, de Laat B, Verbruggen A, Van Laere K, Bormans G, Casteels C: Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F] DPA-714 PET. European journal of nuclear medicine and molecular imaging 2015:1-10.
- Ota M, Ogawa S, Kato K, Masuda C, Kunugi H: Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [18 F] fallypride. Neuroscience research 2015.
- Ota M, Ogawa S, Kato K, Wakabayashi C, Kunugi H: Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: A positron emission tomography using [18 F] fallypride. Psychiatry Research: Neuroimaging 2015, 232(1):92-97.
- Pagani M, De Carli F, Morbelli S, Öberg J, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BNM et al: Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer’s disease from healthy controls. A European Alzheimer’s Disease Consortium (EADC) study. NeuroImage: Clinical 2015, 7(0):34-42.
- Park HS, Kim E, Moon BS, Lim NH, Lee BC, Kim SE: In Vivo Tissue Pharmacokinetics of Carbon-11-Labeled Clozapine in Healthy Volunteers: A Positron Emission Tomography Study. CPT: Pharmacometrics & Systems Pharmacology 2015, 4(5):305-311.
- Park JH, Lee YK, Kim DH, Kim SJ, Lee J-H, Jeon TJ, Ryu YH, Lee JD: Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Monitoring Adhesive Capsulitis After Breast Cancer Treatment. Journal of computer assisted tomography 2015, 39(3):349-355.
- Parthoens J, Servaes S, Verhaeghe J, Stroobants S, Staelens S: Prelimbic Cortical Injections of a GABA Agonist and Antagonist: In Vivo Quantification of the Effect in the Rat Brain Using [18F] FDG MicroPET. Molecular Imaging and Biology 2015:1-9.
- Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y: [11C]‐(+)‐PHNO PET imaging of dopamine D2/3 receptors in Parkinson’s disease with impulse control disorders. Movement Disorders 2015, 30(2):160-166.
- Perrotin A, Desgranges B, Landeau B, Mézenge F, La Joie R, Egret S, Pélerin A, de la Sayette V, Eustache F, Chételat G: Anosognosia in Alzheimer disease: Disconnection between memory and self‐related brain networks. Annals of neurology 2015, 78(3):477-486.
- Peters M, Willems P, Weijers R, Wierts R, Jutten L, Urbach C, Arts C, van Rhijn L, Brans B: Pseudarthrosis after lumbar spinal fusion: the role of 18F-fluoride PET/CT. European journal of nuclear medicine and molecular imaging 2015, 42(12):1891-1898.
- Peters MJ, Wierts R, Jutten EM, Halders SG, Willems PC, Brans B: Evaluation of a short dynamic 18F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics. Annals of Nuclear Medicine 2015:1-11.
- Petrik M, Zhai C, Novy Z, Urbanek L, Haas H, Decristoforo C: In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores. Molecular Imaging and Biology 2015:1-9.
- Pierce II LA, Elston BF, Clunie DA, Nelson D, Kinahan PE: A Digital Reference Object to Analyze Calculation Accuracy of PET Standardized Uptake Value. Radiology 2015.
- Pifferi F, Dorieux O, Castellano C-A, Croteau E, Masson M, Guillermier M, Van Camp N, Guesnet P, Alessandri J-M, Cunnane S: Long-chain n-3 PUFAs from fish oil enhance resting state brain glucose utilization and reduce anxiety in an adult nonhuman primate, the grey mouse lemur. Journal of lipid research 2015, 56(8):1511-1518.
- Placzek MS, Van de Bittner GC, Wey H-Y, Lukas SE, Hooker JM: Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET. Neuropsychopharmacology 2015.
- Ponto LLB, Brashers-Krug TM, Pierson RK, Menda Y, Acion L, Watkins GL, Sunderland JJ, Koeppel JA, Jorge RE: Preliminary Investigation of Cerebral Blood Flow and Amyloid Burden in Veterans With and Without Combat-Related Traumatic Brain Injury. The Journal of neuropsychiatry and clinical neurosciences 2015.
- Ponto LLB, Menda Y, Magnotta VA, Yamada TH, Denburg NL, Schultz SK: Frontal hypometabolism in elderly breast cancer survivors determined by [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study. International journal of geriatric psychiatry 2015, 30(6):587-594.
- Poulin É, Lebel R, Croteau É, Blanchette M, Tremblay L, Lecomte R, Lepage M: Optimization of the reference region method for dual pharmacokinetic modeling using Gd‐DTPA/MRI and 18F‐FDG/PET. Magnetic Resonance in Medicine 2015, 73(2):740-748.
- Prasannan A, Debele TA, Tsai H-C, Chao C-C, Lin C-P, Hsiue G-H: Synthesis and evaluation of the targeted binding of RGD-containing PEGylated-PEI/DNA polyplex micelles as radiotracers for a tumor-targeting imaging probe. RSC Advances 2015, 5(130):107455-107465.
- Prieto E, Martí-Climent JM, Morán V, Sancho L, Barbés B, Arbizu J, Richter JA: Brain PET imaging optimization with time of flight and point spread function modelling. Physica Medica 2015.
- Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N: Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease. Brain 2015:awv215.
- Rademacher L, Prinz S, Winz O, Henkel K, Dietrich CA, Schmaljohann J, Shali SM, Schabram I, Stoppe C, Cumming P: Effects of smoking cessation on presynaptic dopamine function of addicted male smokers. Biological Psychiatry 2015.
- Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA: A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET. Journal of The Royal Society Interface 2015, 12(103):20141174.
- Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A: Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European journal of nuclear medicine and molecular imaging 2015:1-14.
- Roelcke U, Wyss MT, Nowosielski M, Ruda R, Roth P, Hofer S, Galldiks N, Crippa F, Weller M, Soffietti R: Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro-oncology 2015.
- Rong Y, Vernaleken I, Winz OH, Goedicke A, Mottaghy FM, Kops ER: Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy. Z Med Phys 2015, 25(3):230-242.
- Rook JM, Tantawy MN, Ansari MS, Felts AS, Stauffer SR, Emmitte KA, Kessler RM, Niswender CM, Daniels JS, Jones CK et al: Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles. Neuropsychopharmacology 2015, 40(3):755-765.
- Rosenberger I, Strauss A, Dobiasch S, Weis C, Szanyi S, Gil-Iceta L, Alonso E, Esparza MG, Gómez-Vallejo V, Szczupak B: Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer. Journal of Controlled Release 2015, 214:76-84.
- Rosestedt M, Andersson KG, Mitran B, Tolmachev V, Löfblom J, Orlova A, Ståhl S: Affibody-mediated PET imaging of HER3 expression in malignant tumours. Scientific reports 2015, 5.
- Rothe JH, Rudolph I, Rohwer N, Kupitz D, Gregor-Mamoudou B, Derlin T, Furth C, Amthauer H, Brenner W, Buchert R et al: Time Course of Contrast Enhancement by Micro-CT with Dedicated Contrast Agents in Normal Mice and Mice with Hepatocellular Carcinoma: Comparison of One Iodinated and Two Nanoparticle-Based Agents. Academic Radiology 2015, 22(2):169-178.
- Rullmann M, Dukart J, Hoffmann K-T, Luthardt J, Tiepolt S, Patt M, Gertz H-J, Schroeter ML, Seibyl J, Schulz-Schaeffer WJ: Partial volume effect correction improves quantitative florbetaben beta-amyloid PET scan analysis. Journal of Nuclear Medicine 2015:jnumed. 115.161893.
- Sabri O, Becker G-A, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A: First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18 F] Flubatine. NeuroImage 2015, 118:199-208.
- Sah B-R, Burger IA, Schibli R, Friebe M, Dinkelborg L, Graham K, Borkowski S, Bacher-Stier C, Valencia R, Srinivasan A et al: Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer. Journal of Nuclear Medicine 2015, 56(3):372-378.
- Sahlholm K, Sijbesma JW, Maas B, Kwizera C, Marcellino D, Ramakrishnan NK, Dierckx RA, Elsinga PH, van Waarde A: Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses. Psychopharmacology 2015, 232(18):3443-3453.
- Šarić A, Sobočanec S, Šafranko ŽM, Hadžija MP, Bagarić R, Farkaš V, Švarc A, Marotti T, Balog T: Diminished Resistance to Hyperoxia in Brains of Reproductively Senescent Female CBA/H Mice. Medical science monitor basic research 2015, 21:191-199.
- Sasser TA, Chapman SE, Sanders I, Liepert L, Leevy M: Cross-Platform MRI/PET or MRI/SPECT Imaging, and Co-Registration. Bruker Application Note 2015.
- Saur L, Bagatini PB, Greggio S, Venturin GT, Vaz SP, dos Reis Ferreira K, Junqueira JS, Lara DR, DaCosta JC, Jeckel CMM: Antidepressant Effects of Ketamine Are Not Related to 18F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats. Neurochemical research 2015:1-12.
- Savonenko AV, Melnikova T, Wang Y, Ravert H, Gao Y, Koppel J, Lee D, Pletnikova O, Cho E, Sayyida N: Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation. PloS one 2015, 10(6):e0129618.
- Sawatzke AB, Norris AW, Spyropoulos F, Walsh SA, Acevedo MR, Hu S, Yao J, Wang C, Sunderland JJ, Boles Ponto LL: PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissues. Placenta 2015, 36(2):115-120.
- Sayman HB, Kanmaz B, Uslu I, Adil A-N, Cuocolo A, Carril JM, Cinaral F, Sherif E-R, Senocak M: Utility of left lateral supine position for myocardial perfusion single-photon emission computed tomography compared with other methods of correcting inferior wall attenuation. Nuclear medicine communications 2015, 36(3):268-278.
- Schieferstein H, Piel M, Beyerlein F, Lüddens H, Bausbacher N, Buchholz H-G, Ross TL, Rösch F: Selective binding to monoamine oxidase A: In vitro and in vivo evaluation of 18 F-labeled β-carboline derivatives. Bioorganic & medicinal chemistry 2015, 23(3):612-623.
- Schou M, Varnäs K, Jureus A, Ahlgren C, Malmquist J, Häggkvist J, Tari L, Wesolowski SS, Throner SR, Brown DG: Discovery and Preclinical Validation of [11C] AZ13153556, a Novel Probe for the Histamine Type 3 Receptor. ACS chemical neuroscience 2015.
- Sciagrà R, Passeri A, Cipollini F, Castagnoli H, Olivotto I, Burger C, Cecchi F, Pupi A: Validation of pixel-wise parametric mapping of myocardial blood flow with 13NH3 PET in patients with hypertrophic cardiomyopathy. European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(10):1581-1588.
- Sekine T, Buck A, Delso G, ter Voert E, Huellner M, Veit-Haibach P, Warnock G: Evaluation of atlas-based MR-attenuation correction for integrated PET-MR in human brain by using PET-CT and PET-MR patient data. Journal of Nuclear Medicine 2015, 56(supplement 3):1618-1618.
- Selivanova SV, Toscano A, Abate C, Berardi F, Müller A, Krämer SD, Schibli R, Ametamey SM: Synthesis and pharmacological evaluation of 11 C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging. Nuclear medicine and biology 2015, 42(4):399-405.
- Selvaraju RK, Bulenga TN, Espes D, Lubberink M, Sörensen J, Eriksson B, Estrada S, Velikyan I, Eriksson O: Dosimetry of [68Ga] Ga-DO3A-VS-Cys40-Exendin-4 in rodents, pigs, non-human primates and human-repeated scanning in human is possible. American journal of nuclear medicine and molecular imaging 2015, 5(3):259-269.
- Sérrière S, Doméné A, Vercouillie J, Mothes C, Bodard S, Rodrigues N, Guilloteau D, Routier S, Page G, Chalon S: Assessment of the protection of dopaminergic neurons by an α7 nicotinic receptor agonist, PHA 543613 using [18F] LBT-999 in a Parkinson’s disease rat model. Frontiers in medicine 2015, 2.
- Sérrière S, Tauber C, Vercouillie J, Mothes C, Pruckner C, Guilloteau D, Kassiou M, Doméné A, Garreau L, Page G et al: Amyloid load and translocator protein 18 kDa in APPswePS1-dE9 mice: a longitudinal study. Neurobiology of Aging 2015, 36(4):1639-1652.
- Servagi-Vernat S, Differding S, Sterpin E, Hanin F-X, Labar D, Bol A, Lee JA, Grégoire V: Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: A planning study. Acta Oncologica 2015(0):1-9.
- Shah D, Deleye S, Verhoye M, Staelens S, Van der Linden A: Resting-state functional MRI and [18F]-FDG PET demonstrate differences in neuronal activity between commonly used mouse strains. Neuroimage 2015.
- Shaikh F, Savells D, Awan O, Inayat F, Chaudhry A, Jerath N, Graham MM: Quantitative Imaging Analysis of FDG PET/CT Imaging for Detection of Central Neurolymphomatosis in a Case of Recurrent Diffuse B-Cell Lymphoma. Cureus 2015, 7(11).
- Shidahara M, Watabe H, Tashiro M, Okamura N, Furumoto S, Watanuki S, Furukawa K, Arakawa Y, Funaki Y, Iwata R: Quantitative kinetic analysis of PET amyloid imaging agents [11 C] BF227 and [18 F] FACT in human brain. Nuclear Medicine and Biology 2015.
- Shiha AA, de Cristóbal J, Delgado M, Fernández de la Rosa R, Bascuñana P, Pozo MA, García-García L: Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats. Brain Research Bulletin 2015, 111(0):36-47.
- Shingaki T, Hume WE, Takashima T, Katayama Y, Okauchi T, Hayashinaka E, Wada Y, Cui Y, Kusuhara H, Sugiyama Y et al: Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [11C]Metformin in Mouse. Pharmaceutical Research 2015:1-10.
- Shukuri M, Mawatari A, Ohno M, Suzuki M, Doi H, Watanabe Y, Onoe H: Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer’s disease model mice. Journal of Nuclear Medicine 2015:jnumed. 115.166116.
- Sigurdardottir HL, Kranz GS, Rami‐Mark C, James GM, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub‐Weidinger T, Mitterhauser M: Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET. Human brain mapping 2015.
- Simoncic U, Zanotti-Fregonara P: Image-derived input function with factor analysis and a-priori information. Nuclear medicine communications 2015, 36(2):187-193.
- Slavik R, Grether U, Müller Herder A, Gobbi L, Fingerle J, Ullmer C, Krämer SD, Schibli R, Mu L, Ametamey SM: Discovery of a High Affinity and Selective Pyridine Analog as a Potential PET Imaging Agent for Cannabinoid Type 2 Receptor. Journal of medicinal chemistry 2015.
- Slavik R, Herde AM, Bieri D, Weber M, Schibli R, Krämer SD, Ametamey SM, Mu L: Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. European Journal of Medicinal Chemistry 2015, 92(0):554-564.
- Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C: 18F‐FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). The Cochrane Library 2015.
- Spehl TS, Frings L, Hellwig S, Weiller C, Hüll M, Meyer PT, Amtage F: Role of Semiquantitative Assessment of Regional Binding Potential in 123I-FP-CIT SPECT for the Differentiation of Frontotemporal Dementia, Dementia With Lewy Bodies, and Alzheimer’s Dementia. Clinical nuclear medicine 2015, 40(1):e27-e33.
- Spiegelberg D, Mortensen AC, Selvaraju RK, Eriksson O, Stenerlöw B, Nestor M: Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model. European journal of nuclear medicine and molecular imaging 2015:1-9.
- Stegmayr C, Schöneck M, Oliveira D, Willuweit A, Filss C, Galldiks N, Shah NJ, Coenen HH, Langen K-J: Reproducibility of O-(2-18F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas. European journal of nuclear medicine and molecular imaging 2015:1-9.
- Suda M, Onoguchi M, Tomiyama T, Ishihara K, Takahashi N, Sakurai M, Matsumoto K, Kumita S-i: The reproducibility of time-of-flight PET and conventional PET for the quantification of myocardial blood flow and coronary flow reserve with 13N-ammonia. J Nucl Cardiol 2015:1-16.
- Suridjan I, Pollock B, Verhoeff N, Voineskos A, Chow T, Rusjan P, Lobaugh N, Houle S, Mulsant B, Mizrahi R: In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [ 18F]-FEPPA. Molecular psychiatry 2015.
- Szczupak B, Martín A: Positron Emission Tomography Imaging of Dopaminergic Receptors in Rats. In: Dopamine Receptor Technologies. Volume 96, edn. Edited by Tiberi M: Springer New York; 2015: 197-208.
- T O’Brien J, Herholz K: Amyloid imaging for dementia in clinical practice. BMC medicine 2015, 13(1):163.
- Tahmasian M, Pasquini L, Scherr M, Meng C, Förster S, Bratec SM, Shi K, Yakushev I, Schwaiger M, Grimmer T: The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease. Neurology 2015, 84(19):1956-1963.
- Takahashi K, Mizuno K, Sasaki AT, Wada Y, Tanaka M, Ishii A, Tajima K, Tsuyuguchi N, Watanabe K, Zeki S: Imaging the passionate stage of romantic love by dopamine dynamics. Frontiers in human neuroscience 2015, 9.
- Takuwa H, Maeda J, Ikoma Y, Tokunaga M, Wakizaka H, Uchida S, Kanno I, Taniguchi J, Ito H, Higuchi M: [11C] Raclopride binding in the striatum of minimally restrained and free‐walking awake mice in a positron emission tomography study. Synapse 2015.
- Temma T, Nishigori K, Onoe S, Sampei S, Kimura I, Ono M, Saji H: Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer. Nuclear medicine and biology 2015, 42(2):184-191.
- Terada T, Kakimoto A, Yoshikawa E, Kono S, Bunai T, Hosoi Y, Sakao-Suzuki M, Konishi T, Miyajima H, Ouchi Y: The Possible Link between GABAergic Dysfunction and Cognitive Decline in a Patient with Idiopathic Hypoparathyroidism. Internal Medicine 2015, 54(17):2245-2250.
- Terbeck S, Akkus F, Chesterman LP, Hasler G: The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies. Frontiers in neuroscience 2015, 9.
- Thackeray J, Bankstahl J, Wang Y, Wollert K, Bengel F: Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice. European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(5):771-780.
- Thackeray JT, Bankstahl JP, Bengel FM: Impact of image-derived input function and fit time intervals on Patlak quantification of myocardial glucose u